0001571049-17-007311.txt : 20170809 0001571049-17-007311.hdr.sgml : 20170809 20170809111404 ACCESSION NUMBER: 0001571049-17-007311 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 110 CONFORMED PERIOD OF REPORT: 20170630 FILED AS OF DATE: 20170809 DATE AS OF CHANGE: 20170809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 171016867 BUSINESS ADDRESS: STREET 1: 200 INTERNATIONAL CIRCLE STREET 2: SUITE 3500 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 200 INTERNATIONAL CIRCLE STREET 2: SUITE 3500 CITY: HUNT VALLEY STATE: MD ZIP: 21030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OHI Healthcare Properties Limited Partnership CENTRAL INDEX KEY: 0001639315 IRS NUMBER: 364796206 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-203447-11 FILM NUMBER: 171016868 BUSINESS ADDRESS: STREET 1: C/O OMEGA HEALTHCARE INVESTORS, INC. STREET 2: 200 INTERNATIONAL CIRCLE, STE. 3500 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: C/O OMEGA HEALTHCARE INVESTORS, INC. STREET 2: 200 INTERNATIONAL CIRCLE, STE. 3500 CITY: HUNT VALLEY STATE: MD ZIP: 21030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OHI Healthcare Properties Holdco, Inc. CENTRAL INDEX KEY: 0001639311 IRS NUMBER: 472148273 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-203447-12 FILM NUMBER: 171016869 BUSINESS ADDRESS: STREET 1: C/O OMEGA HEALTHCARE INVESTORS, INC. STREET 2: 200 INTERNATIONAL CIRCLE, STE. 3500 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: C/O OMEGA HEALTHCARE INVESTORS, INC. STREET 2: 200 INTERNATIONAL CIRCLE, STE. 3500 CITY: HUNT VALLEY STATE: MD ZIP: 21030 10-Q 1 t1700448_10q.htm FORM 10-Q

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 10-Q

(Mark One)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)  
  OF THE SECURITIES EXCHANGE ACT OF 1934  

 

For the quarterly period ended June 30, 2017

or

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE  
  SECURITIES EXCHANGE ACT OF 1934  

 

For the transition period from _______________ to _______________

 

OMEGA HEALTHCARE INVESTORS, INC.

OHI HEALTHCARE PROPERTIES HOLDCO, INC.

OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

(Exact name of Registrant as specified in its charter)

 

Maryland 1-11316 38-3041398
(Omega Healthcare Investors, Inc.) (Omega Healthcare Investors, Inc.) (Omega Healthcare Investors, Inc.)
Delaware 333-203447-12 47-2148273
     
(OHI Healthcare Properties Holdco, Inc.) (OHI Healthcare Properties Holdco, Inc.) (OHI Healthcare Properties Holdco, Inc.)
Delaware 333-203447-11 36-4796206
     
(OHI Healthcare Properties Limited Partnership) (OHI Healthcare Properties Limited Partnership) (OHI Healthcare Properties Limited Partnership)
(State of incorporation or organization) (Commission file number)

(IRS Employer

Identification No.)

 

303 International Circle, Suite 200, Hunt Valley, MD 21030

(Address of principal executive offices)

 

(410) 427-1700

(Telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

 

Omega Healthcare Investors, Inc. Yes x   No o     OHI Healthcare Properties Holdco, Inc. Yes o  No   x

 

OHI Healthcare Properties Limited Partnership Yes  o   No   x

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

 

Omega Healthcare Investors, Inc. Yes   x    No   o       OHI Healthcare Properties Holdco, Inc. Yes    x    No   o

 

OHI Healthcare Properties Limited Partnership Yes    x     No    o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one:)

 

Omega Healthcare Investors, Inc.      
  Large accelerated filer x Accelerated filer o Non-accelerated filer o
  Smaller reporting company o Emerging growth company o    
             
             
OHI Healthcare Properties Holdco, Inc.      
  Large accelerated filer o Accelerated filer o Non-accelerated filer x
  Smaller reporting company o Emerging growth company o    
             
OHI Healthcare Properties Limited Partnership      
  Large accelerated filer o Accelerated filer o Non-accelerated filer x
  Smaller reporting company o Emerging growth company o    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.

 

Omega Healthcare Investors, Inc. o   OHI Healthcare Properties Holdco, Inc. o  

 

OHI Healthcare Properties Limited Partnership o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Omega Healthcare Investors, Inc. Yes   o   No   x      OHI Healthcare Properties Holdco, Inc. Yes     o   No   x

 

OHI Healthcare Properties Limited Partnership Yes    o    No   x

 

Indicate the number of shares outstanding of each of the issuers’ classes of common stock as of August 2, 2017

 

Omega Healthcare Investors, Inc.
Common Stock, $.10 par value   197,241,081
     
OHI Healthcare Properties Holdco, Inc.
Common Stock, $.01 par value   1,000
     
OHI Healthcare Properties Limited Partnership
N/A   No common stock outstanding
(Class)   (Number of shares)

 

 

 

 

 

  

EXPLANATORY NOTE

 

This report combines the quarterly reports on Form 10-Q for the period ended June 30, 2017 of Omega Healthcare Investors, Inc., OHI Healthcare Properties Holdco, Inc. (“OHI Holdco”) and OHI Healthcare Properties Limited Partnership (“Omega OP”). Unless stated otherwise or the context otherwise requires, (i) references to “Omega” or the “Company” means Omega Healthcare Investors, Inc. and its consolidated subsidiaries, (ii) references to “Parent” refer to Omega Healthcare Investors, Inc. without regard to its consolidated subsidiaries, (iii) references to “OHI Holdco” means OHI Healthcare Properties Holdco, Inc. and its consolidated subsidiaries and (iv) references to “Omega OP” means OHI Healthcare Properties Limited Partnership and its consolidated subsidiaries.

 

Omega is a self-administered real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”). Omega is structured as an umbrella partnership REIT (“UPREIT”) under which, all of Omega's assets are owned directly or indirectly, and all of Omega's operations are conducted directly or indirectly, by its subsidiaries, OHI Holdco and Omega OP.

 

Parent owned either directly or indirectly approximately 96% of the issued and outstanding partnership units in Omega OP (the “Omega OP Units”) at June 30, 2017. Parent owned approximately 74% of Omega OP Units directly and an additional approximately 22% through its 100% ownership in OHI Holdco. Omega OP Units, other than those owned by Parent and OHI Holdco, are exchangeable on a one-for-one basis for Parent’s common shares. The management of Parent consists of the same members as the management of OHI Holdco and Omega OP.

 

The financial results of OHI Holdco and Omega OP are consolidated into the financial statements of Omega. Omega has no significant assets other than its investments in OHI Holdco and Omega OP. Omega, OHI Holdco and Omega OP are managed and operated as one entity. OHI Holdco has no assets other than its interests in Omega OP. Omega OP has no significant assets other than its interests in non-guarantor subsidiaries.

 

We believe it is important for investors to understand the few differences between Omega, OHI Holdco and Omega OP in the context of how we operate as a consolidated company. Omega and OHI Holdco act as the general partners of Omega OP. Net proceeds from equity issuances by Parent are contributed to Omega OP in exchange for additional partnership units. Parent and Omega OP incur indebtedness. The outstanding senior notes and certain other debt of Parent is guaranteed by OHI Holdco and Omega OP.

 

We believe combining the quarterly reports on Form 10-Q of Omega, OHI Holdco and Omega OP into this single report results in the following benefits:

 

·combined reports better reflect how management and the analyst community view the business as a single operating unit;
·combined reports enhance investors’ understanding of Omega, OHI Holdco and Omega OP by enabling them to view the business as a whole and in the same manner as management;
·combined reports are more efficient for Omega, OHI Holdco and Omega OP and result in savings in time, effort and expense; and
·combined reports are more efficient for investors by reducing duplicative disclosure and providing a single document for their review.

 

In order to highlight the differences between Omega, OHI Holdco and Omega OP, the separate sections in this report for Omega, OHI Holdco and the Omega OP specifically refer to Omega, OHI Holdco and the Omega OP. In the sections that combine disclosure of Omega, OHI Holdco and the Omega OP, this report refers to “we” and “us” actions or holdings as being “our” actions or holdings. Although Omega OP and its subsidiaries hold all of our assets, we believe that reference to “we,” “us” or “our” in this context is appropriate because the business is one enterprise and we operate substantially all of our business through OHI Holdco and Omega OP.

 

 

 

  

OMEGA HEALTHCARE INVESTORS, INC.

OHI HEALTHCARE PROPERTIES HOLDCO, INC.

OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

FORM 10-Q

June 30, 2017

 

TABLE OF CONTENTS

 

    Page
No.
PART I Financial Information  
     
Item 1. Financial Statements of Omega Healthcare Investors, Inc.:  
  Consolidated Balance Sheets June 30, 2017 (unaudited) and December 31, 2016 2
  Consolidated Statements of Income (unaudited) Three and Six months ended June 30, 2017 and 2016 3
  Consolidated Statements of Comprehensive Income (unaudited) Three and Six months ended June 30, 2017 and 2016 4
  Consolidated Statement of Changes in Equity (unaudited) Six months ended June 30, 2017 5
  Consolidated Statements of Cash Flows (unaudited) Six months ended June 30, 2017 and 2016 6
     
  Financial Statements of OHI Healthcare Properties Holdco, Inc.:  
  Consolidated Balance Sheets June 30, 2017 (unaudited) and December 31, 2016 8
  Consolidated Statements of Income (unaudited) Three and Six months ended June 30, 2017 and 2016 9
  Consolidated Statements of Comprehensive Income (unaudited) Three and Six months ended June 30, 2017 and 2016 10
  Consolidated Statement of Changes in Equity (unaudited) Six months ended June 30, 2017 11
  Consolidated Statements of Cash Flows (unaudited) Six months ended June 30, 2017 and 2016 12
     
  Financial Statements of OHI Healthcare Properties Limited Partnership:  
  Consolidated Balance Sheets June 30, 2017 (unaudited) and December 31, 2016 14
  Consolidated Statements of Income (unaudited) Three and Six months ended June 30, 2017 and 2016 15
  Consolidated Statements of Comprehensive Income (unaudited) Three and Six months ended June 30, 2017 and 2016 16
  Consolidated Statement of Changes in Owners’ Equity (unaudited) Six months ended June 30, 2017 17
  Consolidated Statements of Cash Flows (unaudited) Six months ended June 30, 2017 and 2016 18
     
  Notes to Consolidated Financial Statements June 30, 2017 (unaudited) 20
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 43
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 60
     
Item 4. Controls and Procedures 60
     
PART II Other Information  
     
Item 1. Legal Proceedings 62
     
Item 1A. Risk Factors 62
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 62
     
Item 6. Exhibits 63

 

 

 

  

PART I – FINANCIAL INFORMATION

 

Item 1 - Financial Statements

 

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands, except per share amounts)

 

   June 30,   December 31, 
   2017   2016 
   (Unaudited)     
ASSETS          
Real estate properties          
Real estate investments (see Note 2)  $7,730,199   $7,566,358 
Less accumulated depreciation   (1,366,376)   (1,240,336)
Real estate investments – net   6,363,823    6,326,022 
Investments in direct financing leases – net   582,307    601,938 
Mortgage notes receivable – net   662,709    639,343 
    7,608,839    7,567,303 
Other investments – net   278,985    256,846 
Investment in unconsolidated joint venture   38,968    48,776 
Assets held for sale – net   18,889    52,868 
Total investments   7,945,681    7,925,793 
           
Cash and cash equivalents   21,031    93,687 
Restricted cash   12,203    13,589 
Accounts receivable – net   288,686    240,035 
Goodwill   644,184    643,474 
Other assets   34,869    32,682 
Total assets  $8,946,654   $8,949,260 
           
LIABILITIES AND EQUITY          
Revolving line of credit  $155,000   $190,000 
Term loans – net   899,292    1,094,343 
Secured borrowings – net   53,737    54,365 
Unsecured borrowings – net   3,321,858    3,028,146 
Accrued expenses and other liabilities   323,543    360,514 
Deferred income taxes   17,714    9,906 
Total liabilities   4,771,144    4,737,274 
           
Equity:          
Common stock $.10 par value authorized – 350,000 shares, issued and outstanding – 197,224 shares as of June 30, 2017 and 196,142 as of December 31, 2016   19,722    19,614 
Common stock – additional paid-in capital   4,896,076    4,861,408 
Cumulative net earnings   1,908,634    1,738,937 
Cumulative dividends paid   (2,954,230)   (2,707,387)
Accumulated other comprehensive loss   (41,903)   (53,827)
Total stockholders’ equity   3,828,299    3,858,745 
Noncontrolling interest   347,211    353,241 
Total equity   4,175,510    4,211,986 
Total liabilities and equity  $8,946,654   $8,949,260 

 

See notes to consolidated financial statements.

 

 2 

 

  

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATED STATEMENTS OF INCOME

Unaudited

(in thousands, except per share amounts)

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2017   2016   2017   2016 
Revenue                    
Rental income  $193,997   $186,454   $386,534   $363,157 
Income from direct financing leases   15,462    15,521    31,108    30,963 
Mortgage interest income   16,297    21,371    32,253    37,977 
Other investment income – net   7,278    4,982    14,192    8,413 
Miscellaneous income   2,763    496    3,454    1,193 
Total operating revenues   235,797    228,824    467,541    441,703 
                     
Expenses                    
Depreciation and amortization   70,350    65,505    140,343    127,938 
General and administrative   11,541    11,832    24,065    22,287 
Acquisition costs   19    3,504    (22)   7,275 
Impairment loss on real estate properties   10,135    6,893    17,773    41,451 
Provision for uncollectible accounts   2,673    (1,154)   5,077    3,970 
Total operating expenses   94,718    86,580    187,236    202,921 
                     
Income before other income and expense   141,079    142,244    280,305    238,782 
Other income (expense)                    
Interest income   254    4    258    12 
Interest expense   (48,085)   (39,651)   (93,126)   (76,873)
Interest – amortization of deferred financing costs   (2,543)   (2,210)   (5,045)   (4,342)
Interest – refinancing costs   (21,965)   -    (21,965)   (298)
Contractual settlement   -    -    10,412    - 
Realized gain (loss) on foreign exchange   79    -    140    (22)
Total other expense   (72,260)   (41,857)   (109,326)   (81,523)
                     
Income before (loss) gain on assets sold   68,819    100,387    170,979    157,259 
(Loss) gain on assets sold – net   (622)   13,221    6,798    14,792 
Income from continuing operations   68,197    113,608    177,777    172,051 
Income taxes   (591)   (454)   (1,691)   (701)
Income from unconsolidated joint venture   551    -    1,183    - 
Net income   68,157    113,154    177,269    171,350 
Net income attributable to noncontrolling interest   (2,900)   (5,102)   (7,572)   (7,743)
Net income available to common stockholders  $65,257   $108,052   $169,697   $163,607 
                     
Earnings per common share available to common stockholders:                    
Basic:                    
Net income available to common stockholders  $0.33   $0.57   $0.86   $0.87 
Diluted:                    
Net income  $0.33   $0.57   $0.86   $0.86 
                     
Dividends declared per common share  $0.63   $0.58   $1.25   $1.15 
                     
Weighted-average shares outstanding, basic   197,433    188,981    197,223    188,604 
Weighted-average shares outstanding, diluted   206,672    199,157    206,423    198,754 

 

See notes to consolidated financial statements.

 

 3 

 

  

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Unaudited

(in thousands)

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2017   2016   2017   2016 
                 
Net income  $68,157   $113,154   $177,269   $171,350 
Other comprehensive income (loss)                    
Foreign currency translation   10,274    (21,836)   14,608    (26,566)
Derivative instruments   (3,407)   (4,198)   (2,153)   (13,074)
Total other comprehensive income (loss)   6,867    (26,034)   12,455    (39,640)
Comprehensive income   75,024    87,120    189,724    131,710 
Comprehensive income attributable to noncontrolling interest   (3,192)   (3,928)   (8,103)   (5,953)
Comprehensive income attributable to common stockholders  $71,832   $83,192   $181,621   $125,757 

 

See notes to consolidated financial statements.

 

 4 

 

  

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Unaudited

(in thousands, except per share amounts)

 

   Common
Stock Par
Value
   Additional
Paid-in
Capital
   Cumulative
Net
Earnings
   Cumulative
Dividends
   Accumulated
Other
Comprehensive
Loss
   Total
Stockholders’
Equity
   Noncontrolling
Interest
   Total
Equity
 
                                         
Balance at December 31, 2016 (196,142 common shares & 8,862 Omega OP Units)  $19,614   $4,861,408   $1,738,937   $(2,707,387)  $(53,827)  $3,858,745   $353,241   $4,211,986 
Grant of restricted stock to company directors (32 shares at $31.23 per share)   3    (3)                        
Stock-based compensation expense       7,478                7,478        7,478 
Vesting/exercising of equity compensation plan, net of tax withholdings (114 shares)   11    (2,131)               (2,120)       (2,120)
Dividend reinvestment and stock purchase plan (614 shares at an average of $32.11 per share)   61    19,660                19,721        19,721 
Grant of stock as payment of directors fees (5 shares at an average of $32.18 per share)   1    149                150        150 
Deferred compensation directors       (29)               (29)       (29)
Equity Shelf Program (228 shares at $29.17 per share, net of issuance costs)   23    6,611                6,634        6,634 
Common dividends declared ($1.25 per share)               (246,843)       (246,843)       (246,843)
Conversion of Omega OP Units to common stock (89 shares at $32.91 per share)   9    2,933                2,942        2,942 
Redemption of Omega OP Units (90 units)                           (2,990)   (2,990)
Omega OP Units distributions                           (11,143)   (11,143)
Foreign currency translation                   13,986    13,986    622    14,608 
Derivative instruments                   (2,062)   (2,062)   (91)   (2,153)
Net income           169,697            169,697    7,572    177,269 
Balance at June 30, 2017 (197,224 shares & 8,772 Omega OP Units)  $19,722   $4,896,076   $1,908,634   $(2,954,230)  $(41,903)  $3,828,299   $347,211   $4,175,510 

 

See notes to consolidated financial statements.

 

 5 

 

 

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

Unaudited (in thousands)

 

  

Six Months Ended

June 30,

 
   2017   2016 
Cash flows from operating activities          
Net income  $177,269   $171,350 
Adjustment to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization   140,343    127,938 
Impairment loss on real estate properties   17,773    41,451 
Provision for uncollectible accounts   5,077    3,970 
Refinancing costs and amortization of deferred financing costs   15,240    4,640 
Accretion of direct financing leases   (6,164)   (5,915)
Stock-based compensation expense   7,478    6,443 
Gain on assets sold – net   (6,798)   (14,792)
Amortization of acquired in-place leases - net   (6,202)   (7,910)
Effective yield receivable on mortgage notes   (1,191)   (619)
Change in operating assets and liabilities – net:          
Contractual receivables   (33,293)   856 
Straight-line rent receivables   (23,174)   (17,756)
Lease inducements   895    1,294 
Other operating assets and liabilities   (21,667)   (24,055)
Net cash provided by operating activities   265,586    286,895 
Cash flows from investing activities          
Acquisition of real estate   (130,977)   (622,848)
Cash acquired   2,341     
Investments in construction in progress   (46,108)   (26,960)
Investments in direct financing leases   (4,767)   (30)
Proceeds from direct financing leases   27,253     
Placement of mortgage loans   (24,978)   (12,528)
Distributions from unconsolidated joint venture   9,741     
Proceeds from sale of real estate investments   64,061    43,772 
Capital improvements to real estate investments   (16,861)   (21,812)
Proceeds from other investments   35,997    25,923 
Investments in other investments   (52,228)   (136,536)
Collection of mortgage principal   673    42,051 
Net cash used in investing activities   (135,853)   (708,968)
Cash flows from financing activities          
Proceeds from credit facility borrowings   817,000    879,000 
Payments on credit facility borrowings   (852,000)   (639,000)
Receipts of other long-term borrowings   1,346,749    350,000 
Payments of other long-term borrowings   (1,252,139)   (620)
Payments of financing related costs   (28,483)   (3,581)
Receipts from dividend reinvestment plan   19,721    93,333 
Payments for exercised options and restricted stock   (2,120)   (2,380)
Net proceeds from issuance of common stock   6,634    487 
Dividends paid   (246,722)   (217,068)
Redemption of Omega OP Units   (48)   (10)
Distributions to Omega OP Unit Holders   (11,143)   (10,351)
Net cash (used in) provided by financing activities   (202,551)   449,810 
           
Effect of foreign currency translation on cash and cash equivalents   162    (202)
(Decrease) increase in cash and cash equivalents   (72,656)   27,535 
Cash and cash equivalents at beginning of period   93,687    5,424 
Cash and cash equivalents at end of period  $21,031   $32,959 

 

 6 

 

  

Supplemental disclosures of cash flow information:

 

  

Six Months Ended

June 30,

 
   2017   2016 
Interest paid during the period, net of amounts capitalized  $97,610   $74,010 
Taxes paid during the period  $2,032   $748 
           
Non cash investing activities          
Non cash acquisition of real estate (See Note 2)  $(9,430)  $ 
Non cash acquisition of business       (25,000)
Non cash surrender of mortgage       25,000 
Non cash investment in other investments   (6,353)    
Total  $(15,783)  $ 
           
Non cash financing activities          
Change in fair value of cash flow hedges  $(108)  $13,074 
Remeasurement of debt denominated in a foreign currency   2,190     
Total  $2,082   $13,074 

 

See notes to consolidated financial statements.

 

 7 

 

  

OHI HEALTHCARE PROPERTIES HOLDCO, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands, except per share amounts)

 

   June 30,   December 31, 
   2017   2016 
   (Unaudited)     
ASSETS          
Real estate properties          
Real estate investments (see Note 2)  $7,730,199   $7,566,358 
Less accumulated depreciation   (1,366,376)   (1,240,336)
Real estate investments – net   6,363,823    6,326,022 
Investments in direct financing leases – net   582,307    601,938 
Mortgage notes receivable – net   662,709    639,343 
    7,608,839    7,567,303 
Other investments – net   278,985    256,846 
Investment in unconsolidated joint venture   38,968    48,776 
Assets held for sale – net   18,889    52,868 
Total investments   7,945,681    7,925,793 
           
Cash and cash equivalents   21,031    93,687 
Restricted cash   12,203    13,589 
Accounts receivable – net   288,686    240,035 
Goodwill   644,184    643,474 
Other assets   34,869    32,682 
Total assets  $8,946,654   $8,949,260 
           
LIABILITIES AND EQUITY          
Term loans – net  $99,372   $100,000 
Secured borrowings – net   53,737    54,365 
Accrued expenses and other liabilities   267,346    302,959 
Deferred income taxes   17,714    9,906 
Intercompany loans payable   4,332,975    4,270,044 
Total liabilities   4,771,144    4,737,274 
           
Equity:          
Common stock – additional paid-in capital   923,218    923,218 
Cumulative net earnings   163,808    126,187 
Cumulative dividends paid   (229,930)   (175,289)
Accumulated other comprehensive loss   (9,797)   (12,439)
Total stockholders’ equity   847,299    861,677 
Noncontrolling interest   3,328,211    3,350,309 
Total equity   4,175,510    4,211,986 
Total liabilities and equity  $8,946,654   $8,949,260 

 

See notes to consolidated financial statements.

 

 8 

 

 

OHI HEALTHCARE PROPERTIES HOLDCO, INC.

CONSOLIDATED STATEMENTS OF INCOME

Unaudited

(in thousands)

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2017   2016   2017   2016 
Revenue                    
Rental income  $193,997   $186,454   $386,534   $363,157 
Income from direct financing leases   15,462    15,521    31,108    30,963 
Mortgage interest income   16,297    21,371    32,253    37,977 
Other investment income – net   7,278    4,982    14,192    8,413 
Miscellaneous income   2,763    496    3,454    1,193 
Total operating revenues   235,797    228,824    467,541    441,703 
                     
Expenses                    
Depreciation and amortization   70,350    65,505    140,343    127,938 
General and administrative   11,541    11,832    24,065    22,287 
Acquisition costs   19    3,504    (22)   7,275 
Impairment loss on real estate properties   10,135    6,893    17,773    41,451 
Provision for uncollectible accounts   2,673    (1,154)   5,077    3,970 
Total operating expenses   94,718    86,580    187,236    202,921 
                     
Income before other income and expense   141,079    142,244    280,305    238,782 
Other income (expense)                    
Interest income   254    4    258    12 
Interest expense   (48,085)   (39,651)   (93,126)   (76,873)
Interest – amortization of deferred financing costs   (2,543)   (2,210)   (5,045)   (4,342)
Interest – refinancing costs   (21,965)   -    (21,965)   (298)
Contractual settlement   -    -    10,412    - 
Realized gain (loss) on foreign exchange   79    -    140    (22)
Total other expense   (72,260)   (41,857)   (109,326)   (81,523)
                     
Income before (loss) gain on assets sold   68,819    100,387    170,979    157,259 
(Loss) gain on assets sold – net   (622)   13,221    6,798    14,792 
Income from continuing operations   68,197    113,608    177,777    172,051 
Income taxes   (591)   (454)   (1,691)   (701)
Income from unconsolidated joint venture   551    -    1,183    - 
Net income   68,157    113,154    177,269    171,350 
Net income attributable to noncontrolling interest   (53,709)   (88,160)   (139,648)   (133,455)
Net income available to common stockholders  $14,448   $24,994   $37,621   $37,895 

 

See notes to consolidated financial statements.

 

 9 

 

  

OHI HEALTHCARE PROPERTIES HOLDCO, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Unaudited

(in thousands)

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2017   2016   2017   2016 
                 
Net income  $68,157   $113,154   $177,269   $171,350 
Other comprehensive income (loss)                    
Foreign currency translation   10,274    (21,836)   14,608    (26,566)
Derivative instruments   (3,407)   (4,198)   (2,153)   (13,074)
Total other comprehensive income (loss)   6,867    (26,034)   12,455    (39,640)
Comprehensive income   75,024    87,120    189,724    131,710 
Comprehensive income attributable to noncontrolling interest   (59,120)   (67,877)   (149,460)   (102,581)
Comprehensive income attributable to common stockholders  $15,904   $19,243   $40,264   $29,129 

 

See notes to consolidated financial statements.

 

 10 

 

  

OHI HEALTHCARE PROPERTIES HOLDCO, INC.

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Unaudited

(in thousands)

 

   Common
stock –
additional
paid-in
capital
   Cumulative
Net
Earnings
   Cumulative
Dividends
   Accumulated
Other
Comprehensive
Loss
   Total
Stockholders’
Equity
   Noncontrolling
Interest
   Total Equity 
                             
Balance at December 31, 2016(1 shares)  $923,218   $126,187   $(175,289)  $(12,439)  $861,677   $3,350,309   $4,211,986 
Contributions                       34,776    34,776 
Distributions           (54,641)       (54,641)   (206,335)   (260,976)
Foreign currency translation               3,098    3,098    11,510    14,608 
Derivative instruments               (456)   (456)   (1,697)   (2,153)
Net income       37,621            37,621    139,648    177,269 
Balance at June 30, 2017 (1 shares)  $923,218   $163,808   $(229,930)  $(9,797)  $847,299   $3,328,211   $4,175,510 

 

See notes to consolidated financial statements.

 

 11 

 

 

OHI HEALTHCARE PROPERTIES HOLDCO, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

Unaudited (in thousands)

 

  

Six Months Ended

June 30,

 
   2017   2016 
Cash flows from operating activities          
Net income  $177,269   $171,350 
Adjustment to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization   140,343    127,938 
Impairment loss on real estate properties   17,773    41,451 
Provision for uncollectible accounts   5,077    3,970 
Refinancing costs and amortization of deferred financing costs   15,240    4,640 
Accretion of direct financing leases   (6,164)   (5,915)
Stock-based compensation expense   7,478    6,443 
Gain on assets sold – net   (6,798)   (14,792)
Amortization of acquired in-place leases - net   (6,202)   (7,910)
Effective yield receivable on mortgage notes   (1,191)   (619)
Change in operating assets and liabilities – net:          
Contractual receivables   (33,293)   856 
Straight-line rent receivables   (23,174)   (17,756)
Lease inducements   895    1,294 
Other operating assets and liabilities   (21,667)   (24,055)
Net cash provided by operating activities   265,586    286,895 
Cash flows from investing activities          
Acquisition of real estate   (130,977)   (622,848)
Cash acquired   2,341     
Investments in construction in progress   (46,108)   (26,960)
Investments in direct financing leases   (4,767)   (30)
Proceeds from direct financing leases   27,253     
Placement of mortgage loans   (24,978)   (12,528)
Distributions from unconsolidated joint venture   9,741     
Proceeds from sale of real estate investments   64,061    43,772 
Capital improvements to real estate investments   (16,861)   (21,812)
Proceeds from other investments   35,997    25,923 
Investments in other investments   (52,228)   (136,536)
Collection of mortgage principal   673    42,051 
Net cash used in investing activities   (135,853)   (708,968)
Cash flows from financing activities          
Proceeds from intercompany loans payable from Omega   2,163,749    1,229,000 
Repayment of intercompany loans payable to Omega   (2,104,139)   (639,620)
Payment of financing related costs incurred by Omega   (28,483)   (3,581)
Dividends paid   (54,641)   (25,354)
Contributions from noncontrolling interests   24,235    91,440 
Distributions to Omega   (203,272)   (202,075)
Net cash (used in) provided by financing activities   (202,551)   449,810 
           
Effect of foreign currency translation on cash and cash equivalents   162    (202)
(Decrease) increase in cash and cash equivalents   (72,656)   27,535 
Cash and cash equivalents at beginning of period   93,687    5,424 
Cash and cash equivalents at end of period  $21,031   $32,959 

 

 12 

 

 

Supplemental disclosures of cash flow information:

  

Six Months Ended

June 30,

 
   2017   2016 
Interest paid during the period, net of amounts capitalized  $97,610   $74,010 
Taxes paid during the period  $2,032   $748 
          
Non cash investing activities          
Non cash acquisition of real estate (See Note 2)  $(9,430)  $ 
Non cash acquisition of business       (25,000)
Non cash surrender of mortgage       25,000 
Non cash investment in other investments   (6,353)    
Total  $(15,783)  $ 
           
Non cash financing activities          
Change in fair value of cash flow hedges  $(108)  $13,074 
Remeasurement of debt denominated in a foreign currency   2,190     
   $2,082   $13,074 

 

See notes to consolidated financial statements.

 

 13 

 

  

OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

CONSOLIDATED BALANCE SHEETS

(in thousands, except per share amounts)

 

   June 30,   December 31, 
   2017   2016 
   (Unaudited)     
ASSETS          
Real estate properties          
Real estate investments (see Note 2)  $7,730,199   $7,566,358 
Less accumulated depreciation   (1,366,376)   (1,240,336)
Real estate investments – net   6,363,823    6,326,022 
Investments in direct financing leases – net   582,307    601,938 
Mortgage notes receivable – net   662,709    639,343 
    7,608,839    7,567,303 
Other investments – net   278,985    256,846 
Investment in unconsolidated joint venture   38,968    48,776 
Assets held for sale – net   18,889    52,868 
Total investments   7,945,681    7,925,793 
           
Cash and cash equivalents   21,031    93,687 
Restricted cash   12,203    13,589 
Accounts receivable – net   288,686    240,035 
Goodwill   644,184    643,474 
Other assets   34,869    32,682 
Total assets  $8,946,654   $8,949,260 
           
LIABILITIES AND OWNERS’ EQUITY          
Term loans – net  $99,372   $100,000 
Secured borrowings – net   53,737    54,365 
Accrued expenses and other liabilities   267,346    302,959 
Deferred income taxes   17,714    9,906 
Intercompany loans payable   4,332,975    4,270,044 
Total liabilities   4,771,144    4,737,274 
           
Owners’ Equity:          
General partners’ equity   3,828,299    3,858,745 
Limited partners’ equity   347,211    353,241 
Total owners’ equity   4,175,510    4,211,986 
Total liabilities and owners’ equity  $8,946,654   $8,949,260 
           

 

See notes to consolidated financial statements.

 

 14 

 

 

OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

CONSOLIDATED STATEMENTS OF INCOME

Unaudited

(in thousands, except per share amounts)

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2017   2016   2017   2016 
Revenue                    
Rental income  $193,997   $186,454   $386,534   $363,157 
Income from direct financing leases   15,462    15,521    31,108    30,963 
Mortgage interest income   16,297    21,371    32,253    37,977 
Other investment income – net   7,278    4,982    14,192    8,413 
Miscellaneous income   2,763    496    3,454    1,193 
Total operating revenues   235,797    228,824    467,541    441,703 
                     
Expenses                    
Depreciation and amortization   70,350    65,505    140,343    127,938 
General and administrative   11,541    11,832    24,065    22,287 
Acquisition costs   19    3,504    (22)   7,275 
Impairment loss on real estate properties   10,135    6,893    17,773    41,451 
Provision for uncollectible accounts   2,673    (1,154)   5,077    3,970 
Total operating expenses   94,718    86,580    187,236    202,921 
                     
Income before other income and expense   141,079    142,244    280,305    238,782 
Other income (expense)                    
Interest income   254    4    258    12 
Interest expense   (48,085)   (39,651)   (93,126)   (76,873)
Interest – amortization of deferred financing costs   (2,543)   (2,210)   (5,045)   (4,342)
Interest – refinancing costs   (21,965)   -    (21,965)   (298)
Contractual settlement   -    -    10,412    - 
Realized gain (loss) on foreign exchange   79    -    140    (22)
Total other expense   (72,260)   (41,857)   (109,326)   (81,523)
                     
Income before (loss) gain on assets sold   68,819    100,387    170,979    157,259 
(Loss) gain on assets sold – net   (622)   13,221    6,798    14,792 
Income from continuing operations   68,197    113,608    177,777    172,051 
Income taxes   (591)   (454)   (1,691)   (701)
Income from unconsolidated joint venture   551    -    1,183    - 
Net income  $68,157   $113,154   $177,269   $171,350 
                     
Earnings per unit:                    
Basic:                    
Net income  $0.33   $0.57   $0.86   $0.87 
Diluted:                    
Net income  $0.33   $0.57   $0.86   $0.86 
                     
Dividends declared per Omega OP Unit  $0.63   $0.58   $1.25   $1.15 
                     
Weighted-average Omega OP Units outstanding, basic   206,205    197,903    206,016    197,539 
Weighted-average Omega OP Units outstanding, diluted   206,672    199,157    206,423    198,754 

 

See notes to consolidated financial statements.

 

 15 

 

  

OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Unaudited

(in thousands)

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2017   2016   2017   2016 
                 
Net income  $68,157   $113,154   $177,269   $171,350 
Other comprehensive income (loss)                    
Foreign currency translation   10,274    (21,836)   14,608    (26,566)
Derivative instruments   (3,407)   (4,198)   (2,153)   (13,074)
Total other comprehensive income (loss)   6,867    (26,034)   12,455    (39,640)
Comprehensive income  $75,024   $87,120   $189,724   $131,710 

 

See notes to consolidated financial statements.

 

 16 

 

 

OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

CONSOLIDATED STATEMENT OF CHANGES IN OWNERS’ EQUITY

Unaudited

(in thousands)

 

   General
Partners’
Omega
OP Units
   Limited
Partners’
Omega OP
Units
   Total
Omega OP
Units
   General
Partners’
Equity
  

Limited

Partners’
Equity

   Total
Owners’
Equity
 
Balance at December 31, 2016   196,142    8,862    205,004   $3,858,745   $353,241   $4,211,986 
Contributions from partners   1,082        1,082    34,776        34,776 
Distributions to partners               (246,843)   (11,143)   (257,986)
Omega OP Unit redemptions       (90)   (90)       (2,990)   (2,990)
Foreign currency translation               13,986    622    14,608 
Derivative instruments               (2,062)   (91)   (2,153)
Net income               169,697    7,572    177,269 
Balance at June 30, 2017   197,224    8,772    205,996   $3,828,299   $347,211   $4,175,510 

 

See notes to consolidated financial statements.

 

 17 

 

 

OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

CONSOLIDATED STATEMENTS OF CASH FLOWS

Unaudited (in thousands)

  

Six Months Ended

June 30,

 
   2017   2016 
Cash flows from operating activities          
Net income  $177,269   $171,350 
Adjustment to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization   140,343    127,938 
Impairment loss on real estate properties   17,773    41,451 
Provision for uncollectible accounts   5,077    3,970 
Refinancing costs and amortization of deferred financing costs   15,240    4,640 
Accretion of direct financing leases   (6,164)   (5,915)
Stock-based compensation expense   7,478    6,443 
Gain on assets sold – net   (6,798)   (14,792)
Amortization of acquired in-place leases - net   (6,202)   (7,910)
Effective yield receivable on mortgage notes   (1,191)   (619)
Change in operating assets and liabilities – net:          
Contractual receivables   (33,293)   856 
Straight-line rent receivables   (23,174)   (17,756)
Lease inducements   895    1,294 
Other operating assets and liabilities   (21,667)   (24,055)
Net cash provided by operating activities   265,586    286,895 
Cash flows from investing activities          
Acquisition of real estate   (130,977)   (622,848)
Cash acquired   2,341     
Investments in construction in progress   (46,108)   (26,960)
Investments in direct financing leases   (4,767)   (30)
Proceeds from direct financing leases   27,253     
Placement of mortgage loans   (24,978)   (12,528)
Distributions from unconsolidated joint venture   9,741     
Proceeds from sale of real estate investments   64,061    43,772 
Capital improvements to real estate investments   (16,861)   (21,812)
Proceeds from other investments   35,997    25,923 
Investments in other investments   (52,228)   (136,536)
Collection of mortgage principal   673    42,051 
Net cash used in investing activities   (135,853)   (708,968)
Cash flows from financing activities          
Proceeds from intercompany loans payable from Omega   2,163,749    1,229,000 
Repayment of intercompany loans payable to Omega   (2,104,139)   (639,620)
Payment of financing related costs incurred by Omega   (28,483)   (3,581)
Equity contributions from general partners   24,235    91,440 
Distributions to general partners   (246,722)   (217,068)
Distributions to limited partners   (11,143)   (10,351)
Redemption of Omega OP Units   (48)   (10)
Net cash (used in) provided by financing activities   (202,551)   449,810 
           
Effect of foreign currency translation on cash and cash equivalents   162    (202)
(Decrease) increase in cash and cash equivalents   (72,656)   27,535 
Cash and cash equivalents at beginning of period   93,687    5,424 
Cash and cash equivalents at end of period  $21,031   $32,959 

 

 18 

 

  

Supplemental disclosures of cash flow information:

 

  

Six Months Ended

June 30,

 
   2017   2016 
Interest paid during the period, net of amounts capitalized  $97,610   $74,010 
Taxes paid during the period  $2,032   $748 
           
Non-cash investing activities          
Non cash acquisition of real estate (See Note 2)  $(9,430)  $ 
Non cash acquisition of business       (25,000)
Non cash surrender of mortgage       25,000 
Non cash investment in other investments   (6,353)    
Total  $(15,783)  $ 
           
Non-cash financing activities          
Change in fair value of cash flow hedges  $(108)  $13,074 
Remeasurement of debt denominated in a foreign currency   2,190     
   $2,082   $13,074 

 

See notes to consolidated financial statements.

 

 19 

 

  

OMEGA HEALTHCARE INVESTORS, INC., OHI HEALTHCARE PROPERTIES HOLDCO, INC., AND OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Unaudited

June 30, 2017

 

NOTE 1 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

 

Business Overview and Organization

 

Omega Healthcare Investors, Inc. (“Omega”) was formed as a real estate investment trust (“REIT”) and incorporated in the State of Maryland on March 31, 1992. All of Omega's assets are owned directly or indirectly, and all of Omega's operations are conducted directly or indirectly, through its subsidiaries, OHI Healthcare Properties Holdco, Inc. (“OHI Holdco”), a direct wholly owned subsidiary of Omega, and OHI Healthcare Properties Limited Partnership (“Omega OP”). OHI Holdco was formed as a corporation and incorporated in the State of Delaware on October 22, 2014. Omega OP was formed as a limited partnership and organized in the State of Delaware on October 24, 2014. No substantive assets or activity occurred in either of these entities until the merger with Aviv REIT, Inc. on April 1, 2015. Unless stated otherwise or the context otherwise requires, the terms the “Company,” “we,” “our” and “us” means Omega, OHI Holdco and Omega OP, collectively.

 

The Company has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States (“U.S.”) and the United Kingdom (“U.K.”). Our core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (“SNFs”) and, to a lesser extent, assisted living facilities (“ALFs”), independent living facilities and rehabilitation and acute care facilities. Our core portfolio consists of long-term leases and mortgage agreements. All of our leases are “triple-net” leases, which require the tenants to pay all property-related expenses. Our mortgage revenue derives from fixed rate mortgage loans, which are secured by first mortgage liens on the underlying real estate and personal property of the mortgagor.

 

In April 2015, Aviv REIT, Inc., a Maryland corporation (“Aviv”), merged (the “Aviv Merger”) with and into a wholly owned subsidiary of Omega, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 30, 2014 (the “Merger Agreement”), by and among Omega, Aviv, OHI Holdco, Omega OP, and Aviv Healthcare Properties Limited Partnership, a Delaware limited partnership.

 

Prior to April 1, 2015 and in accordance with the Merger Agreement, Omega restructured the manner in which it holds its assets by converting to an umbrella partnership real estate investment trust structure (the “UPREIT Conversion”). As a result of the UPREIT Conversion and following the consummation of the Aviv Merger, all of Omega’s assets are held by Omega OP, through its equity interests in its subsidiaries.

 

Omega OP is governed by the Second Amended and Restated Agreement of Limited Partnership of OHI Healthcare Properties Limited Partnership, dated as of April 1, 2015 (the “Partnership Agreement”). Pursuant to the Partnership Agreement, Omega and OHI Holdco are the general partners of Omega OP, and have exclusive control over Omega OP’s day-to-day management. As of June 30, 2017, Omega and OHI Holdco together owned approximately 96% of the issued and outstanding units of partnership interest in Omega OP (“Omega OP Units”), and investors owned approximately 4% of the Omega OP Units.

 

 20 

 

  

Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the interim periods reported herein are not necessarily indicative of results to be expected for the full year. These unaudited consolidated financial statements should be read in conjunction with the financial statements and the footnotes thereto included in our Form 10-K/A filed with the SEC on August 9, 2017.

 

Our consolidated financial statements include the accounts of (i) Omega, (ii) OHI Holdco, (iii) Omega OP, and (iv) all direct and indirect wholly owned subsidiaries of Omega. All intercompany transactions and balances have been eliminated in consolidation, and our net earnings are reduced by the portion of net earnings attributable to noncontrolling interests.

 

Asset Impairment

 

Management evaluates our real estate investments for impairment indicators at each reporting period, including the evaluation of our assets’ useful lives. The judgment regarding the existence of impairment indicators is based on factors such as, but not limited to, market conditions, operator performance, legal structure, as well as our intent with respect to holding or disposing of the asset. If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows based on our intended use of the property are determined to be less than the carrying values of the assets. An adjustment is made to the net carrying value of the real estate investments for the excess of carrying value over fair value. The fair value of the real estate investment is determined based on current market conditions and consider matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. Additionally, our evaluation of fair value may consider valuing the property as a nursing home as well as alternative uses. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset. Management’s impairment evaluation process, and when applicable, impairment calculations involve estimation of the future cash flows from management’s intended use of the property. Changes in the facts and circumstances that drive management’s assumptions may result in an impairment of the Company’s assets in a future period that could be material to the Company’s results of operations.

 

For the three and six months ended June 30, 2017 and 2016, we recognized impairment losses of $10.1 million, $17.8 million, $6.9 million and $41.5 million, respectively. For additional information see Note 2 – Properties and Investments.

 

Goodwill Impairment

 

We assess goodwill for potential impairment during the fourth quarter of each fiscal year, or during the year if an event or other circumstance indicates that we may not be able to recover the carrying amount of the net assets of the reporting unit. In evaluating goodwill for impairment on an interim basis, we assess qualitative factors such as a significant decline in real estate valuations, current macroeconomic conditions, state of the equity and capital markets and our overall financial and operating performance or a significant decline in the value of our market capitalization, to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of the reporting unit is less than its carrying amount. On an annual basis during the fourth quarter of each fiscal year, or on an interim basis if we conclude it is more likely than not that the fair value of the reporting unit is less than its carrying value, we perform a two-step goodwill impairment test to identify potential impairment and measure the amount of impairment we will recognize, if any.

 

 21 

 

  

Noncontrolling Interests

 

Noncontrolling interests is the portion of equity not attributable to the respective reporting entity. We present the portion of any equity that we do not own in consolidated entities as noncontrolling interests and classify those interests as a component of total equity, separate from total stockholders’ equity, or owners’ equity on our Consolidated Balance Sheets. We include net income attributable to the noncontrolling interests in net income in our Consolidated Statements of Income.

 

As our ownership of a controlled subsidiary increases or decreases, any difference between the aggregate consideration paid to acquire the noncontrolling interests and our noncontrolling interest balance is recorded as a component of equity in additional paid-in capital, so long as we maintain a controlling ownership interest.

 

The noncontrolling interest for Omega represents the outstanding Omega OP Units held by outside investors. The noncontrolling interest for OHI Holdco represents the Omega OP Units held by the Parent and the outstanding Omega OP Units held by outside investors.

 

Foreign Operations

 

The U.S. dollar is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound. For our consolidated subsidiaries whose functional currency is not the U.S. dollar, we translate their financial statements into the U.S. dollar. We translate assets and liabilities at the exchange rate in effect as of the financial statement date. Revenue and expense accounts are translated using an average exchange rate for the period. Gains and losses resulting from translation are included in accumulated other comprehensive loss (“AOCL”), as a separate component of equity and a proportionate amount of gain or loss is allocated to noncontrolling interests.

 

We and certain of our consolidated subsidiaries may have intercompany and third-party debt that is not denominated in the entity’s functional currency. When the debt is remeasured against the functional currency of the entity, a gain or loss can result. The resulting adjustment is reflected in results of operations, unless it is intercompany debt that is deemed to be long-term in nature and then the adjustments are included in AOCL.

 

Derivative Instruments

 

Cash flow hedges

 

During our normal course of business, we may use certain types of derivative instruments for the purpose of managing interest rate and currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at the inception of a qualifying cash flow hedging relationship, the underlying transaction or transactions, must be, and are expected to remain, probable of occurring in accordance with the Company’s related assertions. The Company recognizes all derivative instruments, including embedded derivatives required to be bifurcated, as assets or liabilities in the Consolidated Balance Sheets at their fair value which are determined using a market approach and Level 2 inputs. Changes in the fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria of hedge accounting are recognized in earnings. For derivatives designated as qualifying cash flow hedging relationships, the change in fair value of the effective portion of the derivatives is recognized in AOCL as a separate component of equity and a proportionate amount of gain or loss is allocated to noncontrolling interest, whereas the change in fair value of the ineffective portion is recognized in earnings. We formally document all relationships between hedging instruments and hedged items, as well as our risk-management objectives and strategy for undertaking various hedge transactions. This process includes designating all derivatives that are part of a hedging relationship to specific forecasted transactions as well as recognized obligations or assets in the Consolidated Balance Sheets. We also assess and document, both at inception of the hedging relationship and on a quarterly basis thereafter, whether the derivatives are highly effective in offsetting the designated risks associated with the respective hedged items. If it is determined that a derivative ceases to be highly effective as a hedge, or that it is probable the underlying forecasted transaction will not occur, we discontinue hedge accounting prospectively and record the appropriate adjustment to earnings based on the current fair value of the derivative. As a matter of policy, we do not use derivatives for trading or speculative purposes. At June 30, 2017 and December 31, 2016, we had $1.4 million and $1.5 million, respectively, of qualifying cash flow hedges recorded at fair value in accrued expenses and other liabilities on our Consolidated Balance Sheets.

 

 22 

 

  

Net investment hedge

 

We use the spot method to measure the effectiveness of our net investment hedge. Under this method, for each reporting period, the change in the carrying value of the hedging instrument due to remeasurement of the effective portion is reported in AOCL in our Consolidated Balance Sheets and the remaining change in the carrying value of the ineffective portion, if any, is recognized in earnings. We evaluate the effectiveness of our net investment hedge on a quarterly basis. We did not record any ineffectiveness for fiscal 2017.

 

Accounts Receivable

 

Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts. Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements. Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line rent receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement. Lease inducements result from value provided by us to the lessee, at the inception or renewal of the lease, and are amortized as a reduction of rental revenue over the non-cancellable lease term.

 

At June 30, 2017, two of our top 10 operators were approximately 90 days past due on rent payments to the Company. On a quarterly basis, we review our accounts receivable to determine their collectability. The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement.  If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance. In the case of a lease recognized on a straight-line basis, a mortgage recognized on an effective yield basis or the existence of lease inducements, we generally provide an allowance for straight-line, effective interest, and/or lease inducement accounts receivable when certain conditions or indicators of adverse collectability are present. If the accounts receivable balance is subsequently deemed uncollectible, the receivable and allowance for doubtful account balance are written off.

 

 23 

 

  

A summary of our net receivables by type is as follows:

 

   June 30,   December 31, 
   2017   2016 
   (in thousands) 
         
Contractual receivables  $40,484   $13,376 
Effective yield interest receivables   10,940    9,749 
Straight-line rent receivables   231,233    208,874 
Lease inducements   7,498    8,393 
Allowance   (1,469)   (357)
Accounts receivable – net  $288,686   $240,035 

 

Related Party Transactions

 

The Company has a policy which generally requires related party transactions to be approved or ratified by the Audit Committee. On February 1, 2016, we acquired 10 SNFs from Laurel Healthcare Holdings, Inc. (“Laurel”) for approximately $169.0 million in cash and leased them to an unrelated existing operator. A former member of the Board of Directors of the Company, together with certain members of his immediate family, beneficially owned approximately 34% of the equity of Laurel prior to the transaction. Immediately following our acquisition, the unrelated existing operator acquired all of the outstanding equity interests of Laurel, including the interests previously held by the former director of the Company and his family.

 

Accounting Pronouncement Adopted in 2017

 

In March 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-09, Compensation-Stock Compensation (Topic 718) (“ASU 2016-09”). ASU 2016-09 amends the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. This guidance is effective for annual and interim reporting periods of public entities beginning after December 15, 2016. We adopted this accounting standard on January 1, 2017, at which time the Company began prospectively accounting for excess tax benefits or tax deficiencies as an adjustment to income tax expense in our Consolidated Statements of Income as opposed to the prior requirement that these excess tax benefits be recognized in additional paid-in capital and tax deficiencies be recognized either as an offset to accumulated excess tax benefits, if any, or in the income statement. The Company will continue to account for forfeitures as they occur and present employee taxes paid as a financing activity on our Consolidated Statements of Cash Flows. The adoption of this accounting standard did not have a material impact on our consolidated financial statements.

 

Recent Accounting Pronouncements - Pending Adoption

 

In 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), which outlines a comprehensive model for entities to use in accounting for revenue arising from contracts with customers. ASU 2014-09 states that “an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.” While ASU 2014-09 specifically references contracts with customers, it may apply to certain other transactions such as the sale of real estate or equipment. ASU 2014-09 is effective for the Company beginning January 1, 2018. In addition, the FASB has begun to issue targeted updates to clarify specific implementation issues of ASU 2014-09. These updates include ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Identifying Performance Obligations and Licensing, and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients. The Company is currently evaluating the provisions of ASU 2014-09 and its related updates and will be closely monitoring developments and additional guidance to determine the potential impact of the new standard. The Company intends to adopt ASU 2014-09 and its subsequent updates in accordance with the modified retrospective approach. We do not expect the adoption of ASU 2014-09 and its updates to have a significant impact on our consolidated financial statements, as a substantial portion of our revenue consists of rental income from leasing arrangements and interest income from loan arrangements, both of which are specifically excluded from ASU 2014-09.

 

 24 

 

  

In February 2016, the FASB issued ASU 2016-02, Leases (“ASU 2016-02”), which amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. ASU 2016-02 will be effective for the Company beginning January 1, 2019. Early adoption of ASU 2016-02 as of its issuance is permitted. The new standard requires a modified retrospective transition approach for all leases existing at, or entered into after, the date of initial application, with an option to use certain transition relief. As a result of the pending adoption ASU 2016-02 and in connection with the pending adoption of ASU 2014-09, the Company may be required to record real estate tax revenues and an equal an offsetting real estate tax expense, as a result of our operators paying real estate taxes on our behalf. We are continuing to evaluate the other impacts of adopting ASU 2016-02 on our consolidated financial statements.

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) (“ASU 2016-13”), which changes the impairment model for most financial assets. The new model uses a forward-looking expected loss method, which will generally result in earlier recognition of allowances for losses. ASU 2016-13 is effective for annual and interim periods beginning after December 15, 2019 and early adoption is permitted for annual and interim periods beginning after December 15, 2018. We are currently evaluating the impact of adopting ASU 2016-13 on our consolidated financial statements.

  

NOTE 2 – PROPERTIES AND INVESTMENTS

 

Leased Property

 

Our real estate properties, represented by 803 SNFs, 119 ALFs, 16 specialty facilities and one medical office building at June 30, 2017, are leased under provisions of single or master leases with initial terms typically ranging from five to 15 years, plus renewal options. Substantially all of our leases contain provisions for specified annual increases over the rents of the prior year and are generally computed in one of three methods depending on specific provisions of each lease as follows: (i) a specific annual percentage increase over the prior year’s rent, generally between 2.0% and 3.0%; (ii) an increase based on the change in pre-determined formulas from year to year (e.g., increases in the Consumer Price Index (“CPI”)); or (iii) specific dollar increases over prior years. Under the terms of the leases, the lessee is responsible for all maintenance, repairs, taxes and insurance on the leased properties.

 

A summary of our investment in leased real estate properties is as follows:

 

   June 30,   December 31, 
   2017   2016 
   (in thousands) 
Buildings  $6,055,423   $5,954,771 
Land   796,561    759,295 
Furniture, fixtures and equipment   458,427    454,760 
Site improvements   204,993    206,206 
Construction in progress   214,795    191,326 
Total real estate investments   7,730,199    7,566,358 
Less accumulated depreciation   (1,366,376)   (1,240,336)
Real estate investments - net  $6,363,823   $6,326,022 

 

 25 

 

 

 

The following table summarizes the significant acquisitions that occurred during the first six months of 2017:

 

  Number of
Facilities
   Country/  Total
Investment
   Land  

Building & Site
Improvements

   Furniture
& Fixtures
   Initial
Annual
Cash Yield
 
Period  SNF   ALF   State  (in millions)   (2)(%) 
Q1   -    1   VA  $7.6   $0.5   $6.8   $0.3    7.50 
Q2   1    -   NC   8.6    0.7    7.3    0.6    9.50 
Q2   -    18   UK   124.2  (1)   34.1    85.1    5.0    8.50 
Total   1    19      $140.4   $35.3   $99.2   $5.9      

 

(1)Omega recorded a non-cash deferred tax liability and acquisitions costs of approximately $8.2 million and $1.2 million, respectively, in connection with this acquisition.
(2)The cash yield is based on the purchase price.

 

During the second quarter of 2017, we acquired two parcels of land which are not reflected in the table above for approximately $5.5 million with the intent of building new facilities for an existing operator.

 

Asset Sales, Impairments and Other

 

During the first quarter of 2017, we sold 15 facilities for approximately $45.8 million in net proceeds recognizing a gain on sale of approximately $7.4 million. Eleven of the sold facilities were previously classified as held for sale. In addition, we recorded a provision for impairment of approximately $7.6 million on three facilities, one of which was reclassified to held for sale as of March 31, 2017.

 

During the second quarter of 2017, we sold three facilities for approximately $18.3 million in net cash proceeds recognizing a loss on sale of approximately $0.6 million. Two of the sold facilities were previously classified as assets held for sale. In addition, we recorded a provision for impairment of approximately $10.1 million on six facilities.

 

We reduced the net book value of the impaired facilities to their estimated fair values or, with respect to the facility reclassified to held for sale, to its estimated fair value less costs to sell. To estimate the fair value of the facilities, we utilized a market approach and Level 3 inputs (which generally consist of non-binding offers from unrelated third parties). Also see Note 7 – Assets Held For Sale for details. Our recorded impairments were primarily the result of a decision to exit certain non-strategic facilities and/or operators.

 

 

NOTE 3 – DIRECT FINANCING LEASES

 

The components of investments in direct financing leases consist of the following:

 

   June 30,   December 31, 
   2017   2016 
   (in thousands) 
Minimum lease payments receivable  $4,085,493   $4,287,069 
Less unearned income   (3,499,877)   (3,685,131)
Less allowance for loss on direct financing lease   (3,309)    
Investment in direct financing leases - net  $582,307   $601,938 
           
Properties subject to direct financing leases   53    58 

 

 26 

 

  

The following minimum rents are due under our direct financing leases for the remainder of 2017 and the subsequent five years (in thousands):

 

2017 2018 2019 2020 2021 2022
$24,407 $50,019 $51,246 $52,493 $53,681 $55,008

 

New Ark Investment Inc.

 

On November 27, 2013, we closed an aggregate $529 million purchase/leaseback transaction in connection with the acquisition of Ark Holding Company, Inc. (“Ark Holding”) by 4 West Holdings Inc. At closing, we acquired 55 SNFs and 1 ALF operated by Ark Holding and leased the facilities back to Ark Holding, now known as New Ark Investment Inc. (“New Ark”), pursuant to four 50-year master leases with rental payments yielding 10.6% per annum over the term of the leases. The purchase/leaseback transaction is being accounted for as a direct financing lease.

 

The lease agreements allow the tenant the right to purchase the facilities for a bargain purchase price plus closing costs at the end of the lease term. In addition, commencing in the 41st year of each lease, the tenant will have the right to prepay the remainder of its obligations thereunder for an amount equal to the sum of the unamortized portion of the original aggregate $529 million investment plus the net present value of the remaining payments under the lease and closing costs. In the event the tenant exercises either of these options, we have the right to purchase the properties for fair value at the time.

 

The remaining 50 facilities under these master leases as of June 30, 2017 are located in 10 states, predominantly in the southeastern U.S. The facilities are separated by region and divided amongst four cross-defaulted master leases. The four regions include the Southeast (38 facilities), the Northwest (2 facilities), Texas (9 facilities) and Indiana (1 facility).

 

Additionally, we own four facilities and lease them to New Ark under a master lease which expires in 2026. The four facility lease is being accounted for as an operating lease.

 

In March 2017, we executed sale agreements with two unrelated third parties to sell seven facilities leased to New Ark located in the Northwest with a carrying value of approximately $36.4 million for approximately $34.0 million. During the first quarter of 2017, we recorded an allowance for loss of approximately $2.4 million. In the second quarter of 2017, we sold five of the Northwest facilities and received net cash proceeds of approximately $27.3 million and recorded an additional allowance for loss of approximately $0.9 million. For the three and six months ended June 30, 2017, we recognized approximately $0.5 million and $1.3 million, respectively, of direct financing lease income on a cash basis related to the Northwest facilities lease. The sale of the remaining two Northwest facilities is expected to close in the third quarter of 2017.

 

 27 

 

  

NOTE 4 – MORTGAGE NOTES RECEIVABLE

 

As of June 30, 2017, mortgage notes receivable relate to 29 fixed rate mortgages on 52 long-term care facilities. The mortgage notes are secured by first mortgage liens on the borrowers' underlying real estate and personal property. The mortgage notes receivable relate to facilities located in ten states that are operated by seven independent healthcare operating companies. We monitor compliance with mortgages and when necessary have initiated collection, foreclosure and other proceedings with respect to certain outstanding mortgage notes.

 

Mortgage interest income is recognized as earned over the terms of the related mortgage notes, using the effective yield method. Allowances are provided against earned revenues from mortgage interest when collection of amounts due becomes questionable or when negotiations for restructurings of troubled operators lead to lower expectations regarding ultimate collection. When collection is uncertain, mortgage interest income on impaired mortgage loans is recognized as received after taking into account the application of security deposits.

 

The outstanding principal amounts of mortgage notes receivable, net of allowances, were as follows:

 

   June 30,   December 31, 
   2017   2016 
   (in thousands) 
         
Mortgage note due 2024; interest at 9.98%  $112,500   $112,500 
Mortgage note due 2029; interest at 9.45%   411,467    412,140 
Other mortgage notes outstanding (1)   143,489    118,637 
Mortgage notes receivable, gross   667,456    643,277 
Allowance for loss on mortgage notes receivable   (4,747)   (3,934)
Total mortgages — net  $662,709   $639,343 

 

(1)Other mortgage notes outstanding have stated interest rates ranging from 8.35% to 14.0% and maturity dates through 2029.

 

NOTE 5 – OTHER INVESTMENTS

 

A summary of our other investments is as follows:

 

   June 30,   December 31, 
   2017   2016 
   (in thousands) 
         
Other investment note due 2019; interest at 10.96%  $49,583   $49,458 
Other investment note due 2020; interest at 14.00%   47,899    47,913 
Other investment note due 2022, interest at 9.00%   31,987    31,987 
Other investment note due 2030; interest at 6.66%   50,000    44,595 
Other investment notes outstanding (1)   104,314    87,691 
Other investments, gross   283,783    261,644 
Allowance for loss on other investments   (4,798)   (4,798)
Total other investments  $278,985   $256,846 

 

(1)Other investment notes have maturity dates through 2028 and interest rates ranging from 6.50% to 13.0%.

 

 28 

 

  

NOTE 6 – INVESTMENT IN UNCONSOLIDATED JOINT VENTURE

 

On November 1, 2016, we invested approximately $50.0 million for an approximate 15% ownership interest in a joint venture operating as Second Spring Healthcare Investments. The other approximate 85% interest is owned by affiliates of Lindsey Goldberg LLC. We account for the joint venture using the equity method. On November 1, 2016, the joint venture acquired 64 SNFs from Welltower Inc. for approximately $1.1 billion and leased them to a single operator.

 

We receive asset management fees from the joint venture for services provided. For the three and six months ended June 30, 2017, we recognized $0.5 million and $1.0 million, respectively, of asset management fees. These fees are included in miscellaneous income in the accompanying Consolidated Statements of Income. The accounting policies for the unconsolidated joint venture are the same as those of the Company.

  

NOTE 7 – ASSETS HELD FOR SALE

 

The following is a summary of our assets held for sale:

 

   Properties Held For Sale 
   Number of
Properties
   Net Book Value
(in thousands)
 
     
December 31, 2016   20   $52,868 
Properties sold/other (1)   (12)   (30,023)
Properties added (2)   1    400 
March 31, 2017   9   $23,245 
Properties sold/other (1)   (2)   (4,356)
June 30, 2017(3)   7   $18,889 

 

(1)In the first quarter of 2017, we sold nine SNFs and two ALFs for approximately $29.4 million in net proceeds recognizing a gain on sale of approximately $3.6 million. One SNF classified as an asset held for sale at December 31, 2016 was no longer considered held for sale during the first quarter of 2017 and was reclassified back to leased properties at approximately $5.1 million which represents the facility’s then carrying value adjusted for depreciation that was not recognized while classified as held for sale. In the second quarter of 2017, we sold one ALF and one SNF for approximately $5.0 million in net proceeds, generating a gain on sale of approximately $0.6 million.
(2)In the first quarter of 2017, we recorded a $3.5 million impairment to reduce one ALF’s net book value to its estimated fair value less costs to sell before it was reclassified to assets held for sale.
(3)We plan to sell the facilities classified as held for sale at June 30, 2017 within the next twelve months.

 

 29 

 

  

NOTE 8 – INTANGIBLES

 

The following is a summary of our intangibles as of June 30, 2017 and December 31, 2016:

 

   June 30,   December 31, 
   2017   2016 
   (in thousands) 
Assets:          
Goodwill  $644,184   $643,474 
           
Above market leases  $22,426   $22,476 
In-place leases   167    167 
Accumulated amortization   (16,477)   (15,864)
Net intangible assets  $6,116   $6,779 
           
Liabilities:          
Below market leases  $164,735   $165,028 
Accumulated amortization   (77,534)   (70,738)
Net intangible liabilities  $87,201   $94,290 

 

Above market leases and in-place leases, net of accumulated amortization, are included in other assets on our Consolidated Balance Sheets. Below market leases, net of accumulated amortization, are included in accrued expenses and other liabilities on our Consolidated Balance Sheets. The net amortization related to the above and below market leases is included in our Consolidated Statements of Income as an adjustment to rental income.

 

For the three months ended June 30, 2017 and 2016, our net amortization related to intangibles was $3.1 million and $3.6 million, respectively. For the six months ended June 30, 2017 and 2016, our net amortization related to intangibles was $6.2 million and $7.9 million, respectively. The estimated net amortization related to these intangibles for the remainder of 2017 and the subsequent four years is as follows: remainder of 2017 – $5.8 million; 2018 – $10.5 million; 2019 – $9.5 million; 2020 – $9.3 million and 2021 – $8.7 million. As of June 30, 2017 the weighted average remaining amortization period of above market leases (inclusive of in-place leases) and below market leases is approximately eight years and nine years, respectively.

 

The following is a reconciliation of our goodwill as of June 30, 2017:

 

   (in thousands) 
Balance as of December 31, 2016  $643,474 
Add: foreign currency translation   710 
Balance as of June 30, 2017  $644,184 

 

NOTE 9 – CONCENTRATION OF RISK

 

As of June 30, 2017, our portfolio of real estate investments consisted of 999 healthcare facilities, located in 42 states and the U.K. and operated by 77 third party operators. Our investment in these facilities, net of impairments and reserve for uncollectible loans, totaled approximately $9.0 billion at June 30, 2017, with approximately 99% of our real estate investments related to long-term care facilities. Our portfolio is made up of 803 SNFs, 119 ALFs, 16 specialty facilities, one medical office building, fixed rate mortgages on 47 SNFs and four ALFs, and nine facilities that are closed/held-for-sale. At June 30, 2017, we also held other investments of approximately $279.0 million, consisting primarily of secured loans to third-party operators of our facilities and a $39.0 million investment in an unconsolidated joint venture.

 

 30 

 

  

At June 30, 2017, we had investments with one operator/or manager that exceeded 10% of our total investments: Ciena Healthcare (10%). No operator generated more than 10% of our total revenues from operations for the three and six months ended June 30, 2017. At June 30, 2017, the three states in which we had our highest concentration of investments were Ohio (9%), Texas (9%) and Florida (9%).

 

NOTE 10 – STOCKHOLDERS’/OWNERS' EQUITY

 

On July 13, 2017, the Board of Directors declared a common stock dividend of $0.64 per share, increasing the quarterly common dividend rate by $0.01 per share over the prior quarter, to be paid on August 15, 2017 to common stockholders of record as of the close of business on August 1, 2017.

 

On April 13, 2017, the Board of Directors declared a common stock dividend of $0.63 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter. The common dividends were paid May 15, 2017 to common stockholders of record as of the close of business on May 1, 2017.

 

On January 12, 2017, the Board of Directors declared a common stock dividend of $0.62 per share, increasing the quarterly common dividend by $0.01 per share over the previous quarter. The common dividends were paid February 15, 2017 to common stockholders of record as of the close of business on January 31, 2017.

 

On the same dates listed above, Omega OP Unit holders received the same distributions per unit as those paid to the common stockholders of Omega.

 

$500 Million Equity Shelf Program

 

For the three months ended June 30, 2017, no shares were issued under our $500 million Equity Shelf Program. For the six months ended June 30, 2017, we issued 0.2 million shares of common stock at an average price of $29.17 per share, net of issuance costs, generating net proceeds of $6.6 million under our $500 million Equity Shelf Program.

 

Dividend Reinvestment and Common Stock Purchase Plan

 

For the three months ended June 30, 2017, approximately 0.4 million shares of our common stock at an average price of $33.02 per share were issued through our Dividend Reinvestment and Common Stock Purchase Program for gross proceeds of approximately $12.4 million. For the six months ended June 30, 2017, approximately 0.6 million shares of our common stock at an average price of $32.11 per share were issued through our Dividend Reinvestment and Common Stock Purchase Program for gross proceeds of approximately $19.7 million.

 

 31 

 

  

Accumulated Other Comprehensive Loss

 

The following is a summary of our accumulated other comprehensive loss, net of tax where applicable:

 

   Omega 
   As of and For the Three
Months Ended June 30,
   As of and For the Six
Months Ended June 30,
 
   2017   2016   2017   2016 
   (in thousands) 
                     
Foreign Currency Translation:                    
Beginning balance  $(50,614)  $(13,143)  $(54,948)  $(8,413)
Translation gain (loss)   10,195    (21,836)   14,468    (26,544)
Realized gain (loss)   79    -    140    (22)
Ending balance   (40,340)   (34,979)   (40,340)   (34,979)
                     
Derivative Instruments:                    
Cash flow hedges:                    
Beginning balance   (166)   (9,594)   (1,420)   (718)
Unrealized loss   (1,840)   (4,198)   (1,350)   (13,074)
Realized gain   626    -    1,390    - 
Ending balance   (1,380)   (13,792)   (1,380)   (13,792)
Net investment hedge:                    
Beginning balance   -    -    -    - 
Unrealized loss   (2,193)   -    (2,193)   - 
Ending balance   (2,193)   -    (2,193)   - 
                     
Total accumulated other comprehensive loss   (43,913)   (48,771)   (43,913)   (48,771)
Add: portion included in noncontrolling interest   2,010    2,308    2,010    2,308 
                     
Total accumulated other comprehensive loss  $(41,903)  $(46,463)  $(41,903)  $(46,463)

 

 32 

 

  

   OHI Holdco 
   As of and For the Three
Months Ended June 30,
   As of and For the Six
Months Ended June 30,
 
   2017   2016   2017   2016 
   (in thousands) 
                     
Foreign Currency Translation:                    
Beginning balance  $(50,614)  $(13,143)  $(54,948)  $(8,413)
Translation gain (loss)   10,195    (21,836)   14,468    (26,544)
Realized gain (loss)   79    -    140    (22)
Ending balance   (40,340)   (34,979)   (40,340)   (34,979)
                     
Derivative Instruments:                    
Cash flow hedges:                    
Beginning balance   (166)   (9,594)   (1,420)   (718)
Unrealized loss   (1,840)   (4,198)   (1,350)   (13,074)
Realized gain   626    -    1,390    - 
Ending balance   (1,380)   (13,792)   (1,380)   (13,792)
Net investment hedge:                    
Beginning balance   -    -    -    - 
Unrealized loss   (2,193)   -    (2,193)   - 
Ending balance   (2,193)   -    (2,193)   - 
                     
Total accumulated other comprehensive loss   (43,913)   (48,771)   (43,913)   (48,771)
Add: portion included in noncontrolling interest   34,116    37,965    34,116    37,965 
                     
Total accumulated other comprehensive loss  $(9,797)  $(10,806)  $(9,797)  $(10,806)

 

   Omega OP 
   As of and For the Three
Months Ended June 30,
   As of and For the Six
Months Ended June 30,
 
   2017   2016   2017   2016 
   (in thousands) 
                     
Foreign Currency Translation:                    
Beginning balance  $(50,614)  $(13,143)  $(54,948)  $(8,413)
Translation gain (loss)   10,195    (21,836)   14,468    (26,544)
Realized gain (loss)   79    -    140    (22)
Ending balance   (40,340)   (34,979)   (40,340)   (34,979)
                     
Derivative Instruments:                    
Cash flow hedges:                    
Beginning balance   (166)   (9,594)   (1,420)   (718)
Unrealized loss   (1,840)   (4,198)   (1,350)   (13,074)
Realized gain   626    -    1,390    - 
Ending balance   (1,380)   (13,792)   (1,380)   (13,792)
Net investment hedge:                    
Beginning balance   -    -    -    - 
Unrealized loss   (2,193)   -    (2,193)   - 
Ending balance   (2,193)   -    (2,193)   - 
                     
Total accumulated other comprehensive loss  $(43,913)  $(48,771)  $(43,913)  $(48,771)

 

 33 

 

  

NOTE 11 – TAXES

 

OHI Holdco is a wholly owned subsidiary of Omega and is a qualified REIT subsidiary for United States federal income tax purposes, and Omega OP is a pass through entity for United States federal income tax purposes.

 

Since our inception, we have elected to be taxed as a REIT under the applicable provisions of the Internal Revenue Code (“Code”). A REIT is generally not subject to federal income tax on that portion of its REIT taxable income which is distributed to its stockholders, provided that at least 90% of such taxable income is distributed each tax year and certain other requirements are met, including asset and income tests. So long as we qualify as a REIT under the Code, we generally will not be subject to federal income taxes on the REIT taxable income that we distribute to stockholders, subject to certain exceptions.

 

If the Company fails to qualify as a REIT in any taxable year, the Company will be subject to federal income taxes on its taxable income at regular corporate rates and dividends paid to our stockholders will not be deductible by us in computing taxable income. Further, we will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year in which qualification is denied, unless the Internal Revenue Service grants us relief under certain statutory provisions. Failing to qualify as a REIT could materially and adversely affect the Company’s net income; however, we believe we are organized and operate in such a manner as to qualify for treatment as a REIT. We test our compliance within the REIT taxation rules to ensure that we are in compliance with the REIT rules on a quarterly and annual basis. We review our distributions and projected distributions each year to ensure we have met and will continue to meet the annual REIT distribution requirements. In 2017, we expect to distribute dividends in excess of our taxable income.

 

As a result of our UPREIT Conversion, our Company and its subsidiaries may be subject to income or franchise taxes in certain states and municipalities. Also, as a result of our UPREIT Conversion, we created five wholly owned subsidiary REITs and added a sixth wholly owned subsidiary REIT as of January 1, 2016, all of which are subject to all of the REIT qualification rules set forth in the Code. We merged five of the wholly owned subsidiary REITs into a single wholly owned subsidiary REIT in December 2015, and then merged the sixth wholly owned subsidiary REIT into our other wholly owned subsidiary REIT in December 2016, which wholly owned subsidiary REIT remains subject to all of the REIT qualification rules set forth in the Code.

 

Subject to the limitation under the REIT asset test rules, we are permitted to own up to 100% of the stock of one or more taxable REIT subsidiaries (“TRSs”). We have elected for two of our active subsidiaries to be treated as TRSs. One of our TRSs is subject to federal, state and local income taxes at the applicable corporate rates and the other is subject to foreign income taxes. As of June 30, 2017, our TRS that is subject to federal, state and local income taxes at the applicable corporate rates had a net operating loss carry-forward of approximately $0.8 million. The loss carry-forward is fully reserved as of June 30, 2017, with a valuation allowance due to uncertainties regarding realization.

 

During the second quarter of 2017, we recorded approximately $0.5 million of state and local income tax provision and approximately $0.1 million of tax provision for foreign income taxes. For the six months ended June 30, 2017, we recorded approximately $1.5 million of state and local income tax provision and approximately $0.2 million of tax provision for foreign income taxes. The expenses were included in provision for income taxes on our Consolidated Statements of Income.

 

 34 

 

  

NOTE 12 – STOCK-BASED COMPENSATION

 

The following is a summary of our stock-based compensation expense for the three and six months ended June 30, 2017 and 2016, respectively:

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2017   2016   2017   2016 
   (in thousands) 
                     
Stock-based compensation expense  $3,734   $3,665   $7,478   $6,443 

 

Restricted Stock and Restricted Stock Units

 

Restricted stock and restricted stock units (“RSUs”) are subject to forfeiture if the holder’s service to us terminates prior to vesting, subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company. Prior to vesting, ownership of the shares/units cannot be transferred. Restricted stock has the same dividend and voting rights as our common stock. RSUs accrue dividend equivalents but have no voting rights. Restricted stock and RSUs are valued at the price of our common stock on the date of grant. We expense the cost of these awards ratably over their vesting period. We awarded 140,416 RSUs to employees on January 1, 2017.

 

Performance Restricted Stock Units and LTIP Units

 

Performance restricted stock units (“PRSUs”) and long term incentive plan units (“LTIP Units”) are subject to forfeiture if the performance requirements are not achieved or if the holder’s service to us terminates prior to vesting, subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company. The PRSUs and the LTIP Units have varying degrees of performance requirements to be earned and vested, and each PRSU and LTIP Units award represents the right to a variable number of shares of common stock or partnership units. Each LTIP Unit once earned and vested is convertible into one Omega OP Unit in Omega OP, subject to certain conditions. The earning requirements are based on either the (i) total shareholder return (“TSR”) of Omega or (ii) Omega’s TSR relative to other real estate investment trusts in the MSCI U.S. REIT Index or FTSE NAREIT Equity Health Care Index TSR (both “Relative TSR”). Vesting in general requires that the employee remain employed by us until the date specified in the applicable PRSU or LTIP agreement, which may be later than the date that the TSR or Relative TSR requirements are satisfied. We expense the cost of these awards ratably over their service period.

 

Prior to vesting and the distribution of shares, ownership of the PRSUs cannot be transferred. Dividend equivalents on the PRSUs accumulate and with respect to PRSUs granted before 2015 are paid when the PRSUs vest and with respect to PRSUs granted in 2015 or later are paid once the PRSUs are earned. While each LTIP Unit is unearned, the employee receives a partnership distribution equal to 10% of the quarterly approved regular periodic distributions per Omega OP Unit. The remaining partnership distributions (which in the case of normal periodic distributions is equal to the total approved quarterly dividend on Omega’s common stock) on the LTIP Units accumulate, and if the LTIP Units are earned, the accumulated distributions are paid.

 

The number of shares or units earned under the TSR PRSUs or LTIP Units depends generally on the level of achievement of Omega’s TSR over the indicated performance period. We awarded 399,726 LTIP Units to employees on January 1, 2017.

 

The number of shares earned under the Relative TSR PRSUs depends generally on the level of achievement of Omega’s TSR relative to other real estate investment trusts in the MSCI U.S. REIT Index or FTSE NAREIT Equity Health Care Index TSR over the performance period indicated. We awarded 285,338 Relative TSR PRSUs to employees on January 1, 2017.

 

 35 

 

  

The following table summarizes our total unrecognized compensation cost as of June 30, 2017 associated with restricted stock, restricted stock units, PRSU awards, and LTIP Unit awards to employees:

 

   Grant
Year
   Shares/ Units   Grant Date
Average
Fair Value
Per Unit/
Share
   Total
Compensation
Cost (in millions)
(1)
   Weighted
Average
Period of
Expense
Recognition
(in months)
   Unrecognized
Compensation
Cost (in
millions)
   Performance
Period
  Vesting
Dates
RSUs                                    
                                     
3/31/15 RSU   2015    109,985   $40.57   $4.5    33   $0.8   N/A  12/31/2017
4/1/15 RSU   2015    40,464    40.74    1.6    33    0.3   N/A  12/31/2017
Assumed Aviv RSU   2015    7,799    35.08    0.3    33    0.1   N/A  11/1/2017
3/17/16  RSU   2016    130,006    34.78    4.6    33    2.4   N/A  12/31/2018
1/1/2017  RSU   2017    140,416    31.26    4.3    36    3.6   N/A  12/31/2019
Restricted Stock Units Total        428,670   $35.68   $15.3        $7.2       
                                     
TSR PRSUs and LTIP Units                                    
                                     
2016 TSR   2014    135,634   $8.67   $1.2    48   $0.2   1/1/2014-12/31/2016  Quarterly in 2017
3/31/15 2017 LTIP Units   2015    137,249    14.66    2.0    45    0.8   1/1/2015-12/31/2017  Quarterly in 2018
4/1/2015 2017 LTIP Units   2015    54,151    14.80    0.8    45    0.3   1/1/2015-12/31/2017  Quarterly in 2018
3/17/2016 2018 LTIP Units   2016    372,069    13.21    4.9    45    3.2   1/1/2016-12/31/2018  Quarterly in 2019
1/1/2017 2019 LTIP Units   2017    399,726    12.61    5.0    48    4.4   1/1/2017-12/31/2019  Quarterly in 2020
TSR PRSUs & LTIP Total        1,098,829   $12.69   $13.9        $8.9       
                                     
Relative TSR PRSUs                                    
                                     
2016 Relative TSR   2014    135,634   $14.24   $1.9    48   $0.2   1/1/2014-12/31/2016  Quarterly in 2017
3/31/15 2017 Relative TSR   2015    137,249    22.50    3.1    45    1.2   1/1/2015-12/31/2017  Quarterly in 2018
4/1/2015 2017 Relative TSR   2015    54,151    22.91    1.2    45    0.5   1/1/2015-12/31/2017  Quarterly in 2018
3/17/2016 2018 Relative TSR   2016    307,480    16.45    5.1    45    3.4   1/1/2016-12/31/2018  Quarterly in 2019
1/1/2017 2019 Relative TSR   2017    285,338    18.04    5.1    48    4.5   1/1/2017-12/31/2019  Quarterly in 2020
Relative TSR PRSUs Total        919,852   $17.78   $16.4        $9.8       
Grand Total        2,447,351   $18.63   $45.6        $25.9       

 

(1)Total compensation costs are net of shares cancelled.

 

Director Restricted Stock Grants

 

As of June 30, 2017, we had 90,421 shares of restricted stock outstanding to directors. The outstanding restricted stock granted to directors prior to 2017 is scheduled to vest ratably over three years from the date of grant. Beginning with the 2017 grants, director restricted stock grants fully vest at the annual meeting following the grant date. As of June 30, 2017, the unrecognized compensation cost associated with outstanding director restricted stock grants is approximately $2.2 million.

 

 36 

 

  

NOTE 13 – BORROWING ACTIVITIES AND ARRANGEMENTS

 

Secured and Unsecured Borrowings

 

The following is a summary of our borrowings:

 

     

Annual Interest
Rate as of

June 30,

  June 30,   December 31, 
   Maturity  2017  2017   2016 
         (in thousands) 
Secured borrowings:                
HUD mortgages assumed December 2011(1)  2044  3.06%  $54,316   $54,954 
Deferred financing costs – net         (579)   (589)
Total secured borrowings – net(2)         53,737    54,365 
                 
Unsecured borrowings:                
Revolving line of credit  2021  2.47%   155,000    190,000 
                 
                 
Tranche A-1 term loan  -  -       200,000 
Tranche A-2 term loan  -  -       200,000 
Tranche A-3 term loan  -  -       350,000 
U.S. term loan  2022  2.67%   425,000     
Sterling term loan  2022  1.70%   130,250     
Omega OP term loan(2)  2022  2.67%   100,000    100,000 
2015 term loan  2022  3.80%   250,000    250,000 
Discounts and deferred financing costs – net(3)         (5,958)   (5,657)
Total term loans – net         899,292    1,094,343 
                 
2023 notes  2023  4.375%   700,000    700,000 
2024 notes  2024  5.875%       400,000 
2024 notes  2024  4.95%   400,000    400,000 
2025 notes  2025  4.50%   400,000    250,000 
2026 notes  2026  5.25%   600,000    600,000 
2027 notes  2027  4.50%   700,000    700,000 
2028 notes  2028  4.75%   550,000     
Other  2018  -   1,500    3,000 
Subordinated debt  2021  9.00%   20,000    20,000 
Discount - net         (22,345)   (17,151)
Deferred financing costs – net         (27,297)   (27,703)
Total unsecured borrowings – net         3,321,858    3,028,146 
                 
Total secured and unsecured borrowings – net        $4,429,887   $4,366,854 

 

(1)Reflects the weighted average annual contractual interest rate on the mortgages at June 30, 2017 excluding a third-party administration fee of approximately 0.5% annually. Secured by real estate assets with a net carrying value of $63.9 million as of June 30, 2017.
(2)These amounts represent borrowings that were incurred by Omega OP or wholly owned subsidiaries of Omega OP.
(3)This amount includes $0.6 million of net deferred financing costs related to the Omega OP term loan as of June 30, 2017.

 

Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants. As of June 30, 2017 and December 31, 2016, we were in compliance with all affirmative and negative covenants, including financial covenants, for our secured and unsecured borrowings. OHI Holdco and Omega OP, the guarantors of Parent’s outstanding senior notes, do not directly own any substantive assets other than OHI Holdco’s interest in Omega OP and Omega OP’s interest in non-guarantor subsidiaries.

 

 37 

 

 

New and Amended Unsecured Credit Facility – 2017

 

2017 Omega Credit Facilities

 

On May 25, 2017, Omega entered into a credit agreement (the “2017 Omega Credit Agreement”) providing us with a new $1.8 billion senior unsecured revolving and term loan credit facility, consisting of a $1.25 billion senior unsecured multicurrency revolving credit facility (the “Revolving Credit Facility”), a $425 million senior unsecured U.S. Dollar term loan facility (the “U.S. Term Loan Facility”), and a £100 million senior unsecured British Pound Sterling term loan facility (the “Sterling Term Loan Facility” and, together with the Revolving Credit Facility and the U.S. Term Loan Facility, collectively, the “2017 Omega Credit Facilities”). The 2017 Omega Credit Agreement contains an accordion feature permitting us, subject to compliance with customary conditions, to increase the maximum aggregate commitments under the 2017 Omega Credit Facilities to $2.5 billion.

 

The 2017 Omega Credit Facilities replace the previous $1.25 billion senior unsecured 2014 revolving credit facility, the previous $200 million Tranche A-1 senior unsecured term loan facility, and the previous $350 million Tranche A-3 senior unsecured incremental term loan facility established under our 2014 credit agreement, which has been terminated (the “2014 Omega Credit Agreement”). We had previously repaid and terminated the $200 million Tranche A-2 senior unsecured term loan facility established under the 2014 Omega Credit Agreement, with proceeds from our $550 million and $150 million unsecured senior notes issued in April 2017.

 

The Revolving Credit Facility bears interest at LIBOR plus an applicable percentage (with a range of 100 to 195 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The Revolving Credit Facility matures on May 25, 2021, subject to an option by us to extend such maturity date for two, six month periods. The 2017 Omega Credit Agreement provides for the Revolving Credit Facility to be drawn in Euros, British Pounds Sterling, Canadian Dollars (collectively, “Alternative Currencies”) or U.S. Dollars, with a $900 million tranche available in U.S. Dollars and a $350 million tranche available in U.S. Dollars or Alternative Currencies. For purposes of the 2017 Omega Credit Facilities, references to LIBOR include the Canadian dealer offered rates for amounts offered in Canadian Dollars and any other Alternative Currency rate approved in accordance with the terms of the 2017 Omega Credit Agreement for amounts offered in any other non-London interbank offered rate quoted currency, as applicable.

 

The U.S. Term Loan Facility and the Sterling Term Loan Facility bear interest at LIBOR plus an applicable percentage (with a range of 90 to 190 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The U.S. Term Loan Facility and the Sterling Term Loan Facility each mature on May 25, 2022.

 

For the three month period ending June 30, 2017, we recorded a one-time, non-cash charge of approximately $5.5 million relating to the write-off of deferred financing costs associated with the termination of the 2014 Omega Credit Facilities.

 

Amended 2015 Term Loan Facility

 

On May 25, 2017, Omega entered into an amended and restated credit agreement (the “Amended 2015 Credit Agreement”), which amended and restated our previous $250 million senior unsecured term loan facility (the “Amended 2015 Term Loan Facility”). The Amended 2015 Term Loan Facility bears interest at LIBOR plus an applicable percentage (with a range of 140 to 235 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The Amended 2015 Term Loan Facility continues to mature on December 16, 2022. The Amended 2015 Credit Agreement permits us, subject to compliance with customary conditions, to add one or more incremental tranches to the Amended 2015 Term Loan Facility in an aggregate principal amount not exceeding $150 million.

 

 38 

 

 

Omega’s obligations under the 2017 Omega Credit Facilities and the Amended 2015 Term Loan Facility are jointly and severally guaranteed by Omega OP, OHI Holdco, and any domestic subsidiary of Omega that provides a guaranty of any unsecured indebtedness of Omega for borrowed money evidenced by bonds, debentures, notes or other similar instruments in an amount of at least $50 million individually or in the aggregate.

 

2017 Omega OP Term Loan Facility

 

On May 25, 2017, Omega OP entered into a credit agreement (the “2017 Omega OP Credit Agreement”) providing it with a new $100 million senior unsecured term loan facility (the “2017 Omega OP Term Loan Facility”). The 2017 Omega OP Credit Agreement replaces the $100 million senior unsecured term loan facility obtained in 2015 (the “2015 Omega OP Term Loan Facility”) and the related credit agreement (the “2015 Omega OP Credit Agreement”). The 2017 Omega OP Term Loan Facility bears interest at LIBOR plus an applicable percentage (with a range of 90 to 190 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The 2017 Omega OP Term Loan Facility matures on May 25, 2022.

 

Omega OP’s obligations in connection with the 2017 Omega OP Term Loan Facility are not currently guaranteed, but will be jointly and severally guaranteed by any domestic subsidiary of Omega OP that provides a guaranty of any unsecured indebtedness of Omega or Omega OP for borrowed money evidenced by bonds, debentures, notes or other similar instruments in an amount of at least $50 million individually or in the aggregate.

 

$550 Million 4.75% Senior Notes and $150 Million 4.5% Senior Notes

 

On April 4, 2017, Omega issued (i) $550 million aggregate principal amount of our 4.75% Senior Notes due 2028 (the “2028 Notes”) and (ii) an additional $150 million aggregate principal amount of our existing 4.50% Senior Notes due 2025 (the “2025 Notes”, and together with the 2028 Notes collectively, the “Notes”). The 2028 Notes mature on January 15, 2028 and the 2025 Notes mature on January 15, 2025.

 

The 2028 Notes were sold at an issue price of 98.978% of their face value before the underwriters’ discount and the 2025 Notes were sold at an issue price of 99.540% of their face value before the underwriters’ discount. Our net proceeds from the Notes offering, after deducting underwriting discounts and expenses, were approximately $690.7 million. The net proceeds from the Notes offering were used to (i) redeem all of our outstanding $400 million aggregate principal amount of 5.875% Senior Notes due 2024 (the “5.875% Notes”) on April 28, 2017, (ii) prepay the $200 million Tranche A-2 Term Loan Facility on April 5, 2017 that otherwise would have become due on June 27, 2017, and (iii) repay outstanding borrowings under our revolving credit facility.

 

$400 Million 5.875% Senior Notes Redemption

 

On April 28, 2017, Omega redeemed all of our outstanding 5.875% Notes. As a result of the redemption, during the second quarter of 2017, we recorded approximately $16.5 million in redemption related costs and write-offs, including $11.8 million for the call premium and $4.7 million in net write-offs associated with unamortized deferred financing costs.

 

NOTE 14 – FINANCIAL INSTRUMENTS

 

The carrying amount of cash and cash equivalents, restricted cash and accounts receivable reported in the Consolidated Balance Sheets approximates fair value because of the short maturity of these instruments (i.e., less than 90 days) (Level 1).

 

 39 

 

 

At June 30, 2017 and December 31, 2016, the carrying amounts and fair values of our other financial instruments were as follows:

 

   June 30, 2017   December 31, 2016 
  

Carrying

Amount

  

Fair

Value

  

Carrying

Amount

  

Fair

Value

 
   (in thousands) 
Assets:                    
Investments in direct financing leases – net  $582,307   $578,998   $601,938   $598,665 
Mortgage notes receivable – net   662,709    676,396    639,343    644,961 
Other investments – net   278,985    271,306    256,846    253,385 
Total  $1,524,001   $1,526,700   $1,498,127   $1,497,011 
Liabilities:                    
Revolving line of credit  $155,000   $155,000   $190,000   $190,000 
Tranche A-1 term loan           198,830    200,000 
Tranche A-2 term loan           200,000    200,000 
Tranche A-3 term loan           347,449    350,000 
U.S. term loan   422,280    425,000         
Sterling term loan   129,413    130,250         
Omega OP term loan(1)   99,373    100,000    100,000    100,000 
2015 term loan   248,226    250,000    248,064    250,000 
4.375% notes due 2023 – net   692,890    723,805    692,305    693,505 
5.875% notes due 2024 – net           395,065    432,938 
4.95% notes due 2024 – net   393,175    421,504    392,669    406,361 
4.50% notes due 2025 – net   394,368    361,983    245,949    249,075 
5.25% notes due 2026 – net   593,969    641,199    593,616    611,461 
4.50% notes due 2027 – net   685,784    703,514    685,052    681,978 
4.75% notes due 2028 – net   539,741    557,520         
HUD debt – net(1)   53,737    52,535    54,365    52,510 
Subordinated debt – net   20,431    24,045    20,490    23,944 
Other   1,500    1,500    3,000    3,000 
Total  $4,429,887   $4,547,855   $4,366,854   $4,444,772 

 

(1)These amounts represent borrowings that were incurred by Omega OP or wholly owned subsidiaries of Omega OP.

 

Fair value estimates are subjective in nature and are dependent on a number of important assumptions, including estimates of future cash flows, risks, discount rates and relevant comparable market information associated with each financial instrument (see Note 2 – Summary of Significant Accounting Policies in our Annual Report on Form 10-K for the year ended December 31, 2016, as amended). The use of different market assumptions and estimation methodologies may have a material effect on the reported estimated fair value amounts.

 

The following methods and assumptions were used in estimating fair value disclosures for financial instruments.

 

·Direct financing leases: The fair value of the investments in direct financing leases are estimated using a discounted cash flow analysis, using interest rates being offered for similar leases to borrowers with similar credit ratings (Level 3).

 

·Mortgage notes receivable: The fair value of the mortgage notes receivables are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).

 

·Other investments: Other investments are primarily comprised of notes receivable. The fair values of notes receivable are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).

 

 40 

 

 

·Revolving line of credit and term loans: The fair value of our borrowings under variable rate agreements are estimated using a present value technique based on expected cash flows discounted using the current market rates (Level 3).

 

·Senior notes and subordinated debt: The fair value of our borrowings under fixed rate agreements are estimated using a present value technique based on inputs from trading activity provided by a third party (Level 2).

 

·HUD debt: The fair value of our borrowings under HUD debt agreements are estimated using an expected present value technique based on quotes obtained by HUD debt brokers (Level 2).

 

NOTE 15 – LITIGATION

 

We are subject to various legal proceedings, claims and other actions arising out of the normal course of business. While any legal proceeding or claim has an element of uncertainty, management believes that the outcome of each lawsuit, claim or legal proceeding that is pending or threatened, or all of them combined, will not have a material adverse effect on our consolidated financial position or results of operations.

 

NOTE 16 – EARNINGS PER SHARE/UNIT

 

The computation of basic earnings per share/unit (“EPS” or “EPU”) is computed by dividing net income available to common stockholders/Omega OP Unit holders by the weighted-average number of shares of common stock/Omega OP Units outstanding during the relevant period. Diluted EPS/EPU is computed using the treasury stock method, which is net income divided by the total weighted-average number of common outstanding shares/Omega OP Units plus the effect of dilutive common equivalent shares/units during the respective period. Dilutive common shares/Omega OP Units reflect the assumed issuance of additional common shares pursuant to certain of our share-based compensation plans, including stock options, restricted stock and performance restricted stock units and the assumed issuance of additional shares related to Omega OP Units held by outside investors. Dilutive Omega OP Units reflect the assumed issuance of additional Omega OP Units pursuant to certain of our share-based compensation plans, including stock options, restricted stock and performance restricted stock. No per share information was provided for OHI Holdco because the sole stockholder is Omega. OHI Holdco is a wholly owned subsidiary of Omega and has 1,000 shares of $0.01 par value per share common stock outstanding.

 

 41 

 

 

The following tables set forth the computation of basic and diluted earnings per share/unit:

 

   Omega 
  

Three Months Ended

June 30,

  

Six Months Ended

June 30,

 
   2017   2016   2017   2016 
   (in thousands, except per share amounts) 
Numerator:                    
Net income  $68,157   $113,154   $177,269   $171,350 
Less: net income attributable to noncontrolling interests   (2,900)   (5,102)   (7,572)   (7,743)
Net income available to common stockholders  $65,257   $108,052   $169,697   $163,607 
                     
Denominator:                    
Denominator for basic earnings per share   197,433    188,981    197,223    188,604 
Effect of dilutive securities:                    
Common stock equivalents   467    1,254    407    1,215 
Noncontrolling interest – Omega OP Units   8,772    8,922    8,793    8,935 
Denominator for diluted earnings per share   206,672    199,157    206,423    198,754 
                     
Earnings per share – basic:                    
Net income available to common stockholders  $0.33   $0.57   $0.86   $0.87 
Earnings per share – diluted:                    
Net income  $0.33   $0.57   $0.86   $0.86 

 

   Omega OP 
  

Three Months Ended

June 30,

  

Six Months Ended

June 30,

 
   2017   2016   2017   2016 
   (in thousands, except per share amounts) 
Numerator:                    
Net income  $68,157   $113,154   $177,269   $171,350 
                     
Denominator:                    
Denominator for basic earnings per unit   206,205    197,903    206,016    197,539 
Effect of dilutive securities:                    
Omega OP Unit equivalents   467    1,254    407    1,215 
Denominator for diluted earnings per unit   206,672    199,157    206,423    198,754 
                     
Earnings per unit – basic:                    
Net income available to Omega OP Unit holders  $0.33   $0.57   $0.86   $0.87 
Earnings per unit – diluted:                    
Net income  $0.33   $0.57   $0.86   $0.86 

 

 42 

 

 

Item 2 – Management's Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-Looking Statements, Reimbursement Issues and Other Factors Affecting Future Results

 

The following discussion should be read in conjunction with the financial statements and notes thereto appearing elsewhere in this document, including statements regarding potential future changes in reimbursement. This document contains “forward-looking statements” within the meaning of the federal securities laws. These statements relate to our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events, performance and underlying assumptions and other statements other than statements of historical facts. In some cases, you can identify forward-looking statements by the use of forward-looking terminology including, but not limited to, terms such as “may,” “will,” “anticipates,” “expects,” “believes,” “intends,” “should” or comparable terms or the negative thereof. These statements are based on information available on the date of this filing and only speak as to the date hereof and no obligation to update such forward-looking statements should be assumed. Our actual results may differ materially from those reflected in the forward-looking statements contained herein as a result of a variety of factors, including, among other things:

 

(i)those items discussed under “Risk Factors” in Part I, Item 1A to our annual report on Form 10-K for the year ended December 31, 2016, as amended, in Part II, Item 1A of our quarterly report on Form 10-Q for the quarter ended March 31, 2017, as amended (if any) and this report (if any);
(ii)uncertainties relating to the business operations of the operators of our assets, including those relating to reimbursement by third-party payors, regulatory matters and occupancy levels;
(iii)the ability of any operators in bankruptcy to reject unexpired lease obligations, modify the terms of our mortgages and impede our ability to collect unpaid rent or interest during the process of a bankruptcy proceeding and retain security deposits for the debtors’ obligations;
(iv)our ability to sell closed or foreclosed assets on a timely basis and on terms that allow us to realize the carrying value of these assets;
(v)our ability to manage, re-lease or sell any owned and operated facilities;
(vi)the availability and cost of capital to us;
(vii)changes in our credit ratings and the ratings of our debt securities;
(viii)competition in the financing of healthcare facilities;
(ix)regulatory and other changes in the healthcare sector;
(x)changes in the financial position of our operators;
(xi)the effect of economic and market conditions generally and, particularly, in the healthcare industry;
(xii)changes in interest rates;
(xiii)the amount and yield of any additional investments;
(xiv)changes in tax laws and regulations affecting real estate investment trusts (“REITs”);
(xv)the potential impact of changes in the skilled nursing facility (“SNF”) and assisted living facility (“ALF”) market or local real estate conditions on our ability to dispose of assets held for sale for the anticipated proceeds or on a timely basis, or to redeploy the proceeds therefrom on favorable terms; and
(xvi)our ability to maintain our status as a real estate investment trust.

 

Overview

 

Omega Healthcare Investors, Inc. (“Omega”) was formed as a real estate investment trust (“REIT”) and incorporated in the State of Maryland on March 31, 1992. All of Omega's assets are owned directly or indirectly, and all of Omega's operations are conducted directly or indirectly, through its subsidiaries, OHI Healthcare Properties Holdco, Inc. (“OHI Holdco”), a direct wholly owned subsidiary of Omega, and OHI Healthcare Properties Limited Partnership (“Omega OP”). OHI Holdco was formed as a corporation and incorporated in the State of Delaware on October 22, 2014. Omega OP was formed as a limited partnership and organized in the State of Delaware on October 24, 2014. No substantive assets or activity occurred in either of these entities until the merger with Aviv REIT, Inc. on April 1, 2015. Unless stated otherwise or the context otherwise requires, the terms the “Company,” “we,” “our” and “us” means Omega, OHI Holdco and Omega OP, collectively.

 

 43 

 

 

The Company has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States (“U.S.”) and the United Kingdom (“U.K.”). Our core business is to provide financing and capital to the long-term healthcare industry with a particular focus on SNFs and, to a lesser extent, ALFs, independent living facilities and rehabilitation and acute care facilities. Our core portfolio consists of long-term leases and mortgage agreements. All of our leases are “triple-net” leases, which require the tenants to pay all property-related expenses. Our mortgage revenue derives from fixed rate mortgage loans, which are secured by first mortgage liens on the underlying real estate and personal property of the mortgagor.

 

In April 2015, Aviv REIT Inc., a Maryland corporation (“Aviv”), merged (the “Aviv Merger”) with and into a wholly owned subsidiary of Omega, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 30, 2014 (the “Merger Agreement”), by and among Omega, Aviv, OHI Holdco, Omega OP, and Aviv Healthcare Properties Limited Partnership, a Delaware limited partnership.

 

Prior to April 1, 2015 and in accordance with the Merger Agreement, Omega restructured the manner in which it holds its assets by converting to an umbrella partnership real estate investment trust structure (the “UPREIT Conversion”). As a result of the UPREIT Conversion and following the consummation of the Aviv Merger, all of Omega’s assets are held by Omega OP, through its equity interests in its subsidiaries.

 

Omega OP is governed by the Second Amended and Restated Agreement of Limited Partnership of OHI Healthcare Properties Limited Partnership, dated as of April 1, 2015 (the “Partnership Agreement”). Pursuant to the Partnership Agreement, Omega and OHI Holdco are the general partners of Omega OP, and have exclusive control over Omega OP’s day-to-day management. As of June 30, 2017, Omega and OHI Holdco together owned approximately 96% of the issued and outstanding units of partnership interest in Omega OP (“Omega OP Units”), and investors owned approximately 4% of the Omega OP Units.

 

Our portfolio of real estate investments at June 30, 2017, consisted of 999 healthcare facilities, located in 42 states and the United Kingdom and operated by 77 third party operators. Our investment in these facilities, net of impairments and reserves for uncollectible loans, totaled approximately $9.0 billion at June 30, 2017, with approximately 99% of our real estate investments related to long-term care facilities. Our portfolio is made up of: (i) 803 SNFs, (ii) 119 ALFs, (iii) 16 specialty facilities, (iv) one medical office building, (v) fixed rate mortgages on 47 SNFs and four ALFs and (vi) nine facilities that are closed/held-for-sale. At June 30, 2017, we also held other investments of approximately $279.0 million, consisting primarily of secured loans to third-party operators of our facilities and a $39.0 million investment in an unconsolidated joint venture.

 

As of June 30, 2017 and December 31, 2016 we do not have any material properties or operators with facilities that are not materially occupied.

 

Our consolidated financial statements include the accounts of (i) Omega, (ii) OHI Holdco, (iii) Omega OP, and (iv) all direct and indirect wholly owned subsidiaries of Omega. All intercompany transactions and balances have been eliminated in consolidation, and our net earnings are reduced by the portion of net earnings attributable to noncontrolling interests.

 

 44 

 

 

Taxation

 

OHI Holdco is a wholly owned subsidiary of Omega and is a qualified REIT subsidiary for United States federal income tax purposes, and Omega OP is a pass through entity for United States federal income tax purposes.

 

Since our inception, we have elected to be taxed as a REIT under the applicable provisions of the Internal Revenue Code (“Code”). A REIT is generally not subject to federal income tax on that portion of its REIT taxable income which is distributed to its stockholders, provided that at least 90% of such taxable income is distributed each tax year and certain other requirements are met, including asset and income tests. So long as we qualify as a REIT under the Code, we generally will not be subject to federal income taxes on the REIT taxable income that we distribute to stockholders, subject to certain exceptions.

 

If the Company fails to qualify as a REIT in any taxable year, the Company will be subject to federal income taxes on its taxable income at regular corporate rates and dividends paid to our stockholders will not be deductible by us in computing taxable income. Further, we will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year in which qualification is denied, unless the Internal Revenue Service grants us relief under certain statutory provisions. Failing to qualify as a REIT could materially and adversely affect the Company’s net income; however, we believe we are organized and operate in such a manner as to qualify for treatment as a REIT. We test our compliance within the REIT taxation rules to ensure that we are in compliance with the REIT rules on a quarterly and annual basis. We review our distributions and projected distributions each year to ensure we have met and will continue to meet the annual REIT distribution requirements. In 2017, we expect to distribute dividends in excess of our taxable income.

 

As a result of our UPREIT Conversion, our Company and its subsidiaries may be subject to income or franchise taxes in certain states and municipalities. Also, as a result of our UPREIT Conversion, we created five wholly owned subsidiary REITs and added a sixth wholly owned subsidiary REIT as of January 1, 2016, all of which are subject to all of the REIT qualification rules set forth in the Code. We merged five of the wholly owned subsidiary REITs into a single wholly owned subsidiary REIT in December 2015, and then merged the sixth wholly owned subsidiary REIT into our other wholly owned subsidiary REIT in December 2016, which wholly owned subsidiary REIT remains subject to all of the REIT qualification rules set forth in the Code.

 

Subject to the limitation under the REIT asset test rules, we are permitted to own up to 100% of the stock of one or more taxable REIT subsidiaries (“TRSs”). We have elected for two of our active subsidiaries to be treated as TRSs. One of our TRSs is subject to federal, state and local income taxes at the applicable corporate rates and the other is subject to foreign income taxes. As of June 30, 2017, our TRS that is subject to federal, state and local income taxes at the applicable corporate rates had a net operating loss carry-forward of approximately $0.8 million. The loss carry-forward is fully reserved as of June 30, 2017, with a valuation allowance due to uncertainties regarding realization.

 

During the second quarter of 2017, we recorded approximately $0.5 million of state and local income tax provision and approximately $0.1 million of tax provision for foreign income taxes. For the six months ended June 30, 2017, we recorded approximately $1.5 million of state and local income tax provision and approximately $0.2 million of tax provision for foreign income taxes. The expenses were included in provision for income taxes on our Consolidated Statements of Income.

 

Government Regulation and Reimbursement

 

The healthcare industry is heavily regulated. Our operators are subject to extensive and complex federal, state and local healthcare laws and regulations. These laws and regulations are subject to frequent and substantial changes resulting from the adoption of new legislation, rules and regulations, and administrative and judicial interpretations of existing law. The ultimate timing or effect of these changes, which may be applied retroactively, cannot be predicted. Changes in laws and regulations impacting our operators, in addition to regulatory non-compliance by our operators, can have a significant effect on the operations and financial condition of our operators, which in turn may adversely impact us. The following is a discussion of certain laws and regulations generally applicable to our operators, and in certain cases, to us.

 

 45 

 

 

Healthcare Reform. A substantial amount of rules and regulations have been issued under the Patient Protection and Affordable Care Act, as amended by the Health Care and Education and Reconciliation Act of 2010 (collectively referred to as the “Healthcare Reform Law”). The new administration has brought Congressional efforts to repeal and replace the Affordable Care Act. The House of Representatives passed the American Health Care Act (“AHCA”) on May 4, 2017, which contains provisions that would change the level of federal funding of state Medicaid programs and affect funding for long term care recipients, including the elderly and disabled. The Senate then moved to craft its own “repeal and replace” legislation called the Better Care Reconciliation Act (“BCRA”) with more onerous funding changes affecting the elderly and disabled. BCRA and two other amendments failed in the Senate and it is unclear if the Senate will debate potential amendments further. However, even if a different bill or amendment passed in the Senate, reconciliation with the House’s AHCA bill would be required. Under any new legislation, we expect additional rules, regulations and interpretations to be issued that may materially affect our operators’ financial condition and operations. Even if the Healthcare Reform Law is not amended or repealed, the new administration could propose changes impacting implementation of the Healthcare Reform Law. The ultimate composition and timing of any legislation enacted under the new administration that would impact the current implementation of the Healthcare Reform Law remains uncertain. Given the complexity of the Healthcare Reform Law and the substantial requirements for regulation thereunder, the impact of the Healthcare Reform Law on our operators or their ability to meet their obligations to us cannot be predicted, whether in its current form or as amended or repealed.

 

Reform Requirements for Long-Term Care Facilities. On October 4, 2016, the Centers for Medicare and Medicaid Services (“CMS”) issued a final rule modifying the conditions of participation in Medicare and Medicaid for SNFs. CMS stated that the regulations, last updated in 1991, were “necessary to reflect the substantial advances that had been made over the past several years in the theory and practice of service delivery and safety” within long-term care. The extensive modifications require SNFs to implement new processes; make changes to current practices; and create new policies and procedures within a short timeframe to remain in compliance with their conditions for participation. Changes include provisions related to staff training, discharge planning, infection prevention and control programs, and pharmacy services, among others. While many of the regulations became effective on November 28, 2016, some of the regulations become effective in Phase 2, beginning on November 28, 2017, with others becoming effective in Phase 3, beginning on November 28, 2019. According to CMS, it is estimated that the average cost for a SNF to implement the new regulations is estimated to be $62,900 the first year and $55,000 each year thereafter. Further, CMS delayed for one year the imposition of any fines for failure to implement Phase 2 of the new “Requirements of Participation” scheduled for implementation in November 2017.

 

Reimbursement Generally. A significant portion of our operators’ revenue is derived from government-funded reimbursement programs, consisting primarily of Medicare and Medicaid. As federal and state governments continue to focus on healthcare reform initiatives, and as the federal government and many states face significant current and future budget deficits, efforts to reduce costs by government payors will likely continue, which may result in reductions in reimbursement at both the federal and state levels. Additionally, new and evolving payor and provider programs, including but not limited to Medicare Advantage, dual eligible, accountable care organizations, and bundled payments could adversely impact our tenants’ and operators’ liquidity, financial condition or results of operations.

 

We currently believe that our operator coverage ratios are adequate and that our operators can absorb moderate reimbursement rate reductions and still meet their obligations to us. However, significant limits on the scope of services reimbursed and/or reductions of reimbursement rates could have a material adverse effect on our operators’ results of operations and financial condition, which could adversely affect our operators’ ability to meet their obligations to us.

 

 46 

 

 

Medicaid. State budgetary concerns, coupled with the implementation of rules under the Healthcare Reform Law, or prospective changes to the Healthcare Reform Law under the new administration, may result in significant changes in healthcare spending at the state level. Many states are currently focusing on the reduction of expenditures under their state Medicaid programs, which may result in a reduction in reimbursement rates for our operators. The need to control Medicaid expenditures by the states may be exacerbated by the potential for increased enrollment in Medicaid due to unemployment and declines in family incomes. Since our operators’ profit margins on Medicaid patients are generally relatively low, more than modest reductions in Medicaid reimbursement or an increase in the number of Medicaid patients could adversely affect our operators’ results of operations and financial condition, which in turn could negatively impact us.

 

The Healthcare Reform Law provided for Medicaid coverage to be expanded to all individuals under age 65 with incomes up to 133% of the federal poverty level, beginning January 1, 2014. While the federal government committed to paying the entire cost for Medicaid coverage for newly eligible beneficiaries from 2014 through 2016, the federal share declines to 95% in 2017, 94% in 2018, 93% in 2019, and 90% in 2020 and subsequent years. Although the Supreme Court ruled on June 28, 2012 that states could not be required to expand Medicaid or risk losing federal funding of their existing Medicaid programs, as of August 3, 2017, thirty-one (31) states and the District of Columbia have expanded Medicaid eligibility with additional states continuing to consider expansion.

 

As indicated above, both the House and the Senate have proposed bills that contain provisions that would change the level of federal funding of state Medicaid programs. Both bills contain provisions that would change the level of federal funding of state Medicaid programs from the current unlimited amount based on a matching formula that varies by state based on per capita income levels to a capped amount by state based on varying per capita limits for five defined categories of Medicaid beneficiaries, two categories of which cover Medicaid long-term care residents of SNFs. However, the status of Healthcare Reform is far from certain.

 

As noted above, the vote on BCRA has been delayed and it is unclear whether it would pass a vote. Even if passed, reconciliation with the AHCA would be required, so it remains to be seen which of the proposals will prevail or if neither proposal will come to fruition.

 

Medicare. On July 31, 2017, CMS issued a final rule regarding the fiscal year (“FY”) 2018 Medicare payment rates and quality payment programs for SNFs, which continues the trend of shifting Medicare payments from volume to value. Proposed aggregate payments to SNFs effective October 1, 2017 for FY 2018 are expected to increase by $370 million, or 1.0%, over FY 2017 payments. This reimbursement increase is attributable to a 1.0% market basket increase as required under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) after application of the productivity adjustment. Additionally, as mandated by the Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT Act), the annual update is reduced by 2 percentage points for SNFs that fail to submit required quality data to CMS under the SNF Quality Reporting Program (QRP), beginning with FY 2018. The application of this penalty to those SNFs that do not meet the requirements for the FY 2018 SNF QRP would produce a market basket index percentage change that is less than zero and would also result in FY 2018 payment rates that are less than such payment rates for the preceding fiscal year. Similarly, a value-based purchasing program under the 2014 Protecting Access to Medicare Act (“PAMA”) legislation discounts SNF Medicare Fee-for-Service (“FFS”) payments by 2% commencing on October 2018, with reimbursement of those discounts to SNF based on comparative rehospitalization metrics.

 

 47 

 

 

On April 27, 2017, CMS released an Advanced Notice of Proposed Rulemaking (“ANPRM”) to replace the SNF PPS RUG-IV case-mix classification methodology, which forms the basis for SNF payment, with the Resident Classification System, Version I (RCS-I), as early as FY 2019. The RCS-I case-mix model, removes service-based metrics from the SNF PPS and provides for payment, almost exclusively, from objective resident characteristics. CMS extended the comment period on the ANPRM from June 26, 2017 to August 25, 2017 in response to requests from national industry organizations for additional time to analyze this potentially far-reaching proposal. Notably, CMS’ overall model is designed to be budget-neutral with the current system.

 

In addition to FY 2017 Medicare payment rates, SNFs continue to be impacted by the “Bipartisan Budget Act of 2015” (“BBA”) signed on November 2, 2015 which provided $80 billion in discretionary spending sequestration relief over two years, and extended Medicare sequestration, which generally cuts Medicare provider and plan payments by 2% across the board, for an additional year, through 2025. The FY 2025 sequestration will be “front loaded,” such that a 4% reduction will apply during the first six months of the fiscal year and no reduction will be imposed during the second half of the fiscal year.

 

Furthermore, the “Medicare Access and CHIP Reauthorization Act of 2015” continues to have the potential to negatively impact Medicare revenues through the extension of the Medicare therapy cap exceptions process through December 31, 2017; modification of the requirement for manual medical review for services over the $3,700 therapy thresholds; and extension of the application of therapy caps, and related provisions, to outpatient hospitals until January 1, 2018. The statutory Medicare Part B outpatient cap for occupational therapy is $1,980 for 2017, with the combined cap for physical therapy and speech therapy also set at $1,980 for 2017. While the caps do not apply to therapy services covered under Medicare Part A for SNFs and the exception process permits medically necessary therapy services beyond the cap limits, the caps apply in most other circumstances involving patients in SNFs or long-term care facilities who receive therapy services covered under Medicare Part B. Expiration of the therapy cap exceptions process in the future could have a material adverse effect on our operators’ financial condition and operations, which could adversely impact their ability to meet their obligations to us.

 

As indicated above, reimbursement methodology reforms, such as value-based purchasing, continue to be increasingly prevalent and attempt to hold providers accountable for the cost and quality of care provided by redistributing a portion of a provider or facility’s reimbursement based on the relative performance on designated economic, clinical quality, and patient satisfaction metrics. These reimbursement methodologies and similar programs are expected to expand, both in public and commercial health plans.

 

For example, the “Protecting Access to Medicare Act of 2014” called for the U.S. Department of Health and Human Services (“HHS”) to develop a value based purchasing program for SNFs aimed at tying a reimbursement adjustment to lower readmission rates effective October 1, 2018, and on April 26, 2015, CMS announced its goal to have 30% of Medicare payments for quality and value through alternative payment models such as accountable care organizations or bundled payments by the end of 2016 and up to 50% by the end of 2018. In March 2016, CMS announced that its 30% target for 2016 had already been reached.

 

Additionally, CMS’s bundled payment program for Lower Extremity Joint Replacement (“CJR”) procedures went into effect on April 1, 2016, and is mandatory for all hospitals paid under the Medicare Inpatient Prospective Payment System that are located in the 67 selected metropolitan statistical areas. Through this bundled payment model, hospitals in the 67 selected metropolitan areas receive additional payments if quality and costs exceed defined parameters or, if not, must repay Medicare for a portion of the spending. On July 25, 2016, CMS proposed rulemaking to extend the CJR bundled payment models effective July 1, 2017 for both hip/femur fracture surgeries in the same 67 metropolitan as well as additional bundled payment models/Episode Payment Models for heart attacks and bypass surgeries in 98 randomly selected metropolitan statistical areas. SNFs receiving Medicare revenues related to hospital discharges subject to CJR bundled payment programs in the identified geographic areas could be either positively or negatively affected by the CJR bundled payment program. CMS delayed the applicability date of the expanded CJR bundled payment pilot from July 1, 2017 until October 1, 2017 through an interim final rule with comment period published in the Federal Register on March 21, 2017. CMS again delayed the effective date of the CJR bundled payment program until January 1, 2018 through a final rule entitled, “Medicare Program; Advancing Care Coordination Through Episode Payment Models (EPMs); Cardiac Rehabilitation Incentive Payment Model; and Changes to the Comprehensive Care for Joint Replacement Model; Delay of Effective Date,” published in the Federal Register on May 19, 2017 . This final rule also finalized May 20, 2017 as the effective date of the final rule entitled, “Advancing Care Coordination Through Episode Payment Models (EPMs); Cardiac Rehabilitation Incentive Payment Model; and Changes to the Comprehensive Care for Joint Replacement Model,” which was originally published on January 3, 2017.

 

 48 

 

 

Quality of Care Initiatives. In addition to quality or value based reimbursement reforms, CMS has implemented a number of initiatives focused on the quality of care provided by long term care facilities that could affect our operators. On December 2008, CMS released quality ratings for all of the nursing homes that participate in Medicare or Medicaid under its “Five Star Quality Rating System.” Facility rankings, ranging from five stars (“much above average”) to one star (“much below average”) are updated on a monthly basis. SNFs are required to provide information for the CMS Nursing Home Compare website regarding staffing and quality measures. Based on this data and the results of state health inspections, SNFs are then rated based on the five-star rating system.

 

In August 2016, CMS announced a modification to the Five Star Quality Rating System through the introduction of new quality measures based primarily on Medicare claims data submitted by hospitals, including: (1) percentage of short-stay residents who were successfully discharged to the community; (2) percentage of short-stay residents who have had an outpatient emergency department visit; (3) percentage of short-stay residents who were re-hospitalized after a nursing home admission; (4) percentage of short-stay residents who made improvements in function; and (5) percentage of long-stay residents whose ability to move independently worsened. These ratings were incorporated into the nursing home rating system in July 2016 and were phased in through January 2017. Effective September 1, 2016, SNFs that received a Five Star Quality Indicators Survey deficiency cited at a Scope and Severity level J or higher are automatically and immediately assessed civil monetary penalties by CMS, with no opportunity to correct the deficiencies to avoid the heightened and costly monetary penalties. It is possible that this or any other ranking system could lead to future reimbursement policies that reward or penalize facilities on the basis of the reported quality of care parameters.

 

Office of the Inspector General Activities. The Office of Inspector General’s (the “OIG”) Work Plan for government fiscal year 2017, which describes projects that the OIG plans to address during the fiscal year, includes seven projects related specifically to nursing homes: (1) determining to what extent State agencies investigate serious nursing home complaints within the required timeframes; (2) unreported incidents of potential abuse and neglect in SNFs; (3) review of SNF Medicare reimbursement documentation (determine if it meets requirements for each particular resource utilization group); (4) the SNF Adverse Event Screening Tool, which will disseminate practical information about the SNF Adverse Event Trigger Tool; (5) review of the National Background Check Program for long-term care employees; (6) compliance with the SNF prospective payment system requirement related to a three-day qualifying inpatient hospital stay; and (7) review of potentially avoidable hospitalizations of Medicare and Medicaid-Eligible nursing facility residents and prevention and detection services provided by nursing homes. Additionally, regional RAC auditors along with the Office of Inspector General and Department of Justice will also continue their efforts to evaluate SNF Medicare claims for any excessive therapy charges. In order to enhance transparency around the OIG’s continuous work planning efforts, effective June 15, 2017, the OIG will update its Work Plan website monthly.

 

Department of Justice. SNFs are under intense scrutiny for the quality of care being rendered to residents and appropriate billing practices. The Department of Justice launched ten regional Elder Justice Task Forces in 2016 which are coordinating and enhancing efforts to pursue SNFs that provide grossly substandard care to their residents. They are also focusing on therapy billing issues. These Task Forces are composed of representatives from the U.S. Attorneys’ Offices, State Medicaid Fraud Control Units, state and local prosecutors’ offices, HHS, State Adult Protective Services agencies, Long Term Care Ombudsmen programs, and law enforcement.

 

 49 

 

 

Fraud and Abuse. There are various federal and state civil and criminal laws and regulations governing a wide array of healthcare provider referrals, relationships and arrangements, including laws and regulations prohibiting fraud by healthcare providers. Many of these complex laws raise issues that have not been clearly interpreted by the relevant governmental authorities and courts.

 

These laws include: (i) federal and state false claims acts, which, among other things, prohibit providers from filing false claims or making false statements to receive payment from Medicare, Medicaid or other federal or state healthcare programs; (ii) federal and state anti-kickback and fee-splitting statutes, including the Medicare and Medicaid Anti-kickback statute, which prohibit the payment or receipt of remuneration to induce referrals or recommendations of healthcare items or services, such as services provided in a SNF; (iii) federal and state physician self-referral laws (commonly referred to as the Stark Law), which generally prohibit referrals by physicians to entities for designated health services (some of which are provided in SNFs) with which the physician or an immediate family member has a financial relationship; (iv) the federal Civil Monetary Penalties Law, which prohibits, among other things, the knowing presentation of a false or fraudulent claim for certain healthcare services and (v) federal and state privacy laws, including the privacy and security rules contained in the Health Insurance Portability and Accountability Act of 1996, which provide for the privacy and security of personal health information.

 

Violations of healthcare fraud and abuse laws carry civil, criminal and administrative sanctions, including punitive sanctions, monetary penalties, imprisonment, denial of Medicare and Medicaid reimbursement and potential exclusion from Medicare, Medicaid or other federal or state healthcare programs. Additionally, there are criminal provisions that prohibit filing false claims or making false statements to receive payment or certification under Medicare and Medicaid, as well as failing to refund overpayments or improper payments. Violation of the Anti-kickback statute or Stark Law may form the basis for a federal False Claims Act violation. These laws are enforced by a variety of federal, state and local agencies and can also be enforced by private litigants through, among other things, federal and state false claims acts, which allow private litigants to bring qui tam or whistleblower actions, which have become more frequent in recent years.

 

Several of our operators have responded to subpoenas and other requests for information regarding their operations in connection with inquiries by the U.S. Department of Justice or other regulatory agencies. One of our top 10 operators is in ongoing settlement discussions with the Department of Justice.

 

Privacy. Our operators are subject to various federal, state and local laws and regulations designed to protect the confidentiality and security of patient health information, including the federal Health Insurance Portability and Accountability Act of 1996, as amended, the Health Information Technology for Economic and Clinical Health Act (“HITECH”), and the corresponding regulations promulgated thereunder (collectively referred to herein as “HIPAA”). The HITECH Act expanded the scope of these provisions by mandating individual notification in instances of breaches of protected health information, providing enhanced penalties for HIPAA violations, and granting enforcement authority to states’ Attorneys General in addition to the HHS Office for Civil Rights. HHS continued its auditing program in 2016 to assess compliance efforts by covered entities and business associates. Through a second phase of audits, which commenced for covered entities in July 2016, HHS focused on a review of policies and procedures adopted and employed by covered entities and their business associates to meet selected standards and implementation specifications of the HIPAA Privacy, Security, and Breach Notification Rules. Covered entities and business associates selected for a desk audit in 2016 have the potential to be selected for an on-site audit in 2017.

 

Various states have similar laws and regulations that govern the maintenance and safeguarding of patient records, charts and other information generated in connection with the provision of professional medical services. These laws and regulations require our operators to expend the requisite resources to secure protected health information, including the funding of costs associated with technology upgrades. Operators found in violation of HIPAA or any other privacy law or regulation may face large penalties. In addition, compliance with an operator’s notification requirements in the event of a breach of unsecured protected health information could cause reputational harm to an operator’s business.

 

 50 

 

 

Licensing and Certification. Our operators and facilities are subject to various federal, state and local licensing and certification laws and regulations, including laws and regulations under Medicare and Medicaid requiring operators of SNFs and ALFs to comply with extensive standards governing operations. Governmental agencies administering these laws and regulations regularly inspect our operators’ facilities and investigate complaints. Our operators and their managers receive notices of observed violations and deficiencies from time to time, and sanctions have been imposed from time to time on facilities operated by them. In addition, many states require certain healthcare providers to obtain a certificate of need, which requires prior approval for the construction, expansion or closure of certain healthcare facilities, which has the potential to impact some of our operators’ abilities to expand or change their businesses.

 

Americans with Disabilities Act (the “ADA”). Our properties must comply with the ADA and any similar state or local laws to the extent that such properties are public accommodations as defined in those statutes. The ADA may require removal of barriers to access by persons with disabilities in certain public areas of our properties where such removal is readily achievable. Should barriers to access by persons with disabilities be discovered at any of our properties, we may be directly or indirectly responsible for additional costs that may be required to make facilities ADA-compliant. Noncompliance with the ADA could result in the imposition of fines or an award of damages to private litigants. Our commitment to make readily achievable accommodations pursuant to the ADA is ongoing, and we continue to assess our properties and make modifications as appropriate in this respect.

 

Other Laws and Regulations. Additional federal, state and local laws and regulations affect how our operators conduct their operations, including laws and regulations protecting consumers against deceptive practices and otherwise generally affecting our operators’ management of their property and equipment and the conduct of their operations (including laws and regulations involving fire, health and safety; quality of services, including care and food service; residents’ rights, including abuse and neglect laws; and the health standards set by the federal Occupational Safety and Health Administration).

 

General and Professional Liability. Although arbitration agreements have been effective in limiting general and professional liabilities for SNF and long term care providers, there have been numerous lawsuits challenging the validity of arbitration agreements in long term care settings. As set forth in the recent conditions of participation final rule issued on October 4, 2016, CMS prohibited pre-dispute arbitration agreements between SNFs and residents effective November 28, 2016, thereby increasing potential liabilities for SNFs and long-term care providers. Subsequently, the authority of CMS to restrict the rights of these parties to arbitrate was challenged by litigation in various jurisdictions, and enforcement by CMS was suspended on November 7, 2016 following the issuance of a preliminary injunction by the U.S. District Court for the Northern District of Mississippi. In a reversal from its previous position, CMS issued a proposed rule on June 5, 2017, that lifts CMS’ ban on pre-dispute arbitration agreements in the long-term care setting.

 

Critical Accounting Policies and Estimates

 

Our financial statements are prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States, and a summary of our significant accounting policies is included in Note 2 – Summary of Significant Accounting Policies to our Annual Report on Form 10-K for the year ended December 31, 2016, as amended. Our preparation of the financial statements requires us to make estimates and assumptions about future events that affect the amounts reported in our financial statements and accompanying footnotes. Future events and their effects cannot be determined with absolute certainty. Therefore, the determination of estimates requires the exercise of judgment. Actual results inevitably will differ from those estimates, and such differences may be material to the consolidated financial statements. We have described our most critical accounting policies in our 2016 Annual Report on Form 10-K for the year ended December 31, 2016, as amended, in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

There have been no changes to our critical accounting policies or estimates since December 31, 2016. See Note 2 – Summary of Significant Accounting Policies to our Annual Report on Form 10-K for the year ended December 31, 2016, as amended.

 

 51 

 

 

Accounting Pronouncement Adopted in 2017

 

In March 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-09, Compensation-Stock Compensation (Topic 718) (“ASU 2016-09”). ASU 2016-09 amends the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. This guidance is effective for annual and interim reporting periods of public entities beginning after December 15, 2016. We adopted this accounting standard on January 1, 2017, at which time the Company began prospectively accounting for excess tax benefits or tax deficiencies as an adjustment to income tax expense in our Consolidated Statements of Income as opposed to the prior requirement that these excess tax benefits be recognized in additional paid-in capital and tax deficiencies be recognized either as an offset to accumulated excess tax benefits, if any, or in the income statement. The Company will continue to account for forfeitures as they occur and present employee taxes paid as a financing activity on our Consolidated Statements of Cash Flows. The adoption of this accounting standard did not have a material impact on our consolidated financial statements.

 

Recent Accounting Pronouncements - Pending Adoption

 

In 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), which outlines a comprehensive model for entities to use in accounting for revenue arising from contracts with customers. ASU 2014-09 states that “an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.” While ASU 2014-09 specifically references contracts with customers, it may apply to certain other transactions such as the sale of real estate or equipment. ASU 2014-09 is effective for the Company beginning January 1, 2018. In addition, the FASB has begun to issue targeted updates to clarify specific implementation issues of ASU 2014-09. These updates include ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Identifying Performance Obligations and Licensing, and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients. The Company is currently evaluating the provisions of ASU 2014-09 and its related updates and will be closely monitoring developments and additional guidance to determine the potential impact of the new standard. The Company intends to adopt ASU 2014-09 and its subsequent updates in accordance with the modified retrospective approach. We do not expect the adoption of ASU 2014-09 and its updates to have a significant impact on our consolidated financial statements, as a substantial portion of our revenue consists of rental income from leasing arrangements and interest income from loan arrangements, both of which are specifically excluded from ASU 2014-09.

 

In February 2016, the FASB issued ASU 2016-02, Leases (“ASU 2016-02”), which amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. ASU 2016-02 will be effective for the Company beginning January 1, 2019. Early adoption of ASU 2016-02 as of its issuance is permitted. The new standard requires a modified retrospective transition approach for all leases existing at, or entered into after, the date of initial application, with an option to use certain transition relief. As a result of the pending adoption ASU 2016-02 and in connection with the pending adoption of ASU 2014-09, the Company may be required to record real estate tax revenues and an equal an offsetting real estate tax expense, as a result of our operators paying real estate taxes on our behalf. We are continuing to evaluate the other impacts of adopting ASU 2016-02 on our consolidated financial statements.

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) (“ASU 2016-13”), which changes the impairment model for most financial assets. The new model uses a forward-looking expected loss method, which will generally result in earlier recognition of allowances for losses. ASU 2016-13 is effective for annual and interim periods beginning after December 15, 2019 and early adoption is permitted for annual and interim periods beginning after December 15, 2018. We are currently evaluating the impact of adopting ASU 2016-13 on our consolidated financial statements.

 

 52 

 

 

Results of Operations

 

The following is our discussion of the consolidated results of operations, financial position and liquidity and capital resources, which should be read in conjunction with our unaudited consolidated financial statements and accompanying notes.

 

Three Months Ended June 30, 2017 and 2016

 

Operating Revenues

 

Our operating revenues for the three months ended June 30, 2017, totaled $235.8 million, an increase of $7.0 million over the same period in 2016. The $7.0 million increase was primarily the result of: (i) a $1.5 million increase in rental income related to the U.K. Gold Care acquisition in May 2017, (ii) $6.0 million of additional rental income associated with other acquisitions and lease amendments made throughout 2016 and 2017, and (iii) a $2.3 million increase in other investment income primarily related to new notes and additional funding to existing operators made throughout 2016 and 2017. These increases were offset by a $5.1 million decrease in mortgage interest income primarily due to the repayment of certain mortgages in the second quarter of 2016.

 

Operating Expenses

 

Operating expenses for the three months ended June 30, 2017, totaled $94.7 million, an increase of approximately $8.1 million over the same period in 2016. The increase was primarily due to: (i) a $4.8 million increase in depreciation and amortization expense related to acquisitions and the placement of assets in service during 2016 and 2017, (ii) a $3.8 million increase in provision for uncollectible accounts, (iii) a $3.2 million increase in provision for impairment losses, offset by a $3.5 million decrease in acquisition costs primarily due to fewer acquisitions and the capitalization of acquisition costs in 2017.

 

Other Income (Expense)

 

For the three months ended June 30, 2017, total other expenses were $72.3 million, an increase of approximately $30.4 million over the same period in 2016. The increase was primarily related to: (i) a $22.0 million increase in interest refinancing costs related to early extinguishment costs incurred to redeem the $400 million 5.875% Senior Notes due 2024 and the write-off of deferred costs related to the 2014 credit facility and (ii) an $8.4 million increase in interest expense related to higher debt balances outstanding to fund new investments and higher blended borrowing costs.

 

Six Months Ended June 30, 2017 and 2016

 

Operating Revenues

 

Our operating revenues for the six months ended June 30, 2017, totaled $467.5 million, an increase of $25.8 million over the same period in 2016. The $25.8 million increase was primarily the result of: (i) a $1.5 million increase in rental income related to the U.K. Gold Care acquisition in May 2017, (ii) $21.9 million of additional rental income associated with other acquisitions and lease amendments made throughout 2016 and 2017, and (iii) a $5.8 million increase in other investment income primarily related to new notes and additional funding to existing operators made throughout 2016 and 2017. These increases were offset by a $5.7 million decrease in mortgage interest income primarily due to the repayment of certain mortgages in the second quarter of 2016.

 

 53 

 

 

Operating Expenses

 

Operating expenses for the six months ended June 30, 2017, totaled $187.2 million, a decrease of approximately $15.7 million over the same period in 2016. The decrease was primarily due to: (i) a $23.7 million decrease in provision for impairment losses due to fewer facilities impaired during the first six months of 2017 as compared to the same period in 2016, (ii) a $7.3 million decrease in acquisition costs primarily due fewer acquisitions and the capitalization of acquisition costs in 2017, offset by a $12.4 million increase in depreciation and amortization expense related to acquisitions and the placement of assets in service during 2016 and 2017.

 

Other Income (Expense)

 

For the six months ended June 30, 2017, total other expenses were $109.3 million, an increase of approximately $27.8 million over the same period in 2016. The increase was primarily related to: (i) a $21.7 million increase in interest refinancing costs related to early extinguishment costs incurred to redeem the $400 million 5.875% Senior Notes due 2024 and the write-off of deferred costs related to the 2014 credit facility and (ii) a $16.3 million increase in interest expense related to higher debt balances outstanding to fund new investments and higher blended borrowing costs, offset by a one-time $10.4 million contractual settlement with an unrelated third party related to a contingent liability obligation that originated in 2012 and was resolved in the first quarter of 2017.

 

National Association of Real Estate Investment Trusts Funds From Operations

 

Our funds from operations (“NAREIT FFO”) for the three months ended June 30, 2017 was $150.9 million compared to $172.3 million for the same period in 2016. Our NAREIT FFO for the six months ended June 30, 2017 was $331.9 million compared to $325.9 million for the same period in 2016.

 

We calculate and report NAREIT FFO in accordance with the definition of Funds from Operations and interpretive guidelines issued by the National Association of Real Estate Investment Trusts (“NAREIT”), and, consequently, NAREIT FFO is defined as net income (computed in accordance with GAAP), adjusted for the effects of asset dispositions and certain non-cash items, primarily depreciation and amortization and impairment on real estate assets, and after adjustments for unconsolidated partnerships and joint ventures. Adjustments for unconsolidated partnerships and joint ventures will be calculated to reflect funds from operations on the same basis. We believe that NAREIT FFO is an important supplemental measure of our operating performance. Because the historical cost accounting convention used for real estate assets requires depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time, while real estate values instead have historically risen or fallen with market conditions. NAREIT FFO was designed by the real estate industry to address this issue. NAREIT FFO herein is not necessarily comparable to NAREIT FFO of other REITs that do not use the same definition or implementation guidelines or interpret the standards differently from us.

 

NAREIT FFO is a non-GAAP financial measure. We use NAREIT FFO as one of several criteria to measure the operating performance of our business. We further believe that by excluding the effect of depreciation, amortization, impairment on real estate assets and gains or losses from sales of real estate, all of which are based on historical costs and which may be of limited relevance in evaluating current performance, NAREIT FFO can facilitate comparisons of operating performance between periods and between other REITs. We offer this measure to assist the users of our financial statements in evaluating our financial performance under GAAP, and NAREIT FFO should not be considered a measure of liquidity, an alternative to net income or an indicator of any other performance measure determined in accordance with GAAP. Investors and potential investors in our securities should not rely on this measure as a substitute for any GAAP measure, including net income.

 

 54 

 

 

The following table presents our NAREIT FFO results for the three and six months ended June 30, 2017 and 2016:

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2017   2016   2017   2016 
   (in thousands) 
                 
Net income  $68,157   $113,154   $177,269   $171,350 
Add back loss (deduct gain) from real estate dispositions   622    (13,221)   (6,798)   (14,792)
    68,779    99,933    170,471    156,558 
Elimination of non-cash items included in net income:                    
Depreciation and amortization   70,350    65,505    140,343    127,938 
Depreciation – unconsolidated joint venture   1,658        3,316     
Add back impairments on real estate properties   10,135    6,893    17,773    41,451 
NAREIT FFO (a)  $150,922   $172,331   $331,903   $325,947 

 

(a) Includes amounts allocated to Omega stockholders and Omega OP Unit holders.

 

Portfolio and Recent Developments

 

The following table summarizes the significant acquisitions that occurred during the first six months of 2017:

 

   Number of
Facilities
   Country/ 

Total

Investment

   Land  

Building & Site

Improvements

  

Furniture

& Fixtures

  

Initial

Annual Cash

 
Period  SNF   ALF   State  (in millions)   Yield(2) (%) 
Q1   -    1   VA  $7.6   $0.5   $6.8   $0.3    7.50 
Q2   1    -   NC   8.6    0.7    7.3    0.6    9.50 
Q2   -    18   UK   124.2  (1)   34.1    85.1    5.0    8.50 
Total   1    19      $140.4   $35.3   $99.2   $5.9      

 

(1)Omega recorded a non-cash deferred tax liability and acquisitions costs of approximately $8.2 million and $1.2 million, respectively, in connection with the acquisition.
(2)The cash yield is based on the purchase price.

 

During the second quarter of 2017, we acquired two parcels of land which are not reflected in the table above for approximately $5.5 million with the intent of building new facilities for an existing operator.

 

Asset Sales, Impairments and Other

 

During the first quarter of 2017, we sold 15 facilities for approximately $45.8 million in net proceeds recognizing a gain on sale of approximately $7.4 million. Eleven of the sold facilities were previously classified as held for sale. In addition, we recorded a provision for impairment of approximately $7.6 million on three facilities, one of which was reclassified to held for sale as of March 31, 2017.

 

During the second quarter of 2017, we sold three facilities for approximately $18.3 million in net cash proceeds recognizing a loss on sale of approximately $0.6 million. Two of the sold facilities were previously classified as assets held for sale. In addition, we recorded a provision for impairment of approximately $10.1 million on six facilities. We reduced the net book value of the impaired facilities to their estimated fair values. To estimate the fair value of the facilities, we utilized a market approach and Level 3 inputs (which generally consist of non-binding offers from unrelated third parties). Our recorded impairments were primarily the result of a decision to exit certain non-strategic facilities and/or operators.

 

 55 

 

 

During the second quarter of 2017, we sold five facilities previously classified as investments in direct financing leases and received net cash proceeds of approximately $27.3 million and recorded an additional allowance for loss of approximately $0.9 million in addition to $2.4 million allowance for loss recorded in the first quarter of 2017.

 

As of June 30, 2017, seven facilities, totaling $18.9 million are classified as assets held for sale. We expect to sell these facilities over the next few quarters.

 

At June 30, 2017, two of our top 10 operators were approximately 90 days past due on rent payments to the Company. One of these operators has been facing liquidity pressures following a management transition, but has been showing signs of operational improvement and is currently making partial monthly rent payments. The current management of this operator is pursuing operational improvements, such as replacing executive management and senior level management, renegotiating vendor contracts and establishing a centralized referral network. The Company is working with this operator to concentrate its geographic footprint by selling certain facilities, of which five were sold prior to June 30, 2017. The Company expects to sell two other facilities and transition its existing Texas portfolio to another operator during the third quarter of 2017. The Company is optimistic that the combination of these efforts will result in improving margins and performance by this operator. The Company is currently recording rental revenue from this operator on an accrual basis. The Company continues to monitor the operator’s operating plan and in the event its performance deteriorates, the Company will reassess the carrying value of the portfolio and consider recording future rental revenue on a cash basis.

 

The other operator with approximately 90 days rent past due has been adversely affected by an adverse general and professional liability environment in Kentucky and is in ongoing discussions to settle matters arising from a U.S. Department of Justice investigation. The Company has negotiated a proposed restructuring plan with this operator, subject to the operator’s resolution of its obligations with other landlords and lenders and the Department of Justice investigation. Receivables from this operator are backed by a security deposit and guarantees from the principals of the operator.

 

The Company believes the current performance of these two operators primarily reflects specific operator-related or localized issues rather than issues generally impacting the industry. The Company continues to closely monitor the performance of these two operators specifically, as well as industry trends and developments generally.

 

Liquidity and Capital Resources

 

At June 30, 2017, we had total assets of $8.9 billion, total equity of $4.2 billion and debt of $4.4 billion, representing approximately 51.5% of total capitalization.

 

Financing Activities and Borrowing Arrangements

 

Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants. As of June 30, 2017 and December 31, 2016, we were in compliance with all affirmative and negative covenants, including financial covenants, for our secured and unsecured borrowings.

 

 56 

 

 

New and Amended Unsecured Credit Facility – 2017

 

2017 Omega Credit Facilities

 

On May 25, 2017, Omega entered into a credit agreement (the “2017 Omega Credit Agreement”) providing us with a new $1.8 billion senior unsecured revolving and term loan credit facility, consisting of a $1.25 billion senior unsecured multicurrency revolving credit facility (the “Revolving Credit Facility”), a $425 million senior unsecured U.S. Dollar term loan facility (the “U.S. Term Loan Facility”), and a £100 million senior unsecured British Pound Sterling term loan facility (the “Sterling Term Loan Facility” and, together with the Revolving Credit Facility and the U.S. Term Loan Facility, collectively, the “2017 Omega Credit Facilities”). The 2017 Omega Credit Agreement contains an accordion feature permitting us, subject to compliance with customary conditions, to increase the maximum aggregate commitments under the 2017 Omega Credit Facilities to $2.5 billion. Among other things, proceeds from borrowings under the 2017 Omega Credit Facilities were used to refinance existing indebtedness, to finance acquisitions and to fund working capital, capital expenditures and other general corporate purposes.

 

The 2017 Omega Credit Facilities replace the previous $1.25 billion senior unsecured 2014 revolving credit facility, the previous $200 million Tranche A-1 senior unsecured term loan facility, and the previous $350 million Tranche A-3 senior unsecured incremental term loan facility established under our 2014 credit agreement, which has been terminated (the “2014 Omega Credit Agreement”). We had previously repaid and terminated the $200 million Tranche A-2 senior unsecured term loan facility established under the 2014 Omega Credit Agreement, with proceeds from our $550 million and $150 million unsecured senior notes issued in April 2017.

 

The Revolving Credit Facility bears interest at LIBOR plus an applicable percentage (with a range of 100 to 195 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The Revolving Credit Facility matures on May 25, 2021, subject to an option by us to extend such maturity date for two, six month periods. The 2017 Omega Credit Agreement provides for the Revolving Credit Facility to be drawn in Euros, British Pounds Sterling, Canadian Dollars (collectively, “Alternative Currencies”) or U.S. Dollars, with a $900 million tranche available in U.S. Dollars and a $350 million tranche available in U.S. Dollars or Alternative Currencies. For purposes of the 2017 Omega Credit Facilities, references to LIBOR include the Canadian dealer offered rates for amounts offered in Canadian Dollars and any other Alternative Currency rate approved in accordance with the terms of the 2017 Omega Credit Agreement for amounts offered in any other non-London interbank offered rate quoted currency, as applicable. As of June 30, 2017, $155.0 million remains outstanding on the Revolving Credit Facility.

 

The U.S. Term Loan Facility and the Sterling Term Loan Facility bear interest at LIBOR plus an applicable percentage (with a range of 90 to 190 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The U.S. Term Loan Facility and the Sterling Term Loan Facility each mature on May 25, 2022. As of June 30, 2017, we had $425.0 million in borrowings outstanding under the U.S. Term Loan Facility, and £100.0 million (equivalent to $130.3 million in U.S. dollars) in borrowings outstanding under the Sterling Term Loan Facility.

 

For the three month period ending June 30, 2017, we recorded a one-time, non-cash charge of approximately $5.5 million relating to the write-off of deferred financing costs associated with the termination of the 2014 Omega Credit Agreement.

 

Amended 2015 Term Loan Facility

 

On May 25, 2017, Omega entered into an amended and restated credit agreement (the “Amended 2015 Credit Agreement”), which amended and restated our previous $250 million senior unsecured term loan facility (the “Amended 2015 Term Loan Facility”). The Amended 2015 Term Loan Facility bears interest at LIBOR plus an applicable percentage (with a range of 140 to 235 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. As of June 30, 2017, $250 million remains outstanding on the Amended 2015 Term Loan Facility. The Amended 2015 Term Loan Facility continues to mature on December 16, 2022. The Amended 2015 Credit Agreement permits us, subject to compliance with customary conditions, to add one or more incremental tranches to the Amended 2015 Term Loan Facility in an aggregate principal amount not exceeding $150 million.

 

 57 

 

 

Omega’s obligations under the 2017 Omega Credit Facilities and the Amended 2015 Term Loan Facility are jointly and severally guaranteed by Omega OP, OHI Holdco, and any domestic subsidiary of Omega that provides a guaranty of any unsecured indebtedness of Omega for borrowed money evidenced by bonds, debentures, notes or other similar instruments in an amount of at least $50 million individually or in the aggregate.

 

2017 Omega OP Term Loan Facility

 

On May 25, 2017, Omega OP entered into a credit agreement (the “2017 Omega OP Credit Agreement”) providing it with a new $100 million senior unsecured term loan facility (the “2017 Omega OP Term Loan Facility”). The 2017 Omega OP Credit Agreement replaces the $100 million senior unsecured term loan facility obtained in 2015 (the “2015 Omega OP Term Loan Facility”) and the related credit agreement (the “2015 Omega OP Credit Agreement”). The 2017 Omega OP Term Loan Facility bears interest at LIBOR plus an applicable percentage (with a range of 90 to 190 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The 2017 Omega OP Term Loan Facility matures on May 25, 2022. As of June 30, 2017, $100 million in borrowings remains outstanding on the 2017 Omega OP Term Loan Facility. Among other things, proceeds from borrowings under the 2017 Omega OP Term Loan Facility were used to refinance existing indebtedness.

 

Omega OP’s obligations in connection with the 2017 Omega OP Term Loan Facility are not currently guaranteed, but will be jointly and severally guaranteed by any domestic subsidiary of Omega OP that provides a guaranty of any unsecured indebtedness of Omega or Omega OP for borrowed money evidenced by bonds, debentures, notes or other similar instruments in an amount of at least $50 million individually or in the aggregate.

 

$550 Million 4.75% Senior Notes and $150 Million 4.5% Senior Notes

 

On April 4, 2017, Omega issued (i) $550 million aggregate principal amount of our 4.75% Senior Notes due 2028 (the “2028 Notes”) and (ii) an additional $150 million aggregate principal amount of our existing 4.50% Senior Notes due 2025 (the “2025 Notes”, and together with the 2028 Notes collectively, the “Notes”). The 2028 Notes mature on January 15, 2028 and the 2025 Notes mature on January 15, 2025.

 

The 2028 Notes were sold at an issue price of 98.978% of their face value before the underwriters’ discount and the 2025 Notes were sold at an issue price of 99.540% of their face value before the underwriters’ discount. Our net proceeds from the Notes offering, after deducting underwriting discounts and expenses, were approximately $690.7 million. The net proceeds from the Notes offering were used to (i) redeem all of our outstanding $400 million aggregate principal amount of 5.875% Senior Notes due 2024 (the “5.875% Notes”) on April 28, 2017, (ii) prepay the $200 million Tranche A-2 Term Loan Facility on April 5, 2017 that otherwise would have become due on June 27, 2017, and (iii) repay outstanding borrowings under our revolving credit facility.

 

$400 Million 5.875% Senior Notes Redemption

 

On April 28, 2017, Omega redeemed all of our outstanding 5.875% Notes. As a result of the redemption, during the second quarter of 2017, we recorded approximately $16.5 million in redemption related costs and write-offs, including $11.8 million for the call premium and $4.7 million in net write-offs associated with unamortized deferred financing costs.

 

$500 Million Equity Shelf Program

 

For the three months ended June 30, 2017, no shares were issued under our $500 million Equity Shelf Program. For the six months ended June 30, 2017, we issued 0.2 million shares of common stock at an average price of $29.17 per share, net of issuance costs, generating net proceeds of $6.6 million under our $500 million Equity Shelf Program.

 

 58 

 

 

Dividend Reinvestment and Common Stock Purchase Plan

 

For the three months ended June 30, 2017, approximately 0.4 million shares of our common stock at an average price of $33.02 per share were issued through our Dividend Reinvestment and Common Stock Purchase Program for gross proceeds of approximately $12.4 million. For the six months ended June 30, 2017, approximately 0.6 million shares of our common stock at an average price of $32.11 per share were issued through our Dividend Reinvestment and Common Stock Purchase Program for gross proceeds of approximately $19.7 million.

 

Dividends

 

In order to qualify as a REIT, we are required to distribute dividends (other than capital gain dividends) to our stockholders in an amount at least equal to (A) the sum of (i) 90% of our “REIT taxable income” (computed without regard to the dividends paid deduction and our net capital gain), and (ii) 90% of the net income (after tax), if any, from foreclosure property, minus (B) the sum of certain items of non-cash income. In addition, if we dispose of any built-in gain asset during a recognition period, we will be required to distribute at least 90% of the built-in gain (after tax), if any, recognized on the disposition of such asset. Such distributions must be paid in the taxable year to which they relate, or in the following taxable year if declared before we timely file our tax return for such year and paid on or before the first regular dividend payment after such declaration. In addition, such distributions are required to be made pro rata, with no preference to any share of stock as compared with other shares of the same class, and with no preference to one class of stock as compared with another class except to the extent that such class is entitled to such a preference. To the extent that we do not distribute all of our net capital gain or do distribute at least 90%, but less than 100% of our “REIT taxable income” as adjusted, we will be subject to tax thereon at regular ordinary and capital gain corporate tax rates.

 

For the three and six months ended June 30, 2017, we paid dividends of approximately $124.5 million and $246.7 million to our common stockholders, respectively. The Omega OP Unit holders received the same distributions per unit as those paid to the common stockholders of Omega.

 

Liquidity

 

We believe our liquidity and various sources of available capital, including cash from operations, our existing availability under our Omega Credit Facilities and expected proceeds from mortgage payoffs are adequate to finance operations, meet recurring debt service requirements and fund future investments through the next twelve months.

 

We regularly review our liquidity needs, the adequacy of cash flow from operations, and other expected liquidity sources to meet these needs. We believe our principal short-term liquidity needs are to fund:

 

·normal recurring expenses;
·debt service payments;
·capital improvement programs;
·common stock dividends; and
·growth through acquisitions of additional properties.

 

The primary source of liquidity is our cash flows from operations. Operating cash flows have historically been determined by: (i) the number of facilities we lease or have mortgages on; (ii) rental and mortgage rates; (iii) our debt service obligations; and (iv) general and administrative expenses. The timing, source and amount of cash flows provided by or used in financing activities and in investing activities are sensitive to the capital markets environment, especially to changes in interest rates. Changes in the capital markets environment may impact the availability of cost-effective capital and affect our plans for acquisition and disposition activity.

 

 59 

 

 

Cash and cash equivalents totaled $21.0 million as of June 30, 2017, a decrease of $72.7 million as compared to the balance at December 31, 2016. The following is a discussion of changes in cash and cash equivalents due to operating, investing and financing activities, which are presented in our Consolidated Statements of Cash Flows.

 

Operating Activities – Operating activities generated $265.6 million of net cash flow for the six months ended June 30, 2017, as compared to $286.9 million for the same period in 2016, a decrease of $21.3 million which is primarily due to an increase in contractual receivables from two operators.

 

Investing Activities – Net cash flow from investing activities was an outflow of $135.9 million for the six months ended June 30, 2017, as compared to an outflow of $709.0 million for the same period in 2016. The $573.1 million change in cash flow from investing activities related primarily to (i) a $491.9 million reduction in real estate acquisitions, (ii) a $94.4 million reduction from other investments – net primarily related to funding fewer other investments in 2017, (iii) a $47.5 million increase in proceeds from the sale of real estate investments (including five facilities previously classified as investment in direct financing leases) in 2017, as compared to the same period in 2016 and (iv) an increase of $9.7 million in distributions from our unconsolidated joint venture in 2017. Offsetting these outflows were: (i) a $41.4 million decrease in collection of mortgages primarily related to the repayment of certain mortgages in 2016 and (ii) a $19.1 million increase in investments in construction in progress in 2017, as compared to the same period in 2016.

 

Financing Activities – Net cash flow from financing activities was an outflow of $202.6 million for the six months ended June 30, 2017, as compared to an inflow of $449.8 million for the same period in 2016. The $652.4 million increase in cash outflow from financing activities was primarily related to (i) a net decrease in cash provided by our credit facility of $275.0 million, in 2016 our credit facility provided $240.0 million in net cash as compared to a use of $35.0 million in net cash in 2017, (ii) a net decrease of $254.8 million from long-term borrowings, primarily from the redemption of the $400 million 5.875% Senior Notes due 2024 and the repayment of certain 2014 credit facility borrowings offset by new borrowings under the 2017 credit facility, (iii) a decrease in net proceeds of $73.6 million from our dividend reinvestment plan in 2017, as compared to the same period in 2016, (iv) an increase of $29.7 million in dividends paid and (v) an increase of $24.9 million in financing related costs in 2017, as compared to the same period in 2016. Offsetting these outflows was a $6.1 million increase in cash proceeds from the issuance of common stock in 2017, as compared to the same period in 2016.

 

Item 3 – Quantitative and Qualitative Disclosures about Market Risk

 

During the quarter ended June 30, 2017, there were no material changes in our primary market risk exposures or how those exposures are managed from the information disclosed under Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2016, as amended.

 

Item 4 – Controls and Procedures

 

Disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

In connection with the preparation of this Form 10-Q, management evaluated the effectiveness of the design and operation of the disclosure controls and procedures of Omega, OHI Holdco, and Omega OP (for purposes of this Item 4 the “Companies”) as of June 30, 2017. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that disclosure controls and procedures of the Companies were effective at a reasonable assurance level as of June 30, 2017.

 

 60 

 

 

Internal Control Over Financial Reporting

 

There were no changes in the Companies’ internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the period covered by this report identified in connection with the evaluation of our disclosure controls and procedures described above that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 61 

 

 

PART II OTHER INFORMATION

 

Item 1 Legal Proceedings

 

See Note 15 – Litigation to the Consolidated Financial Statements in Part I, Item 1 hereto, which is hereby incorporated by reference in response to this item.

 

Item 1A – Risk Factors

 

There have been no material changes to our risk factors as previously disclosed in Item 1A contained in Part I of Amendment No. 1 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2016 and filed with the Securities and Exchange Commission (“SEC”) on August 9, 2017.

 

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

 

During the quarterly period ended June 30, 2017, Omega issued an aggregate of 42,539 shares of Omega common stock, in exchange for an equivalent number of Omega OP Units tendered to Omega OP for redemption in accordance with the provisions of the Partnership Agreement. The Company issued these shares of Omega common stock in reliance on an exemption from registration under Section 4(a) (2) of the Securities Act of 1933, as amended, based upon factual representations received from the limited partners who received the Omega common stock.

 

 62 

 

 

Item 6–Exhibits

 

Exhibit No.    
3.1   Amended and Restated Bylaws of Omega Healthcare Investors, Inc. as of June 8, 2017 (Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on June 9, 2017).
4.1   Thirteenth Supplemental Indenture, dated as of May 11, 2017, among Omega Healthcare Investors, Inc., each of the subsidiary guarantors listed therein and U.S. Bank National Association, as trustee, related to the 4.950% Senior Notes due 2024, including the Form of 4.950% Senior Notes and Form of Subsidiary Guarantee related thereto.*
4.1A   Fourteenth Supplemental Indenture, dated as of May 25, 2017, among Omega Healthcare Investors, Inc., each of the subsidiary guarantors listed therein and U.S. Bank National Association, as trustee, related to the 4.950% Senior Notes due 2024, including the Form of 4.950% Senior Notes and Form of Partial Release of Subsidiary Guarantors related thereto.*
4.2   Twelfth Supplemental Indenture, dated as of May 11, 2017, among Omega Healthcare Investors, Inc., each of the subsidiary guarantors listed therein and U.S. Bank National Association, as trustee, related to the 4.50% Senior Notes due 2025, including the Form of 4.50% Senior Notes and Form of Subsidiary Guarantee related thereto.*
4.2A   Thirteenth Supplemental Indenture, dated as of May 25, 2017, among Omega Healthcare Investors, Inc., each of the subsidiary guarantors listed therein and U.S. Bank National Association, as trustee, related to the 4.50% Senior Notes due 2025, including the Form of 4.50% Senior Notes and Form of Partial Release of Subsidiary Guarantors related thereto.*
4.3   Ninth Supplemental Indenture, dated as of May 11, 2017, among Omega Healthcare Investors, Inc., each of the subsidiary guarantors listed therein and U.S. Bank National Association, as trustee, related to the 4.500% Senior Notes due 2027, including the Form of 4.500% Senior Notes and Form of Subsidiary Guarantee related thereto.*
4.3A   Tenth Supplemental Indenture, dated as of May 25, 2017, among Omega Healthcare Investors, Inc., each of the subsidiary guarantors listed therein and U.S. Bank National Association, as trustee, related to the 4.500% Senior Notes due 2027, including the Form of 4.500% Senior Notes and Form of Form of Partial Release of Subsidiary Guarantors related thereto.*
4.4   Seventh Supplemental Indenture, dated as of May 11, 2017 among Omega Healthcare Investors, Inc., each of the subsidiary guarantors listed therein and U.S. Bank National Association, as trustee, related to the 5.250% Senior Notes due 2026, including the Form of 5.250% Senior Notes and Form of Subsidiary Guarantee related thereto.*
4.4A   Eighth Supplemental Indenture, dated as of May 25, 2017 among Omega Healthcare Investors, Inc., each of the subsidiary guarantors listed therein and U.S. Bank National Association, as trustee, related to the 5.250% Senior Notes due 2026, including the Form of 5.250% Senior Notes and Form of Partial Release of Subsidiary Guarantors related thereto.*
4.5   Fourth Supplemental Indenture, dated as of May 11, 2017, among Omega Healthcare Investors, Inc., each of the subsidiary guarantors listed therein and U.S. Bank National Association, as trustee, related to the 4.375% Senior Notes due 2023, including the Form of 4.375% Senior Notes and Form of Subsidiary Guarantee related thereto.*

 

 63 

 

 

4.5A   Fifth Supplemental Indenture, dated as of May 25, 2017, among Omega Healthcare Investors, Inc., each of the subsidiary guarantors listed therein and U.S. Bank National Association, as trustee, related to the 4.375% Senior Notes due 2023, including the Form of 4.375% Senior Notes and Form of Partial Release of Subsidiary Guarantors related thereto.*
4.6   Indenture, dated as of April 4, 2017, by and among Omega Healthcare Investors, Inc., each of the subsidiary guarantors listed therein, and U.S. Bank National Association, as trustee (Incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed with the SEC on April 4, 2017).
4.6A   First Supplemental Indenture, dated as of May 11, 2017, among Omega Healthcare Investors, Inc., each of the subsidiary guarantors listed therein and U.S. Bank National Association, as trustee, related to the 4.750% Senior Notes due 2028, including the Form of 4.750% Senior Notes and Form of Subsidiary Guarantee related thereto.*
4.6B   Second Supplemental Indenture, dated as of May 25, 2017, among Omega Healthcare Investors, Inc., each of the subsidiary guarantors listed therein and U.S. Bank National Association, as trustee, related to the 4.750% Senior Notes due 2028, including the Form of 4.750% Senior Notes and Form of Partial Release of Subsidiary Guarantors related thereto.*
10.1   Credit Agreement, dated as of May 25, 2017, among Omega Healthcare Investors, Inc., certain subsidiaries of Omega Healthcare Investors, Inc. identified therein as guarantors, the lenders named therein and Bank of America, N.A., as administrative agent for such lenders (Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on May 31, 2017).
10.2   Credit Agreement, dated as of May 25, 2017, among OHI Healthcare Properties Limited Partnership, the lenders named therein and Bank of America, N.A., as administrative agent for such lenders (Incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed with the SEC on May 31, 2017).
10.3   Amended and Restated Credit Agreement, dated as of May 25, 2017, among Omega Healthcare Investors, Inc., certain subsidiaries of Omega Healthcare Investors, Inc. identified therein as guarantors, the lenders named therein and The Bank of Tokyo-Mitsubishi UFJ, Ltd., as administrative agent for such lenders (Incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K, filed with the SEC on May 31, 2017).
31.1   Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.*
31.2   Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.*
31.3   Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer of OHI Healthcare Properties Holdco, Inc.*
31.4   Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer of OHI Healthcare Properties Holdco, Inc.*
31.5   Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer of OHI Healthcare Properties Holdco, Inc. , in its capacity as primary general partner of OHI Healthcare Properties Limited Partnership.*
31.6   Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer of OHI Healthcare Properties Holdco, Inc. , in its capacity as primary general partner of OHI Healthcare Properties Limited Partnership.*
32.1   Section 1350 Certification of the Chief Executive Officer.*
32.2   Section 1350 Certification of the Chief Financial Officer.*

 

 64 

 

 

32.3   Section 1350 Certification of the Chief Executive Officer of OHI Healthcare Properties Holdco, Inc.*
32.4   Section 1350 Certification of the Chief Financial Officer of OHI Healthcare Properties Holdco, Inc.*
32.5   Section 1350 Certification of the Chief Executive Officer of OHI Healthcare Properties Holdco, Inc., as Chief Financial Officer of the primary general partner of OHI Healthcare Properties Limited Partnership.*
32.6   Section 1350 Certification of the Chief Financial Officer of OHI Healthcare Properties Holdco, Inc., as Chief Financial Officer of the primary general partner of OHI Healthcare Properties Limited Partnership.*
101.INS   XBRL Instance Document.
101.SCH   XBRL Taxonomy Extension Schema Document.
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB   XBRL Taxonomy Extension Label Linkbase Document.
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document.

* Exhibits that are filed herewith.

 

 65 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

OMEGA HEALTHCARE INVESTORS, INC.

Registrant

 

Date: August 9, 2017 By: /S/ C. TAYLOR PICKETT  
      C. Taylor Pickett  
      Chief Executive Officer  
         
Date: August 9, 2017 By: /S/ ROBERT O. STEPHENSON  
      Robert O. Stephenson  
      Chief Financial Officer  

 

OHI HEALTHCARE PROPERTIES HOLDCO, INC.

Co-Registrant

 

Date: August 9, 2017 By: /S/ C. TAYLOR PICKETT  
      C. Taylor Pickett  
      Chief Executive Officer  
         
Date: August 9, 2017 By: /S/ ROBERT O. STEPHENSON  
      Robert O. Stephenson  
      Chief Financial Officer  

 

OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

Co-Registrant

 

By: OHI Healthcare Properties Holdco, Inc., its Primary General Partner

 

Date: August 9, 2017 By: /S/ C. TAYLOR PICKETT  
      C. Taylor Pickett  
      Chief Executive Officer  
         
Date: August 9, 2017 By: /S/ ROBERT O. STEPHENSON  
      Robert O. Stephenson  
      Chief Financial Officer  

 

 66 

EX-4.1 2 t1700448_ex4-1.htm EXHIBIT 4.1

 

 

Exhibit 4.1

 

THIRTEENTH SUPPLEMENTAL INDENTURE

(Senior Notes due 2024)

 

THIS THIRTEENTH SUPPLEMENTAL INDENTURE (this “Thirteenth Supplemental Indenture”) is dated as of May 11, 2017 among OMEGA HEALTHCARE INVESTORS, INC., a Maryland corporation (the “Issuer”), each of the SUBSIDIARY GUARANTORS listed on Schedule I hereto (collectively, the “Subsidiary Guarantors”), each of the entities listed on Schedule II hereto (collectively, the “New Subsidiaries”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, as trustee (the “Trustee”).

 

W I T N E S S E T H :

 

WHEREAS, the Issuer and the Subsidiary Guarantors have heretofore executed and delivered to the Trustee an Indenture, dated as of March 11, 2014 (as supplemented by that First Supplemental Indenture, dated as of June 27, 2014, that Second Supplemental Indenture, dated as of November 25, 2014, that Third Supplemental Indenture, dated as of January 23, 2015, that Fourth Supplemental Indenture, effective as of March 2, 2015, that Fifth Supplemental Indenture, dated as of April 1, 2015, that Sixth Supplemental Indenture, dated as of August 4, 2015, that Seventh Supplemental Indenture, dated as of November 9, 2015, that Eighth Supplemental Indenture, dated as of March 29, 2016, that Ninth Supplemental Indenture, dated as of May 13, 2016, that Tenth Supplemental Indenture, dated as of August 9, 2016, that Eleventh Supplemental Indenture, dated as of November 10, 2016, and that Twelfth Supplemental Indenture, dated as of March 17, 2017; the “Indenture”), providing for the issuance of the Issuer’s 4.950% Senior Notes due 2024 (the “Notes”);

 

WHEREAS, Section 9.01 of the Indenture authorizes the Issuer, the Subsidiary Guarantors and the Trustee, together, to amend or supplement the Indenture, without notice to or consent of any Holder of the Notes, for the purpose of making any change that would not materially adversely affect the rights of any Holder of the Notes;

 

WHEREAS, the Issuer has created or acquired the New Subsidiaries, which are required to become Subsidiary Guarantors pursuant to Section 4.14 of the Indenture;

 

WHEREAS, in Section 1.01 of the Indenture, the term “Subsidiary Guarantors” is defined to include all Persons that become a Subsidiary Guarantor by the terms of the Indenture after the Closing Date; and

 

WHEREAS, Section 10.01 of the Indenture provides that each Subsidiary Guarantor shall be a guarantor of the Issuer’s obligations under the Notes, subject to the terms and conditions described in the Indenture.

 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Issuer, the Subsidiary Guarantors, the New Subsidiaries and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:

 

[13th Supplemental Indenture – 2024 Notes]

 

 

 

 

1.CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 

2.AMENDMENT TO GUARANTEE. The New Subsidiaries hereby agree, jointly and severally with all other Subsidiary Guarantors, to guarantee the Issuer’s obligations under the Notes on the terms and subject to the conditions set forth in the Indenture, and to be bound by, and to receive the benefit of, all other applicable provisions of the Indenture as Subsidiary Guarantors. Such guarantee shall be evidenced by the New Subsidiaries’ execution of Subsidiary Guarantees, the form of which is attached as Exhibit E to the Indenture, and shall be effective as of the date hereof.

 

3.NO RECOURSE AGAINST OTHERS. No past, present or future director, officer, employee, incorporator, stockholder, member or manager of the New Subsidiaries, as such, shall have any liability for any obligations of the Issuer or any Subsidiary Guarantor under the Notes, any Guarantees, the Indenture or this Thirteenth Supplemental Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder of the Notes, by accepting and holding a Note, waives and releases all such liability. Such waiver and release are part of the consideration for the issuance of the Notes.

 

4.NEW YORK LAW TO GOVERN. The laws of the State of New York shall govern and be used to construe this Thirteenth Supplemental Indenture.

 

5.COUNTERPARTS. The parties may sign any number of copies of this Thirteenth Supplemental Indenture. Each signed copy shall be an original, but all of them together shall represent the same agreement.

 

6.EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

 

7.THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Thirteenth Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Issuer, the Subsidiary Guarantors and the New Subsidiaries.

 

[Remainder of Page Intentionally Left Blank] 

 

[13th Supplemental Indenture – 2024 Notes] 

 

 2 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Thirteenth Supplemental Indenture to be duly executed, all as of the date first above written.

 

ISSUER:
   
  OMEGA HEALTHCARE INVESTORS, INC.,
  a Maryland corporation
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
  SUBSIDIARY GUARANTORS:
     
  OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP
     
  By: OHI Healthcare Properties Holdco, Inc., as primary General Partner

 

  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

  ON BEHALF OF EACH OF THE OTHER SUBSIDIARY GUARANTORS LISTED ON SCHEDULE I
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

  NEW SUBSIDIARIES:
   
  ON BEHALF OF EACH OF THE NEW SUBSIDIARIES LISTED ON SCHEDULE II
     
  By:  /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

  U.S. BANK NATIONAL ASSOCIATION,
  as Trustee
       
  By: /s/ David Ferrell
    Name: David Ferrell
    Title: Vice President

 

[Signature Page – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

Schedule I

 

SUBSIDIARY GUARANTORS

 

1. 11900 East Artesia Boulevard, LLC
2. 1200 Ely Street Holdings Co. LLC
3. 13922 Cerise Avenue, LLC
4. 1628 B Street, LLC
5. 2400 Parkside Drive, LLC
6. 2425 Teller Avenue, LLC
7. 245 East Wilshire Avenue, LLC
8. 3232 Artesia Real Estate, LLC
9. 3806 Clayton Road, LLC
10. 42235 County Road Holdings Co. LLC
11. 446 Sycamore Road, L.L.C.
12. 48 High Point Road, LLC
13. 523 Hayes Lane, LLC
14. 637 East Romie Lane, LLC
15. Alamogordo Aviv, L.L.C.
16. Albany Street Property, L.L.C.
17. Arizona Lessor - Infinia, LLC
18. Arkansas Aviv, L.L.C.
19. Arma Yates, L.L.C.
20. Avery Street Property, L.L.C
21. Aviv Asset Management, L.L.C.
22. Aviv Financing I, L.L.C.
23. Aviv Financing II, L.L.C.
24. Aviv Financing III, L.L.C.
25. Aviv Financing IV, L.L.C.
26. Aviv Financing V, L.L.C.
27. Aviv Foothills, L.L.C.
28. Aviv Healthcare Properties Operating Partnership I, L.P.
29. Aviv Liberty, L.L.C.
30. Avon Ohio, L.L.C.
31. Bala Cynwyd Real Estate, LP
32. Bayside Colorado Healthcare Associates, LLC
33. Bayside Street II, LLC
34. Bayside Street, LLC (f/k/a Bayside Street, Inc.)
35. Belleville Illinois, L.L.C.
36. Bellingham II Associates, L.L.C.
37. Bethel ALF Property, L.L.C.
38. BHG Aviv, L.L.C.
39. Biglerville Road, L.L.C.
40. Bonham Texas, L.L.C.
41. Bradenton ALF Property, L.L.C.
42. Burton NH Property, L.L.C.

 

[Schedule I – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

43. California Aviv Two, L.L.C.
44. California Aviv, L.L.C.
45. Camas Associates, L.L.C.
46. Canton Health Care Land, LLC (f/k/a Canton Health Care Land, Inc.)
47. Carnegie Gardens LLC
48. Casa/Sierra California Associates, L.L.C.
49. CFG 2115 Woodstock Place LLC
50. Champaign Williamson Franklin, L.L.C.
51. Chardon Ohio Property Holdings, L.L.C.
52. Chardon Ohio Property, L.L.C.
53. Chatham Aviv, L.L.C.
54. Chippewa Valley, L.L.C.
55. CHR Bartow LLC
56. CHR Boca Raton  LLC
57. CHR Bradenton LLC
58. CHR Cape Coral LLC
59. CHR Fort Myers LLC
60. CHR Fort Walton Beach LLC
61. CHR Lake Wales LLC
62. CHR Lakeland LLC
63. CHR Pompano Beach Broward LLC
64. CHR Pompano Beach LLC
65. CHR Sanford LLC
66. CHR Spring Hill LLC
67. CHR St. Pete Bay LLC
68. CHR St. Pete Egret LLC
69. CHR Tampa Carrollwood LLC
70. CHR Tampa LLC
71. CHR Tarpon Springs LLC
72. CHR Titusville LLC
73. Clarkston Care, L.L.C.
74. Clayton Associates, L.L.C.
75. Colonial Gardens, LLC
76. Colonial Madison Associates, L.L.C.
77. Colorado Lessor - Conifer, LLC
78. Columbus Texas Aviv, L.L.C.
79. Columbus Western Avenue, L.L.C.
80. Colville Washington Property, L.L.C.
81. Commerce Nursing Homes, L.L.C.
82. Commerce Sterling Hart Drive, L.L.C.
83. Conroe Rigby Owen Road, L.L.C.
84. CR Aviv, L.L.C.
85. Crete Plus Five Property, L.L.C.
86. Crooked River Road, L.L.C.
87. CSE Albany LLC
88. CSE Amarillo LLC

 

[Schedule I – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

89. CSE Arden L.P.
90. CSE Augusta LLC
91. CSE Bedford LLC
92. CSE Blountville LLC
93. CSE Bolivar LLC
94. CSE Cambridge LLC
95. CSE Cambridge Realty LLC
96. CSE Camden LLC
97. CSE Canton LLC
98. CSE Casablanca Holdings II LLC
99. CSE Casablanca Holdings LLC
100. CSE Cedar Rapids LLC
101. CSE Centennial Village, LP
102. CSE Chelmsford LLC
103. CSE Chesterton LLC
104. CSE Claremont LLC
105. CSE Corpus North LLC
106. CSE Denver Iliff LLC
107. CSE Denver LLC
108. CSE Douglas LLC
109. CSE Elkton LLC
110. CSE Elkton Realty LLC
111. CSE Fairhaven LLC
112. CSE Fort Wayne LLC
113. CSE Frankston LLC
114. CSE Georgetown LLC
115. CSE Green Bay LLC
116. CSE Hilliard LLC
117. CSE Huntingdon LLC
118. CSE Huntsville LLC
119. CSE Indianapolis-Continental LLC
120. CSE Indianapolis-Greenbriar LLC
121. CSE Jacinto City LLC
122. CSE Jefferson City LLC
123. CSE Jeffersonville-Hillcrest Center LLC
124. CSE Jeffersonville-Jennings House LLC
125. CSE Kerrville LLC
126. CSE King L.P.
127. CSE Kingsport LLC
128. CSE Knightdale L.P.
129. CSE Lake City LLC
130. CSE Lake Worth LLC
131. CSE Lakewood LLC
132. CSE Las Vegas LLC
133. CSE Lawrenceburg LLC
134. CSE Lenoir L.P.

 

[Schedule I – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

135. CSE Lexington Park LLC
136. CSE Lexington Park Realty LLC
137. CSE Ligonier LLC
138. CSE Live Oak LLC
139. CSE Lowell LLC
140. CSE Marianna Holdings LLC
141. CSE Memphis LLC
142. CSE Mobile LLC
143. CSE Moore LLC
144. CSE North Carolina Holdings I LLC
145. CSE North Carolina Holdings II LLC
146. CSE Omro LLC
147. CSE Orange Park LLC
148. CSE Orlando-Pinar Terrace Manor LLC
149. CSE Orlando-Terra Vista Rehab LLC
150. CSE Pennsylvania Holdings, LP
151. CSE Piggott LLC
152. CSE Pilot Point LLC
153. CSE Pine View LLC
154. CSE Ponca City LLC
155. CSE Port St. Lucie LLC
156. CSE Richmond LLC
157. CSE Ripley LLC
158. CSE Ripon LLC
159. CSE Safford LLC
160. CSE Salina LLC
161. CSE Seminole LLC
162. CSE Shawnee LLC
163. CSE Spring Branch LLC
164. CSE Stillwater LLC
165. CSE Taylorsville LLC
166. CSE Texarkana LLC
167. CSE Texas City LLC
168. CSE The Village LLC
169. CSE Upland LLC
170. CSE Walnut Cove L.P.
171. CSE West Point LLC
172. CSE Whitehouse LLC
173. CSE Williamsport LLC
174. CSE Winter Haven LLC
175. CSE Woodfin L.P.
176. CSE Yorktown LLC
177. Cuyahoga Falls Property, L.L.C.
178. Cuyahoga Falls Property II, L.L.C.
179. Dallas Two Property, L.L.C.
180. Danbury ALF Property, L.L.C.

 

[Schedule I – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

181. Darien ALF Property, L.L.C.
182. Delta Investors I, LLC
183. Delta Investors II, LLC
184. Denison Texas, L.L.C.
185. Desert Lane LLC
186. Dixie White House Nursing Home, LLC (f/k/a Dixie White House Nursing Home, Inc.)
187. Dixon Health Care Center, LLC (f/k/a Dixon Health Care Center, Inc.)
188. East Rollins Street, L.L.C.
189. Edgewood Drive Property, L.L.C.
190. Effingham Associates, L.L.C.
191. Elite Mattoon, L.L.C.
192. Elite Yorkville, L.L.C.
193. Encanto Senior Care, LLC
194. Falcon Four Property Holding, L.L.C.
195. Falcon Four Property, L.L.C.
196. Falfurrias Texas, L.L.C.
197. Florida ALF Properties, L.L.C.
198. Florida Four Properties, L.L.C.
199. Florida Lessor – Meadowview, LLC
200. Florida Real Estate Company, LLC
201. Fort Stockton Property, L.L.C.
202. Four Fountains Aviv, L.L.C.
203. Fredericksburg South Adams Street, L.L.C.
204. Freewater Oregon, L.L.C.
205. Fullerton California, L.L.C.
206. G&L Gardens, LLC
207. Gardnerville Property, L.L.C.
208. Georgia Lessor - Bonterra/Parkview, LLC
209. Germantown Property, L.L.C.
210. Giltex Care, L.L.C.
211. Glendale NH Property, L.L.C.
212. Golden Hill Real Estate Company, LLC
213. Gonzales Texas Property, L.L.C.
214. Great Bend Property, L.L.C.
215. Greenbough, LLC
216. Greenville Kentucky Property, L.L.C.
217. Heritage Monterey Associates, L.L.C.
218. HHM Aviv, L.L.C.
219. Hidden Acres Property, L.L.C.
220. Highland Leasehold, L.L.C.
221. Hobbs Associates, L.L.C.
222. Hot Springs Atrium Owner, LLC
223. Hot Springs Aviv, L.L.C.
224. Hot Springs Cottages Owner, LLC
225. Hot Springs Marina Owner, LLC

 

[Schedule I – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

226. Houston Texas Aviv, L.L.C.
227. Hutchinson Kansas, L.L.C.
228. Hutton I Land, LLC (f/k/a Hutton I Land, Inc.)
229. Hutton II Land, LLC (f/k/a Hutton II Land, Inc.)
230. Hutton III Land, LLC (f/k/a Hutton III Land, Inc.)
231. Idaho Associates, L.L.C.
232. Illinois Missouri Properties, L.L.C.
233. Indiana Lessor – Wellington Manor, LLC
234. Iowa Lincoln County Property, L.L.C.
235. Jasper Springhill Street, L.L.C.
236. Kansas Five Property, L.L.C.
237. Karan Associates Two, L.L.C.
238. Karan Associates, L.L.C.
239. Karissa Court Property, L.L.C.
240. KB Northwest Associates, L.L.C.
241. Kentucky NH Properties, L.L.C.
242. Kingsville Texas, L.L.C.
243. LAD I Real Estate Company, LLC
244. Leatherman 90-1, LLC (f/k/a Leatherman 90-1, Inc.)
245. Leatherman Partnership 89-1, LLC (f/k/a Leatherman Partnership 89-1, Inc.)
246. Leatherman Partnership 89-2, LLC (f/k/a Leatherman Partnership 89-2, Inc.)
247. Louisville Dutchmans Property, L.L.C.
248. Magnolia Drive Property, L.L.C.
249. Manor Associates, L.L.C.
250. Mansfield Aviv, L.L.C.
251. Massachusetts Nursing Homes, L.L.C.
252. McCarthy Street Property, L.L.C.
253. Meridian Arms Land, LLC (f/k/a Meridian Arms Land, Inc.)
254. Minnesota Associates, L.L.C.
255. Mishawaka Property, L.L.C.
256. Missouri Associates, L.L.C.
257. Missouri Regency Associates, L.L.C.
258. Montana Associates, L.L.C.
259. Monterey Park Leasehold Mortgage, L.L.C.
260. Mount Washington Property, L.L.C.
261. Mt. Vernon Texas, L.L.C.
262. Murray County, L.L.C.
263. Muscatine Toledo Properties, L.L.C.
264. N.M. Bloomfield Three Plus One Limited Company
265. N.M. Espanola Three Plus One Limited Company
266. N.M. Lordsburg Three Plus One Limited Company
267. N.M. Silver City Three Plus One Limited Company
268. New Hope Property, L.L.C.
269. Newtown ALF Property, L.L.C.

 

[Schedule I – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

270. Nicholasville Kentucky Property, L.L.C.
271. North Las Vegas LLC
272. North Royalton Ohio Property, L.L.C.
273. Norwalk ALF Property, L.L.C.
274. NRS Ventures, L.L.C.
275. Oakland Nursing Homes, L.L.C.
276. Ocean Springs Nursing Home, LLC (f/k/a Ocean Springs Nursing Home, Inc.)
277. October Associates, L.L.C.
278. Ogden Associates, L.L.C.
279. OHI (Connecticut), LLC
280. OHI (Illinois), LLC(f/k/a OHI (Illinois), Inc.)
281. OHI (Indiana), LLC
282. OHI (Iowa), LLC(f/k/a OHI (Iowa), Inc.)
283. OHI Asset (AR) Ash Flat, LLC
284. OHI Asset (AR) Camden, LLC
285. OHI Asset (AR) Conway, LLC
286. OHI Asset (AR) Des Arc, LLC
287. OHI Asset (AR) Hot Springs, LLC
288. OHI Asset (AR) Malvern, LLC
289. OHI Asset (AR) Mena, LLC
290. OHI Asset (AR) Pocahontas, LLC
291. OHI Asset (AR) Sheridan, LLC
292. OHI Asset (AR) Walnut Ridge, LLC
293. OHI Asset (AZ) Austin House, LLC
294. OHI Asset (CA), LLC
295. OHI Asset (CO), LLC
296. OHI Asset (CO) Brighton, LLC
297. OHI Asset (CO) Denver, LLC
298. OHI Asset (CO) Mesa, LLC
299. OHI Asset (CT) Lender, LLC
300. OHI Asset (FL), LLC
301. OHI Asset (FL) Eustis, LLC
302. OHI Asset (FL) Graceville, LLC
303. OHI Asset (FL) Lake Placid, LLC
304. OHI Asset (FL) Lender, LLC
305. OHI Asset (FL) Lutz, LLC
306. OHI Asset (FL) Marianna, LLC
307. OHI Asset (FL) Middleburg, LLC
308. OHI Asset (FL) Pensacola - Hillview, LLC
309. OHI Asset (FL) Pensacola, LLC
310. OHI Asset (FL) Port St. Joe, LLC
311. OHI Asset (FL) Sebring, LLC
312. OHI Asset (GA) Cordele, LLC
313. OHI Asset (GA) Dunwoody, LLC
314. OHI Asset (GA) Macon, LLC

 

[Schedule I – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

315. OHI Asset (GA) Moultrie, LLC
316. OHI Asset (GA) Nashville, LLC
317. OHI Asset (GA) Roswell, LLC
318. OHI Asset (GA) Snellville, LLC
319. OHI Asset (GA) Valdosta, LLC
320. OHI Asset (ID) Holly, LLC
321. OHI Asset (ID) Midland, LLC
322. OHI Asset (ID), LLC
323. OHI Asset (IL), LLC
324. OHI Asset (IN) American Village, LLC
325. OHI Asset (IN) Anderson, LLC
326. OHI Asset (IN) Beech Grove, LLC
327. OHI Asset (IN) Clarksville, LLC
328. OHI Asset (IN) Clinton, LLC
329. OHI Asset (IN) Connersville, LLC
330. OHI Asset (IN) Crown Point, LLC
331. OHI Asset (IN) Eagle Valley, LLC
332. OHI Asset (IN) Elkhart, LLC
333. OHI Asset (IN) Forest Creek, LLC
334. OHI Asset (IN) Fort Wayne, LLC
335. OHI Asset (IN) Franklin, LLC
336. OHI Asset (IN) Greensburg, LLC
337. OHI Asset (IN) Indianapolis, LLC
338. OHI Asset (IN) Jasper, LLC
339. OHI Asset (IN) Kokomo, LLC
340. OHI Asset (IN) Lafayette, LLC
341. OHI Asset (IN) Madison, LLC
342. OHI Asset (IN) Monticello, LLC
343. OHI Asset (IN) Noblesville, LLC
344. OHI Asset (IN) Rosewalk, LLC
345. OHI Asset (IN) Salem, LLC
346. OHI Asset (IN) Seymour, LLC
347. OHI Asset (IN) Spring Mill, LLC
348. OHI Asset (IN) Terre Haute, LLC
349. OHI Asset (IN) Wabash, LLC
350. OHI Asset (IN) Westfield, LLC
351. OHI Asset (IN) Zionsville, LLC
352. OHI Asset (KY) Beattyville, LLC
353. OHI Asset (KY) Louisville – 1120 Cristland, LLC
354. OHI Asset (KY) Louisville – 2529 Six Mile Lane, LLC
355. OHI Asset (KY) Morgantown, LLC
356. OHI Asset (KY) Owensboro, LLC
357. OHI Asset (LA) Baton Rouge, LLC
358. OHI Asset (LA), LLC
359. OHI Asset (MD), LLC
360. OHI Asset (MD) Baltimore - Pall Mall, LLC

 

[Schedule I – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

361. OHI Asset (MD) Baltimore - West Belvedere, LLC
362. OHI Asset (MD) Salisbury, LLC
363. OHI Asset (MI) Heather Hills, LLC
364. OHI Asset (MI), LLC
365. OHI Asset (MI) Carson City, LLC
366. OHI Asset (MO), LLC
367. OHI Asset (MO) Jackson, LLC
368. OHI Asset (MS) Byhalia, LLC
369. OHI Asset (MS) Cleveland, LLC
370. OHI Asset (MS) Clinton, LLC
371. OHI Asset (MS) Columbia, LLC
372. OHI Asset (MS) Corinth, LLC
373. OHI Asset (MS) Greenwood, LLC
374. OHI Asset (MS) Grenada, LLC
375. OHI Asset (MS) Holly Springs, LLC
376. OHI Asset (MS) Indianola, LLC
377. OHI Asset (MS) Natchez, LLC
378. OHI Asset (MS) Picayune, LLC
379. OHI Asset (MS) Vicksburg, LLC
380. OHI Asset (MS) Yazoo City, LLC
381. OHI Asset (NC) Biscoe, LLC
382. OHI Asset (NC) Cornelius, LLC
383. OHI Asset (NC) Drexel, LLC
384. OHI Asset (NC) Fayetteville, LLC
385. OHI Asset (NC) Hallsboro, LLC
386. OHI Asset (NC) Marion, LLC
387. OHI Asset (NC) Marshville, LLC
388. OHI Asset (NC) Mocksville – 1007 Howard Street, LLC
389. OHI Asset (NC) Mocksville – 1304 Madison Road, LLC
390. OHI Asset (NC) Nashville, LLC
391. OHI Asset (NC) Raeford, LLC
392. OHI Asset (NC) Rocky Mount – 1558 S. Winstead, LLC
393. OHI Asset (NC) Rocky Mount – 415 N. Winstead, LLC
394. OHI Asset (NC) Salisbury, LLC
395. OHI Asset (NC) Saluda, LLC
396. OHI Asset (NC) Shallotte, LLC
397. OHI Asset (NC) Wadesboro, LLC
398. OHI Asset (NC) Waynesville, LLC
399. OHI Asset (NC) Wilmington, LLC
400. OHI Asset (NC) Winston Salem, LLC
401. OHI Asset (NY) 2nd Avenue, LLC
402. OHI Asset (NY) 93rd Street, LLC
403. OHI Asset (OH) Huber Heights, LLC
404. OHI Asset (OH) Lender, LLC
405. OHI Asset (OH), LLC
406. OHI Asset (OH) New London, LLC

 

[Schedule I – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

407. OHI Asset (OR) Portland, LLC
408. OHI Asset (OH) Steubenville, LLC
409. OHI Asset (OH) Toledo, LLC
410. OHI Asset (OR) Troutdale, LLC
411. OHI Asset (OH) West Carrollton, LLC
412. OHI Asset (PA) GP, LLC
413. OHI Asset (PA) West Mifflin, LP
414. OHI Asset (PA), LLC
415. OHI Asset (PA), LP
416. OHI Asset (SC) Aiken, LLC
417. OHI Asset (SC) Anderson, LLC
418. OHI Asset (SC) Easley Anne, LLC
419. OHI Asset (SC) Easley Crestview, LLC
420. OHI Asset (SC) Edgefield, LLC
421. OHI Asset (SC) Five Forks, LLC
422. OHI Asset (SC) Greenville Cottages, LLC 
423. OHI Asset (SC) Greenville Griffith, LLC
424. OHI Asset (SC) Greenville Laurens, LLC
425. OHI Asset (SC) Greenville North, LLC
426. OHI Asset (SC) Greenville, LLC
427. OHI Asset (SC) Greer, LLC
428. OHI Asset (SC) Marietta, LLC
429. OHI Asset (SC) McCormick, LLC
430. OHI Asset (SC) Orangeburg, LLC
431. OHI Asset (SC) Pickens East Cedar, LLC
432. OHI Asset (SC) Pickens Rosemond, LLC
433. OHI Asset (SC) Piedmont, LLC
434. OHI Asset (SC) Simpsonville SE Main, LLC
435. OHI Asset (SC) Simpsonville West Broad, LLC
436. OHI Asset (SC) Simpsonville West Curtis, LLC
437. OHI Asset (TN) Bartlett, LLC
438. OHI Asset (TN) Cleveland, LLC
439. OHI Asset (TN) Collierville, LLC
440. OHI Asset (TN) Columbia, LLC
441. OHI Asset (TN) Elizabethton, LLC
442. OHI Asset (TN) Jamestown, LLC 
443. OHI Asset (TN) Jefferson City, LLC
444. OHI Asset (TN) Memphis, LLC
445. OHI Asset (TN) Memphis – 1150 Dovecrest, LLC
446. OHI Asset (TN) Monteagle, LLC
447. OHI Asset (TN) Monterey, LLC 
448. OHI Asset (TN) Mountain City, LLC
449. OHI Asset (TN) Nashville, LLC
450. OHI Asset (TN) Pigeon Forge, LLC
451. OHI Asset (TN) Rockwood, LLC
452. OHI Asset (TN) Rogersville, LLC

 

[Schedule I – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

453. OHI Asset (TN) Rogersville – 109 Highway 70 North, LLC
454. OHI Asset (TN) South Pittsburg, LLC
455. OHI Asset (TN) Spring City, LLC
456. OHI Asset (TN) Westmoreland, LLC
457. OHI Asset (TX) Anderson, LLC
458. OHI Asset (TX) Athens, LLC
459. OHI Asset (TX) Bryan, LLC
460. OHI Asset (TX) Burleson, LLC
461. OHI Asset (TX) College Station, LLC
462. OHI Asset (TX) Comfort, LLC
463. OHI Asset (TX) Diboll, LLC
464. OHI Asset (TX) Granbury, LLC
465. OHI Asset (TX) Hondo, LLC
466. OHI Asset (TX) Italy, LLC
467. OHI Asset (TX) Longview, LLC
468. OHI Asset (TX) Schertz, LLC
469. OHI Asset (TX) Winnsboro, LLC
470. OHI Asset (TX) Winnsboro ALF, LLC
471. OHI Asset (TX), LLC
472. OHI Asset (UT) Ogden, LLC
473. OHI Asset (UT) Provo, LLC
474. OHI Asset (UT) Roy, LLC
475. OHI Asset (VA) Charlottesville - 1165 Pepsi Place, LLC
476. OHI Asset (VA) Charlottesville, LLC
477. OHI Asset (VA) Chesapeake, LLC
478. OHI Asset (VA) Farmville, LLC
479. OHI Asset (VA) Galax, LLC
480. OHI Asset (VA) Hillsville, LLC
481. OHI Asset (VA) Martinsville SNF, LLC
482. OHI Asset (VA) Madison, LLC
483. OHI Asset (VA) Mechanicsville, LLC
484. OHI Asset (VA) Midlothian, LLC
485. OHI Asset (VA) Norfolk, LLC
486. OHI Asset (VA) Portsmouth, LLC
487. OHI Asset (VA) Richmond - 2420 Pemberton Road, LLC
488. OHI Asset (VA) Richmond - 9101 Bon Air, LLC
489. OHI Asset (VA) Rocky Mount, LLC
490. OHI Asset (VA) Suffolk, LLC
491. OHI Asset (WA) Battle Ground, LLC
492. OHI Asset (WA) Fort Vancouver, LLC
493. OHI Asset (WV) Danville, LLC
494. OHI Asset (WV) Ivydale, LLC
495. OHI Asset CHG ALF, LLC
496. OHI Asset CSB LLC
497. OHI Asset CSE – E, LLC
498. OHI Asset CSE – U, LLC

 

[Schedule I – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

499. OHI Asset CSE–E Subsidiary, LLC
500. OHI Asset CSE–U Subsidiary, LLC
501. OHI Asset HUD CFG, LLC
502. OHI Asset HUD Delta, LLC
503. OHI Asset HUD H-F, LLC
504. OHI Asset HUD SF CA, LLC
505. OHI Asset HUD SF, LLC
506. OHI Asset HUD WO, LLC
507. OHI Asset II (CA), LLC
508. OHI Asset II (FL), LLC
509. OHI Asset II (PA), LP
510. OHI Asset III (PA), LP
511. OHI Asset IV (PA) Silver Lake, LP
512. OHI Asset Management, LLC
513. OHI Asset RO PMM Services, LLC
514. OHI Asset RO, LLC
515. OHI Asset S-W, LLC
516. OHI Asset, LLC
517. OHI Healthcare Properties Holdco, Inc.
518. OHI Healthcare Properties Limited Partnership
519. OHI Mezz Lender, LLC
520. OHI Tennessee, LLC (f/k/a OHI Tennessee, Inc.)
521. OHIMA, LLC (f/k/a OHIMA, Inc.)
522. Ohio Aviv Three, L.L.C.
523. Ohio Aviv Two, L.L.C.
524. Ohio Aviv, L.L.C.
525. Ohio Indiana Property, L.L.C.
526. Ohio Pennsylvania Property, L.L.C.
527. Oklahoma Two Property, L.L.C.
528. Oklahoma Warr Wind, L.L.C.
529. Omaha Associates, L.L.C.
530. Omega TRS I, Inc.
531. Orange ALF Property, L.L.C.
532. Orange Village Care Center, LLC (f/k/a Orange Village Care Center, Inc.)
533. Orange, L.L.C.
534. Oregon Associates, L.L.C.
535. Oso Avenue Property, L.L.C.
536. Ostrom Avenue Property, L.L.C.
537. Palm Valley Senior Care, LLC
538. Panama City Nursing Center LLC
539. Pavillion North Partners, LLC
540. Pavillion North, LLP
541. Pavillion Nursing Center North, LLC
542. Peabody Associates Two, L.L.C.
543. Peabody Associates, L.L.C.

 

[Schedule I – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

544. Pennington Road Property, L.L.C.
545. Pensacola Real Estate Holdings I, LLC (f/k/a Pensacola Real Estate Holdings I, Inc.)
546. Pensacola Real Estate Holdings II, LLC (f/k/a Pensacola Real Estate Holdings II, Inc.)
547. Pensacola Real Estate Holdings III, LLC (f/k/a Pensacola Real Estate Holdings III, Inc.)
548. Pensacola Real Estate Holdings IV, LLC (f/k/a Pensacola Real Estate Holdings IV, Inc.)
549. Pensacola Real Estate Holdings V, LLC (f/k/a Pensacola Real Estate Holdings V, Inc.)
550. Pocatello Idaho Property, L.L.C.
551. Pomona Vista L.L.C.
552. Prescott Arkansas, L.L.C.
553. PV Realty-Clinton, LLC
554. PV Realty-Kensington, LLC
555. PV Realty–Willow Tree, LLC
556. Raton Property Limited Company
557. Ravenna Ohio Property, L.L.C.
558. Red Rocks, L.L.C.
559. Richland Washington, L.L.C.
560. Ridgecrest Senior Care, LLC
561. Riverside Nursing Home Associates Two, L.L.C.
562. Riverside Nursing Home Associates, L.L.C.
563. Rockingham Drive Property, L.L.C.
564. Rose Baldwin Park Property L.L.C.
565. S.C. Portfolio Property, L.L.C.
566. Salem Associates, L.L.C.
567. San Juan NH Property, LLC
568. Sandalwood Arkansas Property, L.L.C.
569. Santa Ana-Bartlett, L.L.C.
570. Santa Fe Missouri Associates, L.L.C.
571. Savoy/Bonham Venture, L.L.C.
572. Searcy Aviv, L.L.C.
573. Sedgwick Properties, L.L.C.
574. Seguin Texas Property, L.L.C.
575. Sierra Ponds Property, L.L.C.
576. Skyler Boyington, LLC (f/k/a Skyler Boyington, Inc.)
577. Skyler Florida, LLC (f/k/a Skyler Florida, Inc.)
578. Skyler Maitland LLC
579. Skyler Pensacola, LLC (f/k/a Skyler Pensacola, Inc.)
580. Skyview Associates, L.L.C.
581. Southeast Missouri Property, L.L.C.
582. Southern California Nevada, L.L.C.
583. St. Joseph Missouri Property, L.L.C.
584. St. Mary’s Properties, LLC (f/k/a St. Mary’s Properties, Inc.)

 

[Schedule I – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

585. Star City Arkansas, L.L.C.
586. Stephenville Texas Property, L.L.C.
587. Sterling Acquisition, LLC
588. Stevens Avenue Property, L.L.C.
589. Sun-Mesa Properties, L.L.C.
590. Suwanee, LLC
591. Texas Fifteen Property, L.L.C.
592. Texas Four Property, L.L.C.
593. Texas Lessor – Stonegate GP, LLC
594. Texas Lessor – Stonegate, Limited, LLC
595. Texas Lessor – Stonegate, LP
596. Texhoma Avenue Property, L.L.C.
597. The Suburban Pavilion, LLC (f/k/a The Suburban Pavilion, Inc.)
598. Tujunga, L.L.C.
599. Tulare County Property, L.L.C.
600. Twinsburg Ohio Property, LLC
601. VRB Aviv, L.L.C.
602. Washington Idaho Property, L.L.C.
603. Washington Lessor – Silverdale, LLC
604. Washington-Oregon Associates, L.L.C.
605. Watauga Associates, L.L.C.
606. Wellington Leasehold, L.L.C.
607. West Pearl Street, L.L.C.
608. West Yarmouth Property I, L.L.C.
609. Westerville Ohio Office Property, L.L.C.
610. Weston ALF Property, LLC
611. Wheeler Healthcare Associates, L.L.C.
612. Whitlock Street Property, L.L.C.
613. Wilcare, LLC
614. Willis Texas Aviv, L.L.C.
615. Yuba Aviv, L.L.C.

 

[Schedule I – 13th Supplemental Indenture – 2024 Notes]

 

 

 

 

Schedule II

 

NEW SUBSIDIARIES

 

1. OHI Asset (AZ) Tucson, LLC
2. OHI Asset (FL) DeFuniak Springs, LLC
3. OHI Asset (FL) Homestead, LLC
4. OHI Asset (FL) Ormond Beach, LLC
5. OHI Asset (TN) Byrdstown, LLC
6. OHI Asset (TN) Erin, LLC
7. OHI Asset (TN) Greeneville, LLC
8. OHI Asset (TN) Harriman, LLC
9. OHI Asset (TN) Ridgely, LLC
10. OHI Asset (VA) Martinsville ALF, LLC

 

[Schedule II – 13th Supplemental Indenture – 2024 Notes]

 

 

 

EX-4.1A 3 t1700448_ex4-1a.htm EXHIBIT 4.1A

 

 

Exhibit 4.1A

 

FOURTEENTH SUPPLEMENTAL INDENTURE

(4.950% Senior Notes due 2024)

 

THIS FOURTEENTH SUPPLEMENTAL INDENTURE (this “Fourteenth Supplemental Indenture”) is dated as of May 25, 2017 among OMEGA HEALTHCARE INVESTORS, INC., a Maryland corporation (the “Issuer”), each of the SUBSIDIARY GUARANTORS listed on Schedule I hereto (collectively, the “Subsidiary Guarantors”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, as trustee (the “Trustee”).

 

W I T N E S S E T H :

 

WHEREAS, the Issuer and the Subsidiary Guarantors have heretofore executed and delivered to the Trustee an Indenture, dated as of March 11, 2014 (as supplemented by that First Supplemental Indenture, dated as of June 27, 2014, that Second Supplemental Indenture, dated as of November 25, 2014, that Third Supplemental Indenture, dated as of January 23, 2015, that Fourth Supplemental Indenture, effective as of March 2, 2015, that Fifth Supplemental Indenture, dated as of April 1, 2015, that Sixth Supplemental Indenture, dated as of August 4, 2015, that Seventh Supplemental Indenture, dated as of November 9, 2015, that Eighth Supplemental Indenture, dated as of March 29, 2016, that Ninth Supplemental Indenture, dated as of May 13, 2016, that Tenth Supplemental Indenture, dated as of August 9, 2016, that Eleventh Supplemental Indenture, dated as of November 10, 2016, that Twelfth Supplemental Indenture, dated as of March 17, 2017 and that Thirteenth Supplemental Indenture, dated as of May 11, 2017; the “Indenture”), providing for the issuance of the Issuer’s 4.950% Senior Notes due 2024 (the “Notes”);

 

WHEREAS, in Section 1.01 of the Indenture, the term “Subsidiary Guarantors” is defined to include (i) each Subsidiary that is a guarantor of Indebtedness under the Existing Note Indentures on the Closing Date and (ii) each other Person that is required to become a Subsidiary Guarantor by the terms of the Indenture after the Closing Date, in each case, until such Person is released from its Subsidiary Guarantee;

 

WHEREAS, Section 10.04(4) of the Indenture provides that if a Subsidiary Guarantor ceases to guarantee the obligations of the Issuer under any Indebtedness of the Issuer that would constitute Indebtedness under clauses (1) or (2) of the definition thereof in the Indenture, in an amount at least equal to $50 million, such Subsidiary Guarantor shall be automatically and unconditionally released from its obligations under its Subsidiary Guarantee and its obligations under the Indenture;

 

WHEREAS, Section 10.04 of the Indenture further provides that upon any such occurrence, at the Issuer’s request and subject to the further requirements of said Section, the Trustee shall execute any documents reasonably requested by the Issuer evidencing such release;

 

[14th Supplemental Indenture – 2024 Notes]

 

 

 

 

WHEREAS, the Subsidiary Guarantors other than OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership (each, a “Released Subsidiary Guarantor” and collectively, the “Released Subsidiary Guarantors”) no longer guarantee the obligations of the Issuer under any Indebtedness of the Issuer described under clauses (1) or (2) of the definition of Indebtedness in the Indenture in an amount at least equal to $50 million and therefore are automatically and unconditionally released from their obligations under their respective Subsidiary Guarantees and under the Indenture;

 

WHEREAS, the Issuer and the Subsidiary Guarantors (including the Released Subsidiary Guarantors) have requested that the Trustee enter into this Fourteenth Supplemental Indenture and the Partial Release (as hereinafter defined) to further evidence such release of the Released Subsidiary Guarantors; and

 

WHEREAS, Section 9.01(a)(4) of the Indenture authorizes the Issuer, the Subsidiary Guarantors and the Trustee, together, to amend or supplement the Indenture, without notice to or consent of any Holder of the Notes, for the purpose of releasing any Subsidiary Guarantor from any of its obligations under its Subsidiary Guarantee or the Indenture to the extent permitted by the Indenture;

 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Issuer, the Subsidiary Guarantors (including the Released Subsidiary Guarantors) and the Trustee mutually covenant and agree as follows:

 

1.CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 

2.RELEASE OF RELEASED SUBSIDIARY GUARANTORS. Pursuant to Section 10.04 of the Indenture, each of the Released Subsidiary Guarantors is hereby released from its obligations under its Subsidiary Guarantees and under the Indenture. Such release shall be further evidenced by the Trustee’s execution and delivery of a Partial Release of Subsidiary Guarantors, the form of which is attached hereto as Exhibit A (the “Partial Release”). From and after the execution and delivery hereof, the term “Subsidiary Guarantor” as used in the Indenture, the Subsidiary Guarantees and the Notes shall exclude each of the Released Subsidiary Guarantors, unless and until such Person again becomes a Subsidiary Guarantor pursuant to the provisions of Section 4.14 of the Indenture. For avoidance of doubt, OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership remain Subsidiary Guarantors.

 

3.NEW YORK LAW TO GOVERN. The laws of the State of New York shall govern and be used to construe this Fourteenth Supplemental Indenture.

 

4.COUNTERPARTS. The parties may sign any number of copies of this Fourteenth Supplemental Indenture. Each signed copy shall be an original, but all of them together shall represent the same agreement.

 

5.EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

 

[14th Supplemental Indenture – 2024 Notes]

 

 

 

 

6.THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Fourteenth Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Issuer and the Subsidiary Guarantors (including the Released Subsidiary Guarantors).

 

[Remainder of Page Intentionally Left Blank]

 

[14th Supplemental Indenture – 2024 Notes]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Fourteenth Supplemental Indenture to be duly executed, all as of the date first above written.

 

  ISSUER:
     
  OMEGA HEALTHCARE INVESTORS, INC.,
  a Maryland corporation
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
  SUBSIDIARY GUARANTORS:
     
  OHI HEALTHCARE PROPERTIES HOLDCO, INC.
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
  OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP
     
  By: OHI Healthcare Properties Holdco, Inc., as primary General Partner
       
    By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page - 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

  ON BEHALF OF EACH OF THE OTHER SUBSIDIARY GUARANTORS LISTED ON SCHEDULE I
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page - 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

 

U.S. BANK NATIONAL ASSOCIATION,

as Trustee

   
  By: /s/ David Ferrell
    David Ferrell
    Vice President

 

[Signature Page - 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

Exhibit A

(Form of Partial Release of Subsidiary Guarantors)

 

[ATTACHED]

 

[Exhibit A – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

[FORM OF ]

PARTIAL RELEASE OF SUBSIDIARY GUARANTORS

 

([INDENTURE DESCRIPTION])

 

[DATE]

 

Reference is hereby made to that certain Indenture dated as of [DATE], among Omega Healthcare Investors, Inc., a Maryland corporation (the "Issuer"), the Subsidiary Guarantors named therein and U.S. Bank National Association, as trustee (the "Trustee"), as amended or supplemented by that [ADD SUPPLEMENTAL INDENTURES] (the "Indenture"). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Indenture.

 

Pursuant to the provisions of Section [REFERENCE] of the Indenture and the terms of that certain Second Supplemental Indenture, dated as of even date herewith, among the Issuer, the Subsidiary Guarantors and the Trustee, amending and supplementing the Indenture, each of the entities set forth on Schedule I attached hereto and incorporated herein by this reference is hereby released from its obligations under its Subsidiary Guarantees and under the Indenture. For avoidance of doubt, OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership remain Subsidiary Guarantors.

 

The validity and enforceability of this Partial Release of Subsidiary Guarantors shall not be affected by the fact that it is not affixed to any particular Subsidiary Guarantee or Note.

 

This Partial Release of Subsidiary Guarantors shall be governed by, and construed in accordance with, the laws of the State of New York.

 

[Remainder of Page Intentionally Left Blank]

 

[Exhibit A – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Partial Release of Subsidiary Guarantors to be duly executed as of the date first written above.

 

 

U.S. BANK NATIONAL ASSOCIATION,

as Trustee

     
  By:  
    [NAME]
    [TITLE][

 

[Exhibit A – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

Schedule I

 

SUBSIDIARY GUARANTORS

 

1. 11900 East Artesia Boulevard, LLC
2. 1200 Ely Street Holdings Co. LLC
3. 13922 Cerise Avenue, LLC
4. 1628 B Street, LLC
5. 2400 Parkside Drive, LLC
6. 2425 Teller Avenue, LLC
7. 245 East Wilshire Avenue, LLC
8. 3232 Artesia Real Estate, LLC
9. 3806 Clayton Road, LLC
10. 42235 County Road Holdings Co. LLC
11. 446 Sycamore Road, L.L.C.
12. 48 High Point Road, LLC
13. 523 Hayes Lane, LLC
14. 637 East Romie Lane, LLC
15. Alamogordo Aviv, L.L.C.
16. Albany Street Property, L.L.C.
17. Arizona Lessor - Infinia, LLC
18. Arkansas Aviv, L.L.C.
19. Arma Yates, L.L.C.
20. Avery Street Property, L.L.C
21. Aviv Asset Management, L.L.C.
22. Aviv Financing I, L.L.C.
23. Aviv Financing II, L.L.C.
24. Aviv Financing III, L.L.C.
25. Aviv Financing IV, L.L.C.
26. Aviv Financing V, L.L.C.
27. Aviv Foothills, L.L.C.
28. Aviv Healthcare Properties Operating Partnership I, L.P.
29. Aviv Liberty, L.L.C.
30. Avon Ohio, L.L.C.
31. Bala Cynwyd Real Estate, LP
32. Bayside Colorado Healthcare Associates, LLC
33. Bayside Street II, LLC
34. Bayside Street, LLC (f/k/a Bayside Street, Inc.)
35. Belleville Illinois, L.L.C.
36. Bellingham II Associates, L.L.C.
37. Bethel ALF Property, L.L.C.
38. BHG Aviv, L.L.C.
39. Biglerville Road, L.L.C.
40. Bonham Texas, L.L.C.
41. Bradenton ALF Property, L.L.C.
42. Burton NH Property, L.L.C.

 

[Schedule I – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

43. California Aviv Two, L.L.C.
44. California Aviv, L.L.C.
45. Camas Associates, L.L.C.
46. Canton Health Care Land, LLC (f/k/a Canton Health Care Land, Inc.)
47. Carnegie Gardens LLC
48. Casa/Sierra California Associates, L.L.C.
49. CFG 2115 Woodstock Place LLC
50. Champaign Williamson Franklin, L.L.C.
51. Chardon Ohio Property Holdings, L.L.C.
52. Chardon Ohio Property, L.L.C.
53. Chatham Aviv, L.L.C.
54. Chippewa Valley, L.L.C.
55. CHR Bartow LLC
56. CHR Boca Raton  LLC
57. CHR Bradenton LLC
58. CHR Cape Coral LLC
59. CHR Fort Myers LLC
60. CHR Fort Walton Beach LLC
61. CHR Lake Wales LLC
62. CHR Lakeland LLC
63. CHR Pompano Beach Broward LLC
64. CHR Pompano Beach LLC
65. CHR Sanford LLC
66. CHR Spring Hill LLC
67. CHR St. Pete Bay LLC
68. CHR St. Pete Egret LLC
69. CHR Tampa Carrollwood LLC
70. CHR Tampa LLC
71. CHR Tarpon Springs LLC
72. CHR Titusville LLC
73. Clarkston Care, L.L.C.
74. Clayton Associates, L.L.C.
75. Colonial Gardens, LLC
76. Colonial Madison Associates, L.L.C.
77. Colorado Lessor - Conifer, LLC
78. Columbus Texas Aviv, L.L.C.
79. Columbus Western Avenue, L.L.C.
80. Colville Washington Property, L.L.C.
81. Commerce Nursing Homes, L.L.C.
82. Commerce Sterling Hart Drive, L.L.C.
83. Conroe Rigby Owen Road, L.L.C.
84. CR Aviv, L.L.C.
85. Crete Plus Five Property, L.L.C.
86. Crooked River Road, L.L.C.
87. CSE Albany LLC
88. CSE Amarillo LLC

 

[Schedule I – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

89. CSE Arden L.P.
90. CSE Augusta LLC
91. CSE Bedford LLC
92. CSE Blountville LLC
93. CSE Bolivar LLC
94. CSE Cambridge LLC
95. CSE Cambridge Realty LLC
96. CSE Camden LLC
97. CSE Canton LLC
98. CSE Casablanca Holdings II LLC
99. CSE Casablanca Holdings LLC
100. CSE Cedar Rapids LLC
101. CSE Centennial Village, LP
102. CSE Chelmsford LLC
103. CSE Chesterton LLC
104. CSE Claremont LLC
105. CSE Corpus North LLC
106. CSE Denver Iliff LLC
107. CSE Denver LLC
108. CSE Douglas LLC
109. CSE Elkton LLC
110. CSE Elkton Realty LLC
111. CSE Fairhaven LLC
112. CSE Fort Wayne LLC
113. CSE Frankston LLC
114. CSE Georgetown LLC
115. CSE Green Bay LLC
116. CSE Hilliard LLC
117. CSE Huntingdon LLC
118. CSE Huntsville LLC
119. CSE Indianapolis-Continental LLC
120. CSE Indianapolis-Greenbriar LLC
121. CSE Jacinto City LLC
122. CSE Jefferson City LLC
123. CSE Jeffersonville-Hillcrest Center LLC
124. CSE Jeffersonville-Jennings House LLC
125. CSE Kerrville LLC
126. CSE King L.P.
127. CSE Kingsport LLC
128. CSE Knightdale L.P.
129. CSE Lake City LLC
130. CSE Lake Worth LLC
131. CSE Lakewood LLC
132. CSE Las Vegas LLC
133. CSE Lawrenceburg LLC
134. CSE Lenoir L.P.

 

[Schedule I – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

135. CSE Lexington Park LLC
136. CSE Lexington Park Realty LLC
137. CSE Ligonier LLC
138. CSE Live Oak LLC
139. CSE Lowell LLC
140. CSE Marianna Holdings LLC
141. CSE Memphis LLC
142. CSE Mobile LLC
143. CSE Moore LLC
144. CSE North Carolina Holdings I LLC
145. CSE North Carolina Holdings II LLC
146. CSE Omro LLC
147. CSE Orange Park LLC
148. CSE Orlando-Pinar Terrace Manor LLC
149. CSE Orlando-Terra Vista Rehab LLC
150. CSE Pennsylvania Holdings, LP
151. CSE Piggott LLC
152. CSE Pilot Point LLC
153. CSE Pine View LLC
154. CSE Ponca City LLC
155. CSE Port St. Lucie LLC
156. CSE Richmond LLC
157. CSE Ripley LLC
158. CSE Ripon LLC
159. CSE Safford LLC
160. CSE Salina LLC
161. CSE Seminole LLC
162. CSE Shawnee LLC
163. CSE Spring Branch LLC
164. CSE Stillwater LLC
165. CSE Taylorsville LLC
166. CSE Texarkana LLC
167. CSE Texas City LLC
168. CSE The Village LLC
169. CSE Upland LLC
170. CSE Walnut Cove L.P.
171. CSE West Point LLC
172. CSE Whitehouse LLC
173. CSE Williamsport LLC
174. CSE Winter Haven LLC
175. CSE Woodfin L.P.
176. CSE Yorktown LLC
177. Cuyahoga Falls Property II, L.L.C.
178. Cuyahoga Falls Property, L.L.C.
179. Dallas Two Property, L.L.C.
180. Danbury ALF Property, L.L.C.

 

[Schedule I – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

181. Darien ALF Property, L.L.C.
182. Delta Investors I, LLC
183. Delta Investors II, LLC
184. Denison Texas, L.L.C.
185. Desert Lane LLC
186. Dixie White House Nursing Home, LLC (f/k/a Dixie White House Nursing Home, Inc.)
187. Dixon Health Care Center, LLC (f/k/a Dixon Health Care Center, Inc.)
188. East Rollins Street, L.L.C.
189. Edgewood Drive Property, L.L.C.
190. Effingham Associates, L.L.C.
191. Elite Mattoon, L.L.C.
192. Elite Yorkville, L.L.C.
193. Encanto Senior Care, LLC
194. Falcon Four Property Holding, L.L.C.
195. Falcon Four Property, L.L.C.
196. Falfurrias Texas, L.L.C.
197. Florida ALF Properties, L.L.C.
198. Florida Four Properties, L.L.C.
199. Florida Lessor – Meadowview, LLC
200. Florida Real Estate Company, LLC
201. Fort Stockton Property, L.L.C.
202. Four Fountains Aviv, L.L.C.
203. Fredericksburg South Adams Street, L.L.C.
204. Freewater Oregon, L.L.C.
205. Fullerton California, L.L.C.
206. G&L Gardens, LLC
207. Gardnerville Property, L.L.C.
208. Georgia Lessor - Bonterra/Parkview, LLC
209. Germantown Property, L.L.C.
210. Giltex Care, L.L.C.
211. Glendale NH Property, L.L.C.
212. Golden Hill Real Estate Company, LLC
213. Gonzales Texas Property, L.L.C.
214. Great Bend Property, L.L.C.
215. Greenbough, LLC
216. Greenville Kentucky Property, L.L.C.
217. Heritage Monterey Associates, L.L.C.
218. HHM Aviv, L.L.C.
219. Hidden Acres Property, L.L.C.
220. Highland Leasehold, L.L.C.
221. Hobbs Associates, L.L.C.
222. Hot Springs Atrium Owner, LLC
223. Hot Springs Aviv, L.L.C.
224. Hot Springs Cottages Owner, LLC
225. Hot Springs Marina Owner, LLC

 

[Schedule I – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

226. Houston Texas Aviv, L.L.C.
227. Hutchinson Kansas, L.L.C.
228. Hutton I Land, LLC (f/k/a Hutton I Land, Inc.)
229. Hutton II Land, LLC (f/k/a Hutton II Land, Inc.)
230. Hutton III Land, LLC (f/k/a Hutton III Land, Inc.)
231. Idaho Associates, L.L.C.
232. Illinois Missouri Properties, L.L.C.
233. Indiana Lessor – Wellington Manor, LLC
234. Iowa Lincoln County Property, L.L.C.
235. Jasper Springhill Street, L.L.C.
236. Kansas Five Property, L.L.C.
237. Karan Associates Two, L.L.C.
238. Karan Associates, L.L.C.
239. Karissa Court Property, L.L.C.
240. KB Northwest Associates, L.L.C.
241. Kentucky NH Properties, L.L.C.
242. Kingsville Texas, L.L.C.
243. LAD I Real Estate Company, LLC
244. Leatherman 90-1, LLC (f/k/a Leatherman 90-1, Inc.)
245. Leatherman Partnership 89-1, LLC (f/k/a Leatherman Partnership 89-1, Inc.)
246. Leatherman Partnership 89-2, LLC (f/k/a Leatherman Partnership 89-2, Inc.)
247. Louisville Dutchmans Property, L.L.C.
248. Magnolia Drive Property, L.L.C.
249. Manor Associates, L.L.C.
250. Mansfield Aviv, L.L.C.
251. Massachusetts Nursing Homes, L.L.C.
252. McCarthy Street Property, L.L.C.
253. Meridian Arms Land, LLC (f/k/a Meridian Arms Land, Inc.)
254. Minnesota Associates, L.L.C.
255. Mishawaka Property, L.L.C.
256. Missouri Associates, L.L.C.
257. Missouri Regency Associates, L.L.C.
258. Montana Associates, L.L.C.
259. Monterey Park Leasehold Mortgage, L.L.C.
260. Mount Washington Property, L.L.C.
261. Mt. Vernon Texas, L.L.C.
262. Murray County, L.L.C.
263. Muscatine Toledo Properties, L.L.C.
264. N.M. Bloomfield Three Plus One Limited Company
265. N.M. Espanola Three Plus One Limited Company
266. N.M. Lordsburg Three Plus One Limited Company
267. N.M. Silver City Three Plus One Limited Company
268. New Hope Property, L.L.C.
269. Newtown ALF Property, L.L.C.

 

[Schedule I – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

270. Nicholasville Kentucky Property, L.L.C.
271. North Las Vegas LLC
272. North Royalton Ohio Property, L.L.C.
273. Norwalk ALF Property, L.L.C.
274. NRS Ventures, L.L.C.
275. Oakland Nursing Homes, L.L.C.
276. Ocean Springs Nursing Home, LLC (f/k/a Ocean Springs Nursing Home, Inc.)
277. October Associates, L.L.C.
278. Ogden Associates, L.L.C.
279. OHI (Connecticut), LLC
280. OHI (Illinois), LLC(f/k/a OHI (Illinois), Inc.)
281. OHI (Indiana), LLC
282. OHI (Iowa), LLC(f/k/a OHI (Iowa), Inc.)
283. OHI Asset (AR) Ash Flat, LLC
284. OHI Asset (AR) Camden, LLC
285. OHI Asset (AR) Conway, LLC
286. OHI Asset (AR) Des Arc, LLC
287. OHI Asset (AR) Hot Springs, LLC
288. OHI Asset (AR) Malvern, LLC
289. OHI Asset (AR) Mena, LLC
290. OHI Asset (AR) Pocahontas, LLC
291. OHI Asset (AR) Sheridan, LLC
292. OHI Asset (AR) Walnut Ridge, LLC
293. OHI Asset (AZ) Austin House, LLC
294. OHI Asset (AZ) Tucson, LLC
295. OHI Asset (CA), LLC
296. OHI Asset (CO) Brighton, LLC
297. OHI Asset (CO) Denver, LLC
298. OHI Asset (CO) Mesa, LLC
299. OHI Asset (CO), LLC
300. OHI Asset (CT) Lender, LLC
301. OHI Asset (FL) DeFuniak Springs, LLC
302. OHI Asset (FL) Eustis, LLC
303. OHI Asset (FL) Graceville, LLC
304. OHI Asset (FL) Homestead, LLC
305. OHI Asset (FL) Lake Placid, LLC
306. OHI Asset (FL) Lender, LLC
307. OHI Asset (FL) Lutz, LLC
308. OHI Asset (FL) Marianna, LLC
309. OHI Asset (FL) Middleburg, LLC
310. OHI Asset (FL) Ormond Beach, LLC
311. OHI Asset (FL) Pensacola - Hillview, LLC
312. OHI Asset (FL) Pensacola, LLC
313. OHI Asset (FL) Port St. Joe, LLC
314. OHI Asset (FL) Sebring, LLC

 

[Schedule I – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

315. OHI Asset (FL), LLC
316. OHI Asset (GA) Cordele, LLC
317. OHI Asset (GA) Dunwoody, LLC
318. OHI Asset (GA) Macon, LLC
319. OHI Asset (GA) Moultrie, LLC
320. OHI Asset (GA) Nashville, LLC
321. OHI Asset (GA) Roswell, LLC
322. OHI Asset (GA) Snellville, LLC
323. OHI Asset (GA) Valdosta, LLC
324. OHI Asset (ID) Holly, LLC
325. OHI Asset (ID) Midland, LLC
326. OHI Asset (ID), LLC
327. OHI Asset (IL), LLC
328. OHI Asset (IN) American Village, LLC
329. OHI Asset (IN) Anderson, LLC
330. OHI Asset (IN) Beech Grove, LLC
331. OHI Asset (IN) Clarksville, LLC
332. OHI Asset (IN) Clinton, LLC
333. OHI Asset (IN) Connersville, LLC
334. OHI Asset (IN) Crown Point, LLC
335. OHI Asset (IN) Eagle Valley, LLC
336. OHI Asset (IN) Elkhart, LLC
337. OHI Asset (IN) Forest Creek, LLC
338. OHI Asset (IN) Fort Wayne, LLC
339. OHI Asset (IN) Franklin, LLC
340. OHI Asset (IN) Greensburg, LLC
341. OHI Asset (IN) Indianapolis, LLC
342. OHI Asset (IN) Jasper, LLC
343. OHI Asset (IN) Kokomo, LLC
344. OHI Asset (IN) Lafayette, LLC
345. OHI Asset (IN) Madison, LLC
346. OHI Asset (IN) Monticello, LLC
347. OHI Asset (IN) Noblesville, LLC
348. OHI Asset (IN) Rosewalk, LLC
349. OHI Asset (IN) Salem, LLC
350. OHI Asset (IN) Seymour, LLC
351. OHI Asset (IN) Spring Mill, LLC
352. OHI Asset (IN) Terre Haute, LLC
353. OHI Asset (IN) Wabash, LLC
354. OHI Asset (IN) Westfield, LLC
355. OHI Asset (IN) Zionsville, LLC
356. OHI Asset (KY) Beattyville, LLC
357. OHI Asset (KY) Louisville – 1120 Cristland, LLC
358. OHI Asset (KY) Louisville – 2529 Six Mile Lane, LLC
359. OHI Asset (KY) Morgantown, LLC
360. OHI Asset (KY) Owensboro, LLC

 

[Schedule I – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

361. OHI Asset (LA) Baton Rouge, LLC
362. OHI Asset (LA), LLC
363. OHI Asset (MD) Baltimore - Pall Mall, LLC
364. OHI Asset (MD) Baltimore - West Belvedere, LLC
365. OHI Asset (MD) Salisbury, LLC
366. OHI Asset (MD), LLC
367. OHI Asset (MI) Carson City, LLC
368. OHI Asset (MI) Heather Hills, LLC
369. OHI Asset (MI), LLC
370. OHI Asset (MO) Jackson, LLC
371. OHI Asset (MO), LLC
372. OHI Asset (MS) Byhalia, LLC
373. OHI Asset (MS) Cleveland, LLC
374. OHI Asset (MS) Clinton, LLC
375. OHI Asset (MS) Columbia, LLC
376. OHI Asset (MS) Corinth, LLC
377. OHI Asset (MS) Greenwood, LLC
378. OHI Asset (MS) Grenada, LLC
379. OHI Asset (MS) Holly Springs, LLC
380. OHI Asset (MS) Indianola, LLC
381. OHI Asset (MS) Natchez, LLC
382. OHI Asset (MS) Picayune, LLC
383. OHI Asset (MS) Vicksburg, LLC
384. OHI Asset (MS) Yazoo City, LLC
385. OHI Asset (NC) Biscoe, LLC
386. OHI Asset (NC) Cornelius, LLC
387. OHI Asset (NC) Drexel, LLC
388. OHI Asset (NC) Fayetteville, LLC
389. OHI Asset (NC) Hallsboro, LLC
390. OHI Asset (NC) Marion, LLC
391. OHI Asset (NC) Marshville, LLC
392. OHI Asset (NC) Mocksville – 1007 Howard Street, LLC
393. OHI Asset (NC) Mocksville – 1304 Madison Road, LLC
394. OHI Asset (NC) Nashville, LLC
395. OHI Asset (NC) Raeford, LLC
396. OHI Asset (NC) Rocky Mount – 1558 S. Winstead, LLC
397. OHI Asset (NC) Rocky Mount – 415 N. Winstead, LLC
398. OHI Asset (NC) Salisbury, LLC
399. OHI Asset (NC) Saluda, LLC
400. OHI Asset (NC) Shallotte, LLC
401. OHI Asset (NC) Wadesboro, LLC
402. OHI Asset (NC) Waynesville, LLC
403. OHI Asset (NC) Wilmington, LLC
404. OHI Asset (NC) Winston Salem, LLC
405. OHI Asset (NY) 2nd Avenue, LLC
406. OHI Asset (NY) 93rd Street, LLC

 

[Schedule I – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

407. OHI Asset (OH) Huber Heights, LLC
408. OHI Asset (OH) Lender, LLC
409. OHI Asset (OH) New London, LLC
410. OHI Asset (OH) Steubenville, LLC
411. OHI Asset (OH) Toledo, LLC
412. OHI Asset (OH) West Carrollton, LLC
413. OHI Asset (OH), LLC
414. OHI Asset (OR) Portland, LLC
415. OHI Asset (OR) Troutdale, LLC
416. OHI Asset (PA) GP, LLC
417. OHI Asset (PA) West Mifflin, LP
418. OHI Asset (PA), LLC
419. OHI Asset (PA), LP
420. OHI Asset (SC) Aiken, LLC
421. OHI Asset (SC) Anderson, LLC
422. OHI Asset (SC) Easley Anne, LLC
423. OHI Asset (SC) Easley Crestview, LLC
424. OHI Asset (SC) Edgefield, LLC
425. OHI Asset (SC) Five Forks, LLC
426. OHI Asset (SC) Greenville Cottages, LLC 
427. OHI Asset (SC) Greenville Griffith, LLC
428. OHI Asset (SC) Greenville Laurens, LLC
429. OHI Asset (SC) Greenville North, LLC
430. OHI Asset (SC) Greenville, LLC
431. OHI Asset (SC) Greer, LLC
432. OHI Asset (SC) Marietta, LLC
433. OHI Asset (SC) McCormick, LLC
434. OHI Asset (SC) Orangeburg, LLC
435. OHI Asset (SC) Pickens East Cedar, LLC
436. OHI Asset (SC) Pickens Rosemond, LLC
437. OHI Asset (SC) Piedmont, LLC
438. OHI Asset (SC) Simpsonville SE Main, LLC
439. OHI Asset (SC) Simpsonville West Broad, LLC
440. OHI Asset (SC) Simpsonville West Curtis, LLC
441. OHI Asset (TN) Bartlett, LLC
442. OHI Asset (TN) Byrdstown, LLC
443. OHI Asset (TN) Cleveland, LLC
444. OHI Asset (TN) Collierville, LLC
445. OHI Asset (TN) Columbia, LLC
446. OHI Asset (TN) Elizabethton, LLC
447. OHI Asset (TN) Erin, LLC
448. OHI Asset (TN) Greeneville, LLC
449. OHI Asset (TN) Harriman, LLC
450. OHI Asset (TN) Jamestown, LLC 
451. OHI Asset (TN) Jefferson City, LLC
452. OHI Asset (TN) Memphis – 1150 Dovecrest, LLC

 

[Schedule I – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

453. OHI Asset (TN) Memphis, LLC
454. OHI Asset (TN) Monteagle, LLC
455. OHI Asset (TN) Monterey, LLC 
456. OHI Asset (TN) Mountain City, LLC
457. OHI Asset (TN) Nashville, LLC
458. OHI Asset (TN) Pigeon Forge, LLC
459. OHI Asset (TN) Ridgely, LLC
460. OHI Asset (TN) Rockwood, LLC
461. OHI Asset (TN) Rogersville – 109 Highway 70 North, LLC
462. OHI Asset (TN) Rogersville, LLC
463. OHI Asset (TN) South Pittsburg, LLC
464. OHI Asset (TN) Spring City, LLC
465. OHI Asset (TN) Westmoreland, LLC
466. OHI Asset (TX) Anderson, LLC
467. OHI Asset (TX) Athens, LLC
468. OHI Asset (TX) Bryan, LLC
469. OHI Asset (TX) Burleson, LLC
470. OHI Asset (TX) College Station, LLC
471. OHI Asset (TX) Comfort, LLC
472. OHI Asset (TX) Diboll, LLC
473. OHI Asset (TX) Granbury, LLC
474. OHI Asset (TX) Hondo, LLC
475. OHI Asset (TX) Italy, LLC
476. OHI Asset (TX) Longview, LLC
477. OHI Asset (TX) Schertz, LLC
478. OHI Asset (TX) Winnsboro ALF, LLC
479. OHI Asset (TX) Winnsboro, LLC
480. OHI Asset (TX), LLC
481. OHI Asset (UT) Ogden, LLC
482. OHI Asset (UT) Provo, LLC
483. OHI Asset (UT) Roy, LLC
484. OHI Asset (VA) Charlottesville - 1165 Pepsi Place, LLC
485. OHI Asset (VA) Charlottesville, LLC
486. OHI Asset (VA) Chesapeake, LLC
487. OHI Asset (VA) Farmville, LLC
488. OHI Asset (VA) Galax, LLC
489. OHI Asset (VA) Hillsville, LLC
490. OHI Asset (VA) Madison, LLC
491. OHI Asset (VA) Martinsville ALF, LLC
492. OHI Asset (VA) Martinsville SNF, LLC
493. OHI Asset (VA) Mechanicsville, LLC
494. OHI Asset (VA) Midlothian, LLC
495. OHI Asset (VA) Norfolk, LLC
496. OHI Asset (VA) Portsmouth, LLC
497. OHI Asset (VA) Richmond - 2420 Pemberton Road, LLC
498. OHI Asset (VA) Richmond - 9101 Bon Air, LLC

 

[Schedule I – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

499. OHI Asset (VA) Rocky Mount, LLC
500. OHI Asset (VA) Suffolk, LLC
501. OHI Asset (WA) Battle Ground, LLC
502. OHI Asset (WA) Fort Vancouver, LLC
503. OHI Asset (WV) Danville, LLC
504. OHI Asset (WV) Ivydale, LLC
505. OHI Asset CHG ALF, LLC
506. OHI Asset CSB LLC
507. OHI Asset CSE – E, LLC
508. OHI Asset CSE – U, LLC
509. OHI Asset CSE–E Subsidiary, LLC
510. OHI Asset CSE–U Subsidiary, LLC
511. OHI Asset HUD CFG, LLC
512. OHI Asset HUD Delta, LLC
513. OHI Asset HUD H-F, LLC
514. OHI Asset HUD SF CA, LLC
515. OHI Asset HUD SF, LLC
516. OHI Asset HUD WO, LLC
517. OHI Asset II (CA), LLC
518. OHI Asset II (FL), LLC
519. OHI Asset II (PA), LP
520. OHI Asset III (PA), LP
521. OHI Asset IV (PA) Silver Lake, LP
522. OHI Asset Management, LLC
523. OHI Asset RO PMM Services, LLC
524. OHI Asset RO, LLC
525. OHI Asset S-W, LLC
526. OHI Asset, LLC
527. OHI Healthcare Properties Holdco, Inc.
528. OHI Healthcare Properties Limited Partnership
529. OHI Mezz Lender, LLC
530. OHI Tennessee, LLC (f/k/a OHI Tennessee, Inc.)
531. OHIMA, LLC (f/k/a OHIMA, Inc.)
532. Ohio Aviv Three, L.L.C.
533. Ohio Aviv Two, L.L.C.
534. Ohio Aviv, L.L.C.
535. Ohio Indiana Property, L.L.C.
536. Ohio Pennsylvania Property, L.L.C.
537. Oklahoma Two Property, L.L.C.
538. Oklahoma Warr Wind, L.L.C.
539. Omaha Associates, L.L.C.
540. Omega TRS I, Inc.
541. Orange ALF Property, L.L.C.
542. Orange Village Care Center, LLC (f/k/a Orange Village Care Center, Inc.)
543. Orange, L.L.C.

 

[Schedule I – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

544. Oregon Associates, L.L.C.
545. Oso Avenue Property, L.L.C.
546. Ostrom Avenue Property, L.L.C.
547. Palm Valley Senior Care, LLC
548. Panama City Nursing Center LLC
549. Pavillion North Partners, LLC
550. Pavillion North, LLP
551. Pavillion Nursing Center North, LLC
552. Peabody Associates Two, L.L.C.
553. Peabody Associates, L.L.C.
554. Pennington Road Property, L.L.C.
555. Pensacola Real Estate Holdings I, LLC (f/k/a Pensacola Real Estate Holdings I, Inc.)
556. Pensacola Real Estate Holdings II, LLC (f/k/a Pensacola Real Estate Holdings II, Inc.)
557. Pensacola Real Estate Holdings III, LLC (f/k/a Pensacola Real Estate Holdings III, Inc.)
558. Pensacola Real Estate Holdings IV, LLC (f/k/a Pensacola Real Estate Holdings IV, Inc.)
559. Pensacola Real Estate Holdings V, LLC (f/k/a Pensacola Real Estate Holdings V, Inc.)
560. Pocatello Idaho Property, L.L.C.
561. Pomona Vista L.L.C.
562. Prescott Arkansas, L.L.C.
563. PV Realty-Clinton, LLC
564. PV Realty-Kensington, LLC
565. PV Realty–Willow Tree, LLC
566. Raton Property Limited Company
567. Ravenna Ohio Property, L.L.C.
568. Red Rocks, L.L.C.
569. Richland Washington, L.L.C.
570. Ridgecrest Senior Care, LLC
571. Riverside Nursing Home Associates Two, L.L.C.
572. Riverside Nursing Home Associates, L.L.C.
573. Rockingham Drive Property, L.L.C.
574. Rose Baldwin Park Property L.L.C.
575. S.C. Portfolio Property, L.L.C.
576. Salem Associates, L.L.C.
577. San Juan NH Property, LLC
578. Sandalwood Arkansas Property, L.L.C.
579. Santa Ana-Bartlett, L.L.C.
580. Santa Fe Missouri Associates, L.L.C.
581. Savoy/Bonham Venture, L.L.C.
582. Searcy Aviv, L.L.C.
583. Sedgwick Properties, L.L.C.
584. Seguin Texas Property, L.L.C.

 

[Schedule I – 14th Supplemental Indenture – 2024 Notes]

 

 

 

 

585. Sierra Ponds Property, L.L.C.
586. Skyler Boyington, LLC (f/k/a Skyler Boyington, Inc.)
587. Skyler Florida, LLC (f/k/a Skyler Florida, Inc.)
588. Skyler Maitland LLC
589. Skyler Pensacola, LLC (f/k/a Skyler Pensacola, Inc.)
590. Skyview Associates, L.L.C.
591. Southeast Missouri Property, L.L.C.
592. Southern California Nevada, L.L.C.
593. St. Joseph Missouri Property, L.L.C.
594. St. Mary’s Properties, LLC (f/k/a St. Mary’s Properties, Inc.)
595. Star City Arkansas, L.L.C.
596. Stephenville Texas Property, L.L.C.
597. Sterling Acquisition, LLC
598. Stevens Avenue Property, L.L.C.
599. Sun-Mesa Properties, L.L.C.
600. Suwanee, LLC
601. Texas Fifteen Property, L.L.C.
602. Texas Four Property, L.L.C.
603. Texas Lessor – Stonegate GP, LLC
604. Texas Lessor – Stonegate, Limited, LLC
605. Texas Lessor – Stonegate, LP
606. Texhoma Avenue Property, L.L.C.
607. The Suburban Pavilion, LLC (f/k/a The Suburban Pavilion, Inc.)
608. Tujunga, L.L.C.
609. Tulare County Property, L.L.C.
610. Twinsburg Ohio Property, LLC
611. VRB Aviv, L.L.C.
612. Washington Idaho Property, L.L.C.
613. Washington Lessor – Silverdale, LLC
614. Washington-Oregon Associates, L.L.C.
615. Watauga Associates, L.L.C.
616. Wellington Leasehold, L.L.C.
617. West Pearl Street, L.L.C.
618. West Yarmouth Property I, L.L.C.
619. Westerville Ohio Office Property, L.L.C.
620. Weston ALF Property, LLC
621. Wheeler Healthcare Associates, L.L.C.
622. Whitlock Street Property, L.L.C.
623. Wilcare, LLC
624. Willis Texas Aviv, L.L.C.
625. Yuba Aviv, L.L.C.

 

[Schedule I – 14th Supplemental Indenture – 2024 Notes]

 

 

 

EX-4.2 4 t1700448_ex4-2.htm EXHIBIT 4.2

 

 

Exhibit 4.2

 

TWELFTH SUPPLEMENTAL INDENTURE

(4.50% Senior Notes due 2025) 

 

THIS TWELFTH SUPPLEMENTAL INDENTURE (this “Twelfth Supplemental Indenture”) is dated as of May 11, 2017, among OMEGA HEALTHCARE INVESTORS, INC., a Maryland corporation (the “Issuer”), each of the SUBSIDIARY GUARANTORS listed on Schedule I hereto (collectively, the “Subsidiary Guarantors”), each of the entities listed on Schedule II hereto (collectively, the “New Subsidiaries”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, as trustee (the “Trustee”).

 

W I T N E S S E T H:

 

WHEREAS, the Issuer and the Subsidiary Guarantors have heretofore executed and delivered to the Trustee an Indenture, dated as of September 11, 2014 (as supplemented by that First Supplemental Indenture, dated as of November 25, 2014, that Second Supplemental Indenture, dated as of January 23, 2015, that Third Supplemental Indenture, effective as of March 2, 2015, that Fourth Supplemental Indenture, dated as of April 1, 2015, that Fifth Supplemental Indenture, dated as of August 4, 2015, that Sixth Supplemental Indenture, dated as of November 9, 2015, that Seventh Supplemental Indenture, dated as of March 29, 2016, that Eighth Supplemental Indenture, dated as of May 13, 2016, that Ninth Supplement Indenture, dated as August 9, 2016, that Tenth Supplemental Indenture, dated as of November 10, 2016, and that Eleventh Supplemental Indenture, dated as of March 17, 2017; the “Indenture”), providing for the issuance of the Issuer’s 4.50% Senior Notes due 2025 (the “Notes”);

 

WHEREAS, Section 9.01 of the Indenture authorizes the Issuer, the Subsidiary Guarantors and the Trustee, together, to amend or supplement the Indenture, without notice to or consent of any Holder of the Notes, for the purpose of making any change that would not materially adversely affect the rights of any Holder of the Notes;

 

WHEREAS, pursuant to Section 4.14 of the Indenture, the New Subsidiaries are required to become Subsidiary Guarantors;

 

WHEREAS, in Section 1.01 of the Indenture, the term “Subsidiary Guarantors” is defined to include all Persons that become a Subsidiary Guarantor by the terms of the Indenture after the Closing Date; and

 

WHEREAS, Section 10.01 of the Indenture provides that each Subsidiary Guarantor shall be a guarantor of the Issuer’s obligations under the Notes, subject to the terms and conditions described in the Indenture.

 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Issuer, the Subsidiary Guarantors, the New Subsidiaries and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:

 

[12th Supplemental Indenture – 2025 Notes]

 

 

 

 

1.CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 

2.AMENDMENT TO GUARANTEE. The New Subsidiaries hereby agree, jointly and severally with all other Subsidiary Guarantors, to guarantee the Issuer’s obligations under the Notes on the terms and subject to the conditions set forth in the Indenture, and to be bound by, and to receive the benefit of, all other applicable provisions of the Indenture as Subsidiary Guarantors. Such guarantee shall be evidenced by the New Subsidiaries’ execution of Subsidiary Guarantees, the form of which is attached as Exhibit E to the Indenture, and shall be effective as of the effective date hereof.

 

3.NO RECOURSE AGAINST OTHERS. No past, present or future director, officer, employee, incorporator, stockholder, member, manager or controlling person of the New Subsidiaries, as such, shall have any liability for any obligations of the Issuer or any Subsidiary Guarantor under the Notes, any Guarantees, the Indenture or this Twelfth Supplemental Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder of the Notes, by accepting and holding a Note, waives and releases all such liability. Such waiver and release are part of the consideration for the issuance of the Notes.

 

4.NEW YORK LAW TO GOVERN. The laws of the State of New York shall govern and be used to construe this Twelfth Supplemental Indenture.

 

5.COUNTERPARTS. The parties may sign any number of copies of this Twelfth Supplemental Indenture. Each signed copy shall be an original, but all of them together shall represent the same agreement.

 

6.EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

 

7.THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Twelfth Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Issuer, the Subsidiary Guarantors and the New Subsidiaries.

 

[Remainder of Page Intentionally Left Blank]

 

[12th Supplemental Indenture – 2025 Notes]

 

 2 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Twelfth Supplemental Indenture to be duly executed, all as of the date first above written.

 

  ISSUER:
   
  OMEGA HEALTHCARE INVESTORS, INC.,
  a Maryland corporation
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
  SUBSIDIARY GUARANTORS:
   
  OHI HEALTHCARE PROPERTIES LIMITED
PARTNERSHIP
     
  By: OHI Healthcare Properties Holdco, Inc., as primary General Partner

 

  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

  ON BEHALF OF EACH OF THE OTHER
SUBSIDIARY GUARANTORS LISTED ON
SCHEDULE I
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

  NEW SUBSIDIARIES:
   
  ON BEHALF OF EACH OF THE NEW SUBSIDIARIES LISTED ON SCHEDULE II
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

  U.S. BANK NATIONAL ASSOCIATION,
  as Trustee
     
  By: /s/ David Ferrell
    Name: David Ferrell
    Title: Vice President

 

[Signature Page – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

Schedule I

 

SUBSIDIARY GUARANTORS

 

1. 11900 East Artesia Boulevard, LLC
2. 1200 Ely Street Holdings Co. LLC
3. 13922 Cerise Avenue, LLC
4. 1628 B Street, LLC
5. 2400 Parkside Drive, LLC
6. 2425 Teller Avenue, LLC
7. 245 East Wilshire Avenue, LLC
8. 3232 Artesia Real Estate, LLC
9. 3806 Clayton Road, LLC
10. 42235 County Road Holdings Co. LLC
11. 446 Sycamore Road, L.L.C.
12. 48 High Point Road, LLC
13. 523 Hayes Lane, LLC
14. 637 East Romie Lane, LLC
15. Alamogordo Aviv, L.L.C.
16. Albany Street Property, L.L.C.
17. Arizona Lessor - Infinia, LLC
18. Arkansas Aviv, L.L.C.
19. Arma Yates, L.L.C.
20. Avery Street Property, L.L.C
21. Aviv Asset Management, L.L.C.
22. Aviv Financing I, L.L.C.
23. Aviv Financing II, L.L.C.
24. Aviv Financing III, L.L.C.
25. Aviv Financing IV, L.L.C.
26. Aviv Financing V, L.L.C.
27. Aviv Foothills, L.L.C.
28. Aviv Healthcare Properties Operating Partnership I, L.P.
29. Aviv Liberty, L.L.C.
30. Avon Ohio, L.L.C.
31. Bala Cynwyd Real Estate, LP
32. Bayside Colorado Healthcare Associates, LLC
33. Bayside Street II, LLC
34. Bayside Street, LLC (f/k/a Bayside Street, Inc.)
35. Belleville Illinois, L.L.C.
36. Bellingham II Associates, L.L.C.
37. Bethel ALF Property, L.L.C.
38. BHG Aviv, L.L.C.
39. Biglerville Road, L.L.C.
40. Bonham Texas, L.L.C.
41. Bradenton ALF Property, L.L.C.
42. Burton NH Property, L.L.C.

 

[Schedule I – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

43. California Aviv Two, L.L.C.
44. California Aviv, L.L.C.
45. Camas Associates, L.L.C.
46. Canton Health Care Land, LLC (f/k/a Canton Health Care Land, Inc.)
47. Carnegie Gardens LLC
48. Casa/Sierra California Associates, L.L.C.
49. CFG 2115 Woodstock Place LLC
50. Champaign Williamson Franklin, L.L.C.
51. Chardon Ohio Property Holdings, L.L.C.
52. Chardon Ohio Property, L.L.C.
53. Chatham Aviv, L.L.C.
54. Chippewa Valley, L.L.C.
55. CHR Bartow LLC
56. CHR Boca Raton LLC
57. CHR Bradenton LLC
58. CHR Cape Coral LLC
59. CHR Fort Myers LLC
60. CHR Fort Walton Beach LLC
61. CHR Lake Wales LLC
62. CHR Lakeland LLC
63. CHR Pompano Beach Broward LLC
64. CHR Pompano Beach LLC
65. CHR Sanford LLC
66. CHR Spring Hill LLC
67. CHR St. Pete Bay LLC
68. CHR St. Pete Egret LLC
69. CHR Tampa Carrollwood LLC
70. CHR Tampa LLC
71. CHR Tarpon Springs LLC
72. CHR Titusville LLC
73. Clarkston Care, L.L.C.
74. Clayton Associates, L.L.C.
75. Colonial Gardens, LLC
76. Colonial Madison Associates, L.L.C.
77. Colorado Lessor - Conifer, LLC
78. Columbus Texas Aviv, L.L.C.
79. Columbus Western Avenue, L.L.C.
80. Colville Washington Property, L.L.C.
81. Commerce Nursing Homes, L.L.C.
82. Commerce Sterling Hart Drive, L.L.C.
83. Conroe Rigby Owen Road, L.L.C.
84. CR Aviv, L.L.C.
85. Crete Plus Five Property, L.L.C.
86. Crooked River Road, L.L.C.
87. CSE Albany LLC
88. CSE Amarillo LLC

 

[Schedule I – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

89. CSE Arden L.P.
90. CSE Augusta LLC
91. CSE Bedford LLC
92. CSE Blountville LLC
93. CSE Bolivar LLC
94. CSE Cambridge LLC
95. CSE Cambridge Realty LLC
96. CSE Camden LLC
97. CSE Canton LLC
98. CSE Casablanca Holdings II LLC
99. CSE Casablanca Holdings LLC
100. CSE Cedar Rapids LLC
101. CSE Centennial Village, LP
102. CSE Chelmsford LLC
103. CSE Chesterton LLC
104. CSE Claremont LLC
105. CSE Corpus North LLC
106. CSE Denver Iliff LLC
107. CSE Denver LLC
108. CSE Douglas LLC
109. CSE Elkton LLC
110. CSE Elkton Realty LLC
111. CSE Fairhaven LLC
112. CSE Fort Wayne LLC
113. CSE Frankston LLC
114. CSE Georgetown LLC
115. CSE Green Bay LLC
116. CSE Hilliard LLC
117. CSE Huntingdon LLC
118. CSE Huntsville LLC
119. CSE Indianapolis-Continental LLC
120. CSE Indianapolis-Greenbriar LLC
121. CSE Jacinto City LLC
122. CSE Jefferson City LLC
123. CSE Jeffersonville-Hillcrest Center LLC
124. CSE Jeffersonville-Jennings House LLC
125. CSE Kerrville LLC
126. CSE King L.P.
127. CSE Kingsport LLC
128. CSE Knightdale L.P.
129. CSE Lake City LLC
130. CSE Lake Worth LLC
131. CSE Lakewood LLC
132. CSE Las Vegas LLC
133. CSE Lawrenceburg LLC
134. CSE Lenoir L.P.

 

[Schedule I – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

135. CSE Lexington Park LLC
136. CSE Lexington Park Realty LLC
137. CSE Ligonier LLC
138. CSE Live Oak LLC
139. CSE Lowell LLC
140. CSE Marianna Holdings LLC
141. CSE Memphis LLC
142. CSE Mobile LLC
143. CSE Moore LLC
144. CSE North Carolina Holdings I LLC
145. CSE North Carolina Holdings II LLC
146. CSE Omro LLC
147. CSE Orange Park LLC
148. CSE Orlando-Pinar Terrace Manor LLC
149. CSE Orlando-Terra Vista Rehab LLC
150. CSE Pennsylvania Holdings, LP
151. CSE Piggott LLC
152. CSE Pilot Point LLC
153. CSE Pine View LLC
154. CSE Ponca City LLC
155. CSE Port St. Lucie LLC
156. CSE Richmond LLC
157. CSE Ripley LLC
158. CSE Ripon LLC
159. CSE Safford LLC
160. CSE Salina LLC
161. CSE Seminole LLC
162. CSE Shawnee LLC
163. CSE Spring Branch LLC
164. CSE Stillwater LLC
165. CSE Taylorsville LLC
166. CSE Texarkana LLC
167. CSE Texas City LLC
168. CSE The Village LLC
169. CSE Upland LLC
170. CSE Walnut Cove L.P.
171. CSE West Point LLC
172. CSE Whitehouse LLC
173. CSE Williamsport LLC
174. CSE Winter Haven LLC
175. CSE Woodfin L.P.
176. CSE Yorktown LLC
177. Cuyahoga Falls Property, L.L.C.
178. Cuyahoga Falls Property II, L.L.C.
179. Dallas Two Property, L.L.C.
180. Danbury ALF Property, L.L.C.

 

[Schedule I – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

181. Darien ALF Property, L.L.C.
182. Delta Investors I, LLC
183. Delta Investors II, LLC
184. Denison Texas, L.L.C.
185. Desert Lane LLC
186. Dixie White House Nursing Home, LLC (f/k/a Dixie White House Nursing Home, Inc.)
187. Dixon Health Care Center, LLC (f/k/a Dixon Health Care Center, Inc.)
188. East Rollins Street, L.L.C.
189. Edgewood Drive Property, L.L.C.
190. Effingham Associates, L.L.C.
191. Elite Mattoon, L.L.C.
192. Elite Yorkville, L.L.C.
193. Encanto Senior Care, LLC
194. Falcon Four Property Holding, L.L.C.
195. Falcon Four Property, L.L.C.
196. Falfurrias Texas, L.L.C.
197. Florida ALF Properties, L.L.C.
198. Florida Four Properties, L.L.C.
199. Florida Lessor – Meadowview, LLC
200. Florida Real Estate Company, LLC
201. Fort Stockton Property, L.L.C.
202. Four Fountains Aviv, L.L.C.
203. Fredericksburg South Adams Street, L.L.C.
204. Freewater Oregon, L.L.C.
205. Fullerton California, L.L.C.
206. G&L Gardens, LLC
207. Gardnerville Property, L.L.C.
208. Georgia Lessor - Bonterra/Parkview, LLC
209. Germantown Property, L.L.C.
210. Giltex Care, L.L.C.
211. Glendale NH Property, L.L.C.
212. Golden Hill Real Estate Company, LLC
213. Gonzales Texas Property, L.L.C.
214. Great Bend Property, L.L.C.
215. Greenbough, LLC
216. Greenville Kentucky Property, L.L.C.
217. Heritage Monterey Associates, L.L.C.
218. HHM Aviv, L.L.C.
219. Hidden Acres Property, L.L.C.
220. Highland Leasehold, L.L.C.
221. Hobbs Associates, L.L.C.
222. Hot Springs Atrium Owner, LLC
223. Hot Springs Aviv, L.L.C.
224. Hot Springs Cottages Owner, LLC
225. Hot Springs Marina Owner, LLC

 

[Schedule I – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

226. Houston Texas Aviv, L.L.C.
227. Hutchinson Kansas, L.L.C.
228. Hutton I Land, LLC (f/k/a Hutton I Land, Inc.)
229. Hutton II Land, LLC (f/k/a Hutton II Land, Inc.)
230. Hutton III Land, LLC (f/k/a Hutton III Land, Inc.)
231. Idaho Associates, L.L.C.
232. Illinois Missouri Properties, L.L.C.
233. Indiana Lessor – Wellington Manor, LLC
234. Iowa Lincoln County Property, L.L.C.
235. Jasper Springhill Street, L.L.C.
236. Kansas Five Property, L.L.C.
237. Karan Associates Two, L.L.C.
238. Karan Associates, L.L.C.
239. Karissa Court Property, L.L.C.
240. KB Northwest Associates, L.L.C.
241. Kentucky NH Properties, L.L.C.
242. Kingsville Texas, L.L.C.
243. LAD I Real Estate Company, LLC
244. Leatherman 90-1, LLC (f/k/a Leatherman 90-1, Inc.)
245. Leatherman Partnership 89-1, LLC (f/k/a Leatherman Partnership 89-1, Inc.)
246. Leatherman Partnership 89-2, LLC (f/k/a Leatherman Partnership 89-2, Inc.)
247. Louisville Dutchmans Property, L.L.C.
248. Magnolia Drive Property, L.L.C.
249. Manor Associates, L.L.C.
250. Mansfield Aviv, L.L.C.
251. Massachusetts Nursing Homes, L.L.C.
252. McCarthy Street Property, L.L.C.
253. Meridian Arms Land, LLC (f/k/a Meridian Arms Land, Inc.)
254. Minnesota Associates, L.L.C.
255. Mishawaka Property, L.L.C.
256. Missouri Associates, L.L.C.
257. Missouri Regency Associates, L.L.C.
258. Montana Associates, L.L.C.
259. Monterey Park Leasehold Mortgage, L.L.C.
260. Mount Washington Property, L.L.C.
261. Mt. Vernon Texas, L.L.C.
262. Murray County, L.L.C.
263. Muscatine Toledo Properties, L.L.C.
264. N.M. Bloomfield Three Plus One Limited Company
265. N.M. Espanola Three Plus One Limited Company
266. N.M. Lordsburg Three Plus One Limited Company
267. N.M. Silver City Three Plus One Limited Company
268. New Hope Property, L.L.C.
269. Newtown ALF Property, L.L.C.

 

[Schedule I – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

270. Nicholasville Kentucky Property, L.L.C.
271. North Las Vegas LLC
272. North Royalton Ohio Property, L.L.C.
273. Norwalk ALF Property, L.L.C.
274. NRS Ventures, L.L.C.
275. Oakland Nursing Homes, L.L.C.
276. Ocean Springs Nursing Home, LLC (f/k/a Ocean Springs Nursing Home, Inc.)
277. October Associates, L.L.C.
278. Ogden Associates, L.L.C.
279. OHI (Connecticut), LLC
280. OHI (Illinois), LLC(f/k/a OHI (Illinois), Inc.)
281. OHI (Indiana), LLC
282. OHI (Iowa), LLC(f/k/a OHI (Iowa), Inc.)
283. OHI Asset (AR) Ash Flat, LLC
284. OHI Asset (AR) Camden, LLC
285. OHI Asset (AR) Conway, LLC
286. OHI Asset (AR) Des Arc, LLC
287. OHI Asset (AR) Hot Springs, LLC
288. OHI Asset (AR) Malvern, LLC
289. OHI Asset (AR) Mena, LLC
290. OHI Asset (AR) Pocahontas, LLC
291. OHI Asset (AR) Sheridan, LLC
292. OHI Asset (AR) Walnut Ridge, LLC
293. OHI Asset (AZ) Austin House, LLC
294. OHI Asset (CA), LLC
295. OHI Asset (CO), LLC
296. OHI Asset (CO) Brighton, LLC
297. OHI Asset (CO) Denver, LLC
298. OHI Asset (CO) Mesa, LLC
299. OHI Asset (CT) Lender, LLC
300. OHI Asset (FL), LLC
301. OHI Asset (FL) Eustis, LLC
302. OHI Asset (FL) Graceville, LLC
303. OHI Asset (FL) Lake Placid, LLC
304. OHI Asset (FL) Lender, LLC
305. OHI Asset (FL) Lutz, LLC
306. OHI Asset (FL) Marianna, LLC
307. OHI Asset (FL) Middleburg, LLC
308. OHI Asset (FL) Pensacola - Hillview, LLC
309. OHI Asset (FL) Pensacola, LLC
310. OHI Asset (FL) Port St. Joe, LLC
311. OHI Asset (FL) Sebring, LLC
312. OHI Asset (GA) Cordele, LLC
313. OHI Asset (GA) Dunwoody, LLC
314. OHI Asset (GA) Macon, LLC

 

[Schedule I – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

315. OHI Asset (GA) Moultrie, LLC
316. OHI Asset (GA) Nashville, LLC
317. OHI Asset (GA) Roswell, LLC
318. OHI Asset (GA) Snellville, LLC
319. OHI Asset (GA) Valdosta, LLC
320. OHI Asset (ID) Holly, LLC
321. OHI Asset (ID) Midland, LLC
322. OHI Asset (ID), LLC
323. OHI Asset (IL), LLC
324. OHI Asset (IN) American Village, LLC
325. OHI Asset (IN) Anderson, LLC
326. OHI Asset (IN) Beech Grove, LLC
327. OHI Asset (IN) Clarksville, LLC
328. OHI Asset (IN) Clinton, LLC
329. OHI Asset (IN) Connersville, LLC
330. OHI Asset (IN) Crown Point, LLC
331. OHI Asset (IN) Eagle Valley, LLC
332. OHI Asset (IN) Elkhart, LLC
333. OHI Asset (IN) Forest Creek, LLC
334. OHI Asset (IN) Fort Wayne, LLC
335. OHI Asset (IN) Franklin, LLC
336. OHI Asset (IN) Greensburg, LLC
337. OHI Asset (IN) Indianapolis, LLC
338. OHI Asset (IN) Jasper, LLC
339. OHI Asset (IN) Kokomo, LLC
340. OHI Asset (IN) Lafayette, LLC
341. OHI Asset (IN) Madison, LLC
342. OHI Asset (IN) Monticello, LLC
343. OHI Asset (IN) Noblesville, LLC
344. OHI Asset (IN) Rosewalk, LLC
345. OHI Asset (IN) Salem, LLC
346. OHI Asset (IN) Seymour, LLC
347. OHI Asset (IN) Spring Mill, LLC
348. OHI Asset (IN) Terre Haute, LLC
349. OHI Asset (IN) Wabash, LLC
350. OHI Asset (IN) Westfield, LLC
351. OHI Asset (IN) Zionsville, LLC
352. OHI Asset (KY) Beattyville, LLC
353. OHI Asset (KY) Louisville – 1120 Cristland, LLC
354. OHI Asset (KY) Louisville – 2529 Six Mile Lane, LLC
355. OHI Asset (KY) Morgantown, LLC
356. OHI Asset (KY) Owensboro, LLC
357. OHI Asset (LA) Baton Rouge, LLC
358. OHI Asset (LA), LLC
359. OHI Asset (MD), LLC
360. OHI Asset (MD) Baltimore - Pall Mall, LLC

 

[Schedule I – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

361. OHI Asset (MD) Baltimore - West Belvedere, LLC
362. OHI Asset (MD) Salisbury, LLC
363. OHI Asset (MI) Heather Hills, LLC
364. OHI Asset (MI), LLC
365. OHI Asset (MI) Carson City, LLC
366. OHI Asset (MO), LLC
367. OHI Asset (MO) Jackson, LLC
368. OHI Asset (MS) Byhalia, LLC
369. OHI Asset (MS) Cleveland, LLC
370. OHI Asset (MS) Clinton, LLC
371. OHI Asset (MS) Columbia, LLC
372. OHI Asset (MS) Corinth, LLC
373. OHI Asset (MS) Greenwood, LLC
374. OHI Asset (MS) Grenada, LLC
375. OHI Asset (MS) Holly Springs, LLC
376. OHI Asset (MS) Indianola, LLC
377. OHI Asset (MS) Natchez, LLC
378. OHI Asset (MS) Picayune, LLC
379. OHI Asset (MS) Vicksburg, LLC
380. OHI Asset (MS) Yazoo City, LLC
381. OHI Asset (NC) Biscoe, LLC
382. OHI Asset (NC) Cornelius, LLC
383. OHI Asset (NC) Drexel, LLC
384. OHI Asset (NC) Fayetteville, LLC
385. OHI Asset (NC) Hallsboro, LLC
386. OHI Asset (NC) Marion, LLC
387. OHI Asset (NC) Marshville, LLC
388. OHI Asset (NC) Mocksville – 1007 Howard Street, LLC
389. OHI Asset (NC) Mocksville – 1304 Madison Road, LLC
390. OHI Asset (NC) Nashville, LLC
391. OHI Asset (NC) Raeford, LLC
392. OHI Asset (NC) Rocky Mount – 1558 S. Winstead, LLC
393. OHI Asset (NC) Rocky Mount – 415 N. Winstead, LLC
394. OHI Asset (NC) Salisbury, LLC
395. OHI Asset (NC) Saluda, LLC
396. OHI Asset (NC) Shallotte, LLC
397. OHI Asset (NC) Wadesboro, LLC
398. OHI Asset (NC) Waynesville, LLC
399. OHI Asset (NC) Wilmington, LLC
400. OHI Asset (NC) Winston Salem, LLC
401. OHI Asset (NY) 2nd Avenue, LLC
402. OHI Asset (NY) 93rd Street, LLC
403. OHI Asset (OH) Huber Heights, LLC
404. OHI Asset (OH) Lender, LLC
405. OHI Asset (OH), LLC
406. OHI Asset (OH) New London, LLC

 

[Schedule I – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

407. OHI Asset (OR) Portland, LLC
408. OHI Asset (OH) Steubenville, LLC
409. OHI Asset (OH) Toledo, LLC
410. OHI Asset (OR) Troutdale, LLC
411. OHI Asset (OH) West Carrollton, LLC
412. OHI Asset (PA) GP, LLC
413. OHI Asset (PA) West Mifflin, LP
414. OHI Asset (PA), LLC
415. OHI Asset (PA), LP
416. OHI Asset (SC) Aiken, LLC
417. OHI Asset (SC) Anderson, LLC
418. OHI Asset (SC) Easley Anne, LLC
419. OHI Asset (SC) Easley Crestview, LLC
420. OHI Asset (SC) Edgefield, LLC
421. OHI Asset (SC) Five Forks, LLC
422. OHI Asset (SC) Greenville Cottages, LLC 
423. OHI Asset (SC) Greenville Griffith, LLC
424. OHI Asset (SC) Greenville Laurens, LLC
425. OHI Asset (SC) Greenville North, LLC
426. OHI Asset (SC) Greenville, LLC
427. OHI Asset (SC) Greer, LLC
428. OHI Asset (SC) Marietta, LLC
429. OHI Asset (SC) McCormick, LLC
430. OHI Asset (SC) Orangeburg, LLC
431. OHI Asset (SC) Pickens East Cedar, LLC
432. OHI Asset (SC) Pickens Rosemond, LLC
433. OHI Asset (SC) Piedmont, LLC
434. OHI Asset (SC) Simpsonville SE Main, LLC
435. OHI Asset (SC) Simpsonville West Broad, LLC
436. OHI Asset (SC) Simpsonville West Curtis, LLC
437. OHI Asset (TN) Bartlett, LLC
438. OHI Asset (TN) Cleveland, LLC
439. OHI Asset (TN) Collierville, LLC
440. OHI Asset (TN) Columbia, LLC
441. OHI Asset (TN) Elizabethton, LLC
442. OHI Asset (TN) Jamestown, LLC 
443. OHI Asset (TN) Jefferson City, LLC
444. OHI Asset (TN) Memphis, LLC
445. OHI Asset (TN) Memphis – 1150 Dovecrest, LLC
446. OHI Asset (TN) Monteagle, LLC
447. OHI Asset (TN) Monterey, LLC 
448. OHI Asset (TN) Mountain City, LLC
449. OHI Asset (TN) Nashville, LLC
450. OHI Asset (TN) Pigeon Forge, LLC
451. OHI Asset (TN) Rockwood, LLC
452. OHI Asset (TN) Rogersville, LLC

 

[Schedule I – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

453. OHI Asset (TN) Rogersville – 109 Highway 70 North, LLC
454. OHI Asset (TN) South Pittsburg, LLC
455. OHI Asset (TN) Spring City, LLC
456. OHI Asset (TN) Westmoreland, LLC
457. OHI Asset (TX) Anderson, LLC
458. OHI Asset (TX) Athens, LLC
459. OHI Asset (TX) Bryan, LLC
460. OHI Asset (TX) Burleson, LLC
461. OHI Asset (TX) College Station, LLC
462. OHI Asset (TX) Comfort, LLC
463. OHI Asset (TX) Diboll, LLC
464. OHI Asset (TX) Granbury, LLC
465. OHI Asset (TX) Hondo, LLC
466. OHI Asset (TX) Italy, LLC
467. OHI Asset (TX) Longview, LLC
468. OHI Asset (TX) Schertz, LLC
469. OHI Asset (TX) Winnsboro, LLC
470. OHI Asset (TX) Winnsboro ALF, LLC
471. OHI Asset (TX), LLC
472. OHI Asset (UT) Ogden, LLC
473. OHI Asset (UT) Provo, LLC
474. OHI Asset (UT) Roy, LLC
475. OHI Asset (VA) Charlottesville - 1165 Pepsi Place, LLC
476. OHI Asset (VA) Charlottesville, LLC
477. OHI Asset (VA) Chesapeake, LLC
478. OHI Asset (VA) Farmville, LLC
479. OHI Asset (VA) Galax, LLC
480. OHI Asset (VA) Hillsville, LLC
481. OHI Asset (VA) Martinsville SNF, LLC
482. OHI Asset (VA) Madison, LLC
483. OHI Asset (VA) Mechanicsville, LLC
484. OHI Asset (VA) Midlothian, LLC
485. OHI Asset (VA) Norfolk, LLC
486. OHI Asset (VA) Portsmouth, LLC
487. OHI Asset (VA) Richmond - 2420 Pemberton Road, LLC
488. OHI Asset (VA) Richmond - 9101 Bon Air, LLC
489. OHI Asset (VA) Rocky Mount, LLC
490. OHI Asset (VA) Suffolk, LLC
491. OHI Asset (WA) Battle Ground, LLC
492. OHI Asset (WA) Fort Vancouver, LLC
493. OHI Asset (WV) Danville, LLC
494. OHI Asset (WV) Ivydale, LLC
495. OHI Asset CHG ALF, LLC
496. OHI Asset CSB LLC
497. OHI Asset CSE – E, LLC
498. OHI Asset CSE – U, LLC

 

[Schedule I – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

499. OHI Asset CSE–E Subsidiary, LLC
500. OHI Asset CSE–U Subsidiary, LLC
501. OHI Asset HUD CFG, LLC
502. OHI Asset HUD Delta, LLC
503. OHI Asset HUD H-F, LLC
504. OHI Asset HUD SF CA, LLC
505. OHI Asset HUD SF, LLC
506. OHI Asset HUD WO, LLC
507. OHI Asset II (CA), LLC
508. OHI Asset II (FL), LLC
509. OHI Asset II (PA), LP
510. OHI Asset III (PA), LP
511. OHI Asset IV (PA) Silver Lake, LP
512. OHI Asset Management, LLC
513. OHI Asset RO PMM Services, LLC
514. OHI Asset RO, LLC
515. OHI Asset S-W, LLC
516. OHI Asset, LLC
517. OHI Healthcare Properties Holdco, Inc.
518. OHI Healthcare Properties Limited Partnership
519. OHI Mezz Lender, LLC
520. OHI Tennessee, LLC (f/k/a OHI Tennessee, Inc.)
521. OHIMA, LLC (f/k/a OHIMA, Inc.)
522. Ohio Aviv Three, L.L.C.
523. Ohio Aviv Two, L.L.C.
524. Ohio Aviv, L.L.C.
525. Ohio Indiana Property, L.L.C.
526. Ohio Pennsylvania Property, L.L.C.
527. Oklahoma Two Property, L.L.C.
528. Oklahoma Warr Wind, L.L.C.
529. Omaha Associates, L.L.C.
530. Omega TRS I, Inc.
531. Orange ALF Property, L.L.C.
532. Orange Village Care Center, LLC (f/k/a Orange Village Care Center, Inc.)
533. Orange, L.L.C.
534. Oregon Associates, L.L.C.
535. Oso Avenue Property, L.L.C.
536. Ostrom Avenue Property, L.L.C.
537. Palm Valley Senior Care, LLC
538. Panama City Nursing Center LLC
539. Pavillion North Partners, LLC
540. Pavillion North, LLP
541. Pavillion Nursing Center North, LLC
542. Peabody Associates Two, L.L.C.
543. Peabody Associates, L.L.C.

 

[Schedule I – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

544. Pennington Road Property, L.L.C.
545. Pensacola Real Estate Holdings I, LLC (f/k/a Pensacola Real Estate Holdings I, Inc.)
546. Pensacola Real Estate Holdings II, LLC (f/k/a Pensacola Real Estate Holdings II, Inc.)
547. Pensacola Real Estate Holdings III, LLC (f/k/a Pensacola Real Estate Holdings III, Inc.)
548. Pensacola Real Estate Holdings IV, LLC (f/k/a Pensacola Real Estate Holdings IV, Inc.)
549. Pensacola Real Estate Holdings V, LLC (f/k/a Pensacola Real Estate Holdings V, Inc.)
550. Pocatello Idaho Property, L.L.C.
551. Pomona Vista L.L.C.
552. Prescott Arkansas, L.L.C.
553. PV Realty-Clinton, LLC
554. PV Realty-Kensington, LLC
555. PV Realty–Willow Tree, LLC
556. Raton Property Limited Company
557. Ravenna Ohio Property, L.L.C.
558. Red Rocks, L.L.C.
559. Richland Washington, L.L.C.
560. Ridgecrest Senior Care, LLC
561. Riverside Nursing Home Associates Two, L.L.C.
562. Riverside Nursing Home Associates, L.L.C.
563. Rockingham Drive Property, L.L.C.
564. Rose Baldwin Park Property L.L.C.
565. S.C. Portfolio Property, L.L.C.
566. Salem Associates, L.L.C.
567. San Juan NH Property, LLC
568. Sandalwood Arkansas Property, L.L.C.
569. Santa Ana-Bartlett, L.L.C.
570. Santa Fe Missouri Associates, L.L.C.
571. Savoy/Bonham Venture, L.L.C.
572. Searcy Aviv, L.L.C.
573. Sedgwick Properties, L.L.C.
574. Seguin Texas Property, L.L.C.
575. Sierra Ponds Property, L.L.C.
576. Skyler Boyington, LLC (f/k/a Skyler Boyington, Inc.)
577. Skyler Florida, LLC (f/k/a Skyler Florida, Inc.)
578. Skyler Maitland LLC
579. Skyler Pensacola, LLC (f/k/a Skyler Pensacola, Inc.)
580. Skyview Associates, L.L.C.
581. Southeast Missouri Property, L.L.C.
582. Southern California Nevada, L.L.C.
583. St. Joseph Missouri Property, L.L.C.
584. St. Mary’s Properties, LLC (f/k/a St. Mary’s Properties, Inc.)

 

[Schedule I – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

585. Star City Arkansas, L.L.C.
586. Stephenville Texas Property, L.L.C.
587. Sterling Acquisition, LLC
588. Stevens Avenue Property, L.L.C.
589. Sun-Mesa Properties, L.L.C.
590. Suwanee, LLC
591. Texas Fifteen Property, L.L.C.
592. Texas Four Property, L.L.C.
593. Texas Lessor – Stonegate GP, LLC
594. Texas Lessor – Stonegate, Limited, LLC
595. Texas Lessor – Stonegate, LP
596. Texhoma Avenue Property, L.L.C.
597. The Suburban Pavilion, LLC (f/k/a The Suburban Pavilion, Inc.)
598. Tujunga, L.L.C.
599. Tulare County Property, L.L.C.
600. Twinsburg Ohio Property, LLC
601. VRB Aviv, L.L.C.
602. Washington Idaho Property, L.L.C.
603. Washington Lessor – Silverdale, LLC
604. Washington-Oregon Associates, L.L.C.
605. Watauga Associates, L.L.C.
606. Wellington Leasehold, L.L.C.
607. West Pearl Street, L.L.C.
608. West Yarmouth Property I, L.L.C.
609. Westerville Ohio Office Property, L.L.C.
610. Weston ALF Property, LLC
611. Wheeler Healthcare Associates, L.L.C.
612. Whitlock Street Property, L.L.C.
613. Wilcare, LLC
614. Willis Texas Aviv, L.L.C.
615. Yuba Aviv, L.L.C.

 

[Schedule I – 12th Supplemental Indenture – 2025 Notes]

 

 

 

 

Schedule II

 

NEW SUBSIDIARIES

 

1. OHI Asset (AZ) Tucson, LLC
2. OHI Asset (FL) DeFuniak Springs, LLC
3. OHI Asset (FL) Homestead, LLC
4. OHI Asset (FL) Ormond Beach, LLC
5. OHI Asset (TN) Byrdstown, LLC
6. OHI Asset (TN) Erin, LLC
7. OHI Asset (TN) Greeneville, LLC
8. OHI Asset (TN) Harriman, LLC
9. OHI Asset (TN) Ridgely, LLC
10. OHI Asset (VA) Martinsville ALF, LLC

 

[Schedule II – 12th Supplemental Indenture – 2025 Notes]

 

 

 

EX-4.2A 5 t1700448_ex4-2a.htm EXHIBIT 4.2A

 

 

Exhibit 4.2A

 

THIRTEENTH SUPPLEMENTAL INDENTURE

(4.50% Senior Notes due 2025)

 

THIS THIRTEENTH SUPPLEMENTAL INDENTURE (this “Thirteenth Supplemental Indenture”) is dated as of May 25, 2017 among OMEGA HEALTHCARE INVESTORS, INC., a Maryland corporation (the “Issuer”), each of the SUBSIDIARY GUARANTORS listed on Schedule I hereto (collectively, the “Subsidiary Guarantors”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, as trustee (the “Trustee”).

 

W I T N E S S E T H :

 

WHEREAS, the Issuer and the Subsidiary Guarantors have heretofore executed and delivered to the Trustee an Indenture, dated as of September 11, 2014 (as supplemented by that First Supplemental Indenture, dated as of November 25, 2014, that Second Supplemental Indenture, dated as of January 23, 2015, that Third Supplemental Indenture, effective as of March 2, 2015, that Fourth Supplemental Indenture, dated as of April 1, 2015, that Fifth Supplemental Indenture, dated as of August 4, 2015, that Sixth Supplemental Indenture, dated as of November 9, 2015, that Seventh Supplemental Indenture, dated as of March 29, 2016, that Eighth Supplemental Indenture, dated as of May 13, 2016, that Ninth Supplement Indenture, dated as August 9, 2016, that Tenth Supplemental Indenture, dated as of November 10, 2016, that Eleventh Supplemental Indenture, dated as of March 17, 2017 and that Twelfth Supplemental Indenture, dated as of May 11, 2017; the “Indenture”), providing for the issuance of the Issuer’s 4.50% Senior Notes due 2025 (the “Notes”);

 

WHEREAS, in Section 1.01 of the Indenture, the term “Subsidiary Guarantors” is defined to include (i) each Subsidiary that is a guarantor of Indebtedness under the Existing Note Indentures on the Closing Date and (ii) each other Person that is required to become a Subsidiary Guarantor by the terms of the Indenture after the Closing Date, in each case, until such Person is released from its Subsidiary Guarantee;

 

WHEREAS, Section 10.04(4) of the Indenture provides that if a Subsidiary Guarantor ceases to guarantee the obligations of the Issuer under any Indebtedness of the Issuer that would constitute Indebtedness under clauses (1) or (2) of the definition thereof in the Indenture, in an amount at least equal to $50 million, such Subsidiary Guarantor shall be automatically and unconditionally released from its obligations under its Subsidiary Guarantee and its obligations under the Indenture;

 

WHEREAS, Section 10.04 of the Indenture further provides that upon any such occurrence, at the Issuer’s request and subject to the further requirements of said Section, the Trustee shall execute any documents reasonably requested by the Issuer evidencing such release;

 

WHEREAS, the Subsidiary Guarantors other than OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership (each, a “Released Subsidiary Guarantor” and collectively, the “Released Subsidiary Guarantors”) no longer guarantee the obligations of the Issuer under any Indebtedness of the Issuer described under clauses (1) or (2) of the definition of Indebtedness in the Indenture in an amount at least equal to $50 million and therefore are automatically and unconditionally released from their obligations under their respective Subsidiary Guarantees and under the Indenture;

 

[13th Supplemental Indenture – 2025 Notes]

 

 

 

 

WHEREAS, the Issuer and the Subsidiary Guarantors (including the Released Subsidiary Guarantors) have requested that the Trustee enter into this Thirteenth Supplemental Indenture and the Partial Release (as hereinafter defined) to further evidence such release of the Released Subsidiary Guarantors; and

 

WHEREAS, Section 9.01(a)(4) of the Indenture authorizes the Issuer, the Subsidiary Guarantors and the Trustee, together, to amend or supplement the Indenture, without notice to or consent of any Holder of the Notes, for the purpose of releasing any Subsidiary Guarantor from any of its obligations under its Subsidiary Guarantee or the Indenture to the extent permitted by the Indenture;

 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Issuer, the Subsidiary Guarantors (including the Released Subsidiary Guarantors) and the Trustee mutually covenant and agree as follows:

 

  1. CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 

  2. RELEASE OF RELEASED SUBSIDIARY GUARANTORS. Pursuant to Section 10.04 of the Indenture, each of the Released Subsidiary Guarantors is hereby released from its obligations under its Subsidiary Guarantees and under the Indenture. Such release shall be further evidenced by the Trustee’s execution and delivery of a Partial Release of Subsidiary Guarantors, the form of which is attached hereto as Exhibit A (the “Partial Release”). From and after the execution and delivery hereof, the term “Subsidiary Guarantor” as used in the Indenture, the Subsidiary Guarantees and the Notes shall exclude each of the Released Subsidiary Guarantors, unless and until such Person again becomes a Subsidiary Guarantor pursuant to the provisions of Section 4.14 of the Indenture. For avoidance of doubt, OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership remain Subsidiary Guarantors.

 

  3. NEW YORK LAW TO GOVERN. The laws of the State of New York shall govern and be used to construe this Thirteenth Supplemental Indenture.

 

  4. COUNTERPARTS. The parties may sign any number of copies of this Thirteenth Supplemental Indenture. Each signed copy shall be an original, but all of them together shall represent the same agreement.

 

  5. EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

 

[13th Supplemental Indenture – 2025 Notes]

 

 

 

 

  6. THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Thirteenth Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Issuer and the Subsidiary Guarantors (including the Released Subsidiary Guarantors).

 

[Remainder of Page Intentionally Left Blank]

 

[13th Supplemental Indenture – 2025 Notes]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Thirteenth Supplemental Indenture to be duly executed, all as of the date first above written.

 

  ISSUER:
   
  OMEGA HEALTHCARE INVESTORS, INC.,
  a Maryland corporation
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
  SUBSIDIARY GUARANTORS:
   
  OHI HEALTHCARE PROPERTIES HOLDCO, INC.
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
  OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP
     
  By: OHI Healthcare Properties Holdco, Inc., as primary General Partner

 

  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page - 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

  ON BEHALF OF EACH OF THE OTHER SUBSIDIARY GUARANTORS LISTED ON SCHEDULE I
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page - 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

  U.S. BANK NATIONAL ASSOCIATION,  
  as Trustee  
       
  By: /s/ David Ferrell  
    David Ferrell  
    Vice President  

 

[Signature Page - 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

Exhibit A

(Form of Partial Release of Subsidiary Guarantors)

 

[ATTACHED]

 

[Exhibit A – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

[FORM OF ]

PARTIAL RELEASE OF SUBSIDIARY GUARANTORS

 

([INDENTURE DESCRIPTION])

 

[DATE]

 

Reference is hereby made to that certain Indenture dated as of [DATE], among Omega Healthcare Investors, Inc., a Maryland corporation (the "Issuer"), the Subsidiary Guarantors named therein and U.S. Bank National Association, as trustee (the "Trustee"), as amended or supplemented by that [ADD SUPPLEMENTAL INDENTURES] (the "Indenture"). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Indenture.

 

Pursuant to the provisions of Section [REFERENCE] of the Indenture and the terms of that certain Second Supplemental Indenture, dated as of even date herewith, among the Issuer, the Subsidiary Guarantors and the Trustee, amending and supplementing the Indenture, each of the entities set forth on Schedule I attached hereto and incorporated herein by this reference is hereby released from its obligations under its Subsidiary Guarantees and under the Indenture. For avoidance of doubt, OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership remain Subsidiary Guarantors.

 

The validity and enforceability of this Partial Release of Subsidiary Guarantors shall not be affected by the fact that it is not affixed to any particular Subsidiary Guarantee or Note.

 

This Partial Release of Subsidiary Guarantors shall be governed by, and construed in accordance with, the laws of the State of New York.

 

[Remainder of Page Intentionally Left Blank]

 

[Exhibit A – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Partial Release of Subsidiary Guarantors to be duly executed as of the date first written above.

 

 

U.S. BANK NATIONAL ASSOCIATION,

as Trustee

     
  By:  
    [NAME]
    [TITLE][

 

[Exhibit A – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

Schedule I

 

SUBSIDIARY GUARANTORS

 

1. 11900 East Artesia Boulevard, LLC
2. 1200 Ely Street Holdings Co. LLC
3. 13922 Cerise Avenue, LLC
4. 1628 B Street, LLC
5. 2400 Parkside Drive, LLC
6. 2425 Teller Avenue, LLC
7. 245 East Wilshire Avenue, LLC
8. 3232 Artesia Real Estate, LLC
9. 3806 Clayton Road, LLC
10. 42235 County Road Holdings Co. LLC
11. 446 Sycamore Road, L.L.C.
12. 48 High Point Road, LLC
13. 523 Hayes Lane, LLC
14. 637 East Romie Lane, LLC
15. Alamogordo Aviv, L.L.C.
16. Albany Street Property, L.L.C.
17. Arizona Lessor - Infinia, LLC
18. Arkansas Aviv, L.L.C.
19. Arma Yates, L.L.C.
20. Avery Street Property, L.L.C
21. Aviv Asset Management, L.L.C.
22. Aviv Financing I, L.L.C.
23. Aviv Financing II, L.L.C.
24. Aviv Financing III, L.L.C.
25. Aviv Financing IV, L.L.C.
26. Aviv Financing V, L.L.C.
27. Aviv Foothills, L.L.C.
28. Aviv Healthcare Properties Operating Partnership I, L.P.
29. Aviv Liberty, L.L.C.
30. Avon Ohio, L.L.C.
31. Bala Cynwyd Real Estate, LP
32. Bayside Colorado Healthcare Associates, LLC
33. Bayside Street II, LLC
34. Bayside Street, LLC (f/k/a Bayside Street, Inc.)
35. Belleville Illinois, L.L.C.
36. Bellingham II Associates, L.L.C.
37. Bethel ALF Property, L.L.C.
38. BHG Aviv, L.L.C.
39. Biglerville Road, L.L.C.
40. Bonham Texas, L.L.C.
41. Bradenton ALF Property, L.L.C.
42. Burton NH Property, L.L.C.

 

[Schedule I – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

43. California Aviv Two, L.L.C.
44. California Aviv, L.L.C.
45. Camas Associates, L.L.C.
46. Canton Health Care Land, LLC (f/k/a Canton Health Care Land, Inc.)
47. Carnegie Gardens LLC
48. Casa/Sierra California Associates, L.L.C.
49. CFG 2115 Woodstock Place LLC
50. Champaign Williamson Franklin, L.L.C.
51. Chardon Ohio Property Holdings, L.L.C.
52. Chardon Ohio Property, L.L.C.
53. Chatham Aviv, L.L.C.
54. Chippewa Valley, L.L.C.
55. CHR Bartow LLC
56. CHR Boca Raton  LLC
57. CHR Bradenton LLC
58. CHR Cape Coral LLC
59. CHR Fort Myers LLC
60. CHR Fort Walton Beach LLC
61. CHR Lake Wales LLC
62. CHR Lakeland LLC
63. CHR Pompano Beach Broward LLC
64. CHR Pompano Beach LLC
65. CHR Sanford LLC
66. CHR Spring Hill LLC
67. CHR St. Pete Bay LLC
68. CHR St. Pete Egret LLC
69. CHR Tampa Carrollwood LLC
70. CHR Tampa LLC
71. CHR Tarpon Springs LLC
72. CHR Titusville LLC
73. Clarkston Care, L.L.C.
74. Clayton Associates, L.L.C.
75. Colonial Gardens, LLC
76. Colonial Madison Associates, L.L.C.
77. Colorado Lessor - Conifer, LLC
78. Columbus Texas Aviv, L.L.C.
79. Columbus Western Avenue, L.L.C.
80. Colville Washington Property, L.L.C.
81. Commerce Nursing Homes, L.L.C.
82. Commerce Sterling Hart Drive, L.L.C.
83. Conroe Rigby Owen Road, L.L.C.
84. CR Aviv, L.L.C.
85. Crete Plus Five Property, L.L.C.
86. Crooked River Road, L.L.C.
87. CSE Albany LLC
88. CSE Amarillo LLC

 

[Schedule I – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

89. CSE Arden L.P.
90. CSE Augusta LLC
91. CSE Bedford LLC
92. CSE Blountville LLC
93. CSE Bolivar LLC
94. CSE Cambridge LLC
95. CSE Cambridge Realty LLC
96. CSE Camden LLC
97. CSE Canton LLC
98. CSE Casablanca Holdings II LLC
99. CSE Casablanca Holdings LLC
100. CSE Cedar Rapids LLC
101. CSE Centennial Village, LP
102. CSE Chelmsford LLC
103. CSE Chesterton LLC
104. CSE Claremont LLC
105. CSE Corpus North LLC
106. CSE Denver Iliff LLC
107. CSE Denver LLC
108. CSE Douglas LLC
109. CSE Elkton LLC
110. CSE Elkton Realty LLC
111. CSE Fairhaven LLC
112. CSE Fort Wayne LLC
113. CSE Frankston LLC
114. CSE Georgetown LLC
115. CSE Green Bay LLC
116. CSE Hilliard LLC
117. CSE Huntingdon LLC
118. CSE Huntsville LLC
119. CSE Indianapolis-Continental LLC
120. CSE Indianapolis-Greenbriar LLC
121. CSE Jacinto City LLC
122. CSE Jefferson City LLC
123. CSE Jeffersonville-Hillcrest Center LLC
124. CSE Jeffersonville-Jennings House LLC
125. CSE Kerrville LLC
126. CSE King L.P.
127. CSE Kingsport LLC
128. CSE Knightdale L.P.
129. CSE Lake City LLC
130. CSE Lake Worth LLC
131. CSE Lakewood LLC
132. CSE Las Vegas LLC
133. CSE Lawrenceburg LLC
134. CSE Lenoir L.P.

 

[Schedule I – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

135. CSE Lexington Park LLC
136. CSE Lexington Park Realty LLC
137. CSE Ligonier LLC
138. CSE Live Oak LLC
139. CSE Lowell LLC
140. CSE Marianna Holdings LLC
141. CSE Memphis LLC
142. CSE Mobile LLC
143. CSE Moore LLC
144. CSE North Carolina Holdings I LLC
145. CSE North Carolina Holdings II LLC
146. CSE Omro LLC
147. CSE Orange Park LLC
148. CSE Orlando-Pinar Terrace Manor LLC
149. CSE Orlando-Terra Vista Rehab LLC
150. CSE Pennsylvania Holdings, LP
151. CSE Piggott LLC
152. CSE Pilot Point LLC
153. CSE Pine View LLC
154. CSE Ponca City LLC
155. CSE Port St. Lucie LLC
156. CSE Richmond LLC
157. CSE Ripley LLC
158. CSE Ripon LLC
159. CSE Safford LLC
160. CSE Salina LLC
161. CSE Seminole LLC
162. CSE Shawnee LLC
163. CSE Spring Branch LLC
164. CSE Stillwater LLC
165. CSE Taylorsville LLC
166. CSE Texarkana LLC
167. CSE Texas City LLC
168. CSE The Village LLC
169. CSE Upland LLC
170. CSE Walnut Cove L.P.
171. CSE West Point LLC
172. CSE Whitehouse LLC
173. CSE Williamsport LLC
174. CSE Winter Haven LLC
175. CSE Woodfin L.P.
176. CSE Yorktown LLC
177. Cuyahoga Falls Property II, L.L.C.
178. Cuyahoga Falls Property, L.L.C.
179. Dallas Two Property, L.L.C.
180. Danbury ALF Property, L.L.C.

 

[Schedule I – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

181. Darien ALF Property, L.L.C.
182. Delta Investors I, LLC
183. Delta Investors II, LLC
184. Denison Texas, L.L.C.
185. Desert Lane LLC
186. Dixie White House Nursing Home, LLC (f/k/a Dixie White House Nursing Home, Inc.)
187. Dixon Health Care Center, LLC (f/k/a Dixon Health Care Center, Inc.)
188. East Rollins Street, L.L.C.
189. Edgewood Drive Property, L.L.C.
190. Effingham Associates, L.L.C.
191. Elite Mattoon, L.L.C.
192. Elite Yorkville, L.L.C.
193. Encanto Senior Care, LLC
194. Falcon Four Property Holding, L.L.C.
195. Falcon Four Property, L.L.C.
196. Falfurrias Texas, L.L.C.
197. Florida ALF Properties, L.L.C.
198. Florida Four Properties, L.L.C.
199. Florida Lessor – Meadowview, LLC
200. Florida Real Estate Company, LLC
201. Fort Stockton Property, L.L.C.
202. Four Fountains Aviv, L.L.C.
203. Fredericksburg South Adams Street, L.L.C.
204. Freewater Oregon, L.L.C.
205. Fullerton California, L.L.C.
206. G&L Gardens, LLC
207. Gardnerville Property, L.L.C.
208. Georgia Lessor - Bonterra/Parkview, LLC
209. Germantown Property, L.L.C.
210. Giltex Care, L.L.C.
211. Glendale NH Property, L.L.C.
212. Golden Hill Real Estate Company, LLC
213. Gonzales Texas Property, L.L.C.
214. Great Bend Property, L.L.C.
215. Greenbough, LLC
216. Greenville Kentucky Property, L.L.C.
217. Heritage Monterey Associates, L.L.C.
218. HHM Aviv, L.L.C.
219. Hidden Acres Property, L.L.C.
220. Highland Leasehold, L.L.C.
221. Hobbs Associates, L.L.C.
222. Hot Springs Atrium Owner, LLC
223. Hot Springs Aviv, L.L.C.
224. Hot Springs Cottages Owner, LLC
225. Hot Springs Marina Owner, LLC

 

[Schedule I – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

226. Houston Texas Aviv, L.L.C.
227. Hutchinson Kansas, L.L.C.
228. Hutton I Land, LLC (f/k/a Hutton I Land, Inc.)
229. Hutton II Land, LLC (f/k/a Hutton II Land, Inc.)
230. Hutton III Land, LLC (f/k/a Hutton III Land, Inc.)
231. Idaho Associates, L.L.C.
232. Illinois Missouri Properties, L.L.C.
233. Indiana Lessor – Wellington Manor, LLC
234. Iowa Lincoln County Property, L.L.C.
235. Jasper Springhill Street, L.L.C.
236. Kansas Five Property, L.L.C.
237. Karan Associates Two, L.L.C.
238. Karan Associates, L.L.C.
239. Karissa Court Property, L.L.C.
240. KB Northwest Associates, L.L.C.
241. Kentucky NH Properties, L.L.C.
242. Kingsville Texas, L.L.C.
243. LAD I Real Estate Company, LLC
244. Leatherman 90-1, LLC (f/k/a Leatherman 90-1, Inc.)
245. Leatherman Partnership 89-1, LLC (f/k/a Leatherman Partnership 89-1, Inc.)
246. Leatherman Partnership 89-2, LLC (f/k/a Leatherman Partnership 89-2, Inc.)
247. Louisville Dutchmans Property, L.L.C.
248. Magnolia Drive Property, L.L.C.
249. Manor Associates, L.L.C.
250. Mansfield Aviv, L.L.C.
251. Massachusetts Nursing Homes, L.L.C.
252. McCarthy Street Property, L.L.C.
253. Meridian Arms Land, LLC (f/k/a Meridian Arms Land, Inc.)
254. Minnesota Associates, L.L.C.
255. Mishawaka Property, L.L.C.
256. Missouri Associates, L.L.C.
257. Missouri Regency Associates, L.L.C.
258. Montana Associates, L.L.C.
259. Monterey Park Leasehold Mortgage, L.L.C.
260. Mount Washington Property, L.L.C.
261. Mt. Vernon Texas, L.L.C.
262. Murray County, L.L.C.
263. Muscatine Toledo Properties, L.L.C.
264. N.M. Bloomfield Three Plus One Limited Company
265. N.M. Espanola Three Plus One Limited Company
266. N.M. Lordsburg Three Plus One Limited Company
267. N.M. Silver City Three Plus One Limited Company
268. New Hope Property, L.L.C.
269. Newtown ALF Property, L.L.C.

 

[Schedule I – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

270. Nicholasville Kentucky Property, L.L.C.
271. North Las Vegas LLC
272. North Royalton Ohio Property, L.L.C.
273. Norwalk ALF Property, L.L.C.
274. NRS Ventures, L.L.C.
275. Oakland Nursing Homes, L.L.C.
276. Ocean Springs Nursing Home, LLC (f/k/a Ocean Springs Nursing Home, Inc.)
277. October Associates, L.L.C.
278. Ogden Associates, L.L.C.
279. OHI (Connecticut), LLC
280. OHI (Illinois), LLC(f/k/a OHI (Illinois), Inc.)
281. OHI (Indiana), LLC
282. OHI (Iowa), LLC(f/k/a OHI (Iowa), Inc.)
283. OHI Asset (AR) Ash Flat, LLC
284. OHI Asset (AR) Camden, LLC
285. OHI Asset (AR) Conway, LLC
286. OHI Asset (AR) Des Arc, LLC
287. OHI Asset (AR) Hot Springs, LLC
288. OHI Asset (AR) Malvern, LLC
289. OHI Asset (AR) Mena, LLC
290. OHI Asset (AR) Pocahontas, LLC
291. OHI Asset (AR) Sheridan, LLC
292. OHI Asset (AR) Walnut Ridge, LLC
293. OHI Asset (AZ) Austin House, LLC
294. OHI Asset (AZ) Tucson, LLC
295. OHI Asset (CA), LLC
296. OHI Asset (CO) Brighton, LLC
297. OHI Asset (CO) Denver, LLC
298. OHI Asset (CO) Mesa, LLC
299. OHI Asset (CO), LLC
300. OHI Asset (CT) Lender, LLC
301. OHI Asset (FL) DeFuniak Springs, LLC
302. OHI Asset (FL) Eustis, LLC
303. OHI Asset (FL) Graceville, LLC
304. OHI Asset (FL) Homestead, LLC
305. OHI Asset (FL) Lake Placid, LLC
306. OHI Asset (FL) Lender, LLC
307. OHI Asset (FL) Lutz, LLC
308. OHI Asset (FL) Marianna, LLC
309. OHI Asset (FL) Middleburg, LLC
310. OHI Asset (FL) Ormond Beach, LLC
311. OHI Asset (FL) Pensacola - Hillview, LLC
312. OHI Asset (FL) Pensacola, LLC
313. OHI Asset (FL) Port St. Joe, LLC
314. OHI Asset (FL) Sebring, LLC

 

[Schedule I – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

315. OHI Asset (FL), LLC
316. OHI Asset (GA) Cordele, LLC
317. OHI Asset (GA) Dunwoody, LLC
318. OHI Asset (GA) Macon, LLC
319. OHI Asset (GA) Moultrie, LLC
320. OHI Asset (GA) Nashville, LLC
321. OHI Asset (GA) Roswell, LLC
322. OHI Asset (GA) Snellville, LLC
323. OHI Asset (GA) Valdosta, LLC
324. OHI Asset (ID) Holly, LLC
325. OHI Asset (ID) Midland, LLC
326. OHI Asset (ID), LLC
327. OHI Asset (IL), LLC
328. OHI Asset (IN) American Village, LLC
329. OHI Asset (IN) Anderson, LLC
330. OHI Asset (IN) Beech Grove, LLC
331. OHI Asset (IN) Clarksville, LLC
332. OHI Asset (IN) Clinton, LLC
333. OHI Asset (IN) Connersville, LLC
334. OHI Asset (IN) Crown Point, LLC
335. OHI Asset (IN) Eagle Valley, LLC
336. OHI Asset (IN) Elkhart, LLC
337. OHI Asset (IN) Forest Creek, LLC
338. OHI Asset (IN) Fort Wayne, LLC
339. OHI Asset (IN) Franklin, LLC
340. OHI Asset (IN) Greensburg, LLC
341. OHI Asset (IN) Indianapolis, LLC
342. OHI Asset (IN) Jasper, LLC
343. OHI Asset (IN) Kokomo, LLC
344. OHI Asset (IN) Lafayette, LLC
345. OHI Asset (IN) Madison, LLC
346. OHI Asset (IN) Monticello, LLC
347. OHI Asset (IN) Noblesville, LLC
348. OHI Asset (IN) Rosewalk, LLC
349. OHI Asset (IN) Salem, LLC
350. OHI Asset (IN) Seymour, LLC
351. OHI Asset (IN) Spring Mill, LLC
352. OHI Asset (IN) Terre Haute, LLC
353. OHI Asset (IN) Wabash, LLC
354. OHI Asset (IN) Westfield, LLC
355. OHI Asset (IN) Zionsville, LLC
356. OHI Asset (KY) Beattyville, LLC
357. OHI Asset (KY) Louisville – 1120 Cristland, LLC
358. OHI Asset (KY) Louisville – 2529 Six Mile Lane, LLC
359. OHI Asset (KY) Morgantown, LLC
360. OHI Asset (KY) Owensboro, LLC

 

[Schedule I – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

361. OHI Asset (LA) Baton Rouge, LLC
362. OHI Asset (LA), LLC
363. OHI Asset (MD) Baltimore - Pall Mall, LLC
364. OHI Asset (MD) Baltimore - West Belvedere, LLC
365. OHI Asset (MD) Salisbury, LLC
366. OHI Asset (MD), LLC
367. OHI Asset (MI) Carson City, LLC
368. OHI Asset (MI) Heather Hills, LLC
369. OHI Asset (MI), LLC
370. OHI Asset (MO) Jackson, LLC
371. OHI Asset (MO), LLC
372. OHI Asset (MS) Byhalia, LLC
373. OHI Asset (MS) Cleveland, LLC
374. OHI Asset (MS) Clinton, LLC
375. OHI Asset (MS) Columbia, LLC
376. OHI Asset (MS) Corinth, LLC
377. OHI Asset (MS) Greenwood, LLC
378. OHI Asset (MS) Grenada, LLC
379. OHI Asset (MS) Holly Springs, LLC
380. OHI Asset (MS) Indianola, LLC
381. OHI Asset (MS) Natchez, LLC
382. OHI Asset (MS) Picayune, LLC
383. OHI Asset (MS) Vicksburg, LLC
384. OHI Asset (MS) Yazoo City, LLC
385. OHI Asset (NC) Biscoe, LLC
386. OHI Asset (NC) Cornelius, LLC
387. OHI Asset (NC) Drexel, LLC
388. OHI Asset (NC) Fayetteville, LLC
389. OHI Asset (NC) Hallsboro, LLC
390. OHI Asset (NC) Marion, LLC
391. OHI Asset (NC) Marshville, LLC
392. OHI Asset (NC) Mocksville – 1007 Howard Street, LLC
393. OHI Asset (NC) Mocksville – 1304 Madison Road, LLC
394. OHI Asset (NC) Nashville, LLC
395. OHI Asset (NC) Raeford, LLC
396. OHI Asset (NC) Rocky Mount – 1558 S. Winstead, LLC
397. OHI Asset (NC) Rocky Mount – 415 N. Winstead, LLC
398. OHI Asset (NC) Salisbury, LLC
399. OHI Asset (NC) Saluda, LLC
400. OHI Asset (NC) Shallotte, LLC
401. OHI Asset (NC) Wadesboro, LLC
402. OHI Asset (NC) Waynesville, LLC
403. OHI Asset (NC) Wilmington, LLC
404. OHI Asset (NC) Winston Salem, LLC
405. OHI Asset (NY) 2nd Avenue, LLC
406. OHI Asset (NY) 93rd Street, LLC

 

[Schedule I – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

407. OHI Asset (OH) Huber Heights, LLC
408. OHI Asset (OH) Lender, LLC
409. OHI Asset (OH) New London, LLC
410. OHI Asset (OH) Steubenville, LLC
411. OHI Asset (OH) Toledo, LLC
412. OHI Asset (OH) West Carrollton, LLC
413. OHI Asset (OH), LLC
414. OHI Asset (OR) Portland, LLC
415. OHI Asset (OR) Troutdale, LLC
416. OHI Asset (PA) GP, LLC
417. OHI Asset (PA) West Mifflin, LP
418. OHI Asset (PA), LLC
419. OHI Asset (PA), LP
420. OHI Asset (SC) Aiken, LLC
421. OHI Asset (SC) Anderson, LLC
422. OHI Asset (SC) Easley Anne, LLC
423. OHI Asset (SC) Easley Crestview, LLC
424. OHI Asset (SC) Edgefield, LLC
425. OHI Asset (SC) Five Forks, LLC
426. OHI Asset (SC) Greenville Cottages, LLC 
427. OHI Asset (SC) Greenville Griffith, LLC
428. OHI Asset (SC) Greenville Laurens, LLC
429. OHI Asset (SC) Greenville North, LLC
430. OHI Asset (SC) Greenville, LLC
431. OHI Asset (SC) Greer, LLC
432. OHI Asset (SC) Marietta, LLC
433. OHI Asset (SC) McCormick, LLC
434. OHI Asset (SC) Orangeburg, LLC
435. OHI Asset (SC) Pickens East Cedar, LLC
436. OHI Asset (SC) Pickens Rosemond, LLC
437. OHI Asset (SC) Piedmont, LLC
438. OHI Asset (SC) Simpsonville SE Main, LLC
439. OHI Asset (SC) Simpsonville West Broad, LLC
440. OHI Asset (SC) Simpsonville West Curtis, LLC
441. OHI Asset (TN) Bartlett, LLC
442. OHI Asset (TN) Byrdstown, LLC
443. OHI Asset (TN) Cleveland, LLC
444. OHI Asset (TN) Collierville, LLC
445. OHI Asset (TN) Columbia, LLC
446. OHI Asset (TN) Elizabethton, LLC
447. OHI Asset (TN) Erin, LLC
448. OHI Asset (TN) Greeneville, LLC
449. OHI Asset (TN) Harriman, LLC
450. OHI Asset (TN) Jamestown, LLC 
451. OHI Asset (TN) Jefferson City, LLC
452. OHI Asset (TN) Memphis – 1150 Dovecrest, LLC

 

[Schedule I – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

453. OHI Asset (TN) Memphis, LLC
454. OHI Asset (TN) Monteagle, LLC
455. OHI Asset (TN) Monterey, LLC 
456. OHI Asset (TN) Mountain City, LLC
457. OHI Asset (TN) Nashville, LLC
458. OHI Asset (TN) Pigeon Forge, LLC
459. OHI Asset (TN) Ridgely, LLC
460. OHI Asset (TN) Rockwood, LLC
461. OHI Asset (TN) Rogersville – 109 Highway 70 North, LLC
462. OHI Asset (TN) Rogersville, LLC
463. OHI Asset (TN) South Pittsburg, LLC
464. OHI Asset (TN) Spring City, LLC
465. OHI Asset (TN) Westmoreland, LLC
466. OHI Asset (TX) Anderson, LLC
467. OHI Asset (TX) Athens, LLC
468. OHI Asset (TX) Bryan, LLC
469. OHI Asset (TX) Burleson, LLC
470. OHI Asset (TX) College Station, LLC
471. OHI Asset (TX) Comfort, LLC
472. OHI Asset (TX) Diboll, LLC
473. OHI Asset (TX) Granbury, LLC
474. OHI Asset (TX) Hondo, LLC
475. OHI Asset (TX) Italy, LLC
476. OHI Asset (TX) Longview, LLC
477. OHI Asset (TX) Schertz, LLC
478. OHI Asset (TX) Winnsboro ALF, LLC
479. OHI Asset (TX) Winnsboro, LLC
480. OHI Asset (TX), LLC
481. OHI Asset (UT) Ogden, LLC
482. OHI Asset (UT) Provo, LLC
483. OHI Asset (UT) Roy, LLC
484. OHI Asset (VA) Charlottesville - 1165 Pepsi Place, LLC
485. OHI Asset (VA) Charlottesville, LLC
486. OHI Asset (VA) Chesapeake, LLC
487. OHI Asset (VA) Farmville, LLC
488. OHI Asset (VA) Galax, LLC
489. OHI Asset (VA) Hillsville, LLC
490. OHI Asset (VA) Madison, LLC
491. OHI Asset (VA) Martinsville ALF, LLC
492. OHI Asset (VA) Martinsville SNF, LLC
493. OHI Asset (VA) Mechanicsville, LLC
494. OHI Asset (VA) Midlothian, LLC
495. OHI Asset (VA) Norfolk, LLC
496. OHI Asset (VA) Portsmouth, LLC
497. OHI Asset (VA) Richmond - 2420 Pemberton Road, LLC
498. OHI Asset (VA) Richmond - 9101 Bon Air, LLC

 

[Schedule I – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

499. OHI Asset (VA) Rocky Mount, LLC
500. OHI Asset (VA) Suffolk, LLC
501. OHI Asset (WA) Battle Ground, LLC
502. OHI Asset (WA) Fort Vancouver, LLC
503. OHI Asset (WV) Danville, LLC
504. OHI Asset (WV) Ivydale, LLC
505. OHI Asset CHG ALF, LLC
506. OHI Asset CSB LLC
507. OHI Asset CSE – E, LLC
508. OHI Asset CSE – U, LLC
509. OHI Asset CSE–E Subsidiary, LLC
510. OHI Asset CSE–U Subsidiary, LLC
511. OHI Asset HUD CFG, LLC
512. OHI Asset HUD Delta, LLC
513. OHI Asset HUD H-F, LLC
514. OHI Asset HUD SF CA, LLC
515. OHI Asset HUD SF, LLC
516. OHI Asset HUD WO, LLC
517. OHI Asset II (CA), LLC
518. OHI Asset II (FL), LLC
519. OHI Asset II (PA), LP
520. OHI Asset III (PA), LP
521. OHI Asset IV (PA) Silver Lake, LP
522. OHI Asset Management, LLC
523. OHI Asset RO PMM Services, LLC
524. OHI Asset RO, LLC
525. OHI Asset S-W, LLC
526. OHI Asset, LLC
527. OHI Healthcare Properties Holdco, Inc.
528. OHI Healthcare Properties Limited Partnership
529. OHI Mezz Lender, LLC
530. OHI Tennessee, LLC (f/k/a OHI Tennessee, Inc.)
531. OHIMA, LLC (f/k/a OHIMA, Inc.)
532. Ohio Aviv Three, L.L.C.
533. Ohio Aviv Two, L.L.C.
534. Ohio Aviv, L.L.C.
535. Ohio Indiana Property, L.L.C.
536. Ohio Pennsylvania Property, L.L.C.
537. Oklahoma Two Property, L.L.C.
538. Oklahoma Warr Wind, L.L.C.
539. Omaha Associates, L.L.C.
540. Omega TRS I, Inc.
541. Orange ALF Property, L.L.C.
542. Orange Village Care Center, LLC (f/k/a Orange Village Care Center, Inc.)
543. Orange, L.L.C.

 

[Schedule I – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

544. Oregon Associates, L.L.C.
545. Oso Avenue Property, L.L.C.
546. Ostrom Avenue Property, L.L.C.
547. Palm Valley Senior Care, LLC
548. Panama City Nursing Center LLC
549. Pavillion North Partners, LLC
550. Pavillion North, LLP
551. Pavillion Nursing Center North, LLC
552. Peabody Associates Two, L.L.C.
553. Peabody Associates, L.L.C.
554. Pennington Road Property, L.L.C.
555. Pensacola Real Estate Holdings I, LLC (f/k/a Pensacola Real Estate Holdings I, Inc.)
556. Pensacola Real Estate Holdings II, LLC (f/k/a Pensacola Real Estate Holdings II, Inc.)
557. Pensacola Real Estate Holdings III, LLC (f/k/a Pensacola Real Estate Holdings III, Inc.)
558. Pensacola Real Estate Holdings IV, LLC (f/k/a Pensacola Real Estate Holdings IV, Inc.)
559. Pensacola Real Estate Holdings V, LLC (f/k/a Pensacola Real Estate Holdings V, Inc.)
560. Pocatello Idaho Property, L.L.C.
561. Pomona Vista L.L.C.
562. Prescott Arkansas, L.L.C.
563. PV Realty-Clinton, LLC
564. PV Realty-Kensington, LLC
565. PV Realty–Willow Tree, LLC
566. Raton Property Limited Company
567. Ravenna Ohio Property, L.L.C.
568. Red Rocks, L.L.C.
569. Richland Washington, L.L.C.
570. Ridgecrest Senior Care, LLC
571. Riverside Nursing Home Associates Two, L.L.C.
572. Riverside Nursing Home Associates, L.L.C.
573. Rockingham Drive Property, L.L.C.
574. Rose Baldwin Park Property L.L.C.
575. S.C. Portfolio Property, L.L.C.
576. Salem Associates, L.L.C.
577. San Juan NH Property, LLC
578. Sandalwood Arkansas Property, L.L.C.
579. Santa Ana-Bartlett, L.L.C.
580. Santa Fe Missouri Associates, L.L.C.
581. Savoy/Bonham Venture, L.L.C.
582. Searcy Aviv, L.L.C.
583. Sedgwick Properties, L.L.C.
584. Seguin Texas Property, L.L.C.

 

[Schedule I – 13th Supplemental Indenture – 2025 Notes]

 

 

 

 

585. Sierra Ponds Property, L.L.C.
586. Skyler Boyington, LLC (f/k/a Skyler Boyington, Inc.)
587. Skyler Florida, LLC (f/k/a Skyler Florida, Inc.)
588. Skyler Maitland LLC
589. Skyler Pensacola, LLC (f/k/a Skyler Pensacola, Inc.)
590. Skyview Associates, L.L.C.
591. Southeast Missouri Property, L.L.C.
592. Southern California Nevada, L.L.C.
593. St. Joseph Missouri Property, L.L.C.
594. St. Mary’s Properties, LLC (f/k/a St. Mary’s Properties, Inc.)
595. Star City Arkansas, L.L.C.
596. Stephenville Texas Property, L.L.C.
597. Sterling Acquisition, LLC
598. Stevens Avenue Property, L.L.C.
599. Sun-Mesa Properties, L.L.C.
600. Suwanee, LLC
601. Texas Fifteen Property, L.L.C.
602. Texas Four Property, L.L.C.
603. Texas Lessor – Stonegate GP, LLC
604. Texas Lessor – Stonegate, Limited, LLC
605. Texas Lessor – Stonegate, LP
606. Texhoma Avenue Property, L.L.C.
607. The Suburban Pavilion, LLC (f/k/a The Suburban Pavilion, Inc.)
608. Tujunga, L.L.C.
609. Tulare County Property, L.L.C.
610. Twinsburg Ohio Property, LLC
611. VRB Aviv, L.L.C.
612. Washington Idaho Property, L.L.C.
613. Washington Lessor – Silverdale, LLC
614. Washington-Oregon Associates, L.L.C.
615. Watauga Associates, L.L.C.
616. Wellington Leasehold, L.L.C.
617. West Pearl Street, L.L.C.
618. West Yarmouth Property I, L.L.C.
619. Westerville Ohio Office Property, L.L.C.
620. Weston ALF Property, LLC
621. Wheeler Healthcare Associates, L.L.C.
622. Whitlock Street Property, L.L.C.
623. Wilcare, LLC
624. Willis Texas Aviv, L.L.C.
625. Yuba Aviv, L.L.C.

 

[Schedule I – 13th Supplemental Indenture – 2025 Notes]

 

 

 

EX-4.3 6 t1700448_ex4-3.htm EXHIBIT 4.3

 

 

Exhibit 4.3

 

NINTH SUPPLEMENTAL INDENTURE

(Senior Notes due 2027)

 

THIS NINTH SUPPLEMENTAL INDENTURE (this “Ninth Supplemental Indenture”) is dated as of May 11, 2017, among OMEGA HEALTHCARE INVESTORS, INC., a Maryland corporation (the “Issuer”), each of the entities listed on Schedule II hereto (the “New Subsidiaries”) and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, as trustee (the “Trustee”).

 

W I T N E S S E T H :

 

WHEREAS, the Issuer and each of its direct and indirect subsidiaries listed on Schedule I hereto (collectively, the “Subsidiary Guarantors”) have heretofore executed and delivered to the Trustee an Indenture, dated as of March 18, 2015 (as supplemented by that First Supplemental Indenture, dated as of April 1, 2015, that Second Supplemental Indenture, dated as of August 4, 2015, that Third Supplemental Indenture, dated as of November 9, 2015, that Fourth Supplemental Indenture, dated as of March 29, 2016, that Fifth Supplemental Indenture, dated as of May 13, 2016, that Sixth Supplemental Indenture, dated as of August 9, 2016, that Seventh Supplemental Indenture, dated as of November 10, 2016, and that Eighth Supplemental Indenture, dated as of March 17, 2017; the “Indenture”) providing for the issuance of the Issuer’s 4.500% Senior Notes due 2027 (the “Notes”);

 

WHEREAS, Section 9.01(a)(4) of the Indenture authorizes the Issuer and the Trustee, together, to amend or supplement the Indenture, without notice to or consent of any Holder of the Notes and without the execution of such amendment or supplement by existing Subsidiary Guarantors, for the purpose of adding any additional Subsidiary Guarantee by any additional Guarantor;

 

WHEREAS, pursuant to Section 4.09 of the Indenture, the New Subsidiaries are required to become Subsidiary Guarantors;

 

WHEREAS, in Section 1.01 of the Indenture, the term “Subsidiary Guarantors” is defined to include all Persons that become a Subsidiary Guarantor by the terms of the Indenture after the Closing Date; and

 

WHEREAS, Section 10.01 of the Indenture provides that each Subsidiary Guarantor shall be a guarantor of the Issuer’s obligations under the Notes, subject to the terms and conditions described in the Indenture.

 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Issuer, the New Subsidiaries and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:

 

1.CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 

[9th Supplemental Indenture – 2027 Notes] 

 

 

 

 

2.AMENDMENT TO GUARANTEE. The New Subsidiaries hereby agree, jointly and severally with all other Subsidiary Guarantors, to guarantee the Issuer’s obligations under the Notes on the terms and subject to the conditions set forth in the Indenture, and to be bound by, and to receive the benefit of, all other applicable provisions of the Indenture as Subsidiary Guarantors. Such guarantee shall be evidenced by the New Subsidiaries’ execution of Subsidiary Guarantees, the form of which is attached as Exhibit E to the Indenture, and shall be effective as of the date hereof.

 

3.NO RECOURSE AGAINST OTHERS. No past, present or future director, officer, employee, incorporator, stockholder, member, manager or controlling person of the New Subsidiaries, as such, shall have any liability for any obligations of the Issuer or any Subsidiary Guarantor under the Notes, any Guarantees, the Indenture or this Ninth Supplemental Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder of the Notes, by accepting and holding a Note, waives and releases all such liability. Such waiver and release are part of the consideration for the issuance of the Notes.

 

4.NEW YORK LAW TO GOVERN. The laws of the State of New York shall govern and be used to construe this Ninth Supplemental Indenture.

 

5.COUNTERPARTS. The parties may sign any number of copies of this Ninth Supplemental Indenture. Each signed copy shall be an original, but all of them together shall represent the same agreement.

 

6.EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

 

7.THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Ninth Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Issuer and the New Subsidiaries.

 

[Remainder of Page Intentionally Left Blank]

 

[9th Supplemental Indenture – 2027 Notes]

 

 2 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Ninth Supplemental Indenture to be duly executed, all as of the date first above written.

 

  ISSUER:
   
  OMEGA HEALTHCARE INVESTORS, INC.,
  a Maryland corporation
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
  NEW SUBSIDIARIES:
   
  ON BEHALF OF EACH OF THE NEW SUBSIDIARIES LISTED ON SCHEDULE II
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page – 9th Supplemental Indenture – 2027 Notes]

 

 

 

 

  U.S. BANK NATIONAL ASSOCIATION,
  as Trustee
   
  By: /s/ David Ferrell
    Name: David Ferrell
    Title: Vice President

 

[Signature Page – 9th Supplemental Indenture – 2027 Notes] 

 

 

 

 

Schedule I

 

SUBSIDIARY GUARANTORS

 

1. 11900 East Artesia Boulevard, LLC
2. 1200 Ely Street Holdings Co. LLC
3. 13922 Cerise Avenue, LLC
4. 1628 B Street, LLC
5. 2400 Parkside Drive, LLC
6. 2425 Teller Avenue, LLC
7. 245 East Wilshire Avenue, LLC
8. 3232 Artesia Real Estate, LLC
9. 3806 Clayton Road, LLC
10. 42235 County Road Holdings Co. LLC
11. 446 Sycamore Road, L.L.C.
12. 48 High Point Road, LLC
13. 523 Hayes Lane, LLC
14. 637 East Romie Lane, LLC
15. Alamogordo Aviv, L.L.C.
16. Albany Street Property, L.L.C.
17. Arizona Lessor - Infinia, LLC
18. Arkansas Aviv, L.L.C.
19. Arma Yates, L.L.C.
20. Avery Street Property, L.L.C
21. Aviv Asset Management, L.L.C.
22. Aviv Financing I, L.L.C.
23. Aviv Financing II, L.L.C.
24. Aviv Financing III, L.L.C.
25. Aviv Financing IV, L.L.C.
26. Aviv Financing V, L.L.C.
27. Aviv Foothills, L.L.C.
28. Aviv Healthcare Properties Operating Partnership I, L.P.
29. Aviv Liberty, L.L.C.
30. Avon Ohio, L.L.C.
31. Bala Cynwyd Real Estate, LP
32. Bayside Colorado Healthcare Associates, LLC
33. Bayside Street II, LLC
34. Bayside Street, LLC (f/k/a Bayside Street, Inc.)
35. Belleville Illinois, L.L.C.
36. Bellingham II Associates, L.L.C.
37. Bethel ALF Property, L.L.C.
38. BHG Aviv, L.L.C.
39. Biglerville Road, L.L.C.
40. Bonham Texas, L.L.C.
41. Bradenton ALF Property, L.L.C.
42. Burton NH Property, L.L.C.

 

[Schedule I – 9th Supplemental Indenture – 2027 Notes]

 

 

 

 

43. California Aviv Two, L.L.C.
44. California Aviv, L.L.C.
45. Camas Associates, L.L.C.
46. Canton Health Care Land, LLC (f/k/a Canton Health Care Land, Inc.)
47. Carnegie Gardens LLC
48. Casa/Sierra California Associates, L.L.C.
49. CFG 2115 Woodstock Place LLC
50. Champaign Williamson Franklin, L.L.C.
51. Chardon Ohio Property Holdings, L.L.C.
52. Chardon Ohio Property, L.L.C.
53. Chatham Aviv, L.L.C.
54. Chippewa Valley, L.L.C.
55. CHR Bartow LLC
56. CHR Boca Raton  LLC
57. CHR Bradenton LLC
58. CHR Cape Coral LLC
59. CHR Fort Myers LLC
60. CHR Fort Walton Beach LLC
61. CHR Lake Wales LLC
62. CHR Lakeland LLC
63. CHR Pompano Beach Broward LLC
64. CHR Pompano Beach LLC
65. CHR Sanford LLC
66. CHR Spring Hill LLC
67. CHR St. Pete Bay LLC
68. CHR St. Pete Egret LLC
69. CHR Tampa Carrollwood LLC
70. CHR Tampa LLC
71. CHR Tarpon Springs LLC
72. CHR Titusville LLC
73. Clarkston Care, L.L.C.
74. Clayton Associates, L.L.C.
75. Colonial Gardens, LLC
76. Colonial Madison Associates, L.L.C.
77. Colorado Lessor - Conifer, LLC
78. Columbus Texas Aviv, L.L.C.
79. Columbus Western Avenue, L.L.C.
80. Colville Washington Property, L.L.C.
81. Commerce Nursing Homes, L.L.C.
82. Commerce Sterling Hart Drive, L.L.C.
83. Conroe Rigby Owen Road, L.L.C.
84. CR Aviv, L.L.C.
85. Crete Plus Five Property, L.L.C.
86. Crooked River Road, L.L.C.
87. CSE Albany LLC
88. CSE Amarillo LLC

 

[Schedule I – 9th Supplemental Indenture – 2027 Notes]

 

 

 

 

89. CSE Arden L.P.
90. CSE Augusta LLC
91. CSE Bedford LLC
92. CSE Blountville LLC
93. CSE Bolivar LLC
94. CSE Cambridge LLC
95. CSE Cambridge Realty LLC
96. CSE Camden LLC
97. CSE Canton LLC
98. CSE Casablanca Holdings II LLC
99. CSE Casablanca Holdings LLC
100. CSE Cedar Rapids LLC
101. CSE Centennial Village, LP
102. CSE Chelmsford LLC
103. CSE Chesterton LLC
104. CSE Claremont LLC
105. CSE Corpus North LLC
106. CSE Denver Iliff LLC
107. CSE Denver LLC
108. CSE Douglas LLC
109. CSE Elkton LLC
110. CSE Elkton Realty LLC
111. CSE Fairhaven LLC
112. CSE Fort Wayne LLC
113. CSE Frankston LLC
114. CSE Georgetown LLC
115. CSE Green Bay LLC
116. CSE Hilliard LLC
117. CSE Huntingdon LLC
118. CSE Huntsville LLC
119. CSE Indianapolis-Continental LLC
120. CSE Indianapolis-Greenbriar LLC
121. CSE Jacinto City LLC
122. CSE Jefferson City LLC
123. CSE Jeffersonville-Hillcrest Center LLC
124. CSE Jeffersonville-Jennings House LLC
125. CSE Kerrville LLC
126. CSE King L.P.
127. CSE Kingsport LLC
128. CSE Knightdale L.P.
129. CSE Lake City LLC
130. CSE Lake Worth LLC
131. CSE Lakewood LLC
132. CSE Las Vegas LLC
133. CSE Lawrenceburg LLC
134. CSE Lenoir L.P.

 

[Schedule I – 9th Supplemental Indenture – 2027 Notes]

 

 

 

 

135. CSE Lexington Park LLC
136. CSE Lexington Park Realty LLC
137. CSE Ligonier LLC
138. CSE Live Oak LLC
139. CSE Lowell LLC
140. CSE Marianna Holdings LLC
141. CSE Memphis LLC
142. CSE Mobile LLC
143. CSE Moore LLC
144. CSE North Carolina Holdings I LLC
145. CSE North Carolina Holdings II LLC
146. CSE Omro LLC
147. CSE Orange Park LLC
148. CSE Orlando-Pinar Terrace Manor LLC
149. CSE Orlando-Terra Vista Rehab LLC
150. CSE Pennsylvania Holdings, LP
151. CSE Piggott LLC
152. CSE Pilot Point LLC
153. CSE Pine View LLC
154. CSE Ponca City LLC
155. CSE Port St. Lucie LLC
156. CSE Richmond LLC
157. CSE Ripley LLC
158. CSE Ripon LLC
159. CSE Safford LLC
160. CSE Salina LLC
161. CSE Seminole LLC
162. CSE Shawnee LLC
163. CSE Spring Branch LLC
164. CSE Stillwater LLC
165. CSE Taylorsville LLC
166. CSE Texarkana LLC
167. CSE Texas City LLC
168. CSE The Village LLC
169. CSE Upland LLC
170. CSE Walnut Cove L.P.
171. CSE West Point LLC
172. CSE Whitehouse LLC
173. CSE Williamsport LLC
174. CSE Winter Haven LLC
175. CSE Woodfin L.P.
176. CSE Yorktown LLC
177. Cuyahoga Falls Property, L.L.C.
178. Cuyahoga Falls Property II, L.L.C.
179. Dallas Two Property, L.L.C.
180. Danbury ALF Property, L.L.C.

 

[Schedule I – 9th Supplemental Indenture – 2027 Notes]

 

 

 

 

181. Darien ALF Property, L.L.C.
182. Delta Investors I, LLC
183. Delta Investors II, LLC
184. Denison Texas, L.L.C.
185. Desert Lane LLC
186. Dixie White House Nursing Home, LLC (f/k/a Dixie White House Nursing Home, Inc.)
187. Dixon Health Care Center, LLC (f/k/a Dixon Health Care Center, Inc.)
188. East Rollins Street, L.L.C.
189. Edgewood Drive Property, L.L.C.
190. Effingham Associates, L.L.C.
191. Elite Mattoon, L.L.C.
192. Elite Yorkville, L.L.C.
193. Encanto Senior Care, LLC
194. Falcon Four Property Holding, L.L.C.
195. Falcon Four Property, L.L.C.
196. Falfurrias Texas, L.L.C.
197. Florida ALF Properties, L.L.C.
198. Florida Four Properties, L.L.C.
199. Florida Lessor – Meadowview, LLC
200. Florida Real Estate Company, LLC
201. Fort Stockton Property, L.L.C.
202. Four Fountains Aviv, L.L.C.
203. Fredericksburg South Adams Street, L.L.C.
204. Freewater Oregon, L.L.C.
205. Fullerton California, L.L.C.
206. G&L Gardens, LLC
207. Gardnerville Property, L.L.C.
208. Georgia Lessor - Bonterra/Parkview, LLC
209. Germantown Property, L.L.C.
210. Giltex Care, L.L.C.
211. Glendale NH Property, L.L.C.
212. Golden Hill Real Estate Company, LLC
213. Gonzales Texas Property, L.L.C.
214. Great Bend Property, L.L.C.
215. Greenbough, LLC
216. Greenville Kentucky Property, L.L.C.
217. Heritage Monterey Associates, L.L.C.
218. HHM Aviv, L.L.C.
219. Hidden Acres Property, L.L.C.
220. Highland Leasehold, L.L.C.
221. Hobbs Associates, L.L.C.
222. Hot Springs Atrium Owner, LLC
223. Hot Springs Aviv, L.L.C.
224. Hot Springs Cottages Owner, LLC
225. Hot Springs Marina Owner, LLC

 

[Schedule I – 9th Supplemental Indenture – 2027 Notes]

 

 

 

 

226. Houston Texas Aviv, L.L.C.
227. Hutchinson Kansas, L.L.C.
228. Hutton I Land, LLC (f/k/a Hutton I Land, Inc.)
229. Hutton II Land, LLC (f/k/a Hutton II Land, Inc.)
230. Hutton III Land, LLC (f/k/a Hutton III Land, Inc.)
231. Idaho Associates, L.L.C.
232. Illinois Missouri Properties, L.L.C.
233. Indiana Lessor – Wellington Manor, LLC
234. Iowa Lincoln County Property, L.L.C.
235. Jasper Springhill Street, L.L.C.
236. Kansas Five Property, L.L.C.
237. Karan Associates Two, L.L.C.
238. Karan Associates, L.L.C.
239. Karissa Court Property, L.L.C.
240. KB Northwest Associates, L.L.C.
241. Kentucky NH Properties, L.L.C.
242. Kingsville Texas, L.L.C.
243. LAD I Real Estate Company, LLC
244. Leatherman 90-1, LLC (f/k/a Leatherman 90-1, Inc.)
245. Leatherman Partnership 89-1, LLC (f/k/a Leatherman Partnership 89-1, Inc.)
246. Leatherman Partnership 89-2, LLC (f/k/a Leatherman Partnership 89-2, Inc.)
247. Louisville Dutchmans Property, L.L.C.
248. Magnolia Drive Property, L.L.C.
249. Manor Associates, L.L.C.
250. Mansfield Aviv, L.L.C.
251. Massachusetts Nursing Homes, L.L.C.
252. McCarthy Street Property, L.L.C.
253. Meridian Arms Land, LLC (f/k/a Meridian Arms Land, Inc.)
254. Minnesota Associates, L.L.C.
255. Mishawaka Property, L.L.C.
256. Missouri Associates, L.L.C.
257. Missouri Regency Associates, L.L.C.
258. Montana Associates, L.L.C.
259. Monterey Park Leasehold Mortgage, L.L.C.
260. Mount Washington Property, L.L.C.
261. Mt. Vernon Texas, L.L.C.
262. Murray County, L.L.C.
263. Muscatine Toledo Properties, L.L.C.
264. N.M. Bloomfield Three Plus One Limited Company
265. N.M. Espanola Three Plus One Limited Company
266. N.M. Lordsburg Three Plus One Limited Company
267. N.M. Silver City Three Plus One Limited Company
268. New Hope Property, L.L.C.
269. Newtown ALF Property, L.L.C.

 

[Schedule I – 9th Supplemental Indenture – 2027 Notes]

 

 

 

 

270. Nicholasville Kentucky Property, L.L.C.
271. North Las Vegas LLC
272. North Royalton Ohio Property, L.L.C.
273. Norwalk ALF Property, L.L.C.
274. NRS Ventures, L.L.C.
275. Oakland Nursing Homes, L.L.C.
276. Ocean Springs Nursing Home, LLC (f/k/a Ocean Springs Nursing Home, Inc.)
277. October Associates, L.L.C.
278. Ogden Associates, L.L.C.
279. OHI (Connecticut), LLC
280. OHI (Illinois), LLC(f/k/a OHI (Illinois), Inc.)
281. OHI (Indiana), LLC
282. OHI (Iowa), LLC(f/k/a OHI (Iowa), Inc.)
283. OHI Asset (AR) Ash Flat, LLC
284. OHI Asset (AR) Camden, LLC
285. OHI Asset (AR) Conway, LLC
286. OHI Asset (AR) Des Arc, LLC
287. OHI Asset (AR) Hot Springs, LLC
288. OHI Asset (AR) Malvern, LLC
289. OHI Asset (AR) Mena, LLC
290. OHI Asset (AR) Pocahontas, LLC
291. OHI Asset (AR) Sheridan, LLC
292. OHI Asset (AR) Walnut Ridge, LLC
293. OHI Asset (AZ) Austin House, LLC
294. OHI Asset (CA), LLC
295. OHI Asset (CO), LLC
296. OHI Asset (CO) Brighton, LLC
297. OHI Asset (CO) Denver, LLC
298. OHI Asset (CO) Mesa, LLC
299. OHI Asset (CT) Lender, LLC
300. OHI Asset (FL), LLC
301. OHI Asset (FL) Eustis, LLC
302. OHI Asset (FL) Graceville, LLC
303. OHI Asset (FL) Lake Placid, LLC
304. OHI Asset (FL) Lender, LLC
305. OHI Asset (FL) Lutz, LLC
306. OHI Asset (FL) Marianna, LLC
307. OHI Asset (FL) Middleburg, LLC
308. OHI Asset (FL) Pensacola - Hillview, LLC
309. OHI Asset (FL) Pensacola, LLC
310. OHI Asset (FL) Port St. Joe, LLC
311. OHI Asset (FL) Sebring, LLC
312. OHI Asset (GA) Cordele, LLC
313. OHI Asset (GA) Dunwoody, LLC
314. OHI Asset (GA) Macon, LLC

 

[Schedule I – 9th Supplemental Indenture – 2027 Notes]

 

 

 

 

315. OHI Asset (GA) Moultrie, LLC
316. OHI Asset (GA) Nashville, LLC
317. OHI Asset (GA) Roswell, LLC
318. OHI Asset (GA) Snellville, LLC
319. OHI Asset (GA) Valdosta, LLC
320. OHI Asset (ID) Holly, LLC
321. OHI Asset (ID) Midland, LLC
322. OHI Asset (ID), LLC
323. OHI Asset (IL), LLC
324. OHI Asset (IN) American Village, LLC
325. OHI Asset (IN) Anderson, LLC
326. OHI Asset (IN) Beech Grove, LLC
327. OHI Asset (IN) Clarksville, LLC
328. OHI Asset (IN) Clinton, LLC
329. OHI Asset (IN) Connersville, LLC
330. OHI Asset (IN) Crown Point, LLC
331. OHI Asset (IN) Eagle Valley, LLC
332. OHI Asset (IN) Elkhart, LLC
333. OHI Asset (IN) Forest Creek, LLC
334. OHI Asset (IN) Fort Wayne, LLC
335. OHI Asset (IN) Franklin, LLC
336. OHI Asset (IN) Greensburg, LLC
337. OHI Asset (IN) Indianapolis, LLC
338. OHI Asset (IN) Jasper, LLC
339. OHI Asset (IN) Kokomo, LLC
340. OHI Asset (IN) Lafayette, LLC
341. OHI Asset (IN) Madison, LLC
342. OHI Asset (IN) Monticello, LLC
343. OHI Asset (IN) Noblesville, LLC
344. OHI Asset (IN) Rosewalk, LLC
345. OHI Asset (IN) Salem, LLC
346. OHI Asset (IN) Seymour, LLC
347. OHI Asset (IN) Spring Mill, LLC
348. OHI Asset (IN) Terre Haute, LLC
349. OHI Asset (IN) Wabash, LLC
350. OHI Asset (IN) Westfield, LLC
351. OHI Asset (IN) Zionsville, LLC
352. OHI Asset (KY) Beattyville, LLC
353. OHI Asset (KY) Louisville – 1120 Cristland, LLC
354. OHI Asset (KY) Louisville – 2529 Six Mile Lane, LLC
355. OHI Asset (KY) Morgantown, LLC
356. OHI Asset (KY) Owensboro, LLC
357. OHI Asset (LA) Baton Rouge, LLC
358. OHI Asset (LA), LLC
359. OHI Asset (MD), LLC
360. OHI Asset (MD) Baltimore - Pall Mall, LLC

 

[Schedule I – 9th Supplemental Indenture – 2027 Notes]

 

 

 

 

361. OHI Asset (MD) Baltimore - West Belvedere, LLC
362. OHI Asset (MD) Salisbury, LLC
363. OHI Asset (MI) Heather Hills, LLC
364. OHI Asset (MI), LLC
365. OHI Asset (MI) Carson City, LLC
366. OHI Asset (MO), LLC
367. OHI Asset (MO) Jackson, LLC
368. OHI Asset (MS) Byhalia, LLC
369. OHI Asset (MS) Cleveland, LLC
370. OHI Asset (MS) Clinton, LLC
371. OHI Asset (MS) Columbia, LLC
372. OHI Asset (MS) Corinth, LLC
373. OHI Asset (MS) Greenwood, LLC
374. OHI Asset (MS) Grenada, LLC
375. OHI Asset (MS) Holly Springs, LLC
376. OHI Asset (MS) Indianola, LLC
377. OHI Asset (MS) Natchez, LLC
378. OHI Asset (MS) Picayune, LLC
379. OHI Asset (MS) Vicksburg, LLC
380. OHI Asset (MS) Yazoo City, LLC
381. OHI Asset (NC) Biscoe, LLC
382. OHI Asset (NC) Cornelius, LLC
383. OHI Asset (NC) Drexel, LLC
384. OHI Asset (NC) Fayetteville, LLC
385. OHI Asset (NC) Hallsboro, LLC
386. OHI Asset (NC) Marion, LLC
387. OHI Asset (NC) Marshville, LLC
388. OHI Asset (NC) Mocksville – 1007 Howard Street, LLC
389. OHI Asset (NC) Mocksville – 1304 Madison Road, LLC
390. OHI Asset (NC) Nashville, LLC
391. OHI Asset (NC) Raeford, LLC
392. OHI Asset (NC) Rocky Mount – 1558 S. Winstead, LLC
393. OHI Asset (NC) Rocky Mount – 415 N. Winstead, LLC
394. OHI Asset (NC) Salisbury, LLC
395. OHI Asset (NC) Saluda, LLC
396. OHI Asset (NC) Shallotte, LLC
397. OHI Asset (NC) Wadesboro, LLC
398. OHI Asset (NC) Waynesville, LLC
399. OHI Asset (NC) Wilmington, LLC
400. OHI Asset (NC) Winston Salem, LLC
401. OHI Asset (NY) 2nd Avenue, LLC
402. OHI Asset (NY) 93rd Street, LLC
403. OHI Asset (OH) Huber Heights, LLC
404. OHI Asset (OH) Lender, LLC
405. OHI Asset (OH), LLC
406. OHI Asset (OH) New London, LLC

 

[Schedule I – 9th Supplemental Indenture – 2027 Notes]

 

 

 

 

407. OHI Asset (OR) Portland, LLC
408. OHI Asset (OH) Steubenville, LLC
409. OHI Asset (OH) Toledo, LLC
410. OHI Asset (OR) Troutdale, LLC
411. OHI Asset (OH) West Carrollton, LLC
412. OHI Asset (PA) GP, LLC
413. OHI Asset (PA) West Mifflin, LP
414. OHI Asset (PA), LLC
415. OHI Asset (PA), LP
416. OHI Asset (SC) Aiken, LLC
417. OHI Asset (SC) Anderson, LLC
418. OHI Asset (SC) Easley Anne, LLC
419. OHI Asset (SC) Easley Crestview, LLC
420. OHI Asset (SC) Edgefield, LLC
421. OHI Asset (SC) Five Forks, LLC
422. OHI Asset (SC) Greenville Cottages, LLC 
423. OHI Asset (SC) Greenville Griffith, LLC
424. OHI Asset (SC) Greenville Laurens, LLC
425. OHI Asset (SC) Greenville North, LLC
426. OHI Asset (SC) Greenville, LLC
427. OHI Asset (SC) Greer, LLC
428. OHI Asset (SC) Marietta, LLC
429. OHI Asset (SC) McCormick, LLC
430. OHI Asset (SC) Orangeburg, LLC
431. OHI Asset (SC) Pickens East Cedar, LLC
432. OHI Asset (SC) Pickens Rosemond, LLC
433. OHI Asset (SC) Piedmont, LLC
434. OHI Asset (SC) Simpsonville SE Main, LLC
435. OHI Asset (SC) Simpsonville West Broad, LLC
436. OHI Asset (SC) Simpsonville West Curtis, LLC
437. OHI Asset (TN) Bartlett, LLC
438. OHI Asset (TN) Cleveland, LLC
439. OHI Asset (TN) Collierville, LLC
440. OHI Asset (TN) Columbia, LLC
441. OHI Asset (TN) Elizabethton, LLC
442. OHI Asset (TN) Jamestown, LLC 
443. OHI Asset (TN) Jefferson City, LLC
444. OHI Asset (TN) Memphis, LLC
445. OHI Asset (TN) Memphis – 1150 Dovecrest, LLC
446. OHI Asset (TN) Monteagle, LLC
447. OHI Asset (TN) Monterey, LLC 
448. OHI Asset (TN) Mountain City, LLC
449. OHI Asset (TN) Nashville, LLC
450. OHI Asset (TN) Pigeon Forge, LLC
451. OHI Asset (TN) Rockwood, LLC
452. OHI Asset (TN) Rogersville, LLC

 

[Schedule I – 9th Supplemental Indenture – 2027 Notes]

 

 

 

 

453. OHI Asset (TN) Rogersville – 109 Highway 70 North, LLC
454. OHI Asset (TN) South Pittsburg, LLC
455. OHI Asset (TN) Spring City, LLC
456. OHI Asset (TN) Westmoreland, LLC
457. OHI Asset (TX) Anderson, LLC
458. OHI Asset (TX) Athens, LLC
459. OHI Asset (TX) Bryan, LLC
460. OHI Asset (TX) Burleson, LLC
461. OHI Asset (TX) College Station, LLC
462. OHI Asset (TX) Comfort, LLC
463. OHI Asset (TX) Diboll, LLC
464. OHI Asset (TX) Granbury, LLC
465. OHI Asset (TX) Hondo, LLC
466. OHI Asset (TX) Italy, LLC
467. OHI Asset (TX) Longview, LLC
468. OHI Asset (TX) Schertz, LLC
469. OHI Asset (TX) Winnsboro, LLC
470. OHI Asset (TX) Winnsboro ALF, LLC
471. OHI Asset (TX), LLC
472. OHI Asset (UT) Ogden, LLC
473. OHI Asset (UT) Provo, LLC
474. OHI Asset (UT) Roy, LLC
475. OHI Asset (VA) Charlottesville - 1165 Pepsi Place, LLC
476. OHI Asset (VA) Charlottesville, LLC
477. OHI Asset (VA) Chesapeake, LLC
478. OHI Asset (VA) Farmville, LLC
479. OHI Asset (VA) Galax, LLC
480. OHI Asset (VA) Hillsville, LLC
481. OHI Asset (VA) Martinsville SNF, LLC
482. OHI Asset (VA) Madison, LLC
483. OHI Asset (VA) Mechanicsville, LLC
484. OHI Asset (VA) Midlothian, LLC
485. OHI Asset (VA) Norfolk, LLC
486. OHI Asset (VA) Portsmouth, LLC
487. OHI Asset (VA) Richmond - 2420 Pemberton Road, LLC
488. OHI Asset (VA) Richmond - 9101 Bon Air, LLC
489. OHI Asset (VA) Rocky Mount, LLC
490. OHI Asset (VA) Suffolk, LLC
491. OHI Asset (WA) Battle Ground, LLC
492. OHI Asset (WA) Fort Vancouver, LLC
493. OHI Asset (WV) Danville, LLC
494. OHI Asset (WV) Ivydale, LLC
495. OHI Asset CHG ALF, LLC
496. OHI Asset CSB LLC
497. OHI Asset CSE – E, LLC
498. OHI Asset CSE – U, LLC

 

[Schedule I – 9th Supplemental Indenture – 2027 Notes]

 

 

 

 

499. OHI Asset CSE–E Subsidiary, LLC
500. OHI Asset CSE–U Subsidiary, LLC
501. OHI Asset HUD CFG, LLC
502. OHI Asset HUD Delta, LLC
503. OHI Asset HUD H-F, LLC
504. OHI Asset HUD SF CA, LLC
505. OHI Asset HUD SF, LLC
506. OHI Asset HUD WO, LLC
507. OHI Asset II (CA), LLC
508. OHI Asset II (FL), LLC
509. OHI Asset II (PA), LP
510. OHI Asset III (PA), LP
511. OHI Asset IV (PA) Silver Lake, LP
512. OHI Asset Management, LLC
513. OHI Asset RO PMM Services, LLC
514. OHI Asset RO, LLC
515. OHI Asset S-W, LLC
516. OHI Asset, LLC
517. OHI Healthcare Properties Holdco, Inc.
518. OHI Healthcare Properties Limited Partnership
519. OHI Mezz Lender, LLC
520. OHI Tennessee, LLC (f/k/a OHI Tennessee, Inc.)
521. OHIMA, LLC (f/k/a OHIMA, Inc.)
522. Ohio Aviv Three, L.L.C.
523. Ohio Aviv Two, L.L.C.
524. Ohio Aviv, L.L.C.
525. Ohio Indiana Property, L.L.C.
526. Ohio Pennsylvania Property, L.L.C.
527. Oklahoma Two Property, L.L.C.
528. Oklahoma Warr Wind, L.L.C.
529. Omaha Associates, L.L.C.
530. Omega TRS I, Inc.
531. Orange ALF Property, L.L.C.
532. Orange Village Care Center, LLC (f/k/a Orange Village Care Center, Inc.)
533. Orange, L.L.C.
534. Oregon Associates, L.L.C.
535. Oso Avenue Property, L.L.C.
536. Ostrom Avenue Property, L.L.C.
537. Palm Valley Senior Care, LLC
538. Panama City Nursing Center LLC
539. Pavillion North Partners, LLC
540. Pavillion North, LLP
541. Pavillion Nursing Center North, LLC
542. Peabody Associates Two, L.L.C.
543. Peabody Associates, L.L.C.

 

[Schedule I – 9th Supplemental Indenture – 2027 Notes]

 

 

 

 

544. Pennington Road Property, L.L.C.
545. Pensacola Real Estate Holdings I, LLC (f/k/a Pensacola Real Estate Holdings I, Inc.)
546. Pensacola Real Estate Holdings II, LLC (f/k/a Pensacola Real Estate Holdings II, Inc.)
547. Pensacola Real Estate Holdings III, LLC (f/k/a Pensacola Real Estate Holdings III, Inc.)
548. Pensacola Real Estate Holdings IV, LLC (f/k/a Pensacola Real Estate Holdings IV, Inc.)
549. Pensacola Real Estate Holdings V, LLC (f/k/a Pensacola Real Estate Holdings V, Inc.)
550. Pocatello Idaho Property, L.L.C.
551. Pomona Vista L.L.C.
552. Prescott Arkansas, L.L.C.
553. PV Realty-Clinton, LLC
554. PV Realty-Kensington, LLC
555. PV Realty–Willow Tree, LLC
556. Raton Property Limited Company
557. Ravenna Ohio Property, L.L.C.
558. Red Rocks, L.L.C.
559. Richland Washington, L.L.C.
560. Ridgecrest Senior Care, LLC
561. Riverside Nursing Home Associates Two, L.L.C.
562. Riverside Nursing Home Associates, L.L.C.
563. Rockingham Drive Property, L.L.C.
564. Rose Baldwin Park Property L.L.C.
565. S.C. Portfolio Property, L.L.C.
566. Salem Associates, L.L.C.
567. San Juan NH Property, LLC
568. Sandalwood Arkansas Property, L.L.C.
569. Santa Ana-Bartlett, L.L.C.
570. Santa Fe Missouri Associates, L.L.C.
571. Savoy/Bonham Venture, L.L.C.
572. Searcy Aviv, L.L.C.
573. Sedgwick Properties, L.L.C.
574. Seguin Texas Property, L.L.C.
575. Sierra Ponds Property, L.L.C.
576. Skyler Boyington, LLC (f/k/a Skyler Boyington, Inc.)
577. Skyler Florida, LLC (f/k/a Skyler Florida, Inc.)
578. Skyler Maitland LLC
579. Skyler Pensacola, LLC (f/k/a Skyler Pensacola, Inc.)
580. Skyview Associates, L.L.C.
581. Southeast Missouri Property, L.L.C.
582. Southern California Nevada, L.L.C.
583. St. Joseph Missouri Property, L.L.C.
584. St. Mary’s Properties, LLC (f/k/a St. Mary’s Properties, Inc.)

 

[Schedule I – 9th Supplemental Indenture – 2027 Notes]

 

 

 

 

585. Star City Arkansas, L.L.C.
586. Stephenville Texas Property, L.L.C.
587. Sterling Acquisition, LLC
588. Stevens Avenue Property, L.L.C.
589. Sun-Mesa Properties, L.L.C.
590. Suwanee, LLC
591. Texas Fifteen Property, L.L.C.
592. Texas Four Property, L.L.C.
593. Texas Lessor – Stonegate GP, LLC
594. Texas Lessor – Stonegate, Limited, LLC
595. Texas Lessor – Stonegate, LP
596. Texhoma Avenue Property, L.L.C.
597. The Suburban Pavilion, LLC (f/k/a The Suburban Pavilion, Inc.)
598. Tujunga, L.L.C.
599. Tulare County Property, L.L.C.
600. Twinsburg Ohio Property, LLC
601. VRB Aviv, L.L.C.
602. Washington Idaho Property, L.L.C.
603. Washington Lessor – Silverdale, LLC
604. Washington-Oregon Associates, L.L.C.
605. Watauga Associates, L.L.C.
606. Wellington Leasehold, L.L.C.
607. West Pearl Street, L.L.C.
608. West Yarmouth Property I, L.L.C.
609. Westerville Ohio Office Property, L.L.C.
610. Weston ALF Property, LLC
611. Wheeler Healthcare Associates, L.L.C.
612. Whitlock Street Property, L.L.C.
613. Wilcare, LLC
614. Willis Texas Aviv, L.L.C.
615. Yuba Aviv, L.L.C.

 

[Schedule I – 9th Supplemental Indenture – 2027 Notes]

 

 

 

 

Schedule II

 

NEW SUBSIDIARIES

 

1. OHI Asset (AZ) Tucson, LLC
2. OHI Asset (FL) DeFuniak Springs, LLC
3. OHI Asset (FL) Homestead, LLC
4. OHI Asset (FL) Ormond Beach, LLC
5. OHI Asset (TN) Byrdstown, LLC
6. OHI Asset (TN) Erin, LLC
7. OHI Asset (TN) Greeneville, LLC
8. OHI Asset (TN) Harriman, LLC
9. OHI Asset (TN) Ridgely, LLC
10. OHI Asset (VA) Martinsville ALF, LLC

 

[Schedule II – 9th Supplemental Indenture – 2027 Notes]

 

 

 

EX-4.3A 7 t1700448_ex4-3a.htm EXHIBIT 4.3A

 

 

Exhibit 4.3A

 

TENTH SUPPLEMENTAL INDENTURE

(4.500% Senior Notes due 2027)

 

THIS TENTH SUPPLEMENTAL INDENTURE (this “Tenth Supplemental Indenture”) is dated as of May 25, 2017 among OMEGA HEALTHCARE INVESTORS, INC., a Maryland corporation (the “Issuer”), each of the SUBSIDIARY GUARANTORS listed on Schedule I hereto (collectively, the “Subsidiary Guarantors”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, as trustee (the “Trustee”).

 

W I T N E S S E T H :

 

WHEREAS, the Issuer and the Subsidiary Guarantors have heretofore executed and delivered to the Trustee an Indenture, dated as of March 18, 2015 (as supplemented by that First Supplemental Indenture, dated as of April 1, 2015, that Second Supplemental Indenture, dated as of August 4, 2015, that Third Supplemental Indenture, dated as of November 9, 2015, that Fourth Supplemental Indenture, dated as of March 29, 2016, that Fifth Supplemental Indenture, dated as of May 13, 2016, that Sixth Supplemental Indenture, dated as of August 9, 2016, that Seventh Supplemental Indenture, dated as of November 10, 2016, that Eighth Supplemental Indenture, dated as of March 17, 2017 and that Ninth Supplemental Indenture, dated as of May 11, 2017; the “Indenture”) providing for the issuance of the Issuer’s 4.500% Senior Notes due 2027 (the “Notes”);

 

WHEREAS, in Section 1.01 of the Indenture, the term “Subsidiary Guarantors” is defined to include (i) each Subsidiary that is a guarantor of Indebtedness under the Existing Note Indentures on the Closing Date and (ii) each other Person that is required to become a Subsidiary Guarantor by the terms of the Indenture after the Closing Date, in each case, until such Person is released from its Subsidiary Guarantee;

 

WHEREAS, Section 10.04(4) of the Indenture provides that if a Subsidiary Guarantor ceases to guarantee the obligations of the Issuer under any Indebtedness of the Issuer that would constitute Indebtedness under clauses (1) or (2) of the definition thereof in the Indenture, in an amount at least equal to $50 million, such Subsidiary Guarantor shall be automatically and unconditionally released from its obligations under its Subsidiary Guarantee and its obligations under the Indenture;

 

WHEREAS, Section 10.04 of the Indenture further provides that upon any such occurrence, at the Issuer’s request and subject to the further requirements of said Section, the Trustee shall execute any documents reasonably requested by the Issuer evidencing such release;

 

WHEREAS, the Subsidiary Guarantors other than OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership (each, a “Released Subsidiary Guarantor” and collectively, the “Released Subsidiary Guarantors”) no longer guarantee the obligations of the Issuer under any Indebtedness of the Issuer described under clauses (1) or (2) of the definition of Indebtedness in the Indenture in an amount at least equal to $50 million and therefore are automatically and unconditionally released from their obligations under their respective Subsidiary Guarantees and under the Indenture;

 

[10th Supplemental Indenture – 2027 Notes]

 

 

 

 

WHEREAS, the Issuer and the Subsidiary Guarantors (including the Released Subsidiary Guarantors) have requested that the Trustee enter into this Tenth Supplemental Indenture and the Partial Release (as hereinafter defined) to further evidence such release of the Released Subsidiary Guarantors; and

 

WHEREAS, Section 9.01(a)(5) of the Indenture authorizes the Issuer, the Subsidiary Guarantors and the Trustee, together, to amend or supplement the Indenture, without notice to or consent of any Holder of the Notes, for the purpose of releasing any Subsidiary Guarantor from any of its obligations under its Subsidiary Guarantee or the Indenture to the extent permitted by the Indenture;

 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Issuer, the Subsidiary Guarantors (including the Released Subsidiary Guarantors) and the Trustee mutually covenant and agree as follows:

 

1.CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 

2.RELEASE OF RELEASED SUBSIDIARY GUARANTORS. Pursuant to Section 10.04 of the Indenture, each of the Released Subsidiary Guarantors is hereby released from its obligations under its Subsidiary Guarantees and under the Indenture. Such release shall be further evidenced by the Trustee’s execution and delivery of a Partial Release of Subsidiary Guarantors, the form of which is attached hereto as Exhibit A (the “Partial Release”). From and after the execution and delivery hereof, the term “Subsidiary Guarantor” as used in the Indenture, the Subsidiary Guarantees and the Notes shall exclude each of the Released Subsidiary Guarantors, unless and until such Person again becomes a Subsidiary Guarantor pursuant to the provisions of Section 4.09 of the Indenture. For avoidance of doubt, OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership remain Subsidiary Guarantors.

 

3.NEW YORK LAW TO GOVERN. The laws of the State of New York shall govern and be used to construe this Tenth Supplemental Indenture.

 

4.COUNTERPARTS. The parties may sign any number of copies of this Tenth Supplemental Indenture. Each signed copy shall be an original, but all of them together shall represent the same agreement.

 

5.EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

 

[10th Supplemental Indenture – 2027 Notes]

 

 

 

 

6.THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Tenth Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Issuer and the Subsidiary Guarantors (including the Released Subsidiary Guarantors).

 

[Remainder of Page Intentionally Left Blank]

 

[10th Supplemental Indenture – 2027 Notes]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Tenth Supplemental Indenture to be duly executed, all as of the date first above written.

 

  ISSUER:
     
  OMEGA HEALTHCARE INVESTORS, INC.,
  a Maryland corporation
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
  SUBSIDIARY GUARANTORS:
     
  OHI HEALTHCARE PROPERTIES HOLDCO, INC.
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
  OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP
     
  By: OHI Healthcare Properties Holdco, Inc., as primary General Partner
       
    By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page - 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

  ON BEHALF OF EACH OF THE OTHER SUBSIDIARY GUARANTORS LISTED ON SCHEDULE I
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page - 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

 

U.S. BANK NATIONAL ASSOCIATION,

as Trustee

   
  By: /S/ David Ferrell
    David Ferrell
    Vice President

 

[Signature Page - 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

Exhibit A

(Form of Partial Release of Subsidiary Guarantors)

 

[ATTACHED]

 

[Exhibit A – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

[FORM OF ]

PARTIAL RELEASE OF SUBSIDIARY GUARANTORS

 

([INDENTURE DESCRIPTION])

 

[DATE]

 

Reference is hereby made to that certain Indenture dated as of [DATE], among Omega Healthcare Investors, Inc., a Maryland corporation (the "Issuer"), the Subsidiary Guarantors named therein and U.S. Bank National Association, as trustee (the "Trustee"), as amended or supplemented by that [ADD SUPPLEMENTAL INDENTURES] (the "Indenture"). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Indenture.

 

Pursuant to the provisions of Section [REFERENCE] of the Indenture and the terms of that certain Second Supplemental Indenture, dated as of even date herewith, among the Issuer, the Subsidiary Guarantors and the Trustee, amending and supplementing the Indenture, each of the entities set forth on Schedule I attached hereto and incorporated herein by this reference is hereby released from its obligations under its Subsidiary Guarantees and under the Indenture. For avoidance of doubt, OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership remain Subsidiary Guarantors.

 

The validity and enforceability of this Partial Release of Subsidiary Guarantors shall not be affected by the fact that it is not affixed to any particular Subsidiary Guarantee or Note.

 

This Partial Release of Subsidiary Guarantors shall be governed by, and construed in accordance with, the laws of the State of New York.

 

[Remainder of Page Intentionally Left Blank]

 

[Exhibit A – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Partial Release of Subsidiary Guarantors to be duly executed as of the date first written above.

 

 

U.S. BANK NATIONAL ASSOCIATION,

as Trustee

     
  By:  
    [NAME]
    [TITLE][

 

[Exhibit A – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

Schedule I

 

SUBSIDIARY GUARANTORS

 

1. 11900 East Artesia Boulevard, LLC
2. 1200 Ely Street Holdings Co. LLC
3. 13922 Cerise Avenue, LLC
4. 1628 B Street, LLC
5. 2400 Parkside Drive, LLC
6. 2425 Teller Avenue, LLC
7. 245 East Wilshire Avenue, LLC
8. 3232 Artesia Real Estate, LLC
9. 3806 Clayton Road, LLC
10. 42235 County Road Holdings Co. LLC
11. 446 Sycamore Road, L.L.C.
12. 48 High Point Road, LLC
13. 523 Hayes Lane, LLC
14. 637 East Romie Lane, LLC
15. Alamogordo Aviv, L.L.C.
16. Albany Street Property, L.L.C.
17. Arizona Lessor - Infinia, LLC
18. Arkansas Aviv, L.L.C.
19. Arma Yates, L.L.C.
20. Avery Street Property, L.L.C
21. Aviv Asset Management, L.L.C.
22. Aviv Financing I, L.L.C.
23. Aviv Financing II, L.L.C.
24. Aviv Financing III, L.L.C.
25. Aviv Financing IV, L.L.C.
26. Aviv Financing V, L.L.C.
27. Aviv Foothills, L.L.C.
28. Aviv Healthcare Properties Operating Partnership I, L.P.
29. Aviv Liberty, L.L.C.
30. Avon Ohio, L.L.C.
31. Bala Cynwyd Real Estate, LP
32. Bayside Colorado Healthcare Associates, LLC
33. Bayside Street II, LLC
34. Bayside Street, LLC (f/k/a Bayside Street, Inc.)
35. Belleville Illinois, L.L.C.
36. Bellingham II Associates, L.L.C.
37. Bethel ALF Property, L.L.C.
38. BHG Aviv, L.L.C.
39. Biglerville Road, L.L.C.
40. Bonham Texas, L.L.C.
41. Bradenton ALF Property, L.L.C.
42. Burton NH Property, L.L.C.

 

[Schedule I – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

43. California Aviv Two, L.L.C.
44. California Aviv, L.L.C.
45. Camas Associates, L.L.C.
46. Canton Health Care Land, LLC (f/k/a Canton Health Care Land, Inc.)
47. Carnegie Gardens LLC
48. Casa/Sierra California Associates, L.L.C.
49. CFG 2115 Woodstock Place LLC
50. Champaign Williamson Franklin, L.L.C.
51. Chardon Ohio Property Holdings, L.L.C.
52. Chardon Ohio Property, L.L.C.
53. Chatham Aviv, L.L.C.
54. Chippewa Valley, L.L.C.
55. CHR Bartow LLC
56. CHR Boca Raton  LLC
57. CHR Bradenton LLC
58. CHR Cape Coral LLC
59. CHR Fort Myers LLC
60. CHR Fort Walton Beach LLC
61. CHR Lake Wales LLC
62. CHR Lakeland LLC
63. CHR Pompano Beach Broward LLC
64. CHR Pompano Beach LLC
65. CHR Sanford LLC
66. CHR Spring Hill LLC
67. CHR St. Pete Bay LLC
68. CHR St. Pete Egret LLC
69. CHR Tampa Carrollwood LLC
70. CHR Tampa LLC
71. CHR Tarpon Springs LLC
72. CHR Titusville LLC
73. Clarkston Care, L.L.C.
74. Clayton Associates, L.L.C.
75. Colonial Gardens, LLC
76. Colonial Madison Associates, L.L.C.
77. Colorado Lessor - Conifer, LLC
78. Columbus Texas Aviv, L.L.C.
79. Columbus Western Avenue, L.L.C.
80. Colville Washington Property, L.L.C.
81. Commerce Nursing Homes, L.L.C.
82. Commerce Sterling Hart Drive, L.L.C.
83. Conroe Rigby Owen Road, L.L.C.
84. CR Aviv, L.L.C.
85. Crete Plus Five Property, L.L.C.
86. Crooked River Road, L.L.C.
87. CSE Albany LLC
88. CSE Amarillo LLC

 

[Schedule I – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

89. CSE Arden L.P.
90. CSE Augusta LLC
91. CSE Bedford LLC
92. CSE Blountville LLC
93. CSE Bolivar LLC
94. CSE Cambridge LLC
95. CSE Cambridge Realty LLC
96. CSE Camden LLC
97. CSE Canton LLC
98. CSE Casablanca Holdings II LLC
99. CSE Casablanca Holdings LLC
100. CSE Cedar Rapids LLC
101. CSE Centennial Village, LP
102. CSE Chelmsford LLC
103. CSE Chesterton LLC
104. CSE Claremont LLC
105. CSE Corpus North LLC
106. CSE Denver Iliff LLC
107. CSE Denver LLC
108. CSE Douglas LLC
109. CSE Elkton LLC
110. CSE Elkton Realty LLC
111. CSE Fairhaven LLC
112. CSE Fort Wayne LLC
113. CSE Frankston LLC
114. CSE Georgetown LLC
115. CSE Green Bay LLC
116. CSE Hilliard LLC
117. CSE Huntingdon LLC
118. CSE Huntsville LLC
119. CSE Indianapolis-Continental LLC
120. CSE Indianapolis-Greenbriar LLC
121. CSE Jacinto City LLC
122. CSE Jefferson City LLC
123. CSE Jeffersonville-Hillcrest Center LLC
124. CSE Jeffersonville-Jennings House LLC
125. CSE Kerrville LLC
126. CSE King L.P.
127. CSE Kingsport LLC
128. CSE Knightdale L.P.
129. CSE Lake City LLC
130. CSE Lake Worth LLC
131. CSE Lakewood LLC
132. CSE Las Vegas LLC
133. CSE Lawrenceburg LLC
134. CSE Lenoir L.P.

 

[Schedule I – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

135. CSE Lexington Park LLC
136. CSE Lexington Park Realty LLC
137. CSE Ligonier LLC
138. CSE Live Oak LLC
139. CSE Lowell LLC
140. CSE Marianna Holdings LLC
141. CSE Memphis LLC
142. CSE Mobile LLC
143. CSE Moore LLC
144. CSE North Carolina Holdings I LLC
145. CSE North Carolina Holdings II LLC
146. CSE Omro LLC
147. CSE Orange Park LLC
148. CSE Orlando-Pinar Terrace Manor LLC
149. CSE Orlando-Terra Vista Rehab LLC
150. CSE Pennsylvania Holdings, LP
151. CSE Piggott LLC
152. CSE Pilot Point LLC
153. CSE Pine View LLC
154. CSE Ponca City LLC
155. CSE Port St. Lucie LLC
156. CSE Richmond LLC
157. CSE Ripley LLC
158. CSE Ripon LLC
159. CSE Safford LLC
160. CSE Salina LLC
161. CSE Seminole LLC
162. CSE Shawnee LLC
163. CSE Spring Branch LLC
164. CSE Stillwater LLC
165. CSE Taylorsville LLC
166. CSE Texarkana LLC
167. CSE Texas City LLC
168. CSE The Village LLC
169. CSE Upland LLC
170. CSE Walnut Cove L.P.
171. CSE West Point LLC
172. CSE Whitehouse LLC
173. CSE Williamsport LLC
174. CSE Winter Haven LLC
175. CSE Woodfin L.P.
176. CSE Yorktown LLC
177. Cuyahoga Falls Property II, L.L.C.
178. Cuyahoga Falls Property, L.L.C.
179. Dallas Two Property, L.L.C.
180. Danbury ALF Property, L.L.C.

 

[Schedule I – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

181. Darien ALF Property, L.L.C.
182. Delta Investors I, LLC
183. Delta Investors II, LLC
184. Denison Texas, L.L.C.
185. Desert Lane LLC
186. Dixie White House Nursing Home, LLC (f/k/a Dixie White House Nursing Home, Inc.)
187. Dixon Health Care Center, LLC (f/k/a Dixon Health Care Center, Inc.)
188. East Rollins Street, L.L.C.
189. Edgewood Drive Property, L.L.C.
190. Effingham Associates, L.L.C.
191. Elite Mattoon, L.L.C.
192. Elite Yorkville, L.L.C.
193. Encanto Senior Care, LLC
194. Falcon Four Property Holding, L.L.C.
195. Falcon Four Property, L.L.C.
196. Falfurrias Texas, L.L.C.
197. Florida ALF Properties, L.L.C.
198. Florida Four Properties, L.L.C.
199. Florida Lessor – Meadowview, LLC
200. Florida Real Estate Company, LLC
201. Fort Stockton Property, L.L.C.
202. Four Fountains Aviv, L.L.C.
203. Fredericksburg South Adams Street, L.L.C.
204. Freewater Oregon, L.L.C.
205. Fullerton California, L.L.C.
206. G&L Gardens, LLC
207. Gardnerville Property, L.L.C.
208. Georgia Lessor - Bonterra/Parkview, LLC
209. Germantown Property, L.L.C.
210. Giltex Care, L.L.C.
211. Glendale NH Property, L.L.C.
212. Golden Hill Real Estate Company, LLC
213. Gonzales Texas Property, L.L.C.
214. Great Bend Property, L.L.C.
215. Greenbough, LLC
216. Greenville Kentucky Property, L.L.C.
217. Heritage Monterey Associates, L.L.C.
218. HHM Aviv, L.L.C.
219. Hidden Acres Property, L.L.C.
220. Highland Leasehold, L.L.C.
221. Hobbs Associates, L.L.C.
222. Hot Springs Atrium Owner, LLC
223. Hot Springs Aviv, L.L.C.
224. Hot Springs Cottages Owner, LLC
225. Hot Springs Marina Owner, LLC

 

[Schedule I – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

226. Houston Texas Aviv, L.L.C.
227. Hutchinson Kansas, L.L.C.
228. Hutton I Land, LLC (f/k/a Hutton I Land, Inc.)
229. Hutton II Land, LLC (f/k/a Hutton II Land, Inc.)
230. Hutton III Land, LLC (f/k/a Hutton III Land, Inc.)
231. Idaho Associates, L.L.C.
232. Illinois Missouri Properties, L.L.C.
233. Indiana Lessor – Wellington Manor, LLC
234. Iowa Lincoln County Property, L.L.C.
235. Jasper Springhill Street, L.L.C.
236. Kansas Five Property, L.L.C.
237. Karan Associates Two, L.L.C.
238. Karan Associates, L.L.C.
239. Karissa Court Property, L.L.C.
240. KB Northwest Associates, L.L.C.
241. Kentucky NH Properties, L.L.C.
242. Kingsville Texas, L.L.C.
243. LAD I Real Estate Company, LLC
244. Leatherman 90-1, LLC (f/k/a Leatherman 90-1, Inc.)
245. Leatherman Partnership 89-1, LLC (f/k/a Leatherman Partnership 89-1, Inc.)
246. Leatherman Partnership 89-2, LLC (f/k/a Leatherman Partnership 89-2, Inc.)
247. Louisville Dutchmans Property, L.L.C.
248. Magnolia Drive Property, L.L.C.
249. Manor Associates, L.L.C.
250. Mansfield Aviv, L.L.C.
251. Massachusetts Nursing Homes, L.L.C.
252. McCarthy Street Property, L.L.C.
253. Meridian Arms Land, LLC (f/k/a Meridian Arms Land, Inc.)
254. Minnesota Associates, L.L.C.
255. Mishawaka Property, L.L.C.
256. Missouri Associates, L.L.C.
257. Missouri Regency Associates, L.L.C.
258. Montana Associates, L.L.C.
259. Monterey Park Leasehold Mortgage, L.L.C.
260. Mount Washington Property, L.L.C.
261. Mt. Vernon Texas, L.L.C.
262. Murray County, L.L.C.
263. Muscatine Toledo Properties, L.L.C.
264. N.M. Bloomfield Three Plus One Limited Company
265. N.M. Espanola Three Plus One Limited Company
266. N.M. Lordsburg Three Plus One Limited Company
267. N.M. Silver City Three Plus One Limited Company
268. New Hope Property, L.L.C.
269. Newtown ALF Property, L.L.C.

 

[Schedule I – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

270. Nicholasville Kentucky Property, L.L.C.
271. North Las Vegas LLC
272. North Royalton Ohio Property, L.L.C.
273. Norwalk ALF Property, L.L.C.
274. NRS Ventures, L.L.C.
275. Oakland Nursing Homes, L.L.C.
276. Ocean Springs Nursing Home, LLC (f/k/a Ocean Springs Nursing Home, Inc.)
277. October Associates, L.L.C.
278. Ogden Associates, L.L.C.
279. OHI (Connecticut), LLC
280. OHI (Illinois), LLC(f/k/a OHI (Illinois), Inc.)
281. OHI (Indiana), LLC
282. OHI (Iowa), LLC(f/k/a OHI (Iowa), Inc.)
283. OHI Asset (AR) Ash Flat, LLC
284. OHI Asset (AR) Camden, LLC
285. OHI Asset (AR) Conway, LLC
286. OHI Asset (AR) Des Arc, LLC
287. OHI Asset (AR) Hot Springs, LLC
288. OHI Asset (AR) Malvern, LLC
289. OHI Asset (AR) Mena, LLC
290. OHI Asset (AR) Pocahontas, LLC
291. OHI Asset (AR) Sheridan, LLC
292. OHI Asset (AR) Walnut Ridge, LLC
293. OHI Asset (AZ) Austin House, LLC
294. OHI Asset (AZ) Tucson, LLC
295. OHI Asset (CA), LLC
296. OHI Asset (CO) Brighton, LLC
297. OHI Asset (CO) Denver, LLC
298. OHI Asset (CO) Mesa, LLC
299. OHI Asset (CO), LLC
300. OHI Asset (CT) Lender, LLC
301. OHI Asset (FL) DeFuniak Springs, LLC
302. OHI Asset (FL) Eustis, LLC
303. OHI Asset (FL) Graceville, LLC
304. OHI Asset (FL) Homestead, LLC
305. OHI Asset (FL) Lake Placid, LLC
306. OHI Asset (FL) Lender, LLC
307. OHI Asset (FL) Lutz, LLC
308. OHI Asset (FL) Marianna, LLC
309. OHI Asset (FL) Middleburg, LLC
310. OHI Asset (FL) Ormond Beach, LLC
311. OHI Asset (FL) Pensacola - Hillview, LLC
312. OHI Asset (FL) Pensacola, LLC
313. OHI Asset (FL) Port St. Joe, LLC
314. OHI Asset (FL) Sebring, LLC

 

[Schedule I – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

315. OHI Asset (FL), LLC
316. OHI Asset (GA) Cordele, LLC
317. OHI Asset (GA) Dunwoody, LLC
318. OHI Asset (GA) Macon, LLC
319. OHI Asset (GA) Moultrie, LLC
320. OHI Asset (GA) Nashville, LLC
321. OHI Asset (GA) Roswell, LLC
322. OHI Asset (GA) Snellville, LLC
323. OHI Asset (GA) Valdosta, LLC
324. OHI Asset (ID) Holly, LLC
325. OHI Asset (ID) Midland, LLC
326. OHI Asset (ID), LLC
327. OHI Asset (IL), LLC
328. OHI Asset (IN) American Village, LLC
329. OHI Asset (IN) Anderson, LLC
330. OHI Asset (IN) Beech Grove, LLC
331. OHI Asset (IN) Clarksville, LLC
332. OHI Asset (IN) Clinton, LLC
333. OHI Asset (IN) Connersville, LLC
334. OHI Asset (IN) Crown Point, LLC
335. OHI Asset (IN) Eagle Valley, LLC
336. OHI Asset (IN) Elkhart, LLC
337. OHI Asset (IN) Forest Creek, LLC
338. OHI Asset (IN) Fort Wayne, LLC
339. OHI Asset (IN) Franklin, LLC
340. OHI Asset (IN) Greensburg, LLC
341. OHI Asset (IN) Indianapolis, LLC
342. OHI Asset (IN) Jasper, LLC
343. OHI Asset (IN) Kokomo, LLC
344. OHI Asset (IN) Lafayette, LLC
345. OHI Asset (IN) Madison, LLC
346. OHI Asset (IN) Monticello, LLC
347. OHI Asset (IN) Noblesville, LLC
348. OHI Asset (IN) Rosewalk, LLC
349. OHI Asset (IN) Salem, LLC
350. OHI Asset (IN) Seymour, LLC
351. OHI Asset (IN) Spring Mill, LLC
352. OHI Asset (IN) Terre Haute, LLC
353. OHI Asset (IN) Wabash, LLC
354. OHI Asset (IN) Westfield, LLC
355. OHI Asset (IN) Zionsville, LLC
356. OHI Asset (KY) Beattyville, LLC
357. OHI Asset (KY) Louisville – 1120 Cristland, LLC
358. OHI Asset (KY) Louisville – 2529 Six Mile Lane, LLC
359. OHI Asset (KY) Morgantown, LLC
360. OHI Asset (KY) Owensboro, LLC

 

[Schedule I – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

361. OHI Asset (LA) Baton Rouge, LLC
362. OHI Asset (LA), LLC
363. OHI Asset (MD) Baltimore - Pall Mall, LLC
364. OHI Asset (MD) Baltimore - West Belvedere, LLC
365. OHI Asset (MD) Salisbury, LLC
366. OHI Asset (MD), LLC
367. OHI Asset (MI) Carson City, LLC
368. OHI Asset (MI) Heather Hills, LLC
369. OHI Asset (MI), LLC
370. OHI Asset (MO) Jackson, LLC
371. OHI Asset (MO), LLC
372. OHI Asset (MS) Byhalia, LLC
373. OHI Asset (MS) Cleveland, LLC
374. OHI Asset (MS) Clinton, LLC
375. OHI Asset (MS) Columbia, LLC
376. OHI Asset (MS) Corinth, LLC
377. OHI Asset (MS) Greenwood, LLC
378. OHI Asset (MS) Grenada, LLC
379. OHI Asset (MS) Holly Springs, LLC
380. OHI Asset (MS) Indianola, LLC
381. OHI Asset (MS) Natchez, LLC
382. OHI Asset (MS) Picayune, LLC
383. OHI Asset (MS) Vicksburg, LLC
384. OHI Asset (MS) Yazoo City, LLC
385. OHI Asset (NC) Biscoe, LLC
386. OHI Asset (NC) Cornelius, LLC
387. OHI Asset (NC) Drexel, LLC
388. OHI Asset (NC) Fayetteville, LLC
389. OHI Asset (NC) Hallsboro, LLC
390. OHI Asset (NC) Marion, LLC
391. OHI Asset (NC) Marshville, LLC
392. OHI Asset (NC) Mocksville – 1007 Howard Street, LLC
393. OHI Asset (NC) Mocksville – 1304 Madison Road, LLC
394. OHI Asset (NC) Nashville, LLC
395. OHI Asset (NC) Raeford, LLC
396. OHI Asset (NC) Rocky Mount – 1558 S. Winstead, LLC
397. OHI Asset (NC) Rocky Mount – 415 N. Winstead, LLC
398. OHI Asset (NC) Salisbury, LLC
399. OHI Asset (NC) Saluda, LLC
400. OHI Asset (NC) Shallotte, LLC
401. OHI Asset (NC) Wadesboro, LLC
402. OHI Asset (NC) Waynesville, LLC
403. OHI Asset (NC) Wilmington, LLC
404. OHI Asset (NC) Winston Salem, LLC
405. OHI Asset (NY) 2nd Avenue, LLC
406. OHI Asset (NY) 93rd Street, LLC

 

[Schedule I – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

407. OHI Asset (OH) Huber Heights, LLC
408. OHI Asset (OH) Lender, LLC
409. OHI Asset (OH) New London, LLC
410. OHI Asset (OH) Steubenville, LLC
411. OHI Asset (OH) Toledo, LLC
412. OHI Asset (OH) West Carrollton, LLC
413. OHI Asset (OH), LLC
414. OHI Asset (OR) Portland, LLC
415. OHI Asset (OR) Troutdale, LLC
416. OHI Asset (PA) GP, LLC
417. OHI Asset (PA) West Mifflin, LP
418. OHI Asset (PA), LLC
419. OHI Asset (PA), LP
420. OHI Asset (SC) Aiken, LLC
421. OHI Asset (SC) Anderson, LLC
422. OHI Asset (SC) Easley Anne, LLC
423. OHI Asset (SC) Easley Crestview, LLC
424. OHI Asset (SC) Edgefield, LLC
425. OHI Asset (SC) Five Forks, LLC
426. OHI Asset (SC) Greenville Cottages, LLC 
427. OHI Asset (SC) Greenville Griffith, LLC
428. OHI Asset (SC) Greenville Laurens, LLC
429. OHI Asset (SC) Greenville North, LLC
430. OHI Asset (SC) Greenville, LLC
431. OHI Asset (SC) Greer, LLC
432. OHI Asset (SC) Marietta, LLC
433. OHI Asset (SC) McCormick, LLC
434. OHI Asset (SC) Orangeburg, LLC
435. OHI Asset (SC) Pickens East Cedar, LLC
436. OHI Asset (SC) Pickens Rosemond, LLC
437. OHI Asset (SC) Piedmont, LLC
438. OHI Asset (SC) Simpsonville SE Main, LLC
439. OHI Asset (SC) Simpsonville West Broad, LLC
440. OHI Asset (SC) Simpsonville West Curtis, LLC
441. OHI Asset (TN) Bartlett, LLC
442. OHI Asset (TN) Byrdstown, LLC
443. OHI Asset (TN) Cleveland, LLC
444. OHI Asset (TN) Collierville, LLC
445. OHI Asset (TN) Columbia, LLC
446. OHI Asset (TN) Elizabethton, LLC
447. OHI Asset (TN) Erin, LLC
448. OHI Asset (TN) Greeneville, LLC
449. OHI Asset (TN) Harriman, LLC
450. OHI Asset (TN) Jamestown, LLC 
451. OHI Asset (TN) Jefferson City, LLC
452. OHI Asset (TN) Memphis – 1150 Dovecrest, LLC

 

[Schedule I – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

453. OHI Asset (TN) Memphis, LLC
454. OHI Asset (TN) Monteagle, LLC
455. OHI Asset (TN) Monterey, LLC 
456. OHI Asset (TN) Mountain City, LLC
457. OHI Asset (TN) Nashville, LLC
458. OHI Asset (TN) Pigeon Forge, LLC
459. OHI Asset (TN) Ridgely, LLC
460. OHI Asset (TN) Rockwood, LLC
461. OHI Asset (TN) Rogersville – 109 Highway 70 North, LLC
462. OHI Asset (TN) Rogersville, LLC
463. OHI Asset (TN) South Pittsburg, LLC
464. OHI Asset (TN) Spring City, LLC
465. OHI Asset (TN) Westmoreland, LLC
466. OHI Asset (TX) Anderson, LLC
467. OHI Asset (TX) Athens, LLC
468. OHI Asset (TX) Bryan, LLC
469. OHI Asset (TX) Burleson, LLC
470. OHI Asset (TX) College Station, LLC
471. OHI Asset (TX) Comfort, LLC
472. OHI Asset (TX) Diboll, LLC
473. OHI Asset (TX) Granbury, LLC
474. OHI Asset (TX) Hondo, LLC
475. OHI Asset (TX) Italy, LLC
476. OHI Asset (TX) Longview, LLC
477. OHI Asset (TX) Schertz, LLC
478. OHI Asset (TX) Winnsboro ALF, LLC
479. OHI Asset (TX) Winnsboro, LLC
480. OHI Asset (TX), LLC
481. OHI Asset (UT) Ogden, LLC
482. OHI Asset (UT) Provo, LLC
483. OHI Asset (UT) Roy, LLC
484. OHI Asset (VA) Charlottesville - 1165 Pepsi Place, LLC
485. OHI Asset (VA) Charlottesville, LLC
486. OHI Asset (VA) Chesapeake, LLC
487. OHI Asset (VA) Farmville, LLC
488. OHI Asset (VA) Galax, LLC
489. OHI Asset (VA) Hillsville, LLC
490. OHI Asset (VA) Madison, LLC
491. OHI Asset (VA) Martinsville ALF, LLC
492. OHI Asset (VA) Martinsville SNF, LLC
493. OHI Asset (VA) Mechanicsville, LLC
494. OHI Asset (VA) Midlothian, LLC
495. OHI Asset (VA) Norfolk, LLC
496. OHI Asset (VA) Portsmouth, LLC
497. OHI Asset (VA) Richmond - 2420 Pemberton Road, LLC
498. OHI Asset (VA) Richmond - 9101 Bon Air, LLC

 

[Schedule I – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

499. OHI Asset (VA) Rocky Mount, LLC
500. OHI Asset (VA) Suffolk, LLC
501. OHI Asset (WA) Battle Ground, LLC
502. OHI Asset (WA) Fort Vancouver, LLC
503. OHI Asset (WV) Danville, LLC
504. OHI Asset (WV) Ivydale, LLC
505. OHI Asset CHG ALF, LLC
506. OHI Asset CSB LLC
507. OHI Asset CSE – E, LLC
508. OHI Asset CSE – U, LLC
509. OHI Asset CSE–E Subsidiary, LLC
510. OHI Asset CSE–U Subsidiary, LLC
511. OHI Asset HUD CFG, LLC
512. OHI Asset HUD Delta, LLC
513. OHI Asset HUD H-F, LLC
514. OHI Asset HUD SF CA, LLC
515. OHI Asset HUD SF, LLC
516. OHI Asset HUD WO, LLC
517. OHI Asset II (CA), LLC
518. OHI Asset II (FL), LLC
519. OHI Asset II (PA), LP
520. OHI Asset III (PA), LP
521. OHI Asset IV (PA) Silver Lake, LP
522. OHI Asset Management, LLC
523. OHI Asset RO PMM Services, LLC
524. OHI Asset RO, LLC
525. OHI Asset S-W, LLC
526. OHI Asset, LLC
527. OHI Healthcare Properties Holdco, Inc.
528. OHI Healthcare Properties Limited Partnership
529. OHI Mezz Lender, LLC
530. OHI Tennessee, LLC (f/k/a OHI Tennessee, Inc.)
531. OHIMA, LLC (f/k/a OHIMA, Inc.)
532. Ohio Aviv Three, L.L.C.
533. Ohio Aviv Two, L.L.C.
534. Ohio Aviv, L.L.C.
535. Ohio Indiana Property, L.L.C.
536. Ohio Pennsylvania Property, L.L.C.
537. Oklahoma Two Property, L.L.C.
538. Oklahoma Warr Wind, L.L.C.
539. Omaha Associates, L.L.C.
540. Omega TRS I, Inc.
541. Orange ALF Property, L.L.C.
542. Orange Village Care Center, LLC (f/k/a Orange Village Care Center, Inc.)
543. Orange, L.L.C.

 

[Schedule I – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

544. Oregon Associates, L.L.C.
545. Oso Avenue Property, L.L.C.
546. Ostrom Avenue Property, L.L.C.
547. Palm Valley Senior Care, LLC
548. Panama City Nursing Center LLC
549. Pavillion North Partners, LLC
550. Pavillion North, LLP
551. Pavillion Nursing Center North, LLC
552. Peabody Associates Two, L.L.C.
553. Peabody Associates, L.L.C.
554. Pennington Road Property, L.L.C.
555. Pensacola Real Estate Holdings I, LLC (f/k/a Pensacola Real Estate Holdings I, Inc.)
556. Pensacola Real Estate Holdings II, LLC (f/k/a Pensacola Real Estate Holdings II, Inc.)
557. Pensacola Real Estate Holdings III, LLC (f/k/a Pensacola Real Estate Holdings III, Inc.)
558. Pensacola Real Estate Holdings IV, LLC (f/k/a Pensacola Real Estate Holdings IV, Inc.)
559. Pensacola Real Estate Holdings V, LLC (f/k/a Pensacola Real Estate Holdings V, Inc.)
560. Pocatello Idaho Property, L.L.C.
561. Pomona Vista L.L.C.
562. Prescott Arkansas, L.L.C.
563. PV Realty-Clinton, LLC
564. PV Realty-Kensington, LLC
565. PV Realty–Willow Tree, LLC
566. Raton Property Limited Company
567. Ravenna Ohio Property, L.L.C.
568. Red Rocks, L.L.C.
569. Richland Washington, L.L.C.
570. Ridgecrest Senior Care, LLC
571. Riverside Nursing Home Associates Two, L.L.C.
572. Riverside Nursing Home Associates, L.L.C.
573. Rockingham Drive Property, L.L.C.
574. Rose Baldwin Park Property L.L.C.
575. S.C. Portfolio Property, L.L.C.
576. Salem Associates, L.L.C.
577. San Juan NH Property, LLC
578. Sandalwood Arkansas Property, L.L.C.
579. Santa Ana-Bartlett, L.L.C.
580. Santa Fe Missouri Associates, L.L.C.
581. Savoy/Bonham Venture, L.L.C.
582. Searcy Aviv, L.L.C.
583. Sedgwick Properties, L.L.C.
584. Seguin Texas Property, L.L.C.

 

[Schedule I – 10th Supplemental Indenture – 2027 Notes]

 

 

 

 

585. Sierra Ponds Property, L.L.C.
586. Skyler Boyington, LLC (f/k/a Skyler Boyington, Inc.)
587. Skyler Florida, LLC (f/k/a Skyler Florida, Inc.)
588. Skyler Maitland LLC
589. Skyler Pensacola, LLC (f/k/a Skyler Pensacola, Inc.)
590. Skyview Associates, L.L.C.
591. Southeast Missouri Property, L.L.C.
592. Southern California Nevada, L.L.C.
593. St. Joseph Missouri Property, L.L.C.
594. St. Mary’s Properties, LLC (f/k/a St. Mary’s Properties, Inc.)
595. Star City Arkansas, L.L.C.
596. Stephenville Texas Property, L.L.C.
597. Sterling Acquisition, LLC
598. Stevens Avenue Property, L.L.C.
599. Sun-Mesa Properties, L.L.C.
600. Suwanee, LLC
601. Texas Fifteen Property, L.L.C.
602. Texas Four Property, L.L.C.
603. Texas Lessor – Stonegate GP, LLC
604. Texas Lessor – Stonegate, Limited, LLC
605. Texas Lessor – Stonegate, LP
606. Texhoma Avenue Property, L.L.C.
607. The Suburban Pavilion, LLC (f/k/a The Suburban Pavilion, Inc.)
608. Tujunga, L.L.C.
609. Tulare County Property, L.L.C.
610. Twinsburg Ohio Property, LLC
611. VRB Aviv, L.L.C.
612. Washington Idaho Property, L.L.C.
613. Washington Lessor – Silverdale, LLC
614. Washington-Oregon Associates, L.L.C.
615. Watauga Associates, L.L.C.
616. Wellington Leasehold, L.L.C.
617. West Pearl Street, L.L.C.
618. West Yarmouth Property I, L.L.C.
619. Westerville Ohio Office Property, L.L.C.
620. Weston ALF Property, LLC
621. Wheeler Healthcare Associates, L.L.C.
622. Whitlock Street Property, L.L.C.
623. Wilcare, LLC
624. Willis Texas Aviv, L.L.C.
625. Yuba Aviv, L.L.C.

 

[Schedule I – 10th Supplemental Indenture – 2027 Notes]

 

 

 

EX-4.4 8 t1700448_ex4-4.htm EXHIBIT 4.4

 

 

Exhibit 4.4

 

SEVENTH SUPPLEMENTAL INDENTURE

(Senior Notes due 2026)

 

THIS SEVENTH SUPPLEMENTAL INDENTURE (this “Seventh Supplemental Indenture”) is dated as of May 11, 2017, among OMEGA HEALTHCARE INVESTORS, INC., a Maryland corporation (the “Issuer”), each of the entities listed on Schedule II hereto (collectively, the “New Subsidiaries”) and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, as trustee (the “Trustee”).

 

W I T N E S S E T H :

 

WHEREAS, the Issuer and each of its direct and indirect subsidiaries listed on Schedule I hereto (collectively, the “Subsidiary Guarantors”) have heretofore executed and delivered to the Trustee an Indenture, dated as of September 23, 2015 (as supplemented by that First Supplemental Indenture, dated as of November 9, 2015, that Second Supplemental Indenture, dated as of March 29, 2016, that Third Supplemental Indenture, dated as of May 13, 2016, that Fourth Supplemental Indenture, dated as of August 9, 2016, that Fifth Supplemental Indenture, dated as of November 10, 2016, and that Fifth Supplemental Indenture, dated as of March 17, 2017; the “Indenture”) providing for the issuance of the Issuer’s 5.250 % Senior Notes due 2026 (the “Notes”);

 

WHEREAS, Section 9.01(a)(4) of the Indenture authorizes the Issuer and the Trustee, together, to amend or supplement the Indenture, without notice to or consent of any Holder of the Notes and without the execution of such amendment or supplement by existing Subsidiary Guarantors, for the purpose of adding any additional Subsidiary Guarantee by any additional Guarantor;

 

WHEREAS, pursuant to Section 4.09 of the Indenture, the New Subsidiaries are required to become Subsidiary Guarantors;

 

WHEREAS, in Section 1.01 of the Indenture, the term “Subsidiary Guarantors” is defined to include all Persons that become a Subsidiary Guarantor by the terms of the Indenture after the Closing Date; and

 

WHEREAS, Section 10.01 of the Indenture provides that each Subsidiary Guarantor shall be a guarantor of the Issuer’s obligations under the Notes, subject to the terms and conditions described in the Indenture.

 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Issuer, the New Subsidiaries and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:

 

1.CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 

[7th Supplemental Indenture – 2026 Notes]

 

 

 

 

2.AMENDMENT TO GUARANTEE. The New Subsidiaries hereby agree, jointly and severally with all other Subsidiary Guarantors, to guarantee the Issuer’s obligations under the Notes on the terms and subject to the conditions set forth in the Indenture, and to be bound by, and to receive the benefit of, all other applicable provisions of the Indenture as Subsidiary Guarantors. Such guarantee shall be evidenced by the New Subsidiaries’ execution of Subsidiary Guarantees, the form of which is attached as Exhibit E to the Indenture, and shall be effective as of the date hereof.

 

3.NO RECOURSE AGAINST OTHERS. No past, present or future director, officer, employee, incorporator, stockholder, member, manager or controlling person of the New Subsidiaries, as such, shall have any liability for any obligations of the Issuer or any Subsidiary Guarantor under the Notes, any Guarantees, the Indenture or this Seventh Supplemental Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder of the Notes, by accepting and holding a Note, waives and releases all such liability. Such waiver and release are part of the consideration for the issuance of the Notes.

 

4.NEW YORK LAW TO GOVERN. The laws of the State of New York shall govern and be used to construe this Seventh Supplemental Indenture.

 

5.COUNTERPARTS. The parties may sign any number of copies of this Seventh Supplemental Indenture. Each signed copy shall be an original, but all of them together shall represent the same agreement.

 

6.EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

 

7.THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Seventh Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Issuer and the New Subsidiaries.

 

[Remainder of Page Intentionally Left Blank]

 

[7th Supplemental Indenture – 2026 Notes]

 

 2 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Seventh Supplemental Indenture to be duly executed, all as of the date first above written.

 

  ISSUER:
   
  OMEGA HEALTHCARE INVESTORS, INC.,
  a Maryland corporation
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
  NEW SUBSIDIARIES:
   
  ON BEHALF OF EACH OF THE NEW SUBSIDIARIES LISTED ON SCHEDULE II
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page – 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

  U.S. BANK NATIONAL ASSOCIATION,
  as Trustee
     
  By: /s/ David Ferrell
    Name: David Ferrell
    Title: Vice President

 

[Signature Page – 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

Schedule I

 

SUBSIDIARY GUARANTORS

 

1. 11900 East Artesia Boulevard, LLC
2. 1200 Ely Street Holdings Co. LLC
3. 13922 Cerise Avenue, LLC
4. 1628 B Street, LLC
5. 2400 Parkside Drive, LLC
6. 2425 Teller Avenue, LLC
7. 245 East Wilshire Avenue, LLC
8. 3232 Artesia Real Estate, LLC
9. 3806 Clayton Road, LLC
10. 42235 County Road Holdings Co. LLC
11. 446 Sycamore Road, L.L.C.
12. 48 High Point Road, LLC
13. 523 Hayes Lane, LLC
14. 637 East Romie Lane, LLC
15. Alamogordo Aviv, L.L.C.
16. Albany Street Property, L.L.C.
17. Arizona Lessor - Infinia, LLC
18. Arkansas Aviv, L.L.C.
19. Arma Yates, L.L.C.
20. Avery Street Property, L.L.C
21. Aviv Asset Management, L.L.C.
22. Aviv Financing I, L.L.C.
23. Aviv Financing II, L.L.C.
24. Aviv Financing III, L.L.C.
25. Aviv Financing IV, L.L.C.
26. Aviv Financing V, L.L.C.
27. Aviv Foothills, L.L.C.
28. Aviv Healthcare Properties Operating Partnership I, L.P.
29. Aviv Liberty, L.L.C.
30. Avon Ohio, L.L.C.
31. Bala Cynwyd Real Estate, LP
32. Bayside Colorado Healthcare Associates, LLC
33. Bayside Street II, LLC
34. Bayside Street, LLC (f/k/a Bayside Street, Inc.)
35. Belleville Illinois, L.L.C.
36. Bellingham II Associates, L.L.C.
37. Bethel ALF Property, L.L.C.
38. BHG Aviv, L.L.C.
39. Biglerville Road, L.L.C.
40. Bonham Texas, L.L.C.
41. Bradenton ALF Property, L.L.C.

 

[Schedule I - 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

42. Burton NH Property, L.L.C.
43. California Aviv Two, L.L.C.
44. California Aviv, L.L.C.
45. Camas Associates, L.L.C.
46. Canton Health Care Land, LLC (f/k/a Canton Health Care Land, Inc.)
47. Carnegie Gardens LLC
48. Casa/Sierra California Associates, L.L.C.
49. CFG 2115 Woodstock Place LLC
50. Champaign Williamson Franklin, L.L.C.
51. Chardon Ohio Property Holdings, L.L.C.
52. Chardon Ohio Property, L.L.C.
53. Chatham Aviv, L.L.C.
54. Chippewa Valley, L.L.C.
55. CHR Bartow LLC
56. CHR Boca Raton LLC
57. CHR Bradenton LLC
58. CHR Cape Coral LLC
59. CHR Fort Myers LLC
60. CHR Fort Walton Beach LLC
61. CHR Lake Wales LLC
62. CHR Lakeland LLC
63. CHR Pompano Beach Broward LLC
64. CHR Pompano Beach LLC
65. CHR Sanford LLC
66. CHR Spring Hill LLC
67. CHR St. Pete Bay LLC
68. CHR St. Pete Egret LLC
69. CHR Tampa Carrollwood LLC
70. CHR Tampa LLC
71. CHR Tarpon Springs LLC
72. CHR Titusville LLC
73. Clarkston Care, L.L.C.
74. Clayton Associates, L.L.C.
75. Colonial Gardens, LLC
76. Colonial Madison Associates, L.L.C.
77. Colorado Lessor - Conifer, LLC
78. Columbus Texas Aviv, L.L.C.
79. Columbus Western Avenue, L.L.C.
80. Colville Washington Property, L.L.C.
81. Commerce Nursing Homes, L.L.C.
82. Commerce Sterling Hart Drive, L.L.C.
83. Conroe Rigby Owen Road, L.L.C.
84. CR Aviv, L.L.C.
85. Crete Plus Five Property, L.L.C.
86. Crooked River Road, L.L.C.
87. CSE Albany LLC

 

[Schedule I - 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

88. CSE Amarillo LLC
89. CSE Arden L.P.
90. CSE Augusta LLC
91. CSE Bedford LLC
92. CSE Blountville LLC
93. CSE Bolivar LLC
94. CSE Cambridge LLC
95. CSE Cambridge Realty LLC
96. CSE Camden LLC
97. CSE Canton LLC
98. CSE Casablanca Holdings II LLC
99. CSE Casablanca Holdings LLC
100. CSE Cedar Rapids LLC
101. CSE Centennial Village, LP
102. CSE Chelmsford LLC
103. CSE Chesterton LLC
104. CSE Claremont LLC
105. CSE Corpus North LLC
106. CSE Denver Iliff LLC
107. CSE Denver LLC
108. CSE Douglas LLC
109. CSE Elkton LLC
110. CSE Elkton Realty LLC
111. CSE Fairhaven LLC
112. CSE Fort Wayne LLC
113. CSE Frankston LLC
114. CSE Georgetown LLC
115. CSE Green Bay LLC
116. CSE Hilliard LLC
117. CSE Huntingdon LLC
118. CSE Huntsville LLC
119. CSE Indianapolis-Continental LLC
120. CSE Indianapolis-Greenbriar LLC
121. CSE Jacinto City LLC
122. CSE Jefferson City LLC
123. CSE Jeffersonville-Hillcrest Center LLC
124. CSE Jeffersonville-Jennings House LLC
125. CSE Kerrville LLC
126. CSE King L.P.
127. CSE Kingsport LLC
128. CSE Knightdale L.P.
129. CSE Lake City LLC
130. CSE Lake Worth LLC
131. CSE Lakewood LLC
132. CSE Las Vegas LLC
133. CSE Lawrenceburg LLC

 

[Schedule I - 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

134. CSE Lenoir L.P.
135. CSE Lexington Park LLC
136. CSE Lexington Park Realty LLC
137. CSE Ligonier LLC
138. CSE Live Oak LLC
139. CSE Lowell LLC
140. CSE Marianna Holdings LLC
141. CSE Memphis LLC
142. CSE Mobile LLC
143. CSE Moore LLC
144. CSE North Carolina Holdings I LLC
145. CSE North Carolina Holdings II LLC
146. CSE Omro LLC
147. CSE Orange Park LLC
148. CSE Orlando-Pinar Terrace Manor LLC
149. CSE Orlando-Terra Vista Rehab LLC
150. CSE Pennsylvania Holdings, LP
151. CSE Piggott LLC
152. CSE Pilot Point LLC
153. CSE Pine View LLC
154. CSE Ponca City LLC
155. CSE Port St. Lucie LLC
156. CSE Richmond LLC
157. CSE Ripley LLC
158. CSE Ripon LLC
159. CSE Safford LLC
160. CSE Salina LLC
161. CSE Seminole LLC
162. CSE Shawnee LLC
163. CSE Spring Branch LLC
164. CSE Stillwater LLC
165. CSE Taylorsville LLC
166. CSE Texarkana LLC
167. CSE Texas City LLC
168. CSE The Village LLC
169. CSE Upland LLC
170. CSE Walnut Cove L.P.
171. CSE West Point LLC
172. CSE Whitehouse LLC
173. CSE Williamsport LLC
174. CSE Winter Haven LLC
175. CSE Woodfin L.P.
176. CSE Yorktown LLC
177. Cuyahoga Falls Property, L.L.C.
178. Cuyahoga Falls Property II, L.L.C.
179. Dallas Two Property, L.L.C.

 

[Schedule I - 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

180. Danbury ALF Property, L.L.C.
181. Darien ALF Property, L.L.C.
182. Delta Investors I, LLC
183. Delta Investors II, LLC
184. Denison Texas, L.L.C.
185. Desert Lane LLC
186. Dixie White House Nursing Home, LLC (f/k/a Dixie White House Nursing Home, Inc.)
187. Dixon Health Care Center, LLC (f/k/a Dixon Health Care Center, Inc.)
188. East Rollins Street, L.L.C.
189. Edgewood Drive Property, L.L.C.
190. Effingham Associates, L.L.C.
191. Elite Mattoon, L.L.C.
192. Elite Yorkville, L.L.C.
193. Encanto Senior Care, LLC
194. Falcon Four Property Holding, L.L.C.
195. Falcon Four Property, L.L.C.
196. Falfurrias Texas, L.L.C.
197. Florida ALF Properties, L.L.C.
198. Florida Four Properties, L.L.C.
199. Florida Lessor – Meadowview, LLC
200. Florida Real Estate Company, LLC
201. Fort Stockton Property, L.L.C.
202. Four Fountains Aviv, L.L.C.
203. Fredericksburg South Adams Street, L.L.C.
204. Freewater Oregon, L.L.C.
205. Fullerton California, L.L.C.
206. G&L Gardens, LLC
207. Gardnerville Property, L.L.C.
208. Georgia Lessor - Bonterra/Parkview, LLC
209. Germantown Property, L.L.C.
210. Giltex Care, L.L.C.
211. Glendale NH Property, L.L.C.
212. Golden Hill Real Estate Company, LLC
213. Gonzales Texas Property, L.L.C.
214. Great Bend Property, L.L.C.
215. Greenbough, LLC
216. Greenville Kentucky Property, L.L.C.
217. Heritage Monterey Associates, L.L.C.
218. HHM Aviv, L.L.C.
219. Hidden Acres Property, L.L.C.
220. Highland Leasehold, L.L.C.
221. Hobbs Associates, L.L.C.
222. Hot Springs Atrium Owner, LLC
223. Hot Springs Aviv, L.L.C.
224. Hot Springs Cottages Owner, LLC

 

[Schedule I - 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

225. Hot Springs Marina Owner, LLC
226. Houston Texas Aviv, L.L.C.
227. Hutchinson Kansas, L.L.C.
228. Hutton I Land, LLC (f/k/a Hutton I Land, Inc.)
229. Hutton II Land, LLC (f/k/a Hutton II Land, Inc.)
230. Hutton III Land, LLC (f/k/a Hutton III Land, Inc.)
231. Idaho Associates, L.L.C.
232. Illinois Missouri Properties, L.L.C.
233. Indiana Lessor – Wellington Manor, LLC
234. Iowa Lincoln County Property, L.L.C.
235. Jasper Springhill Street, L.L.C.
236. Kansas Five Property, L.L.C.
237. Karan Associates Two, L.L.C.
238. Karan Associates, L.L.C.
239. Karissa Court Property, L.L.C.
240. KB Northwest Associates, L.L.C.
241. Kentucky NH Properties, L.L.C.
242. Kingsville Texas, L.L.C.
243. LAD I Real Estate Company, LLC
244. Leatherman 90-1, LLC (f/k/a Leatherman 90-1, Inc.)
245. Leatherman Partnership 89-1, LLC (f/k/a Leatherman Partnership 89-1, Inc.)
246. Leatherman Partnership 89-2, LLC (f/k/a Leatherman Partnership 89-2, Inc.)
247. Louisville Dutchmans Property, L.L.C.
248. Magnolia Drive Property, L.L.C.
249. Manor Associates, L.L.C.
250. Mansfield Aviv, L.L.C.
251. Massachusetts Nursing Homes, L.L.C.
252. McCarthy Street Property, L.L.C.
253. Meridian Arms Land, LLC (f/k/a Meridian Arms Land, Inc.)
254. Minnesota Associates, L.L.C.
255. Mishawaka Property, L.L.C.
256. Missouri Associates, L.L.C.
257. Missouri Regency Associates, L.L.C.
258. Montana Associates, L.L.C.
259. Monterey Park Leasehold Mortgage, L.L.C.
260. Mount Washington Property, L.L.C.
261. Mt. Vernon Texas, L.L.C.
262. Murray County, L.L.C.
263. Muscatine Toledo Properties, L.L.C.
264. N.M. Bloomfield Three Plus One Limited Company
265. N.M. Espanola Three Plus One Limited Company
266. N.M. Lordsburg Three Plus One Limited Company
267. N.M. Silver City Three Plus One Limited Company
268. New Hope Property, L.L.C.

 

[Schedule I - 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

269. Newtown ALF Property, L.L.C.
270. Nicholasville Kentucky Property, L.L.C.
271. North Las Vegas LLC
272. North Royalton Ohio Property, L.L.C.
273. Norwalk ALF Property, L.L.C.
274. NRS Ventures, L.L.C.
275. Oakland Nursing Homes, L.L.C.
276. Ocean Springs Nursing Home, LLC (f/k/a Ocean Springs Nursing Home, Inc.)
277. October Associates, L.L.C.
278. Ogden Associates, L.L.C.
279. OHI (Connecticut), LLC
280. OHI (Illinois), LLC(f/k/a OHI (Illinois), Inc.)
281. OHI (Indiana), LLC
282. OHI (Iowa), LLC(f/k/a OHI (Iowa), Inc.)
283. OHI Asset (AR) Ash Flat, LLC
284. OHI Asset (AR) Camden, LLC
285. OHI Asset (AR) Conway, LLC
286. OHI Asset (AR) Des Arc, LLC
287. OHI Asset (AR) Hot Springs, LLC
288. OHI Asset (AR) Malvern, LLC
289. OHI Asset (AR) Mena, LLC
290. OHI Asset (AR) Pocahontas, LLC
291. OHI Asset (AR) Sheridan, LLC
292. OHI Asset (AR) Walnut Ridge, LLC
293. OHI Asset (AZ) Austin House, LLC
294. OHI Asset (CA), LLC
295. OHI Asset (CO), LLC
296. OHI Asset (CO) Brighton, LLC
297. OHI Asset (CO) Denver, LLC
298. OHI Asset (CO) Mesa, LLC
299. OHI Asset (CT) Lender, LLC
300. OHI Asset (FL), LLC
301. OHI Asset (FL) Eustis, LLC
302. OHI Asset (FL) Graceville, LLC
303. OHI Asset (FL) Lake Placid, LLC
304. OHI Asset (FL) Lender, LLC
305. OHI Asset (FL) Lutz, LLC
306. OHI Asset (FL) Marianna, LLC
307. OHI Asset (FL) Middleburg, LLC
308. OHI Asset (FL) Pensacola - Hillview, LLC
309. OHI Asset (FL) Pensacola, LLC
310. OHI Asset (FL) Port St. Joe, LLC
311. OHI Asset (FL) Sebring, LLC
312. OHI Asset (GA) Cordele, LLC
313. OHI Asset (GA) Dunwoody, LLC

 

[Schedule I - 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

314. OHI Asset (GA) Macon, LLC
315. OHI Asset (GA) Moultrie, LLC
316. OHI Asset (GA) Nashville, LLC
317. OHI Asset (GA) Roswell, LLC
318. OHI Asset (GA) Snellville, LLC
319. OHI Asset (GA) Valdosta, LLC
320. OHI Asset (ID) Holly, LLC
321. OHI Asset (ID) Midland, LLC
322. OHI Asset (ID), LLC
323. OHI Asset (IL), LLC
324. OHI Asset (IN) American Village, LLC
325. OHI Asset (IN) Anderson, LLC
326. OHI Asset (IN) Beech Grove, LLC
327. OHI Asset (IN) Clarksville, LLC
328. OHI Asset (IN) Clinton, LLC
329. OHI Asset (IN) Connersville, LLC
330. OHI Asset (IN) Crown Point, LLC
331. OHI Asset (IN) Eagle Valley, LLC
332. OHI Asset (IN) Elkhart, LLC
333. OHI Asset (IN) Forest Creek, LLC
334. OHI Asset (IN) Fort Wayne, LLC
335. OHI Asset (IN) Franklin, LLC
336. OHI Asset (IN) Greensburg, LLC
337. OHI Asset (IN) Indianapolis, LLC
338. OHI Asset (IN) Jasper, LLC
339. OHI Asset (IN) Kokomo, LLC
340. OHI Asset (IN) Lafayette, LLC
341. OHI Asset (IN) Madison, LLC
342. OHI Asset (IN) Monticello, LLC
343. OHI Asset (IN) Noblesville, LLC
344. OHI Asset (IN) Rosewalk, LLC
345. OHI Asset (IN) Salem, LLC
346. OHI Asset (IN) Seymour, LLC
347. OHI Asset (IN) Spring Mill, LLC
348. OHI Asset (IN) Terre Haute, LLC
349. OHI Asset (IN) Wabash, LLC
350. OHI Asset (IN) Westfield, LLC
351. OHI Asset (IN) Zionsville, LLC
352. OHI Asset (KY) Beattyville, LLC
353. OHI Asset (KY) Louisville – 1120 Cristland, LLC
354. OHI Asset (KY) Louisville – 2529 Six Mile Lane, LLC
355. OHI Asset (KY) Morgantown, LLC
356. OHI Asset (KY) Owensboro, LLC
357. OHI Asset (LA) Baton Rouge, LLC
358. OHI Asset (LA), LLC
359. OHI Asset (MD), LLC

 

[Schedule I - 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

360. OHI Asset (MD) Baltimore - Pall Mall, LLC
361. OHI Asset (MD) Baltimore - West Belvedere, LLC
362. OHI Asset (MD) Salisbury, LLC
363. OHI Asset (MI) Heather Hills, LLC
364. OHI Asset (MI), LLC
365. OHI Asset (MI) Carson City, LLC
366. OHI Asset (MO), LLC
367. OHI Asset (MO) Jackson, LLC
368. OHI Asset (MS) Byhalia, LLC
369. OHI Asset (MS) Cleveland, LLC
370. OHI Asset (MS) Clinton, LLC
371. OHI Asset (MS) Columbia, LLC
372. OHI Asset (MS) Corinth, LLC
373. OHI Asset (MS) Greenwood, LLC
374. OHI Asset (MS) Grenada, LLC
375. OHI Asset (MS) Holly Springs, LLC
376. OHI Asset (MS) Indianola, LLC
377. OHI Asset (MS) Natchez, LLC
378. OHI Asset (MS) Picayune, LLC
379. OHI Asset (MS) Vicksburg, LLC
380. OHI Asset (MS) Yazoo City, LLC
381. OHI Asset (NC) Biscoe, LLC
382. OHI Asset (NC) Cornelius, LLC
383. OHI Asset (NC) Drexel, LLC
384. OHI Asset (NC) Fayetteville, LLC
385. OHI Asset (NC) Hallsboro, LLC
386. OHI Asset (NC) Marion, LLC
387. OHI Asset (NC) Marshville, LLC
388. OHI Asset (NC) Mocksville – 1007 Howard Street, LLC
389. OHI Asset (NC) Mocksville – 1304 Madison Road, LLC
390. OHI Asset (NC) Nashville, LLC
391. OHI Asset (NC) Raeford, LLC
392. OHI Asset (NC) Rocky Mount – 1558 S. Winstead, LLC
393. OHI Asset (NC) Rocky Mount – 415 N. Winstead, LLC
394. OHI Asset (NC) Salisbury, LLC
395. OHI Asset (NC) Saluda, LLC
396. OHI Asset (NC) Shallotte, LLC
397. OHI Asset (NC) Wadesboro, LLC
398. OHI Asset (NC) Waynesville, LLC
399. OHI Asset (NC) Wilmington, LLC
400. OHI Asset (NC) Winston Salem, LLC
401. OHI Asset (NY) 2nd Avenue, LLC
402. OHI Asset (NY) 93rd Street, LLC
403. OHI Asset (OH) Huber Heights, LLC
404. OHI Asset (OH) Lender, LLC
405. OHI Asset (OH), LLC

 

[Schedule I - 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

406. OHI Asset (OH) New London, LLC
407. OHI Asset (OR) Portland, LLC
408. OHI Asset (OH) Steubenville, LLC
409. OHI Asset (OH) Toledo, LLC
410. OHI Asset (OR) Troutdale, LLC
411. OHI Asset (OH) West Carrollton, LLC
412. OHI Asset (PA) GP, LLC
413. OHI Asset (PA) West Mifflin, LP
414. OHI Asset (PA), LLC
415. OHI Asset (PA), LP
416. OHI Asset (SC) Aiken, LLC
417. OHI Asset (SC) Anderson, LLC
418. OHI Asset (SC) Easley Anne, LLC
419. OHI Asset (SC) Easley Crestview, LLC
420. OHI Asset (SC) Edgefield, LLC
421. OHI Asset (SC) Five Forks, LLC
422. OHI Asset (SC) Greenville Cottages, LLC 
423. OHI Asset (SC) Greenville Griffith, LLC
424. OHI Asset (SC) Greenville Laurens, LLC
425. OHI Asset (SC) Greenville North, LLC
426. OHI Asset (SC) Greenville, LLC
427. OHI Asset (SC) Greer, LLC
428. OHI Asset (SC) Marietta, LLC
429. OHI Asset (SC) McCormick, LLC
430. OHI Asset (SC) Orangeburg, LLC
431. OHI Asset (SC) Pickens East Cedar, LLC
432. OHI Asset (SC) Pickens Rosemond, LLC
433. OHI Asset (SC) Piedmont, LLC
434. OHI Asset (SC) Simpsonville SE Main, LLC
435. OHI Asset (SC) Simpsonville West Broad, LLC
436. OHI Asset (SC) Simpsonville West Curtis, LLC
437. OHI Asset (TN) Bartlett, LLC
438. OHI Asset (TN) Cleveland, LLC
439. OHI Asset (TN) Collierville, LLC
440. OHI Asset (TN) Columbia, LLC
441. OHI Asset (TN) Elizabethton, LLC
442. OHI Asset (TN) Jamestown, LLC 
443. OHI Asset (TN) Jefferson City, LLC
444. OHI Asset (TN) Memphis, LLC
445. OHI Asset (TN) Memphis – 1150 Dovecrest, LLC
446. OHI Asset (TN) Monteagle, LLC
447. OHI Asset (TN) Monterey, LLC 
448. OHI Asset (TN) Mountain City, LLC
449. OHI Asset (TN) Nashville, LLC
450. OHI Asset (TN) Pigeon Forge, LLC
451. OHI Asset (TN) Rockwood, LLC

 

[Schedule I - 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

452. OHI Asset (TN) Rogersville, LLC
453. OHI Asset (TN) Rogersville – 109 Highway 70 North, LLC
454. OHI Asset (TN) South Pittsburg, LLC
455. OHI Asset (TN) Spring City, LLC
456. OHI Asset (TN) Westmoreland, LLC
457. OHI Asset (TX) Anderson, LLC
458. OHI Asset (TX) Athens, LLC
459. OHI Asset (TX) Bryan, LLC
460. OHI Asset (TX) Burleson, LLC
461. OHI Asset (TX) College Station, LLC
462. OHI Asset (TX) Comfort, LLC
463. OHI Asset (TX) Diboll, LLC
464. OHI Asset (TX) Granbury, LLC
465. OHI Asset (TX) Hondo, LLC
466. OHI Asset (TX) Italy, LLC
467. OHI Asset (TX) Longview, LLC
468. OHI Asset (TX) Schertz, LLC
469. OHI Asset (TX) Winnsboro, LLC
470. OHI Asset (TX) Winnsboro ALF, LLC
471. OHI Asset (TX), LLC
472. OHI Asset (UT) Ogden, LLC
473. OHI Asset (UT) Provo, LLC
474. OHI Asset (UT) Roy, LLC
475. OHI Asset (VA) Charlottesville - 1165 Pepsi Place, LLC
476. OHI Asset (VA) Charlottesville, LLC
477. OHI Asset (VA) Chesapeake, LLC
478. OHI Asset (VA) Farmville, LLC
479. OHI Asset (VA) Galax, LLC
480. OHI Asset (VA) Hillsville, LLC
481. OHI Asset (VA) Martinsville SNF, LLC
482. OHI Asset (VA) Madison, LLC
483. OHI Asset (VA) Mechanicsville, LLC
484. OHI Asset (VA) Midlothian, LLC
485. OHI Asset (VA) Norfolk, LLC
486. OHI Asset (VA) Portsmouth, LLC
487. OHI Asset (VA) Richmond - 2420 Pemberton Road, LLC
488. OHI Asset (VA) Richmond - 9101 Bon Air, LLC
489. OHI Asset (VA) Rocky Mount, LLC
490. OHI Asset (VA) Suffolk, LLC
491. OHI Asset (WA) Battle Ground, LLC
492. OHI Asset (WA) Fort Vancouver, LLC
493. OHI Asset (WV) Danville, LLC
494. OHI Asset (WV) Ivydale, LLC
495. OHI Asset CHG ALF, LLC
496. OHI Asset CSB LLC
497. OHI Asset CSE – E, LLC

 

[Schedule I - 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

498. OHI Asset CSE – U, LLC
499. OHI Asset CSE–E Subsidiary, LLC
500. OHI Asset CSE–U Subsidiary, LLC
501. OHI Asset HUD CFG, LLC
502. OHI Asset HUD Delta, LLC
503. OHI Asset HUD H-F, LLC
504. OHI Asset HUD SF CA, LLC
505. OHI Asset HUD SF, LLC
506. OHI Asset HUD WO, LLC
507. OHI Asset II (CA), LLC
508. OHI Asset II (FL), LLC
509. OHI Asset II (PA), LP
510. OHI Asset III (PA), LP
511. OHI Asset IV (PA) Silver Lake, LP
512. OHI Asset Management, LLC
513. OHI Asset RO PMM Services, LLC
514. OHI Asset RO, LLC
515. OHI Asset S-W, LLC
516. OHI Asset, LLC
517. OHI Healthcare Properties Holdco, Inc.
518. OHI Healthcare Properties Limited Partnership
519. OHI Mezz Lender, LLC
520. OHI Tennessee, LLC (f/k/a OHI Tennessee, Inc.)
521. OHIMA, LLC (f/k/a OHIMA, Inc.)
522. Ohio Aviv Three, L.L.C.
523. Ohio Aviv Two, L.L.C.
524. Ohio Aviv, L.L.C.
525. Ohio Indiana Property, L.L.C.
526. Ohio Pennsylvania Property, L.L.C.
527. Oklahoma Two Property, L.L.C.
528. Oklahoma Warr Wind, L.L.C.
529. Omaha Associates, L.L.C.
530. Omega TRS I, Inc.
531. Orange ALF Property, L.L.C.
532. Orange Village Care Center, LLC (f/k/a Orange Village Care Center, Inc.)
533. Orange, L.L.C.
534. Oregon Associates, L.L.C.
535. Oso Avenue Property, L.L.C.
536. Ostrom Avenue Property, L.L.C.
537. Palm Valley Senior Care, LLC
538. Panama City Nursing Center LLC
539. Pavillion North Partners, LLC
540. Pavillion North, LLP
541. Pavillion Nursing Center North, LLC
542. Peabody Associates Two, L.L.C.

 

[Schedule I - 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

543. Peabody Associates, L.L.C.
544. Pennington Road Property, L.L.C.
545. Pensacola Real Estate Holdings I, LLC (f/k/a Pensacola Real Estate Holdings I, Inc.)
546. Pensacola Real Estate Holdings II, LLC (f/k/a Pensacola Real Estate Holdings II, Inc.)
547. Pensacola Real Estate Holdings III, LLC (f/k/a Pensacola Real Estate Holdings III, Inc.)
548. Pensacola Real Estate Holdings IV, LLC (f/k/a Pensacola Real Estate Holdings IV, Inc.)
549. Pensacola Real Estate Holdings V, LLC (f/k/a Pensacola Real Estate Holdings V, Inc.)
550. Pocatello Idaho Property, L.L.C.
551. Pomona Vista L.L.C.
552. Prescott Arkansas, L.L.C.
553. PV Realty-Clinton, LLC
554. PV Realty-Kensington, LLC
555. PV Realty–Willow Tree, LLC
556. Raton Property Limited Company
557. Ravenna Ohio Property, L.L.C.
558. Red Rocks, L.L.C.
559. Richland Washington, L.L.C.
560. Ridgecrest Senior Care, LLC
561. Riverside Nursing Home Associates Two, L.L.C.
562. Riverside Nursing Home Associates, L.L.C.
563. Rockingham Drive Property, L.L.C.
564. Rose Baldwin Park Property L.L.C.
565. S.C. Portfolio Property, L.L.C.
566. Salem Associates, L.L.C.
567. San Juan NH Property, LLC
568. Sandalwood Arkansas Property, L.L.C.
569. Santa Ana-Bartlett, L.L.C.
570. Santa Fe Missouri Associates, L.L.C.
571. Savoy/Bonham Venture, L.L.C.
572. Searcy Aviv, L.L.C.
573. Sedgwick Properties, L.L.C.
574. Seguin Texas Property, L.L.C.
575. Sierra Ponds Property, L.L.C.
576. Skyler Boyington, LLC (f/k/a Skyler Boyington, Inc.)
577. Skyler Florida, LLC (f/k/a Skyler Florida, Inc.)
578. Skyler Maitland LLC
579. Skyler Pensacola, LLC (f/k/a Skyler Pensacola, Inc.)
580. Skyview Associates, L.L.C.
581. Southeast Missouri Property, L.L.C.
582. Southern California Nevada, L.L.C.
583. St. Joseph Missouri Property, L.L.C.

 

[Schedule I - 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

584. St. Mary’s Properties, LLC (f/k/a St. Mary’s Properties, Inc.)
585. Star City Arkansas, L.L.C.
586. Stephenville Texas Property, L.L.C.
587. Sterling Acquisition, LLC
588. Stevens Avenue Property, L.L.C.
589. Sun-Mesa Properties, L.L.C.
590. Suwanee, LLC
591. Texas Fifteen Property, L.L.C.
592. Texas Four Property, L.L.C.
593. Texas Lessor – Stonegate GP, LLC
594. Texas Lessor – Stonegate, Limited, LLC
595. Texas Lessor – Stonegate, LP
596. Texhoma Avenue Property, L.L.C.
597. The Suburban Pavilion, LLC (f/k/a The Suburban Pavilion, Inc.)
598. Tujunga, L.L.C.
599. Tulare County Property, L.L.C.
600. Twinsburg Ohio Property, LLC
601. VRB Aviv, L.L.C.
602. Washington Idaho Property, L.L.C.
603. Washington Lessor – Silverdale, LLC
604. Washington-Oregon Associates, L.L.C.
605. Watauga Associates, L.L.C.
606. Wellington Leasehold, L.L.C.
607. West Pearl Street, L.L.C.
608. West Yarmouth Property I, L.L.C.
609. Westerville Ohio Office Property, L.L.C.
610. Weston ALF Property, LLC
611. Wheeler Healthcare Associates, L.L.C.
612. Whitlock Street Property, L.L.C.
613. Wilcare, LLC
614. Willis Texas Aviv, L.L.C.
615. Yuba Aviv, L.L.C.

 

[Schedule I - 7th Supplemental Indenture – 2026 Notes]

 

 

 

 

Schedule II

 

NEW SUBSIDIARIES

 

1. OHI Asset (AZ) Tucson, LLC
2. OHI Asset (FL) DeFuniak Springs, LLC
3. OHI Asset (FL) Homestead, LLC
4. OHI Asset (FL) Ormond Beach, LLC
5. OHI Asset (TN) Byrdstown, LLC
6. OHI Asset (TN) Erin, LLC
7. OHI Asset (TN) Greeneville, LLC
8. OHI Asset (TN) Harriman, LLC
9. OHI Asset (TN) Ridgely, LLC
10. OHI Asset (VA) Martinsville ALF, LLC

 

[Schedule II – 7th Supplemental Indenture – 2026 Notes]

 

 

 

EX-4.4A 9 t1700448_ex4-4a.htm EXHIBIT 4.4A

 

 

Exhibit 4.4A

  

EIGHTH SUPPLEMENTAL INDENTURE

(5.250% Senior Notes due 2026)

 

THIS EIGHTH SUPPLEMENTAL INDENTURE (this “Eighth Supplemental Indenture”) is dated as of May 25, 2017 among OMEGA HEALTHCARE INVESTORS, INC., a Maryland corporation (the “Issuer”), each of the SUBSIDIARY GUARANTORS listed on Schedule I hereto (collectively, the “Subsidiary Guarantors”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, as trustee (the “Trustee”).

 

W I T N E S S E T H :

 

WHEREAS, the Issuer and the Subsidiary Guarantors have heretofore executed and delivered to the Trustee an Indenture, dated as of September 23, 2015 (as supplemented by that First Supplemental Indenture, dated as of November 9, 2015, that Second Supplemental Indenture, dated as of March 29, 2016, that Third Supplemental Indenture, dated as of May 13, 2016, that Fourth Supplemental Indenture, dated as of August 9, 2016, that Fifth Supplemental Indenture, dated as of November 10, 2016, that Sixth Supplemental Indenture, dated as of March 17, 2017 and that Seventh Supplemental Indenture, dated as of May 11, 2017; the “Indenture”) providing for the issuance of the Issuer’s 5.250% Senior Notes due 2026 (the “Notes”);

 

WHEREAS, in Section 1.01 of the Indenture, the term “Subsidiary Guarantors” is defined to include (i) each Subsidiary that is a guarantor of Indebtedness under the Existing Note Indentures on the Closing Date and (ii) each other Person that is required to become a Subsidiary Guarantor by the terms of the Indenture after the Closing Date, in each case, until such Person is released from its Subsidiary Guarantee;

 

WHEREAS, Section 10.04(4) of the Indenture provides that if a Subsidiary Guarantor ceases to guarantee the obligations of the Issuer under any Indebtedness of the Issuer that would constitute Indebtedness under clauses (1) or (2) of the definition thereof in the Indenture, in an amount at least equal to $50 million, such Subsidiary Guarantor shall be automatically and unconditionally released from its obligations under its Subsidiary Guarantee and its obligations under the Indenture;

 

WHEREAS, Section 10.04 of the Indenture further provides that upon any such occurrence, at the Issuer’s request and subject to the further requirements of said Section, the Trustee shall execute any documents reasonably requested by the Issuer evidencing such release;

 

WHEREAS, the Subsidiary Guarantors other than OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership (each, a “Released Subsidiary Guarantor” and collectively, the “Released Subsidiary Guarantors”) no longer guarantee the obligations of the Issuer under any Indebtedness of the Issuer described under clauses (1) or (2) of the definition of Indebtedness in the Indenture in an amount at least equal to $50 million and therefore are automatically and unconditionally released from their obligations under their respective Subsidiary Guarantees and under the Indenture;

 

[8th Supplemental Indenture – 2026 Notes]

 

 

 

 

WHEREAS, the Issuer and the Subsidiary Guarantors (including the Released Subsidiary Guarantors) have requested that the Trustee enter into this Eighth Supplemental Indenture and the Partial Release (as hereinafter defined) to further evidence such release of the Released Subsidiary Guarantors; and

 

WHEREAS, Section 9.01(a)(5) of the Indenture authorizes the Issuer, the Subsidiary Guarantors and the Trustee, together, to amend or supplement the Indenture, without notice to or consent of any Holder of the Notes, for the purpose of releasing any Subsidiary Guarantor from any of its obligations under its Subsidiary Guarantee or the Indenture to the extent permitted by the Indenture;

 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Issuer, the Subsidiary Guarantors (including the Released Subsidiary Guarantors) and the Trustee mutually covenant and agree as follows:

 

1.CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 

2.RELEASE OF RELEASED SUBSIDIARY GUARANTORS. Pursuant to Section 10.04 of the Indenture, each of the Released Subsidiary Guarantors is hereby released from its obligations under its Subsidiary Guarantees and under the Indenture. Such release shall be further evidenced by the Trustee’s execution and delivery of a Partial Release of Subsidiary Guarantors, the form of which is attached hereto as Exhibit A (the “Partial Release”). From and after the execution and delivery hereof, the term “Subsidiary Guarantor” as used in the Indenture, the Subsidiary Guarantees and the Notes shall exclude each of the Released Subsidiary Guarantors, unless and until such Person again becomes a Subsidiary Guarantor pursuant to the provisions of Section 4.09 of the Indenture. For avoidance of doubt, OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership remain Subsidiary Guarantors.

 

3.NEW YORK LAW TO GOVERN. The laws of the State of New York shall govern and be used to construe this Eighth Supplemental Indenture.

 

4.COUNTERPARTS. The parties may sign any number of copies of this Eighth Supplemental Indenture. Each signed copy shall be an original, but all of them together shall represent the same agreement.

 

5.EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

 

6.THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Eighth Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Issuer and the Subsidiary Guarantors (including the Released Subsidiary Guarantors).

 

[8th Supplemental Indenture – 2026 Notes]

 

 

 

 

[Remainder of Page Intentionally Left Blank]

 

[8th Supplemental Indenture – 2026 Notes]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Eighth Supplemental Indenture to be duly executed, all as of the date first above written.

 

ISSUER:
     
  OMEGA HEALTHCARE INVESTORS, INC.,
  a Maryland corporation
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
SUBSIDIARY GUARANTORS:
     
  OHI HEALTHCARE PROPERTIES HOLDCO, INC.
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
  OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP
     
  By: OHI Healthcare Properties Holdco, Inc., as primary General Partner
       
    By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page - 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

  ON BEHALF OF EACH OF THE OTHER SUBSIDIARY GUARANTORS LISTED ON SCHEDULE I
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page - 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

 

U.S. BANK NATIONAL ASSOCIATION,

as Trustee

   
  By: /s/ David Ferrell
    David Ferrell
    Vice President

 

[Signature Page - 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

Exhibit A

(Form of Partial Release of Subsidiary Guarantors)

 

[ATTACHED]

 

[Exhibit A – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

[FORM OF ]

PARTIAL RELEASE OF SUBSIDIARY GUARANTORS

 

([INDENTURE DESCRIPTION])

 

[DATE]

 

Reference is hereby made to that certain Indenture dated as of [DATE], among Omega Healthcare Investors, Inc., a Maryland corporation (the "Issuer"), the Subsidiary Guarantors named therein and U.S. Bank National Association, as trustee (the "Trustee"), as amended or supplemented by that [ADD SUPPLEMENTAL INDENTURES] (the "Indenture"). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Indenture.

 

Pursuant to the provisions of Section [REFERENCE] of the Indenture and the terms of that certain Second Supplemental Indenture, dated as of even date herewith, among the Issuer, the Subsidiary Guarantors and the Trustee, amending and supplementing the Indenture, each of the entities set forth on Schedule I attached hereto and incorporated herein by this reference is hereby released from its obligations under its Subsidiary Guarantees and under the Indenture. For avoidance of doubt, OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership remain Subsidiary Guarantors.

 

The validity and enforceability of this Partial Release of Subsidiary Guarantors shall not be affected by the fact that it is not affixed to any particular Subsidiary Guarantee or Note.

 

This Partial Release of Subsidiary Guarantors shall be governed by, and construed in accordance with, the laws of the State of New York.

 

[Remainder of Page Intentionally Left Blank]

 

[Exhibit A – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Partial Release of Subsidiary Guarantors to be duly executed as of the date first written above.

 

 

U.S. BANK NATIONAL ASSOCIATION,

as Trustee

     
  By:  
    [NAME]
    [TITLE][

 

[Exhibit A – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

Schedule I

 

SUBSIDIARY GUARANTORS

 

1. 11900 East Artesia Boulevard, LLC
2. 1200 Ely Street Holdings Co. LLC
3. 13922 Cerise Avenue, LLC
4. 1628 B Street, LLC
5. 2400 Parkside Drive, LLC
6. 2425 Teller Avenue, LLC
7. 245 East Wilshire Avenue, LLC
8. 3232 Artesia Real Estate, LLC
9. 3806 Clayton Road, LLC
10. 42235 County Road Holdings Co. LLC
11. 446 Sycamore Road, L.L.C.
12. 48 High Point Road, LLC
13. 523 Hayes Lane, LLC
14. 637 East Romie Lane, LLC
15. Alamogordo Aviv, L.L.C.
16. Albany Street Property, L.L.C.
17. Arizona Lessor - Infinia, LLC
18. Arkansas Aviv, L.L.C.
19. Arma Yates, L.L.C.
20. Avery Street Property, L.L.C
21. Aviv Asset Management, L.L.C.
22. Aviv Financing I, L.L.C.
23. Aviv Financing II, L.L.C.
24. Aviv Financing III, L.L.C.
25. Aviv Financing IV, L.L.C.
26. Aviv Financing V, L.L.C.
27. Aviv Foothills, L.L.C.
28. Aviv Healthcare Properties Operating Partnership I, L.P.
29. Aviv Liberty, L.L.C.
30. Avon Ohio, L.L.C.
31. Bala Cynwyd Real Estate, LP
32. Bayside Colorado Healthcare Associates, LLC
33. Bayside Street II, LLC
34. Bayside Street, LLC (f/k/a Bayside Street, Inc.)
35. Belleville Illinois, L.L.C.
36. Bellingham II Associates, L.L.C.
37. Bethel ALF Property, L.L.C.
38. BHG Aviv, L.L.C.
39. Biglerville Road, L.L.C.
40. Bonham Texas, L.L.C.
41. Bradenton ALF Property, L.L.C.
42. Burton NH Property, L.L.C.

 

[Schedule I – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

43. California Aviv Two, L.L.C.
44. California Aviv, L.L.C.
45. Camas Associates, L.L.C.
46. Canton Health Care Land, LLC (f/k/a Canton Health Care Land, Inc.)
47. Carnegie Gardens LLC
48. Casa/Sierra California Associates, L.L.C.
49. CFG 2115 Woodstock Place LLC
50. Champaign Williamson Franklin, L.L.C.
51. Chardon Ohio Property Holdings, L.L.C.
52. Chardon Ohio Property, L.L.C.
53. Chatham Aviv, L.L.C.
54. Chippewa Valley, L.L.C.
55. CHR Bartow LLC
56. CHR Boca Raton  LLC
57. CHR Bradenton LLC
58. CHR Cape Coral LLC
59. CHR Fort Myers LLC
60. CHR Fort Walton Beach LLC
61. CHR Lake Wales LLC
62. CHR Lakeland LLC
63. CHR Pompano Beach Broward LLC
64. CHR Pompano Beach LLC
65. CHR Sanford LLC
66. CHR Spring Hill LLC
67. CHR St. Pete Bay LLC
68. CHR St. Pete Egret LLC
69. CHR Tampa Carrollwood LLC
70. CHR Tampa LLC
71. CHR Tarpon Springs LLC
72. CHR Titusville LLC
73. Clarkston Care, L.L.C.
74. Clayton Associates, L.L.C.
75. Colonial Gardens, LLC
76. Colonial Madison Associates, L.L.C.
77. Colorado Lessor - Conifer, LLC
78. Columbus Texas Aviv, L.L.C.
79. Columbus Western Avenue, L.L.C.
80. Colville Washington Property, L.L.C.
81. Commerce Nursing Homes, L.L.C.
82. Commerce Sterling Hart Drive, L.L.C.
83. Conroe Rigby Owen Road, L.L.C.
84. CR Aviv, L.L.C.
85. Crete Plus Five Property, L.L.C.
86. Crooked River Road, L.L.C.
87. CSE Albany LLC
88. CSE Amarillo LLC

 

[Schedule I – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

89. CSE Arden L.P.
90. CSE Augusta LLC
91. CSE Bedford LLC
92. CSE Blountville LLC
93. CSE Bolivar LLC
94. CSE Cambridge LLC
95. CSE Cambridge Realty LLC
96. CSE Camden LLC
97. CSE Canton LLC
98. CSE Casablanca Holdings II LLC
99. CSE Casablanca Holdings LLC
100. CSE Cedar Rapids LLC
101. CSE Centennial Village, LP
102. CSE Chelmsford LLC
103. CSE Chesterton LLC
104. CSE Claremont LLC
105. CSE Corpus North LLC
106. CSE Denver Iliff LLC
107. CSE Denver LLC
108. CSE Douglas LLC
109. CSE Elkton LLC
110. CSE Elkton Realty LLC
111. CSE Fairhaven LLC
112. CSE Fort Wayne LLC
113. CSE Frankston LLC
114. CSE Georgetown LLC
115. CSE Green Bay LLC
116. CSE Hilliard LLC
117. CSE Huntingdon LLC
118. CSE Huntsville LLC
119. CSE Indianapolis-Continental LLC
120. CSE Indianapolis-Greenbriar LLC
121. CSE Jacinto City LLC
122. CSE Jefferson City LLC
123. CSE Jeffersonville-Hillcrest Center LLC
124. CSE Jeffersonville-Jennings House LLC
125. CSE Kerrville LLC
126. CSE King L.P.
127. CSE Kingsport LLC
128. CSE Knightdale L.P.
129. CSE Lake City LLC
130. CSE Lake Worth LLC
131. CSE Lakewood LLC
132. CSE Las Vegas LLC
133. CSE Lawrenceburg LLC
134. CSE Lenoir L.P.

 

[Schedule I – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

135. CSE Lexington Park LLC
136. CSE Lexington Park Realty LLC
137. CSE Ligonier LLC
138. CSE Live Oak LLC
139. CSE Lowell LLC
140. CSE Marianna Holdings LLC
141. CSE Memphis LLC
142. CSE Mobile LLC
143. CSE Moore LLC
144. CSE North Carolina Holdings I LLC
145. CSE North Carolina Holdings II LLC
146. CSE Omro LLC
147. CSE Orange Park LLC
148. CSE Orlando-Pinar Terrace Manor LLC
149. CSE Orlando-Terra Vista Rehab LLC
150. CSE Pennsylvania Holdings, LP
151. CSE Piggott LLC
152. CSE Pilot Point LLC
153. CSE Pine View LLC
154. CSE Ponca City LLC
155. CSE Port St. Lucie LLC
156. CSE Richmond LLC
157. CSE Ripley LLC
158. CSE Ripon LLC
159. CSE Safford LLC
160. CSE Salina LLC
161. CSE Seminole LLC
162. CSE Shawnee LLC
163. CSE Spring Branch LLC
164. CSE Stillwater LLC
165. CSE Taylorsville LLC
166. CSE Texarkana LLC
167. CSE Texas City LLC
168. CSE The Village LLC
169. CSE Upland LLC
170. CSE Walnut Cove L.P.
171. CSE West Point LLC
172. CSE Whitehouse LLC
173. CSE Williamsport LLC
174. CSE Winter Haven LLC
175. CSE Woodfin L.P.
176. CSE Yorktown LLC
177. Cuyahoga Falls Property II, L.L.C.
178. Cuyahoga Falls Property, L.L.C.
179. Dallas Two Property, L.L.C.
180. Danbury ALF Property, L.L.C.

 

[Schedule I – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

181. Darien ALF Property, L.L.C.
182. Delta Investors I, LLC
183. Delta Investors II, LLC
184. Denison Texas, L.L.C.
185. Desert Lane LLC
186. Dixie White House Nursing Home, LLC (f/k/a Dixie White House Nursing Home, Inc.)
187. Dixon Health Care Center, LLC (f/k/a Dixon Health Care Center, Inc.)
188. East Rollins Street, L.L.C.
189. Edgewood Drive Property, L.L.C.
190. Effingham Associates, L.L.C.
191. Elite Mattoon, L.L.C.
192. Elite Yorkville, L.L.C.
193. Encanto Senior Care, LLC
194. Falcon Four Property Holding, L.L.C.
195. Falcon Four Property, L.L.C.
196. Falfurrias Texas, L.L.C.
197. Florida ALF Properties, L.L.C.
198. Florida Four Properties, L.L.C.
199. Florida Lessor – Meadowview, LLC
200. Florida Real Estate Company, LLC
201. Fort Stockton Property, L.L.C.
202. Four Fountains Aviv, L.L.C.
203. Fredericksburg South Adams Street, L.L.C.
204. Freewater Oregon, L.L.C.
205. Fullerton California, L.L.C.
206. G&L Gardens, LLC
207. Gardnerville Property, L.L.C.
208. Georgia Lessor - Bonterra/Parkview, LLC
209. Germantown Property, L.L.C.
210. Giltex Care, L.L.C.
211. Glendale NH Property, L.L.C.
212. Golden Hill Real Estate Company, LLC
213. Gonzales Texas Property, L.L.C.
214. Great Bend Property, L.L.C.
215. Greenbough, LLC
216. Greenville Kentucky Property, L.L.C.
217. Heritage Monterey Associates, L.L.C.
218. HHM Aviv, L.L.C.
219. Hidden Acres Property, L.L.C.
220. Highland Leasehold, L.L.C.
221. Hobbs Associates, L.L.C.
222. Hot Springs Atrium Owner, LLC
223. Hot Springs Aviv, L.L.C.
224. Hot Springs Cottages Owner, LLC
225. Hot Springs Marina Owner, LLC

 

[Schedule I – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

226. Houston Texas Aviv, L.L.C.
227. Hutchinson Kansas, L.L.C.
228. Hutton I Land, LLC (f/k/a Hutton I Land, Inc.)
229. Hutton II Land, LLC (f/k/a Hutton II Land, Inc.)
230. Hutton III Land, LLC (f/k/a Hutton III Land, Inc.)
231. Idaho Associates, L.L.C.
232. Illinois Missouri Properties, L.L.C.
233. Indiana Lessor – Wellington Manor, LLC
234. Iowa Lincoln County Property, L.L.C.
235. Jasper Springhill Street, L.L.C.
236. Kansas Five Property, L.L.C.
237. Karan Associates Two, L.L.C.
238. Karan Associates, L.L.C.
239. Karissa Court Property, L.L.C.
240. KB Northwest Associates, L.L.C.
241. Kentucky NH Properties, L.L.C.
242. Kingsville Texas, L.L.C.
243. LAD I Real Estate Company, LLC
244. Leatherman 90-1, LLC (f/k/a Leatherman 90-1, Inc.)
245. Leatherman Partnership 89-1, LLC (f/k/a Leatherman Partnership 89-1, Inc.)
246. Leatherman Partnership 89-2, LLC (f/k/a Leatherman Partnership 89-2, Inc.)
247. Louisville Dutchmans Property, L.L.C.
248. Magnolia Drive Property, L.L.C.
249. Manor Associates, L.L.C.
250. Mansfield Aviv, L.L.C.
251. Massachusetts Nursing Homes, L.L.C.
252. McCarthy Street Property, L.L.C.
253. Meridian Arms Land, LLC (f/k/a Meridian Arms Land, Inc.)
254. Minnesota Associates, L.L.C.
255. Mishawaka Property, L.L.C.
256. Missouri Associates, L.L.C.
257. Missouri Regency Associates, L.L.C.
258. Montana Associates, L.L.C.
259. Monterey Park Leasehold Mortgage, L.L.C.
260. Mount Washington Property, L.L.C.
261. Mt. Vernon Texas, L.L.C.
262. Murray County, L.L.C.
263. Muscatine Toledo Properties, L.L.C.
264. N.M. Bloomfield Three Plus One Limited Company
265. N.M. Espanola Three Plus One Limited Company
266. N.M. Lordsburg Three Plus One Limited Company
267. N.M. Silver City Three Plus One Limited Company
268. New Hope Property, L.L.C.
269. Newtown ALF Property, L.L.C.

 

[Schedule I – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

270. Nicholasville Kentucky Property, L.L.C.
271. North Las Vegas LLC
272. North Royalton Ohio Property, L.L.C.
273. Norwalk ALF Property, L.L.C.
274. NRS Ventures, L.L.C.
275. Oakland Nursing Homes, L.L.C.
276. Ocean Springs Nursing Home, LLC (f/k/a Ocean Springs Nursing Home, Inc.)
277. October Associates, L.L.C.
278. Ogden Associates, L.L.C.
279. OHI (Connecticut), LLC
280. OHI (Illinois), LLC(f/k/a OHI (Illinois), Inc.)
281. OHI (Indiana), LLC
282. OHI (Iowa), LLC(f/k/a OHI (Iowa), Inc.)
283. OHI Asset (AR) Ash Flat, LLC
284. OHI Asset (AR) Camden, LLC
285. OHI Asset (AR) Conway, LLC
286. OHI Asset (AR) Des Arc, LLC
287. OHI Asset (AR) Hot Springs, LLC
288. OHI Asset (AR) Malvern, LLC
289. OHI Asset (AR) Mena, LLC
290. OHI Asset (AR) Pocahontas, LLC
291. OHI Asset (AR) Sheridan, LLC
292. OHI Asset (AR) Walnut Ridge, LLC
293. OHI Asset (AZ) Austin House, LLC
294. OHI Asset (AZ) Tucson, LLC
295. OHI Asset (CA), LLC
296. OHI Asset (CO) Brighton, LLC
297. OHI Asset (CO) Denver, LLC
298. OHI Asset (CO) Mesa, LLC
299. OHI Asset (CO), LLC
300. OHI Asset (CT) Lender, LLC
301. OHI Asset (FL) DeFuniak Springs, LLC
302. OHI Asset (FL) Eustis, LLC
303. OHI Asset (FL) Graceville, LLC
304. OHI Asset (FL) Homestead, LLC
305. OHI Asset (FL) Lake Placid, LLC
306. OHI Asset (FL) Lender, LLC
307. OHI Asset (FL) Lutz, LLC
308. OHI Asset (FL) Marianna, LLC
309. OHI Asset (FL) Middleburg, LLC
310. OHI Asset (FL) Ormond Beach, LLC
311. OHI Asset (FL) Pensacola - Hillview, LLC
312. OHI Asset (FL) Pensacola, LLC
313. OHI Asset (FL) Port St. Joe, LLC
314. OHI Asset (FL) Sebring, LLC

 

[Schedule I – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

315. OHI Asset (FL), LLC
316. OHI Asset (GA) Cordele, LLC
317. OHI Asset (GA) Dunwoody, LLC
318. OHI Asset (GA) Macon, LLC
319. OHI Asset (GA) Moultrie, LLC
320. OHI Asset (GA) Nashville, LLC
321. OHI Asset (GA) Roswell, LLC
322. OHI Asset (GA) Snellville, LLC
323. OHI Asset (GA) Valdosta, LLC
324. OHI Asset (ID) Holly, LLC
325. OHI Asset (ID) Midland, LLC
326. OHI Asset (ID), LLC
327. OHI Asset (IL), LLC
328. OHI Asset (IN) American Village, LLC
329. OHI Asset (IN) Anderson, LLC
330. OHI Asset (IN) Beech Grove, LLC
331. OHI Asset (IN) Clarksville, LLC
332. OHI Asset (IN) Clinton, LLC
333. OHI Asset (IN) Connersville, LLC
334. OHI Asset (IN) Crown Point, LLC
335. OHI Asset (IN) Eagle Valley, LLC
336. OHI Asset (IN) Elkhart, LLC
337. OHI Asset (IN) Forest Creek, LLC
338. OHI Asset (IN) Fort Wayne, LLC
339. OHI Asset (IN) Franklin, LLC
340. OHI Asset (IN) Greensburg, LLC
341. OHI Asset (IN) Indianapolis, LLC
342. OHI Asset (IN) Jasper, LLC
343. OHI Asset (IN) Kokomo, LLC
344. OHI Asset (IN) Lafayette, LLC
345. OHI Asset (IN) Madison, LLC
346. OHI Asset (IN) Monticello, LLC
347. OHI Asset (IN) Noblesville, LLC
348. OHI Asset (IN) Rosewalk, LLC
349. OHI Asset (IN) Salem, LLC
350. OHI Asset (IN) Seymour, LLC
351. OHI Asset (IN) Spring Mill, LLC
352. OHI Asset (IN) Terre Haute, LLC
353. OHI Asset (IN) Wabash, LLC
354. OHI Asset (IN) Westfield, LLC
355. OHI Asset (IN) Zionsville, LLC
356. OHI Asset (KY) Beattyville, LLC
357. OHI Asset (KY) Louisville – 1120 Cristland, LLC
358. OHI Asset (KY) Louisville – 2529 Six Mile Lane, LLC
359. OHI Asset (KY) Morgantown, LLC
360. OHI Asset (KY) Owensboro, LLC

 

[Schedule I – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

361. OHI Asset (LA) Baton Rouge, LLC
362. OHI Asset (LA), LLC
363. OHI Asset (MD) Baltimore - Pall Mall, LLC
364. OHI Asset (MD) Baltimore - West Belvedere, LLC
365. OHI Asset (MD) Salisbury, LLC
366. OHI Asset (MD), LLC
367. OHI Asset (MI) Carson City, LLC
368. OHI Asset (MI) Heather Hills, LLC
369. OHI Asset (MI), LLC
370. OHI Asset (MO) Jackson, LLC
371. OHI Asset (MO), LLC
372. OHI Asset (MS) Byhalia, LLC
373. OHI Asset (MS) Cleveland, LLC
374. OHI Asset (MS) Clinton, LLC
375. OHI Asset (MS) Columbia, LLC
376. OHI Asset (MS) Corinth, LLC
377. OHI Asset (MS) Greenwood, LLC
378. OHI Asset (MS) Grenada, LLC
379. OHI Asset (MS) Holly Springs, LLC
380. OHI Asset (MS) Indianola, LLC
381. OHI Asset (MS) Natchez, LLC
382. OHI Asset (MS) Picayune, LLC
383. OHI Asset (MS) Vicksburg, LLC
384. OHI Asset (MS) Yazoo City, LLC
385. OHI Asset (NC) Biscoe, LLC
386. OHI Asset (NC) Cornelius, LLC
387. OHI Asset (NC) Drexel, LLC
388. OHI Asset (NC) Fayetteville, LLC
389. OHI Asset (NC) Hallsboro, LLC
390. OHI Asset (NC) Marion, LLC
391. OHI Asset (NC) Marshville, LLC
392. OHI Asset (NC) Mocksville – 1007 Howard Street, LLC
393. OHI Asset (NC) Mocksville – 1304 Madison Road, LLC
394. OHI Asset (NC) Nashville, LLC
395. OHI Asset (NC) Raeford, LLC
396. OHI Asset (NC) Rocky Mount – 1558 S. Winstead, LLC
397. OHI Asset (NC) Rocky Mount – 415 N. Winstead, LLC
398. OHI Asset (NC) Salisbury, LLC
399. OHI Asset (NC) Saluda, LLC
400. OHI Asset (NC) Shallotte, LLC
401. OHI Asset (NC) Wadesboro, LLC
402. OHI Asset (NC) Waynesville, LLC
403. OHI Asset (NC) Wilmington, LLC
404. OHI Asset (NC) Winston Salem, LLC
405. OHI Asset (NY) 2nd Avenue, LLC
406. OHI Asset (NY) 93rd Street, LLC

 

[Schedule I – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

407. OHI Asset (OH) Huber Heights, LLC
408. OHI Asset (OH) Lender, LLC
409. OHI Asset (OH) New London, LLC
410. OHI Asset (OH) Steubenville, LLC
411. OHI Asset (OH) Toledo, LLC
412. OHI Asset (OH) West Carrollton, LLC
413. OHI Asset (OH), LLC
414. OHI Asset (OR) Portland, LLC
415. OHI Asset (OR) Troutdale, LLC
416. OHI Asset (PA) GP, LLC
417. OHI Asset (PA) West Mifflin, LP
418. OHI Asset (PA), LLC
419. OHI Asset (PA), LP
420. OHI Asset (SC) Aiken, LLC
421. OHI Asset (SC) Anderson, LLC
422. OHI Asset (SC) Easley Anne, LLC
423. OHI Asset (SC) Easley Crestview, LLC
424. OHI Asset (SC) Edgefield, LLC
425. OHI Asset (SC) Five Forks, LLC
426. OHI Asset (SC) Greenville Cottages, LLC 
427. OHI Asset (SC) Greenville Griffith, LLC
428. OHI Asset (SC) Greenville Laurens, LLC
429. OHI Asset (SC) Greenville North, LLC
430. OHI Asset (SC) Greenville, LLC
431. OHI Asset (SC) Greer, LLC
432. OHI Asset (SC) Marietta, LLC
433. OHI Asset (SC) McCormick, LLC
434. OHI Asset (SC) Orangeburg, LLC
435. OHI Asset (SC) Pickens East Cedar, LLC
436. OHI Asset (SC) Pickens Rosemond, LLC
437. OHI Asset (SC) Piedmont, LLC
438. OHI Asset (SC) Simpsonville SE Main, LLC
439. OHI Asset (SC) Simpsonville West Broad, LLC
440. OHI Asset (SC) Simpsonville West Curtis, LLC
441. OHI Asset (TN) Bartlett, LLC
442. OHI Asset (TN) Byrdstown, LLC
443. OHI Asset (TN) Cleveland, LLC
444. OHI Asset (TN) Collierville, LLC
445. OHI Asset (TN) Columbia, LLC
446. OHI Asset (TN) Elizabethton, LLC
447. OHI Asset (TN) Erin, LLC
448. OHI Asset (TN) Greeneville, LLC
449. OHI Asset (TN) Harriman, LLC
450. OHI Asset (TN) Jamestown, LLC 
451. OHI Asset (TN) Jefferson City, LLC
452. OHI Asset (TN) Memphis – 1150 Dovecrest, LLC

 

[Schedule I – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

453. OHI Asset (TN) Memphis, LLC
454. OHI Asset (TN) Monteagle, LLC
455. OHI Asset (TN) Monterey, LLC 
456. OHI Asset (TN) Mountain City, LLC
457. OHI Asset (TN) Nashville, LLC
458. OHI Asset (TN) Pigeon Forge, LLC
459. OHI Asset (TN) Ridgely, LLC
460. OHI Asset (TN) Rockwood, LLC
461. OHI Asset (TN) Rogersville – 109 Highway 70 North, LLC
462. OHI Asset (TN) Rogersville, LLC
463. OHI Asset (TN) South Pittsburg, LLC
464. OHI Asset (TN) Spring City, LLC
465. OHI Asset (TN) Westmoreland, LLC
466. OHI Asset (TX) Anderson, LLC
467. OHI Asset (TX) Athens, LLC
468. OHI Asset (TX) Bryan, LLC
469. OHI Asset (TX) Burleson, LLC
470. OHI Asset (TX) College Station, LLC
471. OHI Asset (TX) Comfort, LLC
472. OHI Asset (TX) Diboll, LLC
473. OHI Asset (TX) Granbury, LLC
474. OHI Asset (TX) Hondo, LLC
475. OHI Asset (TX) Italy, LLC
476. OHI Asset (TX) Longview, LLC
477. OHI Asset (TX) Schertz, LLC
478. OHI Asset (TX) Winnsboro ALF, LLC
479. OHI Asset (TX) Winnsboro, LLC
480. OHI Asset (TX), LLC
481. OHI Asset (UT) Ogden, LLC
482. OHI Asset (UT) Provo, LLC
483. OHI Asset (UT) Roy, LLC
484. OHI Asset (VA) Charlottesville - 1165 Pepsi Place, LLC
485. OHI Asset (VA) Charlottesville, LLC
486. OHI Asset (VA) Chesapeake, LLC
487. OHI Asset (VA) Farmville, LLC
488. OHI Asset (VA) Galax, LLC
489. OHI Asset (VA) Hillsville, LLC
490. OHI Asset (VA) Madison, LLC
491. OHI Asset (VA) Martinsville ALF, LLC
492. OHI Asset (VA) Martinsville SNF, LLC
493. OHI Asset (VA) Mechanicsville, LLC
494. OHI Asset (VA) Midlothian, LLC
495. OHI Asset (VA) Norfolk, LLC
496. OHI Asset (VA) Portsmouth, LLC
497. OHI Asset (VA) Richmond - 2420 Pemberton Road, LLC
498. OHI Asset (VA) Richmond - 9101 Bon Air, LLC

 

[Schedule I – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

499. OHI Asset (VA) Rocky Mount, LLC
500. OHI Asset (VA) Suffolk, LLC
501. OHI Asset (WA) Battle Ground, LLC
502. OHI Asset (WA) Fort Vancouver, LLC
503. OHI Asset (WV) Danville, LLC
504. OHI Asset (WV) Ivydale, LLC
505. OHI Asset CHG ALF, LLC
506. OHI Asset CSB LLC
507. OHI Asset CSE – E, LLC
508. OHI Asset CSE – U, LLC
509. OHI Asset CSE–E Subsidiary, LLC
510. OHI Asset CSE–U Subsidiary, LLC
511. OHI Asset HUD CFG, LLC
512. OHI Asset HUD Delta, LLC
513. OHI Asset HUD H-F, LLC
514. OHI Asset HUD SF CA, LLC
515. OHI Asset HUD SF, LLC
516. OHI Asset HUD WO, LLC
517. OHI Asset II (CA), LLC
518. OHI Asset II (FL), LLC
519. OHI Asset II (PA), LP
520. OHI Asset III (PA), LP
521. OHI Asset IV (PA) Silver Lake, LP
522. OHI Asset Management, LLC
523. OHI Asset RO PMM Services, LLC
524. OHI Asset RO, LLC
525. OHI Asset S-W, LLC
526. OHI Asset, LLC
527. OHI Healthcare Properties Holdco, Inc.
528. OHI Healthcare Properties Limited Partnership
529. OHI Mezz Lender, LLC
530. OHI Tennessee, LLC (f/k/a OHI Tennessee, Inc.)
531. OHIMA, LLC (f/k/a OHIMA, Inc.)
532. Ohio Aviv Three, L.L.C.
533. Ohio Aviv Two, L.L.C.
534. Ohio Aviv, L.L.C.
535. Ohio Indiana Property, L.L.C.
536. Ohio Pennsylvania Property, L.L.C.
537. Oklahoma Two Property, L.L.C.
538. Oklahoma Warr Wind, L.L.C.
539. Omaha Associates, L.L.C.
540. Omega TRS I, Inc.
541. Orange ALF Property, L.L.C.
542. Orange Village Care Center, LLC (f/k/a Orange Village Care Center, Inc.)
543. Orange, L.L.C.

 

[Schedule I – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

544. Oregon Associates, L.L.C.
545. Oso Avenue Property, L.L.C.
546. Ostrom Avenue Property, L.L.C.
547. Palm Valley Senior Care, LLC
548. Panama City Nursing Center LLC
549. Pavillion North Partners, LLC
550. Pavillion North, LLP
551. Pavillion Nursing Center North, LLC
552. Peabody Associates Two, L.L.C.
553. Peabody Associates, L.L.C.
554. Pennington Road Property, L.L.C.
555. Pensacola Real Estate Holdings I, LLC (f/k/a Pensacola Real Estate Holdings I, Inc.)
556. Pensacola Real Estate Holdings II, LLC (f/k/a Pensacola Real Estate Holdings II, Inc.)
557. Pensacola Real Estate Holdings III, LLC (f/k/a Pensacola Real Estate Holdings III, Inc.)
558. Pensacola Real Estate Holdings IV, LLC (f/k/a Pensacola Real Estate Holdings IV, Inc.)
559. Pensacola Real Estate Holdings V, LLC (f/k/a Pensacola Real Estate Holdings V, Inc.)
560. Pocatello Idaho Property, L.L.C.
561. Pomona Vista L.L.C.
562. Prescott Arkansas, L.L.C.
563. PV Realty-Clinton, LLC
564. PV Realty-Kensington, LLC
565. PV Realty–Willow Tree, LLC
566. Raton Property Limited Company
567. Ravenna Ohio Property, L.L.C.
568. Red Rocks, L.L.C.
569. Richland Washington, L.L.C.
570. Ridgecrest Senior Care, LLC
571. Riverside Nursing Home Associates Two, L.L.C.
572. Riverside Nursing Home Associates, L.L.C.
573. Rockingham Drive Property, L.L.C.
574. Rose Baldwin Park Property L.L.C.
575. S.C. Portfolio Property, L.L.C.
576. Salem Associates, L.L.C.
577. San Juan NH Property, LLC
578. Sandalwood Arkansas Property, L.L.C.
579. Santa Ana-Bartlett, L.L.C.
580. Santa Fe Missouri Associates, L.L.C.
581. Savoy/Bonham Venture, L.L.C.
582. Searcy Aviv, L.L.C.
583. Sedgwick Properties, L.L.C.
584. Seguin Texas Property, L.L.C.

 

[Schedule I – 8th Supplemental Indenture – 2026 Notes]

 

 

 

 

585. Sierra Ponds Property, L.L.C.
586. Skyler Boyington, LLC (f/k/a Skyler Boyington, Inc.)
587. Skyler Florida, LLC (f/k/a Skyler Florida, Inc.)
588. Skyler Maitland LLC
589. Skyler Pensacola, LLC (f/k/a Skyler Pensacola, Inc.)
590. Skyview Associates, L.L.C.
591. Southeast Missouri Property, L.L.C.
592. Southern California Nevada, L.L.C.
593. St. Joseph Missouri Property, L.L.C.
594. St. Mary’s Properties, LLC (f/k/a St. Mary’s Properties, Inc.)
595. Star City Arkansas, L.L.C.
596. Stephenville Texas Property, L.L.C.
597. Sterling Acquisition, LLC
598. Stevens Avenue Property, L.L.C.
599. Sun-Mesa Properties, L.L.C.
600. Suwanee, LLC
601. Texas Fifteen Property, L.L.C.
602. Texas Four Property, L.L.C.
603. Texas Lessor – Stonegate GP, LLC
604. Texas Lessor – Stonegate, Limited, LLC
605. Texas Lessor – Stonegate, LP
606. Texhoma Avenue Property, L.L.C.
607. The Suburban Pavilion, LLC (f/k/a The Suburban Pavilion, Inc.)
608. Tujunga, L.L.C.
609. Tulare County Property, L.L.C.
610. Twinsburg Ohio Property, LLC
611. VRB Aviv, L.L.C.
612. Washington Idaho Property, L.L.C.
613. Washington Lessor – Silverdale, LLC
614. Washington-Oregon Associates, L.L.C.
615. Watauga Associates, L.L.C.
616. Wellington Leasehold, L.L.C.
617. West Pearl Street, L.L.C.
618. West Yarmouth Property I, L.L.C.
619. Westerville Ohio Office Property, L.L.C.
620. Weston ALF Property, LLC
621. Wheeler Healthcare Associates, L.L.C.
622. Whitlock Street Property, L.L.C.
623. Wilcare, LLC
624. Willis Texas Aviv, L.L.C.
625. Yuba Aviv, L.L.C.

 

[Schedule I – 8th Supplemental Indenture – 2026 Notes]

 

 

 

EX-4.5 10 t1700448_ex4-5.htm EXHIBIT 4.5

 

 

Exhibit 4.5

 

FOURTH SUPPLEMENTAL INDENTURE

(Senior Notes due 2023)

 

THIS FOURTH SUPPLEMENTAL INDENTURE (this “Fourth Supplemental Indenture”) is dated as of May 11, 2017, among OMEGA HEALTHCARE INVESTORS, INC., a Maryland corporation (the “Issuer”), each of the entities listed on Schedule II hereto (collectively, the “New Subsidiaries”) and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, as trustee (the “Trustee”).

 

W I T N E S S E T H :

 

WHEREAS, the Issuer and each of its direct and indirect subsidiaries listed on Schedule I hereto (collectively, the “Subsidiary Guarantors”) have heretofore executed and delivered to the Trustee an Indenture, dated as of July 12, 2016 (as supplemented by that First Supplemental Indenture, dated as of August 9, 2016, that Second Supplemental Indenture, dated as of November 10, 2016, and that Third Supplemental Indenture, dated as of March 17, 2017; the “Indenture”) providing for the issuance of the Issuer’s 4.375 % Senior Notes due 2023 (the “Notes”);

 

WHEREAS, Section 9.01(a)(4) of the Indenture authorizes the Issuer and the Trustee, together, to amend or supplement the Indenture, without notice to or consent of any Holder of the Notes and without the execution of such amendment or supplement by existing Subsidiary Guarantors, for the purpose of adding any additional Subsidiary Guarantee by any additional Guarantor;

 

WHEREAS, pursuant to Section 4.09 of the Indenture, the New Subsidiaries are required to become Subsidiary Guarantors;

 

WHEREAS, in Section 1.01 of the Indenture, the term “Subsidiary Guarantors” is defined to include all Persons that become a Subsidiary Guarantor by the terms of the Indenture after the Closing Date; and

 

WHEREAS, Section 10.01 of the Indenture provides that each Subsidiary Guarantor shall be a guarantor of the Issuer’s obligations under the Notes, subject to the terms and conditions described in the Indenture.

 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Issuer, the New Subsidiaries and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:

 

1.CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 

[4th Supplemental Indenture – 2023 Notes]

 

 

 

 

2.AMENDMENT TO GUARANTEE. The New Subsidiaries hereby agree, jointly and severally with all other Subsidiary Guarantors, to guarantee the Issuer’s obligations under the Notes on the terms and subject to the conditions set forth in the Indenture, and to be bound by, and to receive the benefit of, all other applicable provisions of the Indenture as Subsidiary Guarantors. Such guarantee shall be evidenced by the New Subsidiaries’ execution of Subsidiary Guarantees, the form of which is attached as Exhibit C to the Indenture, and shall be effective as of the date hereof.

 

3.NO RECOURSE AGAINST OTHERS. No past, present or future director, officer, employee, incorporator, stockholder, member, manager or controlling person of the New Subsidiaries, as such, shall have any liability for any obligations of the Issuer or any Subsidiary Guarantor under the Notes, any Guarantees, the Indenture or this Fourth Supplemental Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder of the Notes, by accepting and holding a Note, waives and releases all such liability. Such waiver and release are part of the consideration for the issuance of the Notes.

 

4.NEW YORK LAW TO GOVERN. The laws of the State of New York shall govern and be used to construe this Fourth Supplemental Indenture.

 

5.COUNTERPARTS. The parties may sign any number of copies of this Fourth Supplemental Indenture. Each signed copy shall be an original, but all of them together shall represent the same agreement.

 

6.EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

 

7.THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Fourth Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Issuer and the New Subsidiaries.

 

[Remainder of Page Intentionally Left Blank]

 

[4th Supplemental Indenture – 2023 Notes]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Fourth Supplemental Indenture to be duly executed, all as of the date first above written.

 

ISSUER:
   
  OMEGA HEALTHCARE INVESTORS, INC.,
  a Maryland corporation
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
NEW SUBSIDIARIES:
   
  ON BEHALF OF EACH OF THE NEW SUBSIDIARIES LISTED ON SCHEDULE II
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

  U.S. BANK NATIONAL ASSOCIATION,
  as Trustee
     
  By: /s/ David Ferrell
    Name: David Ferrell
    Title: Vice President

 

[Signature Page – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

Schedule I

 

SUBSIDIARY GUARANTORS

 

1. 11900 East Artesia Boulevard, LLC
2. 1200 Ely Street Holdings Co. LLC
3. 13922 Cerise Avenue, LLC
4. 1628 B Street, LLC
5. 2400 Parkside Drive, LLC
6. 2425 Teller Avenue, LLC
7. 245 East Wilshire Avenue, LLC
8. 3232 Artesia Real Estate, LLC
9. 3806 Clayton Road, LLC
10. 42235 County Road Holdings Co. LLC
11. 446 Sycamore Road, L.L.C.
12. 48 High Point Road, LLC
13. 523 Hayes Lane, LLC
14. 637 East Romie Lane, LLC
15. Alamogordo Aviv, L.L.C.
16. Albany Street Property, L.L.C.
17. Arizona Lessor - Infinia, LLC
18. Arkansas Aviv, L.L.C.
19. Arma Yates, L.L.C.
20. Avery Street Property, L.L.C
21. Aviv Asset Management, L.L.C.
22. Aviv Financing I, L.L.C.
23. Aviv Financing II, L.L.C.
24. Aviv Financing III, L.L.C.
25. Aviv Financing IV, L.L.C.
26. Aviv Financing V, L.L.C.
27. Aviv Foothills, L.L.C.
28. Aviv Healthcare Properties Operating Partnership I, L.P.
29. Aviv Liberty, L.L.C.
30. Avon Ohio, L.L.C.
31. Bala Cynwyd Real Estate, LP
32. Bayside Colorado Healthcare Associates, LLC
33. Bayside Street II, LLC
34. Bayside Street, LLC (f/k/a Bayside Street, Inc.)
35. Belleville Illinois, L.L.C.
36. Bellingham II Associates, L.L.C.
37. Bethel ALF Property, L.L.C.
38. BHG Aviv, L.L.C.
39. Biglerville Road, L.L.C.
40. Bonham Texas, L.L.C.
41. Bradenton ALF Property, L.L.C.
42. Burton NH Property, L.L.C.

 

[Schedule I – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

43. California Aviv Two, L.L.C.
44. California Aviv, L.L.C.
45. Camas Associates, L.L.C.
46. Canton Health Care Land, LLC (f/k/a Canton Health Care Land, Inc.)
47. Carnegie Gardens LLC
48. Casa/Sierra California Associates, L.L.C.
49. CFG 2115 Woodstock Place LLC
50. Champaign Williamson Franklin, L.L.C.
51. Chardon Ohio Property Holdings, L.L.C.
52. Chardon Ohio Property, L.L.C.
53. Chatham Aviv, L.L.C.
54. Chippewa Valley, L.L.C.
55. CHR Bartow LLC
56. CHR Boca Raton LLC
57. CHR Bradenton LLC
58. CHR Cape Coral LLC
59. CHR Fort Myers LLC
60. CHR Fort Walton Beach LLC
61. CHR Lake Wales LLC
62. CHR Lakeland LLC
63. CHR Pompano Beach Broward LLC
64. CHR Pompano Beach LLC
65. CHR Sanford LLC
66. CHR Spring Hill LLC
67. CHR St. Pete Bay LLC
68. CHR St. Pete Egret LLC
69. CHR Tampa Carrollwood LLC
70. CHR Tampa LLC
71. CHR Tarpon Springs LLC
72. CHR Titusville LLC
73. Clarkston Care, L.L.C.
74. Clayton Associates, L.L.C.
75. Colonial Gardens, LLC
76. Colonial Madison Associates, L.L.C.
77. Colorado Lessor - Conifer, LLC
78. Columbus Texas Aviv, L.L.C.
79. Columbus Western Avenue, L.L.C.
80. Colville Washington Property, L.L.C.
81. Commerce Nursing Homes, L.L.C.
82. Commerce Sterling Hart Drive, L.L.C.
83. Conroe Rigby Owen Road, L.L.C.
84. CR Aviv, L.L.C.
85. Crete Plus Five Property, L.L.C.
86. Crooked River Road, L.L.C.
87. CSE Albany LLC
88. CSE Amarillo LLC

 

[Schedule I – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

89. CSE Arden L.P.
90. CSE Augusta LLC
91. CSE Bedford LLC
92. CSE Blountville LLC
93. CSE Bolivar LLC
94. CSE Cambridge LLC
95. CSE Cambridge Realty LLC
96. CSE Camden LLC
97. CSE Canton LLC
98. CSE Casablanca Holdings II LLC
99. CSE Casablanca Holdings LLC
100. CSE Cedar Rapids LLC
101. CSE Centennial Village, LP
102. CSE Chelmsford LLC
103. CSE Chesterton LLC
104. CSE Claremont LLC
105. CSE Corpus North LLC
106. CSE Denver Iliff LLC
107. CSE Denver LLC
108. CSE Douglas LLC
109. CSE Elkton LLC
110. CSE Elkton Realty LLC
111. CSE Fairhaven LLC
112. CSE Fort Wayne LLC
113. CSE Frankston LLC
114. CSE Georgetown LLC
115. CSE Green Bay LLC
116. CSE Hilliard LLC
117. CSE Huntingdon LLC
118. CSE Huntsville LLC
119. CSE Indianapolis-Continental LLC
120. CSE Indianapolis-Greenbriar LLC
121. CSE Jacinto City LLC
122. CSE Jefferson City LLC
123. CSE Jeffersonville-Hillcrest Center LLC
124. CSE Jeffersonville-Jennings House LLC
125. CSE Kerrville LLC
126. CSE King L.P.
127. CSE Kingsport LLC
128. CSE Knightdale L.P.
129. CSE Lake City LLC
130. CSE Lake Worth LLC
131. CSE Lakewood LLC
132. CSE Las Vegas LLC
133. CSE Lawrenceburg LLC
134. CSE Lenoir L.P.

 

[Schedule I – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

135. CSE Lexington Park LLC
136. CSE Lexington Park Realty LLC
137. CSE Ligonier LLC
138. CSE Live Oak LLC
139. CSE Lowell LLC
140. CSE Marianna Holdings LLC
141. CSE Memphis LLC
142. CSE Mobile LLC
143. CSE Moore LLC
144. CSE North Carolina Holdings I LLC
145. CSE North Carolina Holdings II LLC
146. CSE Omro LLC
147. CSE Orange Park LLC
148. CSE Orlando-Pinar Terrace Manor LLC
149. CSE Orlando-Terra Vista Rehab LLC
150. CSE Pennsylvania Holdings, LP
151. CSE Piggott LLC
152. CSE Pilot Point LLC
153. CSE Pine View LLC
154. CSE Ponca City LLC
155. CSE Port St. Lucie LLC
156. CSE Richmond LLC
157. CSE Ripley LLC
158. CSE Ripon LLC
159. CSE Safford LLC
160. CSE Salina LLC
161. CSE Seminole LLC
162. CSE Shawnee LLC
163. CSE Spring Branch LLC
164. CSE Stillwater LLC
165. CSE Taylorsville LLC
166. CSE Texarkana LLC
167. CSE Texas City LLC
168. CSE The Village LLC
169. CSE Upland LLC
170. CSE Walnut Cove L.P.
171. CSE West Point LLC
172. CSE Whitehouse LLC
173. CSE Williamsport LLC
174. CSE Winter Haven LLC
175. CSE Woodfin L.P.
176. CSE Yorktown LLC
177. Cuyahoga Falls Property, L.L.C.
178. Cuyahoga Falls Property II, L.L.C.
179. Dallas Two Property, L.L.C.
180. Danbury ALF Property, L.L.C.

 

[Schedule I – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

181. Darien ALF Property, L.L.C.
182. Delta Investors I, LLC
183. Delta Investors II, LLC
184. Denison Texas, L.L.C.
185. Desert Lane LLC
186. Dixie White House Nursing Home, LLC (f/k/a Dixie White House Nursing Home, Inc.)
187. Dixon Health Care Center, LLC (f/k/a Dixon Health Care Center, Inc.)
188. East Rollins Street, L.L.C.
189. Edgewood Drive Property, L.L.C.
190. Effingham Associates, L.L.C.
191. Elite Mattoon, L.L.C.
192. Elite Yorkville, L.L.C.
193. Encanto Senior Care, LLC
194. Falcon Four Property Holding, L.L.C.
195. Falcon Four Property, L.L.C.
196. Falfurrias Texas, L.L.C.
197. Florida ALF Properties, L.L.C.
198. Florida Four Properties, L.L.C.
199. Florida Lessor – Meadowview, LLC
200. Florida Real Estate Company, LLC
201. Fort Stockton Property, L.L.C.
202. Four Fountains Aviv, L.L.C.
203. Fredericksburg South Adams Street, L.L.C.
204. Freewater Oregon, L.L.C.
205. Fullerton California, L.L.C.
206. G&L Gardens, LLC
207. Gardnerville Property, L.L.C.
208. Georgia Lessor - Bonterra/Parkview, LLC
209. Germantown Property, L.L.C.
210. Giltex Care, L.L.C.
211. Glendale NH Property, L.L.C.
212. Golden Hill Real Estate Company, LLC
213. Gonzales Texas Property, L.L.C.
214. Great Bend Property, L.L.C.
215. Greenbough, LLC
216. Greenville Kentucky Property, L.L.C.
217. Heritage Monterey Associates, L.L.C.
218. HHM Aviv, L.L.C.
219. Hidden Acres Property, L.L.C.
220. Highland Leasehold, L.L.C.
221. Hobbs Associates, L.L.C.
222. Hot Springs Atrium Owner, LLC
223. Hot Springs Aviv, L.L.C.
224. Hot Springs Cottages Owner, LLC
225. Hot Springs Marina Owner, LLC

 

[Schedule I – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

226. Houston Texas Aviv, L.L.C.
227. Hutchinson Kansas, L.L.C.
228. Hutton I Land, LLC (f/k/a Hutton I Land, Inc.)
229. Hutton II Land, LLC (f/k/a Hutton II Land, Inc.)
230. Hutton III Land, LLC (f/k/a Hutton III Land, Inc.)
231. Idaho Associates, L.L.C.
232. Illinois Missouri Properties, L.L.C.
233. Indiana Lessor – Wellington Manor, LLC
234. Iowa Lincoln County Property, L.L.C.
235. Jasper Springhill Street, L.L.C.
236. Kansas Five Property, L.L.C.
237. Karan Associates Two, L.L.C.
238. Karan Associates, L.L.C.
239. Karissa Court Property, L.L.C.
240. KB Northwest Associates, L.L.C.
241. Kentucky NH Properties, L.L.C.
242. Kingsville Texas, L.L.C.
243. LAD I Real Estate Company, LLC
244. Leatherman 90-1, LLC (f/k/a Leatherman 90-1, Inc.)
245. Leatherman Partnership 89-1, LLC (f/k/a Leatherman Partnership 89-1, Inc.)
246. Leatherman Partnership 89-2, LLC (f/k/a Leatherman Partnership 89-2, Inc.)
247. Louisville Dutchmans Property, L.L.C.
248. Magnolia Drive Property, L.L.C.
249. Manor Associates, L.L.C.
250. Mansfield Aviv, L.L.C.
251. Massachusetts Nursing Homes, L.L.C.
252. McCarthy Street Property, L.L.C.
253. Meridian Arms Land, LLC (f/k/a Meridian Arms Land, Inc.)
254. Minnesota Associates, L.L.C.
255. Mishawaka Property, L.L.C.
256. Missouri Associates, L.L.C.
257. Missouri Regency Associates, L.L.C.
258. Montana Associates, L.L.C.
259. Monterey Park Leasehold Mortgage, L.L.C.
260. Mount Washington Property, L.L.C.
261. Mt. Vernon Texas, L.L.C.
262. Murray County, L.L.C.
263. Muscatine Toledo Properties, L.L.C.
264. N.M. Bloomfield Three Plus One Limited Company
265. N.M. Espanola Three Plus One Limited Company
266. N.M. Lordsburg Three Plus One Limited Company
267. N.M. Silver City Three Plus One Limited Company
268. New Hope Property, L.L.C.
269. Newtown ALF Property, L.L.C.

 

[Schedule I – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

270. Nicholasville Kentucky Property, L.L.C.
271. North Las Vegas LLC
272. North Royalton Ohio Property, L.L.C.
273. Norwalk ALF Property, L.L.C.
274. NRS Ventures, L.L.C.
275. Oakland Nursing Homes, L.L.C.
276. Ocean Springs Nursing Home, LLC (f/k/a Ocean Springs Nursing Home, Inc.)
277. October Associates, L.L.C.
278. Ogden Associates, L.L.C.
279. OHI (Connecticut), LLC
280. OHI (Illinois), LLC(f/k/a OHI (Illinois), Inc.)
281. OHI (Indiana), LLC
282. OHI (Iowa), LLC(f/k/a OHI (Iowa), Inc.)
283. OHI Asset (AR) Ash Flat, LLC
284. OHI Asset (AR) Camden, LLC
285. OHI Asset (AR) Conway, LLC
286. OHI Asset (AR) Des Arc, LLC
287. OHI Asset (AR) Hot Springs, LLC
288. OHI Asset (AR) Malvern, LLC
289. OHI Asset (AR) Mena, LLC
290. OHI Asset (AR) Pocahontas, LLC
291. OHI Asset (AR) Sheridan, LLC
292. OHI Asset (AR) Walnut Ridge, LLC
293. OHI Asset (AZ) Austin House, LLC
294. OHI Asset (CA), LLC
295. OHI Asset (CO), LLC
296. OHI Asset (CO) Brighton, LLC
297. OHI Asset (CO) Denver, LLC
298. OHI Asset (CO) Mesa, LLC
299. OHI Asset (CT) Lender, LLC
300. OHI Asset (FL), LLC
301. OHI Asset (FL) Eustis, LLC
302. OHI Asset (FL) Graceville, LLC
303. OHI Asset (FL) Lake Placid, LLC
304. OHI Asset (FL) Lender, LLC
305. OHI Asset (FL) Lutz, LLC
306. OHI Asset (FL) Marianna, LLC
307. OHI Asset (FL) Middleburg, LLC
308. OHI Asset (FL) Pensacola - Hillview, LLC
309. OHI Asset (FL) Pensacola, LLC
310. OHI Asset (FL) Port St. Joe, LLC
311. OHI Asset (FL) Sebring, LLC
312. OHI Asset (GA) Cordele, LLC
313. OHI Asset (GA) Dunwoody, LLC
314. OHI Asset (GA) Macon, LLC

 

[Schedule I – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

315. OHI Asset (GA) Moultrie, LLC
316. OHI Asset (GA) Nashville, LLC
317. OHI Asset (GA) Roswell, LLC
318. OHI Asset (GA) Snellville, LLC
319. OHI Asset (GA) Valdosta, LLC
320. OHI Asset (ID) Holly, LLC
321. OHI Asset (ID) Midland, LLC
322. OHI Asset (ID), LLC
323. OHI Asset (IL), LLC
324. OHI Asset (IN) American Village, LLC
325. OHI Asset (IN) Anderson, LLC
326. OHI Asset (IN) Beech Grove, LLC
327. OHI Asset (IN) Clarksville, LLC
328. OHI Asset (IN) Clinton, LLC
329. OHI Asset (IN) Connersville, LLC
330. OHI Asset (IN) Crown Point, LLC
331. OHI Asset (IN) Eagle Valley, LLC
332. OHI Asset (IN) Elkhart, LLC
333. OHI Asset (IN) Forest Creek, LLC
334. OHI Asset (IN) Fort Wayne, LLC
335. OHI Asset (IN) Franklin, LLC
336. OHI Asset (IN) Greensburg, LLC
337. OHI Asset (IN) Indianapolis, LLC
338. OHI Asset (IN) Jasper, LLC
339. OHI Asset (IN) Kokomo, LLC
340. OHI Asset (IN) Lafayette, LLC
341. OHI Asset (IN) Madison, LLC
342. OHI Asset (IN) Monticello, LLC
343. OHI Asset (IN) Noblesville, LLC
344. OHI Asset (IN) Rosewalk, LLC
345. OHI Asset (IN) Salem, LLC
346. OHI Asset (IN) Seymour, LLC
347. OHI Asset (IN) Spring Mill, LLC
348. OHI Asset (IN) Terre Haute, LLC
349. OHI Asset (IN) Wabash, LLC
350. OHI Asset (IN) Westfield, LLC
351. OHI Asset (IN) Zionsville, LLC
352. OHI Asset (KY) Beattyville, LLC
353. OHI Asset (KY) Louisville – 1120 Cristland, LLC
354. OHI Asset (KY) Louisville – 2529 Six Mile Lane, LLC
355. OHI Asset (KY) Morgantown, LLC
356. OHI Asset (KY) Owensboro, LLC
357. OHI Asset (LA) Baton Rouge, LLC
358. OHI Asset (LA), LLC
359. OHI Asset (MD), LLC
360. OHI Asset (MD) Baltimore - Pall Mall, LLC

 

[Schedule I – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

361. OHI Asset (MD) Baltimore - West Belvedere, LLC
362. OHI Asset (MD) Salisbury, LLC
363. OHI Asset (MI) Heather Hills, LLC
364. OHI Asset (MI), LLC
365. OHI Asset (MI) Carson City, LLC
366. OHI Asset (MO), LLC
367. OHI Asset (MO) Jackson, LLC
368. OHI Asset (MS) Byhalia, LLC
369. OHI Asset (MS) Cleveland, LLC
370. OHI Asset (MS) Clinton, LLC
371. OHI Asset (MS) Columbia, LLC
372. OHI Asset (MS) Corinth, LLC
373. OHI Asset (MS) Greenwood, LLC
374. OHI Asset (MS) Grenada, LLC
375. OHI Asset (MS) Holly Springs, LLC
376. OHI Asset (MS) Indianola, LLC
377. OHI Asset (MS) Natchez, LLC
378. OHI Asset (MS) Picayune, LLC
379. OHI Asset (MS) Vicksburg, LLC
380. OHI Asset (MS) Yazoo City, LLC
381. OHI Asset (NC) Biscoe, LLC
382. OHI Asset (NC) Cornelius, LLC
383. OHI Asset (NC) Drexel, LLC
384. OHI Asset (NC) Fayetteville, LLC
385. OHI Asset (NC) Hallsboro, LLC
386. OHI Asset (NC) Marion, LLC
387. OHI Asset (NC) Marshville, LLC
388. OHI Asset (NC) Mocksville – 1007 Howard Street, LLC
389. OHI Asset (NC) Mocksville – 1304 Madison Road, LLC
390. OHI Asset (NC) Nashville, LLC
391. OHI Asset (NC) Raeford, LLC
392. OHI Asset (NC) Rocky Mount – 1558 S. Winstead, LLC
393. OHI Asset (NC) Rocky Mount – 415 N. Winstead, LLC
394. OHI Asset (NC) Salisbury, LLC
395. OHI Asset (NC) Saluda, LLC
396. OHI Asset (NC) Shallotte, LLC
397. OHI Asset (NC) Wadesboro, LLC
398. OHI Asset (NC) Waynesville, LLC
399. OHI Asset (NC) Wilmington, LLC
400. OHI Asset (NC) Winston Salem, LLC
401. OHI Asset (NY) 2nd Avenue, LLC
402. OHI Asset (NY) 93rd Street, LLC
403. OHI Asset (OH) Huber Heights, LLC
404. OHI Asset (OH) Lender, LLC
405. OHI Asset (OH), LLC
406. OHI Asset (OH) New London, LLC

 

[Schedule I – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

407. OHI Asset (OR) Portland, LLC
408. OHI Asset (OH) Steubenville, LLC
409. OHI Asset (OH) Toledo, LLC
410. OHI Asset (OR) Troutdale, LLC
411. OHI Asset (OH) West Carrollton, LLC
412. OHI Asset (PA) GP, LLC
413. OHI Asset (PA) West Mifflin, LP
414. OHI Asset (PA), LLC
415. OHI Asset (PA), LP
416. OHI Asset (SC) Aiken, LLC
417. OHI Asset (SC) Anderson, LLC
418. OHI Asset (SC) Easley Anne, LLC
419. OHI Asset (SC) Easley Crestview, LLC
420. OHI Asset (SC) Edgefield, LLC
421. OHI Asset (SC) Five Forks, LLC
422. OHI Asset (SC) Greenville Cottages, LLC 
423. OHI Asset (SC) Greenville Griffith, LLC
424. OHI Asset (SC) Greenville Laurens, LLC
425. OHI Asset (SC) Greenville North, LLC
426. OHI Asset (SC) Greenville, LLC
427. OHI Asset (SC) Greer, LLC
428. OHI Asset (SC) Marietta, LLC
429. OHI Asset (SC) McCormick, LLC
430. OHI Asset (SC) Orangeburg, LLC
431. OHI Asset (SC) Pickens East Cedar, LLC
432. OHI Asset (SC) Pickens Rosemond, LLC
433. OHI Asset (SC) Piedmont, LLC
434. OHI Asset (SC) Simpsonville SE Main, LLC
435. OHI Asset (SC) Simpsonville West Broad, LLC
436. OHI Asset (SC) Simpsonville West Curtis, LLC
437. OHI Asset (TN) Bartlett, LLC
438. OHI Asset (TN) Cleveland, LLC
439. OHI Asset (TN) Collierville, LLC
440. OHI Asset (TN) Columbia, LLC
441. OHI Asset (TN) Elizabethton, LLC
442. OHI Asset (TN) Jamestown, LLC 
443. OHI Asset (TN) Jefferson City, LLC
444. OHI Asset (TN) Memphis, LLC
445. OHI Asset (TN) Memphis – 1150 Dovecrest, LLC
446. OHI Asset (TN) Monteagle, LLC
447. OHI Asset (TN) Monterey, LLC 
448. OHI Asset (TN) Mountain City, LLC
449. OHI Asset (TN) Nashville, LLC
450. OHI Asset (TN) Pigeon Forge, LLC
451. OHI Asset (TN) Rockwood, LLC
452. OHI Asset (TN) Rogersville, LLC

 

[Schedule I – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

453. OHI Asset (TN) Rogersville – 109 Highway 70 North, LLC
454. OHI Asset (TN) South Pittsburg, LLC
455. OHI Asset (TN) Spring City, LLC
456. OHI Asset (TN) Westmoreland, LLC
457. OHI Asset (TX) Anderson, LLC
458. OHI Asset (TX) Athens, LLC
459. OHI Asset (TX) Bryan, LLC
460. OHI Asset (TX) Burleson, LLC
461. OHI Asset (TX) College Station, LLC
462. OHI Asset (TX) Comfort, LLC
463. OHI Asset (TX) Diboll, LLC
464. OHI Asset (TX) Granbury, LLC
465. OHI Asset (TX) Hondo, LLC
466. OHI Asset (TX) Italy, LLC
467. OHI Asset (TX) Longview, LLC
468. OHI Asset (TX) Schertz, LLC
469. OHI Asset (TX) Winnsboro, LLC
470. OHI Asset (TX) Winnsboro ALF, LLC
471. OHI Asset (TX), LLC
472. OHI Asset (UT) Ogden, LLC
473. OHI Asset (UT) Provo, LLC
474. OHI Asset (UT) Roy, LLC
475. OHI Asset (VA) Charlottesville - 1165 Pepsi Place, LLC
476. OHI Asset (VA) Charlottesville, LLC
477. OHI Asset (VA) Chesapeake, LLC
478. OHI Asset (VA) Farmville, LLC
479. OHI Asset (VA) Galax, LLC
480. OHI Asset (VA) Hillsville, LLC
481. OHI Asset (VA) Martinsville SNF, LLC
482. OHI Asset (VA) Madison, LLC
483. OHI Asset (VA) Mechanicsville, LLC
484. OHI Asset (VA) Midlothian, LLC
485. OHI Asset (VA) Norfolk, LLC
486. OHI Asset (VA) Portsmouth, LLC
487. OHI Asset (VA) Richmond - 2420 Pemberton Road, LLC
488. OHI Asset (VA) Richmond - 9101 Bon Air, LLC
489. OHI Asset (VA) Rocky Mount, LLC
490. OHI Asset (VA) Suffolk, LLC
491. OHI Asset (WA) Battle Ground, LLC
492. OHI Asset (WA) Fort Vancouver, LLC
493. OHI Asset (WV) Danville, LLC
494. OHI Asset (WV) Ivydale, LLC
495. OHI Asset CHG ALF, LLC
496. OHI Asset CSB LLC
497. OHI Asset CSE – E, LLC
498. OHI Asset CSE – U, LLC

 

[Schedule I – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

499. OHI Asset CSE–E Subsidiary, LLC
500. OHI Asset CSE–U Subsidiary, LLC
501. OHI Asset HUD CFG, LLC
502. OHI Asset HUD Delta, LLC
503. OHI Asset HUD H-F, LLC
504. OHI Asset HUD SF CA, LLC
505. OHI Asset HUD SF, LLC
506. OHI Asset HUD WO, LLC
507. OHI Asset II (CA), LLC
508. OHI Asset II (FL), LLC
509. OHI Asset II (PA), LP
510. OHI Asset III (PA), LP
511. OHI Asset IV (PA) Silver Lake, LP
512. OHI Asset Management, LLC
513. OHI Asset RO PMM Services, LLC
514. OHI Asset RO, LLC
515. OHI Asset S-W, LLC
516. OHI Asset, LLC
517. OHI Healthcare Properties Holdco, Inc.
518. OHI Healthcare Properties Limited Partnership
519. OHI Mezz Lender, LLC
520. OHI Tennessee, LLC (f/k/a OHI Tennessee, Inc.)
521. OHIMA, LLC (f/k/a OHIMA, Inc.)
522. Ohio Aviv Three, L.L.C.
523. Ohio Aviv Two, L.L.C.
524. Ohio Aviv, L.L.C.
525. Ohio Indiana Property, L.L.C.
526. Ohio Pennsylvania Property, L.L.C.
527. Oklahoma Two Property, L.L.C.
528. Oklahoma Warr Wind, L.L.C.
529. Omaha Associates, L.L.C.
530. Omega TRS I, Inc.
531. Orange ALF Property, L.L.C.
532. Orange Village Care Center, LLC (f/k/a Orange Village Care Center, Inc.)
533. Orange, L.L.C.
534. Oregon Associates, L.L.C.
535. Oso Avenue Property, L.L.C.
536. Ostrom Avenue Property, L.L.C.
537. Palm Valley Senior Care, LLC
538. Panama City Nursing Center LLC
539. Pavillion North Partners, LLC
540. Pavillion North, LLP
541. Pavillion Nursing Center North, LLC
542. Peabody Associates Two, L.L.C.
543. Peabody Associates, L.L.C.

 

[Schedule I – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

544. Pennington Road Property, L.L.C.
545. Pensacola Real Estate Holdings I, LLC (f/k/a Pensacola Real Estate Holdings I, Inc.)
546. Pensacola Real Estate Holdings II, LLC (f/k/a Pensacola Real Estate Holdings II, Inc.)
547. Pensacola Real Estate Holdings III, LLC (f/k/a Pensacola Real Estate Holdings III, Inc.)
548. Pensacola Real Estate Holdings IV, LLC (f/k/a Pensacola Real Estate Holdings IV, Inc.)
549. Pensacola Real Estate Holdings V, LLC (f/k/a Pensacola Real Estate Holdings V, Inc.)
550. Pocatello Idaho Property, L.L.C.
551. Pomona Vista L.L.C.
552. Prescott Arkansas, L.L.C.
553. PV Realty-Clinton, LLC
554. PV Realty-Kensington, LLC
555. PV Realty–Willow Tree, LLC
556. Raton Property Limited Company
557. Ravenna Ohio Property, L.L.C.
558. Red Rocks, L.L.C.
559. Richland Washington, L.L.C.
560. Ridgecrest Senior Care, LLC
561. Riverside Nursing Home Associates Two, L.L.C.
562. Riverside Nursing Home Associates, L.L.C.
563. Rockingham Drive Property, L.L.C.
564. Rose Baldwin Park Property L.L.C.
565. S.C. Portfolio Property, L.L.C.
566. Salem Associates, L.L.C.
567. San Juan NH Property, LLC
568. Sandalwood Arkansas Property, L.L.C.
569. Santa Ana-Bartlett, L.L.C.
570. Santa Fe Missouri Associates, L.L.C.
571. Savoy/Bonham Venture, L.L.C.
572. Searcy Aviv, L.L.C.
573. Sedgwick Properties, L.L.C.
574. Seguin Texas Property, L.L.C.
575. Sierra Ponds Property, L.L.C.
576. Skyler Boyington, LLC (f/k/a Skyler Boyington, Inc.)
577. Skyler Florida, LLC (f/k/a Skyler Florida, Inc.)
578. Skyler Maitland LLC
579. Skyler Pensacola, LLC (f/k/a Skyler Pensacola, Inc.)
580. Skyview Associates, L.L.C.
581. Southeast Missouri Property, L.L.C.
582. Southern California Nevada, L.L.C.
583. St. Joseph Missouri Property, L.L.C.
584. St. Mary’s Properties, LLC (f/k/a St. Mary’s Properties, Inc.)

 

[Schedule I – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

585. Star City Arkansas, L.L.C.
586. Stephenville Texas Property, L.L.C.
587. Sterling Acquisition, LLC
588. Stevens Avenue Property, L.L.C.
589. Sun-Mesa Properties, L.L.C.
590. Suwanee, LLC
591. Texas Fifteen Property, L.L.C.
592. Texas Four Property, L.L.C.
593. Texas Lessor – Stonegate GP, LLC
594. Texas Lessor – Stonegate, Limited, LLC
595. Texas Lessor – Stonegate, LP
596. Texhoma Avenue Property, L.L.C.
597. The Suburban Pavilion, LLC (f/k/a The Suburban Pavilion, Inc.)
598. Tujunga, L.L.C.
599. Tulare County Property, L.L.C.
600. Twinsburg Ohio Property, LLC
601. VRB Aviv, L.L.C.
602. Washington Idaho Property, L.L.C.
603. Washington Lessor – Silverdale, LLC
604. Washington-Oregon Associates, L.L.C.
605. Watauga Associates, L.L.C.
606. Wellington Leasehold, L.L.C.
607. West Pearl Street, L.L.C.
608. West Yarmouth Property I, L.L.C.
609. Westerville Ohio Office Property, L.L.C.
610. Weston ALF Property, LLC
611. Wheeler Healthcare Associates, L.L.C.
612. Whitlock Street Property, L.L.C.
613. Wilcare, LLC
614. Willis Texas Aviv, L.L.C.
615. Yuba Aviv, L.L.C.

 

[Schedule I – 4th Supplemental Indenture – 2023 Notes]

 

 

 

 

Schedule II

NEW SUBSIDIARIES

 

1. OHI Asset (AZ) Tucson, LLC
2. OHI Asset (FL) DeFuniak Springs, LLC
3. OHI Asset (FL) Homestead, LLC
4. OHI Asset (FL) Ormond Beach, LLC
5. OHI Asset (TN) Byrdstown, LLC
6. OHI Asset (TN) Erin, LLC
7. OHI Asset (TN) Greeneville, LLC
8. OHI Asset (TN) Harriman, LLC
9. OHI Asset (TN) Ridgely, LLC
10. OHI Asset (VA) Martinsville ALF, LLC

 

[Schedule II – 4th Supplemental Indenture – 2023 Notes]

 

 

 

EX-4.5A 11 t1700448_ex4-5a.htm EXHIBIT 4.5A

 

 

Exhibit 4.5A

  

FIFTH SUPPLEMENTAL INDENTURE

(4.375% Senior Notes due 2023)

 

THIS FIFTH SUPPLEMENTAL INDENTURE (this “Fifth Supplemental Indenture”) is dated as of May 25, 2017 among OMEGA HEALTHCARE INVESTORS, INC., a Maryland corporation (the “Issuer”), each of the SUBSIDIARY GUARANTORS listed on Schedule I hereto (collectively, the “Subsidiary Guarantors”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, as trustee (the “Trustee”).

 

W I T N E S S E T H :

 

WHEREAS, the Issuer and the Subsidiary Guarantors have heretofore executed and delivered to the Trustee an Indenture, dated as of July 12, 2016 (as supplemented by that First Supplemental Indenture, dated as of August 9, 2016, that Second Supplemental Indenture, dated as of November 10, 2016, that Third Supplemental Indenture, dated as of March 17, 2017 and that Fourth Supplemental Indenture, dated as of May 11, 2017; the “Indenture”) providing for the issuance of the Issuer’s 4.375% Senior Notes due 2023 (the “Notes”);

 

WHEREAS, in Section 1.01 of the Indenture, the term “Subsidiary Guarantors” is defined to include (i) each Subsidiary that is a guarantor of Indebtedness under the Existing Note Indentures on the Closing Date and (ii) each other Person that is required to become a Subsidiary Guarantor by the terms of the Indenture after the Closing Date, in each case, until such Person is released from its Subsidiary Guarantee;

 

WHEREAS, Section 10.04(4) of the Indenture provides that if a Subsidiary Guarantor ceases to guarantee the obligations of the Issuer under any Indebtedness of the Issuer that would constitute Indebtedness under clauses (1) or (2) of the definition thereof in the Indenture, in an amount at least equal to $50 million, such Subsidiary Guarantor shall be automatically and unconditionally released from its obligations under its Subsidiary Guarantee and its obligations under the Indenture;

 

WHEREAS, Section 10.04 of the Indenture further provides that upon any such occurrence, at the Issuer’s request and subject to the further requirements of said Section, the Trustee shall execute any documents reasonably requested by the Issuer evidencing such release;

 

WHEREAS, the Subsidiary Guarantors other than OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership (each, a “Released Subsidiary Guarantor” and collectively, the “Released Subsidiary Guarantors”) no longer guarantee the obligations of the Issuer under any Indebtedness of the Issuer described under clauses (1) or (2) of the definition of Indebtedness in the Indenture in an amount at least equal to $50 million and therefore are automatically and unconditionally released from their obligations under their respective Subsidiary Guarantees and under the Indenture;

 

WHEREAS, the Issuer and the Subsidiary Guarantors (including the Released Subsidiary Guarantors) have requested that the Trustee enter into this Fifth Supplemental Indenture and the Partial Release (as hereinafter defined) to further evidence such release of the Released Subsidiary Guarantors; and

 

[5th Supplemental Indenture – 2023 Notes]

 

 

 

 

WHEREAS, Section 9.01(a)(5) of the Indenture authorizes the Issuer, the Subsidiary Guarantors and the Trustee, together, to amend or supplement the Indenture, without notice to or consent of any Holder of the Notes, for the purpose of releasing any Subsidiary Guarantor from any of its obligations under its Subsidiary Guarantee or the Indenture to the extent permitted by the Indenture;

 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Issuer, the Subsidiary Guarantors (including the Released Subsidiary Guarantors) and the Trustee mutually covenant and agree as follows:

 

1.CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 

2.RELEASE OF RELEASED SUBSIDIARY GUARANTORS. Pursuant to Section 10.04 of the Indenture, each of the Released Subsidiary Guarantors is hereby released from its obligations under its Subsidiary Guarantees and under the Indenture. Such release shall be further evidenced by the Trustee’s execution and delivery of a Partial Release of Subsidiary Guarantors, the form of which is attached hereto as Exhibit A (the “Partial Release”). From and after the execution and delivery hereof, the term “Subsidiary Guarantor” as used in the Indenture, the Subsidiary Guarantees and the Notes shall exclude each of the Released Subsidiary Guarantors, unless and until such Person again becomes a Subsidiary Guarantor pursuant to the provisions of Section 4.09 of the Indenture. For avoidance of doubt, OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership remain Subsidiary Guarantors.

 

3.NEW YORK LAW TO GOVERN. The laws of the State of New York shall govern and be used to construe this Fifth Supplemental Indenture.

 

4.COUNTERPARTS. The parties may sign any number of copies of this Fifth Supplemental Indenture. Each signed copy shall be an original, but all of them together shall represent the same agreement.

 

5.EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

 

6.THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Fifth Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Issuer and the Subsidiary Guarantors (including the Released Subsidiary Guarantors).

 

[Remainder of Page Intentionally Left Blank]

 

[5th Supplemental Indenture – 2023 Notes]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Fifth Supplemental Indenture to be duly executed, all as of the date first above written.

 

  ISSUER:
     
  OMEGA HEALTHCARE INVESTORS, INC.,
  a Maryland corporation
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
  SUBSIDIARY GUARANTORS:
     
  OHI HEALTHCARE PROPERTIES HOLDCO, INC.
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
  OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP
     
  By: OHI Healthcare Properties Holdco, Inc., as primary General Partner
       
    By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page - 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

  ON BEHALF OF EACH OF THE OTHER SUBSIDIARY GUARANTORS LISTED ON SCHEDULE I
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page - 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

 

U.S. BANK NATIONAL ASSOCIATION,

as Trustee

   
  By: /s/ David Ferrell
    David Ferrell
    Vice President

 

[Signature Page - 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

Exhibit A

(Form of Partial Release of Subsidiary Guarantors)

 

[ATTACHED]

 

[Exhibit A – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

[FORM OF ]

PARTIAL RELEASE OF SUBSIDIARY GUARANTORS

 

([INDENTURE DESCRIPTION])

 

[DATE]

 

Reference is hereby made to that certain Indenture dated as of [DATE], among Omega Healthcare Investors, Inc., a Maryland corporation (the "Issuer"), the Subsidiary Guarantors named therein and U.S. Bank National Association, as trustee (the "Trustee"), as amended or supplemented by that [ADD SUPPLEMENTAL INDENTURES] (the "Indenture"). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Indenture.

 

Pursuant to the provisions of Section [REFERENCE] of the Indenture and the terms of that certain Second Supplemental Indenture, dated as of even date herewith, among the Issuer, the Subsidiary Guarantors and the Trustee, amending and supplementing the Indenture, each of the entities set forth on Schedule I attached hereto and incorporated herein by this reference is hereby released from its obligations under its Subsidiary Guarantees and under the Indenture. For avoidance of doubt, OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership remain Subsidiary Guarantors.

 

The validity and enforceability of this Partial Release of Subsidiary Guarantors shall not be affected by the fact that it is not affixed to any particular Subsidiary Guarantee or Note.

 

This Partial Release of Subsidiary Guarantors shall be governed by, and construed in accordance with, the laws of the State of New York.

 

[Remainder of Page Intentionally Left Blank]

 

[Exhibit A – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Partial Release of Subsidiary Guarantors to be duly executed as of the date first written above.

 

 

U.S. BANK NATIONAL ASSOCIATION,

as Trustee

     
  By:  
    [NAME]
    [TITLE][

 

[Exhibit A – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

Schedule I

 

SUBSIDIARY GUARANTORS

 

1. 11900 East Artesia Boulevard, LLC
2. 1200 Ely Street Holdings Co. LLC
3. 13922 Cerise Avenue, LLC
4. 1628 B Street, LLC
5. 2400 Parkside Drive, LLC
6. 2425 Teller Avenue, LLC
7. 245 East Wilshire Avenue, LLC
8. 3232 Artesia Real Estate, LLC
9. 3806 Clayton Road, LLC
10. 42235 County Road Holdings Co. LLC
11. 446 Sycamore Road, L.L.C.
12. 48 High Point Road, LLC
13. 523 Hayes Lane, LLC
14. 637 East Romie Lane, LLC
15. Alamogordo Aviv, L.L.C.
16. Albany Street Property, L.L.C.
17. Arizona Lessor - Infinia, LLC
18. Arkansas Aviv, L.L.C.
19. Arma Yates, L.L.C.
20. Avery Street Property, L.L.C
21. Aviv Asset Management, L.L.C.
22. Aviv Financing I, L.L.C.
23. Aviv Financing II, L.L.C.
24. Aviv Financing III, L.L.C.
25. Aviv Financing IV, L.L.C.
26. Aviv Financing V, L.L.C.
27. Aviv Foothills, L.L.C.
28. Aviv Healthcare Properties Operating Partnership I, L.P.
29. Aviv Liberty, L.L.C.
30. Avon Ohio, L.L.C.
31. Bala Cynwyd Real Estate, LP
32. Bayside Colorado Healthcare Associates, LLC
33. Bayside Street II, LLC
34. Bayside Street, LLC (f/k/a Bayside Street, Inc.)
35. Belleville Illinois, L.L.C.
36. Bellingham II Associates, L.L.C.
37. Bethel ALF Property, L.L.C.
38. BHG Aviv, L.L.C.
39. Biglerville Road, L.L.C.
40. Bonham Texas, L.L.C.
41. Bradenton ALF Property, L.L.C.
42. Burton NH Property, L.L.C.

 

[Schedule I – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

43. California Aviv Two, L.L.C.
44. California Aviv, L.L.C.
45. Camas Associates, L.L.C.
46. Canton Health Care Land, LLC (f/k/a Canton Health Care Land, Inc.)
47. Carnegie Gardens LLC
48. Casa/Sierra California Associates, L.L.C.
49. CFG 2115 Woodstock Place LLC
50. Champaign Williamson Franklin, L.L.C.
51. Chardon Ohio Property Holdings, L.L.C.
52. Chardon Ohio Property, L.L.C.
53. Chatham Aviv, L.L.C.
54. Chippewa Valley, L.L.C.
55. CHR Bartow LLC
56. CHR Boca Raton  LLC
57. CHR Bradenton LLC
58. CHR Cape Coral LLC
59. CHR Fort Myers LLC
60. CHR Fort Walton Beach LLC
61. CHR Lake Wales LLC
62. CHR Lakeland LLC
63. CHR Pompano Beach Broward LLC
64. CHR Pompano Beach LLC
65. CHR Sanford LLC
66. CHR Spring Hill LLC
67. CHR St. Pete Bay LLC
68. CHR St. Pete Egret LLC
69. CHR Tampa Carrollwood LLC
70. CHR Tampa LLC
71. CHR Tarpon Springs LLC
72. CHR Titusville LLC
73. Clarkston Care, L.L.C.
74. Clayton Associates, L.L.C.
75. Colonial Gardens, LLC
76. Colonial Madison Associates, L.L.C.
77. Colorado Lessor - Conifer, LLC
78. Columbus Texas Aviv, L.L.C.
79. Columbus Western Avenue, L.L.C.
80. Colville Washington Property, L.L.C.
81. Commerce Nursing Homes, L.L.C.
82. Commerce Sterling Hart Drive, L.L.C.
83. Conroe Rigby Owen Road, L.L.C.
84. CR Aviv, L.L.C.
85. Crete Plus Five Property, L.L.C.
86. Crooked River Road, L.L.C.
87. CSE Albany LLC
88. CSE Amarillo LLC

 

[Schedule I – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

89. CSE Arden L.P.
90. CSE Augusta LLC
91. CSE Bedford LLC
92. CSE Blountville LLC
93. CSE Bolivar LLC
94. CSE Cambridge LLC
95. CSE Cambridge Realty LLC
96. CSE Camden LLC
97. CSE Canton LLC
98. CSE Casablanca Holdings II LLC
99. CSE Casablanca Holdings LLC
100. CSE Cedar Rapids LLC
101. CSE Centennial Village, LP
102. CSE Chelmsford LLC
103. CSE Chesterton LLC
104. CSE Claremont LLC
105. CSE Corpus North LLC
106. CSE Denver Iliff LLC
107. CSE Denver LLC
108. CSE Douglas LLC
109. CSE Elkton LLC
110. CSE Elkton Realty LLC
111. CSE Fairhaven LLC
112. CSE Fort Wayne LLC
113. CSE Frankston LLC
114. CSE Georgetown LLC
115. CSE Green Bay LLC
116. CSE Hilliard LLC
117. CSE Huntingdon LLC
118. CSE Huntsville LLC
119. CSE Indianapolis-Continental LLC
120. CSE Indianapolis-Greenbriar LLC
121. CSE Jacinto City LLC
122. CSE Jefferson City LLC
123. CSE Jeffersonville-Hillcrest Center LLC
124. CSE Jeffersonville-Jennings House LLC
125. CSE Kerrville LLC
126. CSE King L.P.
127. CSE Kingsport LLC
128. CSE Knightdale L.P.
129. CSE Lake City LLC
130. CSE Lake Worth LLC
131. CSE Lakewood LLC
132. CSE Las Vegas LLC
133. CSE Lawrenceburg LLC
134. CSE Lenoir L.P.

 

[Schedule I – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

135. CSE Lexington Park LLC
136. CSE Lexington Park Realty LLC
137. CSE Ligonier LLC
138. CSE Live Oak LLC
139. CSE Lowell LLC
140. CSE Marianna Holdings LLC
141. CSE Memphis LLC
142. CSE Mobile LLC
143. CSE Moore LLC
144. CSE North Carolina Holdings I LLC
145. CSE North Carolina Holdings II LLC
146. CSE Omro LLC
147. CSE Orange Park LLC
148. CSE Orlando-Pinar Terrace Manor LLC
149. CSE Orlando-Terra Vista Rehab LLC
150. CSE Pennsylvania Holdings, LP
151. CSE Piggott LLC
152. CSE Pilot Point LLC
153. CSE Pine View LLC
154. CSE Ponca City LLC
155. CSE Port St. Lucie LLC
156. CSE Richmond LLC
157. CSE Ripley LLC
158. CSE Ripon LLC
159. CSE Safford LLC
160. CSE Salina LLC
161. CSE Seminole LLC
162. CSE Shawnee LLC
163. CSE Spring Branch LLC
164. CSE Stillwater LLC
165. CSE Taylorsville LLC
166. CSE Texarkana LLC
167. CSE Texas City LLC
168. CSE The Village LLC
169. CSE Upland LLC
170. CSE Walnut Cove L.P.
171. CSE West Point LLC
172. CSE Whitehouse LLC
173. CSE Williamsport LLC
174. CSE Winter Haven LLC
175. CSE Woodfin L.P.
176. CSE Yorktown LLC
177. Cuyahoga Falls Property II, L.L.C.
178. Cuyahoga Falls Property, L.L.C.
179. Dallas Two Property, L.L.C.
180. Danbury ALF Property, L.L.C.

 

[Schedule I – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

181. Darien ALF Property, L.L.C.
182. Delta Investors I, LLC
183. Delta Investors II, LLC
184. Denison Texas, L.L.C.
185. Desert Lane LLC
186. Dixie White House Nursing Home, LLC (f/k/a Dixie White House Nursing Home, Inc.)
187. Dixon Health Care Center, LLC (f/k/a Dixon Health Care Center, Inc.)
188. East Rollins Street, L.L.C.
189. Edgewood Drive Property, L.L.C.
190. Effingham Associates, L.L.C.
191. Elite Mattoon, L.L.C.
192. Elite Yorkville, L.L.C.
193. Encanto Senior Care, LLC
194. Falcon Four Property Holding, L.L.C.
195. Falcon Four Property, L.L.C.
196. Falfurrias Texas, L.L.C.
197. Florida ALF Properties, L.L.C.
198. Florida Four Properties, L.L.C.
199. Florida Lessor – Meadowview, LLC
200. Florida Real Estate Company, LLC
201. Fort Stockton Property, L.L.C.
202. Four Fountains Aviv, L.L.C.
203. Fredericksburg South Adams Street, L.L.C.
204. Freewater Oregon, L.L.C.
205. Fullerton California, L.L.C.
206. G&L Gardens, LLC
207. Gardnerville Property, L.L.C.
208. Georgia Lessor - Bonterra/Parkview, LLC
209. Germantown Property, L.L.C.
210. Giltex Care, L.L.C.
211. Glendale NH Property, L.L.C.
212. Golden Hill Real Estate Company, LLC
213. Gonzales Texas Property, L.L.C.
214. Great Bend Property, L.L.C.
215. Greenbough, LLC
216. Greenville Kentucky Property, L.L.C.
217. Heritage Monterey Associates, L.L.C.
218. HHM Aviv, L.L.C.
219. Hidden Acres Property, L.L.C.
220. Highland Leasehold, L.L.C.
221. Hobbs Associates, L.L.C.
222. Hot Springs Atrium Owner, LLC
223. Hot Springs Aviv, L.L.C.
224. Hot Springs Cottages Owner, LLC
225. Hot Springs Marina Owner, LLC

 

[Schedule I – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

226. Houston Texas Aviv, L.L.C.
227. Hutchinson Kansas, L.L.C.
228. Hutton I Land, LLC (f/k/a Hutton I Land, Inc.)
229. Hutton II Land, LLC (f/k/a Hutton II Land, Inc.)
230. Hutton III Land, LLC (f/k/a Hutton III Land, Inc.)
231. Idaho Associates, L.L.C.
232. Illinois Missouri Properties, L.L.C.
233. Indiana Lessor – Wellington Manor, LLC
234. Iowa Lincoln County Property, L.L.C.
235. Jasper Springhill Street, L.L.C.
236. Kansas Five Property, L.L.C.
237. Karan Associates Two, L.L.C.
238. Karan Associates, L.L.C.
239. Karissa Court Property, L.L.C.
240. KB Northwest Associates, L.L.C.
241. Kentucky NH Properties, L.L.C.
242. Kingsville Texas, L.L.C.
243. LAD I Real Estate Company, LLC
244. Leatherman 90-1, LLC (f/k/a Leatherman 90-1, Inc.)
245. Leatherman Partnership 89-1, LLC (f/k/a Leatherman Partnership 89-1, Inc.)
246. Leatherman Partnership 89-2, LLC (f/k/a Leatherman Partnership 89-2, Inc.)
247. Louisville Dutchmans Property, L.L.C.
248. Magnolia Drive Property, L.L.C.
249. Manor Associates, L.L.C.
250. Mansfield Aviv, L.L.C.
251. Massachusetts Nursing Homes, L.L.C.
252. McCarthy Street Property, L.L.C.
253. Meridian Arms Land, LLC (f/k/a Meridian Arms Land, Inc.)
254. Minnesota Associates, L.L.C.
255. Mishawaka Property, L.L.C.
256. Missouri Associates, L.L.C.
257. Missouri Regency Associates, L.L.C.
258. Montana Associates, L.L.C.
259. Monterey Park Leasehold Mortgage, L.L.C.
260. Mount Washington Property, L.L.C.
261. Mt. Vernon Texas, L.L.C.
262. Murray County, L.L.C.
263. Muscatine Toledo Properties, L.L.C.
264. N.M. Bloomfield Three Plus One Limited Company
265. N.M. Espanola Three Plus One Limited Company
266. N.M. Lordsburg Three Plus One Limited Company
267. N.M. Silver City Three Plus One Limited Company
268. New Hope Property, L.L.C.
269. Newtown ALF Property, L.L.C.

 

[Schedule I – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

270. Nicholasville Kentucky Property, L.L.C.
271. North Las Vegas LLC
272. North Royalton Ohio Property, L.L.C.
273. Norwalk ALF Property, L.L.C.
274. NRS Ventures, L.L.C.
275. Oakland Nursing Homes, L.L.C.
276. Ocean Springs Nursing Home, LLC (f/k/a Ocean Springs Nursing Home, Inc.)
277. October Associates, L.L.C.
278. Ogden Associates, L.L.C.
279. OHI (Connecticut), LLC
280. OHI (Illinois), LLC(f/k/a OHI (Illinois), Inc.)
281. OHI (Indiana), LLC
282. OHI (Iowa), LLC(f/k/a OHI (Iowa), Inc.)
283. OHI Asset (AR) Ash Flat, LLC
284. OHI Asset (AR) Camden, LLC
285. OHI Asset (AR) Conway, LLC
286. OHI Asset (AR) Des Arc, LLC
287. OHI Asset (AR) Hot Springs, LLC
288. OHI Asset (AR) Malvern, LLC
289. OHI Asset (AR) Mena, LLC
290. OHI Asset (AR) Pocahontas, LLC
291. OHI Asset (AR) Sheridan, LLC
292. OHI Asset (AR) Walnut Ridge, LLC
293. OHI Asset (AZ) Austin House, LLC
294. OHI Asset (AZ) Tucson, LLC
295. OHI Asset (CA), LLC
296. OHI Asset (CO) Brighton, LLC
297. OHI Asset (CO) Denver, LLC
298. OHI Asset (CO) Mesa, LLC
299. OHI Asset (CO), LLC
300. OHI Asset (CT) Lender, LLC
301. OHI Asset (FL) DeFuniak Springs, LLC
302. OHI Asset (FL) Eustis, LLC
303. OHI Asset (FL) Graceville, LLC
304. OHI Asset (FL) Homestead, LLC
305. OHI Asset (FL) Lake Placid, LLC
306. OHI Asset (FL) Lender, LLC
307. OHI Asset (FL) Lutz, LLC
308. OHI Asset (FL) Marianna, LLC
309. OHI Asset (FL) Middleburg, LLC
310. OHI Asset (FL) Ormond Beach, LLC
311. OHI Asset (FL) Pensacola - Hillview, LLC
312. OHI Asset (FL) Pensacola, LLC
313. OHI Asset (FL) Port St. Joe, LLC
314. OHI Asset (FL) Sebring, LLC

 

[Schedule I – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

315. OHI Asset (FL), LLC
316. OHI Asset (GA) Cordele, LLC
317. OHI Asset (GA) Dunwoody, LLC
318. OHI Asset (GA) Macon, LLC
319. OHI Asset (GA) Moultrie, LLC
320. OHI Asset (GA) Nashville, LLC
321. OHI Asset (GA) Roswell, LLC
322. OHI Asset (GA) Snellville, LLC
323. OHI Asset (GA) Valdosta, LLC
324. OHI Asset (ID) Holly, LLC
325. OHI Asset (ID) Midland, LLC
326. OHI Asset (ID), LLC
327. OHI Asset (IL), LLC
328. OHI Asset (IN) American Village, LLC
329. OHI Asset (IN) Anderson, LLC
330. OHI Asset (IN) Beech Grove, LLC
331. OHI Asset (IN) Clarksville, LLC
332. OHI Asset (IN) Clinton, LLC
333. OHI Asset (IN) Connersville, LLC
334. OHI Asset (IN) Crown Point, LLC
335. OHI Asset (IN) Eagle Valley, LLC
336. OHI Asset (IN) Elkhart, LLC
337. OHI Asset (IN) Forest Creek, LLC
338. OHI Asset (IN) Fort Wayne, LLC
339. OHI Asset (IN) Franklin, LLC
340. OHI Asset (IN) Greensburg, LLC
341. OHI Asset (IN) Indianapolis, LLC
342. OHI Asset (IN) Jasper, LLC
343. OHI Asset (IN) Kokomo, LLC
344. OHI Asset (IN) Lafayette, LLC
345. OHI Asset (IN) Madison, LLC
346. OHI Asset (IN) Monticello, LLC
347. OHI Asset (IN) Noblesville, LLC
348. OHI Asset (IN) Rosewalk, LLC
349. OHI Asset (IN) Salem, LLC
350. OHI Asset (IN) Seymour, LLC
351. OHI Asset (IN) Spring Mill, LLC
352. OHI Asset (IN) Terre Haute, LLC
353. OHI Asset (IN) Wabash, LLC
354. OHI Asset (IN) Westfield, LLC
355. OHI Asset (IN) Zionsville, LLC
356. OHI Asset (KY) Beattyville, LLC
357. OHI Asset (KY) Louisville – 1120 Cristland, LLC
358. OHI Asset (KY) Louisville – 2529 Six Mile Lane, LLC
359. OHI Asset (KY) Morgantown, LLC
360. OHI Asset (KY) Owensboro, LLC

 

[Schedule I – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

361. OHI Asset (LA) Baton Rouge, LLC
362. OHI Asset (LA), LLC
363. OHI Asset (MD) Baltimore - Pall Mall, LLC
364. OHI Asset (MD) Baltimore - West Belvedere, LLC
365. OHI Asset (MD) Salisbury, LLC
366. OHI Asset (MD), LLC
367. OHI Asset (MI) Carson City, LLC
368. OHI Asset (MI) Heather Hills, LLC
369. OHI Asset (MI), LLC
370. OHI Asset (MO) Jackson, LLC
371. OHI Asset (MO), LLC
372. OHI Asset (MS) Byhalia, LLC
373. OHI Asset (MS) Cleveland, LLC
374. OHI Asset (MS) Clinton, LLC
375. OHI Asset (MS) Columbia, LLC
376. OHI Asset (MS) Corinth, LLC
377. OHI Asset (MS) Greenwood, LLC
378. OHI Asset (MS) Grenada, LLC
379. OHI Asset (MS) Holly Springs, LLC
380. OHI Asset (MS) Indianola, LLC
381. OHI Asset (MS) Natchez, LLC
382. OHI Asset (MS) Picayune, LLC
383. OHI Asset (MS) Vicksburg, LLC
384. OHI Asset (MS) Yazoo City, LLC
385. OHI Asset (NC) Biscoe, LLC
386. OHI Asset (NC) Cornelius, LLC
387. OHI Asset (NC) Drexel, LLC
388. OHI Asset (NC) Fayetteville, LLC
389. OHI Asset (NC) Hallsboro, LLC
390. OHI Asset (NC) Marion, LLC
391. OHI Asset (NC) Marshville, LLC
392. OHI Asset (NC) Mocksville – 1007 Howard Street, LLC
393. OHI Asset (NC) Mocksville – 1304 Madison Road, LLC
394. OHI Asset (NC) Nashville, LLC
395. OHI Asset (NC) Raeford, LLC
396. OHI Asset (NC) Rocky Mount – 1558 S. Winstead, LLC
397. OHI Asset (NC) Rocky Mount – 415 N. Winstead, LLC
398. OHI Asset (NC) Salisbury, LLC
399. OHI Asset (NC) Saluda, LLC
400. OHI Asset (NC) Shallotte, LLC
401. OHI Asset (NC) Wadesboro, LLC
402. OHI Asset (NC) Waynesville, LLC
403. OHI Asset (NC) Wilmington, LLC
404. OHI Asset (NC) Winston Salem, LLC
405. OHI Asset (NY) 2nd Avenue, LLC
406. OHI Asset (NY) 93rd Street, LLC

 

[Schedule I – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

407. OHI Asset (OH) Huber Heights, LLC
408. OHI Asset (OH) Lender, LLC
409. OHI Asset (OH) New London, LLC
410. OHI Asset (OH) Steubenville, LLC
411. OHI Asset (OH) Toledo, LLC
412. OHI Asset (OH) West Carrollton, LLC
413. OHI Asset (OH), LLC
414. OHI Asset (OR) Portland, LLC
415. OHI Asset (OR) Troutdale, LLC
416. OHI Asset (PA) GP, LLC
417. OHI Asset (PA) West Mifflin, LP
418. OHI Asset (PA), LLC
419. OHI Asset (PA), LP
420. OHI Asset (SC) Aiken, LLC
421. OHI Asset (SC) Anderson, LLC
422. OHI Asset (SC) Easley Anne, LLC
423. OHI Asset (SC) Easley Crestview, LLC
424. OHI Asset (SC) Edgefield, LLC
425. OHI Asset (SC) Five Forks, LLC
426. OHI Asset (SC) Greenville Cottages, LLC 
427. OHI Asset (SC) Greenville Griffith, LLC
428. OHI Asset (SC) Greenville Laurens, LLC
429. OHI Asset (SC) Greenville North, LLC
430. OHI Asset (SC) Greenville, LLC
431. OHI Asset (SC) Greer, LLC
432. OHI Asset (SC) Marietta, LLC
433. OHI Asset (SC) McCormick, LLC
434. OHI Asset (SC) Orangeburg, LLC
435. OHI Asset (SC) Pickens East Cedar, LLC
436. OHI Asset (SC) Pickens Rosemond, LLC
437. OHI Asset (SC) Piedmont, LLC
438. OHI Asset (SC) Simpsonville SE Main, LLC
439. OHI Asset (SC) Simpsonville West Broad, LLC
440. OHI Asset (SC) Simpsonville West Curtis, LLC
441. OHI Asset (TN) Bartlett, LLC
442. OHI Asset (TN) Byrdstown, LLC
443. OHI Asset (TN) Cleveland, LLC
444. OHI Asset (TN) Collierville, LLC
445. OHI Asset (TN) Columbia, LLC
446. OHI Asset (TN) Elizabethton, LLC
447. OHI Asset (TN) Erin, LLC
448. OHI Asset (TN) Greeneville, LLC
449. OHI Asset (TN) Harriman, LLC
450. OHI Asset (TN) Jamestown, LLC 
451. OHI Asset (TN) Jefferson City, LLC
452. OHI Asset (TN) Memphis – 1150 Dovecrest, LLC

 

[Schedule I – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

453. OHI Asset (TN) Memphis, LLC
454. OHI Asset (TN) Monteagle, LLC
455. OHI Asset (TN) Monterey, LLC 
456. OHI Asset (TN) Mountain City, LLC
457. OHI Asset (TN) Nashville, LLC
458. OHI Asset (TN) Pigeon Forge, LLC
459. OHI Asset (TN) Ridgely, LLC
460. OHI Asset (TN) Rockwood, LLC
461. OHI Asset (TN) Rogersville – 109 Highway 70 North, LLC
462. OHI Asset (TN) Rogersville, LLC
463. OHI Asset (TN) South Pittsburg, LLC
464. OHI Asset (TN) Spring City, LLC
465. OHI Asset (TN) Westmoreland, LLC
466. OHI Asset (TX) Anderson, LLC
467. OHI Asset (TX) Athens, LLC
468. OHI Asset (TX) Bryan, LLC
469. OHI Asset (TX) Burleson, LLC
470. OHI Asset (TX) College Station, LLC
471. OHI Asset (TX) Comfort, LLC
472. OHI Asset (TX) Diboll, LLC
473. OHI Asset (TX) Granbury, LLC
474. OHI Asset (TX) Hondo, LLC
475. OHI Asset (TX) Italy, LLC
476. OHI Asset (TX) Longview, LLC
477. OHI Asset (TX) Schertz, LLC
478. OHI Asset (TX) Winnsboro ALF, LLC
479. OHI Asset (TX) Winnsboro, LLC
480. OHI Asset (TX), LLC
481. OHI Asset (UT) Ogden, LLC
482. OHI Asset (UT) Provo, LLC
483. OHI Asset (UT) Roy, LLC
484. OHI Asset (VA) Charlottesville - 1165 Pepsi Place, LLC
485. OHI Asset (VA) Charlottesville, LLC
486. OHI Asset (VA) Chesapeake, LLC
487. OHI Asset (VA) Farmville, LLC
488. OHI Asset (VA) Galax, LLC
489. OHI Asset (VA) Hillsville, LLC
490. OHI Asset (VA) Madison, LLC
491. OHI Asset (VA) Martinsville ALF, LLC
492. OHI Asset (VA) Martinsville SNF, LLC
493. OHI Asset (VA) Mechanicsville, LLC
494. OHI Asset (VA) Midlothian, LLC
495. OHI Asset (VA) Norfolk, LLC
496. OHI Asset (VA) Portsmouth, LLC
497. OHI Asset (VA) Richmond - 2420 Pemberton Road, LLC
498. OHI Asset (VA) Richmond - 9101 Bon Air, LLC

 

[Schedule I – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

499. OHI Asset (VA) Rocky Mount, LLC
500. OHI Asset (VA) Suffolk, LLC
501. OHI Asset (WA) Battle Ground, LLC
502. OHI Asset (WA) Fort Vancouver, LLC
503. OHI Asset (WV) Danville, LLC
504. OHI Asset (WV) Ivydale, LLC
505. OHI Asset CHG ALF, LLC
506. OHI Asset CSB LLC
507. OHI Asset CSE – E, LLC
508. OHI Asset CSE – U, LLC
509. OHI Asset CSE–E Subsidiary, LLC
510. OHI Asset CSE–U Subsidiary, LLC
511. OHI Asset HUD CFG, LLC
512. OHI Asset HUD Delta, LLC
513. OHI Asset HUD H-F, LLC
514. OHI Asset HUD SF CA, LLC
515. OHI Asset HUD SF, LLC
516. OHI Asset HUD WO, LLC
517. OHI Asset II (CA), LLC
518. OHI Asset II (FL), LLC
519. OHI Asset II (PA), LP
520. OHI Asset III (PA), LP
521. OHI Asset IV (PA) Silver Lake, LP
522. OHI Asset Management, LLC
523. OHI Asset RO PMM Services, LLC
524. OHI Asset RO, LLC
525. OHI Asset S-W, LLC
526. OHI Asset, LLC
527. OHI Healthcare Properties Holdco, Inc.
528. OHI Healthcare Properties Limited Partnership
529. OHI Mezz Lender, LLC
530. OHI Tennessee, LLC (f/k/a OHI Tennessee, Inc.)
531. OHIMA, LLC (f/k/a OHIMA, Inc.)
532. Ohio Aviv Three, L.L.C.
533. Ohio Aviv Two, L.L.C.
534. Ohio Aviv, L.L.C.
535. Ohio Indiana Property, L.L.C.
536. Ohio Pennsylvania Property, L.L.C.
537. Oklahoma Two Property, L.L.C.
538. Oklahoma Warr Wind, L.L.C.
539. Omaha Associates, L.L.C.
540. Omega TRS I, Inc.
541. Orange ALF Property, L.L.C.
542. Orange Village Care Center, LLC (f/k/a Orange Village Care Center, Inc.)
543. Orange, L.L.C.

 

[Schedule I – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

544. Oregon Associates, L.L.C.
545. Oso Avenue Property, L.L.C.
546. Ostrom Avenue Property, L.L.C.
547. Palm Valley Senior Care, LLC
548. Panama City Nursing Center LLC
549. Pavillion North Partners, LLC
550. Pavillion North, LLP
551. Pavillion Nursing Center North, LLC
552. Peabody Associates Two, L.L.C.
553. Peabody Associates, L.L.C.
554. Pennington Road Property, L.L.C.
555. Pensacola Real Estate Holdings I, LLC (f/k/a Pensacola Real Estate Holdings I, Inc.)
556. Pensacola Real Estate Holdings II, LLC (f/k/a Pensacola Real Estate Holdings II, Inc.)
557. Pensacola Real Estate Holdings III, LLC (f/k/a Pensacola Real Estate Holdings III, Inc.)
558. Pensacola Real Estate Holdings IV, LLC (f/k/a Pensacola Real Estate Holdings IV, Inc.)
559. Pensacola Real Estate Holdings V, LLC (f/k/a Pensacola Real Estate Holdings V, Inc.)
560. Pocatello Idaho Property, L.L.C.
561. Pomona Vista L.L.C.
562. Prescott Arkansas, L.L.C.
563. PV Realty-Clinton, LLC
564. PV Realty-Kensington, LLC
565. PV Realty–Willow Tree, LLC
566. Raton Property Limited Company
567. Ravenna Ohio Property, L.L.C.
568. Red Rocks, L.L.C.
569. Richland Washington, L.L.C.
570. Ridgecrest Senior Care, LLC
571. Riverside Nursing Home Associates Two, L.L.C.
572. Riverside Nursing Home Associates, L.L.C.
573. Rockingham Drive Property, L.L.C.
574. Rose Baldwin Park Property L.L.C.
575. S.C. Portfolio Property, L.L.C.
576. Salem Associates, L.L.C.
577. San Juan NH Property, LLC
578. Sandalwood Arkansas Property, L.L.C.
579. Santa Ana-Bartlett, L.L.C.
580. Santa Fe Missouri Associates, L.L.C.
581. Savoy/Bonham Venture, L.L.C.
582. Searcy Aviv, L.L.C.
583. Sedgwick Properties, L.L.C.
584. Seguin Texas Property, L.L.C.

 

[Schedule I – 5th Supplemental Indenture – 2023 Notes]

 

 

 

 

585. Sierra Ponds Property, L.L.C.
586. Skyler Boyington, LLC (f/k/a Skyler Boyington, Inc.)
587. Skyler Florida, LLC (f/k/a Skyler Florida, Inc.)
588. Skyler Maitland LLC
589. Skyler Pensacola, LLC (f/k/a Skyler Pensacola, Inc.)
590. Skyview Associates, L.L.C.
591. Southeast Missouri Property, L.L.C.
592. Southern California Nevada, L.L.C.
593. St. Joseph Missouri Property, L.L.C.
594. St. Mary’s Properties, LLC (f/k/a St. Mary’s Properties, Inc.)
595. Star City Arkansas, L.L.C.
596. Stephenville Texas Property, L.L.C.
597. Sterling Acquisition, LLC
598. Stevens Avenue Property, L.L.C.
599. Sun-Mesa Properties, L.L.C.
600. Suwanee, LLC
601. Texas Fifteen Property, L.L.C.
602. Texas Four Property, L.L.C.
603. Texas Lessor – Stonegate GP, LLC
604. Texas Lessor – Stonegate, Limited, LLC
605. Texas Lessor – Stonegate, LP
606. Texhoma Avenue Property, L.L.C.
607. The Suburban Pavilion, LLC (f/k/a The Suburban Pavilion, Inc.)
608. Tujunga, L.L.C.
609. Tulare County Property, L.L.C.
610. Twinsburg Ohio Property, LLC
611. VRB Aviv, L.L.C.
612. Washington Idaho Property, L.L.C.
613. Washington Lessor – Silverdale, LLC
614. Washington-Oregon Associates, L.L.C.
615. Watauga Associates, L.L.C.
616. Wellington Leasehold, L.L.C.
617. West Pearl Street, L.L.C.
618. West Yarmouth Property I, L.L.C.
619. Westerville Ohio Office Property, L.L.C.
620. Weston ALF Property, LLC
621. Wheeler Healthcare Associates, L.L.C.
622. Whitlock Street Property, L.L.C.
623. Wilcare, LLC
624. Willis Texas Aviv, L.L.C.
625. Yuba Aviv, L.L.C.

 

[Schedule I – 5th Supplemental Indenture – 2023 Notes]

 

 

 

EX-4.6A 12 t1700448_ex4-6a.htm EXHIBIT 4.6A

 

 

Exhibit 4.6A

 

FIRST SUPPLEMENTAL INDENTURE

(Senior Notes due 2028)

 

THIS FIRST SUPPLEMENTAL INDENTURE (this “First Supplemental Indenture”) is dated as of May 11, 2017, among OMEGA HEALTHCARE INVESTORS, INC., a Maryland corporation (the “Issuer”), each of the entities listed on Schedule II hereto (collectively, the “New Subsidiaries”) and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, as trustee (the “Trustee”).

 

W I T N E S S E T H :

 

WHEREAS, the Issuer and each of its direct and indirect subsidiaries listed on Schedule I hereto (collectively, the “Subsidiary Guarantors”) have heretofore executed and delivered to the Trustee an Indenture, dated as of April 4, 2017 (the “Indenture”) providing for the issuance of the Issuer’s 4.750 % Senior Notes due 2028 (the “Notes”);

 

WHEREAS, Section 9.01(a)(4) of the Indenture authorizes the Issuer and the Trustee, together, to amend or supplement the Indenture, without notice to or consent of any Holder of the Notes and without the execution of such amendment or supplement by existing Subsidiary Guarantors, for the purpose of adding any additional Subsidiary Guarantee by any additional Guarantor;

 

WHEREAS, pursuant to Section 4.09 of the Indenture, the New Subsidiaries are required to become Subsidiary Guarantors;

 

WHEREAS, in Section 1.01 of the Indenture, the term “Subsidiary Guarantors” is defined to include all Persons that become a Subsidiary Guarantor by the terms of the Indenture after the Closing Date; and

 

WHEREAS, Section 10.01 of the Indenture provides that each Subsidiary Guarantor shall be a guarantor of the Issuer’s obligations under the Notes, subject to the terms and conditions described in the Indenture.

 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Issuer, the New Subsidiaries and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:

 

1.CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 

[1st Supplemental Indenture – 2028 Notes]

 

 

 

 

2.AMENDMENT TO GUARANTEE. The New Subsidiaries hereby agree, jointly and severally with all other Subsidiary Guarantors, to guarantee the Issuer’s obligations under the Notes on the terms and subject to the conditions set forth in the Indenture, and to be bound by, and to receive the benefit of, all other applicable provisions of the Indenture as Subsidiary Guarantors. Such guarantee shall be evidenced by the New Subsidiaries’ execution of Subsidiary Guarantees, the form of which is attached as Exhibit C to the Indenture, and shall be effective as of the date hereof.

 

3.NO RECOURSE AGAINST OTHERS. No past, present or future director, officer, employee, incorporator, stockholder, member, manager or controlling person of the New Subsidiaries, as such, shall have any liability for any obligations of the Issuer or any Subsidiary Guarantor under the Notes, any Guarantees, the Indenture or this First Supplemental Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder of the Notes, by accepting and holding a Note, waives and releases all such liability. Such waiver and release are part of the consideration for the issuance of the Notes.

 

4.NEW YORK LAW TO GOVERN. The laws of the State of New York shall govern and be used to construe this First Supplemental Indenture.

 

5.COUNTERPARTS. The parties may sign any number of copies of this First Supplemental Indenture. Each signed copy shall be an original, but all of them together shall represent the same agreement.

 

6.EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

 

7.THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this First Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Issuer and the New Subsidiaries.

 

[Remainder of Page Intentionally Left Blank]

 

[1st Supplemental Indenture – 2028 Notes]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this First Supplemental Indenture to be duly executed, all as of the date first above written.

 

ISSUER:
   
  OMEGA HEALTHCARE INVESTORS, INC.,
  a Maryland corporation
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
NEW SUBSIDIARIES:
   
  ON BEHALF OF EACH OF THE NEW SUBSIDIARIES LISTED ON SCHEDULE II
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

  U.S. BANK NATIONAL ASSOCIATION,
  as Trustee
   
  By: /s/ David Ferrell
    Name: David Ferrell
    Title: Vice President

 

[Signature Page – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

Schedule I

 

SUBSIDIARY GUARANTORS

 

1. 11900 East Artesia Boulevard, LLC
2. 1200 Ely Street Holdings Co. LLC
3. 13922 Cerise Avenue, LLC
4. 1628 B Street, LLC
5. 2400 Parkside Drive, LLC
6. 2425 Teller Avenue, LLC
7. 245 East Wilshire Avenue, LLC
8. 3232 Artesia Real Estate, LLC
9. 3806 Clayton Road, LLC
10. 42235 County Road Holdings Co. LLC
11. 446 Sycamore Road, L.L.C.
12. 48 High Point Road, LLC
13. 523 Hayes Lane, LLC
14. 637 East Romie Lane, LLC
15. Alamogordo Aviv, L.L.C.
16. Albany Street Property, L.L.C.
17. Arizona Lessor - Infinia, LLC
18. Arkansas Aviv, L.L.C.
19. Arma Yates, L.L.C.
20. Avery Street Property, L.L.C
21. Aviv Asset Management, L.L.C.
22. Aviv Financing I, L.L.C.
23. Aviv Financing II, L.L.C.
24. Aviv Financing III, L.L.C.
25. Aviv Financing IV, L.L.C.
26. Aviv Financing V, L.L.C.
27. Aviv Foothills, L.L.C.
28. Aviv Healthcare Properties Operating Partnership I, L.P.
29. Aviv Liberty, L.L.C.
30. Avon Ohio, L.L.C.
31. Bala Cynwyd Real Estate, LP
32. Bayside Colorado Healthcare Associates, LLC
33. Bayside Street II, LLC
34. Bayside Street, LLC (f/k/a Bayside Street, Inc.)
35. Belleville Illinois, L.L.C.
36. Bellingham II Associates, L.L.C.
37. Bethel ALF Property, L.L.C.
38. BHG Aviv, L.L.C.
39. Biglerville Road, L.L.C.
40. Bonham Texas, L.L.C.
41. Bradenton ALF Property, L.L.C.

 

[Schedule I – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

42. Burton NH Property, L.L.C.
43. California Aviv Two, L.L.C.
44. California Aviv, L.L.C.
45. Camas Associates, L.L.C.
46. Canton Health Care Land, LLC (f/k/a Canton Health Care Land, Inc.)
47. Carnegie Gardens LLC
48. Casa/Sierra California Associates, L.L.C.
49. CFG 2115 Woodstock Place LLC
50. Champaign Williamson Franklin, L.L.C.
51. Chardon Ohio Property Holdings, L.L.C.
52. Chardon Ohio Property, L.L.C.
53. Chatham Aviv, L.L.C.
54. Chippewa Valley, L.L.C.
55. CHR Bartow LLC
56. CHR Boca Raton LLC
57. CHR Bradenton LLC
58. CHR Cape Coral LLC
59. CHR Fort Myers LLC
60. CHR Fort Walton Beach LLC
61. CHR Lake Wales LLC
62. CHR Lakeland LLC
63. CHR Pompano Beach Broward LLC
64. CHR Pompano Beach LLC
65. CHR Sanford LLC
66. CHR Spring Hill LLC
67. CHR St. Pete Bay LLC
68. CHR St. Pete Egret LLC
69. CHR Tampa Carrollwood LLC
70. CHR Tampa LLC
71. CHR Tarpon Springs LLC
72. CHR Titusville LLC
73. Clarkston Care, L.L.C.
74. Clayton Associates, L.L.C.
75. Colonial Gardens, LLC
76. Colonial Madison Associates, L.L.C.
77. Colorado Lessor - Conifer, LLC
78. Columbus Texas Aviv, L.L.C.
79. Columbus Western Avenue, L.L.C.
80. Colville Washington Property, L.L.C.
81. Commerce Nursing Homes, L.L.C.
82. Commerce Sterling Hart Drive, L.L.C.
83. Conroe Rigby Owen Road, L.L.C.
84. CR Aviv, L.L.C.
85. Crete Plus Five Property, L.L.C.
86. Crooked River Road, L.L.C.
87. CSE Albany LLC

 

[Schedule I – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

88. CSE Amarillo LLC
89. CSE Arden L.P.
90. CSE Augusta LLC
91. CSE Bedford LLC
92. CSE Blountville LLC
93. CSE Bolivar LLC
94. CSE Cambridge LLC
95. CSE Cambridge Realty LLC
96. CSE Camden LLC
97. CSE Canton LLC
98. CSE Casablanca Holdings II LLC
99. CSE Casablanca Holdings LLC
100. CSE Cedar Rapids LLC
101. CSE Centennial Village, LP
102. CSE Chelmsford LLC
103. CSE Chesterton LLC
104. CSE Claremont LLC
105. CSE Corpus North LLC
106. CSE Denver Iliff LLC
107. CSE Denver LLC
108. CSE Douglas LLC
109. CSE Elkton LLC
110. CSE Elkton Realty LLC
111. CSE Fairhaven LLC
112. CSE Fort Wayne LLC
113. CSE Frankston LLC
114. CSE Georgetown LLC
115. CSE Green Bay LLC
116. CSE Hilliard LLC
117. CSE Huntingdon LLC
118. CSE Huntsville LLC
119. CSE Indianapolis-Continental LLC
120. CSE Indianapolis-Greenbriar LLC
121. CSE Jacinto City LLC
122. CSE Jefferson City LLC
123. CSE Jeffersonville-Hillcrest Center LLC
124. CSE Jeffersonville-Jennings House LLC
125. CSE Kerrville LLC
126. CSE King L.P.
127. CSE Kingsport LLC
128. CSE Knightdale L.P.
129. CSE Lake City LLC
130. CSE Lake Worth LLC
131. CSE Lakewood LLC
132. CSE Las Vegas LLC
133. CSE Lawrenceburg LLC

 

[Schedule I – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

134. CSE Lenoir L.P.
135. CSE Lexington Park LLC
136. CSE Lexington Park Realty LLC
137. CSE Ligonier LLC
138. CSE Live Oak LLC
139. CSE Lowell LLC
140. CSE Marianna Holdings LLC
141. CSE Memphis LLC
142. CSE Mobile LLC
143. CSE Moore LLC
144. CSE North Carolina Holdings I LLC
145. CSE North Carolina Holdings II LLC
146. CSE Omro LLC
147. CSE Orange Park LLC
148. CSE Orlando-Pinar Terrace Manor LLC
149. CSE Orlando-Terra Vista Rehab LLC
150. CSE Pennsylvania Holdings, LP
151. CSE Piggott LLC
152. CSE Pilot Point LLC
153. CSE Pine View LLC
154. CSE Ponca City LLC
155. CSE Port St. Lucie LLC
156. CSE Richmond LLC
157. CSE Ripley LLC
158. CSE Ripon LLC
159. CSE Safford LLC
160. CSE Salina LLC
161. CSE Seminole LLC
162. CSE Shawnee LLC
163. CSE Spring Branch LLC
164. CSE Stillwater LLC
165. CSE Taylorsville LLC
166. CSE Texarkana LLC
167. CSE Texas City LLC
168. CSE The Village LLC
169. CSE Upland LLC
170. CSE Walnut Cove L.P.
171. CSE West Point LLC
172. CSE Whitehouse LLC
173. CSE Williamsport LLC
174. CSE Winter Haven LLC
175. CSE Woodfin L.P.
176. CSE Yorktown LLC
177. Cuyahoga Falls Property, L.L.C.
178. Cuyahoga Falls Property II, L.L.C.
179. Dallas Two Property, L.L.C.

 

[Schedule I – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

180. Danbury ALF Property, L.L.C.
181. Darien ALF Property, L.L.C.
182. Delta Investors I, LLC
183. Delta Investors II, LLC
184. Denison Texas, L.L.C.
185. Desert Lane LLC
186. Dixie White House Nursing Home, LLC (f/k/a Dixie White House Nursing Home, Inc.)
187. Dixon Health Care Center, LLC (f/k/a Dixon Health Care Center, Inc.)
188. East Rollins Street, L.L.C.
189. Edgewood Drive Property, L.L.C.
190. Effingham Associates, L.L.C.
191. Elite Mattoon, L.L.C.
192. Elite Yorkville, L.L.C.
193. Encanto Senior Care, LLC
194. Falcon Four Property Holding, L.L.C.
195. Falcon Four Property, L.L.C.
196. Falfurrias Texas, L.L.C.
197. Florida ALF Properties, L.L.C.
198. Florida Four Properties, L.L.C.
199. Florida Lessor – Meadowview, LLC
200. Florida Real Estate Company, LLC
201. Fort Stockton Property, L.L.C.
202. Four Fountains Aviv, L.L.C.
203. Fredericksburg South Adams Street, L.L.C.
204. Freewater Oregon, L.L.C.
205. Fullerton California, L.L.C.
206. G&L Gardens, LLC
207. Gardnerville Property, L.L.C.
208. Georgia Lessor - Bonterra/Parkview, LLC
209. Germantown Property, L.L.C.
210. Giltex Care, L.L.C.
211. Glendale NH Property, L.L.C.
212. Golden Hill Real Estate Company, LLC
213. Gonzales Texas Property, L.L.C.
214. Great Bend Property, L.L.C.
215. Greenbough, LLC
216. Greenville Kentucky Property, L.L.C.
217. Heritage Monterey Associates, L.L.C.
218. HHM Aviv, L.L.C.
219. Hidden Acres Property, L.L.C.
220. Highland Leasehold, L.L.C.
221. Hobbs Associates, L.L.C.
222. Hot Springs Atrium Owner, LLC
223. Hot Springs Aviv, L.L.C.
224. Hot Springs Cottages Owner, LLC

 

[Schedule I – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

225. Hot Springs Marina Owner, LLC
226. Houston Texas Aviv, L.L.C.
227. Hutchinson Kansas, L.L.C.
228. Hutton I Land, LLC (f/k/a Hutton I Land, Inc.)
229. Hutton II Land, LLC (f/k/a Hutton II Land, Inc.)
230. Hutton III Land, LLC (f/k/a Hutton III Land, Inc.)
231. Idaho Associates, L.L.C.
232. Illinois Missouri Properties, L.L.C.
233. Indiana Lessor – Wellington Manor, LLC
234. Iowa Lincoln County Property, L.L.C.
235. Jasper Springhill Street, L.L.C.
236. Kansas Five Property, L.L.C.
237. Karan Associates Two, L.L.C.
238. Karan Associates, L.L.C.
239. Karissa Court Property, L.L.C.
240. KB Northwest Associates, L.L.C.
241. Kentucky NH Properties, L.L.C.
242. Kingsville Texas, L.L.C.
243. LAD I Real Estate Company, LLC
244. Leatherman 90-1, LLC (f/k/a Leatherman 90-1, Inc.)
245. Leatherman Partnership 89-1, LLC (f/k/a Leatherman Partnership 89-1, Inc.)
246. Leatherman Partnership 89-2, LLC (f/k/a Leatherman Partnership 89-2, Inc.)
247. Louisville Dutchmans Property, L.L.C.
248. Magnolia Drive Property, L.L.C.
249. Manor Associates, L.L.C.
250. Mansfield Aviv, L.L.C.
251. Massachusetts Nursing Homes, L.L.C.
252. McCarthy Street Property, L.L.C.
253. Meridian Arms Land, LLC (f/k/a Meridian Arms Land, Inc.)
254. Minnesota Associates, L.L.C.
255. Mishawaka Property, L.L.C.
256. Missouri Associates, L.L.C.
257. Missouri Regency Associates, L.L.C.
258. Montana Associates, L.L.C.
259. Monterey Park Leasehold Mortgage, L.L.C.
260. Mount Washington Property, L.L.C.
261. Mt. Vernon Texas, L.L.C.
262. Murray County, L.L.C.
263. Muscatine Toledo Properties, L.L.C.
264. N.M. Bloomfield Three Plus One Limited Company
265. N.M. Espanola Three Plus One Limited Company
266. N.M. Lordsburg Three Plus One Limited Company
267. N.M. Silver City Three Plus One Limited Company
268. New Hope Property, L.L.C.

 

[Schedule I – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

269. Newtown ALF Property, L.L.C.
270. Nicholasville Kentucky Property, L.L.C.
271. North Las Vegas LLC
272. North Royalton Ohio Property, L.L.C.
273. Norwalk ALF Property, L.L.C.
274. NRS Ventures, L.L.C.
275. Oakland Nursing Homes, L.L.C.
276. Ocean Springs Nursing Home, LLC (f/k/a Ocean Springs Nursing Home, Inc.)
277. October Associates, L.L.C.
278. Ogden Associates, L.L.C.
279. OHI (Connecticut), LLC
280. OHI (Illinois), LLC(f/k/a OHI (Illinois), Inc.)
281. OHI (Indiana), LLC
282. OHI (Iowa), LLC(f/k/a OHI (Iowa), Inc.)
283. OHI Asset (AR) Ash Flat, LLC
284. OHI Asset (AR) Camden, LLC
285. OHI Asset (AR) Conway, LLC
286. OHI Asset (AR) Des Arc, LLC
287. OHI Asset (AR) Hot Springs, LLC
288. OHI Asset (AR) Malvern, LLC
289. OHI Asset (AR) Mena, LLC
290. OHI Asset (AR) Pocahontas, LLC
291. OHI Asset (AR) Sheridan, LLC
292. OHI Asset (AR) Walnut Ridge, LLC
293. OHI Asset (AZ) Austin House, LLC
294. OHI Asset (CA), LLC
295. OHI Asset (CO), LLC
296. OHI Asset (CO) Brighton, LLC
297. OHI Asset (CO) Denver, LLC
298. OHI Asset (CO) Mesa, LLC
299. OHI Asset (CT) Lender, LLC
300. OHI Asset (FL), LLC
301. OHI Asset (FL) Eustis, LLC
302. OHI Asset (FL) Graceville, LLC
303. OHI Asset (FL) Lake Placid, LLC
304. OHI Asset (FL) Lender, LLC
305. OHI Asset (FL) Lutz, LLC
306. OHI Asset (FL) Marianna, LLC
307. OHI Asset (FL) Middleburg, LLC
308. OHI Asset (FL) Pensacola - Hillview, LLC
309. OHI Asset (FL) Pensacola, LLC
310. OHI Asset (FL) Port St. Joe, LLC
311. OHI Asset (FL) Sebring, LLC
312. OHI Asset (GA) Cordele, LLC
313. OHI Asset (GA) Dunwoody, LLC

 

[Schedule I – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

314. OHI Asset (GA) Macon, LLC
315. OHI Asset (GA) Moultrie, LLC
316. OHI Asset (GA) Nashville, LLC
317. OHI Asset (GA) Roswell, LLC
318. OHI Asset (GA) Snellville, LLC
319. OHI Asset (GA) Valdosta, LLC
320. OHI Asset (ID) Holly, LLC
321. OHI Asset (ID) Midland, LLC
322. OHI Asset (ID), LLC
323. OHI Asset (IL), LLC
324. OHI Asset (IN) American Village, LLC
325. OHI Asset (IN) Anderson, LLC
326. OHI Asset (IN) Beech Grove, LLC
327. OHI Asset (IN) Clarksville, LLC
328. OHI Asset (IN) Clinton, LLC
329. OHI Asset (IN) Connersville, LLC
330. OHI Asset (IN) Crown Point, LLC
331. OHI Asset (IN) Eagle Valley, LLC
332. OHI Asset (IN) Elkhart, LLC
333. OHI Asset (IN) Forest Creek, LLC
334. OHI Asset (IN) Fort Wayne, LLC
335. OHI Asset (IN) Franklin, LLC
336. OHI Asset (IN) Greensburg, LLC
337. OHI Asset (IN) Indianapolis, LLC
338. OHI Asset (IN) Jasper, LLC
339. OHI Asset (IN) Kokomo, LLC
340. OHI Asset (IN) Lafayette, LLC
341. OHI Asset (IN) Madison, LLC
342. OHI Asset (IN) Monticello, LLC
343. OHI Asset (IN) Noblesville, LLC
344. OHI Asset (IN) Rosewalk, LLC
345. OHI Asset (IN) Salem, LLC
346. OHI Asset (IN) Seymour, LLC
347. OHI Asset (IN) Spring Mill, LLC
348. OHI Asset (IN) Terre Haute, LLC
349. OHI Asset (IN) Wabash, LLC
350. OHI Asset (IN) Westfield, LLC
351. OHI Asset (IN) Zionsville, LLC
352. OHI Asset (KY) Beattyville, LLC
353. OHI Asset (KY) Louisville – 1120 Cristland, LLC
354. OHI Asset (KY) Louisville – 2529 Six Mile Lane, LLC
355. OHI Asset (KY) Morgantown, LLC
356. OHI Asset (KY) Owensboro, LLC
357. OHI Asset (LA) Baton Rouge, LLC
358. OHI Asset (LA), LLC
359. OHI Asset (MD), LLC

 

[Schedule I – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

360. OHI Asset (MD) Baltimore - Pall Mall, LLC
361. OHI Asset (MD) Baltimore - West Belvedere, LLC
362. OHI Asset (MD) Salisbury, LLC
363. OHI Asset (MI) Heather Hills, LLC
364. OHI Asset (MI), LLC
365. OHI Asset (MI) Carson City, LLC
366. OHI Asset (MO), LLC
367. OHI Asset (MO) Jackson, LLC
368. OHI Asset (MS) Byhalia, LLC
369. OHI Asset (MS) Cleveland, LLC
370. OHI Asset (MS) Clinton, LLC
371. OHI Asset (MS) Columbia, LLC
372. OHI Asset (MS) Corinth, LLC
373. OHI Asset (MS) Greenwood, LLC
374. OHI Asset (MS) Grenada, LLC
375. OHI Asset (MS) Holly Springs, LLC
376. OHI Asset (MS) Indianola, LLC
377. OHI Asset (MS) Natchez, LLC
378. OHI Asset (MS) Picayune, LLC
379. OHI Asset (MS) Vicksburg, LLC
380. OHI Asset (MS) Yazoo City, LLC
381. OHI Asset (NC) Biscoe, LLC
382. OHI Asset (NC) Cornelius, LLC
383. OHI Asset (NC) Drexel, LLC
384. OHI Asset (NC) Fayetteville, LLC
385. OHI Asset (NC) Hallsboro, LLC
386. OHI Asset (NC) Marion, LLC
387. OHI Asset (NC) Marshville, LLC
388. OHI Asset (NC) Mocksville – 1007 Howard Street, LLC
389. OHI Asset (NC) Mocksville – 1304 Madison Road, LLC
390. OHI Asset (NC) Nashville, LLC
391. OHI Asset (NC) Raeford, LLC
392. OHI Asset (NC) Rocky Mount – 1558 S. Winstead, LLC
393. OHI Asset (NC) Rocky Mount – 415 N. Winstead, LLC
394. OHI Asset (NC) Salisbury, LLC
395. OHI Asset (NC) Saluda, LLC
396. OHI Asset (NC) Shallotte, LLC
397. OHI Asset (NC) Wadesboro, LLC
398. OHI Asset (NC) Waynesville, LLC
399. OHI Asset (NC) Wilmington, LLC
400. OHI Asset (NC) Winston Salem, LLC
401. OHI Asset (NY) 2nd Avenue, LLC
402. OHI Asset (NY) 93rd Street, LLC
403. OHI Asset (OH) Huber Heights, LLC
404. OHI Asset (OH) Lender, LLC
405. OHI Asset (OH), LLC

 

[Schedule I – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

406. OHI Asset (OH) New London, LLC
407. OHI Asset (OR) Portland, LLC
408. OHI Asset (OH) Steubenville, LLC
409. OHI Asset (OH) Toledo, LLC
410. OHI Asset (OR) Troutdale, LLC
411. OHI Asset (OH) West Carrollton, LLC
412. OHI Asset (PA) GP, LLC
413. OHI Asset (PA) West Mifflin, LP
414. OHI Asset (PA), LLC
415. OHI Asset (PA), LP
416. OHI Asset (SC) Aiken, LLC
417. OHI Asset (SC) Anderson, LLC
418. OHI Asset (SC) Easley Anne, LLC
419. OHI Asset (SC) Easley Crestview, LLC
420. OHI Asset (SC) Edgefield, LLC
421. OHI Asset (SC) Five Forks, LLC
422. OHI Asset (SC) Greenville Cottages, LLC 
423. OHI Asset (SC) Greenville Griffith, LLC
424. OHI Asset (SC) Greenville Laurens, LLC
425. OHI Asset (SC) Greenville North, LLC
426. OHI Asset (SC) Greenville, LLC
427. OHI Asset (SC) Greer, LLC
428. OHI Asset (SC) Marietta, LLC
429. OHI Asset (SC) McCormick, LLC
430. OHI Asset (SC) Orangeburg, LLC
431. OHI Asset (SC) Pickens East Cedar, LLC
432. OHI Asset (SC) Pickens Rosemond, LLC
433. OHI Asset (SC) Piedmont, LLC
434. OHI Asset (SC) Simpsonville SE Main, LLC
435. OHI Asset (SC) Simpsonville West Broad, LLC
436. OHI Asset (SC) Simpsonville West Curtis, LLC
437. OHI Asset (TN) Bartlett, LLC
438. OHI Asset (TN) Cleveland, LLC
439. OHI Asset (TN) Collierville, LLC
440. OHI Asset (TN) Columbia, LLC
441. OHI Asset (TN) Elizabethton, LLC
442. OHI Asset (TN) Jamestown, LLC 
443. OHI Asset (TN) Jefferson City, LLC
444. OHI Asset (TN) Memphis, LLC
445. OHI Asset (TN) Memphis – 1150 Dovecrest, LLC
446. OHI Asset (TN) Monteagle, LLC
447. OHI Asset (TN) Monterey, LLC 
448. OHI Asset (TN) Mountain City, LLC
449. OHI Asset (TN) Nashville, LLC
450. OHI Asset (TN) Pigeon Forge, LLC
451. OHI Asset (TN) Rockwood, LLC

 

[Schedule I – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

452. OHI Asset (TN) Rogersville, LLC
453. OHI Asset (TN) Rogersville – 109 Highway 70 North, LLC
454. OHI Asset (TN) South Pittsburg, LLC
455. OHI Asset (TN) Spring City, LLC
456. OHI Asset (TN) Westmoreland, LLC
457. OHI Asset (TX) Anderson, LLC
458. OHI Asset (TX) Athens, LLC
459. OHI Asset (TX) Bryan, LLC
460. OHI Asset (TX) Burleson, LLC
461. OHI Asset (TX) College Station, LLC
462. OHI Asset (TX) Comfort, LLC
463. OHI Asset (TX) Diboll, LLC
464. OHI Asset (TX) Granbury, LLC
465. OHI Asset (TX) Hondo, LLC
466. OHI Asset (TX) Italy, LLC
467. OHI Asset (TX) Longview, LLC
468. OHI Asset (TX) Schertz, LLC
469. OHI Asset (TX) Winnsboro, LLC
470. OHI Asset (TX) Winnsboro ALF, LLC
471. OHI Asset (TX), LLC
472. OHI Asset (UT) Ogden, LLC
473. OHI Asset (UT) Provo, LLC
474. OHI Asset (UT) Roy, LLC
475. OHI Asset (VA) Charlottesville - 1165 Pepsi Place, LLC
476. OHI Asset (VA) Charlottesville, LLC
477. OHI Asset (VA) Chesapeake, LLC
478. OHI Asset (VA) Farmville, LLC
479. OHI Asset (VA) Galax, LLC
480. OHI Asset (VA) Hillsville, LLC
481. OHI Asset (VA) Martinsville SNF, LLC
482. OHI Asset (VA) Madison, LLC
483. OHI Asset (VA) Mechanicsville, LLC
484. OHI Asset (VA) Midlothian, LLC
485. OHI Asset (VA) Norfolk, LLC
486. OHI Asset (VA) Portsmouth, LLC
487. OHI Asset (VA) Richmond - 2420 Pemberton Road, LLC
488. OHI Asset (VA) Richmond - 9101 Bon Air, LLC
489. OHI Asset (VA) Rocky Mount, LLC
490. OHI Asset (VA) Suffolk, LLC
491. OHI Asset (WA) Battle Ground, LLC
492. OHI Asset (WA) Fort Vancouver, LLC
493. OHI Asset (WV) Danville, LLC
494. OHI Asset (WV) Ivydale, LLC
495. OHI Asset CHG ALF, LLC
496. OHI Asset CSB LLC
497. OHI Asset CSE – E, LLC

 

[Schedule I – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

498. OHI Asset CSE – U, LLC
499. OHI Asset CSE–E Subsidiary, LLC
500. OHI Asset CSE–U Subsidiary, LLC
501. OHI Asset HUD CFG, LLC
502. OHI Asset HUD Delta, LLC
503. OHI Asset HUD H-F, LLC
504. OHI Asset HUD SF CA, LLC
505. OHI Asset HUD SF, LLC
506. OHI Asset HUD WO, LLC
507. OHI Asset II (CA), LLC
508. OHI Asset II (FL), LLC
509. OHI Asset II (PA), LP
510. OHI Asset III (PA), LP
511. OHI Asset IV (PA) Silver Lake, LP
512. OHI Asset Management, LLC
513. OHI Asset RO PMM Services, LLC
514. OHI Asset RO, LLC
515. OHI Asset S-W, LLC
516. OHI Asset, LLC
517. OHI Healthcare Properties Holdco, Inc.
518. OHI Healthcare Properties Limited Partnership
519. OHI Mezz Lender, LLC
520. OHI Tennessee, LLC (f/k/a OHI Tennessee, Inc.)
521. OHIMA, LLC (f/k/a OHIMA, Inc.)
522. Ohio Aviv Three, L.L.C.
523. Ohio Aviv Two, L.L.C.
524. Ohio Aviv, L.L.C.
525. Ohio Indiana Property, L.L.C.
526. Ohio Pennsylvania Property, L.L.C.
527. Oklahoma Two Property, L.L.C.
528. Oklahoma Warr Wind, L.L.C.
529. Omaha Associates, L.L.C.
530. Omega TRS I, Inc.
531. Orange ALF Property, L.L.C.
532. Orange Village Care Center, LLC (f/k/a Orange Village Care Center, Inc.)
533. Orange, L.L.C.
534. Oregon Associates, L.L.C.
535. Oso Avenue Property, L.L.C.
536. Ostrom Avenue Property, L.L.C.
537. Palm Valley Senior Care, LLC
538. Panama City Nursing Center LLC
539. Pavillion North Partners, LLC
540. Pavillion North, LLP
541. Pavillion Nursing Center North, LLC
542. Peabody Associates Two, L.L.C.

 

[Schedule I – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

543. Peabody Associates, L.L.C.
544. Pennington Road Property, L.L.C.
545. Pensacola Real Estate Holdings I, LLC (f/k/a Pensacola Real Estate Holdings I, Inc.)
546. Pensacola Real Estate Holdings II, LLC (f/k/a Pensacola Real Estate Holdings II, Inc.)
547. Pensacola Real Estate Holdings III, LLC (f/k/a Pensacola Real Estate Holdings III, Inc.)
548. Pensacola Real Estate Holdings IV, LLC (f/k/a Pensacola Real Estate Holdings IV, Inc.)
549. Pensacola Real Estate Holdings V, LLC (f/k/a Pensacola Real Estate Holdings V, Inc.)
550. Pocatello Idaho Property, L.L.C.
551. Pomona Vista L.L.C.
552. Prescott Arkansas, L.L.C.
553. PV Realty-Clinton, LLC
554. PV Realty-Kensington, LLC
555. PV Realty–Willow Tree, LLC
556. Raton Property Limited Company
557. Ravenna Ohio Property, L.L.C.
558. Red Rocks, L.L.C.
559. Richland Washington, L.L.C.
560. Ridgecrest Senior Care, LLC
561. Riverside Nursing Home Associates Two, L.L.C.
562. Riverside Nursing Home Associates, L.L.C.
563. Rockingham Drive Property, L.L.C.
564. Rose Baldwin Park Property L.L.C.
565. S.C. Portfolio Property, L.L.C.
566. Salem Associates, L.L.C.
567. San Juan NH Property, LLC
568. Sandalwood Arkansas Property, L.L.C.
569. Santa Ana-Bartlett, L.L.C.
570. Santa Fe Missouri Associates, L.L.C.
571. Savoy/Bonham Venture, L.L.C.
572. Searcy Aviv, L.L.C.
573. Sedgwick Properties, L.L.C.
574. Seguin Texas Property, L.L.C.
575. Sierra Ponds Property, L.L.C.
576. Skyler Boyington, LLC (f/k/a Skyler Boyington, Inc.)
577. Skyler Florida, LLC (f/k/a Skyler Florida, Inc.)
578. Skyler Maitland LLC
579. Skyler Pensacola, LLC (f/k/a Skyler Pensacola, Inc.)
580. Skyview Associates, L.L.C.
581. Southeast Missouri Property, L.L.C.
582. Southern California Nevada, L.L.C.
583. St. Joseph Missouri Property, L.L.C.

 

[Schedule I – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

584. St. Mary’s Properties, LLC (f/k/a St. Mary’s Properties, Inc.)
585. Star City Arkansas, L.L.C.
586. Stephenville Texas Property, L.L.C.
587. Sterling Acquisition, LLC
588. Stevens Avenue Property, L.L.C.
589. Sun-Mesa Properties, L.L.C.
590. Suwanee, LLC
591. Texas Fifteen Property, L.L.C.
592. Texas Four Property, L.L.C.
593. Texas Lessor – Stonegate GP, LLC
594. Texas Lessor – Stonegate, Limited, LLC
595. Texas Lessor – Stonegate, LP
596. Texhoma Avenue Property, L.L.C.
597. The Suburban Pavilion, LLC (f/k/a The Suburban Pavilion, Inc.)
598. Tujunga, L.L.C.
599. Tulare County Property, L.L.C.
600. Twinsburg Ohio Property, LLC
601. VRB Aviv, L.L.C.
602. Washington Idaho Property, L.L.C.
603. Washington Lessor – Silverdale, LLC
604. Washington-Oregon Associates, L.L.C.
605. Watauga Associates, L.L.C.
606. Wellington Leasehold, L.L.C.
607. West Pearl Street, L.L.C.
608. West Yarmouth Property I, L.L.C.
609. Westerville Ohio Office Property, L.L.C.
610. Weston ALF Property, LLC
611. Wheeler Healthcare Associates, L.L.C.
612. Whitlock Street Property, L.L.C.
613. Wilcare, LLC
614. Willis Texas Aviv, L.L.C.
615. Yuba Aviv, L.L.C.

 

[Schedule I – 1st Supplemental Indenture – 2028 Notes]

 

 

 

 

Schedule II

NEW SUBSIDIARIES

 

1. OHI Asset (AZ) Tucson, LLC
2. OHI Asset (FL) DeFuniak Springs, LLC
3. OHI Asset (FL) Homestead, LLC
4. OHI Asset (FL) Ormond Beach, LLC
5. OHI Asset (TN) Byrdstown, LLC
6. OHI Asset (TN) Erin, LLC
7. OHI Asset (TN) Greeneville, LLC
8. OHI Asset (TN) Harriman, LLC
9. OHI Asset (TN) Ridgely, LLC
10. OHI Asset (VA) Martinsville ALF, LLC

 

[Schedule II – 1st Supplemental Indenture – 2028 Notes]

 

 

 

EX-4.6B 13 t1700448_ex4-6b.htm EXHIBIT 4.6B

 

 

Exhibit 4.6B

  

SECOND SUPPLEMENTAL INDENTURE

(4.750% Senior Notes due 2028)

 

THIS SECOND SUPPLEMENTAL INDENTURE (this “Second Supplemental Indenture”) is dated as of May 25, 2017 among OMEGA HEALTHCARE INVESTORS, INC., a Maryland corporation (the “Issuer”), each of the SUBSIDIARY GUARANTORS listed on Schedule I hereto (collectively, the “Subsidiary Guarantors”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, as trustee (the “Trustee”).

 

W I T N E S S E T H :

 

WHEREAS, the Issuer and the Subsidiary Guarantors have heretofore executed and delivered to the Trustee an Indenture, dated as of April 4, 2017 (as supplemented by that First Supplemental Indenture, dated as of May 11, 2017; the “Indenture”), providing for the issuance of the Issuer’s 4.750% Senior Notes due 2028 (the “Notes”);

 

WHEREAS, in Section 1.01 of the Indenture, the term “Subsidiary Guarantors” is defined to include (i) each Subsidiary that is a guarantor of Indebtedness under the Existing Note Indentures on the Closing Date and (ii) each other Person that is required to become a Subsidiary Guarantor by the terms of the Indenture after the Closing Date, in each case, until such Person is released from its Subsidiary Guarantee;

 

WHEREAS, Section 10.04(4) of the Indenture provides that if a Subsidiary Guarantor ceases to guarantee the obligations of the Issuer under any Indebtedness of the Issuer that would constitute Indebtedness under clauses (1) or (2) of the definition thereof in the Indenture, in an amount at least equal to $50 million, such Subsidiary Guarantor shall be automatically and unconditionally released from its obligations under its Subsidiary Guarantee and its obligations under the Indenture;

 

WHEREAS, Section 10.04 of the Indenture further provides that upon any such occurrence, at the Issuer’s request and subject to the further requirements of said Section, the Trustee shall execute any documents reasonably requested by the Issuer evidencing such release;

 

WHEREAS, the Subsidiary Guarantors other than OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership (each, a “Released Subsidiary Guarantor” and collectively, the “Released Subsidiary Guarantors”) no longer guarantee the obligations of the Issuer under any Indebtedness of the Issuer described under clauses (1) or (2) of the definition of Indebtedness in the Indenture in an amount at least equal to $50 million and therefore are automatically and unconditionally released from their obligations under their respective Subsidiary Guarantees and under the Indenture;

 

WHEREAS, the Issuer and the Subsidiary Guarantors (including the Released Subsidiary Guarantors) have requested that the Trustee enter into this Second Supplemental Indenture and the Partial Release (as hereinafter defined) to further evidence such release of the Released Subsidiary Guarantors; and

 

[2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

WHEREAS, Section 9.01(a)(5) of the Indenture authorizes the Issuer, the Subsidiary Guarantors and the Trustee, together, to amend or supplement the Indenture, without notice to or consent of any Holder of the Notes, for the purpose of releasing any Subsidiary Guarantor from any of its obligations under its Subsidiary Guarantee or the Indenture to the extent permitted by the Indenture;

 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Issuer, the Subsidiary Guarantors (including the Released Subsidiary Guarantors) and the Trustee mutually covenant and agree as follows:

 

1.CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 

2.RELEASE OF RELEASED SUBSIDIARY GUARANTORS. Pursuant to Section 10.04 of the Indenture, each of the Released Subsidiary Guarantors is hereby released from its obligations under its Subsidiary Guarantees and under the Indenture. Such release shall be further evidenced by the Trustee’s execution and delivery of a Partial Release of Subsidiary Guarantors, the form of which is attached hereto as Exhibit A (the “Partial Release”). From and after the execution and delivery hereof, the term “Subsidiary Guarantor” as used in the Indenture, the Subsidiary Guarantees and the Notes shall exclude each of the Released Subsidiary Guarantors, unless and until such Person again becomes a Subsidiary Guarantor pursuant to the provisions of Section 4.09 of the Indenture. For avoidance of doubt, OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership remain Subsidiary Guarantors.

 

3.NEW YORK LAW TO GOVERN. The laws of the State of New York shall govern and be used to construe this Second Supplemental Indenture.

 

4.COUNTERPARTS. The parties may sign any number of copies of this Second Supplemental Indenture. Each signed copy shall be an original, but all of them together shall represent the same agreement.

 

5.EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.

 

6.THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Second Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Issuer and the Subsidiary Guarantors (including the Released Subsidiary Guarantors).

 

[Remainder of Page Intentionally Left Blank]

 

[2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be duly executed, all as of the date first written above.

 

  ISSUER:
     
  OMEGA HEALTHCARE INVESTORS, INC.,
  a Maryland corporation
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
  SUBSIDIARY GUARANTORS:
     
  OHI HEALTHCARE PROPERTIES HOLDCO, INC.
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary
     
  OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP
     
  By: OHI Healthcare Properties Holdco, Inc., as primary General Partner
       
    By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

  ON BEHALF OF EACH OF THE OTHER SUBSIDIARY GUARANTORS LISTED ON SCHEDULE I
     
  By: /s/ Daniel J. Booth
    Daniel J. Booth
    Chief Operating Officer and Secretary

 

[Signatures continued on the following page]

 

[Signature Page – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

 

U.S. BANK NATIONAL ASSOCIATION,

as Trustee

   
  By: /s/ David Ferrell
    David Ferrell
    Vice President

 

[Signature Page – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

Exhibit A

(Form of Partial Release of Subsidiary Guarantors)

 

[ATTACHED]

 

[Exhibit A – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

[FORM OF ]

PARTIAL RELEASE OF SUBSIDIARY GUARANTORS

 

([INDENTURE DESCRIPTION])

 

[DATE]

 

Reference is hereby made to that certain Indenture dated as of [DATE], among Omega Healthcare Investors, Inc., a Maryland corporation (the "Issuer"), the Subsidiary Guarantors named therein and U.S. Bank National Association, as trustee (the "Trustee"), as amended or supplemented by that [ADD SUPPLEMENTAL INDENTURES] (the "Indenture"). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Indenture.

 

Pursuant to the provisions of Section [REFERENCE] of the Indenture and the terms of that certain Second Supplemental Indenture, dated as of even date herewith, among the Issuer, the Subsidiary Guarantors and the Trustee, amending and supplementing the Indenture, each of the entities set forth on Schedule I attached hereto and incorporated herein by this reference is hereby released from its obligations under its Subsidiary Guarantees and under the Indenture. For avoidance of doubt, OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership remain Subsidiary Guarantors.

 

The validity and enforceability of this Partial Release of Subsidiary Guarantors shall not be affected by the fact that it is not affixed to any particular Subsidiary Guarantee or Note.

 

This Partial Release of Subsidiary Guarantors shall be governed by, and construed in accordance with, the laws of the State of New York.

 

[Remainder of Page Intentionally Left Blank]

 

[Exhibit A – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Partial Release of Subsidiary Guarantors to be duly executed as of the date first written above.

 

  U.S. BANK NATIONAL ASSOCIATION, as Trustee
     
  By:  
    [NAME]
    [TITLE][

 

[Exhibit A – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

Schedule I

 

SUBSIDIARY GUARANTORS

 

1. 11900 East Artesia Boulevard, LLC
2. 1200 Ely Street Holdings Co. LLC
3. 13922 Cerise Avenue, LLC
4. 1628 B Street, LLC
5. 2400 Parkside Drive, LLC
6. 2425 Teller Avenue, LLC
7. 245 East Wilshire Avenue, LLC
8. 3232 Artesia Real Estate, LLC
9. 3806 Clayton Road, LLC
10. 42235 County Road Holdings Co. LLC
11. 446 Sycamore Road, L.L.C.
12. 48 High Point Road, LLC
13. 523 Hayes Lane, LLC
14. 637 East Romie Lane, LLC
15. Alamogordo Aviv, L.L.C.
16. Albany Street Property, L.L.C.
17. Arizona Lessor - Infinia, LLC
18. Arkansas Aviv, L.L.C.
19. Arma Yates, L.L.C.
20. Avery Street Property, L.L.C
21. Aviv Asset Management, L.L.C.
22. Aviv Financing I, L.L.C.
23. Aviv Financing II, L.L.C.
24. Aviv Financing III, L.L.C.
25. Aviv Financing IV, L.L.C.
26. Aviv Financing V, L.L.C.
27. Aviv Foothills, L.L.C.
28. Aviv Healthcare Properties Operating Partnership I, L.P.
29. Aviv Liberty, L.L.C.
30. Avon Ohio, L.L.C.
31. Bala Cynwyd Real Estate, LP
32. Bayside Colorado Healthcare Associates, LLC
33. Bayside Street II, LLC
34. Bayside Street, LLC (f/k/a Bayside Street, Inc.)
35. Belleville Illinois, L.L.C.
36. Bellingham II Associates, L.L.C.
37. Bethel ALF Property, L.L.C.
38. BHG Aviv, L.L.C.
39. Biglerville Road, L.L.C.
40. Bonham Texas, L.L.C.
41. Bradenton ALF Property, L.L.C.
42. Burton NH Property, L.L.C.

 

[Schedule I – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

43. California Aviv Two, L.L.C.
44. California Aviv, L.L.C.
45. Camas Associates, L.L.C.
46. Canton Health Care Land, LLC (f/k/a Canton Health Care Land, Inc.)
47. Carnegie Gardens LLC
48. Casa/Sierra California Associates, L.L.C.
49. CFG 2115 Woodstock Place LLC
50. Champaign Williamson Franklin, L.L.C.
51. Chardon Ohio Property Holdings, L.L.C.
52. Chardon Ohio Property, L.L.C.
53. Chatham Aviv, L.L.C.
54. Chippewa Valley, L.L.C.
55. CHR Bartow LLC
56. CHR Boca Raton  LLC
57. CHR Bradenton LLC
58. CHR Cape Coral LLC
59. CHR Fort Myers LLC
60. CHR Fort Walton Beach LLC
61. CHR Lake Wales LLC
62. CHR Lakeland LLC
63. CHR Pompano Beach Broward LLC
64. CHR Pompano Beach LLC
65. CHR Sanford LLC
66. CHR Spring Hill LLC
67. CHR St. Pete Bay LLC
68. CHR St. Pete Egret LLC
69. CHR Tampa Carrollwood LLC
70. CHR Tampa LLC
71. CHR Tarpon Springs LLC
72. CHR Titusville LLC
73. Clarkston Care, L.L.C.
74. Clayton Associates, L.L.C.
75. Colonial Gardens, LLC
76. Colonial Madison Associates, L.L.C.
77. Colorado Lessor - Conifer, LLC
78. Columbus Texas Aviv, L.L.C.
79. Columbus Western Avenue, L.L.C.
80. Colville Washington Property, L.L.C.
81. Commerce Nursing Homes, L.L.C.
82. Commerce Sterling Hart Drive, L.L.C.
83. Conroe Rigby Owen Road, L.L.C.
84. CR Aviv, L.L.C.
85. Crete Plus Five Property, L.L.C.
86. Crooked River Road, L.L.C.
87. CSE Albany LLC
88. CSE Amarillo LLC

 

[Schedule I – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

89. CSE Arden L.P.
90. CSE Augusta LLC
91. CSE Bedford LLC
92. CSE Blountville LLC
93. CSE Bolivar LLC
94. CSE Cambridge LLC
95. CSE Cambridge Realty LLC
96. CSE Camden LLC
97. CSE Canton LLC
98. CSE Casablanca Holdings II LLC
99. CSE Casablanca Holdings LLC
100. CSE Cedar Rapids LLC
101. CSE Centennial Village, LP
102. CSE Chelmsford LLC
103. CSE Chesterton LLC
104. CSE Claremont LLC
105. CSE Corpus North LLC
106. CSE Denver Iliff LLC
107. CSE Denver LLC
108. CSE Douglas LLC
109. CSE Elkton LLC
110. CSE Elkton Realty LLC
111. CSE Fairhaven LLC
112. CSE Fort Wayne LLC
113. CSE Frankston LLC
114. CSE Georgetown LLC
115. CSE Green Bay LLC
116. CSE Hilliard LLC
117. CSE Huntingdon LLC
118. CSE Huntsville LLC
119. CSE Indianapolis-Continental LLC
120. CSE Indianapolis-Greenbriar LLC
121. CSE Jacinto City LLC
122. CSE Jefferson City LLC
123. CSE Jeffersonville-Hillcrest Center LLC
124. CSE Jeffersonville-Jennings House LLC
125. CSE Kerrville LLC
126. CSE King L.P.
127. CSE Kingsport LLC
128. CSE Knightdale L.P.
129. CSE Lake City LLC
130. CSE Lake Worth LLC
131. CSE Lakewood LLC
132. CSE Las Vegas LLC
133. CSE Lawrenceburg LLC
134. CSE Lenoir L.P.

 

[Schedule I – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

135. CSE Lexington Park LLC
136. CSE Lexington Park Realty LLC
137. CSE Ligonier LLC
138. CSE Live Oak LLC
139. CSE Lowell LLC
140. CSE Marianna Holdings LLC
141. CSE Memphis LLC
142. CSE Mobile LLC
143. CSE Moore LLC
144. CSE North Carolina Holdings I LLC
145. CSE North Carolina Holdings II LLC
146. CSE Omro LLC
147. CSE Orange Park LLC
148. CSE Orlando-Pinar Terrace Manor LLC
149. CSE Orlando-Terra Vista Rehab LLC
150. CSE Pennsylvania Holdings, LP
151. CSE Piggott LLC
152. CSE Pilot Point LLC
153. CSE Pine View LLC
154. CSE Ponca City LLC
155. CSE Port St. Lucie LLC
156. CSE Richmond LLC
157. CSE Ripley LLC
158. CSE Ripon LLC
159. CSE Safford LLC
160. CSE Salina LLC
161. CSE Seminole LLC
162. CSE Shawnee LLC
163. CSE Spring Branch LLC
164. CSE Stillwater LLC
165. CSE Taylorsville LLC
166. CSE Texarkana LLC
167. CSE Texas City LLC
168. CSE The Village LLC
169. CSE Upland LLC
170. CSE Walnut Cove L.P.
171. CSE West Point LLC
172. CSE Whitehouse LLC
173. CSE Williamsport LLC
174. CSE Winter Haven LLC
175. CSE Woodfin L.P.
176. CSE Yorktown LLC
177. Cuyahoga Falls Property II, L.L.C.
178. Cuyahoga Falls Property, L.L.C.
179. Dallas Two Property, L.L.C.
180. Danbury ALF Property, L.L.C.

 

[Schedule I – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

181. Darien ALF Property, L.L.C.
182. Delta Investors I, LLC
183. Delta Investors II, LLC
184. Denison Texas, L.L.C.
185. Desert Lane LLC
186. Dixie White House Nursing Home, LLC (f/k/a Dixie White House Nursing Home, Inc.)
187. Dixon Health Care Center, LLC (f/k/a Dixon Health Care Center, Inc.)
188. East Rollins Street, L.L.C.
189. Edgewood Drive Property, L.L.C.
190. Effingham Associates, L.L.C.
191. Elite Mattoon, L.L.C.
192. Elite Yorkville, L.L.C.
193. Encanto Senior Care, LLC
194. Falcon Four Property Holding, L.L.C.
195. Falcon Four Property, L.L.C.
196. Falfurrias Texas, L.L.C.
197. Florida ALF Properties, L.L.C.
198. Florida Four Properties, L.L.C.
199. Florida Lessor – Meadowview, LLC
200. Florida Real Estate Company, LLC
201. Fort Stockton Property, L.L.C.
202. Four Fountains Aviv, L.L.C.
203. Fredericksburg South Adams Street, L.L.C.
204. Freewater Oregon, L.L.C.
205. Fullerton California, L.L.C.
206. G&L Gardens, LLC
207. Gardnerville Property, L.L.C.
208. Georgia Lessor - Bonterra/Parkview, LLC
209. Germantown Property, L.L.C.
210. Giltex Care, L.L.C.
211. Glendale NH Property, L.L.C.
212. Golden Hill Real Estate Company, LLC
213. Gonzales Texas Property, L.L.C.
214. Great Bend Property, L.L.C.
215. Greenbough, LLC
216. Greenville Kentucky Property, L.L.C.
217. Heritage Monterey Associates, L.L.C.
218. HHM Aviv, L.L.C.
219. Hidden Acres Property, L.L.C.
220. Highland Leasehold, L.L.C.
221. Hobbs Associates, L.L.C.
222. Hot Springs Atrium Owner, LLC
223. Hot Springs Aviv, L.L.C.
224. Hot Springs Cottages Owner, LLC
225. Hot Springs Marina Owner, LLC

 

[Schedule I – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

226. Houston Texas Aviv, L.L.C.
227. Hutchinson Kansas, L.L.C.
228. Hutton I Land, LLC (f/k/a Hutton I Land, Inc.)
229. Hutton II Land, LLC (f/k/a Hutton II Land, Inc.)
230. Hutton III Land, LLC (f/k/a Hutton III Land, Inc.)
231. Idaho Associates, L.L.C.
232. Illinois Missouri Properties, L.L.C.
233. Indiana Lessor – Wellington Manor, LLC
234. Iowa Lincoln County Property, L.L.C.
235. Jasper Springhill Street, L.L.C.
236. Kansas Five Property, L.L.C.
237. Karan Associates Two, L.L.C.
238. Karan Associates, L.L.C.
239. Karissa Court Property, L.L.C.
240. KB Northwest Associates, L.L.C.
241. Kentucky NH Properties, L.L.C.
242. Kingsville Texas, L.L.C.
243. LAD I Real Estate Company, LLC
244. Leatherman 90-1, LLC (f/k/a Leatherman 90-1, Inc.)
245. Leatherman Partnership 89-1, LLC (f/k/a Leatherman Partnership 89-1, Inc.)
246. Leatherman Partnership 89-2, LLC (f/k/a Leatherman Partnership 89-2, Inc.)
247. Louisville Dutchmans Property, L.L.C.
248. Magnolia Drive Property, L.L.C.
249. Manor Associates, L.L.C.
250. Mansfield Aviv, L.L.C.
251. Massachusetts Nursing Homes, L.L.C.
252. McCarthy Street Property, L.L.C.
253. Meridian Arms Land, LLC (f/k/a Meridian Arms Land, Inc.)
254. Minnesota Associates, L.L.C.
255. Mishawaka Property, L.L.C.
256. Missouri Associates, L.L.C.
257. Missouri Regency Associates, L.L.C.
258. Montana Associates, L.L.C.
259. Monterey Park Leasehold Mortgage, L.L.C.
260. Mount Washington Property, L.L.C.
261. Mt. Vernon Texas, L.L.C.
262. Murray County, L.L.C.
263. Muscatine Toledo Properties, L.L.C.
264. N.M. Bloomfield Three Plus One Limited Company
265. N.M. Espanola Three Plus One Limited Company
266. N.M. Lordsburg Three Plus One Limited Company
267. N.M. Silver City Three Plus One Limited Company
268. New Hope Property, L.L.C.
269. Newtown ALF Property, L.L.C.

 

[Schedule I – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

270. Nicholasville Kentucky Property, L.L.C.
271. North Las Vegas LLC
272. North Royalton Ohio Property, L.L.C.
273. Norwalk ALF Property, L.L.C.
274. NRS Ventures, L.L.C.
275. Oakland Nursing Homes, L.L.C.
276. Ocean Springs Nursing Home, LLC (f/k/a Ocean Springs Nursing Home, Inc.)
277. October Associates, L.L.C.
278. Ogden Associates, L.L.C.
279. OHI (Connecticut), LLC
280. OHI (Illinois), LLC(f/k/a OHI (Illinois), Inc.)
281. OHI (Indiana), LLC
282. OHI (Iowa), LLC(f/k/a OHI (Iowa), Inc.)
283. OHI Asset (AR) Ash Flat, LLC
284. OHI Asset (AR) Camden, LLC
285. OHI Asset (AR) Conway, LLC
286. OHI Asset (AR) Des Arc, LLC
287. OHI Asset (AR) Hot Springs, LLC
288. OHI Asset (AR) Malvern, LLC
289. OHI Asset (AR) Mena, LLC
290. OHI Asset (AR) Pocahontas, LLC
291. OHI Asset (AR) Sheridan, LLC
292. OHI Asset (AR) Walnut Ridge, LLC
293. OHI Asset (AZ) Austin House, LLC
294. OHI Asset (AZ) Tucson, LLC
295. OHI Asset (CA), LLC
296. OHI Asset (CO) Brighton, LLC
297. OHI Asset (CO) Denver, LLC
298. OHI Asset (CO) Mesa, LLC
299. OHI Asset (CO), LLC
300. OHI Asset (CT) Lender, LLC
301. OHI Asset (FL) DeFuniak Springs, LLC
302. OHI Asset (FL) Eustis, LLC
303. OHI Asset (FL) Graceville, LLC
304. OHI Asset (FL) Homestead, LLC
305. OHI Asset (FL) Lake Placid, LLC
306. OHI Asset (FL) Lender, LLC
307. OHI Asset (FL) Lutz, LLC
308. OHI Asset (FL) Marianna, LLC
309. OHI Asset (FL) Middleburg, LLC
310. OHI Asset (FL) Ormond Beach, LLC
311. OHI Asset (FL) Pensacola - Hillview, LLC
312. OHI Asset (FL) Pensacola, LLC
313. OHI Asset (FL) Port St. Joe, LLC
314. OHI Asset (FL) Sebring, LLC

 

[Schedule I – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

315. OHI Asset (FL), LLC
316. OHI Asset (GA) Cordele, LLC
317. OHI Asset (GA) Dunwoody, LLC
318. OHI Asset (GA) Macon, LLC
319. OHI Asset (GA) Moultrie, LLC
320. OHI Asset (GA) Nashville, LLC
321. OHI Asset (GA) Roswell, LLC
322. OHI Asset (GA) Snellville, LLC
323. OHI Asset (GA) Valdosta, LLC
324. OHI Asset (ID) Holly, LLC
325. OHI Asset (ID) Midland, LLC
326. OHI Asset (ID), LLC
327. OHI Asset (IL), LLC
328. OHI Asset (IN) American Village, LLC
329. OHI Asset (IN) Anderson, LLC
330. OHI Asset (IN) Beech Grove, LLC
331. OHI Asset (IN) Clarksville, LLC
332. OHI Asset (IN) Clinton, LLC
333. OHI Asset (IN) Connersville, LLC
334. OHI Asset (IN) Crown Point, LLC
335. OHI Asset (IN) Eagle Valley, LLC
336. OHI Asset (IN) Elkhart, LLC
337. OHI Asset (IN) Forest Creek, LLC
338. OHI Asset (IN) Fort Wayne, LLC
339. OHI Asset (IN) Franklin, LLC
340. OHI Asset (IN) Greensburg, LLC
341. OHI Asset (IN) Indianapolis, LLC
342. OHI Asset (IN) Jasper, LLC
343. OHI Asset (IN) Kokomo, LLC
344. OHI Asset (IN) Lafayette, LLC
345. OHI Asset (IN) Madison, LLC
346. OHI Asset (IN) Monticello, LLC
347. OHI Asset (IN) Noblesville, LLC
348. OHI Asset (IN) Rosewalk, LLC
349. OHI Asset (IN) Salem, LLC
350. OHI Asset (IN) Seymour, LLC
351. OHI Asset (IN) Spring Mill, LLC
352. OHI Asset (IN) Terre Haute, LLC
353. OHI Asset (IN) Wabash, LLC
354. OHI Asset (IN) Westfield, LLC
355. OHI Asset (IN) Zionsville, LLC
356. OHI Asset (KY) Beattyville, LLC
357. OHI Asset (KY) Louisville – 1120 Cristland, LLC
358. OHI Asset (KY) Louisville – 2529 Six Mile Lane, LLC
359. OHI Asset (KY) Morgantown, LLC
360. OHI Asset (KY) Owensboro, LLC

 

[Schedule I – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

361. OHI Asset (LA) Baton Rouge, LLC
362. OHI Asset (LA), LLC
363. OHI Asset (MD) Baltimore - Pall Mall, LLC
364. OHI Asset (MD) Baltimore - West Belvedere, LLC
365. OHI Asset (MD) Salisbury, LLC
366. OHI Asset (MD), LLC
367. OHI Asset (MI) Carson City, LLC
368. OHI Asset (MI) Heather Hills, LLC
369. OHI Asset (MI), LLC
370. OHI Asset (MO) Jackson, LLC
371. OHI Asset (MO), LLC
372. OHI Asset (MS) Byhalia, LLC
373. OHI Asset (MS) Cleveland, LLC
374. OHI Asset (MS) Clinton, LLC
375. OHI Asset (MS) Columbia, LLC
376. OHI Asset (MS) Corinth, LLC
377. OHI Asset (MS) Greenwood, LLC
378. OHI Asset (MS) Grenada, LLC
379. OHI Asset (MS) Holly Springs, LLC
380. OHI Asset (MS) Indianola, LLC
381. OHI Asset (MS) Natchez, LLC
382. OHI Asset (MS) Picayune, LLC
383. OHI Asset (MS) Vicksburg, LLC
384. OHI Asset (MS) Yazoo City, LLC
385. OHI Asset (NC) Biscoe, LLC
386. OHI Asset (NC) Cornelius, LLC
387. OHI Asset (NC) Drexel, LLC
388. OHI Asset (NC) Fayetteville, LLC
389. OHI Asset (NC) Hallsboro, LLC
390. OHI Asset (NC) Marion, LLC
391. OHI Asset (NC) Marshville, LLC
392. OHI Asset (NC) Mocksville – 1007 Howard Street, LLC
393. OHI Asset (NC) Mocksville – 1304 Madison Road, LLC
394. OHI Asset (NC) Nashville, LLC
395. OHI Asset (NC) Raeford, LLC
396. OHI Asset (NC) Rocky Mount – 1558 S. Winstead, LLC
397. OHI Asset (NC) Rocky Mount – 415 N. Winstead, LLC
398. OHI Asset (NC) Salisbury, LLC
399. OHI Asset (NC) Saluda, LLC
400. OHI Asset (NC) Shallotte, LLC
401. OHI Asset (NC) Wadesboro, LLC
402. OHI Asset (NC) Waynesville, LLC
403. OHI Asset (NC) Wilmington, LLC
404. OHI Asset (NC) Winston Salem, LLC
405. OHI Asset (NY) 2nd Avenue, LLC
406. OHI Asset (NY) 93rd Street, LLC

 

[Schedule I – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

407. OHI Asset (OH) Huber Heights, LLC
408. OHI Asset (OH) Lender, LLC
409. OHI Asset (OH) New London, LLC
410. OHI Asset (OH) Steubenville, LLC
411. OHI Asset (OH) Toledo, LLC
412. OHI Asset (OH) West Carrollton, LLC
413. OHI Asset (OH), LLC
414. OHI Asset (OR) Portland, LLC
415. OHI Asset (OR) Troutdale, LLC
416. OHI Asset (PA) GP, LLC
417. OHI Asset (PA) West Mifflin, LP
418. OHI Asset (PA), LLC
419. OHI Asset (PA), LP
420. OHI Asset (SC) Aiken, LLC
421. OHI Asset (SC) Anderson, LLC
422. OHI Asset (SC) Easley Anne, LLC
423. OHI Asset (SC) Easley Crestview, LLC
424. OHI Asset (SC) Edgefield, LLC
425. OHI Asset (SC) Five Forks, LLC
426. OHI Asset (SC) Greenville Cottages, LLC 
427. OHI Asset (SC) Greenville Griffith, LLC
428. OHI Asset (SC) Greenville Laurens, LLC
429. OHI Asset (SC) Greenville North, LLC
430. OHI Asset (SC) Greenville, LLC
431. OHI Asset (SC) Greer, LLC
432. OHI Asset (SC) Marietta, LLC
433. OHI Asset (SC) McCormick, LLC
434. OHI Asset (SC) Orangeburg, LLC
435. OHI Asset (SC) Pickens East Cedar, LLC
436. OHI Asset (SC) Pickens Rosemond, LLC
437. OHI Asset (SC) Piedmont, LLC
438. OHI Asset (SC) Simpsonville SE Main, LLC
439. OHI Asset (SC) Simpsonville West Broad, LLC
440. OHI Asset (SC) Simpsonville West Curtis, LLC
441. OHI Asset (TN) Bartlett, LLC
442. OHI Asset (TN) Byrdstown, LLC
443. OHI Asset (TN) Cleveland, LLC
444. OHI Asset (TN) Collierville, LLC
445. OHI Asset (TN) Columbia, LLC
446. OHI Asset (TN) Elizabethton, LLC
447. OHI Asset (TN) Erin, LLC
448. OHI Asset (TN) Greeneville, LLC
449. OHI Asset (TN) Harriman, LLC
450. OHI Asset (TN) Jamestown, LLC 
451. OHI Asset (TN) Jefferson City, LLC
452. OHI Asset (TN) Memphis – 1150 Dovecrest, LLC

 

[Schedule I – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

453. OHI Asset (TN) Memphis, LLC
454. OHI Asset (TN) Monteagle, LLC
455. OHI Asset (TN) Monterey, LLC 
456. OHI Asset (TN) Mountain City, LLC
457. OHI Asset (TN) Nashville, LLC
458. OHI Asset (TN) Pigeon Forge, LLC
459. OHI Asset (TN) Ridgely, LLC
460. OHI Asset (TN) Rockwood, LLC
461. OHI Asset (TN) Rogersville – 109 Highway 70 North, LLC
462. OHI Asset (TN) Rogersville, LLC
463. OHI Asset (TN) South Pittsburg, LLC
464. OHI Asset (TN) Spring City, LLC
465. OHI Asset (TN) Westmoreland, LLC
466. OHI Asset (TX) Anderson, LLC
467. OHI Asset (TX) Athens, LLC
468. OHI Asset (TX) Bryan, LLC
469. OHI Asset (TX) Burleson, LLC
470. OHI Asset (TX) College Station, LLC
471. OHI Asset (TX) Comfort, LLC
472. OHI Asset (TX) Diboll, LLC
473. OHI Asset (TX) Granbury, LLC
474. OHI Asset (TX) Hondo, LLC
475. OHI Asset (TX) Italy, LLC
476. OHI Asset (TX) Longview, LLC
477. OHI Asset (TX) Schertz, LLC
478. OHI Asset (TX) Winnsboro ALF, LLC
479. OHI Asset (TX) Winnsboro, LLC
480. OHI Asset (TX), LLC
481. OHI Asset (UT) Ogden, LLC
482. OHI Asset (UT) Provo, LLC
483. OHI Asset (UT) Roy, LLC
484. OHI Asset (VA) Charlottesville - 1165 Pepsi Place, LLC
485. OHI Asset (VA) Charlottesville, LLC
486. OHI Asset (VA) Chesapeake, LLC
487. OHI Asset (VA) Farmville, LLC
488. OHI Asset (VA) Galax, LLC
489. OHI Asset (VA) Hillsville, LLC
490. OHI Asset (VA) Madison, LLC
491. OHI Asset (VA) Martinsville ALF, LLC
492. OHI Asset (VA) Martinsville SNF, LLC
493. OHI Asset (VA) Mechanicsville, LLC
494. OHI Asset (VA) Midlothian, LLC
495. OHI Asset (VA) Norfolk, LLC
496. OHI Asset (VA) Portsmouth, LLC
497. OHI Asset (VA) Richmond - 2420 Pemberton Road, LLC
498. OHI Asset (VA) Richmond - 9101 Bon Air, LLC

 

[Schedule I – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

499. OHI Asset (VA) Rocky Mount, LLC
500. OHI Asset (VA) Suffolk, LLC
501. OHI Asset (WA) Battle Ground, LLC
502. OHI Asset (WA) Fort Vancouver, LLC
503. OHI Asset (WV) Danville, LLC
504. OHI Asset (WV) Ivydale, LLC
505. OHI Asset CHG ALF, LLC
506. OHI Asset CSB LLC
507. OHI Asset CSE – E, LLC
508. OHI Asset CSE – U, LLC
509. OHI Asset CSE–E Subsidiary, LLC
510. OHI Asset CSE–U Subsidiary, LLC
511. OHI Asset HUD CFG, LLC
512. OHI Asset HUD Delta, LLC
513. OHI Asset HUD H-F, LLC
514. OHI Asset HUD SF CA, LLC
515. OHI Asset HUD SF, LLC
516. OHI Asset HUD WO, LLC
517. OHI Asset II (CA), LLC
518. OHI Asset II (FL), LLC
519. OHI Asset II (PA), LP
520. OHI Asset III (PA), LP
521. OHI Asset IV (PA) Silver Lake, LP
522. OHI Asset Management, LLC
523. OHI Asset RO PMM Services, LLC
524. OHI Asset RO, LLC
525. OHI Asset S-W, LLC
526. OHI Asset, LLC
527. OHI Healthcare Properties Holdco, Inc.
528. OHI Healthcare Properties Limited Partnership
529. OHI Mezz Lender, LLC
530. OHI Tennessee, LLC (f/k/a OHI Tennessee, Inc.)
531. OHIMA, LLC (f/k/a OHIMA, Inc.)
532. Ohio Aviv Three, L.L.C.
533. Ohio Aviv Two, L.L.C.
534. Ohio Aviv, L.L.C.
535. Ohio Indiana Property, L.L.C.
536. Ohio Pennsylvania Property, L.L.C.
537. Oklahoma Two Property, L.L.C.
538. Oklahoma Warr Wind, L.L.C.
539. Omaha Associates, L.L.C.
540. Omega TRS I, Inc.
541. Orange ALF Property, L.L.C.
542. Orange Village Care Center, LLC (f/k/a Orange Village Care Center, Inc.)
543. Orange, L.L.C.

 

[Schedule I – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

544. Oregon Associates, L.L.C.
545. Oso Avenue Property, L.L.C.
546. Ostrom Avenue Property, L.L.C.
547. Palm Valley Senior Care, LLC
548. Panama City Nursing Center LLC
549. Pavillion North Partners, LLC
550. Pavillion North, LLP
551. Pavillion Nursing Center North, LLC
552. Peabody Associates Two, L.L.C.
553. Peabody Associates, L.L.C.
554. Pennington Road Property, L.L.C.
555. Pensacola Real Estate Holdings I, LLC (f/k/a Pensacola Real Estate Holdings I, Inc.)
556. Pensacola Real Estate Holdings II, LLC (f/k/a Pensacola Real Estate Holdings II, Inc.)
557. Pensacola Real Estate Holdings III, LLC (f/k/a Pensacola Real Estate Holdings III, Inc.)
558. Pensacola Real Estate Holdings IV, LLC (f/k/a Pensacola Real Estate Holdings IV, Inc.)
559. Pensacola Real Estate Holdings V, LLC (f/k/a Pensacola Real Estate Holdings V, Inc.)
560. Pocatello Idaho Property, L.L.C.
561. Pomona Vista L.L.C.
562. Prescott Arkansas, L.L.C.
563. PV Realty-Clinton, LLC
564. PV Realty-Kensington, LLC
565. PV Realty–Willow Tree, LLC
566. Raton Property Limited Company
567. Ravenna Ohio Property, L.L.C.
568. Red Rocks, L.L.C.
569. Richland Washington, L.L.C.
570. Ridgecrest Senior Care, LLC
571. Riverside Nursing Home Associates Two, L.L.C.
572. Riverside Nursing Home Associates, L.L.C.
573. Rockingham Drive Property, L.L.C.
574. Rose Baldwin Park Property L.L.C.
575. S.C. Portfolio Property, L.L.C.
576. Salem Associates, L.L.C.
577. San Juan NH Property, LLC
578. Sandalwood Arkansas Property, L.L.C.
579. Santa Ana-Bartlett, L.L.C.
580. Santa Fe Missouri Associates, L.L.C.
581. Savoy/Bonham Venture, L.L.C.
582. Searcy Aviv, L.L.C.
583. Sedgwick Properties, L.L.C.
584. Seguin Texas Property, L.L.C.

 

[Schedule I – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

 

585. Sierra Ponds Property, L.L.C.
586. Skyler Boyington, LLC (f/k/a Skyler Boyington, Inc.)
587. Skyler Florida, LLC (f/k/a Skyler Florida, Inc.)
588. Skyler Maitland LLC
589. Skyler Pensacola, LLC (f/k/a Skyler Pensacola, Inc.)
590. Skyview Associates, L.L.C.
591. Southeast Missouri Property, L.L.C.
592. Southern California Nevada, L.L.C.
593. St. Joseph Missouri Property, L.L.C.
594. St. Mary’s Properties, LLC (f/k/a St. Mary’s Properties, Inc.)
595. Star City Arkansas, L.L.C.
596. Stephenville Texas Property, L.L.C.
597. Sterling Acquisition, LLC
598. Stevens Avenue Property, L.L.C.
599. Sun-Mesa Properties, L.L.C.
600. Suwanee, LLC
601. Texas Fifteen Property, L.L.C.
602. Texas Four Property, L.L.C.
603. Texas Lessor – Stonegate GP, LLC
604. Texas Lessor – Stonegate, Limited, LLC
605. Texas Lessor – Stonegate, LP
606. Texhoma Avenue Property, L.L.C.
607. The Suburban Pavilion, LLC (f/k/a The Suburban Pavilion, Inc.)
608. Tujunga, L.L.C.
609. Tulare County Property, L.L.C.
610. Twinsburg Ohio Property, LLC
611. VRB Aviv, L.L.C.
612. Washington Idaho Property, L.L.C.
613. Washington Lessor – Silverdale, LLC
614. Washington-Oregon Associates, L.L.C.
615. Watauga Associates, L.L.C.
616. Wellington Leasehold, L.L.C.
617. West Pearl Street, L.L.C.
618. West Yarmouth Property I, L.L.C.
619. Westerville Ohio Office Property, L.L.C.
620. Weston ALF Property, LLC
621. Wheeler Healthcare Associates, L.L.C.
622. Whitlock Street Property, L.L.C.
623. Wilcare, LLC
624. Willis Texas Aviv, L.L.C.
625. Yuba Aviv, L.L.C.

 

[Schedule I – 2nd Supplemental Indenture – 2028 Notes]

 

 

 

EX-31.1 14 t1700448_ex31-1.htm EXHIBIT 31.1

 

 

Exhibit 31.1

 

RULE 13a-14(a)/15d-14(a) CERTIFICATION OF CHIEF EXECUTIVE OFFICER

 

Certification

 

I, C. Taylor Pickett, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Omega Healthcare Investors, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date:August 9, 2017

 

  /S/ C. TAYLOR PICKETT
  C. Taylor Pickett
  Chief Executive Officer

 

 

EX-31.2 15 t1700448_ex31-2.htm EXHIBIT 31.2

 

 

Exhibit 31.2

 

RULE 13a-14(a)/15d-14(a) CERTIFICATION OF CHIEF FINANCIAL OFFICER

 

Certifications

 

I, Robert O. Stephenson, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Omega Healthcare Investors, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date:August 9, 2017

 

  /S/ ROBERT O. STEPHENSON
  Robert O. Stephenson
  Chief Financial Officer

 

 

EX-31.3 16 t1700448_ex31-3.htm EXHIBIT 31.3

 

 

Exhibit 31.3

 

RULE 13a-14(a)/15d-14(a) CERTIFICATION OF CHIEF EXECUTIVE OFFICER

 

Certification

 

I, C. Taylor Pickett, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of OHI Healthcare Properties Holdco, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date:August 9, 2017

 

  /S/ C. TAYLOR PICKETT
  C. Taylor Pickett
  Chief Executive Officer

 

 

EX-31.4 17 t1700448_ex31-4.htm EXHIBIT 31.4

 

 

Exhibit 31.4

 

RULE 13a-14(a)/15d-14(a) CERTIFICATION OF CHIEF FINANCIAL OFFICER

 

Certifications

 

I, Robert O. Stephenson, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of OHI Healthcare Properties Holdco, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date:August 9, 2017

 

  /S/ ROBERT O. STEPHENSON
  Robert O. Stephenson
  Chief Financial Officer

 

 

EX-31.5 18 t1700448_ex31-5.htm EXHIBIT 31.5

 

 

Exhibit 31.5

 

RULE 13a-14(a)/15d-14(a) CERTIFICATION OF CHIEF EXECUTIVE OFFICER

 

Certification

 

I, C. Taylor Pickett, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of OHI Healthcare Properties Limited Partnership;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date:August 9, 2017

 

  /S/ C. TAYLOR PICKETT
  C. Taylor Pickett
  Chief Executive Officer of
  OHI Healthcare Properties Holdco, Inc.,
  the Primary General Partner

 

 

EX-31.6 19 t1700448_ex31-6.htm EXHIBIT 31.6

 

 

Exhibit 31.6

 

RULE 13a-14(a)/15d-14(a) CERTIFICATION OF CHIEF FINANCIAL OFFICER

 

Certifications

 

I, Robert O. Stephenson, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of OHI Healthcare Properties Limited Partnership;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date:August 9, 2017

 

  /S/ ROBERT O. STEPHENSON
  Robert O. Stephenson
  Chief Financial Officer of
  OHI Healthcare Properties Holdco, Inc.,
  the Primary General Partner

 

 

EX-32.1 20 t1700448_ex32-1.htm EXHIBIT 32.1

 

 

Exhibit 32.1

 

SECTION 1350 CERTIFICATION

OF THE CHIEF EXECUTIVE OFFICER

 

I, C. Taylor Pickett, Chief Executive Officer of Omega Healthcare Investors, Inc. (the “Company”), hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge:

 

(1)the Quarterly Report on Form 10-Q of the Company for the three months ended June 30, 2017 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date:August 9, 2017

 

/S/ C. TAYLOR PICKETT  
 C. Taylor Pickett  
 Chief Executive Officer  

 

 

EX-32.2 21 t1700448_ex32-2.htm EXHIBIT 32.2

 

 

Exhibit 32.2

 

SECTION 1350 CERTIFICATION

OF THE CHIEF FINANCIAL OFFICER

 

I, Robert O. Stephenson, Chief Financial Officer of Omega Healthcare Investors, Inc. (the “Company”), hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of my knowledge:

 

(1)the Quarterly Report on Form 10-Q of the Company for the three months ended June 30, 2017 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date:August 9, 2017

 

/S/ ROBERT O. STEPHENSON  
 Robert O. Stephenson  
 Chief Financial Officer  

 

 

EX-32.3 22 t1700448_ex32-3.htm EXHIBIT 32.3

 

 

Exhibit 32.3

 

SECTION 1350 CERTIFICATION

OF THE CHIEF EXECUTIVE OFFICER

 

I, C. Taylor Pickett, hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge:

 

(1)the Quarterly Report on Form 10-Q of OHI Healthcare Properties Holdco, Inc. (the “Company”) for the three months ended June 30, 2017 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date:August 9, 2017

 

/S/ C. TAYLOR PICKETT  
 C. Taylor Pickett  
 Chief Executive Officer  

 

 

EX-32.4 23 t1700448_ex32-4.htm EXHIBIT 32.4

 

 

Exhibit 32.4

 

SECTION 1350 CERTIFICATION

OF THE CHIEF FINANCIAL OFFICER

 

I, Robert O. Stephenson, hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of my knowledge:

 

(1)the Quarterly Report on Form 10-Q of OHI Healthcare Properties Holdco, Inc. (the “Company’) for the three months ended June 30, 2017 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date:August 9, 2017

 

/S/ ROBERT O. STEPHENSON  
 Robert O. Stephenson  
 Chief Financial Officer  

 

 

EX-32.5 24 t1700448_ex32-5.htm EXHIBIT 32.5

 

 

Exhibit 32.5

 

SECTION 1350 CERTIFICATION

OF THE CHIEF EXECUTIVE OFFICER

 

I, C. Taylor Pickett, Chief Executive Officer of OHI Healthcare Properties Holdco, Inc., the primary general partner of OHI Healthcare Properties Limited Partnership (the “Company”), hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge:

 

(1)the Quarterly Report on Form 10-Q of the Company for the three months ended June 30, 2017 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date:August 9, 2017

 

/S/ C. TAYLOR PICKETT  
 C. Taylor Pickett  
 Chief Executive Officer of  
 OHI Healthcare Properties Holdco, Inc.,  
 the Primary General Partner  

 

 

EX-32.6 25 t1700448_ex32-6.htm EXHIBIT 32.6

 

 

Exhibit 32.6

 

SECTION 1350 CERTIFICATION

OF THE CHIEF FINANCIAL OFFICER

 

I, Robert O. Stephenson, Chief Financial Officer of OHI Healthcare Properties Holdco, Inc., the primary general partner of OHI Healthcare Properties Limited Partnership (the “Company”), hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of my knowledge:

 

(1)the Quarterly Report on Form 10-Q of the Company for the three months ended June 30, 2017 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date:August 9, 2017

 

/S/ ROBERT O. STEPHENSON  
 Robert O. Stephenson  
 Chief Financial Officer of  
 OHI Healthcare Properties Holdco, Inc.,  
 the Primary General Partner  

 

 

EX-101.INS 26 ohi-20170630.xml XBRL INSTANCE DOCUMENT 0000888491 ohi:ArkHoldingCompanyIncMember 2013-11-27 0000888491 ohi:ArkHoldingCompanyIncMember ohi:SoutheastMember 2013-11-27 0000888491 ohi:ArkHoldingCompanyIncMember ohi:NorthwestMember 2013-11-27 0000888491 ohi:ArkHoldingCompanyIncMember stpr:TX 2013-11-27 0000888491 ohi:ArkHoldingCompanyIncMember stpr:IN 2013-11-27 0000888491 ohi:DirectFinancingLeasesMember ohi:ArkHoldingCompanyIncMember ohi:SkilledNursingFacilitiesMember 2013-11-27 0000888491 ohi:DirectFinancingLeasesMember ohi:ArkHoldingCompanyIncMember ohi:AssistedLivingFacilitiesMember 2013-11-27 0000888491 ohi:ArkHoldingCompanyIncMember 2013-11-01 2013-11-27 0000888491 2015-12-31 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember 2015-12-31 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-12-31 0000888491 us-gaap:SubsidiariesMember 2015-12-31 0000888491 us-gaap:PartnershipInterestMember 2015-12-31 0000888491 ohi:SkilledNursingFacilitiesMember ohi:LaurelHealthcareHoldingsMember 2016-02-01 0000888491 ohi:SkilledNursingFacilitiesMember ohi:LaurelHealthcareHoldingsMember 2016-01-25 2016-02-01 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember 2016-03-31 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-03-31 0000888491 2016-04-01 2016-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember 2016-04-01 2016-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-04-01 2016-06-30 0000888491 us-gaap:SubsidiariesMember 2016-04-01 2016-06-30 0000888491 us-gaap:PartnershipInterestMember 2016-04-01 2016-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:SubsidiariesMember 2016-04-01 2016-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:SubsidiariesMember 2016-04-01 2016-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:SubsidiariesMember 2016-04-01 2016-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:PartnershipInterestMember 2016-04-01 2016-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-04-01 2016-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:PartnershipInterestMember 2016-04-01 2016-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:PartnershipInterestMember 2016-04-01 2016-06-30 0000888491 2016-01-01 2016-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember 2016-01-01 2016-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-01-01 2016-06-30 0000888491 us-gaap:SubsidiariesMember 2016-01-01 2016-06-30 0000888491 us-gaap:PartnershipInterestMember 2016-01-01 2016-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:SubsidiariesMember 2016-01-01 2016-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:SubsidiariesMember 2016-01-01 2016-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:SubsidiariesMember 2016-01-01 2016-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:PartnershipInterestMember 2016-01-01 2016-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-01-01 2016-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:PartnershipInterestMember 2016-01-01 2016-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:PartnershipInterestMember 2016-01-01 2016-06-30 0000888491 2016-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember 2016-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-06-30 0000888491 us-gaap:SubsidiariesMember 2016-06-30 0000888491 us-gaap:PartnershipInterestMember 2016-06-30 0000888491 ohi:SecondSpringHealthcareInvestmentsMember ohi:AffiliatesOfLindseyGoldbergLlcMember 2016-11-01 0000888491 ohi:SecondSpringHealthcareInvestmentsMember 2016-11-01 0000888491 ohi:SecondSpringHealthcareInvestmentsMember ohi:WelltowerIncMember ohi:SkilledNursingFacilitiesMember 2016-10-30 2016-11-01 0000888491 2016-01-01 2016-12-31 0000888491 ohi:MortgageNoteDue2029InterestAtNinePointFortyFivePercentMember 2016-01-01 2016-12-31 0000888491 ohi:MortgageNoteDue2024InterestAtNinePointNinetyEightPercentMember 2016-01-01 2016-12-31 0000888491 2016-12-31 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember 2016-12-31 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-12-31 0000888491 us-gaap:SubsidiariesMember 2016-12-31 0000888491 us-gaap:PartnershipInterestMember 2016-12-31 0000888491 ohi:MortgageNoteDue2029InterestAtNinePointFortyFivePercentMember 2016-12-31 0000888491 ohi:MortgageNoteDue2024InterestAtNinePointNinetyEightPercentMember 2016-12-31 0000888491 ohi:OtherInvestmentNotesOutstandingMember 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:HudPortfolioDebtMember 2016-12-31 0000888491 us-gaap:SecuredDebtMember ohi:HudMortgagesAssumedDecember2011Member 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2024Member 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2025Member 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2024TwoMember 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2027Member 2016-12-31 0000888491 us-gaap:AboveMarketLeasesMember 2016-12-31 0000888491 us-gaap:LeasesAcquiredInPlaceMember 2016-12-31 0000888491 ohi:OmegaOpTermLoanMember us-gaap:UnsecuredDebtMember 2016-12-31 0000888491 us-gaap:SecuredDebtMember 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2026Member 2016-12-31 0000888491 ohi:OtherMortgageNotesMember 2016-12-31 0000888491 ohi:OtherInvestmentNoteDue2019InterestAtTenPointFiftyPercentMember 2016-12-31 0000888491 ohi:OtherInvestmentNoteDue2030InterestAtSixPointSixtySixPercentMember 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:TrancheAOneTermLoanMember 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:TrancheATwoTermLoanMember 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember 2016-12-31 0000888491 ohi:SeniorNotesDue2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-12-31 0000888491 ohi:SeniorNotesDue2024TwoMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-12-31 0000888491 ohi:SeniorNotesDue2025Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-12-31 0000888491 ohi:SeniorNotesDue2026Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-12-31 0000888491 ohi:SeniorNotesDue2027Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-12-31 0000888491 ohi:SeniorNotesDue2024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-12-31 0000888491 ohi:SeniorNotesDue2024TwoMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-12-31 0000888491 ohi:SeniorNotesDue2025Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-12-31 0000888491 ohi:SeniorNotesDue2026Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-12-31 0000888491 ohi:SeniorNotesDue2027Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-12-31 0000888491 us-gaap:CashFlowHedgingMember 2016-12-31 0000888491 ohi:OtherInvestmentNoteDue2020InterestAtFourteenPercentMember 2016-12-31 0000888491 ohi:OtherInvestmentNoteDue2022InterestAtNinePercentMember 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:TrancheAThreeTermLoanMember 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:OtherNotesMember 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2023Member 2016-12-31 0000888491 us-gaap:CarryingReportedAmountFairValueDisclosureMember ohi:SeniorNotesDue2023Member 2016-12-31 0000888491 us-gaap:EstimateOfFairValueFairValueDisclosureMember ohi:SeniorNotesDue2023Member 2016-12-31 0000888491 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-12-31 0000888491 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-12-31 0000888491 us-gaap:SecuredDebtMember ohi:DeferredFinancingCostsNetMember 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:DeferredFinancingCostsNetMember 2016-12-31 0000888491 us-gaap:BuildingMember 2016-12-31 0000888491 us-gaap:LandMember 2016-12-31 0000888491 us-gaap:FurnitureAndFixturesMember 2016-12-31 0000888491 ohi:SiteImprovementsAndEquipmentMember 2016-12-31 0000888491 us-gaap:ConstructionInProgressMember 2016-12-31 0000888491 us-gaap:CarryingReportedAmountFairValueDisclosureMember ohi:Seniornotesdue2028Member 2016-12-31 0000888491 us-gaap:EstimateOfFairValueFairValueDisclosureMember ohi:Seniornotesdue2028Member 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:USTermLoanMember 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:Seniornotesdue2028Member 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:SterlingTermLoanMember 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember us-gaap:LongTermDebtMember 2016-12-31 0000888491 us-gaap:UnsecuredDebtMember ohi:CreditFacilityMember 2016-12-31 0000888491 ohi:CumulativeDividendsMember 2016-12-31 0000888491 us-gaap:RetainedEarningsMember 2016-12-31 0000888491 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0000888491 us-gaap:CommonStockMember 2016-12-31 0000888491 us-gaap:ParentMember 2016-12-31 0000888491 us-gaap:NoncontrollingInterestMember 2016-12-31 0000888491 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0000888491 us-gaap:SubsidiariesMember us-gaap:RetainedEarningsMember 2016-12-31 0000888491 us-gaap:SubsidiariesMember ohi:CumulativeDividendsMember 2016-12-31 0000888491 us-gaap:SubsidiariesMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0000888491 us-gaap:SubsidiariesMember us-gaap:ParentMember 2016-12-31 0000888491 us-gaap:SubsidiariesMember us-gaap:NoncontrollingInterestMember 2016-12-31 0000888491 us-gaap:PartnershipInterestMember us-gaap:LimitedPartnerMember 2016-12-31 0000888491 us-gaap:PartnershipInterestMember us-gaap:GeneralPartnerMember 2016-12-31 0000888491 us-gaap:SubsidiariesMember us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0000888491 us-gaap:BoardOfDirectorsChairmanMember 2017-01-01 2017-01-12 0000888491 2017-01-01 2017-03-31 0000888491 ohi:AssistedLivingFacilitiesMember 2017-01-01 2017-03-31 0000888491 ohi:NorthwestMember ohi:DirectFinancingLeasesMember ohi:SalesAgreementMember 2017-01-01 2017-03-31 0000888491 2017-03-31 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember 2017-03-31 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-03-31 0000888491 ohi:AssistedLivingFacilitiesMember 2017-03-31 0000888491 ohi:NorthwestMember ohi:DirectFinancingLeasesMember ohi:SalesAgreementMember 2017-03-31 0000888491 ohi:SkilledNursingFacilitiesMember 2017-03-31 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2024Member 2017-04-04 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2025Member 2017-04-04 0000888491 us-gaap:UnsecuredDebtMember ohi:Seniornotesdue2028Member 2017-04-04 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2024Member 2017-04-01 2017-04-04 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2025Member 2017-04-01 2017-04-04 0000888491 us-gaap:UnsecuredDebtMember ohi:TrancheATwoTermLoanMember 2017-04-01 2017-04-04 0000888491 us-gaap:UnsecuredDebtMember 2017-04-01 2017-04-04 0000888491 us-gaap:UnsecuredDebtMember ohi:Seniornotesdue2028Member 2017-04-01 2017-04-04 0000888491 us-gaap:BoardOfDirectorsChairmanMember 2017-04-01 2017-04-13 0000888491 us-gaap:UnsecuredDebtMember 2017-04-01 2017-04-28 0000888491 ohi:OmegaOpTermLoanMember us-gaap:UnsecuredDebtMember 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember us-gaap:LongTermDebtMember 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member ohi:CreditFacilityMember 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member ohi:USTermLoanMember 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member ohi:SterlingTermLoanMember 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member 2017-05-25 0000888491 ohi:OmegaOpTermLoanMember us-gaap:UnsecuredDebtMember 2017-05-01 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember us-gaap:LongTermDebtMember 2017-05-01 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member ohi:CreditFacilityMember 2017-05-01 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member ohi:TrancheAOneTermLoanMember 2017-05-01 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member ohi:TrancheATwoTermLoanMember 2017-05-01 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member ohi:TrancheAThreeTermLoanMember 2017-05-01 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member ohi:UsAndSterlingTermLoanMember 2017-05-01 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member ohi:UsAndSterlingTermLoanMember us-gaap:MinimumMember 2017-05-01 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member ohi:UsAndSterlingTermLoanMember us-gaap:MaximumMember 2017-05-01 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaOpTermLoanMember us-gaap:MinimumMember 2017-05-01 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaOpTermLoanMember us-gaap:MaximumMember 2017-05-01 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member ohi:CreditFacilityMember us-gaap:MinimumMember 2017-05-01 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member ohi:CreditFacilityMember us-gaap:MaximumMember 2017-05-01 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member us-gaap:MaximumMember us-gaap:LongTermDebtMember 2017-05-01 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member us-gaap:MinimumMember us-gaap:LongTermDebtMember 2017-05-01 2017-05-25 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member ohi:SeniorUnsecured2014RevolvingCreditFacilityMember 2017-05-01 2017-05-25 0000888491 2017-04-01 2017-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember 2017-04-01 2017-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-04-01 2017-06-30 0000888491 us-gaap:SubsidiariesMember 2017-04-01 2017-06-30 0000888491 us-gaap:PartnershipInterestMember 2017-04-01 2017-06-30 0000888491 ohi:NorthwestMember ohi:DirectFinancingLeasesMember ohi:SalesAgreementMember 2017-04-01 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:OmegaCreditFacilities2017Member 2017-04-01 2017-06-30 0000888491 ohi:EquityShelfUsd500Million2015ProgramMember 2017-04-01 2017-06-30 0000888491 ohi:DividendReinvestmentAndCommonStockPurchasePlanMember 2017-04-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember us-gaap:LandMember 2017-04-01 2017-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:SubsidiariesMember 2017-04-01 2017-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:SubsidiariesMember 2017-04-01 2017-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:SubsidiariesMember 2017-04-01 2017-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:PartnershipInterestMember 2017-04-01 2017-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-04-01 2017-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:PartnershipInterestMember 2017-04-01 2017-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:PartnershipInterestMember 2017-04-01 2017-06-30 0000888491 2017-01-01 2017-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember 2017-01-01 2017-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-01-01 2017-06-30 0000888491 us-gaap:SubsidiariesMember 2017-01-01 2017-06-30 0000888491 us-gaap:PartnershipInterestMember 2017-01-01 2017-06-30 0000888491 ohi:MortgageNoteDue2029InterestAtNinePointFortyFivePercentMember 2017-01-01 2017-06-30 0000888491 ohi:MortgageNoteDue2024InterestAtNinePointNinetyEightPercentMember 2017-01-01 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:HudPortfolioDebtMember 2017-01-01 2017-06-30 0000888491 us-gaap:SecuredDebtMember ohi:HudMortgagesAssumedDecember2011Member 2017-01-01 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2024Member 2017-01-01 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2025Member 2017-01-01 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2024TwoMember 2017-01-01 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2027Member 2017-01-01 2017-06-30 0000888491 us-gaap:AboveMarketLeasesMember 2017-01-01 2017-06-30 0000888491 ohi:OmegaOpTermLoanMember us-gaap:UnsecuredDebtMember 2017-01-01 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2026Member 2017-01-01 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:OtherNotesMember 2017-01-01 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2023Member 2017-01-01 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:USTermLoanMember 2017-01-01 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:Seniornotesdue2028Member 2017-01-01 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:SterlingTermLoanMember 2017-01-01 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember us-gaap:LongTermDebtMember 2017-01-01 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:CreditFacilityMember 2017-01-01 2017-06-30 0000888491 ohi:CumulativeDividendsMember 2017-01-01 2017-06-30 0000888491 us-gaap:RetainedEarningsMember 2017-01-01 2017-06-30 0000888491 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-06-30 0000888491 us-gaap:CommonStockMember 2017-01-01 2017-06-30 0000888491 us-gaap:ParentMember 2017-01-01 2017-06-30 0000888491 us-gaap:NoncontrollingInterestMember 2017-01-01 2017-06-30 0000888491 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-06-30 0000888491 us-gaap:SubsidiariesMember us-gaap:RetainedEarningsMember 2017-01-01 2017-06-30 0000888491 us-gaap:SubsidiariesMember ohi:CumulativeDividendsMember 2017-01-01 2017-06-30 0000888491 us-gaap:SubsidiariesMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-06-30 0000888491 us-gaap:SubsidiariesMember us-gaap:ParentMember 2017-01-01 2017-06-30 0000888491 us-gaap:SubsidiariesMember us-gaap:NoncontrollingInterestMember 2017-01-01 2017-06-30 0000888491 us-gaap:PartnershipInterestMember us-gaap:LimitedPartnerMember 2017-01-01 2017-06-30 0000888491 us-gaap:PartnershipInterestMember us-gaap:GeneralPartnerMember 2017-01-01 2017-06-30 0000888491 ohi:NorthwestMember ohi:DirectFinancingLeasesMember ohi:SalesAgreementMember 2017-01-01 2017-06-30 0000888491 ohi:EquityShelfUsd500Million2015ProgramMember 2017-01-01 2017-06-30 0000888491 ohi:DividendReinvestmentAndCommonStockPurchasePlanMember 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember us-gaap:LandMember 2017-01-01 2017-06-30 0000888491 ohi:OtherInvestmentNotesOutstandingMember us-gaap:MaximumMember 2017-01-01 2017-06-30 0000888491 us-gaap:MortgageLoansOver1000000Member 2017-01-01 2017-06-30 0000888491 ohi:PerformanceRestrictedStockUnitsMember ohi:FinancialYearTwoThousandSixteenTsrMember 2017-01-01 2017-06-30 0000888491 us-gaap:PropertyAvailableForOperatingLeaseMember us-gaap:MinimumMember 2017-01-01 2017-06-30 0000888491 us-gaap:PropertyAvailableForOperatingLeaseMember us-gaap:MaximumMember 2017-01-01 2017-06-30 0000888491 us-gaap:RestrictedStockMember us-gaap:DirectorMember 2017-01-01 2017-06-30 0000888491 ohi:PerformanceRestrictedStockUnitsMember ohi:FinancialYearTwoThousandSeventeenTwoLtipMember 2017-01-01 2017-06-30 0000888491 us-gaap:RestrictedStockUnitsRSUMember ohi:ThirtyOneMarchTwoThousandFifteenMember 2017-01-01 2017-06-30 0000888491 us-gaap:RestrictedStockUnitsRSUMember ohi:FirstAprilTwoThousandFifteenMember 2017-01-01 2017-06-30 0000888491 us-gaap:RestrictedStockUnitsRSUMember ohi:FirstAprilTwoThousandFifteenTwoMember 2017-01-01 2017-06-30 0000888491 us-gaap:RestrictedStockUnitsRSUMember ohi:SeventeenthMarchTwoThousandSixteenMember 2017-01-01 2017-06-30 0000888491 ohi:PerformanceRestrictedStockUnitsMember ohi:FinancialYearTwoThousandEighteenMember 2017-01-01 2017-06-30 0000888491 ohi:OtherRealEstateInvestmentTrustsMember ohi:FinancialYearTwoThousandSixteenRelativeTsrMember 2017-01-01 2017-06-30 0000888491 ohi:OtherRealEstateInvestmentTrustsMember ohi:FinancialYearTwoThousandSeventeenRelativePrsusMember 2017-01-01 2017-06-30 0000888491 ohi:OtherRealEstateInvestmentTrustsMember ohi:FinancialYearTwoThousandSeventeenRelativePrsusTwoMember 2017-01-01 2017-06-30 0000888491 ohi:OtherRealEstateInvestmentTrustsMember ohi:FinancialYearTwoThousandEighteenRelativePrsusMember 2017-01-01 2017-06-30 0000888491 us-gaap:MinimumMember ohi:OtherMortgageNotesMember 2017-01-01 2017-06-30 0000888491 us-gaap:MaximumMember ohi:OtherMortgageNotesMember 2017-01-01 2017-06-30 0000888491 ohi:FinancialYearTwoThousandSeventeenLTIPMember ohi:PerformanceRestrictedStockUnitsMember 2017-01-01 2017-06-30 0000888491 us-gaap:RestrictedStockUnitsRSUMember ohi:FirstJanuaryTwoThousandSeventeenRestrictedStockUnitMember 2017-01-01 2017-06-30 0000888491 ohi:PerformanceRestrictedStockUnitsMember ohi:FirstJanuaryTwoThousandSeventeenMember 2017-01-01 2017-06-30 0000888491 ohi:OtherRealEstateInvestmentTrustsMember ohi:FirstJanuaryTwoThousandSeventeenRelativeTsrPrsusMember 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:FirstQuarterMember stpr:VA us-gaap:LandMember 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:FirstQuarterMember stpr:VA us-gaap:BuildingImprovementsMember 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:FirstQuarterMember stpr:VA us-gaap:FurnitureAndFixturesMember 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:SecondQuarterMember country:NC us-gaap:LandMember 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:SecondQuarterMember country:NC us-gaap:BuildingImprovementsMember 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:SecondQuarterMember country:NC us-gaap:FurnitureAndFixturesMember 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:SecondQuarterMember country:GB us-gaap:LandMember 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:SecondQuarterMember country:GB us-gaap:BuildingImprovementsMember 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:SecondQuarterMember country:GB us-gaap:FurnitureAndFixturesMember 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:FirstQuarterMember stpr:VA 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:SecondQuarterMember country:NC 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:SecondQuarterMember country:GB 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember us-gaap:BuildingImprovementsMember 2017-01-01 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember us-gaap:FurnitureAndFixturesMember 2017-01-01 2017-06-30 0000888491 ohi:CienaHealthcareMember 2017-01-01 2017-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:SubsidiariesMember 2017-01-01 2017-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:SubsidiariesMember 2017-01-01 2017-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:SubsidiariesMember 2017-01-01 2017-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:PartnershipInterestMember 2017-01-01 2017-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-01-01 2017-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:PartnershipInterestMember 2017-01-01 2017-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:PartnershipInterestMember 2017-01-01 2017-06-30 0000888491 2017-06-30 0000888491 ohi:ArkHoldingCompanyIncMember 2017-06-30 0000888491 ohi:ArkHoldingCompanyIncMember ohi:NorthwestMember 2017-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember 2017-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-06-30 0000888491 us-gaap:SubsidiariesMember 2017-06-30 0000888491 us-gaap:PartnershipInterestMember 2017-06-30 0000888491 ohi:MortgageNoteDue2029InterestAtNinePointFortyFivePercentMember 2017-06-30 0000888491 ohi:MortgageNoteDue2024InterestAtNinePointNinetyEightPercentMember 2017-06-30 0000888491 ohi:OtherInvestmentNotesOutstandingMember 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:HudPortfolioDebtMember 2017-06-30 0000888491 us-gaap:SecuredDebtMember ohi:HudMortgagesAssumedDecember2011Member 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2024Member 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2025Member 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2024TwoMember 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2027Member 2017-06-30 0000888491 us-gaap:AboveMarketLeasesMember 2017-06-30 0000888491 us-gaap:LeasesAcquiredInPlaceMember 2017-06-30 0000888491 ohi:OmegaOpTermLoanMember us-gaap:UnsecuredDebtMember 2017-06-30 0000888491 us-gaap:SecuredDebtMember 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2026Member 2017-06-30 0000888491 ohi:OtherMortgageNotesMember 2017-06-30 0000888491 ohi:OtherInvestmentNoteDue2019InterestAtTenPointFiftyPercentMember 2017-06-30 0000888491 ohi:OtherInvestmentNoteDue2030InterestAtSixPointSixtySixPercentMember 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember 2017-06-30 0000888491 ohi:SeniorNotesDue2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2017-06-30 0000888491 ohi:SeniorNotesDue2024TwoMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2017-06-30 0000888491 ohi:SeniorNotesDue2025Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2017-06-30 0000888491 ohi:SeniorNotesDue2026Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2017-06-30 0000888491 ohi:SeniorNotesDue2027Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2017-06-30 0000888491 ohi:SeniorNotesDue2024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-06-30 0000888491 ohi:SeniorNotesDue2024TwoMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-06-30 0000888491 ohi:SeniorNotesDue2025Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-06-30 0000888491 ohi:SeniorNotesDue2026Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-06-30 0000888491 ohi:SeniorNotesDue2027Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-06-30 0000888491 us-gaap:CashFlowHedgingMember 2017-06-30 0000888491 ohi:OtherInvestmentNoteDue2020InterestAtFourteenPercentMember 2017-06-30 0000888491 ohi:OtherInvestmentNoteDue2022InterestAtNinePercentMember 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:OtherNotesMember 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:SeniorNotesDue2023Member 2017-06-30 0000888491 us-gaap:CarryingReportedAmountFairValueDisclosureMember ohi:SeniorNotesDue2023Member 2017-06-30 0000888491 us-gaap:EstimateOfFairValueFairValueDisclosureMember ohi:SeniorNotesDue2023Member 2017-06-30 0000888491 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2017-06-30 0000888491 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-06-30 0000888491 us-gaap:SecuredDebtMember ohi:DeferredFinancingCostsNetMember 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:DeferredFinancingCostsNetMember 2017-06-30 0000888491 us-gaap:BuildingMember 2017-06-30 0000888491 us-gaap:LandMember 2017-06-30 0000888491 us-gaap:FurnitureAndFixturesMember 2017-06-30 0000888491 ohi:SiteImprovementsAndEquipmentMember 2017-06-30 0000888491 us-gaap:ConstructionInProgressMember 2017-06-30 0000888491 us-gaap:CarryingReportedAmountFairValueDisclosureMember ohi:Seniornotesdue2028Member 2017-06-30 0000888491 us-gaap:EstimateOfFairValueFairValueDisclosureMember ohi:Seniornotesdue2028Member 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:USTermLoanMember 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:Seniornotesdue2028Member 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:SterlingTermLoanMember 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember us-gaap:LongTermDebtMember 2017-06-30 0000888491 us-gaap:UnsecuredDebtMember ohi:CreditFacilityMember 2017-06-30 0000888491 ohi:CumulativeDividendsMember 2017-06-30 0000888491 us-gaap:RetainedEarningsMember 2017-06-30 0000888491 us-gaap:AdditionalPaidInCapitalMember 2017-06-30 0000888491 us-gaap:CommonStockMember 2017-06-30 0000888491 us-gaap:ParentMember 2017-06-30 0000888491 us-gaap:NoncontrollingInterestMember 2017-06-30 0000888491 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-06-30 0000888491 us-gaap:SubsidiariesMember us-gaap:RetainedEarningsMember 2017-06-30 0000888491 us-gaap:SubsidiariesMember ohi:CumulativeDividendsMember 2017-06-30 0000888491 us-gaap:SubsidiariesMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-06-30 0000888491 us-gaap:SubsidiariesMember us-gaap:ParentMember 2017-06-30 0000888491 us-gaap:SubsidiariesMember us-gaap:NoncontrollingInterestMember 2017-06-30 0000888491 us-gaap:PartnershipInterestMember us-gaap:LimitedPartnerMember 2017-06-30 0000888491 us-gaap:PartnershipInterestMember us-gaap:GeneralPartnerMember 2017-06-30 0000888491 us-gaap:SubsidiariesMember us-gaap:AdditionalPaidInCapitalMember 2017-06-30 0000888491 ohi:AssistedLivingFacilitiesMember 2017-06-30 0000888491 ohi:SkilledNursingFacilitiesMember 2017-06-30 0000888491 ohi:OtherInvestmentNotesOutstandingMember us-gaap:MaximumMember 2017-06-30 0000888491 us-gaap:MortgageLoansOver1000000Member 2017-06-30 0000888491 ohi:PerformanceRestrictedStockUnitsMember ohi:FinancialYearTwoThousandSixteenTsrMember 2017-06-30 0000888491 us-gaap:RestrictedStockMember us-gaap:DirectorMember 2017-06-30 0000888491 ohi:PerformanceRestrictedStockUnitsMember ohi:FinancialYearTwoThousandSeventeenTwoLtipMember 2017-06-30 0000888491 us-gaap:RestrictedStockUnitsRSUMember ohi:ThirtyOneMarchTwoThousandFifteenMember 2017-06-30 0000888491 us-gaap:RestrictedStockUnitsRSUMember ohi:FirstAprilTwoThousandFifteenMember 2017-06-30 0000888491 us-gaap:RestrictedStockUnitsRSUMember ohi:FirstAprilTwoThousandFifteenTwoMember 2017-06-30 0000888491 us-gaap:RestrictedStockUnitsRSUMember ohi:SeventeenthMarchTwoThousandSixteenMember 2017-06-30 0000888491 ohi:PerformanceRestrictedStockUnitsMember ohi:FinancialYearTwoThousandEighteenMember 2017-06-30 0000888491 ohi:OtherRealEstateInvestmentTrustsMember ohi:FinancialYearTwoThousandSixteenRelativeTsrMember 2017-06-30 0000888491 ohi:OtherRealEstateInvestmentTrustsMember ohi:FinancialYearTwoThousandSeventeenRelativePrsusMember 2017-06-30 0000888491 ohi:OtherRealEstateInvestmentTrustsMember ohi:FinancialYearTwoThousandSeventeenRelativePrsusTwoMember 2017-06-30 0000888491 ohi:OtherRealEstateInvestmentTrustsMember ohi:FinancialYearTwoThousandEighteenRelativePrsusMember 2017-06-30 0000888491 ohi:FinancialYearTwoThousandSeventeenLTIPMember ohi:PerformanceRestrictedStockUnitsMember 2017-06-30 0000888491 us-gaap:RestrictedStockUnitsRSUMember ohi:FirstJanuaryTwoThousandSeventeenRestrictedStockUnitMember 2017-06-30 0000888491 ohi:PerformanceRestrictedStockUnitsMember ohi:FirstJanuaryTwoThousandSeventeenMember 2017-06-30 0000888491 ohi:OtherRealEstateInvestmentTrustsMember ohi:FirstJanuaryTwoThousandSeventeenRelativeTsrPrsusMember 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:SecondQuarterMember country:GB 2017-06-30 0000888491 ohi:OtherInvestmentNotesOutstandingMember us-gaap:MinimumMember 2017-06-30 0000888491 ohi:AwardDateOneJanuary2017Member ohi:PerformanceRestrictedStockUnitsMember 2017-06-30 0000888491 ohi:AwardDateOneJanuary2017Member us-gaap:RestrictedStockUnitsRSUMember 2017-06-30 0000888491 ohi:AwardDateOneJanuary2017Member ohi:OtherRealEstateInvestmentTrustsMember 2017-06-30 0000888491 ohi:OmegaOpUnitsMember 2017-06-30 0000888491 ohi:OmegaOpUnitsMember ohi:OtherInvestorsMember 2017-06-30 0000888491 ohi:PerformanceRestrictedStockUnitsMember 2017-06-30 0000888491 ohi:SpecialtyMember 2017-06-30 0000888491 stpr:FL 2017-06-30 0000888491 stpr:OH 2017-06-30 0000888491 stpr:TX 2017-06-30 0000888491 us-gaap:RestrictedStockUnitsRSUMember 2017-06-30 0000888491 ohi:OtherRealEstateInvestmentTrustsMember 2017-06-30 0000888491 ohi:SeniorNotesDue2024Member 2017-06-30 0000888491 ohi:SeniorNotesDue2024TwoMember 2017-06-30 0000888491 ohi:SeniorNotesDue2025Member 2017-06-30 0000888491 ohi:SeniorNotesDue2026Member 2017-06-30 0000888491 ohi:SeniorNotesDue2027Member 2017-06-30 0000888491 ohi:SeniorNotesDue2023Member 2017-06-30 0000888491 ohi:Seniornotesdue2028Member 2017-06-30 0000888491 ohi:MedicalOfficeBuildingMember 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:FirstQuarterMember ohi:AssistedLivingFacilitiesMember 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:SecondQuarterMember ohi:SkilledNursingFacilitiesMember 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:SecondQuarterMember ohi:AssistedLivingFacilitiesMember 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:SkilledNursingFacilitiesMember 2017-06-30 0000888491 ohi:Acquisitions2017AndOtherMember ohi:AssistedLivingFacilitiesMember 2017-06-30 0000888491 us-gaap:BoardOfDirectorsChairmanMember us-gaap:SubsequentEventMember 2017-07-01 2017-07-13 0000888491 2017-08-02 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:SubsidiariesMember 2016-03-31 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:SubsidiariesMember 2016-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:SubsidiariesMember 2016-03-31 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:SubsidiariesMember 2016-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:SubsidiariesMember 2016-03-31 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:SubsidiariesMember 2016-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:PartnershipInterestMember 2016-03-31 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:PartnershipInterestMember 2016-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-03-31 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:PartnershipInterestMember 2016-03-31 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:PartnershipInterestMember 2016-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:PartnershipInterestMember 2016-03-31 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:PartnershipInterestMember 2016-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:SubsidiariesMember 2015-12-31 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:SubsidiariesMember 2015-12-31 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:SubsidiariesMember 2015-12-31 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:PartnershipInterestMember 2015-12-31 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2015-12-31 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:PartnershipInterestMember 2015-12-31 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:PartnershipInterestMember 2015-12-31 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:SubsidiariesMember 2017-03-31 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:SubsidiariesMember 2017-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:SubsidiariesMember 2017-03-31 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:SubsidiariesMember 2017-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:SubsidiariesMember 2017-03-31 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:SubsidiariesMember 2017-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:PartnershipInterestMember 2017-03-31 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:PartnershipInterestMember 2017-06-30 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-03-31 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-06-30 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:PartnershipInterestMember 2017-03-31 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:PartnershipInterestMember 2017-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:PartnershipInterestMember 2017-03-31 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:PartnershipInterestMember 2017-06-30 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:SubsidiariesMember 2016-12-31 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:SubsidiariesMember 2016-12-31 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:SubsidiariesMember 2016-12-31 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:PartnershipInterestMember 2016-12-31 0000888491 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-12-31 0000888491 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember us-gaap:PartnershipInterestMember 2016-12-31 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember us-gaap:PartnershipInterestMember 2016-12-31 xbrli:shares iso4217:USD iso4217:GBP iso4217:USDxbrli:shares ohi:Segment xbrli:pure ohi:Facility ohi:Healthcare_facility ohi:Parcel ohi:Lease ohi:State ohi:Mortgage ohi:Entity ohi:Property ohi:Operator OMEGA HEALTHCARE INVESTORS INC OHI Healthcare Properties Holdco, Inc. OHI Healthcare Properties Limited Partnership 0000888491 0001639311 0001639315 ohi --12-31 --12-31 --12-31 Large Accelerated Filer Non-accelerated Filer Non-accelerated Filer 197241081 10-Q 10-Q 10-Q 2017-06-30 2017-06-30 2017-06-30 false false false 2017 2017 2017 Q2 Q2 Q2 7566358000 7566358000 7566358000 5954771000 759295000 454760000 206206000 191326000 7730199000 7730199000 7730199000 6055423000 796561000 458427000 204993000 214795000 1240336000 1240336000 1240336000 1366376000 1366376000 1366376000 6326022000 6326022000 6326022000 6363823000 6363823000 6363823000 601938000 601938000 601938000 582307000 582307000 582307000 639343000 639343000 639343000 639343000 662709000 662709000 662709000 662709000 7567303000 7567303000 7567303000 7608839000 7608839000 7608839000 256846000 256846000 256846000 3000000 256846000 278985000 278985000 278985000 1500000 278985000 50000000 48776000 48776000 48776000 38968000 38968000 38968000 52868000 52868000 52868000 18889000 18889000 18889000 7925793000 7925793000 7925793000 7945681000 7945681000 7945681000 5424000 5424000 5424000 32959000 32959000 32959000 93687000 93687000 93687000 21031000 21031000 21031000 13589000 13589000 13589000 12203000 12203000 12203000 240035000 240035000 240035000 288686000 288686000 288686000 643474000 643474000 643474000 644184000 644184000 644184000 32682000 32682000 32682000 34869000 34869000 34869000 8949260000 8949260000 8949260000 8946654000 8946654000 8946654000 190000000 190000000 190000000 1250000000 425000000 100000000 1800000000 155000000 155000000 155000000 1094343000 100000000 100000000 100000000 248064000 250000000 100000000 250000000 899292000 99372000 99372000 100000000 248226000 425000000 130250000 250000000 54365000 54365000 54365000 54954000 54365000 54365000 53737000 53737000 53737000 54316000 53737000 53737000 3028146000 3321858000 360514000 302959000 302959000 323543000 267346000 267346000 9906000 9906000 9906000 17714000 17714000 17714000 4270044000 4270044000 4332975000 4332975000 4737274000 4737274000 4737274000 4771144000 4771144000 4771144000 19614000 19722000 4861408000 923218000 4896076000 923218000 1738937000 126187000 1908634000 163808000 2707387000 175289000 2954230000 229930000 3858745000 861677000 3828299000 847299000 353241000 3350309000 347211000 3328211000 -46463000 -10806000 -48771000 -53827000 -12439000 -41903000 -9797000 -43913000 4211986000 4211986000 -2707387000 1738937000 4861408000 19614000 3858745000 353241000 -53827000 126187000 -175289000 -12439000 861677000 3350309000 923218000 4175510000 4175510000 -2954230000 1908634000 4896076000 19722000 3828299000 347211000 -41903000 163808000 -229930000 -9797000 847299000 3328211000 923218000 3858745000 3828299000 353241000 347211000 4211986000 353241000 3858745000 4175510000 347211000 3828299000 8949260000 8949260000 8949260000 8946654000 8946654000 8946654000 0.10 0.10 350000000 350000000 196142000 197224000 196142000 1000 197224000 1000 186454000 186454000 186454000 363157000 363157000 363157000 193997000 193997000 193997000 386534000 386534000 386534000 15521000 15521000 15521000 30963000 30963000 30963000 15462000 15462000 15462000 500000 31108000 31108000 31108000 1300000 21371000 21371000 21371000 37977000 37977000 37977000 16297000 16297000 16297000 32253000 32253000 32253000 4982000 4982000 4982000 8413000 8413000 8413000 7278000 7278000 7278000 14192000 14192000 14192000 496000 496000 496000 1193000 1193000 1193000 2763000 2763000 2763000 3454000 3454000 3454000 228824000 228824000 228824000 441703000 441703000 441703000 235797000 235797000 235797000 467541000 467541000 467541000 65505000 65505000 65505000 127938000 127938000 127938000 70350000 70350000 70350000 140343000 140343000 140343000 11832000 11832000 11832000 22287000 22287000 22287000 11541000 11541000 11541000 24065000 24065000 24065000 3504000 3504000 3504000 7275000 7275000 7275000 19000 19000 19000 -22000 -22000 -22000 6893000 6893000 6893000 41451000 41451000 41451000 7600000 10135000 10135000 10135000 17773000 17773000 17773000 -1154000 -1154000 -1154000 3970000 3970000 3970000 2673000 2673000 2673000 5077000 5077000 5077000 86580000 86580000 86580000 202921000 202921000 202921000 94718000 94718000 94718000 187236000 187236000 187236000 4000 4000 4000 12000 12000 12000 254000 254000 254000 258000 258000 258000 39651000 39651000 39651000 76873000 76873000 76873000 48085000 48085000 48085000 93126000 93126000 93126000 2210000 2210000 2210000 4342000 4342000 4342000 2543000 2543000 2543000 5045000 5045000 5045000 298000 298000 298000 21965000 21965000 21965000 21965000 21965000 21965000 10412000 10412000 10412000 -22000 -22000 -22000 79000 79000 79000 140000 140000 140000 -41857000 -41857000 -41857000 -81523000 -81523000 -81523000 -72260000 -72260000 -72260000 -109326000 -109326000 -109326000 142244000 142244000 142244000 238782000 238782000 238782000 141079000 141079000 141079000 280305000 280305000 280305000 100387000 100387000 100387000 157259000 157259000 157259000 68819000 68819000 68819000 170979000 170979000 170979000 13221000 13221000 13221000 14792000 14792000 14792000 -622000 -622000 -622000 6798000 6798000 6798000 113608000 113608000 113608000 172051000 172051000 172051000 68197000 68197000 68197000 177777000 177777000 177777000 454000 454000 454000 701000 701000 701000 591000 591000 591000 1691000 1691000 1691000 551000 551000 551000 1183000 1183000 1183000 113154000 113154000 113154000 171350000 171350000 171350000 68157000 68157000 68157000 177269000 177269000 177269000 169697000 169697000 7572000 37621000 37621000 139648000 7572000 169697000 5102000 88160000 7743000 133455000 2900000 53709000 7572000 139648000 108052000 24994000 163607000 37895000 65257000 14448000 169697000 37621000 0.57 0.87 0.33 0.86 0.57 0.86 0.33 0.86 0.57 0.87 0.33 0.86 0.57 0.86 0.33 0.86 0.58 0.58 1.15 1.15 0.62 0.63 0.63 0.63 1.25 1.25 0.64 188981000 188604000 197433000 197223000 199157000 198754000 206672000 206423000 197903000 197539000 206205000 206016000 199157000 198754000 206672000 206423000 -21836000 -21836000 -21836000 -26566000 -26566000 -26566000 10274000 10274000 10274000 14608000 14608000 14608000 13986000 622000 13986000 3098000 3098000 11510000 622000 13986000 -4198000 -4198000 -4198000 -13074000 -13074000 -13074000 -3407000 -3407000 -3407000 -2153000 -2153000 -2153000 -2062000 -91000 -2062000 -456000 -456000 -1697000 -91000 -2062000 -26034000 -26034000 -26034000 -39640000 -39640000 -39640000 6867000 6867000 6867000 12455000 12455000 12455000 87120000 87120000 87120000 131710000 131710000 131710000 75024000 75024000 75024000 189724000 189724000 189724000 3928000 67877000 5953000 102581000 3192000 59120000 8103000 149460000 83192000 19243000 125757000 29129000 71832000 15904000 181621000 40264000 205004000 8862000 196142000 205996000 8772000 197224000 -3000 3000 7478000 7478000 7478000 -2120000 -2131000 11000 -2120000 19721000 19660000 61000 19721000 150000 149000 1000 150000 -29000 -29000 -29000 6634000 6611000 23000 6634000 246843000 246843000 246843000 2942000 2933000 9000 2942000 2990000 2990000 11143000 11143000 34776000 34776000 1082000 1082000 2990000 2990000 90000 90000 34776000 34776000 260976000 257986000 54641000 54641000 206335000 11143000 246843000 32000 31.23 114000 614000 32.11 5000 32.18 400000 228000 200000 614000 29.17 1.25 89000 32.91 90000 8862000 8772000 4640000 4640000 4640000 15240000 15240000 15240000 5915000 5915000 5915000 6164000 6164000 6164000 6443000 6443000 6443000 7478000 7478000 7478000 7910000 7910000 7910000 6202000 6202000 6202000 619000 619000 619000 1191000 1191000 1191000 -856000 -856000 -856000 33293000 33293000 33293000 17756000 17756000 17756000 23174000 23174000 23174000 -1294000 -1294000 -1294000 -895000 -895000 -895000 24055000 24055000 24055000 21667000 21667000 21667000 286895000 286895000 286895000 265586000 265586000 265586000 622848000 622848000 622848000 130977000 130977000 130977000 2341000 2341000 2341000 26960000 26960000 26960000 46108000 46108000 46108000 30000 30000 30000 4767000 4767000 4767000 -27253000 -27253000 -27253000 12528000 12528000 12528000 24978000 24978000 24978000 9741000 9741000 9741000 43772000 43772000 43772000 64061000 64061000 64061000 21812000 21812000 21812000 16861000 16861000 16861000 25923000 25923000 25923000 35997000 35997000 35997000 136536000 136536000 136536000 52228000 52228000 52228000 42051000 42051000 42051000 673000 673000 673000 -708968000 -708968000 -708968000 -135853000 -135853000 -135853000 1229000000 1229000000 2163749000 2163749000 350000000 1346749000 620000 1252139000 3581000 28483000 93333000 19721000 2380000 2120000 487000 12400000 6634000 6600000 19700000 639620000 639620000 2104139000 2104139000 3581000 3581000 28483000 28483000 91440000 24235000 217068000 246722000 217068000 25354000 246722000 54641000 91440000 24235000 10351000 11143000 10000 10000 48000 48000 10351000 202075000 11143000 203272000 449810000 449810000 449810000 -202551000 -202551000 -202551000 -202000 -202000 -202000 162000 162000 162000 27535000 27535000 27535000 -72656000 -72656000 -72656000 74010000 74010000 74010000 97610000 97610000 97610000 748000 748000 748000 2032000 2032000 2032000 -9430000 -9430000 -9430000 25000000 25000000 25000000 -6353000 -6353000 -6353000 -15783000 -15783000 -15783000 13074000 13074000 13074000 -108000 -108000 -108000 2190000 2190000 2190000 13074000 13074000 13074000 2082000 2082000 2082000 879000000 817000000 639000000 200000000 852000000 -25000000 -25000000 -25000000 <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 1 &#8211; BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Business Overview and Organization</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Omega Healthcare Investors, Inc. (&#8220;Omega&#8221;) was formed as a real estate investment trust (&#8220;REIT&#8221;) and incorporated in the State of Maryland on March 31, 1992. All of Omega's assets are owned directly or indirectly, and all of Omega's operations are conducted directly or indirectly, through its subsidiaries, OHI Healthcare Properties Holdco, Inc. (&#8220;OHI Holdco&#8221;), a direct wholly owned subsidiary of Omega, and OHI Healthcare Properties Limited Partnership (&#8220;Omega OP&#8221;). OHI Holdco was formed as a corporation and incorporated in the State of Delaware on October 22, 2014. Omega OP was formed as a limited partnership and organized in the State of Delaware on October 24, 2014. No substantive assets or activity occurred in either of these entities until the merger with Aviv REIT, Inc. on April 1, 2015. Unless stated otherwise or the context otherwise requires, the terms the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; and &#8220;us&#8221; means Omega, OHI Holdco and Omega OP, collectively.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The Company has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States (&#8220;U.S.&#8221;) and the United Kingdom (&#8220;U.K.&#8221;). Our core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (&#8220;SNFs&#8221;) and, to a lesser extent, assisted living facilities (&#8220;ALFs&#8221;), independent living facilities and rehabilitation and acute care facilities. Our core portfolio consists of long-term leases and mortgage agreements. All of our leases are &#8220;triple-net&#8221; leases, which require the tenants to pay all property-related expenses. Our mortgage revenue derives from fixed rate mortgage loans, which are secured by first mortgage liens on the underlying real estate and personal property of the mortgagor.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">In April 2015, Aviv REIT, Inc., a Maryland corporation (&#8220;Aviv&#8221;), merged (the &#8220;Aviv Merger&#8221;) with and into a wholly owned subsidiary of Omega, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 30, 2014 (the &#8220;Merger Agreement&#8221;), by and among Omega, Aviv, OHI Holdco, Omega OP, and Aviv Healthcare Properties Limited Partnership, a Delaware limited partnership.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Prior to April 1, 2015 and in accordance with the Merger Agreement, Omega restructured the manner in which it holds its assets by converting to an umbrella partnership real estate investment trust structure (the &#8220;UPREIT Conversion&#8221;). As a result of the UPREIT Conversion and following the consummation of the Aviv Merger, all of Omega&#8217;s assets are held by Omega OP, through its equity interests in its subsidiaries.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Omega OP is governed by the Second Amended and Restated Agreement of Limited Partnership of OHI Healthcare Properties Limited Partnership, dated as of April 1, 2015 (the &#8220;Partnership Agreement&#8221;). Pursuant to the Partnership Agreement, Omega and OHI Holdco are the general partners of Omega OP, and have exclusive control over Omega OP&#8217;s day-to-day management. As of June 30, 2017, Omega and OHI Holdco together owned approximately 96% of the issued and outstanding units of partnership interest in Omega OP (&#8220;Omega OP Units&#8221;), and investors owned approximately 4% of the Omega OP Units.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Basis of Presentation</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The accompanying unaudited consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the interim periods reported herein are not necessarily indicative of results to be expected for the full year. These unaudited consolidated financial statements should be read in conjunction with the financial statements and the footnotes thereto included in our Form 10-K/A filed with the SEC on August 9, 2017.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 36.9pt; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><font style="font-size: 10pt;">Our consolidated financial statements include the accounts of (i) Omega, (ii) OHI Holdco, (iii) Omega OP, and (iv) all direct and indirect wholly owned subsidiaries of Omega. All intercompany transactions and balances have been eliminated in consolidation</font>,&#160;<font style="font-size: 10pt;">and our net earnings are reduced by the portion of net earnings attributable to noncontrolling interests.</font></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Asset Impairment</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Management evaluates our real estate investments for impairment indicators at each reporting period, including the evaluation of our assets&#8217; useful lives. The judgment regarding the existence of impairment indicators is based on factors such as, but not limited to, market conditions, operator performance, legal structure, as well as our intent with respect to holding or disposing of the asset. If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows based on our intended use of the property are determined to be less than the carrying values of the assets. An adjustment is made to the net carrying value of the real estate investments for the excess of carrying value over fair value. The fair value of the real estate investment is determined based on current market conditions and consider matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. Additionally, our evaluation of fair value may consider valuing the property as a nursing home as well as alternative uses. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset. Management&#8217;s impairment evaluation process, and when applicable, impairment calculations involve estimation of the future cash flows from management&#8217;s intended use of the property. Changes in the facts and circumstances that drive management&#8217;s assumptions may result in an impairment of the Company&#8217;s assets in a future period that could be material to the Company&#8217;s results of operations.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">For the three and six months ended June 30, 2017 and 2016, we recognized impairment losses of $10.1 million, $17.8 million, $6.9 million and $41.5 million, respectively. For additional information see Note 2 &#8211; Properties and Investments.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Goodwill Impairment</b></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">We assess goodwill for potential impairment during the fourth quarter of each fiscal year, or during the year if an event or other circumstance indicates that we may not be able to recover the carrying amount of the net assets of the reporting unit. In evaluating goodwill for impairment on an interim basis, we assess qualitative factors&#160;<font style="font-family: 'times new roman', times, serif;">such as a&#160;</font>significant decline in real estate valuations,&#160;<font style="font-family: 'times new roman', times, serif;">current macroeconomic conditions, state of the equity and capital markets and our overall financial and operating performance&#160;</font>or a significant decline in the value of our market capitalization, to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of&#160;the reporting unit is less than its carrying amount. On an annual basis during the fourth quarter of each fiscal year, or on an interim basis if we conclude it is more likely than not that the fair value of the reporting unit is less than its carrying value, we perform a two-step goodwill impairment test to identify potential impairment and measure the amount of impairment we will recognize, if any.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Noncontrolling Interests</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Noncontrolling interests is the portion of equity not attributable to the respective reporting entity. We present the portion of any equity that we do not own in consolidated entities as noncontrolling interests and classify those interests as a component of total equity, separate from total stockholders&#8217; equity, or owners&#8217; equity on our Consolidated Balance Sheets. We include net income attributable to the noncontrolling interests in net income in our Consolidated Statements of Income.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">As our ownership of a controlled subsidiary increases or decreases, any difference between the aggregate consideration paid to acquire the noncontrolling interests and our noncontrolling interest balance is recorded as a component of equity in additional paid-in capital, so long as we maintain a controlling ownership interest.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The noncontrolling interest for Omega represents the outstanding Omega OP Units held by outside investors. The noncontrolling interest for OHI Holdco represents the Omega OP Units held by the Parent and the outstanding Omega OP Units held by outside investors.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Foreign Operations</b></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The U.S. dollar is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound. For our consolidated subsidiaries whose functional currency is not the U.S. dollar, we translate their financial statements into the U.S. dollar. We translate assets and liabilities at the exchange rate in effect as of the financial statement date. Revenue and expense accounts are translated using an average exchange rate for the period. Gains and losses resulting from translation are included in accumulated other comprehensive loss (&#8220;AOCL&#8221;), as a separate component of equity and a proportionate amount of gain or loss is allocated to noncontrolling interests.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">We and certain of our consolidated subsidiaries may have intercompany and third-party debt that is not denominated in the entity&#8217;s functional currency. When the debt is remeasured against the functional currency of the entity, a gain or loss can result. The resulting adjustment is reflected in results of operations, unless it is intercompany debt that is deemed to be long-term in nature and then the adjustments are included in AOCL.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Derivative Instruments</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>&#160;</i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>Cash flow hedges</i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>&#160;</i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">During our normal course of business, we may use certain types of derivative instruments for the purpose of managing interest rate and currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at the inception of a qualifying cash flow hedging relationship, the underlying transaction or transactions, must be, and are expected to remain, probable of occurring in accordance with the Company&#8217;s related assertions. The Company recognizes all derivative instruments, including embedded derivatives required to be bifurcated, as assets or liabilities in the Consolidated Balance Sheets at their fair value which are determined using a market approach and Level 2 inputs. Changes in the fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria of hedge accounting are recognized in earnings. For derivatives designated as qualifying cash flow hedging relationships, the change in fair value of the effective portion of the derivatives is recognized in AOCL as a separate component of equity and a proportionate amount of gain or loss is allocated to noncontrolling interest, whereas the change in fair value of the ineffective portion is recognized in earnings. We formally document all relationships between hedging instruments and hedged items, as well as our risk-management objectives and strategy for undertaking various hedge transactions. This process includes designating all derivatives that are part of a hedging relationship to specific forecasted transactions as well as recognized obligations or assets in the Consolidated Balance Sheets. We also assess and document, both at inception of the hedging relationship and on a quarterly basis thereafter, whether the derivatives are highly effective in offsetting the designated risks associated with the respective hedged items. If it is determined that a derivative ceases to be highly effective as a hedge, or that it is probable the underlying forecasted transaction will not occur, we discontinue hedge accounting prospectively and record the appropriate adjustment to earnings based on the current fair value of the derivative. As a matter of policy, we do not use derivatives for trading or speculative purposes. At June 30, 2017 and December 31, 2016, we had $1.4 million and $1.5 million, respectively, of qualifying cash flow hedges recorded at fair value in accrued expenses and other liabilities on our Consolidated Balance Sheets.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>Net investment hedge</i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; background-color: white; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">We use the spot method to measure the effectiveness of our net investment hedge. Under this method, for each reporting period, the change in the carrying value of the hedging instrument due to remeasurement of the effective portion is reported in AOCL in our Consolidated Balance Sheets and the remaining change in the carrying value of the ineffective portion, if any, is recognized in earnings. We evaluate the effectiveness of our net investment hedge on a quarterly basis. We did not record any ineffectiveness for fiscal 2017.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Accounts Receivable</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts. Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements. Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line rent receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement. Lease inducements result from value provided by us to the lessee, at the inception or renewal of the lease, and are amortized as a reduction of rental revenue over the non-cancellable lease term.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">At June 30, 2017, two of our top 10 operators were approximately 90 days past due on rent payments to the Company. On a quarterly basis, we review our accounts receivable to determine their collectability. The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement.&#160; If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance. In the case of a lease recognized on a straight-line basis, a mortgage recognized on an effective yield basis or the existence of lease inducements, we generally provide an allowance for straight-line, effective interest, and/or lease inducement accounts receivable when certain conditions or indicators of adverse collectability are present. If the accounts receivable balance is subsequently deemed uncollectible, the receivable and allowance for doubtful account balance are written off.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">A summary of our net receivables by type is as follows:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"></p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: justify;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: justify;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: justify;" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="6" nowrap="nowrap">(in thousands)</td> <td>&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: justify;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: justify;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in; width: 916px;">Contractual receivables</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 197px;">40,484</td> <td style="text-align: left; width: 14px;">&#160;</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 197px;">13,376</td> <td style="text-align: left; width: 14px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Effective yield interest receivables</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">10,940</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">9,749</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Straight-line rent receivables</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">231,233</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">208,874</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Lease inducements</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7,498</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">8,393</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.15in;">Allowance</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(1,469</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(357</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; text-indent: -0.15in; padding-left: 0.15in;">Accounts receivable &#8211; net</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">288,686</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">240,035</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Related Party Transactions</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The Company has a policy which generally requires related party transactions to be approved or ratified by the Audit Committee. On February 1, 2016, we acquired 10 SNFs from Laurel Healthcare Holdings, Inc. (&#8220;Laurel&#8221;) for approximately $169.0 million in cash and leased them to an unrelated existing operator. A former member of the Board of Directors of the Company, together with certain members of his immediate family, beneficially owned approximately 34% of the equity of Laurel prior to the transaction. Immediately following our acquisition, the unrelated existing operator acquired all of the outstanding equity interests of Laurel, including the interests previously held by the former director of the Company and his family.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Accounting Pronouncement Adopted in 2017</b></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">In March 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-09,&#160;<i>Compensation-Stock Compensation (Topic 718)</i>&#160;(&#8220;ASU 2016-09&#8221;). ASU 2016-09 amends the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. This guidance is effective for annual and interim reporting periods of public entities beginning after December 15, 2016. We adopted this accounting standard on January 1, 2017, at which time the Company began prospectively accounting for excess tax benefits or tax deficiencies as an adjustment to income tax expense in our Consolidated Statements of Income as opposed to the prior requirement that these excess tax benefits be recognized in additional paid-in capital and tax deficiencies be recognized either as an offset to accumulated excess tax benefits, if any, or in the income statement. The Company will continue to account for forfeitures as they occur and present employee taxes paid as a financing activity on our Consolidated Statements of Cash Flows. The adoption of this accounting standard did not have a material impact on our consolidated financial statements.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Recent Accounting Pronouncements - Pending Adoption</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">In 2014, the FASB issued ASU 2014-09,&#160;<i>Revenue from Contracts with Customers</i>&#160;(&#8220;ASU 2014-09&#8221;), which outlines a comprehensive model for entities to use in accounting for revenue arising from contracts with customers. ASU 2014-09 states that &#8220;an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&#8221; While ASU 2014-09 specifically references contracts with customers, it may apply to certain other transactions such as the sale of real estate or equipment. ASU 2014-09 is effective for the Company beginning January 1, 2018. In addition, the FASB has begun to issue targeted updates to clarify specific implementation issues of ASU 2014-09. These updates include ASU 2016-08,&#160;<i>Principal versus Agent Considerations (Reporting Revenue Gross versus Net),</i>&#160;ASU 2016-10,&#160;<i>Identifying Performance Obligations and Licensing,</i>&#160;and ASU 2016-12,&#160;<i>Narrow-Scope Improvements and Practical Expedients.&#160;</i>The Company is currently evaluating the provisions of ASU 2014-09 and its related updates and will be closely monitoring developments and additional guidance to determine the potential impact of the new standard. The Company intends to adopt ASU 2014-09 and its subsequent updates in accordance with the modified retrospective approach. We do not expect the adoption of ASU 2014-09 and its updates to have a significant impact on our consolidated financial statements, as a substantial portion of our revenue consists of rental income from leasing arrangements and interest income from loan arrangements, both of which are specifically excluded from ASU 2014-09.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">In February 2016, the FASB issued ASU 2016-02,&#160;<i>Leases&#160;</i>(&#8220;ASU 2016-02&#8221;), which amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. ASU 2016-02 will be effective for the Company beginning January 1, 2019. Early adoption of ASU 2016-02 as of its issuance is permitted. The new standard requires a modified retrospective transition approach for all leases existing at, or entered into after, the date of initial application, with an option to use certain transition relief. As a result of the pending adoption ASU 2016-02 and in connection with the pending adoption of ASU 2014-09, the Company may be required to record real estate tax revenues and an equal an offsetting real estate tax expense, as a result of our operators paying real estate taxes on our behalf. We are continuing to evaluate the other impacts of adopting ASU 2016-02 on our consolidated financial statements.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">In June 2016, the FASB issued ASU 2016-13,&#160;<i>Financial Instruments - Credit Losses</i>&#160;<i>(Topic 326</i>) (&#8220;ASU 2016-13&#8221;), which changes the impairment model for most financial assets. The new model uses a forward-looking expected loss method, which will generally result in earlier recognition of allowances for losses. ASU 2016-13 is effective for annual and interim periods beginning after December 15, 2019 and early adoption is permitted for annual and interim periods beginning after December 15, 2018. We are currently evaluating the impact of adopting ASU 2016-13 on our consolidated financial statements.</p> <p style="widows: 2; text-transform: none; text-indent: 0.9pt; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 2 &#8211; PROPERTIES AND INVESTMENTS</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Leased Property</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Our real estate properties, represented by 803 SNFs, 119 ALFs, 16 specialty facilities and one medical office building at June 30, 2017, are leased under provisions of single or master leases with initial terms typically ranging from five to 15 years, plus renewal options. Substantially all of our leases contain provisions for specified annual increases over the rents of the prior year and are generally computed in one of three methods depending on specific provisions of each lease as follows: (i) a specific annual percentage increase over the prior year&#8217;s rent, generally between 2.0% and 3.0%; (ii) an increase based on the change in pre-determined formulas from year to year (e.g., increases in the Consumer Price Index (&#8220;CPI&#8221;)); or (iii) specific dollar increases over prior years. Under the terms of the leases, the lessee is responsible for all maintenance, repairs, taxes and insurance on the leased properties.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px 0px 0px 0.5in; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">A summary of our investment in leased real estate properties is as follows:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 80%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">(in thousands)</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in; width: 864px;">Buildings</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 186px;">6,055,423</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 186px;">5,954,771</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">Land</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">796,561</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">759,295</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Furniture, fixtures and equipment</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">458,427</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">454,760</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Site improvements</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">204,993</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">206,206</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.15in;">Construction in progress</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">214,795</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">191,326</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Total real estate investments</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7,730,199</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7,566,358</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.3in; padding-left: 0.3in;">Less accumulated depreciation</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(1,366,376</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(1,240,336</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Real estate investments - net</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">6,363,823</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">6,326,022</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b></b>&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The following table summarizes the significant acquisitions that occurred during the first six months of 2017:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: -20.7pt; margin: 0px 0px 0px 32.85pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"></p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center; padding-bottom: 2px; font-weight: bold;" nowrap="nowrap"></td> <td style="padding-bottom: 2px; font-weight: bold;"><i>&#160;</i></td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Number of<br />Facilities</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; padding-bottom: 2px; font-weight: bold;" nowrap="nowrap">Country/</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Total<br />Investment</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Land</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="2" nowrap="nowrap"> <p style="text-align: center; margin: 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Building &amp; Site&#160;</b><br /><b>Improvements</b></p> </td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Furniture&#160;<br />&amp; Fixtures</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> <td style="text-align: center; padding-bottom: 2px; font-weight: bold;" colspan="2" nowrap="nowrap">Initial<br />Annual&#160;<br />Cash Yield</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="border-bottom: black 2px solid; text-align: center;" nowrap="nowrap"><b>Period</b></td> <td style="border-bottom: black 2px solid; font-weight: bold;"><i>&#160;</i></td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">SNF</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">ALF</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" nowrap="nowrap">State</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="14" nowrap="nowrap"><b>(in millions)</b></td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"><sup>(2)</sup>(%)</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: center; width: 173px;">Q1</td> <td style="width: 16px;"><i>&#160;</i></td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="text-align: right; width: 142px;">-</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="text-align: right; width: 141px;">1</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: center; width: 156px;">VA</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 141px;">7.6</td> <td style="text-align: left; width: 22px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 141px;">0.5</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 141px;">6.8</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 141px;">0.3</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="text-align: right; width: 62px;">7.50</td> <td style="text-align: left; width: 4px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: center;">Q2</td> <td><i>&#160;</i></td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">1</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">NC</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">8.6</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">0.7</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7.3</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">0.6</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">9.50</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: center; padding-bottom: 2px;">Q2</td> <td><i>&#160;</i></td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">-</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">18</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">UK</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">124.2</td> <td style="border-bottom: black 2px solid; text-align: left;"><b><sup>&#160;&#160;</sup>(1)</b></td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">34.1</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">85.1</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">5.0</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left; padding-bottom: 2px;">&#160;</td> <td style="text-align: right; padding-bottom: 2px;">8.50</td> <td style="text-align: left; padding-bottom: 2px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: center; padding-bottom: 4px;">Total</td> <td><i>&#160;</i></td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">1</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">19</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 4px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">140.4</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">35.3</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">99.2</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">5.9</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> <td style="text-align: right; padding-bottom: 4px;">&#160;</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: -20.7pt; margin: 0px 0px 0px 32.85pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 20pt;"></td> <td style="text-align: left; width: 20pt;">(1)</td> <td style="text-align: justify;">Omega recorded a non-cash deferred tax liability and acquisitions costs of approximately $8.2 million and $1.2 million, respectively, in connection with this acquisition.</td> </tr> </table> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 20pt;"></td> <td style="text-align: left; width: 20pt;">(2)</td> <td style="text-align: justify;">The cash yield is based on the purchase price.</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">During the second quarter of 2017, we acquired two parcels of land which are not reflected in the table above for approximately $5.5 million with the intent of building new facilities for an existing operator.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Asset Sales, Impairments and Other</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>&#160;</i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">During the first quarter of 2017, we sold 15 facilities for approximately $45.8 million in net proceeds recognizing a gain on sale of approximately $7.4 million. Eleven of the sold facilities were previously classified as held for sale. In addition, we recorded a provision for impairment of approximately $7.6 million on three facilities, one of which was reclassified to held for sale as of March 31, 2017.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">During the second quarter of 2017, we sold three facilities for approximately $18.3 million in net cash proceeds recognizing a loss on sale of approximately $0.6 million. Two of the sold facilities were previously classified as assets held for sale. In addition, we recorded a provision for impairment of approximately $10.1 million on six facilities.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">We reduced the net book value of the impaired facilities to their estimated fair values or, with respect to the facility reclassified to held for sale, to its estimated fair value less costs to sell. To estimate the fair value of the facilities, we utilized a market approach and Level 3 inputs (which generally consist of non-binding offers from unrelated third parties). Also see Note 7 &#8211; Assets Held For Sale for details. Our recorded impairments were primarily the result of a decision to exit certain non-strategic facilities and/or operators.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 3 &#8211; DIRECT FINANCING LEASES</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The components of investments in direct financing leases consist of the following:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">(in thousands)</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in; width: 1005px;">Minimum lease payments receivable</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 175px;">4,085,493</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 174px;">4,287,069</td> <td style="text-align: left; width: 14px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Less unearned income</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(3,499,877</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(3,685,131</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.15in;">Less allowance for loss on direct financing lease</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(3,309</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; text-indent: -0.15in; padding-left: 0.15in;">Investment in direct financing leases - net</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">582,307</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">601,938</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; text-indent: -0.15in; padding-left: 0.15in;">Properties subject to direct financing leases</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">53</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">58</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The following minimum rents are due under our direct financing leases for the remainder of 2017 and the subsequent five years (in thousands):</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"></p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 98%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.25in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="text-align: center; width: 221px; border: black 1.5pt solid;"><font style="font-size: 10pt;">2017</font></td> <td style="border-bottom: black 1.5pt solid; text-align: center; width: 311px; border-top: black 1.5pt solid; border-right: black 1.5pt solid;"><font style="font-size: 10pt;">2018</font></td> <td style="border-bottom: black 1.5pt solid; text-align: center; width: 236px; border-top: black 1.5pt solid; border-right: black 1.5pt solid;"><font style="font-size: 10pt;">2019</font></td> <td style="border-bottom: black 1.5pt solid; text-align: center; width: 236px; border-top: black 1.5pt solid; border-right: black 1.5pt solid;"><font style="font-size: 10pt;">2020</font></td> <td style="border-bottom: black 1.5pt solid; text-align: center; width: 235px; border-top: black 1.5pt solid; border-right: black 1.5pt solid;"><font style="font-size: 10pt;">2021</font></td> <td style="border-bottom: black 1.5pt solid; text-align: center; width: 235px; border-top: black 1.5pt solid; border-right: black 1.5pt solid;"><font style="font-size: 10pt;">2022</font></td> </tr> <tr style="vertical-align: top;"> <td style="border-bottom: black 1.5pt solid; text-align: center; border-left: black 1.5pt solid; border-right: black 1.5pt solid;"><font style="font-size: 10pt;">$24,407</font></td> <td style="border-bottom: black 1.5pt solid; text-align: center; border-right: black 1.5pt solid;"><font style="font-size: 10pt;">$50,019</font></td> <td style="border-bottom: black 1.5pt solid; text-align: center; border-right: black 1.5pt solid;"><font style="font-size: 10pt;">$51,246</font></td> <td style="border-bottom: black 1.5pt solid; text-align: center; border-right: black 1.5pt solid;"><font style="font-size: 10pt;">$52,493</font></td> <td style="border-bottom: black 1.5pt solid; text-align: center; border-right: black 1.5pt solid;"><font style="font-size: 10pt;">$53,681</font></td> <td style="border-bottom: black 1.5pt solid; text-align: center; border-right: black 1.5pt solid;"><font style="font-size: 10pt;">$55,008</font></td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>New Ark Investment Inc.<b></b></i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>&#160;</i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">On November 27, 2013, we closed an aggregate $529 million purchase/leaseback transaction in connection with the acquisition of Ark Holding Company, Inc. (&#8220;Ark Holding&#8221;) by 4 West Holdings Inc. At closing, we acquired 55 SNFs and 1 ALF operated by Ark Holding and leased the facilities back to Ark Holding, now known as New Ark Investment Inc. (&#8220;New Ark&#8221;), pursuant to four 50-year master leases with rental payments yielding 10.6% per annum over the term of the leases. The purchase/leaseback transaction is being accounted for as a direct financing lease.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The lease agreements allow the tenant the right to purchase the facilities for a bargain purchase price plus closing costs at the end of the lease term. In addition, commencing in the 41st year of each lease, the tenant will have the right to prepay the remainder of its obligations thereunder for an amount equal to the sum of the unamortized portion of the original aggregate $529 million investment plus the net present value of the remaining payments under the lease and closing costs. In the event the tenant exercises either of these options, we have the right to purchase the properties for fair value at the time.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The remaining 50 facilities under these master leases as of June 30, 2017 are located in 10 states, predominantly in the southeastern U.S. The facilities are separated by region and divided amongst four cross-defaulted master leases. The four regions include the Southeast (38 facilities), the Northwest (2 facilities), Texas (9 facilities) and Indiana (1 facility).</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Additionally, we own four facilities and lease them to New Ark under a master lease which expires in 2026. The four facility lease is being accounted for as an operating lease.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">In March 2017, we executed sale agreements with two unrelated third parties to sell seven facilities leased to New Ark located in the Northwest with a carrying value of approximately $36.4 million for approximately $34.0 million. During the first quarter of 2017, we recorded an allowance for loss of approximately $2.4 million. In the second quarter of 2017, we sold five of the Northwest facilities and received net cash proceeds of approximately $27.3 million and recorded an additional allowance for loss of approximately $0.9 million. For the three and six months ended June 30, 2017, we recognized approximately $0.5 million and $1.3 million, respectively, of direct financing lease income on a cash basis related to the Northwest facilities lease. The sale of the remaining two Northwest facilities is expected to close in the third quarter of 2017.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 4 &#8211; MORTGAGE NOTES RECEIVABLE</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">As of June 30, 2017, mortgage notes receivable relate to 29 fixed rate mortgages on 52 long-term care facilities. The mortgage notes are secured by first mortgage liens on the borrowers' underlying real estate and personal property. The mortgage notes receivable relate to facilities located in ten states that are operated by seven independent healthcare operating companies. We monitor compliance with mortgages and when necessary have initiated collection, foreclosure and other proceedings with respect to certain outstanding mortgage notes.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Mortgage interest income is recognized as earned over the terms of the related mortgage notes, using the effective yield method. Allowances are provided against earned revenues from mortgage interest when collection of amounts due becomes questionable or when negotiations for restructurings of troubled operators lead to lower expectations regarding ultimate collection. When collection is uncertain, mortgage interest income on impaired mortgage loans is recognized as received after taking into account the application of security deposits.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The outstanding principal amounts of mortgage notes receivable, net of allowances, were as follows:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 85%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">(in thousands)</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; width: 932px;">Mortgage note due 2024; interest at 9.98%</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 160px;">112,500</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 159px;">112,500</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Mortgage note due 2029; interest at 9.45%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">411,467</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">412,140</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.15in;">Other mortgage notes outstanding&#160;<sup>(1)</sup></td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">143,489</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">118,637</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.45in; padding-left: 0.45in;">Mortgage notes receivable, gross</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">667,456</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">643,277</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.45in; padding-left: 0.45in;">Allowance for loss on mortgage notes receivable</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(4,747</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(3,934</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Total mortgages &#8212; net</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">662,709</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">639,343</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: -0.25in; margin: 0px 0px 0px 67.5pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><sup>&#160;</sup></p> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="text-align: left; width: 20pt;"><font style="font-size: 10pt;"><sup>(1)</sup></font></td> <td style="text-align: justify;"><sup>Other mortgage notes outstanding have stated interest rates ranging from 8.35% to 14.0% and maturity dates through 2029.</sup></td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 5 &#8211; OTHER INVESTMENTS</b></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">A summary of our other investments is as follows:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 85%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="6" nowrap="nowrap">(in thousands)</td> <td>&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.25in; width: 908px;">Other investment note due 2019; interest at 10.96%</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 160px;">49,583</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 159px;">49,458</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.25in;">Other investment note due 2020; interest at 14.00%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">47,899</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">47,913</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.25in;">Other investment note due 2022, interest at 9.00%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">31,987</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">31,987</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.25in;">Other investment note due 2030; interest at 6.66%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">50,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">44,595</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.25in;">Other investment notes outstanding&#160;<sup>(1)</sup></td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">104,314</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">87,691</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Other investments, gross</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">283,783</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">261,644</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.15in;">Allowance for loss on other investments</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(4,798</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(4,798</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; text-indent: -0.15in; padding-left: 0.15in;">Total other investments</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">278,985</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">256,846</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="widows: 2; text-transform: none; font-style: normal; margin-top: 0px; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; margin-bottom: 0px; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal;">&#160;</p> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="text-align: left; width: 20pt;"><sup>(1)</sup></td> <td style="text-align: justify;"><sup>Other investment notes have maturity dates through 2028 and interest rates ranging from 6.50% to 13.0%.</sup></td> </tr> </table> <div>&#160;</div> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 6 &#8211; INVESTMENT IN UNCONSOLIDATED JOINT VENTURE</b></p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">On November 1, 2016, we invested approximately $50.0 million for an approximate 15% ownership interest in a joint venture operating as Second Spring Healthcare Investments. The other approximate 85% interest is owned by affiliates of Lindsey Goldberg LLC. We account for the joint venture using the equity method. On November 1, 2016, the joint venture acquired 64 SNFs from Welltower Inc. for approximately $1.1 billion and leased them to a single operator.</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">We receive asset management fees from the joint venture for services provided. For the three and six months ended June 30, 2017, we recognized $0.5 million and $1.0 million, respectively, of asset management fees. These fees are included in miscellaneous income in the accompanying Consolidated Statements of Income. The accounting policies for the unconsolidated joint venture are the same as those of the Company.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 7 &#8211; ASSETS HELD FOR SALE</b></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The following is a summary of our assets held for sale:</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Properties Held For Sale</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Number of<br />Properties</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Net Book Value<br />(in thousands)</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="6" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in; width: 798px;">December 31, 2016</td> <td style="width: 12px;">&#160;</td> <td style="text-align: left; width: 12px;">&#160;</td> <td style="text-align: right; width: 138px;">20</td> <td style="text-align: left; width: 11px;">&#160;</td> <td style="width: 11px;">&#160;</td> <td style="text-align: left; width: 11px;">$</td> <td style="text-align: right; width: 138px;">52,868</td> <td style="text-align: left; width: 11px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.25in;"><font style="font-size: 10pt;">Properties sold/other&#160;<sup>(1)</sup></font></td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(12</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(30,023</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.25in;"><font style="font-size: 10pt;">Properties added&#160;<sup>(2)</sup></font></td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">1</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">400</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">March 31, 2017</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">9</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">23,245</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.25in;"><font style="font-size: 10pt;">Properties sold/other&#160;<sup>(1)</sup></font></td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(4,356</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-bottom: 4px; text-indent: -0.15in; padding-left: 0.15in;"><font style="font-size: 10pt;">June 30, 2017<sup>(3)</sup></font></td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">7</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">18,889</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: -18.9pt; margin: 0px 0px 0px 0.9in; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><sup>&#160;</sup></p> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="text-align: left; width: 0.25in;"><sup>(1)</sup></td> <td style="text-align: justify;">In the first quarter of 2017, we sold nine SNFs and two ALFs for approximately $29.4 million in net proceeds recognizing a gain on sale of approximately $3.6 million. One SNF classified as an asset held for sale at December 31, 2016 was no longer considered held for sale during the first quarter of 2017 and was reclassified back to leased properties at approximately $5.1 million which represents the facility&#8217;s then carrying value adjusted for depreciation that was not recognized while classified as held for sale. In the second quarter of 2017, we sold one ALF and one SNF for approximately $5.0 million in net proceeds, generating a gain on sale of approximately $0.6 million.</td> </tr> </table> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.25in;"><sup>(2)</sup></td> <td style="text-align: justify;">In the first quarter of 2017, we recorded a $3.5 million impairment to reduce one ALF&#8217;s net book value to its estimated fair value less costs to sell before it was reclassified to assets held for sale.</td> </tr> </table> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.25in;"><sup>(3)</sup></td> <td style="text-align: justify;">We plan to sell the facilities classified as held for sale at June 30, 2017 within the next twelve months.</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 8 &#8211; INTANGIBLES</b></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><font style="font-size: 10pt;">The following is a summary of our intangibles as of June 30, 2017 and December 31, 2016</font>:</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"></p> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 60%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="6" nowrap="nowrap">(in thousands)</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>Assets:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-bottom: 4px; padding-left: 9pt; width: 712px;">Goodwill</td> <td style="width: 11px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; width: 11px;">$</td> <td style="border-bottom: black 4px double; text-align: right; width: 154px;">644,184</td> <td style="border-bottom: black 4px double; text-align: left; width: 11px;">&#160;</td> <td style="border-bottom: black 4px double; width: 11px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; width: 11px;">$</td> <td style="border-bottom: black 4px double; text-align: right; width: 153px;">643,474</td> <td style="text-align: left; width: 10px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Above market leases</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">22,426</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">22,476</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">In-place leases</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">167</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">167</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Accumulated amortization</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(16,477</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(15,864</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 0.25in;">Net intangible assets</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">6,116</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">6,779</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>Liabilities:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Below market leases</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">164,735</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">165,028</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Accumulated amortization</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(77,534</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(70,738</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 0.25in;">Net intangible liabilities</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">87,201</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">94,290</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Above market leases and in-place leases, net of accumulated amortization, are included in other assets on our Consolidated Balance Sheets. Below market leases, net of accumulated amortization, are included in accrued expenses and other liabilities on our Consolidated Balance Sheets. The net amortization related to the above and below market leases is included in our Consolidated Statements of Income as an adjustment to rental income.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">For the three months ended June 30, 2017 and 2016, our net amortization related to intangibles was $3.1 million and $3.6 million, respectively. For the six months ended June 30, 2017 and 2016, our net amortization related to intangibles was $6.2 million and $7.9 million, respectively. The estimated net amortization related to these intangibles for the remainder of 2017 and the subsequent four years is as follows: remainder of 2017 &#8211; $5.8 million; 2018 &#8211; $10.5 million; 2019 &#8211; $9.5 million; 2020 &#8211; $9.3 million and 2021 &#8211; $8.7 million. As of June 30, 2017 the weighted average remaining amortization period of above market leases (inclusive of in-place leases) and below market leases is approximately eight years and nine years, respectively.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The following is a reconciliation of our goodwill as of June 30, 2017:</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 70%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">(in thousands)</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in; width: 1013px;">Balance as of December 31, 2016</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 187px;">643,474</td> <td style="text-align: left; width: 12px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Add: foreign currency translation</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">710</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-bottom: 4px; text-indent: -0.15in; padding-left: 0.15in;">Balance as of June 30, 2017</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">644,184</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 9 &#8211; CONCENTRATION OF RISK</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">As of June 30, 2017, our portfolio of real estate investments consisted of 999 healthcare facilities, located in 42 states and the U.K. and operated by 77 third party operators. Our investment in these facilities, net of impairments and reserve for uncollectible loans, totaled approximately $9.0 billion at June 30, 2017, with approximately 99% of our real estate investments related to long-term care facilities. Our portfolio is made up of 803 SNFs, 119 ALFs, 16 specialty facilities, one medical office building, fixed rate mortgages on 47 SNFs and four ALFs, and nine facilities that are closed/held-for-sale. At June 30, 2017, we also held other investments of approximately $279.0 million, consisting primarily of secured loans to third-party operators of our facilities and a $39.0 million investment in an unconsolidated joint venture.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;&#160;&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">At June 30, 2017, we had investments with one operator/or manager that exceeded 10% of our total investments: Ciena Healthcare (10%). No operator generated more than 10% of our total revenues from operations for the three and six months ended June 30, 2017. At June 30, 2017, the three states in which we had our highest concentration of investments were Ohio (9%), Texas (9%) and Florida (9%).</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 10 &#8211; STOCKHOLDERS&#8217;/OWNERS' EQUITY</b></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">On July 13, 2017, the Board of Directors declared a common stock dividend of $0.64 per share, increasing the quarterly common dividend rate by $0.01 per share over the prior quarter, to be paid on August 15, 2017 to common stockholders of record as of the close of business on August 1, 2017.</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">On April 13, 2017, the Board of Directors declared a common stock dividend of $0.63 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter. The common dividends were paid May 15, 2017 to common stockholders of record as of the close of business on May 1, 2017.</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">On January 12, 2017, the Board of Directors declared a common stock dividend of $0.62 per share, increasing the quarterly common dividend by $0.01 per share over the previous quarter. The common dividends were paid February 15, 2017 to common stockholders of record as of the close of business on January 31, 2017.</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">On the same dates listed above, Omega OP Unit holders received the same distributions per unit as those paid to the common stockholders of Omega.</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>&#160;</i></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>$500 Million Equity Shelf Program</i></p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">For the three months ended June 30, 2017, no shares were issued under our $500 million Equity Shelf Program. For the six months ended June 30, 2017, we issued 0.2 million shares of common stock at an average price of $29.17 per share, net of issuance costs, generating net proceeds of $6.6 million under our $500 million Equity Shelf Program.</p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>Dividend Reinvestment and Common Stock Purchase Plan</i></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">For the three months ended June 30, 2017, approximately 0.4 million shares of our common stock at an average price of $33.02 per share were issued through our Dividend Reinvestment and Common Stock Purchase Program for gross proceeds of approximately $12.4 million. For the six months ended June 30, 2017, approximately 0.6 million shares of our common stock at an average price of $32.11 per share were issued through our Dividend Reinvestment and Common Stock Purchase Program for gross proceeds of approximately $19.7 million.</p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;&#160;&#160;</p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>Accumulated Other Comprehensive Loss</i></p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>&#160;</i></p><p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The following is a summary of our accumulated other comprehensive loss, net of tax where applicable:<i></i></p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"></p><table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="14" nowrap="nowrap">Omega</td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">As of and For the Three<br />Months Ended June 30,</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">As of and For the Six<br />Months Ended June 30,</td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td>&#160;</td><td style="text-align: center;" colspan="14" nowrap="nowrap">(in thousands)</td><td>&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-indent: 1.35pt;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; font-weight: bold;">Foreign Currency Translation:</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; width: 655px;">Beginning balance</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">$</td><td style="text-align: right; width: 137px;">(50,614</td><td style="text-align: left; width: 13px;">)</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">$</td><td style="text-align: right; width: 137px;">(13,143</td><td style="text-align: left; width: 13px;">)</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">$</td><td style="text-align: right; width: 136px;">(54,948</td><td style="text-align: left; width: 13px;">)</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">$</td><td style="text-align: right; width: 136px;">(8,413</td><td style="text-align: left; width: 13px;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Translation gain (loss)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">10,195</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(21,836</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">14,468</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(26,544</td><td style="text-align: left;">)</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px;">Realized gain (loss)</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">79</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">-</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">140</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(22</td><td style="text-align: left;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-bottom: 2px;">Ending balance</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(40,340</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(34,979</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(40,340</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(34,979</td><td style="text-align: left;">)</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; font-weight: bold;">Derivative Instruments:</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; font-weight: bold;">Cash flow hedges:</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Beginning balance</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(166</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(9,594</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(1,420</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(718</td><td style="text-align: left;">)</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;">Unrealized loss</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(1,840</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(4,198</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(1,350</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(13,074</td><td style="text-align: left;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px;">Realized gain</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">626</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">-</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">1,390</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="padding-bottom: 2px;">Ending balance</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(1,380</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(13,792</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(1,380</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(13,792</td><td style="text-align: left;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; font-weight: bold;">Net investment hedge:</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;">Beginning balance</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px;">Unrealized loss</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(2,193</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">-</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(2,193</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="padding-bottom: 2px;">Ending balance</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(2,193</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">-</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(2,193</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; font-weight: bold;">Total accumulated other comprehensive loss</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">(43,913</td><td style="text-align: left; font-weight: bold;">)</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">(48,771</td><td style="text-align: left; font-weight: bold;">)</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">(43,913</td><td style="text-align: left; font-weight: bold;">)</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">(48,771</td><td style="text-align: left; font-weight: bold;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px;">Add: portion included in noncontrolling interest</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">2,010</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">2,308</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">2,010</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">2,308</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 4px; font-weight: bold;">Total accumulated other comprehensive loss</td><td style="font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(41,903</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td><td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(46,463</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td><td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(41,903</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td><td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(46,463</td><td style="text-align: left; font-weight: bold;">)</td></tr></table><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b><b>&#160;&#160;</b></p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"></p><table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="14" nowrap="nowrap">OHI Holdco</td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">As of and For the Three<br />Months Ended June 30,</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">As of and For the Six<br />Months Ended June 30,</td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td>&#160;</td><td style="text-align: center;" colspan="14" nowrap="nowrap">(in thousands)</td><td>&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-indent: 1.35pt;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; font-weight: bold;">Foreign Currency Translation:</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; width: 655px;">Beginning balance</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">$</td><td style="text-align: right; width: 137px;">(50,614</td><td style="text-align: left; width: 13px;">)</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">$</td><td style="text-align: right; width: 137px;">(13,143</td><td style="text-align: left; width: 13px;">)</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">$</td><td style="text-align: right; width: 136px;">(54,948</td><td style="text-align: left; width: 13px;">)</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">$</td><td style="text-align: right; width: 136px;">(8,413</td><td style="text-align: left; width: 13px;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Translation gain (loss)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">10,195</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(21,836</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">14,468</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(26,544</td><td style="text-align: left;">)</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px;">Realized gain (loss)</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">79</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">-</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">140</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(22</td><td style="text-align: left;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-bottom: 2px;">Ending balance</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(40,340</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(34,979</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(40,340</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(34,979</td><td style="text-align: left;">)</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; font-weight: bold;">Derivative Instruments:</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; font-weight: bold;">Cash flow hedges:</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Beginning balance</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(166</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(9,594</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(1,420</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(718</td><td style="text-align: left;">)</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;">Unrealized loss</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(1,840</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(4,198</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(1,350</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(13,074</td><td style="text-align: left;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px;">Realized gain</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">626</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">-</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">1,390</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="padding-bottom: 2px;">Ending balance</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(1,380</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(13,792</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(1,380</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(13,792</td><td style="text-align: left;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; font-weight: bold;">Net investment hedge:</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;">Beginning balance</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px;">Unrealized loss</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(2,193</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">-</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(2,193</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="padding-bottom: 2px;">Ending balance</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(2,193</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">-</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(2,193</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; font-weight: bold;">Total accumulated other comprehensive loss</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">(43,913</td><td style="text-align: left; font-weight: bold;">)</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">(48,771</td><td style="text-align: left; font-weight: bold;">)</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">(43,913</td><td style="text-align: left; font-weight: bold;">)</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">(48,771</td><td style="text-align: left; font-weight: bold;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px;">Add: portion included in noncontrolling interest</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">34,116</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">37,965</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">34,116</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">37,965</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 4px; font-weight: bold;">Total accumulated other comprehensive loss</td><td style="font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(9,797</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td><td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(10,806</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td><td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(9,797</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td><td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(10,806</td><td style="text-align: left; font-weight: bold;">)</td></tr></table><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"></p><table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="14" nowrap="nowrap">Omega OP</td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">As of and For the Three<br />Months Ended June 30,</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">As of and For the Six<br />Months Ended June 30,</td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td>&#160;</td><td style="text-align: center;" colspan="14" nowrap="nowrap">(in thousands)</td><td>&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-indent: 1.35pt;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; font-weight: bold;">Foreign Currency Translation:</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; width: 655px;">Beginning balance</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">$</td><td style="text-align: right; width: 137px;">(50,614</td><td style="text-align: left; width: 13px;">)</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">$</td><td style="text-align: right; width: 137px;">(13,143</td><td style="text-align: left; width: 13px;">)</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">$</td><td style="text-align: right; width: 136px;">(54,948</td><td style="text-align: left; width: 13px;">)</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">$</td><td style="text-align: right; width: 136px;">(8,413</td><td style="text-align: left; width: 13px;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Translation gain (loss)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">10,195</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(21,836</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">14,468</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(26,544</td><td style="text-align: left;">)</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px;">Realized gain (loss)</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">79</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">-</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">140</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(22</td><td style="text-align: left;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-bottom: 2px;">Ending balance</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(40,340</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(34,979</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(40,340</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(34,979</td><td style="text-align: left;">)</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; font-weight: bold;">Derivative Instruments:</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; font-weight: bold;">Cash flow hedges:</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">Beginning balance</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(166</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(9,594</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(1,420</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(718</td><td style="text-align: left;">)</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;">Unrealized loss</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(1,840</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(4,198</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(1,350</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(13,074</td><td style="text-align: left;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px;">Realized gain</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">626</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">-</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">1,390</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="padding-bottom: 2px;">Ending balance</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(1,380</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(13,792</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(1,380</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(13,792</td><td style="text-align: left;">)</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; font-weight: bold;">Net investment hedge:</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;">Beginning balance</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="text-align: left; font-weight: bold;">&#160;</td><td style="text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px;">Unrealized loss</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(2,193</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">-</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(2,193</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="padding-bottom: 2px;">Ending balance</td><td>&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(2,193</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">-</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">(2,193</td><td style="border-bottom: black 2px solid; text-align: left;">)</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td><td style="text-align: left; font-weight: bold;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 4px; font-weight: bold;">Total accumulated other comprehensive loss</td><td style="font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(43,913</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td><td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(48,771</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td><td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(43,913</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td><td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(48,771</td><td style="text-align: left; font-weight: bold;">)</td></tr></table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 11 &#8211; TAXES</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">OHI Holdco is a wholly owned subsidiary of Omega and is a qualified REIT subsidiary for United States federal income tax purposes, and Omega OP is a pass through entity for United States federal income tax purposes.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Since our inception, we have elected to be taxed as a REIT under the applicable provisions of the Internal Revenue Code (&#8220;Code&#8221;). A REIT is generally not subject to federal income tax on that portion of its REIT taxable income which is distributed to its stockholders, provided that at least 90% of such taxable income is distributed each tax year and certain other requirements are met, including asset and income tests. So long as we qualify as a REIT under the Code, we generally will not be subject to federal income taxes on the REIT taxable income that we distribute to stockholders, subject to certain exceptions.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">If the Company fails to qualify as a REIT in any taxable year, the Company will be subject to federal income taxes on its taxable income at regular corporate rates and dividends paid to our stockholders will not be deductible by us in computing taxable income. Further, we will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year in which qualification is denied, unless the Internal Revenue Service grants us relief under certain statutory provisions. Failing to qualify as a REIT could materially and adversely affect the Company&#8217;s net income; however, we believe we are organized and operate in such a manner as to qualify for treatment as a REIT. We test our compliance within the REIT taxation rules to ensure that we are in compliance with the REIT rules on a quarterly and annual basis. We review our distributions and projected distributions each year to ensure we have met and will continue to meet the annual REIT distribution requirements. In 2017, we expect to distribute dividends in excess of our taxable income.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">As a result of our UPREIT Conversion, our Company and its subsidiaries may be subject to income or franchise taxes in certain states and municipalities. Also, as a result of our UPREIT Conversion, we created five wholly owned subsidiary REITs and added a sixth wholly owned subsidiary REIT as of January 1, 2016, all of which are subject to all of the REIT qualification rules set forth in the Code. We merged five of the wholly owned subsidiary REITs into a single wholly owned subsidiary REIT in December 2015, and then merged the sixth wholly owned subsidiary REIT into our other wholly owned subsidiary REIT in December 2016, which wholly owned subsidiary REIT remains subject to all of the REIT qualification rules set forth in the Code.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Subject to the limitation under the REIT asset test rules, we are permitted to own up to 100% of the stock of one or more taxable REIT subsidiaries (&#8220;TRSs&#8221;). We have elected for two of our active subsidiaries to be treated as TRSs. One of our TRSs is subject to federal, state and local income taxes at the applicable corporate rates and the other is subject to foreign income taxes. As of June 30, 2017, our TRS that is subject to federal, state and local income taxes at the applicable corporate rates had a net operating loss carry-forward of approximately $0.8 million. The loss carry-forward is fully reserved as of June 30, 2017, with a valuation allowance due to uncertainties regarding realization.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">During the second quarter of 2017, we recorded approximately $0.5 million of state and local income tax provision and approximately $0.1 million of tax provision for foreign income taxes. For the six months ended June 30, 2017, we recorded approximately $1.5 million of state and local income tax provision and approximately $0.2 million of tax provision for foreign income taxes. The expenses were included in provision for income taxes on our Consolidated Statements of Income.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 12 &#8211; STOCK-BASED COMPENSATION</b></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The following is a summary of our stock-based compensation expense for the three and six months ended June 30, 2017 and 2016, respectively:</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><table style="widows: 2; text-transform: none; text-indent: 0px; width: 85%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="padding-bottom: 2px; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three Months Ended<br />June 30,</td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Six Months Ended<br />June 30,</td><td style="padding-bottom: 2px; font-weight: bold;" nowrap="nowrap">&#160;</td></tr><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="padding-bottom: 2px; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td><td style="padding-bottom: 2px; font-weight: bold;" nowrap="nowrap">&#160;</td></tr><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td nowrap="nowrap">&#160;</td><td style="text-align: center;" colspan="14" nowrap="nowrap">(in thousands)</td><td nowrap="nowrap">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-indent: -0.15in; padding-left: 0.15in; width: 624px;">&#160;</td><td style="width: 14px;">&#160;</td><td style="text-align: left; width: 14px;">&#160;</td><td style="text-align: right; width: 134px;">&#160;</td><td style="text-align: left; width: 14px;">&#160;</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">&#160;</td><td style="text-align: right; width: 133px;">&#160;</td><td style="text-align: left; width: 13px;">&#160;</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">&#160;</td><td style="text-align: right; width: 133px;">&#160;</td><td style="text-align: left; width: 13px;">&#160;</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">&#160;</td><td style="text-align: right; width: 133px;">&#160;</td><td style="text-align: left; width: 13px;">&#160;</td></tr><tr style="background-color: #eeffff; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 4px; text-indent: -0.15in; padding-left: 0.15in;">Stock-based compensation expense</td><td style="padding-bottom: 4px;">&#160;</td><td style="border-bottom: black 4px double; text-align: left;">$</td><td style="border-bottom: black 4px double; text-align: right;">3,734</td><td style="border-bottom: black 4px double; text-align: left;">&#160;</td><td style="border-bottom: black 4px double;">&#160;</td><td style="border-bottom: black 4px double; text-align: left;">$</td><td style="border-bottom: black 4px double; text-align: right;">3,665</td><td style="border-bottom: black 4px double; text-align: left;">&#160;</td><td style="border-bottom: black 4px double;">&#160;</td><td style="border-bottom: black 4px double; text-align: left;">$</td><td style="border-bottom: black 4px double; text-align: right;">7,478</td><td style="border-bottom: black 4px double; text-align: left;">&#160;</td><td style="border-bottom: black 4px double;">&#160;</td><td style="border-bottom: black 4px double; text-align: left;">$</td><td style="border-bottom: black 4px double; text-align: right;">6,443</td><td style="text-align: left; padding-bottom: 4px;">&#160;</td></tr></table><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b><i>Restricted Stock and Restricted Stock Units</i></b></p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Restricted stock and restricted stock units (&#8220;RSUs&#8221;) are subject to forfeiture if the holder&#8217;s service to us terminates prior to vesting, subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company. Prior to vesting, ownership of the shares/units cannot be transferred. Restricted stock has the same dividend and voting rights as our common stock. RSUs accrue dividend equivalents but have no voting rights. Restricted stock and RSUs are valued at the price of our common stock on the date of grant. We expense the cost of these awards ratably over their vesting period. We awarded 140,416 RSUs to employees on January 1, 2017.</p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b><i>Performance Restricted Stock Units and LTIP Units</i></b></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Performance restricted stock units (&#8220;PRSUs&#8221;) and long term incentive plan units (&#8220;LTIP Units&#8221;) are subject to forfeiture if the performance requirements are not achieved or if the holder&#8217;s service to us terminates prior to vesting, subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company. The PRSUs and the LTIP Units have varying degrees of performance requirements to be earned and vested, and each PRSU and LTIP Units award represents the right to a variable number of shares of common stock or partnership units. Each LTIP Unit once earned and vested is convertible into one Omega OP Unit in Omega OP, subject to certain conditions. The earning requirements are based on either the (i) total shareholder return (&#8220;TSR&#8221;) of Omega or (ii) Omega&#8217;s TSR relative to other real estate investment trusts in the MSCI U.S. REIT Index or FTSE NAREIT Equity Health Care Index TSR (both &#8220;Relative TSR&#8221;). Vesting in general requires that the employee remain employed by us until the date specified in the applicable PRSU or LTIP agreement, which may be later than the date that the TSR or Relative TSR requirements are satisfied. We expense the cost of these awards ratably over their service period.</p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"></p><p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Prior to vesting and the distribution of shares, ownership of the PRSUs cannot be transferred. Dividend equivalents on the PRSUs accumulate and with respect to PRSUs granted before 2015 are paid when the PRSUs vest and with respect to PRSUs granted in 2015 or later are paid once the PRSUs are earned. While each LTIP Unit is unearned, the employee receives a partnership distribution equal to 10% of the quarterly approved regular periodic distributions per Omega OP Unit. The remaining partnership distributions (which in the case of normal periodic distributions is equal to the total approved quarterly dividend on Omega&#8217;s common stock) on the LTIP Units accumulate, and if the LTIP Units are earned, the accumulated distributions are paid.</p><p style="widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The number of shares or units earned under the TSR PRSUs or LTIP Units depends generally on the level of achievement of Omega&#8217;s TSR over the indicated performance period. We awarded 399,726 LTIP Units to employees on January 1, 2017.</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The number of shares earned under the Relative TSR PRSUs depends generally on the level of achievement of Omega&#8217;s TSR relative to other real estate investment trusts in the MSCI U.S. REIT Index or FTSE NAREIT Equity Health Care Index TSR over the performance period indicated. We awarded 285,338 Relative TSR PRSUs to employees on January 1, 2017.</p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The following table summarizes our total unrecognized compensation cost as of June 30, 2017 associated with restricted stock, restricted stock units, PRSU awards, and LTIP Unit awards to employees:</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"><font style="font-size: 8pt;">Grant</font><br /><font style="font-size: 8pt;">Year</font></td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"><font style="font-size: 8pt;">Shares/ Units</font></td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"><font style="font-size: 8pt;">Grant Date</font><br /><font style="font-size: 8pt;">Average</font><br /><font style="font-size: 8pt;">Fair Value</font><br /><font style="font-size: 8pt;">Per Unit/</font><br /><font style="font-size: 8pt;">Share</font></td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"><font style="font-size: 8pt;"><b>Total</b></font><br /><font style="font-size: 8pt;"><b>Compensation</b></font><br /><font style="font-size: 8pt;"><b>Cost (in millions)</b></font><br /><font style="font-size: 8pt;"><b><sup>(1)</sup></b></font></td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"><font style="font-size: 8pt;">Weighted</font><br /><font style="font-size: 8pt;">Average</font><br /><font style="font-size: 8pt;">Period of</font><br /><font style="font-size: 8pt;">Expense</font><br /><font style="font-size: 8pt;">Recognition</font><br /><font style="font-size: 8pt;">(in months)</font></td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"><font style="font-size: 8pt;">Unrecognized</font><br /><font style="font-size: 8pt;">Compensation</font><br /><font style="font-size: 8pt;">Cost (in</font><br /><font style="font-size: 8pt;">millions)</font></td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">Performance</font><br /><font style="font-size: 8pt;">Period</font></td><td style="border-bottom: black 2px solid; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" nowrap="nowrap"><font style="font-size: 8pt;">Vesting</font><br /><font style="font-size: 8pt;">Dates</font></td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="border-bottom: black 2px solid; font-weight: bold;"><font style="font-size: 8pt;">RSUs</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td></tr><tr style="background-color: white; vertical-align: bottom;"><td><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: center;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: center;"><font style="font-size: 8pt;">&#160;</font></td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="width: 251px;"><font style="font-size: 8pt;">3/31/15 RSU</font></td><td style="width: 16px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; width: 16px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; width: 79px;"><font style="font-size: 8pt;">2015</font></td><td style="text-align: left; width: 16px;"><font style="font-size: 8pt;">&#160;</font></td><td style="width: 16px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; width: 16px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; width: 95px;"><font style="font-size: 8pt;">109,985</font></td><td style="text-align: left; width: 16px;"><font style="font-size: 8pt;">&#160;</font></td><td style="width: 16px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; width: 16px;"><font style="font-size: 8pt;">$</font></td><td style="text-align: right; width: 95px;"><font style="font-size: 8pt;">40.57</font></td><td style="text-align: left; width: 16px;"><font style="font-size: 8pt;">&#160;</font></td><td style="width: 16px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; width: 16px;"><font style="font-size: 8pt;">$</font></td><td style="text-align: right; width: 110px;"><font style="font-size: 8pt;">4.5</font></td><td style="text-align: left; width: 16px;"><font style="font-size: 8pt;">&#160;</font></td><td style="width: 16px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; width: 15px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; width: 109px;"><font style="font-size: 8pt;">33</font></td><td style="text-align: left; width: 15px;"><font style="font-size: 8pt;">&#160;</font></td><td style="width: 15px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; width: 15px;"><font style="font-size: 8pt;">$</font></td><td style="text-align: right; width: 109px;"><font style="font-size: 8pt;">0.8</font></td><td style="text-align: left; width: 15px;"><font style="font-size: 8pt;">&#160;</font></td><td style="width: 15px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: center; width: 203px;" nowrap="nowrap"><font style="font-size: 8pt;">N/A</font></td><td style="width: 15px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: center; width: 203px;"><font style="font-size: 8pt;">12/31/2017</font></td></tr><tr style="background-color: white; vertical-align: bottom;"><td><font style="font-size: 8pt;">4/1/15 RSU</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">2015</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">40,464</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">40.74</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">1.6</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">33</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">0.3</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: center;" nowrap="nowrap"><font style="font-size: 8pt;">N/A</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: center;"><font style="font-size: 8pt;">12/31/2017</font></td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;"><font style="font-size: 8pt;">Assumed Aviv RSU</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">2015</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">7,799</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">35.08</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">0.3</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">33</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">0.1</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: center;" nowrap="nowrap"><font style="font-size: 8pt;">N/A</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: center;"><font style="font-size: 8pt;">11/1/2017</font></td></tr><tr style="background-color: white; vertical-align: bottom;"><td><font style="font-size: 8pt;">3/17/16&#160;&#160;RSU</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">2016</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">130,006</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">34.78</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">4.6</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">33</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">2.4</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: center;" nowrap="nowrap"><font style="font-size: 8pt;">N/A</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: center;"><font style="font-size: 8pt;">12/31/2018</font></td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">1/1/2017&#160;&#160;RSU</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">2017</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">140,416</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">31.26</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">4.3</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">36</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">3.6</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: center; padding-bottom: 2px;" nowrap="nowrap"><font style="font-size: 8pt;">N/A</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: center; padding-bottom: 2px;"><font style="font-size: 8pt;">12/31/2019</font></td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px; text-indent: 0pt; padding-left: 10pt; font-weight: bold;"><font style="font-size: 8pt;">Restricted Stock Units Total</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">428,670</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">$</font></td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">35.68</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">$</font></td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">15.3</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;"><font style="font-size: 8pt;"><b>&#160;</b></font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">$</font></td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">7.2</font></td><td style="text-align: left; padding-bottom: 2px; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td></tr><tr style="background-color: azure; vertical-align: bottom;"><td><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">TSR PRSUs and LTIP Units</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td></tr><tr style="background-color: azure; vertical-align: bottom;"><td><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td></tr><tr style="background-color: white; vertical-align: bottom;"><td><font style="font-size: 8pt;">2016 TSR</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">2014</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">135,634</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">$</font></td><td style="text-align: right;"><font style="font-size: 8pt;">8.67</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">$</font></td><td style="text-align: right;"><font style="font-size: 8pt;">1.2</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">48</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">$</font></td><td style="text-align: right;"><font style="font-size: 8pt;">0.2</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td nowrap="nowrap"><font style="font-size: 8pt;">1/1/2014-12/31/2016</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">Quarterly in 2017</font></td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;"><font style="font-size: 8pt;">3/31/15 2017 LTIP Units</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">2015</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">137,249</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">14.66</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">2.0</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">45</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">0.8</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td nowrap="nowrap"><font style="font-size: 8pt;">1/1/2015-12/31/2017</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">Quarterly in 2018</font></td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;"><font style="font-size: 8pt;">4/1/2015 2017 LTIP Units</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">2015</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">54,151</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">14.80</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">0.8</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">45</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">0.3</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td nowrap="nowrap"><font style="font-size: 8pt;">1/1/2015-12/31/2017</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">Quarterly in 2018</font></td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;"><font style="font-size: 8pt;">3/17/2016 2018 LTIP Units</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">2016</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">372,069</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">13.21</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">4.9</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">45</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">3.2</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td nowrap="nowrap"><font style="font-size: 8pt;">1/1/2016-12/31/2018</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">Quarterly in 2019</font></td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">1/1/2017 2019 LTIP Units</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">2017</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">399,726</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">12.61</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">5.0</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">48</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">4.4</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;" nowrap="nowrap"><font style="font-size: 8pt;">1/1/2017-12/31/2019</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">Quarterly in 2020</font></td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px; text-indent: 0pt; padding-left: 10pt; font-weight: bold;"><font style="font-size: 8pt;">TSR PRSUs &amp; LTIP Total</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">1,098,829</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">$</font></td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">12.69</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">$</font></td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">13.9</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">$</font></td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">8.9</font></td><td style="text-align: left; padding-bottom: 2px; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td></tr><tr style="background-color: white; vertical-align: bottom;"><td><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">Relative TSR PRSUs</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td></tr><tr style="background-color: white; vertical-align: bottom;"><td><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;"><font style="font-size: 8pt;">2016 Relative TSR</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">2014</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">135,634</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">$</font></td><td style="text-align: right;"><font style="font-size: 8pt;">14.24</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">$</font></td><td style="text-align: right;"><font style="font-size: 8pt;">1.9</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">48</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">$</font></td><td style="text-align: right;"><font style="font-size: 8pt;">0.2</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td nowrap="nowrap"><font style="font-size: 8pt;">1/1/2014-12/31/2016</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">Quarterly in 2017</font></td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;"><font style="font-size: 8pt;">3/31/15 2017 Relative TSR</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">2015</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">137,249</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">22.50</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">3.1</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">45</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">1.2</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td nowrap="nowrap"><font style="font-size: 8pt;">1/1/2015-12/31/2017</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">Quarterly in 2018</font></td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;"><font style="font-size: 8pt;">4/1/2015 2017 Relative TSR</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">2015</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">54,151</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">22.91</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">1.2</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">45</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">0.5</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td nowrap="nowrap"><font style="font-size: 8pt;">1/1/2015-12/31/2017</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">Quarterly in 2018</font></td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;"><font style="font-size: 8pt;">3/17/2016 2018 Relative TSR</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">2016</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">307,480</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">16.45</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">5.1</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">45</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right;"><font style="font-size: 8pt;">3.4</font></td><td style="text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td nowrap="nowrap"><font style="font-size: 8pt;">1/1/2016-12/31/2018</font></td><td><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left;"><font style="font-size: 8pt;">Quarterly in 2019</font></td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">1/1/2017 2019 Relative TSR</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">2017</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">285,338</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">18.04</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">5.1</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">48</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right;"><font style="font-size: 8pt;">4.5</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;" nowrap="nowrap"><font style="font-size: 8pt;">1/1/2017-12/31/2019</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">Quarterly in 2020</font></td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px; text-indent: 0pt; padding-left: 10pt; font-weight: bold;"><font style="font-size: 8pt;">Relative TSR PRSUs Total</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">919,852</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">$</font></td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">17.78</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">$</font></td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">16.4</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">$</font></td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">9.8</font></td><td style="text-align: left; padding-bottom: 2px; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 2px;"><font style="font-size: 8pt;">&#160;</font></td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 4px; text-indent: -30pt; padding-left: 50pt; font-weight: bold;"><font style="font-size: 8pt;">Grand Total</font></td><td style="padding-bottom: 4px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 4px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: right; padding-bottom: 4px;"><font style="font-size: 8pt;">&#160;</font></td><td style="text-align: left; padding-bottom: 4px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 4px; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">2,447,351</font></td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 4px double; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">$</font></td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">18.63</font></td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 4px double; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">$</font></td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">45.6</font></td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 4px double; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 4px double; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;"><font style="font-size: 8pt;">$</font></td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;"><font style="font-size: 8pt;">25.9</font></td><td style="text-align: left; padding-bottom: 4px; font-weight: bold;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 4px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 4px;" nowrap="nowrap"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 4px;"><font style="font-size: 8pt;">&#160;</font></td><td style="padding-bottom: 4px;"><font style="font-size: 8pt;">&#160;</font></td></tr></table><p style="text-align: justify; widows: 2; text-transform: none; text-indent: -0.25in; margin: 0px 0px 0px 0.5in; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0.25in;"></td><td style="width: 0.25in;">(1)</td><td style="text-align: justify;">Total compensation costs are net of shares cancelled.</td></tr></table><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Director Restricted Stock Grants</b></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">As of June 30, 2017, we had 90,421 shares of restricted stock outstanding to directors. The outstanding restricted stock granted to directors prior to 2017 is scheduled to vest ratably over three years from the date of grant. Beginning with the 2017 grants, director restricted stock grants fully vest at the annual meeting following the grant date. As of June 30, 2017, the unrecognized compensation cost associated with outstanding director restricted stock grants is approximately $2.2 million.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 13 &#8211; BORROWING ACTIVITIES AND ARRANGEMENTS</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Secured and Unsecured Borrowings</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The following is a summary of our borrowings:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;" nowrap="nowrap"> <p style="text-align: center; margin: 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Annual Interest<br />Rate as of</b></p> <p style="text-align: center; margin: 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>June 30,</b></p> </td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" nowrap="nowrap">Maturity</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" nowrap="nowrap">2017</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="6" nowrap="nowrap">(in thousands)</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left;">Secured borrowings:</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt; width: 741px;">HUD mortgages assumed December 2011<sup>(1)</sup></td> <td style="width: 16px;">&#160;</td> <td style="text-align: center; width: 189px;">2044</td> <td style="width: 16px;">&#160;</td> <td style="text-align: center; width: 189px;">3.06%</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 156px;">54,316</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 156px;">54,954</td> <td style="text-align: left; width: 15px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Deferred financing costs &#8211; net</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(579</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(589</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Total secured borrowings &#8211; net<sup>(2)</sup></td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">53,737</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">54,365</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Unsecured borrowings:</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Revolving line of credit</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">2021</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">2.47%</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">155,000</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">190,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Tranche A-1 term loan</td> <td>&#160;</td> <td style="text-align: center;">-</td> <td>&#160;</td> <td style="text-align: center;">-</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">200,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Tranche A-2 term loan</td> <td>&#160;</td> <td style="text-align: center;">-</td> <td>&#160;</td> <td style="text-align: center;">-</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">200,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Tranche A-3 term loan</td> <td>&#160;</td> <td style="text-align: center;">-</td> <td>&#160;</td> <td style="text-align: center;">-</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">350,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">U.S. term loan</td> <td>&#160;</td> <td style="text-align: center;">2022</td> <td>&#160;</td> <td style="text-align: center;">2.67%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">425,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Sterling term loan</td> <td>&#160;</td> <td style="text-align: center;">2022</td> <td>&#160;</td> <td style="text-align: center;">1.70%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">130,250</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Omega OP term loan<sup>(2)</sup></td> <td>&#160;</td> <td style="text-align: center;">2022</td> <td>&#160;</td> <td style="text-align: center;">2.67%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">100,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">100,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">2015 term loan</td> <td>&#160;</td> <td style="text-align: center;">2022</td> <td>&#160;</td> <td style="text-align: center;">3.80%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">250,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">250,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Discounts and deferred financing costs &#8211; net<sup>(3)</sup></td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(5,958</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(5,657</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Total term loans &#8211; net</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">899,292</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">1,094,343</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-left: 9pt;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-left: 9pt;">2023 notes</td> <td>&#160;</td> <td style="text-align: center;">2023</td> <td>&#160;</td> <td style="text-align: center;">4.375%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">700,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">700,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-left: 9pt;">2024 notes</td> <td>&#160;</td> <td style="text-align: center;">2024</td> <td>&#160;</td> <td style="text-align: center;">5.875%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">400,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-left: 9pt;">2024 notes</td> <td>&#160;</td> <td style="text-align: center;">2024</td> <td>&#160;</td> <td style="text-align: center;">4.95%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">400,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">400,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-left: 9pt;">2025 notes</td> <td>&#160;</td> <td style="text-align: center;">2025</td> <td>&#160;</td> <td style="text-align: center;">4.50%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">400,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">250,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-left: 9pt;">2026 notes</td> <td>&#160;</td> <td style="text-align: center;">2026</td> <td>&#160;</td> <td style="text-align: center;">5.25%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">600,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">600,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-left: 9pt;">2027 notes</td> <td>&#160;</td> <td style="text-align: center;">2027</td> <td>&#160;</td> <td style="text-align: center;">4.50%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">700,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">700,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-left: 9pt;">2028 notes</td> <td>&#160;</td> <td style="text-align: center;">2028</td> <td>&#160;</td> <td style="text-align: center;">4.75%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">550,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-left: 9pt;">Other</td> <td>&#160;</td> <td style="text-align: center;">2018</td> <td>&#160;</td> <td style="text-align: center;">-</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">1,500</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">3,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Subordinated debt</td> <td>&#160;</td> <td style="text-align: center;">2021</td> <td>&#160;</td> <td style="text-align: center;">9.00%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">20,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">20,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Discount - net</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(22,345</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(17,151</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Deferred financing costs &#8211; net</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(27,297</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(27,703</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Total unsecured borrowings &#8211; net</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">3,321,858</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">3,028,146</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-left: 9pt;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Total secured and unsecured borrowings &#8211; net</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 4px;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 4px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">4,429,887</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">4,366,854</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: -0.25in; margin: 0px 0px 0px 45pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><sup>&#160;</sup></p> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 27pt;"></td> <td style="width: 18pt;"><sup>(1)</sup></td> <td style="text-align: justify;">Reflects the weighted average annual contractual interest rate on the mortgages at June 30, 2017 excluding a third-party administration fee of approximately 0.5% annually. Secured by real estate assets with a net carrying value of $63.9 million as of June 30, 2017.</td> </tr> </table> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 27pt;"></td> <td style="width: 18pt;"><sup>(2)</sup></td> <td style="text-align: justify;">These amounts represent borrowings that were incurred by Omega OP or wholly owned subsidiaries of Omega OP.</td> </tr> </table> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 27pt;"></td> <td style="width: 18pt;"><sup>(3)</sup></td> <td style="text-align: justify;">This amount includes $0.6 million of net deferred financing costs related to the Omega OP term loan as of June 30, 2017.</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants. As of June 30, 2017 and December 31, 2016, we were in compliance with all affirmative and negative covenants, including financial covenants, for our secured and unsecured borrowings. OHI Holdco and Omega OP, the guarantors of Parent&#8217;s outstanding senior notes, do not directly own any substantive assets other than OHI Holdco&#8217;s interest in Omega OP and Omega OP&#8217;s interest in non-guarantor subsidiaries.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b><i>New and Amended Unsecured Credit Facility &#8211; 2017</i></b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b><i>&#160;</i></b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>2017 Omega Credit Facilities</i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">On May 25, 2017, Omega entered into a credit agreement (the &#8220;2017 Omega Credit Agreement&#8221;) providing us with a new $1.8 billion senior unsecured revolving and term loan credit facility, consisting of a $1.25 billion senior unsecured multicurrency revolving credit facility (the &#8220;Revolving Credit Facility&#8221;), a $425 million senior unsecured U.S. Dollar term loan facility (the &#8220;U.S. Term Loan Facility&#8221;), and a &#163;100 million senior unsecured British Pound Sterling term loan facility (the &#8220;Sterling Term Loan Facility&#8221; and, together with the Revolving Credit Facility and the U.S. Term Loan Facility, collectively, the &#8220;2017 Omega Credit Facilities&#8221;). The 2017 Omega Credit Agreement contains an accordion feature permitting us, subject to compliance with customary conditions, to increase the maximum aggregate commitments under the 2017 Omega Credit Facilities to $2.5 billion.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The 2017 Omega Credit Facilities replace the previous $1.25 billion senior unsecured 2014 revolving credit facility, the previous $200 million Tranche A-1 senior unsecured term loan facility, and the previous $350 million Tranche A-3 senior unsecured incremental term loan facility established under our 2014 credit agreement, which has been terminated (the &#8220;2014 Omega Credit Agreement&#8221;). We had previously repaid and terminated the $200 million Tranche A-2 senior unsecured term loan facility established under the 2014 Omega Credit Agreement, with proceeds from our $550 million and $150 million unsecured senior notes issued in April 2017.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The Revolving Credit Facility bears interest at LIBOR plus an applicable percentage (with a range of 100 to 195 basis points) based on our ratings from Standard &amp; Poor&#8217;s, Moody&#8217;s and/or Fitch Ratings. The Revolving Credit Facility matures on May 25, 2021, subject to an option by us to extend such maturity date for two, six month periods. The 2017 Omega Credit Agreement provides for the Revolving Credit Facility to be drawn in Euros, British Pounds Sterling, Canadian Dollars (collectively, &#8220;Alternative Currencies&#8221;) or U.S. Dollars, with a $900 million tranche available in U.S. Dollars and a $350 million tranche available in U.S. Dollars or Alternative Currencies. For purposes of the 2017 Omega Credit Facilities, references to LIBOR include the Canadian dealer offered rates for amounts offered in Canadian Dollars and any other Alternative Currency rate approved in accordance with the terms of the 2017 Omega Credit Agreement for amounts offered in any other non-London interbank offered rate quoted currency, as applicable.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The U.S. Term Loan Facility and the Sterling Term Loan Facility bear interest at LIBOR plus an applicable percentage (with a range of 90 to 190 basis points) based on our ratings from Standard &amp; Poor&#8217;s, Moody&#8217;s and/or Fitch Ratings. The U.S. Term Loan Facility and the Sterling Term Loan Facility each mature on May&#160;25, 2022.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">For the three month period ending June 30, 2017, we recorded a one-time, non-cash charge of approximately $5.5 million relating to the write-off of deferred financing costs associated with the termination of the 2014 Omega Credit Facilities.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>Amended 2015 Term Loan Facility</i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">On May 25, 2017, Omega entered into an amended and restated credit agreement (the &#8220;Amended 2015 Credit Agreement&#8221;), which amended and restated our previous $250 million senior unsecured term loan facility (the &#8220;Amended 2015 Term Loan Facility&#8221;). The Amended 2015 Term Loan Facility bears interest at LIBOR plus an applicable percentage (with a range of 140 to 235 basis points) based on our ratings from Standard &amp; Poor&#8217;s, Moody&#8217;s and/or Fitch Ratings. The Amended 2015 Term Loan Facility continues to mature on December 16, 2022. The Amended 2015 Credit Agreement permits us, subject to compliance with customary conditions, to add one or more incremental tranches to the Amended 2015 Term Loan Facility in an aggregate principal amount not exceeding $150 million.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Omega&#8217;s obligations under the 2017 Omega Credit Facilities and the Amended 2015 Term Loan Facility are jointly and severally guaranteed by Omega OP, OHI Holdco, and any domestic subsidiary of Omega that provides a guaranty of any unsecured indebtedness of Omega for borrowed money evidenced by bonds, debentures, notes or other similar instruments in an amount of at least $50 million individually or in the aggregate.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>2017 Omega OP Term Loan Facility</i></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">On May 25, 2017, Omega OP<i>&#160;</i>entered into a credit agreement (the &#8220;2017 Omega OP<i>&#160;</i>Credit Agreement&#8221;) providing it with a new $100 million senior unsecured term loan facility (the &#8220;2017 Omega OP<i>&#160;</i>Term Loan Facility&#8221;). The 2017 Omega OP Credit Agreement replaces the $100 million senior unsecured term loan facility obtained in 2015 (the &#8220;2015 Omega OP<i>&#160;</i>Term Loan Facility&#8221;) and the related credit agreement (the &#8220;2015 Omega OP<i>&#160;</i>Credit Agreement&#8221;). The 2017 Omega OP<i>&#160;</i>Term Loan Facility bears interest at LIBOR plus an applicable percentage (with a range of 90 to 190 basis points) based on our ratings from Standard &amp; Poor&#8217;s, Moody&#8217;s and/or Fitch Ratings. The 2017 Omega OP<i>&#160;</i>Term Loan Facility matures on May 25, 2022.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Omega OP&#8217;s obligations in connection with the 2017 Omega OP<i>&#160;</i>Term Loan Facility are not currently guaranteed, but will be jointly and severally guaranteed by any domestic subsidiary of Omega OP<i>&#160;</i>that provides a guaranty of any unsecured indebtedness of Omega or Omega OP<i>&#160;</i>for borrowed money evidenced by bonds, debentures, notes or other similar instruments in an amount of at least $50 million individually or in the aggregate.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b><i>$550 Million 4.75% Senior Notes and $150 Million 4.5% Senior Notes</i></b></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">On April 4, 2017, Omega issued (i) $550 million aggregate principal amount of our 4.75% Senior Notes due 2028 (the &#8220;2028 Notes&#8221;) and (ii) an additional $150 million aggregate principal amount of our existing 4.50% Senior Notes due 2025 (the &#8220;2025 Notes&#8221;, and together with the 2028 Notes collectively, the &#8220;Notes&#8221;). The 2028 Notes mature on January 15, 2028 and the 2025 Notes mature on January 15, 2025.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The 2028 Notes were sold at an issue price of 98.978% of their face value before the underwriters&#8217; discount and the 2025 Notes were sold at an issue price of 99.540% of their face value before the underwriters&#8217; discount. Our net proceeds from the Notes offering, after deducting underwriting discounts and expenses, were approximately $690.7 million. The net proceeds from the Notes offering were used to (i) redeem all of our outstanding $400 million aggregate principal amount of 5.875% Senior Notes due 2024 (the &#8220;5.875% Notes&#8221;) on April 28, 2017, (ii) prepay the $200 million Tranche A-2 Term Loan Facility on April 5, 2017 that otherwise would have become due on June 27, 2017, and (iii) repay outstanding borrowings under our revolving credit facility.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b><i>$400 Million 5.875% Senior Notes Redemption</i></b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b><i>&#160;</i></b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">On April 28, 2017, Omega redeemed all of our outstanding 5.875% Notes. As a result of the redemption, during the second quarter of 2017, we recorded approximately $16.5 million in redemption related costs and write-offs, including $11.8 million for the call premium and $4.7 million in net write-offs associated with unamortized deferred financing costs.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 14 &#8211; FINANCIAL INSTRUMENTS</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The carrying amount of cash and cash equivalents, restricted cash and accounts receivable reported in the Consolidated Balance Sheets approximates fair value because of the short maturity of these instruments (i.e., less than 90 days) (Level 1).</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">At June 30, 2017 and December 31, 2016, the carrying amounts and fair values of our other financial instruments were as follows:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">June 30, 2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">December 31, 2016</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="2" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Carrying</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Amount</b></p> </td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="2" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Fair</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Value</b></p> </td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="2" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Carrying</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Amount</b></p> </td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="2" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Fair</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Value</b></p> </td> <td style="padding-bottom: 2px;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="14" nowrap="nowrap">(in thousands)</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in; font-weight: bold;">Assets:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt; width: 507px;">Investments in direct financing leases &#8211; net</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 156px;">582,307</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 156px;">578,998</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 155px;">601,938</td> <td style="text-align: left; width: 12px;">&#160;</td> <td style="width: 12px;">&#160;</td> <td style="text-align: left; width: 12px;">$</td> <td style="text-align: right; width: 155px;">598,665</td> <td style="text-align: left; width: 12px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Mortgage notes receivable &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">662,709</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">676,396</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">639,343</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">644,961</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Other investments &#8211; net</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">278,985</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">271,306</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">256,846</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">253,385</td> <td style="text-align: left; padding-bottom: 2px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-bottom: 4px; padding-left: 0.25in;">Total</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">1,524,001</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">1,526,700</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">1,498,127</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">1,497,011</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in; font-weight: bold;">Liabilities:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Revolving line of credit</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">155,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">155,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">190,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">190,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Tranche A-1 term loan</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">198,830</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">200,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Tranche A-2 term loan</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">200,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">200,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Tranche A-3 term loan</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">347,449</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">350,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">U.S. term loan</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">422,280</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">425,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Sterling term loan</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">129,413</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">130,250</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;"><font style="font-size: 10pt;">Omega OP term loan</font><sup>(1)</sup></td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">99,373</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">100,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">100,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">100,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">2015 term loan</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">248,226</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">250,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">248,064</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">250,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">4.375% notes due 2023 &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">692,890</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">723,805</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">692,305</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">693,505</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">5.875% notes due 2024 &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">395,065</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">432,938</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">4.95% notes due 2024 &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">393,175</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">421,504</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">392,669</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">406,361</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">4.50% notes due 2025 &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">394,368</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">361,983</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">245,949</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">249,075</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">5.25% notes due 2026 &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">593,969</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">641,199</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">593,616</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">611,461</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">4.50% notes due 2027 &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">685,784</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">703,514</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">685,052</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">681,978</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">4.75% notes due 2028 &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">539,741</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">557,520</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;"><font style="font-size: 10pt;">HUD debt &#8211; net</font><sup>(1)</sup></td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">53,737</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">52,535</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">54,365</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">52,510</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Subordinated debt &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">20,431</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">24,045</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">20,490</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">23,944</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-bottom: 2px; padding-left: 9pt;">Other</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">1,500</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">1,500</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">3,000</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">3,000</td> <td style="text-align: left; padding-bottom: 2px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-bottom: 4px; padding-left: 0.25in;">Total</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">4,429,887</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">4,547,855</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">4,366,854</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">4,444,772</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> </table> <p style="widows: 2; text-transform: none; font-style: normal; margin-top: 0px; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; margin-bottom: 0px; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal;">&#160;</p> <table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 27pt;"></td> <td style="width: 18pt;"><sup>(1)</sup></td> <td style="text-align: justify;">These amounts represent borrowings that were incurred by Omega OP or wholly owned subsidiaries of Omega OP.</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Fair value estimates are subjective in nature and are dependent on a number of important assumptions, including estimates of future cash flows, risks, discount rates and relevant comparable market information associated with each financial instrument (see Note 2 &#8211; Summary of Significant Accounting Policies in our Annual Report on Form 10-K for the year ended December 31, 2016, as amended). The use of different market assumptions and estimation methodologies may have a material effect on the reported estimated fair value amounts.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The following methods and assumptions were used in estimating fair value disclosures for financial instruments.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.25in;"><font style="font-family: symbol;">&#183;</font></td> <td style="text-align: justify;">Direct financing leases: The fair value of the investments in direct financing leases are estimated using a discounted cash flow analysis, using interest rates being offered for similar leases to borrowers with similar credit ratings (Level 3).</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 0.25in; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.25in;"><font style="font-family: symbol;">&#183;</font></td> <td style="text-align: justify;">Mortgage notes receivable: The fair value of the mortgage notes receivables are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 0.25in; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.25in;"><font style="font-family: symbol;">&#183;</font></td> <td style="text-align: justify;">Other investments: Other investments are primarily comprised of notes receivable. The fair values of notes receivable are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 0.75in; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 0.75in; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"></p> <table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.25in;"><font style="font-family: symbol;">&#183;</font></td> <td style="text-align: justify;">Revolving line of credit and term loans: The fair value of our borrowings under variable rate agreements are estimated using a present value technique based on expected cash flows discounted using the current market rates (Level 3).</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 0.25in; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.25in;"><font style="font-family: symbol;">&#183;</font></td> <td style="text-align: justify;">Senior notes and subordinated debt: The fair value of our borrowings under fixed rate agreements are estimated using a present value technique based on inputs from trading activity provided by a third party (Level 2).</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px 0pt 0.5in; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.25in;"><font style="font-family: symbol;">&#183;</font></td> <td style="text-align: justify;">HUD debt: The fair value of our borrowings under HUD debt agreements are estimated using an expected present value technique based on quotes obtained by HUD debt brokers (Level 2).</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 15 &#8211; LITIGATION</b></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">We are subject to various legal proceedings, claims and other actions arising out of the normal course of business. While any legal proceeding or claim has an element of uncertainty, management believes that the outcome of each lawsuit, claim or legal proceeding that is pending or threatened, or all of them combined, will not have a material adverse effect on our consolidated financial position or results of operations.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>NOTE 16 &#8211; EARNINGS PER SHARE/UNIT</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The computation of basic earnings per share/unit (&#8220;EPS&#8221; or &#8220;EPU&#8221;) is computed by dividing net income available to common stockholders/Omega OP Unit holders by the weighted-average number of shares of common stock/Omega OP Units outstanding during the relevant period. Diluted EPS/EPU is computed using the treasury stock method, which is net income divided by the total weighted-average number of common outstanding shares/Omega OP Units plus the effect of dilutive common equivalent shares/units during the respective period. Dilutive common shares/Omega OP Units reflect the assumed issuance of additional common shares pursuant to certain of our share-based compensation plans, including stock options, restricted stock and performance restricted stock units and the assumed issuance of additional shares related to Omega OP Units held by outside investors. Dilutive Omega OP Units reflect the assumed issuance of additional Omega OP Units pursuant to certain of our share-based compensation plans, including stock options, restricted stock and performance restricted stock. No per share information was provided for OHI Holdco because the sole stockholder is Omega. OHI Holdco is a wholly owned subsidiary of Omega and has 1,000 shares of $0.01 par value per share common stock outstanding.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The following tables set forth the computation of basic and diluted earnings per share/unit:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="14" nowrap="nowrap">Omega</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="6" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Three Months Ended</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>June 30,</b></p> </td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="6" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Six Months Ended</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>June 30,</b></p> </td> <td style="padding-bottom: 2px;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="14" nowrap="nowrap">(in thousands, except per share amounts)</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">Numerator:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt; width: 615px;">Net income</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 189px;">68,157</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 189px;">113,154</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 188px;">177,269</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 188px;">171,350</td> <td style="text-align: left; width: 15px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Less: net income attributable to noncontrolling interests</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2,900</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(5,102</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(7,572</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(7,743</td> <td style="text-align: left; padding-bottom: 2px;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Net income available to common stockholders</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">65,257</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">108,052</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">169,697</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">163,607</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">Denominator:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Denominator for basic earnings per share</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">197,433</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">188,981</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">197,223</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">188,604</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Effect of dilutive securities:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 0.25in;">Common stock equivalents</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">467</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">1,254</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">407</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">1,215</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 0.25in;">Noncontrolling interest &#8211; Omega OP Units</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">8,772</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">8,922</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">8,793</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">8,935</td> <td style="text-align: left; padding-bottom: 2px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Denominator for diluted earnings per share</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">206,672</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">199,157</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">206,423</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">198,754</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>Earnings per share &#8211; basic:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Net income available to common stockholders</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.33</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.57</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.86</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.87</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>Earnings per share &#8211; diluted:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Net income</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.33</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.57</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.86</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.86</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="14" nowrap="nowrap">Omega OP</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="6" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Three Months Ended</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>June 30,</b></p> </td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="6" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Six Months Ended</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>June 30,</b></p> </td> <td style="padding-bottom: 2px;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="14" nowrap="nowrap">(in thousands, except per share amounts)</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">Numerator:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt; width: 615px;">Net income</td> <td style="padding-bottom: 4px; width: 16px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; width: 16px;">$</td> <td style="border-bottom: black 4px double; text-align: right; width: 189px;">68,157</td> <td style="border-bottom: black 4px double; text-align: left; width: 16px;">&#160;</td> <td style="border-bottom: black 4px double; width: 16px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; width: 16px;">$</td> <td style="border-bottom: black 4px double; text-align: right; width: 189px;">113,154</td> <td style="border-bottom: black 4px double; text-align: left; width: 16px;">&#160;</td> <td style="border-bottom: black 4px double; width: 15px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; width: 15px;">$</td> <td style="border-bottom: black 4px double; text-align: right; width: 188px;">177,269</td> <td style="border-bottom: black 4px double; text-align: left; width: 15px;">&#160;</td> <td style="border-bottom: black 4px double; width: 15px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; width: 15px;">$</td> <td style="border-bottom: black 4px double; text-align: right; width: 188px;">171,350</td> <td style="text-align: left; padding-bottom: 4px; width: 15px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">Denominator:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Denominator for basic earnings per unit</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">206,205</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">197,903</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">206,016</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">197,539</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Effect of dilutive securities:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 0.25in;">Omega OP Unit equivalents</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">467</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">1,254</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">407</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">1,215</td> <td style="text-align: left; padding-bottom: 2px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Denominator for diluted earnings per unit</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">206,672</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">199,157</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">206,423</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">198,754</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Earnings per unit &#8211; basic:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Net income available to Omega OP Unit holders</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.33</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.57</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.86</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.87</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Earnings per unit &#8211; diluted:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Net income</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.33</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.57</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.86</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.86</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Basis of Presentation</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The accompanying unaudited consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the interim periods reported herein are not necessarily indicative of results to be expected for the full year. These unaudited consolidated financial statements should be read in conjunction with the financial statements and the footnotes thereto included in our Form 10-K/A filed with the SEC on August 9, 2017.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 36.9pt; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><font style="font-size: 10pt;">Our consolidated financial statements include the accounts of (i) Omega, (ii) OHI Holdco, (iii) Omega OP, and (iv) all direct and indirect wholly owned subsidiaries of Omega. All intercompany transactions and balances have been eliminated in consolidation</font>,&#160;<font style="font-size: 10pt;">and our net earnings are reduced by the portion of net earnings attributable to noncontrolling interests.</font></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Asset Impairment</b></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Management evaluates our real estate investments for impairment indicators at each reporting period, including the evaluation of our assets&#8217; useful lives. The judgment regarding the existence of impairment indicators is based on factors such as, but not limited to, market conditions, operator performance, legal structure, as well as our intent with respect to holding or disposing of the asset. If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows based on our intended use of the property are determined to be less than the carrying values of the assets. An adjustment is made to the net carrying value of the real estate investments for the excess of carrying value over fair value. The fair value of the real estate investment is determined based on current market conditions and consider matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. Additionally, our evaluation of fair value may consider valuing the property as a nursing home as well as alternative uses. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset. Management&#8217;s impairment evaluation process, and when applicable, impairment calculations involve estimation of the future cash flows from management&#8217;s intended use of the property. Changes in the facts and circumstances that drive management&#8217;s assumptions may result in an impairment of the Company&#8217;s assets in a future period that could be material to the Company&#8217;s results of operations.</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">For the three and six months ended June 30, 2017 and 2016, we recognized impairment losses of $10.1 million, $17.8 million, $6.9 million and $41.5 million, respectively. For additional information see Note 2 &#8211; Properties and Investments.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Goodwill Impairment</b></p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">We assess goodwill for potential impairment during the fourth quarter of each fiscal year, or during the year if an event or other circumstance indicates that we may not be able to recover the carrying amount of the net assets of the reporting unit. In evaluating goodwill for impairment on an interim basis, we assess qualitative factors&#160;<font style="font-family: 'times new roman', times, serif;">such as a&#160;</font>significant decline in real estate valuations,&#160;<font style="font-family: 'times new roman', times, serif;">current macroeconomic conditions, state of the equity and capital markets and our overall financial and operating performance&#160;</font>or a significant decline in the value of our market capitalization, to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of&#160;the reporting unit is less than its carrying amount. On an annual basis during the fourth quarter of each fiscal year, or on an interim basis if we conclude it is more likely than not that the fair value of the reporting unit is less than its carrying value, we perform a two-step goodwill impairment test to identify potential impairment and measure the amount of impairment we will recognize, if any.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Noncontrolling Interests</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Noncontrolling interests is the portion of equity not attributable to the respective reporting entity. We present the portion of any equity that we do not own in consolidated entities as noncontrolling interests and classify those interests as a component of total equity, separate from total stockholders&#8217; equity, or owners&#8217; equity on our Consolidated Balance Sheets. We include net income attributable to the noncontrolling interests in net income in our Consolidated Statements of Income.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">As our ownership of a controlled subsidiary increases or decreases, any difference between the aggregate consideration paid to acquire the noncontrolling interests and our noncontrolling interest balance is recorded as a component of equity in additional paid-in capital, so long as we maintain a controlling ownership interest.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 24.5pt; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The noncontrolling interest for Omega represents the outstanding Omega OP Units held by outside investors. The noncontrolling interest for OHI Holdco represents the Omega OP Units held by the Parent and the outstanding Omega OP Units held by outside investors.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Foreign Operations</b></p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The U.S. dollar is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound. For our consolidated subsidiaries whose functional currency is not the U.S. dollar, we translate their financial statements into the U.S. dollar. We translate assets and liabilities at the exchange rate in effect as of the financial statement date. Revenue and expense accounts are translated using an average exchange rate for the period. Gains and losses resulting from translation are included in accumulated other comprehensive loss (&#8220;AOCL&#8221;), as a separate component of equity and a proportionate amount of gain or loss is allocated to noncontrolling interests.</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">We and certain of our consolidated subsidiaries may have intercompany and third-party debt that is not denominated in the entity&#8217;s functional currency. When the debt is remeasured against the functional currency of the entity, a gain or loss can result. The resulting adjustment is reflected in results of operations, unless it is intercompany debt that is deemed to be long-term in nature and then the adjustments are included in AOCL.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Derivative Instruments</b></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>&#160;</i></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>Cash flow hedges</i></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>&#160;</i></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">During our normal course of business, we may use certain types of derivative instruments for the purpose of managing interest rate and currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at the inception of a qualifying cash flow hedging relationship, the underlying transaction or transactions, must be, and are expected to remain, probable of occurring in accordance with the Company&#8217;s related assertions. The Company recognizes all derivative instruments, including embedded derivatives required to be bifurcated, as assets or liabilities in the Consolidated Balance Sheets at their fair value which are determined using a market approach and Level 2 inputs. Changes in the fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria of hedge accounting are recognized in earnings. For derivatives designated as qualifying cash flow hedging relationships, the change in fair value of the effective portion of the derivatives is recognized in AOCL as a separate component of equity and a proportionate amount of gain or loss is allocated to noncontrolling interest, whereas the change in fair value of the ineffective portion is recognized in earnings. We formally document all relationships between hedging instruments and hedged items, as well as our risk-management objectives and strategy for undertaking various hedge transactions. This process includes designating all derivatives that are part of a hedging relationship to specific forecasted transactions as well as recognized obligations or assets in the Consolidated Balance Sheets. We also assess and document, both at inception of the hedging relationship and on a quarterly basis thereafter, whether the derivatives are highly effective in offsetting the designated risks associated with the respective hedged items. If it is determined that a derivative ceases to be highly effective as a hedge, or that it is probable the underlying forecasted transaction will not occur, we discontinue hedge accounting prospectively and record the appropriate adjustment to earnings based on the current fair value of the derivative. As a matter of policy, we do not use derivatives for trading or speculative purposes. At June 30, 2017 and December 31, 2016, we had $1.4 million and $1.5 million, respectively, of qualifying cash flow hedges recorded at fair value in accrued expenses and other liabilities on our Consolidated Balance Sheets.</p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><i>Net investment hedge</i></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">We use the spot method to measure the effectiveness of our net investment hedge. Under this method, for each reporting period, the change in the carrying value of the hedging instrument due to remeasurement of the effective portion is reported in AOCL in our Consolidated Balance Sheets and the remaining change in the carrying value of the ineffective portion, if any, is recognized in earnings. We evaluate the effectiveness of our net investment hedge on a quarterly basis. We did not record any ineffectiveness for fiscal 2017.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Accounts Receivable</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts. Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements. Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line rent receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement. Lease inducements result from value provided by us to the lessee, at the inception or renewal of the lease, and are amortized as a reduction of rental revenue over the non-cancellable lease term.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">At June 30, 2017, two of our top 10 operators were approximately 90 days past due on rent payments to the Company. On a quarterly basis, we review our accounts receivable to determine their collectability. The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement.&#160; If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance. In the case of a lease recognized on a straight-line basis, a mortgage recognized on an effective yield basis or the existence of lease inducements, we generally provide an allowance for straight-line, effective interest, and/or lease inducement accounts receivable when certain conditions or indicators of adverse collectability are present. If the accounts receivable balance is subsequently deemed uncollectible, the receivable and allowance for doubtful account balance are written off.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">A summary of our net receivables by type is as follows:</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"></p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: justify;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: justify;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: justify;" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="6" nowrap="nowrap">(in thousands)</td> <td>&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: justify;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: justify;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in; width: 916px;">Contractual receivables</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 197px;">40,484</td> <td style="text-align: left; width: 14px;">&#160;</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 197px;">13,376</td> <td style="text-align: left; width: 14px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Effective yield interest receivables</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">10,940</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">9,749</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Straight-line rent receivables</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">231,233</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">208,874</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Lease inducements</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7,498</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">8,393</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.15in;">Allowance</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(1,469</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(357</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; text-indent: -0.15in; padding-left: 0.15in;">Accounts receivable &#8211; net</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">288,686</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">240,035</td> <td style="text-align: left;">&#160;</td> </tr> </table> <div>&#160;</div> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Related Party Transactions</b></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">The Company has a policy which generally requires related party transactions to be approved or ratified by the Audit Committee. On February 1, 2016, we acquired 10 SNFs from Laurel Healthcare Holdings, Inc. (&#8220;Laurel&#8221;) for approximately $169.0 million in cash and leased them to an unrelated existing operator. A former member of the Board of Directors of the Company, together with certain members of his immediate family, beneficially owned approximately 34% of the equity of Laurel prior to the transaction. Immediately following our acquisition, the unrelated existing operator acquired all of the outstanding equity interests of Laurel, including the interests previously held by the former director of the Company and his family.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Accounting Pronouncement Adopted in 2017</b></p><p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">In March 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-09,&#160;<i>Compensation-Stock Compensation (Topic 718)</i>&#160;(&#8220;ASU 2016-09&#8221;). ASU 2016-09 amends the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. This guidance is effective for annual and interim reporting periods of public entities beginning after December 15, 2016. We adopted this accounting standard on January 1, 2017, at which time the Company began prospectively accounting for excess tax benefits or tax deficiencies as an adjustment to income tax expense in our Consolidated Statements of Income as opposed to the prior requirement that these excess tax benefits be recognized in additional paid-in capital and tax deficiencies be recognized either as an offset to accumulated excess tax benefits, if any, or in the income statement. The Company will continue to account for forfeitures as they occur and present employee taxes paid as a financing activity on our Consolidated Statements of Cash Flows. The adoption of this accounting standard did not have a material impact on our consolidated financial statements.</p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>Recent Accounting Pronouncements - Pending Adoption</b></p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">In 2014, the FASB issued ASU 2014-09,&#160;<i>Revenue from Contracts with Customers</i>&#160;(&#8220;ASU 2014-09&#8221;), which outlines a comprehensive model for entities to use in accounting for revenue arising from contracts with customers. ASU 2014-09 states that &#8220;an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&#8221; While ASU 2014-09 specifically references contracts with customers, it may apply to certain other transactions such as the sale of real estate or equipment. ASU 2014-09 is effective for the Company beginning January 1, 2018. In addition, the FASB has begun to issue targeted updates to clarify specific implementation issues of ASU 2014-09. These updates include ASU 2016-08,&#160;<i>Principal versus Agent Considerations (Reporting Revenue Gross versus Net),</i>&#160;ASU 2016-10,&#160;<i>Identifying Performance Obligations and Licensing,</i>&#160;and ASU 2016-12,&#160;<i>Narrow-Scope Improvements and Practical Expedients.&#160;</i>The Company is currently evaluating the provisions of ASU 2014-09 and its related updates and will be closely monitoring developments and additional guidance to determine the potential impact of the new standard. The Company intends to adopt ASU 2014-09 and its subsequent updates in accordance with the modified retrospective approach. We do not expect the adoption of ASU 2014-09 and its updates to have a significant impact on our consolidated financial statements, as a substantial portion of our revenue consists of rental income from leasing arrangements and interest income from loan arrangements, both of which are specifically excluded from ASU 2014-09.</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">In February 2016, the FASB issued ASU 2016-02,&#160;<i>Leases&#160;</i>(&#8220;ASU 2016-02&#8221;), which amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. ASU 2016-02 will be effective for the Company beginning January 1, 2019. Early adoption of ASU 2016-02 as of its issuance is permitted. The new standard requires a modified retrospective transition approach for all leases existing at, or entered into after, the date of initial application, with an option to use certain transition relief. As a result of the pending adoption ASU 2016-02 and in connection with the pending adoption of ASU 2014-09, the Company may be required to record real estate tax revenues and an equal an offsetting real estate tax expense, as a result of our operators paying real estate taxes on our behalf. We are continuing to evaluate the other impacts of adopting ASU 2016-02 on our consolidated financial statements.</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p><p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">In June 2016, the FASB issued ASU 2016-13,&#160;<i>Financial Instruments - Credit Losses (Topic 326</i>) (&#8220;ASU 2016-13&#8221;), which changes the impairment model for most financial assets. The new model uses a forward-looking expected loss method, which will generally result in earlier recognition of allowances for losses. ASU 2016-13 is effective for annual and interim periods beginning after December 15, 2019 and early adoption is permitted for annual and interim periods beginning after December 15, 2018. We are currently evaluating the impact of adopting ASU 2016-13 on our consolidated financial statements.</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"></p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: justify;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: justify;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: justify;" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="6" nowrap="nowrap">(in thousands)</td> <td>&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: justify;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: justify;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in; width: 916px;">Contractual receivables</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 197px;">40,484</td> <td style="text-align: left; width: 14px;">&#160;</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 197px;">13,376</td> <td style="text-align: left; width: 14px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Effective yield interest receivables</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">10,940</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">9,749</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Straight-line rent receivables</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">231,233</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">208,874</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Lease inducements</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7,498</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">8,393</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.15in;">Allowance</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(1,469</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(357</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; text-indent: -0.15in; padding-left: 0.15in;">Accounts receivable &#8211; net</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">288,686</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">240,035</td> <td style="text-align: left;">&#160;</td> </tr> </table> <div>&#160;</div> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0px 0px 0px 0.5in; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 85%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">(in thousands)</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in; width: 864px;">Buildings</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 186px;">6,055,423</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 186px;">5,954,771</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">Land</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">796,561</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">759,295</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Furniture, fixtures and equipment</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">458,427</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">454,760</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Site improvements</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">204,993</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">206,206</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.15in;">Construction in progress</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">214,795</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">191,326</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Total real estate investments</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7,730,199</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7,566,358</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.3in; padding-left: 0.3in;">Less accumulated depreciation</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(1,366,376</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(1,240,336</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Real estate investments - net</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">6,363,823</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">6,326,022</td> <td style="text-align: left;">&#160;</td> </tr> </table> <div>&#160;</div> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center; padding-bottom: 2px; font-weight: bold;" nowrap="nowrap"></td> <td style="padding-bottom: 2px; font-weight: bold;"><i>&#160;</i></td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Number of<br />Facilities</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; padding-bottom: 2px; font-weight: bold;" nowrap="nowrap">Country/</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Total<br />Investment</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Land</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="2" nowrap="nowrap"> <p style="text-align: center; margin: 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Building &amp; Site&#160;</b><br /><b>Improvements</b></p> </td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Furniture&#160;<br />&amp; Fixtures</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> <td style="text-align: center; padding-bottom: 2px; font-weight: bold;" colspan="2" nowrap="nowrap">Initial<br />Annual&#160;<br />Cash Yield</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="border-bottom: black 2px solid; text-align: center;" nowrap="nowrap"><b>Period</b></td> <td style="border-bottom: black 2px solid; font-weight: bold;"><i>&#160;</i></td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">SNF</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">ALF</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" nowrap="nowrap">State</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="14" nowrap="nowrap"><b>(in millions)</b></td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"><sup>(2)</sup>(%)</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: center; width: 150px;">Q1</td> <td style="width: 13px;"><i>&#160;</i></td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="text-align: right; width: 122px;">-</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="text-align: right; width: 122px;">1</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: center; width: 136px;">VA</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 122px;">7.6</td> <td style="text-align: left; width: 21px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 122px;">0.5</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 122px;">6.8</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 122px;">0.3</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="text-align: right; width: 55px;">7.50</td> <td style="text-align: left; width: 3px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: center;">Q2</td> <td><i>&#160;</i></td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">1</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">-</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">NC</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">8.6</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">0.7</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">7.3</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">0.6</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">9.50</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: center; padding-bottom: 2px;">Q2</td> <td><i>&#160;</i></td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">-</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">18</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">UK</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">124.2</td> <td style="border-bottom: black 2px solid; text-align: left;"><b><sup>&#160;&#160;</sup>(1)</b></td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">34.1</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">85.1</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">5.0</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left; padding-bottom: 2px;">&#160;</td> <td style="text-align: right; padding-bottom: 2px;">8.50</td> <td style="text-align: left; padding-bottom: 2px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: center; padding-bottom: 4px;">Total</td> <td><i>&#160;</i></td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">1</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">19</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 4px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">140.4</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">35.3</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">99.2</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">5.9</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> <td style="text-align: right; padding-bottom: 4px;">&#160;</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: -20.7pt; margin: 0px 0px 0px 32.85pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 20pt;"></td> <td style="text-align: left; width: 20pt;">(1)</td> <td style="text-align: justify;">Omega recorded a non-cash deferred tax liability and acquisitions costs of approximately $8.2 million and $1.2 million, respectively, in connection with this acquisition.</td> </tr> </table> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 20pt;"></td> <td style="text-align: left; width: 20pt;">(2)</td> <td style="text-align: justify;">The cash yield is based on the purchase price.</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0.5in; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">(in thousands)</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in; width: 1005px;">Minimum lease payments receivable</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 175px;">4,085,493</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 174px;">4,287,069</td> <td style="text-align: left; width: 14px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Less unearned income</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(3,499,877</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(3,685,131</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.15in;">Less allowance for loss on direct financing lease</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(3,309</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; text-indent: -0.15in; padding-left: 0.15in;">Investment in direct financing leases - net</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">582,307</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">601,938</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; text-indent: -0.15in; padding-left: 0.15in;">Properties subject to direct financing leases</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">53</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">58</td> <td style="text-align: left;">&#160;</td> </tr> </table> <div>&#160;</div> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="text-align: center; border-left: black 2px solid; width: 238px; border-top: black 2px solid; border-right: black 2px solid;"><font style="font-size: 10pt;">2017</font></td><td style="text-align: center; width: 224px; border-top: black 2px solid;"><font style="font-size: 10pt;">2018</font></td><td style="text-align: center; border-left: black 2px solid; width: 223px; border-top: black 2px solid; border-right: black 2px solid;"><font style="font-size: 10pt;">2019</font></td><td style="text-align: center; width: 237px; border-top: black 2px solid;"><font style="font-size: 10pt;">2020</font></td><td style="text-align: center; border-left: black 2px solid; width: 237px; border-top: black 2px solid; border-right: black 2px solid;"><font style="font-size: 10pt;">2021</font></td><td style="text-align: center; width: 237px; border-top: black 2px solid; border-right: black 2px solid;"><font style="font-size: 10pt;">2022</font></td></tr><tr style="vertical-align: top;"><td style="text-align: center; border: black 2px solid;"><font style="font-size: 10pt;">$24,407</font></td><td style="border-bottom: black 2px solid; text-align: center; border-top: black 2px solid;"><font style="font-size: 10pt;">$50,019</font></td><td style="text-align: center; border: black 2px solid;"><font style="font-size: 10pt;">$51,246</font></td><td style="border-bottom: black 2px solid; text-align: center; border-top: black 2px solid;"><font style="font-size: 10pt;">$52,493</font></td><td style="text-align: center; border: black 2px solid;"><font style="font-size: 10pt;">$53,681</font></td><td style="border-bottom: black 2px solid; text-align: center; border-top: black 2px solid; border-right: black 2px solid;"><font style="font-size: 10pt;">$55,008</font></td></tr></table> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 85%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">(in thousands)</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right;" colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; width: 932px;">Mortgage note due 2024; interest at 9.98%</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 160px;">112,500</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 159px;">112,500</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Mortgage note due 2029; interest at 9.45%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">411,467</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">412,140</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.15in;">Other mortgage notes outstanding&#160;<sup>(1)</sup></td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">143,489</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">118,637</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.45in; padding-left: 0.45in;">Mortgage notes receivable, gross</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">667,456</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">643,277</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.45in; padding-left: 0.45in;">Allowance for loss on mortgage notes receivable</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(4,747</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(3,934</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Total mortgages &#8212; net</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">662,709</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">639,343</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: -0.25in; margin: 0px 0px 0px 67.5pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><sup>&#160;</sup></p> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="text-align: left; width: 20pt;"><font style="font-size: 10pt;"><sup>(1)</sup></font></td> <td style="text-align: justify;"><sup>Other mortgage notes outstanding have stated interest rates ranging from 8.35% to 14.0% and maturity dates through 2029.</sup></td> </tr> </table> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 85%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="6" nowrap="nowrap">(in thousands)</td> <td>&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.25in; width: 908px;">Other investment note due 2019; interest at 10.96%</td> <td style="width: 14px;">&#160;</td> <td style="text-align: left; width: 14px;">$</td> <td style="text-align: right; width: 160px;">49,583</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 159px;">49,458</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.25in;">Other investment note due 2020; interest at 14.00%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">47,899</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">47,913</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.25in;">Other investment note due 2022, interest at 9.00%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">31,987</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">31,987</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.25in;">Other investment note due 2030; interest at 6.66%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">50,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">44,595</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.25in;">Other investment notes outstanding&#160;<sup>(1)</sup></td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">104,314</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">87,691</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.15in;">Other investments, gross</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">283,783</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">261,644</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.15in;">Allowance for loss on other investments</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(4,798</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(4,798</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; text-indent: -0.15in; padding-left: 0.15in;">Total other investments</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">278,985</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">256,846</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="widows: 2; text-transform: none; font-style: normal; margin-top: 0px; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; margin-bottom: 0px; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal;">&#160;</p> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="text-align: left; width: 20pt;"><sup>(1)</sup></td> <td style="text-align: justify;"><sup>Other investment notes have maturity dates through 2028 and interest rates ranging from 6.50% to 13.0%.</sup></td> </tr> </table> <div>&#160;</div> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 50%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Properties Held For Sale</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Number of<br />Properties</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Net Book Value<br />(in thousands)</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="6" nowrap="nowrap">&#160;</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in; width: 339px;">December 31, 2016</td> <td style="width: 5px;">&#160;</td> <td style="text-align: left; width: 5px;">&#160;</td> <td style="text-align: right; width: 63px;">20</td> <td style="text-align: left; width: 5px;">&#160;</td> <td style="width: 5px;">&#160;</td> <td style="text-align: left; width: 6px;">$</td> <td style="text-align: right; width: 82px;">52,868</td> <td style="text-align: left; width: 5px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; text-indent: -0.15in; padding-left: 0.25in;"><font style="font-size: 10pt;">Properties sold/other&#160;<sup>(1)</sup></font></td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(12</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(30,023</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.25in;"><font style="font-size: 10pt;">Properties added&#160;<sup>(2)</sup></font></td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">1</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">400</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">March 31, 2017</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">9</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">23,245</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; text-indent: -0.15in; padding-left: 0.25in;"><font style="font-size: 10pt;">Properties sold/other&#160;<sup>(1)</sup></font></td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(4,356</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-bottom: 4px; text-indent: -0.15in; padding-left: 0.15in;"><font style="font-size: 10pt;">June 30, 2017<sup>(3)</sup></font></td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">7</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">18,889</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: -18.9pt; margin: 0px 0px 0px 0.9in; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><sup>&#160;</sup></p> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="text-align: left; width: 0.25in;"><sup>(1)</sup></td> <td style="text-align: justify;">In the first quarter of 2017, we sold nine SNFs and two ALFs for approximately $29.4 million in net proceeds recognizing a gain on sale of approximately $3.6 million. One SNF classified as an asset held for sale at December 31, 2016 was no longer considered held for sale during the first quarter of 2017 and was reclassified back to leased properties at approximately $5.1 million which represents the facility&#8217;s then carrying value adjusted for depreciation that was not recognized while classified as held for sale. In the second quarter of 2017, we sold one ALF and one SNF for approximately $5.0 million in net proceeds, generating a gain on sale of approximately $0.6 million.</td> </tr> </table> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.25in;"><sup>(2)</sup></td> <td style="text-align: justify;">In the first quarter of 2017, we recorded a $3.5 million impairment to reduce one ALF&#8217;s net book value to its estimated fair value less costs to sell before it was reclassified to assets held for sale.</td> </tr> </table> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.25in;"><sup>(3)</sup></td> <td style="text-align: justify;">We plan to sell the facilities classified as held for sale at June 30, 2017 within the next twelve months.</td> </tr> </table> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 60%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,</td> <td style="font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="6" nowrap="nowrap">(in thousands)</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>Assets:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-bottom: 4px; padding-left: 9pt; width: 712px;">Goodwill</td> <td style="width: 11px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; width: 11px;">$</td> <td style="border-bottom: black 4px double; text-align: right; width: 154px;">644,184</td> <td style="border-bottom: black 4px double; text-align: left; width: 11px;">&#160;</td> <td style="border-bottom: black 4px double; width: 11px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; width: 11px;">$</td> <td style="border-bottom: black 4px double; text-align: right; width: 153px;">643,474</td> <td style="text-align: left; width: 10px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Above market leases</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">22,426</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">22,476</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">In-place leases</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">167</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">167</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Accumulated amortization</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(16,477</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(15,864</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 0.25in;">Net intangible assets</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">6,116</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">6,779</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>Liabilities:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Below market leases</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">164,735</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">165,028</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Accumulated amortization</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(77,534</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(70,738</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 0.25in;">Net intangible liabilities</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">87,201</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">94,290</td> <td style="text-align: left;">&#160;</td> </tr> </table> <div>&#160;</div> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 75%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 2px; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">(in thousands)</td><td style="padding-bottom: 2px; font-weight: bold;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-indent: -0.15in; padding-left: 0.15in; width: 1013px;">Balance as of December 31, 2016</td><td style="width: 13px;">&#160;</td><td style="text-align: left; width: 13px;">$</td><td style="text-align: right; width: 187px;">643,474</td><td style="text-align: left; width: 12px;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Add: foreign currency translation</td><td style="padding-bottom: 2px;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">710</td><td style="text-align: left; padding-bottom: 2px;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="padding-bottom: 4px; text-indent: -0.15in; padding-left: 0.15in;">Balance as of June 30, 2017</td><td style="padding-bottom: 4px;">&#160;</td><td style="border-bottom: black 4px double; text-align: left;">$</td><td style="border-bottom: black 4px double; text-align: right;">644,184</td><td style="text-align: left; padding-bottom: 4px;">&#160;</td></tr></table> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 60%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="14" nowrap="nowrap">Omega</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">As of and For the Three<br />Months Ended June 30,</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">As of and For the Six<br />Months Ended June 30,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="14" nowrap="nowrap">(in thousands)</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: 1.35pt;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; font-weight: bold;">Foreign Currency Translation:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; width: 301px;">Beginning balance</td> <td style="width: 6px;">&#160;</td> <td style="text-align: left; width: 6px;">$</td> <td style="text-align: right; width: 61px;">(50,614</td> <td style="text-align: left; width: 6px;">)</td> <td style="width: 6px;">&#160;</td> <td style="text-align: left; width: 6px;">$</td> <td style="text-align: right; width: 61px;">(13,143</td> <td style="text-align: left; width: 6px;">)</td> <td style="width: 6px;">&#160;</td> <td style="text-align: left; width: 6px;">$</td> <td style="text-align: right; width: 61px;">(54,948</td> <td style="text-align: left; width: 6px;">)</td> <td style="width: 6px;">&#160;</td> <td style="text-align: left; width: 6px;">$</td> <td style="text-align: right; width: 61px;">(8,413</td> <td style="text-align: left; width: 6px;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Translation gain (loss)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">10,195</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(21,836</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">14,468</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(26,544</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px;">Realized gain (loss)</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">79</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">-</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">140</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(22</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-bottom: 2px;">Ending balance</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(40,340</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(34,979</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(40,340</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(34,979</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; font-weight: bold;">Derivative Instruments:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; font-weight: bold;">Cash flow hedges:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Beginning balance</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(166</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(9,594</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(1,420</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(718</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left;">Unrealized loss</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(1,840</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(4,198</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(1,350</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(13,074</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px;">Realized gain</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">626</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">-</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">1,390</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-bottom: 2px;">Ending balance</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(1,380</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(13,792</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(1,380</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(13,792</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; font-weight: bold;">Net investment hedge:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left;">Beginning balance</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px;">Unrealized loss</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2,193</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">-</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2,193</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-bottom: 2px;">Ending balance</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2,193</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">-</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2,193</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; font-weight: bold;">Total accumulated other comprehensive loss</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">(43,913</td> <td style="text-align: left; font-weight: bold;">)</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">(48,771</td> <td style="text-align: left; font-weight: bold;">)</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">(43,913</td> <td style="text-align: left; font-weight: bold;">)</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">(48,771</td> <td style="text-align: left; font-weight: bold;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px;">Add: portion included in noncontrolling interest</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">2,010</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">2,308</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">2,010</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">2,308</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; font-weight: bold;">Total accumulated other comprehensive loss</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td> <td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(41,903</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td> <td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td> <td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(46,463</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td> <td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td> <td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(41,903</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td> <td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td> <td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(46,463</td> <td style="text-align: left; font-weight: bold;">)</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"></p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 60%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="14" nowrap="nowrap">OHI Holdco</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">As of and For the Three<br />Months Ended June 30,</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">As of and For the Six<br />Months Ended June 30,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="14" nowrap="nowrap">(in thousands)</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: 1.35pt;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; font-weight: bold;">Foreign Currency Translation:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; width: 301px;">Beginning balance</td> <td style="width: 6px;">&#160;</td> <td style="text-align: left; width: 6px;">$</td> <td style="text-align: right; width: 61px;">(50,614</td> <td style="text-align: left; width: 6px;">)</td> <td style="width: 6px;">&#160;</td> <td style="text-align: left; width: 6px;">$</td> <td style="text-align: right; width: 61px;">(13,143</td> <td style="text-align: left; width: 6px;">)</td> <td style="width: 6px;">&#160;</td> <td style="text-align: left; width: 6px;">$</td> <td style="text-align: right; width: 61px;">(54,948</td> <td style="text-align: left; width: 6px;">)</td> <td style="width: 6px;">&#160;</td> <td style="text-align: left; width: 6px;">$</td> <td style="text-align: right; width: 61px;">(8,413</td> <td style="text-align: left; width: 6px;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Translation gain (loss)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">10,195</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(21,836</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">14,468</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(26,544</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px;">Realized gain (loss)</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">79</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">-</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">140</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(22</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-bottom: 2px;">Ending balance</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(40,340</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(34,979</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(40,340</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(34,979</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; font-weight: bold;">Derivative Instruments:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; font-weight: bold;">Cash flow hedges:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Beginning balance</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(166</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(9,594</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(1,420</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(718</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left;">Unrealized loss</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(1,840</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(4,198</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(1,350</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(13,074</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px;">Realized gain</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">626</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">-</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">1,390</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-bottom: 2px;">Ending balance</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(1,380</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(13,792</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(1,380</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(13,792</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; font-weight: bold;">Net investment hedge:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left;">Beginning balance</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px;">Unrealized loss</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2,193</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">-</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2,193</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-bottom: 2px;">Ending balance</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2,193</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">-</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2,193</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; font-weight: bold;">Total accumulated other comprehensive loss</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">(43,913</td> <td style="text-align: left; font-weight: bold;">)</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">(48,771</td> <td style="text-align: left; font-weight: bold;">)</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">(43,913</td> <td style="text-align: left; font-weight: bold;">)</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">(48,771</td> <td style="text-align: left; font-weight: bold;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px;">Add: portion included in noncontrolling interest</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">34,116</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">37,965</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">34,116</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">37,965</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; font-weight: bold;">Total accumulated other comprehensive loss</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td> <td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(9,797</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td> <td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td> <td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(10,806</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td> <td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td> <td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(9,797</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td> <td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td> <td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(10,806</td> <td style="text-align: left; font-weight: bold;">)</td> </tr> </table> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><b>&#160;</b></p> <p style="widows: 2; text-transform: none; text-indent: 0px; margin: 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"></p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 60%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="14" nowrap="nowrap">Omega OP</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">As of and For the Three<br />Months Ended June 30,</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">As of and For the Six<br />Months Ended June 30,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="14" nowrap="nowrap">(in thousands)</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: 1.35pt;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; font-weight: bold;">Foreign Currency Translation:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; width: 301px;">Beginning balance</td> <td style="width: 6px;">&#160;</td> <td style="text-align: left; width: 6px;">$</td> <td style="text-align: right; width: 61px;">(50,614</td> <td style="text-align: left; width: 6px;">)</td> <td style="width: 6px;">&#160;</td> <td style="text-align: left; width: 6px;">$</td> <td style="text-align: right; width: 61px;">(13,143</td> <td style="text-align: left; width: 6px;">)</td> <td style="width: 6px;">&#160;</td> <td style="text-align: left; width: 6px;">$</td> <td style="text-align: right; width: 61px;">(54,948</td> <td style="text-align: left; width: 6px;">)</td> <td style="width: 6px;">&#160;</td> <td style="text-align: left; width: 6px;">$</td> <td style="text-align: right; width: 61px;">(8,413</td> <td style="text-align: left; width: 6px;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Translation gain (loss)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">10,195</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(21,836</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">14,468</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(26,544</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px;">Realized gain (loss)</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">79</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">-</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">140</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(22</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-bottom: 2px;">Ending balance</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(40,340</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(34,979</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(40,340</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(34,979</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; font-weight: bold;">Derivative Instruments:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; font-weight: bold;">Cash flow hedges:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Beginning balance</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(166</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(9,594</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(1,420</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(718</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left;">Unrealized loss</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(1,840</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(4,198</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(1,350</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(13,074</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px;">Realized gain</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">626</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">-</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">1,390</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-bottom: 2px;">Ending balance</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(1,380</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(13,792</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(1,380</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(13,792</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; font-weight: bold;">Net investment hedge:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left;">Beginning balance</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="text-align: left; font-weight: bold;">&#160;</td> <td style="text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px;">Unrealized loss</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2,193</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">-</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2,193</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-bottom: 2px;">Ending balance</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2,193</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">-</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2,193</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">-</td> <td style="text-align: left; font-weight: bold;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; font-weight: bold;">Total accumulated other comprehensive loss</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td> <td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(43,913</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td> <td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td> <td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(48,771</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td> <td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td> <td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(43,913</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">)</td> <td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td> <td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">(48,771</td> <td style="text-align: left; font-weight: bold;">)</td> </tr> </table> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 90%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">Three Months Ended&#160;<br />June 30,</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center;" colspan="6" nowrap="nowrap"><p style="text-align: center; margin: 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Six Months Ended</b></p><p style="text-align: center; margin: 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>June 30,</b></p></td><td>&#160;</td></tr><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td><td style="font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td>&#160;</td><td style="text-align: center;" colspan="14" nowrap="nowrap">(in thousands)</td><td>&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="padding-left: 0.15in; width: 662px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="text-align: left; width: 14px;">&#160;</td><td style="text-align: right; width: 141px;">&#160;</td><td style="text-align: left; width: 14px;">&#160;</td><td style="width: 14px;">&#160;</td><td style="text-align: left; width: 14px;">&#160;</td><td style="text-align: right; width: 141px;">&#160;</td><td style="text-align: left; width: 14px;">&#160;</td><td style="width: 14px;">&#160;</td><td style="text-align: left; width: 14px;">&#160;</td><td style="text-align: right; width: 141px;">&#160;</td><td style="text-align: left; width: 14px;">&#160;</td><td style="width: 14px;">&#160;</td><td style="text-align: left; width: 14px;">&#160;</td><td style="text-align: right; width: 141px;">&#160;</td><td style="text-align: left; width: 14px;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 4px; padding-left: 0.15in;">Stock-based compensation expense</td><td>&#160;</td><td style="border-bottom: black 4px double; text-align: left;">$</td><td style="border-bottom: black 4px double; text-align: right;">3,734</td><td style="border-bottom: black 4px double; text-align: left;">&#160;</td><td style="border-bottom: black 4px double;">&#160;</td><td style="border-bottom: black 4px double; text-align: left;">$</td><td style="border-bottom: black 4px double; text-align: right;">3,665</td><td style="border-bottom: black 4px double; text-align: left;">&#160;</td><td style="border-bottom: black 4px double;">&#160;</td><td style="border-bottom: black 4px double; text-align: left;">$</td><td style="border-bottom: black 4px double; text-align: right;">7,478</td><td style="border-bottom: black 4px double; text-align: left;">&#160;</td><td style="border-bottom: black 4px double;">&#160;</td><td style="border-bottom: black 4px double; text-align: left;">$</td><td style="border-bottom: black 4px double; text-align: right;">6,443</td><td style="text-align: left;">&#160;</td></tr></table> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 8pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td nowrap="nowrap">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" nowrap="nowrap">Grant&#160;<br />Year</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Shares/ Units</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Grant Date&#160;<br />Average&#160;<br />Fair Value&#160;<br />Per Unit/&#160;<br />Share</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap"><font style="font-size: 8pt;"><b>Total&#160;<br />Compensation<br />Cost (in millions)<br /><sup>(1)</sup></b></font></td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Weighted&#160;<br />Average&#160;<br />Period of&#160;<br />Expense&#160;<br />Recognition<br />(in months)</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">Unrecognized&#160;<br />Compensation&#160;<br />Cost (in&#160;<br />millions)</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" nowrap="nowrap">Performance&#160;<br />Period</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" nowrap="nowrap">Vesting&#160;<br />Dates</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="border-bottom: black 2px solid; font-weight: bold;">RSUs</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: center;">&#160;</td><td>&#160;</td><td style="text-align: center;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="width: 439px;">3/31/15 RSU</td><td style="width: 16px;">&#160;</td><td style="text-align: right; width: 126px;">2015</td><td style="width: 16px;">&#160;</td><td style="text-align: left; width: 16px;">&#160;</td><td style="text-align: right; width: 95px;">109,985</td><td style="text-align: left; width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="text-align: left; width: 16px;">$</td><td style="text-align: right; width: 95px;">40.57</td><td style="text-align: left; width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="text-align: left; width: 16px;">$</td><td style="text-align: right; width: 95px;">4.5</td><td style="text-align: left; width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="text-align: left; width: 15px;">&#160;</td><td style="text-align: right; width: 94px;">33</td><td style="text-align: left; width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="text-align: left; width: 15px;">$</td><td style="text-align: right; width: 94px;">0.8</td><td style="text-align: left; width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="text-align: center; width: 125px;">N/A</td><td style="width: 15px;">&#160;</td><td style="text-align: center; width: 125px;">12/31/2017</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>4/1/15 RSU</td><td>&#160;</td><td style="text-align: right;">2015</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">40,464</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">40.74</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1.6</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">33</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">0.3</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: center;">N/A</td><td>&#160;</td><td style="text-align: center;">12/31/2017</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;">Assumed Aviv RSU</td><td>&#160;</td><td style="text-align: right;">2015</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">7,799</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">35.08</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">0.3</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">33</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">0.1</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: center;">N/A</td><td>&#160;</td><td style="text-align: center;">11/1/2017</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>3/17/16&#160;&#160;RSU</td><td>&#160;</td><td style="text-align: right;">2016</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">130,006</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">34.78</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">4.6</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">33</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">2.4</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: center;">N/A</td><td>&#160;</td><td style="text-align: center;">12/31/2018</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="padding-bottom: 2px;">1/1/2017&#160;&#160;RSU</td><td style="padding-bottom: 2px;">&#160;</td><td style="text-align: right; padding-bottom: 2px;">2017</td><td style="padding-bottom: 2px;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">140,416</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">31.26</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">4.3</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">36</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">3.6</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: center; padding-bottom: 2px;">N/A</td><td>&#160;</td><td style="text-align: center; padding-bottom: 2px;">12/31/2019</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px; padding-left: 0.125in; font-weight: bold;">Restricted Stock Units Total</td><td style="padding-bottom: 2px;">&#160;</td><td style="text-align: right; padding-bottom: 2px;">&#160;</td><td style="padding-bottom: 2px; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">428,670</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">35.68</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">15.3</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;"><font style="font-size: 8pt;"><b>&#160;</b></font></td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">7.2</td><td style="text-align: left; font-weight: bold;">&#160;</td><td>&#160;</td><td style="padding-bottom: 2px;">&#160;</td><td>&#160;</td><td style="padding-bottom: 2px;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="border-bottom: black 2px solid; text-align: left; padding-left: 9pt; font-weight: bold;">TSR PRSUs and LTIP Units</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>2016 TSR</td><td>&#160;</td><td style="text-align: right;">2014</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">135,634</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">8.67</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1.2</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">48</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">0.2</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td>1/1/2014-12/31/2016</td><td>&#160;</td><td style="text-align: left;">Quarterly in 2017</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;">3/31/15 2017 LTIP Units</td><td>&#160;</td><td style="text-align: right;">2015</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">137,249</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">14.66</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">2.0</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">45</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">0.8</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td>1/1/2015-12/31/2017</td><td>&#160;</td><td style="text-align: left;">Quarterly in 2018</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">4/1/2015 2017 LTIP Units</td><td>&#160;</td><td style="text-align: right;">2015</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">54,151</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">14.80</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">0.8</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">45</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">0.3</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td>1/1/2015-12/31/2017</td><td>&#160;</td><td style="text-align: left;">Quarterly in 2018</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;">3/17/2016 2018 LTIP Units</td><td>&#160;</td><td style="text-align: right;">2016</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">372,069</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">13.21</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">4.9</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">45</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">3.2</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td>1/1/2016-12/31/2018</td><td>&#160;</td><td style="text-align: left;">Quarterly in 2019</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px;">1/1/2017 2019 LTIP Units</td><td style="padding-bottom: 2px;">&#160;</td><td style="text-align: right; padding-bottom: 2px;">2017</td><td style="padding-bottom: 2px;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">399,726</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">12.61</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">5.0</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">48</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">4.4</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="padding-bottom: 2px;">1/1/2017-12/31/2019</td><td>&#160;</td><td style="text-align: left; padding-bottom: 2px;">Quarterly in 2020</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px; padding-left: 0.125in; font-weight: bold;">TSR PRSUs &amp; LTIP Total</td><td style="padding-bottom: 2px;">&#160;</td><td style="text-align: right; padding-bottom: 2px;">&#160;</td><td style="padding-bottom: 2px; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">1,098,829</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">12.69</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">13.9</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">8.9</td><td style="text-align: left; font-weight: bold;">&#160;</td><td>&#160;</td><td style="padding-bottom: 2px;">&#160;</td><td>&#160;</td><td style="padding-bottom: 2px;">&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="border-bottom: black 2px solid; text-align: left; padding-left: 9pt; font-weight: bold;">Relative TSR PRSUs</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr><tr style="background-color: white; vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;">2016 Relative TSR</td><td>&#160;</td><td style="text-align: right;">2014</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">135,634</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">14.24</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1.9</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">48</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">0.2</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td>1/1/2014-12/31/2016</td><td>&#160;</td><td style="text-align: left;">Quarterly in 2017</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">3/31/15 2017 Relative TSR</td><td>&#160;</td><td style="text-align: right;">2015</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">137,249</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">22.50</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">3.1</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">45</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1.2</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td>1/1/2015-12/31/2017</td><td>&#160;</td><td style="text-align: left;">Quarterly in 2018</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left;">4/1/2015 2017 Relative TSR</td><td>&#160;</td><td style="text-align: right;">2015</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">54,151</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">22.91</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">1.2</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">45</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">0.5</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td>1/1/2015-12/31/2017</td><td>&#160;</td><td style="text-align: left;">Quarterly in 2018</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left;">3/17/2016 2018 Relative TSR</td><td>&#160;</td><td style="text-align: right;">2016</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">307,480</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">16.45</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">5.1</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">45</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">3.4</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td>1/1/2016-12/31/2018</td><td>&#160;</td><td style="text-align: left;">Quarterly in 2019</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px;">1/1/2017 2019 Relative TSR</td><td style="padding-bottom: 2px;">&#160;</td><td style="text-align: right; padding-bottom: 2px;">2017</td><td style="padding-bottom: 2px;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">285,338</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">18.04</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">5.1</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">48</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right;">4.5</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="padding-bottom: 2px;">1/1/2017-12/31/2019</td><td>&#160;</td><td style="text-align: left; padding-bottom: 2px;">Quarterly in 2020</td></tr><tr style="background-color: white; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 2px; padding-left: 9pt; font-weight: bold;">Relative TSR PRSUs Total</td><td style="padding-bottom: 2px;">&#160;</td><td style="text-align: right; padding-bottom: 2px;">&#160;</td><td style="padding-bottom: 2px; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">919,852</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">17.78</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">16.4</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td><td style="border-bottom: black 2px solid; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 2px solid; text-align: right; font-weight: bold;">9.8</td><td style="text-align: left; font-weight: bold;">&#160;</td><td>&#160;</td><td style="padding-bottom: 2px;">&#160;</td><td>&#160;</td><td style="padding-bottom: 2px;">&#160;</td></tr><tr style="background-color: azure; vertical-align: bottom;"><td style="text-align: left; padding-bottom: 4px; padding-left: 0.25in; font-weight: bold;">Grand Total</td><td style="padding-bottom: 4px;">&#160;</td><td style="text-align: right; padding-bottom: 4px;">&#160;</td><td style="padding-bottom: 4px; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">2,447,351</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">18.63</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">45.6</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; font-weight: bold;">&#160;</td><td style="border-bottom: black 4px double; text-align: left; font-weight: bold;">$</td><td style="border-bottom: black 4px double; text-align: right; font-weight: bold;">25.9</td><td style="text-align: left; font-weight: bold;">&#160;</td><td>&#160;</td><td style="padding-bottom: 4px;">&#160;</td><td>&#160;</td><td style="padding-bottom: 4px;">&#160;</td></tr></table><table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0.25in;"></td><td style="width: 0.25in;">(1)</td><td style="text-align: justify;">Total compensation costs are net of shares cancelled.</td></tr></table> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;" nowrap="nowrap"> <p style="text-align: center; margin: 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Annual Interest<br />Rate as of</b></p> <p style="text-align: center; margin: 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>June 30,</b></p> </td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">June 30,</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">December 31,</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" nowrap="nowrap">Maturity</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" nowrap="nowrap">2017</td> <td style="font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="6" nowrap="nowrap">(in thousands)</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left;">Secured borrowings:</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt; width: 643px;">HUD mortgages assumed December 2011<sup>(1)</sup></td> <td style="width: 13px;">&#160;</td> <td style="text-align: center; width: 164px;">2044</td> <td style="width: 13px;">&#160;</td> <td style="text-align: center; width: 164px;">3.06%</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 136px;">54,316</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 136px;">54,954</td> <td style="text-align: left; width: 13px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Deferred financing costs &#8211; net</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(579</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(589</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Total secured borrowings &#8211; net<sup>(2)</sup></td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">53,737</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">54,365</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Unsecured borrowings:</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Revolving line of credit</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">2021</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">2.47%</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">155,000</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">190,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Tranche A-1 term loan</td> <td>&#160;</td> <td style="text-align: center;">-</td> <td>&#160;</td> <td style="text-align: center;">-</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">200,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Tranche A-2 term loan</td> <td>&#160;</td> <td style="text-align: center;">-</td> <td>&#160;</td> <td style="text-align: center;">-</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">200,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Tranche A-3 term loan</td> <td>&#160;</td> <td style="text-align: center;">-</td> <td>&#160;</td> <td style="text-align: center;">-</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">350,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">U.S. term loan</td> <td>&#160;</td> <td style="text-align: center;">2022</td> <td>&#160;</td> <td style="text-align: center;">2.67%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">425,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Sterling term loan</td> <td>&#160;</td> <td style="text-align: center;">2022</td> <td>&#160;</td> <td style="text-align: center;">1.70%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">130,250</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Omega OP term loan<sup>(2)</sup></td> <td>&#160;</td> <td style="text-align: center;">2022</td> <td>&#160;</td> <td style="text-align: center;">2.67%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">100,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">100,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">2015 term loan</td> <td>&#160;</td> <td style="text-align: center;">2022</td> <td>&#160;</td> <td style="text-align: center;">3.80%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">250,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">250,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Discounts and deferred financing costs &#8211; net<sup>(3)</sup></td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(5,958</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(5,657</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Total term loans &#8211; net</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">899,292</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">1,094,343</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-left: 9pt;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-left: 9pt;">2023 notes</td> <td>&#160;</td> <td style="text-align: center;">2023</td> <td>&#160;</td> <td style="text-align: center;">4.375%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">700,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">700,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-left: 9pt;">2024 notes</td> <td>&#160;</td> <td style="text-align: center;">2024</td> <td>&#160;</td> <td style="text-align: center;">5.875%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">400,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-left: 9pt;">2024 notes</td> <td>&#160;</td> <td style="text-align: center;">2024</td> <td>&#160;</td> <td style="text-align: center;">4.95%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">400,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">400,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-left: 9pt;">2025 notes</td> <td>&#160;</td> <td style="text-align: center;">2025</td> <td>&#160;</td> <td style="text-align: center;">4.50%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">400,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">250,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-left: 9pt;">2026 notes</td> <td>&#160;</td> <td style="text-align: center;">2026</td> <td>&#160;</td> <td style="text-align: center;">5.25%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">600,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">600,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-left: 9pt;">2027 notes</td> <td>&#160;</td> <td style="text-align: center;">2027</td> <td>&#160;</td> <td style="text-align: center;">4.50%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">700,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">700,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-left: 9pt;">2028 notes</td> <td>&#160;</td> <td style="text-align: center;">2028</td> <td>&#160;</td> <td style="text-align: center;">4.75%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">550,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-left: 9pt;">Other</td> <td>&#160;</td> <td style="text-align: center;">2018</td> <td>&#160;</td> <td style="text-align: center;">-</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">1,500</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">3,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Subordinated debt</td> <td>&#160;</td> <td style="text-align: center;">2021</td> <td>&#160;</td> <td style="text-align: center;">9.00%</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">20,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">20,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Discount - net</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(22,345</td> <td style="text-align: left;">)</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">(17,151</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Deferred financing costs &#8211; net</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(27,297</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(27,703</td> <td style="text-align: left;">)</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Total unsecured borrowings &#8211; net</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 2px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">3,321,858</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">3,028,146</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-left: 9pt;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: center;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Total secured and unsecured borrowings &#8211; net</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 4px;">&#160;</td> <td>&#160;</td> <td style="text-align: center; padding-bottom: 4px;">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">4,429,887</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">4,366,854</td> <td style="text-align: left;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: -0.25in; margin: 0px 0px 0px 45pt; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;"><sup>&#160;</sup></p> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 27pt;"></td> <td style="width: 18pt;"><sup>(1)</sup></td> <td style="text-align: justify;">Reflects the weighted average annual contractual interest rate on the mortgages at June 30, 2017 excluding a third-party administration fee of approximately 0.5% annually. Secured by real estate assets with a net carrying value of $63.9 million as of June 30, 2017.</td> </tr> </table> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 27pt;"></td> <td style="width: 18pt;"><sup>(2)</sup></td> <td style="text-align: justify;">These amounts represent borrowings that were incurred by Omega OP or wholly owned subsidiaries of Omega OP.</td> </tr> </table> <table style="widows: 2; text-transform: none; margin-top: 0px; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0px; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 27pt;"></td> <td style="width: 18pt;"><sup>(3)</sup></td> <td style="text-align: justify;">This amount includes $0.6 million of net deferred financing costs related to the Omega OP term loan as of June 30, 2017.</td> </tr> </table> <table align="center" style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">June 30, 2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="6" nowrap="nowrap">December 31, 2016</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="2" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Carrying</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Amount</b></p> </td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="2" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Fair</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Value</b></p> </td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="2" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Carrying</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Amount</b></p> </td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="2" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Fair</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Value</b></p> </td> <td style="padding-bottom: 2px;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="14" nowrap="nowrap">(in thousands)</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in; font-weight: bold;">Assets:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt; width: 507px;">Investments in direct financing leases &#8211; net</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 156px;">582,307</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 156px;">578,998</td> <td style="text-align: left; width: 13px;">&#160;</td> <td style="width: 13px;">&#160;</td> <td style="text-align: left; width: 13px;">$</td> <td style="text-align: right; width: 155px;">601,938</td> <td style="text-align: left; width: 12px;">&#160;</td> <td style="width: 12px;">&#160;</td> <td style="text-align: left; width: 12px;">$</td> <td style="text-align: right; width: 155px;">598,665</td> <td style="text-align: left; width: 12px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Mortgage notes receivable &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">662,709</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">676,396</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">639,343</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">644,961</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Other investments &#8211; net</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">278,985</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">271,306</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">256,846</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">253,385</td> <td style="text-align: left; padding-bottom: 2px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-bottom: 4px; padding-left: 0.25in;">Total</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">1,524,001</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">1,526,700</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">1,498,127</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">1,497,011</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in; font-weight: bold;">Liabilities:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Revolving line of credit</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">155,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">155,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">190,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">$</td> <td style="text-align: right;">190,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Tranche A-1 term loan</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">198,830</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">200,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Tranche A-2 term loan</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">200,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">200,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Tranche A-3 term loan</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">347,449</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">350,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">U.S. term loan</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">422,280</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">425,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Sterling term loan</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">129,413</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">130,250</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;"><font style="font-size: 10pt;">Omega OP term loan</font><sup>(1)</sup></td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">99,373</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">100,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">100,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">100,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">2015 term loan</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">248,226</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">250,000</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">248,064</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">250,000</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">4.375% notes due 2023 &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">692,890</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">723,805</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">692,305</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">693,505</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">5.875% notes due 2024 &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">395,065</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">432,938</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">4.95% notes due 2024 &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">393,175</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">421,504</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">392,669</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">406,361</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">4.50% notes due 2025 &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">394,368</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">361,983</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">245,949</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">249,075</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">5.25% notes due 2026 &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">593,969</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">641,199</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">593,616</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">611,461</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">4.50% notes due 2027 &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">685,784</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">703,514</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">685,052</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">681,978</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">4.75% notes due 2028 &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">539,741</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">557,520</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#8212;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;"><font style="font-size: 10pt;">HUD debt &#8211; net</font><sup>(1)</sup></td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">53,737</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">52,535</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">54,365</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">52,510</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Subordinated debt &#8211; net</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">20,431</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">24,045</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">20,490</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">23,944</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="padding-bottom: 2px; padding-left: 9pt;">Other</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">1,500</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">1,500</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">3,000</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">3,000</td> <td style="text-align: left; padding-bottom: 2px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="padding-bottom: 4px; padding-left: 0.25in;">Total</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">4,429,887</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">4,547,855</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">4,366,854</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">4,444,772</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> </table> <p style="widows: 2; text-transform: none; font-style: normal; margin-top: 0px; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; margin-bottom: 0px; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal;">&#160;</p> <table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 27pt;"></td> <td style="width: 18pt;"><sup>(1)</sup></td> <td style="text-align: justify;">These amounts represent borrowings that were incurred by Omega OP or wholly owned subsidiaries of Omega OP.</td> </tr> </table> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="14" nowrap="nowrap">Omega</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="6" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Three Months Ended</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>June 30,</b></p> </td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="6" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Six Months Ended</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>June 30,</b></p> </td> <td style="padding-bottom: 2px;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="14" nowrap="nowrap">(in thousands, except per share amounts)</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">Numerator:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt; width: 615px;">Net income</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 189px;">68,157</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 16px;">&#160;</td> <td style="text-align: left; width: 16px;">$</td> <td style="text-align: right; width: 189px;">113,154</td> <td style="text-align: left; width: 16px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 188px;">177,269</td> <td style="text-align: left; width: 15px;">&#160;</td> <td style="width: 15px;">&#160;</td> <td style="text-align: left; width: 15px;">$</td> <td style="text-align: right; width: 188px;">171,350</td> <td style="text-align: left; width: 15px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 9pt;">Less: net income attributable to noncontrolling interests</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(2,900</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(5,102</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(7,572</td> <td style="border-bottom: black 2px solid; text-align: left;">)</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">(7,743</td> <td style="text-align: left; padding-bottom: 2px;">)</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Net income available to common stockholders</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">65,257</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">108,052</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">169,697</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">163,607</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">Denominator:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Denominator for basic earnings per share</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">197,433</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">188,981</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">197,223</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">188,604</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Effect of dilutive securities:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 0.25in;">Common stock equivalents</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">467</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">1,254</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">407</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">1,215</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 0.25in;">Noncontrolling interest &#8211; Omega OP Units</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">8,772</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">8,922</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">8,793</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">8,935</td> <td style="text-align: left; padding-bottom: 2px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Denominator for diluted earnings per share</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">206,672</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">199,157</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">206,423</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">198,754</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>Earnings per share &#8211; basic:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Net income available to common stockholders</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.33</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.57</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.86</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.87</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>Earnings per share &#8211; diluted:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Net income</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.33</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.57</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.86</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.86</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> </table> <p style="text-align: justify; widows: 2; text-transform: none; text-indent: 0px; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; word-spacing: 0px; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <table style="widows: 2; text-transform: none; text-indent: 0px; width: 100%; border-collapse: collapse; font: 10pt 'times new roman', times, serif; orphans: 2; letter-spacing: normal; word-spacing: 0px; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="14" nowrap="nowrap">Omega OP</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="6" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Three Months Ended</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>June 30,</b></p> </td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center;" colspan="6" nowrap="nowrap"> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>Six Months Ended</b></p> <p style="text-align: center; margin: 0pt 0px; font: 10pt 'times new roman', times, serif; font-stretch: normal;"><b>June 30,</b></p> </td> <td style="padding-bottom: 2px;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2017</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; font-weight: bold;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: center; font-weight: bold;" colspan="2" nowrap="nowrap">2016</td> <td style="padding-bottom: 2px; font-weight: bold;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap">&#160;</td> <td>&#160;</td> <td style="text-align: center;" colspan="14" nowrap="nowrap">(in thousands, except per share amounts)</td> <td>&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">Numerator:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt; width: 615px;">Net income</td> <td style="padding-bottom: 4px; width: 16px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; width: 16px;">$</td> <td style="border-bottom: black 4px double; text-align: right; width: 189px;">68,157</td> <td style="border-bottom: black 4px double; text-align: left; width: 16px;">&#160;</td> <td style="border-bottom: black 4px double; width: 16px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; width: 16px;">$</td> <td style="border-bottom: black 4px double; text-align: right; width: 189px;">113,154</td> <td style="border-bottom: black 4px double; text-align: left; width: 16px;">&#160;</td> <td style="border-bottom: black 4px double; width: 15px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; width: 15px;">$</td> <td style="border-bottom: black 4px double; text-align: right; width: 188px;">177,269</td> <td style="border-bottom: black 4px double; text-align: left; width: 15px;">&#160;</td> <td style="border-bottom: black 4px double; width: 15px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left; width: 15px;">$</td> <td style="border-bottom: black 4px double; text-align: right; width: 188px;">171,350</td> <td style="text-align: left; padding-bottom: 4px; width: 15px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-indent: -0.15in; padding-left: 0.15in;">Denominator:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Denominator for basic earnings per unit</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">206,205</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">197,903</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">206,016</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">197,539</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-left: 9pt;">Effect of dilutive securities:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 2px; padding-left: 0.25in;">Omega OP Unit equivalents</td> <td style="padding-bottom: 2px;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">467</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">1,254</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">407</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: left;">&#160;</td> <td style="border-bottom: black 2px solid; text-align: right;">1,215</td> <td style="text-align: left; padding-bottom: 2px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Denominator for diluted earnings per unit</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">206,672</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">199,157</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">206,423</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double; text-align: right;">198,754</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Earnings per unit &#8211; basic:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Net income available to Omega OP Unit holders</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.33</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.57</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.86</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.87</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> <tr style="background-color: white; vertical-align: bottom;"> <td style="text-align: left;">Earnings per unit &#8211; diluted:</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> <td>&#160;</td> <td style="text-align: left;">&#160;</td> <td style="text-align: right;">&#160;</td> <td style="text-align: left;">&#160;</td> </tr> <tr style="background-color: azure; vertical-align: bottom;"> <td style="text-align: left; padding-bottom: 4px; padding-left: 9pt;">Net income</td> <td style="padding-bottom: 4px;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.33</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.57</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.86</td> <td style="border-bottom: black 4px double; text-align: left;">&#160;</td> <td style="border-bottom: black 4px double;">&#160;</td> <td style="border-bottom: black 4px double; text-align: left;">$</td> <td style="border-bottom: black 4px double; text-align: right;">0.86</td> <td style="text-align: left; padding-bottom: 4px;">&#160;</td> </tr> </table> 13376000 40484000 9749000 10940000 208874000 231233000 8393000 7498000 357000 1469000 1 0.96 0.04 56 55 1 10 999 50 119 803 16 1 1 1 18 1 19 529000000 169000000 35300000 500000 6800000 300000 700000 7300000 600000 34100000 85100000 5000000 140400000 7600000 8600000 124200000 99200000 5900000 0.34 0.85 0.15 1500000 1400000 0.0750 0.0950 0.0850 8200000 1200000 P50Y P5Y P15Y 0.020 0.030 64 2 1100000000 5500000 15 3 45800000 18300000 7400000 -600000 11 2 3 6 1 1 4287069000 4085493000 3685131000 3499877000 -3309000 601938000 601938000 582307000 582307000 58 53 24407000 50019000 51246000 52493000 53681000 55008000 4 0.106 10 42 10 38 2 9 1 36400000 5 34000000 27300000 2400000 900000 643277000 412140000 112500000 118637000 667456000 411467000 112500000 143489000 3934000 4747000 639343000 662709000 0.0945 0.0998 0.0945 0.0998 0.0835 0.140 2029 29 52 7 261644000 87691000 49458000 44595000 47913000 31987000 283783000 104314000 49583000 50000000 47899000 31987000 4798000 4798000 0.1096 0.0666 0.1400 0.0900 0.05875 0.0450 0.0475 0.1096 0.0666 0.1400 0.0900 0.130 0.0650 0.05875 0.0495 0.0450 0.0525 0.0450 0.04375 0.0475 2028 500000 1000000 20 9 7 12 2 1 52868000 23245000 18889000 30023000 4356000 400000 2 9 1 1 29400000 5000000 3600000 -600000 1 3500000 5100000 22476000 167000 22426000 167000 15864000 16477000 6779000 6116000 165028000 164735000 70738000 77534000 94290000 87201000 710000 3600000 7900000 3100000 6200000 5800000 10500000 9500000 9300000 8700000 P8Y P9Y 77 9000000000 39000000 0.99 9 4 47 0.09 0.09 0.09 No single operator or manager generated more than 10% of our total revenues for the six months ended June 30, 2017. 0.10 8413000 718000 13143000 9594000 34979000 13792000 54948000 1420000 50614000 166000 40340000 1380000 13143000 34979000 9594000 13792000 9594000 13792000 13143000 34979000 8413000 718000 718000 8413000 50614000 40340000 166000 1380000 2193000 2193000 2193000 166000 1380000 50614000 40340000 54948000 1420000 1420000 54948000 -21836000 -21836000 -21836000 -26544000 -26544000 -26544000 10195000 10195000 -1840000 10195000 14468000 14468000 14468000 -4198000 -13074000 -13074000 -1840000 -1840000 -2193000 -2193000 -2193000 -1350000 -2193000 -2193000 -2193000 -22000 22000 -22000 79000 626000 79000 626000 626000 79000 140000 1390000 140000 1390000 1390000 140000 -48771000 -48771000 -43913000 -43913000 2308000 37965000 2010000 34116000 Quarterly Quarterly Quarterly 0.01 0.01 0.01 2017-01-12 2017-04-13 2017-07-13 2017-02-15 2017-05-15 2017-08-15 2017-01-31 2017-05-01 2017-08-01 33.02 29.17 32.11 500000000 500000000 0.90 1.00 800000 500000 1500000 100000 200000 3665000 6443000 3734000 7478000 2014 2015 2015 2015 2015 2016 2016 2014 2015 2015 2016 2015 2017 2017 2017 2447351 135634 90421 54151 109985 40464 7799 130006 372069 135634 137249 54151 307480 137249 140416 399726 285338 399726 140416 285338 1098829 428670 919852 18.63 8.67 14.80 40.57 40.74 35.08 34.78 13.21 14.24 22.50 22.91 16.45 14.66 31.26 12.61 18.04 12.69 35.68 17.78 45600000 1200000 800000 4500000 1600000 300000 4600000 4900000 1900000 3100000 1200000 5100000 2000000 4300000 5000000 5100000 13900000 15300000 16400000 P48M P45M P33M P33M P33M P33M P45M P48M P45M P45M P45M P45M P36M P48M P48M 25900000 200000 2200000 300000 800000 300000 100000 2400000 3200000 200000 1200000 500000 3400000 800000 3600000 4400000 4500000 8900000 7200000 9800000 1/1/2014-12/31/2016 1/1/2015-12/31/2017 1/1/2016-12/31/2018 1/1/2014-12/31/2016 1/1/2015-12/31/2017 1/1/2015-12/31/2017 1/1/2016-12/31/2018 1/1/2015-12/31/2017 1/1/2017-12/31/2019 1/1/2017-12/31/2019 Quarterly in 2017 Quarterly in 2018 12/31/2017 12/31/2017 11/1/2017 12/31/2018 Quarterly in 2019 Quarterly in 2017 Quarterly in 2018 Quarterly in 2018 Quarterly in 2019 Quarterly in 2018 12/31/2019 Quarterly in 2020 Quarterly in 2020 P3Y 0.10 2024 2025 2028 2021 2044 2024 2025 2024 2027 2022 2026 2018 2023 2022 2028 2022 2022 2021 0.99540 0.98978 0.0900 0.0306 0.05875 0.0450 0.0495 0.0450 0.0267 0.0525 0.04375 0.0267 0.0475 0.0170 0.0380 0.0247 589000 579000 200000000 200000000 350000000 5657000 600000 5958000 400000000 250000000 400000000 700000000 600000000 700000000 400000000 150000000 550000000 400000000 400000000 700000000 600000000 700000000 550000000 20000000 20490000 20000000 20431000 -17151000 -22345000 27703000 27297000 3028146000 3321858000 4366854000 4429887000 0.005 63900000 900000000 350000000 2500000000 0.009 0.0190 0.009 0.0190 0.0100 0.0195 0.0235 0.0140 2017-04-28 2025-01-15 2028-01-15 2022-05-25 2022-12-16 2022-05-25 4700000 5500000 LIBOR plus an applicable percentage (with a range of 90 to 190 basis points) based on our ratings from Standard &amp; Poor&#8217;s, Moody&#8217;s and/or Fitch Ratings LIBOR plus an applicable percentage (with a range of 140 to 235 basis points) based on our ratings from Standard &amp; Poor's, Moody's and/or Fitch Ratings LIBOR plus an applicable percentage (with a range of 100 to 195 basis points) based on our ratings from Standard &amp; Poor's, Moody's and/or Fitch Ratings LIBOR plus an applicable percentage (with a range of 90 to 190 basis points) based on our ratings from Standard &amp; Poor's, Moody's and/or Fitch Ratings 150000000 50000000 50000000 200000000 200000000 350000000 1250000000 200000000 690700000 16500000 11800000 598665000 578998000 644961000 676396000 253385000 271306000 1498127000 1524001000 1497011000 1526700000 190000000 155000000 198830000 200000000 200000000 200000000 347449000 350000000 422280000 425000000 129413000 130250000 100000000 99373000 100000000 100000000 250000000 250000000 395065000 392669000 245949000 593616000 685052000 692305000 393175000 394368000 593969000 685784000 692890000 539741000 432938000 406361000 249075000 611461000 681978000 693505000 421504000 361983000 641199000 703514000 723805000 557520000 52510000 52535000 23944000 24045000 3000000 1500000 3000000 1500000 4366854000 4429887000 4444772000 4547855000 1254000 1215000 467000 407000 8922000 1254000 8935000 1215000 8772000 467000 8793000 407000 These amounts represent borrowings that were incurred by Omega OP or wholly owned subsidiaries of Omega OP. Reflects the weighted average annual contractual interest rate on the mortgages at June 30, 2017 excluding a third-party administration fee of approximately 0.5% annually. Secured by real estate assets with a net carrying value of $63.9 million as of June 30, 2017. Omega recorded a non-cash deferred tax liability and acquisitions costs of approximately $8.2 million and $1.2 million, respectively, in connection with this acquisition. The cash yield is based on the purchase price. Other mortgage notes outstanding have stated interest rates ranging from 8.35% to 14.0% and maturity dates through 2029. Other investment notes have maturity dates through 2028 and interest rates ranging from 6.50% to 13.0%. We plan to sell the facilities classified as held for sale at June 30, 2017 within the next twelve months. In the first quarter of 2017, we sold nine SNFs and two ALFs for approximately $29.4 million in net proceeds recognizing a gain on sale of approximately $3.6 million. One SNF classified as an asset held for sale at December 31, 2016 was no longer considered held for sale during the first quarter of 2017 and was reclassified back to leased properties at approximately $5.1 million which represents the facility's then carrying value adjusted for depreciation that was not recognized while classified as held for sale. In the second quarter of 2017, we sold one ALF and one SNF for approximately $5.0 million in net proceeds, generating a gain on sale of approximately $0.6 million. In the first quarter of 2017, we recorded a $3.5 million impairment to reduce one ALF's net book value to its estimated fair value less costs to sell before it was reclassified to assets held for sale. Total compensation costs are net of shares cancelled. This amount includes $0.6 million of net deferred financing costs related to the Omega OP term loan as of June 30, 2017. -4198000 -4198000 -1350000 -1350000 -13074000 0000888491us-gaap:SubsidiariesMember2017-08-02 1000 0000888491us-gaap:PartnershipInterestMember2017-08-02 0 EX-101.SCH 27 ohi-20170630.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 003 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (Unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - PROPERTIES AND INVESTMENTS link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - DIRECT FINANCING LEASES link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - MORTGAGE NOTES RECEIVABLE link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - OTHER INVESTMENTS link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - INVESTMENT IN UNCONSOLIDATED JOINT VENTURE link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - ASSETS HELD FOR SALE link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - INTANGIBLES link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - CONCENTRATION OF RISK link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - STOCKHOLDERS'/OWNERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - TAXES link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - BORROWING ACTIVITIES AND ARRANGEMENTS link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - FINANCIAL INSTRUMENTS link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - LITIGATION link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - EARNINGS PER SHARE/UNIT link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - PROPERTIES AND INVESTMENTS (Tables) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - DIRECT FINANCING LEASES (Tables) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - MORTGAGE NOTES RECEIVABLE (Tables) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - OTHER INVESTMENTS (Tables) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - ASSETS HELD FOR SALE (Tables) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - INTANGIBLES (Tables) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - STOCKHOLDERS'/OWNERS' EQUITY (Tables) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - BORROWING ACTIVITIES AND ARRANGEMENTS (Tables) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - FINANCIAL INSTRUMENTS (Tables) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - EARNINGS PER SHARE/UNIT (Tables) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Detail) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail) link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail 1) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - PROPERTIES AND INVESTMENTS - Investment in leased real estate properties (Detail) link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - PROPERTIES AND INVESTMENTS - Significant acquisitions that occurred during the first six months of 2017 (Detail 1) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - PROPERTIES AND INVESTMENTS (Parentheticals) (Detail 1) link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - PROPERTIES AND INVESTMENTS - Leased Property (Narrative) (Detail) link:presentationLink link:definitionLink link:calculationLink 045 - Disclosure - PROPERTIES AND INVESTMENTS - Assets Sold or Held for Sale (Narrative) (Detail 1) link:presentationLink link:definitionLink link:calculationLink 046 - Disclosure - DIRECT FINANCING LEASES (Detail) link:presentationLink link:definitionLink link:calculationLink 047 - Disclosure - DIRECT FINANCING LEASES (Detail 1) link:presentationLink link:definitionLink link:calculationLink 048 - Disclosure - DIRECT FINANCING LEASES (Narrative) (Detail) link:presentationLink link:definitionLink link:calculationLink 049 - Disclosure - MORTGAGE NOTES RECEIVABLE (Details) link:presentationLink link:definitionLink link:calculationLink 050 - Disclosure - MORTGAGE NOTES RECEIVABLE (Parentheticals) (Details) link:presentationLink link:definitionLink link:calculationLink 051 - Disclosure - MORTGAGE NOTES RECEIVABLE (Narrative) (Detail) link:presentationLink link:definitionLink link:calculationLink 052 - Disclosure - OTHER INVESTMENTS (Details) link:presentationLink link:definitionLink link:calculationLink 053 - Disclosure - OTHER INVESTMENTS (Parentheticals) (Details) link:presentationLink link:definitionLink link:calculationLink 054 - Disclosure - INVESTMENT IN UNCONSOLIDATED JOINT VENTURE (Details) link:presentationLink link:definitionLink link:calculationLink 055 - Disclosure - ASSETS HELD FOR SALE (Details) link:presentationLink link:definitionLink link:calculationLink 056 - Disclosure - ASSETS HELD FOR SALE (Parentheticals) (Details) link:presentationLink link:definitionLink link:calculationLink 057 - Disclosure - INTANGIBLES - Summary of our intangibles (Details) link:presentationLink link:definitionLink link:calculationLink 058 - Disclosure - INTANGIBLES - Reconciliation of goodwill (Details 1) link:presentationLink link:definitionLink link:calculationLink 059 - Disclosure - INTANGIBLES (Narrative) (Detail) link:presentationLink link:definitionLink link:calculationLink 060 - Disclosure - INTANGIBLES (Narrative) (Detail 1) link:presentationLink link:definitionLink link:calculationLink 061 - Disclosure - CONCENTRATION OF RISK (Narrative) (Detail) link:presentationLink link:definitionLink link:calculationLink 062 - Disclosure - STOCKHOLDERS'/OWNERS' EQUITY (Details) link:presentationLink link:definitionLink link:calculationLink 063 - Disclosure - STOCKHOLDERS'/OWNERS' EQUITY (Narrative) (Detail) link:presentationLink link:definitionLink link:calculationLink 064 - Disclosure - TAXES (Narrative) (Detail) link:presentationLink link:definitionLink link:calculationLink 065 - Disclosure - STOCK-BASED COMPENSATION (Details) link:presentationLink link:definitionLink link:calculationLink 066 - Disclosure - STOCK-BASED COMPENSATION (Details 1) link:presentationLink link:definitionLink link:calculationLink 067 - Disclosure - STOCK-BASED COMPENSATION (Narrative) (Detail) link:presentationLink link:definitionLink link:calculationLink 068 - Disclosure - BORROWING ACTIVITIES AND ARRANGEMENTS (Details) link:presentationLink link:definitionLink link:calculationLink 069 - Disclosure - BORROWING ACTIVITIES AND ARRANGEMENTS (Parentheticals) (Details) link:presentationLink link:definitionLink link:calculationLink 070 - Disclosure - BORROWING ACTIVITIES AND ARRANGEMENTS (Narrative) (Detail) link:presentationLink link:definitionLink link:calculationLink 071 - Disclosure - BORROWING ACTIVITIES AND ARRANGEMENTS (Narrative) (Detail 1) link:presentationLink link:definitionLink link:calculationLink 072 - Disclosure - FINANCIAL INSTRUMENTS (Detail) link:presentationLink link:definitionLink link:calculationLink 073 - Disclosure - FINANCIAL INSTRUMENTS (Parentheticals) (Detail) link:presentationLink link:definitionLink link:calculationLink 074 - Disclosure - EARNINGS PER SHARE/UNIT - Computation of basic and diluted earnings per share (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 28 ohi-20170630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 29 ohi-20170630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 30 ohi-20170630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 31 ohi-20170630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 32 R1.htm IDEA: XBRL DOCUMENT v3.7.0.1
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2017
Aug. 02, 2017
Document And Entity Information [Line Items]    
Entity Registrant Name OMEGA HEALTHCARE INVESTORS INC  
Entity Central Index Key 0000888491  
Trading Symbol ohi  
Current Fiscal Year End Date --12-31  
Entity Filer Category Large Accelerated Filer  
Entity Common Stock Shares Outstanding   197,241,081
Document Type 10-Q  
Document Period End Date Jun. 30, 2017  
Amendment Flag false  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q2  
OHI Healthcare Properties Holdco, Inc.    
Document And Entity Information [Line Items]    
Entity Registrant Name OHI Healthcare Properties Holdco, Inc.  
Entity Central Index Key 0001639311  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Common Stock Shares Outstanding   1,000
Document Type 10-Q  
Document Period End Date Jun. 30, 2017  
Amendment Flag false  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q2  
OHI Healthcare Properties Limited Partnership    
Document And Entity Information [Line Items]    
Entity Registrant Name OHI Healthcare Properties Limited Partnership  
Entity Central Index Key 0001639315  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Common Stock Shares Outstanding   0
Document Type 10-Q  
Document Period End Date Jun. 30, 2017  
Amendment Flag false  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q2  
XML 33 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2017
Dec. 31, 2016
Real estate properties    
Real estate investments (see Note 2) $ 7,730,199 $ 7,566,358
Less accumulated depreciation (1,366,376) (1,240,336)
Real estate investments - net 6,363,823 6,326,022
Investments in direct financing leases - net 582,307 601,938
Mortgage notes receivable - net 662,709 639,343
Total 7,608,839 7,567,303
Other investments - net 278,985 256,846
Investment in unconsolidated joint venture 38,968 48,776
Assets held for sale - net 18,889 52,868
Total investments 7,945,681 7,925,793
Cash and cash equivalents 21,031 93,687
Restricted cash 12,203 13,589
Accounts receivable - net 288,686 240,035
Goodwill 644,184 643,474
Other assets 34,869 32,682
Total assets 8,946,654 8,949,260
LIABILITIES AND OWNERS' EQUITY    
Revolving line of credit 155,000 190,000
Term loans - net 899,292 1,094,343
Secured borrowings - net 53,737 54,365
Unsecured borrowings - net 3,321,858 3,028,146
Accrued expenses and other liabilities 323,543 360,514
Deferred income taxes 17,714 9,906
Total liabilities 4,771,144 4,737,274
Equity:    
Common stock $.10 par value authorized - 350,000 shares, issued and outstanding - 197,224 shares as of June 30, 2017 and 196,142 as of December 31, 2016 19,722 19,614
Common stock - additional paid-in capital 4,896,076 4,861,408
Cumulative net earnings 1,908,634 1,738,937
Cumulative dividends paid (2,954,230) (2,707,387)
Accumulated other comprehensive loss (41,903) (53,827)
Total stockholders' equity 3,828,299 3,858,745
Noncontrolling interest 347,211 353,241
Total equity 4,175,510 4,211,986
Owners' Equity:    
Total liabilities and equity 8,946,654 8,949,260
OHI Healthcare Properties Holdco, Inc.    
Real estate properties    
Real estate investments (see Note 2) 7,730,199 7,566,358
Less accumulated depreciation (1,366,376) (1,240,336)
Real estate investments - net 6,363,823 6,326,022
Investments in direct financing leases - net 582,307 601,938
Mortgage notes receivable - net 662,709 639,343
Total 7,608,839 7,567,303
Other investments - net 278,985 256,846
Investment in unconsolidated joint venture 38,968 48,776
Assets held for sale - net 18,889 52,868
Total investments 7,945,681 7,925,793
Cash and cash equivalents 21,031 93,687
Restricted cash 12,203 13,589
Accounts receivable - net 288,686 240,035
Goodwill 644,184 643,474
Other assets 34,869 32,682
Total assets 8,946,654 8,949,260
LIABILITIES AND OWNERS' EQUITY    
Term loans - net 99,372 100,000
Secured borrowings - net 53,737 54,365
Accrued expenses and other liabilities 267,346 302,959
Deferred income taxes 17,714 9,906
Intercompany loans payable 4,332,975 4,270,044
Total liabilities 4,771,144 4,737,274
Equity:    
Common stock - additional paid-in capital 923,218 923,218
Cumulative net earnings 163,808 126,187
Cumulative dividends paid (229,930) (175,289)
Accumulated other comprehensive loss (9,797) (12,439)
Total stockholders' equity 847,299 861,677
Noncontrolling interest 3,328,211 3,350,309
Total equity 4,175,510 4,211,986
Owners' Equity:    
Total liabilities and equity 8,946,654 8,949,260
OHI Healthcare Properties Limited Partnership    
Real estate properties    
Real estate investments (see Note 2) 7,730,199 7,566,358
Less accumulated depreciation (1,366,376) (1,240,336)
Real estate investments - net 6,363,823 6,326,022
Investments in direct financing leases - net 582,307 601,938
Mortgage notes receivable - net 662,709 639,343
Total 7,608,839 7,567,303
Other investments - net 278,985 256,846
Investment in unconsolidated joint venture 38,968 48,776
Assets held for sale - net 18,889 52,868
Total investments 7,945,681 7,925,793
Cash and cash equivalents 21,031 93,687
Restricted cash 12,203 13,589
Accounts receivable - net 288,686 240,035
Goodwill 644,184 643,474
Other assets 34,869 32,682
Total assets 8,946,654 8,949,260
LIABILITIES AND OWNERS' EQUITY    
Term loans - net 99,372 100,000
Secured borrowings - net 53,737 54,365
Accrued expenses and other liabilities 267,346 302,959
Deferred income taxes 17,714 9,906
Intercompany loans payable 4,332,975 4,270,044
Total liabilities 4,771,144 4,737,274
Equity:    
Accumulated other comprehensive loss (43,913)  
Owners' Equity:    
General partners' equity 3,828,299 3,858,745
Limited partners' equity 347,211 353,241
Total owners' equity 4,175,510 4,211,986
Total liabilities and equity $ 8,946,654 $ 8,949,260
XML 34 R3.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares
shares in Thousands
Jun. 30, 2017
Dec. 31, 2016
Statement Of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 0.10 $ 0.10
Common stock, shares authorized 350,000 350,000
Common stock, shares issued 197,224 196,142
Common stock, shares outstanding 197,224 196,142
XML 35 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Revenue        
Rental income $ 193,997 $ 186,454 $ 386,534 $ 363,157
Income from direct financing leases 15,462 15,521 31,108 30,963
Mortgage interest income 16,297 21,371 32,253 37,977
Other investment income - net 7,278 4,982 14,192 8,413
Miscellaneous income 2,763 496 3,454 1,193
Total operating revenues 235,797 228,824 467,541 441,703
Expenses        
Depreciation and amortization 70,350 65,505 140,343 127,938
General and administrative 11,541 11,832 24,065 22,287
Acquisition costs 19 3,504 (22) 7,275
Impairment loss on real estate properties 10,135 6,893 17,773 41,451
Provision for uncollectible accounts 2,673 (1,154) 5,077 3,970
Total operating expenses 94,718 86,580 187,236 202,921
Income before other income and expense 141,079 142,244 280,305 238,782
Other income (expense)        
Interest income 254 4 258 12
Interest expense (48,085) (39,651) (93,126) (76,873)
Interest - amortization of deferred financing costs (2,543) (2,210) (5,045) (4,342)
Interest - refinancing costs (21,965)   (21,965) (298)
Contractual settlement     10,412  
Realized gain (loss) on foreign exchange 79   140 (22)
Total other expense (72,260) (41,857) (109,326) (81,523)
Income before (loss) gain on assets sold 68,819 100,387 170,979 157,259
(Loss) gain on assets sold - net (622) 13,221 6,798 14,792
Income from continuing operations 68,197 113,608 177,777 172,051
Income taxes (591) (454) (1,691) (701)
Income from unconsolidated joint venture 551   1,183  
Net income 68,157 113,154 177,269 171,350
Net income attributable to noncontrolling interest (2,900) (5,102) (7,572) (7,743)
Net income available to common stockholders $ 65,257 $ 108,052 $ 169,697 $ 163,607
Basic:        
Net income available to common stockholders $ 0.33 $ 0.57 $ 0.86 $ 0.87
Diluted:        
Net income 0.33 0.57 0.86 0.86
Diluted:        
Dividends declared per common share (in dollars per share) $ 0.63 $ 0.58 $ 1.25 $ 1.15
Weighted-average shares outstanding, basic (in shares) 197,433 188,981 197,223 188,604
Weighted-average shares outstanding, diluted (in shares) 206,672 199,157 206,423 198,754
OHI Healthcare Properties Holdco, Inc.        
Revenue        
Rental income $ 193,997 $ 186,454 $ 386,534 $ 363,157
Income from direct financing leases 15,462 15,521 31,108 30,963
Mortgage interest income 16,297 21,371 32,253 37,977
Other investment income - net 7,278 4,982 14,192 8,413
Miscellaneous income 2,763 496 3,454 1,193
Total operating revenues 235,797 228,824 467,541 441,703
Expenses        
Depreciation and amortization 70,350 65,505 140,343 127,938
General and administrative 11,541 11,832 24,065 22,287
Acquisition costs 19 3,504 (22) 7,275
Impairment loss on real estate properties 10,135 6,893 17,773 41,451
Provision for uncollectible accounts 2,673 (1,154) 5,077 3,970
Total operating expenses 94,718 86,580 187,236 202,921
Income before other income and expense 141,079 142,244 280,305 238,782
Other income (expense)        
Interest income 254 4 258 12
Interest expense (48,085) (39,651) (93,126) (76,873)
Interest - amortization of deferred financing costs (2,543) (2,210) (5,045) (4,342)
Interest - refinancing costs (21,965)   (21,965) (298)
Contractual settlement     10,412  
Realized gain (loss) on foreign exchange 79   140 (22)
Total other expense (72,260) (41,857) (109,326) (81,523)
Income before (loss) gain on assets sold 68,819 100,387 170,979 157,259
(Loss) gain on assets sold - net (622) 13,221 6,798 14,792
Income from continuing operations 68,197 113,608 177,777 172,051
Income taxes (591) (454) (1,691) (701)
Income from unconsolidated joint venture 551   1,183  
Net income 68,157 113,154 177,269 171,350
Net income attributable to noncontrolling interest (53,709) (88,160) (139,648) (133,455)
Net income available to common stockholders 14,448 24,994 37,621 37,895
OHI Healthcare Properties Limited Partnership        
Revenue        
Rental income 193,997 186,454 386,534 363,157
Income from direct financing leases 15,462 15,521 31,108 30,963
Mortgage interest income 16,297 21,371 32,253 37,977
Other investment income - net 7,278 4,982 14,192 8,413
Miscellaneous income 2,763 496 3,454 1,193
Total operating revenues 235,797 228,824 467,541 441,703
Expenses        
Depreciation and amortization 70,350 65,505 140,343 127,938
General and administrative 11,541 11,832 24,065 22,287
Acquisition costs 19 3,504 (22) 7,275
Impairment loss on real estate properties 10,135 6,893 17,773 41,451
Provision for uncollectible accounts 2,673 (1,154) 5,077 3,970
Total operating expenses 94,718 86,580 187,236 202,921
Income before other income and expense 141,079 142,244 280,305 238,782
Other income (expense)        
Interest income 254 4 258 12
Interest expense (48,085) (39,651) (93,126) (76,873)
Interest - amortization of deferred financing costs (2,543) (2,210) (5,045) (4,342)
Interest - refinancing costs (21,965)   (21,965) (298)
Contractual settlement     10,412  
Realized gain (loss) on foreign exchange 79   140 (22)
Total other expense (72,260) (41,857) (109,326) (81,523)
Income before (loss) gain on assets sold 68,819 100,387 170,979 157,259
(Loss) gain on assets sold - net (622) 13,221 6,798 14,792
Income from continuing operations 68,197 113,608 177,777 172,051
Income taxes (591) (454) (1,691) (701)
Income from unconsolidated joint venture 551   1,183  
Net income $ 68,157 $ 113,154 $ 177,269 $ 171,350
Basic:        
Net income (in dollars per share) $ 0.33 $ 0.57 $ 0.86 $ 0.87
Diluted:        
Net income (in dollars per shares) 0.33 0.57 0.86 0.86
Dividends declared per common share (in dollars per share) $ 0.63 $ 0.58 $ 1.25 $ 1.15
Weighted-average Omega OP Units outstanding, basic (in shares) 206,205 197,903 206,016 197,539
Weighted-average Omega OP Units outstanding, diluted (in shares) 206,672 199,157 206,423 198,754
XML 36 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Net income $ 68,157 $ 113,154 $ 177,269 $ 171,350
Other comprehensive income (loss)        
Foreign currency translation 10,274 (21,836) 14,608 (26,566)
Derivative instruments (3,407) (4,198) (2,153) (13,074)
Total other comprehensive income (loss) 6,867 (26,034) 12,455 (39,640)
Comprehensive income 75,024 87,120 189,724 131,710
Comprehensive income attributable to noncontrolling interest (3,192) (3,928) (8,103) (5,953)
Comprehensive income attributable to common stockholders 71,832 83,192 181,621 125,757
OHI Healthcare Properties Holdco, Inc.        
Net income 68,157 113,154 177,269 171,350
Other comprehensive income (loss)        
Foreign currency translation 10,274 (21,836) 14,608 (26,566)
Derivative instruments (3,407) (4,198) (2,153) (13,074)
Total other comprehensive income (loss) 6,867 (26,034) 12,455 (39,640)
Comprehensive income 75,024 87,120 189,724 131,710
Comprehensive income attributable to noncontrolling interest (59,120) (67,877) (149,460) (102,581)
Comprehensive income attributable to common stockholders 15,904 19,243 40,264 29,129
OHI Healthcare Properties Limited Partnership        
Net income 68,157 113,154 177,269 171,350
Other comprehensive income (loss)        
Foreign currency translation 10,274 (21,836) 14,608 (26,566)
Derivative instruments (3,407) (4,198) (2,153) (13,074)
Total other comprehensive income (loss) 6,867 (26,034) 12,455 (39,640)
Comprehensive income $ 75,024 $ 87,120 $ 189,724 $ 131,710
XML 37 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (Unaudited) - 6 months ended Jun. 30, 2017 - USD ($)
shares in Thousands, $ in Thousands
Common Stock Par Value
Additional Paid-in Capital
Cumulative Net Earnings
Cumulative Dividends
Accumulated Other Comprehensive Loss
Total Stockholders' Equity
Noncontrolling Interest
Total
OHI Healthcare Properties Holdco, Inc.
Additional Paid-in Capital
OHI Healthcare Properties Holdco, Inc.
Cumulative Net Earnings
OHI Healthcare Properties Holdco, Inc.
Cumulative Dividends
OHI Healthcare Properties Holdco, Inc.
Accumulated Other Comprehensive Loss
OHI Healthcare Properties Holdco, Inc.
Total Stockholders' Equity
OHI Healthcare Properties Holdco, Inc.
Noncontrolling Interest
OHI Healthcare Properties Holdco, Inc.
OHI Healthcare Properties Limited Partnership
General Partners' Omega OP Units
OHI Healthcare Properties Limited Partnership
Limited Partners' Omega OP Units
OHI Healthcare Properties Limited Partnership
Balance (196,142 common shares & 8,862 Omega OP Units) at Dec. 31, 2016 $ 19,614 $ 4,861,408 $ 1,738,937 $ (2,707,387) $ (53,827) $ 3,858,745 $ 353,241 $ 4,211,986 $ 923,218 $ 126,187 $ (175,289) $ (12,439) $ 861,677 $ 3,350,309 $ 4,211,986      
Balance at Dec. 31, 2016                               $ 3,858,745 $ 353,241 $ 4,211,986
Balance (in units) at Dec. 31, 2016                               196,142 8,862 205,004
Increase (Decrease) In Stockholders' Equity [Roll Forward]                                    
Grant of restricted stock to company directors (32 shares at $31.23 per share) 3 (3)                                
Stock-based compensation expense   7,478       7,478   7,478                    
Vesting/exercising of equity compensation plan, net of tax withholdings (114 shares) 11 (2,131)       (2,120)   (2,120)                    
Dividend reinvestment and stock purchase plan (614 shares at an average of $32.11 per share) 61 19,660       19,721   19,721                    
Grant of stock as payment of directors fees (5 shares at an average of $32.18 per share) 1 149       150   150                    
Deferred compensation directors   (29)       (29)   (29)                    
Equity Shelf Program (228 shares at $29.17 per share, net of issuance costs) 23 6,611       6,634   6,634                    
Common dividends declared ($1.25 per share)       (246,843)   (246,843)   (246,843)                    
Conversion of Omega OP Units to common stock (89 shares at $32.91 per share) 9 2,933       2,942   2,942                    
Redemption of Omega OP Units (90 units)             (2,990) (2,990)                    
Omega OP Units distributions             (11,143) (11,143)                    
Contributions from partners                               $ 34,776   $ 34,776
Contributions from partners (in shares)                               1,082   1,082
Omega OP Unit redemptions                                 $ (2,990) $ (2,990)
Omega OP Unit redemptions (in shares)                                 (90) (90)
Contributions                           34,776 34,776      
Distributions                     (54,641)   (54,641) (206,335) (260,976) $ (246,843) $ (11,143) $ (257,986)
Foreign currency translation         13,986 13,986 622 14,608       3,098 3,098 11,510 14,608 13,986 622 14,608
Derivative instruments         (2,062) (2,062) (91) (2,153)       (456) (456) (1,697) (2,153) (2,062) (91) (2,153)
Net income     169,697     169,697 7,572 177,269   37,621     37,621 139,648 177,269 169,697 7,572 177,269
Balance (197,224 shares & 8,772 Omega OP Units) at Jun. 30, 2017 $ 19,722 $ 4,896,076 $ 1,908,634 $ (2,954,230) $ (41,903) $ 3,828,299 $ 347,211 $ 4,175,510 $ 923,218 $ 163,808 $ (229,930) $ (9,797) $ 847,299 $ 3,328,211 $ 4,175,510      
Balance at Jun. 30, 2017                               $ 3,828,299 $ 347,211 $ 4,175,510
Balance (in units) at Jun. 30, 2017                               197,224 8,772 205,996
XML 38 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (Unaudited) (Parentheticals) - $ / shares
shares in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2017
Dec. 31, 2016
Increase (Decrease) In Stockholders' Equity [Roll Forward]    
Balance (in shares) 196,142  
Grant of restricted stock (in shares) 32  
Grant of restricted stock (in dollars per share) $ 31.23  
Vesting/exercising of equity compensation plan (in shares) 114  
Shares issued under dividend reinvestment (in shares) 614  
Dividend reinvestment and stock purchase plan (in dollars per share) $ 32.11  
Grant of stock as payment of fees (in shares) 5  
Grant of stock as payment of fees (in dollars per share) $ 32.18  
Equity shelf program (in shares) 228  
Equity shelf program (in dollars per share) $ 29.17  
Common dividends (in dollars per share) $ 1.25  
Conversion of OP Units to Common stock (in shares) 89  
Conversion of OP Units to Common stock (in dollars per share) $ 32.91  
Redemption of OP Units (in units) 90  
Balance (in shares) 197,224 196,142
Balance (in units) 8,772 8,862
OHI Healthcare Properties Holdco, Inc.    
Increase (Decrease) In Stockholders' Equity [Roll Forward]    
Balance (in shares) 1  
Balance (in shares) 1 1
XML 39 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash flows from operating activities    
Net income $ 177,269 $ 171,350
Adjustment to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 140,343 127,938
Impairment loss on real estate properties 17,773 41,451
Provision for uncollectible accounts 5,077 3,970
Refinancing costs and amortization of deferred financing costs 15,240 4,640
Accretion of direct financing leases (6,164) (5,915)
Stock-based compensation expense 7,478 6,443
Gain on assets sold - net (6,798) (14,792)
Amortization of acquired in-place leases - net (6,202) (7,910)
Effective yield receivable on mortgage notes (1,191) (619)
Change in operating assets and liabilities - net:    
Contractual receivables (33,293) 856
Straight-line rent receivables (23,174) (17,756)
Lease inducements 895 1,294
Other operating assets and liabilities (21,667) (24,055)
Net cash provided by operating activities 265,586 286,895
Cash flows from investing activities    
Acquisition of real estate (130,977) (622,848)
Cash acquired 2,341  
Investments in construction in progress (46,108) (26,960)
Investments in direct financing leases (4,767) (30)
Proceeds from direct financing leases 27,253  
Placement of mortgage loans (24,978) (12,528)
Distributions from unconsolidated joint venture 9,741  
Proceeds from sale of real estate investments 64,061 43,772
Capital improvements to real estate investments (16,861) (21,812)
Proceeds from other investments 35,997 25,923
Investments in other investments (52,228) (136,536)
Collection of mortgage principal 673 42,051
Net cash used in investing activities (135,853) (708,968)
Cash flows from financing activities    
Proceeds from credit facility borrowings 817,000 879,000
Payments on credit facility borrowings (852,000) (639,000)
Receipts of other long-term borrowings 1,346,749 350,000
Payments of other long-term borrowings (1,252,139) (620)
Payments of financing related costs (28,483) (3,581)
Receipts from dividend reinvestment plan 19,721 93,333
Payments for exercised options and restricted stock (2,120) (2,380)
Net proceeds from issuance of common stock 6,634 487
Dividends paid (246,722) (217,068)
Redemption of Omega OP Units (48) (10)
Distributions to Omega OP Unit Holders (11,143) (10,351)
Net cash (used in) provided by financing activities (202,551) 449,810
Effect of foreign currency translation on cash and cash equivalents 162 (202)
(Decrease) increase in cash and cash equivalents (72,656) 27,535
Cash and cash equivalents at beginning of period 93,687 5,424
Cash and cash equivalents at end of period 21,031 32,959
Supplemental disclosures of cash flow information:    
Interest paid during the period, net of amounts capitalized 97,610 74,010
Taxes paid during the period 2,032 748
Non cash investing activities    
Non cash acquisition of real estate (See Note 2) (9,430)  
Non cash acquisition of business   (25,000)
Non cash surrender of mortgage   25,000
Non cash investment in other investments (6,353)  
Total (15,783)
Non cash financing activities    
Change in fair value of cash flow hedges (108) 13,074
Remeasurement of debt denominated in a foreign currency 2,190  
Non cash acquisition of real estate (See Note 2) 2,082 13,074
OHI Healthcare Properties Holdco, Inc.    
Cash flows from operating activities    
Net income 177,269 171,350
Adjustment to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 140,343 127,938
Impairment loss on real estate properties 17,773 41,451
Provision for uncollectible accounts 5,077 3,970
Refinancing costs and amortization of deferred financing costs 15,240 4,640
Accretion of direct financing leases (6,164) (5,915)
Stock-based compensation expense 7,478 6,443
Gain on assets sold - net (6,798) (14,792)
Amortization of acquired in-place leases - net (6,202) (7,910)
Effective yield receivable on mortgage notes (1,191) (619)
Change in operating assets and liabilities - net:    
Contractual receivables (33,293) 856
Straight-line rent receivables (23,174) (17,756)
Lease inducements 895 1,294
Other operating assets and liabilities (21,667) (24,055)
Net cash provided by operating activities 265,586 286,895
Cash flows from investing activities    
Acquisition of real estate (130,977) (622,848)
Cash acquired 2,341  
Investments in construction in progress (46,108) (26,960)
Investments in direct financing leases (4,767) (30)
Proceeds from direct financing leases 27,253  
Placement of mortgage loans (24,978) (12,528)
Distributions from unconsolidated joint venture 9,741  
Proceeds from sale of real estate investments 64,061 43,772
Capital improvements to real estate investments (16,861) (21,812)
Proceeds from other investments 35,997 25,923
Investments in other investments (52,228) (136,536)
Collection of mortgage principal 673 42,051
Net cash used in investing activities (135,853) (708,968)
Cash flows from financing activities    
Proceeds from intercompany loans payable from Omega 2,163,749 1,229,000
Repayment of intercompany loans payable to Omega (2,104,139) (639,620)
Payment of financing related costs incurred by Omega (28,483) (3,581)
Dividends paid (54,641) (25,354)
Contributions from noncontrolling interests 24,235 91,440
Distributions to Omega OP Unit Holders (203,272) (202,075)
Net cash (used in) provided by financing activities (202,551) 449,810
Effect of foreign currency translation on cash and cash equivalents 162 (202)
(Decrease) increase in cash and cash equivalents (72,656) 27,535
Cash and cash equivalents at beginning of period 93,687 5,424
Cash and cash equivalents at end of period 21,031 32,959
Supplemental disclosures of cash flow information:    
Interest paid during the period, net of amounts capitalized 97,610 74,010
Taxes paid during the period 2,032 748
Non cash investing activities    
Non cash acquisition of real estate (See Note 2) (9,430)  
Non cash acquisition of business   (25,000)
Non cash surrender of mortgage   25,000
Non cash investment in other investments (6,353)  
Total (15,783)
Non cash financing activities    
Change in fair value of cash flow hedges (108) 13,074
Remeasurement of debt denominated in a foreign currency 2,190  
Non cash acquisition of real estate (See Note 2) 2,082 13,074
OHI Healthcare Properties Limited Partnership    
Cash flows from operating activities    
Net income 177,269 171,350
Adjustment to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 140,343 127,938
Impairment loss on real estate properties 17,773 41,451
Provision for uncollectible accounts 5,077 3,970
Refinancing costs and amortization of deferred financing costs 15,240 4,640
Accretion of direct financing leases (6,164) (5,915)
Stock-based compensation expense 7,478 6,443
Gain on assets sold - net (6,798) (14,792)
Amortization of acquired in-place leases - net (6,202) (7,910)
Effective yield receivable on mortgage notes (1,191) (619)
Change in operating assets and liabilities - net:    
Contractual receivables (33,293) 856
Straight-line rent receivables (23,174) (17,756)
Lease inducements 895 1,294
Other operating assets and liabilities (21,667) (24,055)
Net cash provided by operating activities 265,586 286,895
Cash flows from investing activities    
Acquisition of real estate (130,977) (622,848)
Cash acquired 2,341  
Investments in construction in progress (46,108) (26,960)
Investments in direct financing leases (4,767) (30)
Proceeds from direct financing leases 27,253  
Placement of mortgage loans (24,978) (12,528)
Distributions from unconsolidated joint venture 9,741  
Proceeds from sale of real estate investments 64,061 43,772
Capital improvements to real estate investments (16,861) (21,812)
Proceeds from other investments 35,997 25,923
Investments in other investments (52,228) (136,536)
Collection of mortgage principal 673 42,051
Net cash used in investing activities (135,853) (708,968)
Cash flows from financing activities    
Proceeds from intercompany loans payable from Omega 2,163,749 1,229,000
Repayment of intercompany loans payable to Omega (2,104,139) (639,620)
Payment of financing related costs incurred by Omega (28,483) (3,581)
Equity contributions from general partners 24,235 91,440
Distributions to general partners (246,722) (217,068)
Distributions to limited partners (11,143) (10,351)
Redemption of Omega OP Units (48) (10)
Net cash (used in) provided by financing activities (202,551) 449,810
Effect of foreign currency translation on cash and cash equivalents 162 (202)
(Decrease) increase in cash and cash equivalents (72,656) 27,535
Cash and cash equivalents at beginning of period 93,687 5,424
Cash and cash equivalents at end of period 21,031 32,959
Supplemental disclosures of cash flow information:    
Interest paid during the period, net of amounts capitalized 97,610 74,010
Taxes paid during the period 2,032 748
Non cash investing activities    
Non cash acquisition of real estate (See Note 2) (9,430)  
Non cash acquisition of business   (25,000)
Non cash surrender of mortgage   25,000
Non cash investment in other investments (6,353)  
Total (15,783)
Non cash financing activities    
Change in fair value of cash flow hedges (108) 13,074
Remeasurement of debt denominated in a foreign currency 2,190  
Non cash acquisition of real estate (See Note 2) $ 2,082 $ 13,074
XML 40 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2017
Accounting Policies [Abstract]  
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

 

Business Overview and Organization

 

Omega Healthcare Investors, Inc. (“Omega”) was formed as a real estate investment trust (“REIT”) and incorporated in the State of Maryland on March 31, 1992. All of Omega's assets are owned directly or indirectly, and all of Omega's operations are conducted directly or indirectly, through its subsidiaries, OHI Healthcare Properties Holdco, Inc. (“OHI Holdco”), a direct wholly owned subsidiary of Omega, and OHI Healthcare Properties Limited Partnership (“Omega OP”). OHI Holdco was formed as a corporation and incorporated in the State of Delaware on October 22, 2014. Omega OP was formed as a limited partnership and organized in the State of Delaware on October 24, 2014. No substantive assets or activity occurred in either of these entities until the merger with Aviv REIT, Inc. on April 1, 2015. Unless stated otherwise or the context otherwise requires, the terms the “Company,” “we,” “our” and “us” means Omega, OHI Holdco and Omega OP, collectively.

 

The Company has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States (“U.S.”) and the United Kingdom (“U.K.”). Our core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (“SNFs”) and, to a lesser extent, assisted living facilities (“ALFs”), independent living facilities and rehabilitation and acute care facilities. Our core portfolio consists of long-term leases and mortgage agreements. All of our leases are “triple-net” leases, which require the tenants to pay all property-related expenses. Our mortgage revenue derives from fixed rate mortgage loans, which are secured by first mortgage liens on the underlying real estate and personal property of the mortgagor.

 

In April 2015, Aviv REIT, Inc., a Maryland corporation (“Aviv”), merged (the “Aviv Merger”) with and into a wholly owned subsidiary of Omega, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 30, 2014 (the “Merger Agreement”), by and among Omega, Aviv, OHI Holdco, Omega OP, and Aviv Healthcare Properties Limited Partnership, a Delaware limited partnership.

 

Prior to April 1, 2015 and in accordance with the Merger Agreement, Omega restructured the manner in which it holds its assets by converting to an umbrella partnership real estate investment trust structure (the “UPREIT Conversion”). As a result of the UPREIT Conversion and following the consummation of the Aviv Merger, all of Omega’s assets are held by Omega OP, through its equity interests in its subsidiaries.

 

Omega OP is governed by the Second Amended and Restated Agreement of Limited Partnership of OHI Healthcare Properties Limited Partnership, dated as of April 1, 2015 (the “Partnership Agreement”). Pursuant to the Partnership Agreement, Omega and OHI Holdco are the general partners of Omega OP, and have exclusive control over Omega OP’s day-to-day management. As of June 30, 2017, Omega and OHI Holdco together owned approximately 96% of the issued and outstanding units of partnership interest in Omega OP (“Omega OP Units”), and investors owned approximately 4% of the Omega OP Units.

  

Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the interim periods reported herein are not necessarily indicative of results to be expected for the full year. These unaudited consolidated financial statements should be read in conjunction with the financial statements and the footnotes thereto included in our Form 10-K/A filed with the SEC on August 9, 2017.

 

Our consolidated financial statements include the accounts of (i) Omega, (ii) OHI Holdco, (iii) Omega OP, and (iv) all direct and indirect wholly owned subsidiaries of Omega. All intercompany transactions and balances have been eliminated in consolidationand our net earnings are reduced by the portion of net earnings attributable to noncontrolling interests.

 

Asset Impairment

 

Management evaluates our real estate investments for impairment indicators at each reporting period, including the evaluation of our assets’ useful lives. The judgment regarding the existence of impairment indicators is based on factors such as, but not limited to, market conditions, operator performance, legal structure, as well as our intent with respect to holding or disposing of the asset. If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows based on our intended use of the property are determined to be less than the carrying values of the assets. An adjustment is made to the net carrying value of the real estate investments for the excess of carrying value over fair value. The fair value of the real estate investment is determined based on current market conditions and consider matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. Additionally, our evaluation of fair value may consider valuing the property as a nursing home as well as alternative uses. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset. Management’s impairment evaluation process, and when applicable, impairment calculations involve estimation of the future cash flows from management’s intended use of the property. Changes in the facts and circumstances that drive management’s assumptions may result in an impairment of the Company’s assets in a future period that could be material to the Company’s results of operations.

 

For the three and six months ended June 30, 2017 and 2016, we recognized impairment losses of $10.1 million, $17.8 million, $6.9 million and $41.5 million, respectively. For additional information see Note 2 – Properties and Investments.

 

Goodwill Impairment

 

We assess goodwill for potential impairment during the fourth quarter of each fiscal year, or during the year if an event or other circumstance indicates that we may not be able to recover the carrying amount of the net assets of the reporting unit. In evaluating goodwill for impairment on an interim basis, we assess qualitative factors such as a significant decline in real estate valuations, current macroeconomic conditions, state of the equity and capital markets and our overall financial and operating performance or a significant decline in the value of our market capitalization, to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of the reporting unit is less than its carrying amount. On an annual basis during the fourth quarter of each fiscal year, or on an interim basis if we conclude it is more likely than not that the fair value of the reporting unit is less than its carrying value, we perform a two-step goodwill impairment test to identify potential impairment and measure the amount of impairment we will recognize, if any.

  

Noncontrolling Interests

 

Noncontrolling interests is the portion of equity not attributable to the respective reporting entity. We present the portion of any equity that we do not own in consolidated entities as noncontrolling interests and classify those interests as a component of total equity, separate from total stockholders’ equity, or owners’ equity on our Consolidated Balance Sheets. We include net income attributable to the noncontrolling interests in net income in our Consolidated Statements of Income.

 

As our ownership of a controlled subsidiary increases or decreases, any difference between the aggregate consideration paid to acquire the noncontrolling interests and our noncontrolling interest balance is recorded as a component of equity in additional paid-in capital, so long as we maintain a controlling ownership interest.

 

The noncontrolling interest for Omega represents the outstanding Omega OP Units held by outside investors. The noncontrolling interest for OHI Holdco represents the Omega OP Units held by the Parent and the outstanding Omega OP Units held by outside investors.

 

Foreign Operations

 

The U.S. dollar is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound. For our consolidated subsidiaries whose functional currency is not the U.S. dollar, we translate their financial statements into the U.S. dollar. We translate assets and liabilities at the exchange rate in effect as of the financial statement date. Revenue and expense accounts are translated using an average exchange rate for the period. Gains and losses resulting from translation are included in accumulated other comprehensive loss (“AOCL”), as a separate component of equity and a proportionate amount of gain or loss is allocated to noncontrolling interests.

 

We and certain of our consolidated subsidiaries may have intercompany and third-party debt that is not denominated in the entity’s functional currency. When the debt is remeasured against the functional currency of the entity, a gain or loss can result. The resulting adjustment is reflected in results of operations, unless it is intercompany debt that is deemed to be long-term in nature and then the adjustments are included in AOCL.

 

Derivative Instruments

 

Cash flow hedges

 

During our normal course of business, we may use certain types of derivative instruments for the purpose of managing interest rate and currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at the inception of a qualifying cash flow hedging relationship, the underlying transaction or transactions, must be, and are expected to remain, probable of occurring in accordance with the Company’s related assertions. The Company recognizes all derivative instruments, including embedded derivatives required to be bifurcated, as assets or liabilities in the Consolidated Balance Sheets at their fair value which are determined using a market approach and Level 2 inputs. Changes in the fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria of hedge accounting are recognized in earnings. For derivatives designated as qualifying cash flow hedging relationships, the change in fair value of the effective portion of the derivatives is recognized in AOCL as a separate component of equity and a proportionate amount of gain or loss is allocated to noncontrolling interest, whereas the change in fair value of the ineffective portion is recognized in earnings. We formally document all relationships between hedging instruments and hedged items, as well as our risk-management objectives and strategy for undertaking various hedge transactions. This process includes designating all derivatives that are part of a hedging relationship to specific forecasted transactions as well as recognized obligations or assets in the Consolidated Balance Sheets. We also assess and document, both at inception of the hedging relationship and on a quarterly basis thereafter, whether the derivatives are highly effective in offsetting the designated risks associated with the respective hedged items. If it is determined that a derivative ceases to be highly effective as a hedge, or that it is probable the underlying forecasted transaction will not occur, we discontinue hedge accounting prospectively and record the appropriate adjustment to earnings based on the current fair value of the derivative. As a matter of policy, we do not use derivatives for trading or speculative purposes. At June 30, 2017 and December 31, 2016, we had $1.4 million and $1.5 million, respectively, of qualifying cash flow hedges recorded at fair value in accrued expenses and other liabilities on our Consolidated Balance Sheets.

  

Net investment hedge

 

We use the spot method to measure the effectiveness of our net investment hedge. Under this method, for each reporting period, the change in the carrying value of the hedging instrument due to remeasurement of the effective portion is reported in AOCL in our Consolidated Balance Sheets and the remaining change in the carrying value of the ineffective portion, if any, is recognized in earnings. We evaluate the effectiveness of our net investment hedge on a quarterly basis. We did not record any ineffectiveness for fiscal 2017.

 

Accounts Receivable

 

Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts. Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements. Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line rent receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement. Lease inducements result from value provided by us to the lessee, at the inception or renewal of the lease, and are amortized as a reduction of rental revenue over the non-cancellable lease term.

 

At June 30, 2017, two of our top 10 operators were approximately 90 days past due on rent payments to the Company. On a quarterly basis, we review our accounts receivable to determine their collectability. The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement.  If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance. In the case of a lease recognized on a straight-line basis, a mortgage recognized on an effective yield basis or the existence of lease inducements, we generally provide an allowance for straight-line, effective interest, and/or lease inducement accounts receivable when certain conditions or indicators of adverse collectability are present. If the accounts receivable balance is subsequently deemed uncollectible, the receivable and allowance for doubtful account balance are written off.

  

A summary of our net receivables by type is as follows:

 

    June 30,     December 31,  
    2017     2016  
    (in thousands)  
             
Contractual receivables   $ 40,484     $ 13,376  
Effective yield interest receivables     10,940       9,749  
Straight-line rent receivables     231,233       208,874  
Lease inducements     7,498       8,393  
Allowance     (1,469 )     (357 )
Accounts receivable – net   $ 288,686     $ 240,035  

 

Related Party Transactions

 

The Company has a policy which generally requires related party transactions to be approved or ratified by the Audit Committee. On February 1, 2016, we acquired 10 SNFs from Laurel Healthcare Holdings, Inc. (“Laurel”) for approximately $169.0 million in cash and leased them to an unrelated existing operator. A former member of the Board of Directors of the Company, together with certain members of his immediate family, beneficially owned approximately 34% of the equity of Laurel prior to the transaction. Immediately following our acquisition, the unrelated existing operator acquired all of the outstanding equity interests of Laurel, including the interests previously held by the former director of the Company and his family.

 

Accounting Pronouncement Adopted in 2017

 

In March 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-09, Compensation-Stock Compensation (Topic 718) (“ASU 2016-09”). ASU 2016-09 amends the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. This guidance is effective for annual and interim reporting periods of public entities beginning after December 15, 2016. We adopted this accounting standard on January 1, 2017, at which time the Company began prospectively accounting for excess tax benefits or tax deficiencies as an adjustment to income tax expense in our Consolidated Statements of Income as opposed to the prior requirement that these excess tax benefits be recognized in additional paid-in capital and tax deficiencies be recognized either as an offset to accumulated excess tax benefits, if any, or in the income statement. The Company will continue to account for forfeitures as they occur and present employee taxes paid as a financing activity on our Consolidated Statements of Cash Flows. The adoption of this accounting standard did not have a material impact on our consolidated financial statements.

 

Recent Accounting Pronouncements - Pending Adoption

 

In 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), which outlines a comprehensive model for entities to use in accounting for revenue arising from contracts with customers. ASU 2014-09 states that “an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.” While ASU 2014-09 specifically references contracts with customers, it may apply to certain other transactions such as the sale of real estate or equipment. ASU 2014-09 is effective for the Company beginning January 1, 2018. In addition, the FASB has begun to issue targeted updates to clarify specific implementation issues of ASU 2014-09. These updates include ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Identifying Performance Obligations and Licensing, and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients. The Company is currently evaluating the provisions of ASU 2014-09 and its related updates and will be closely monitoring developments and additional guidance to determine the potential impact of the new standard. The Company intends to adopt ASU 2014-09 and its subsequent updates in accordance with the modified retrospective approach. We do not expect the adoption of ASU 2014-09 and its updates to have a significant impact on our consolidated financial statements, as a substantial portion of our revenue consists of rental income from leasing arrangements and interest income from loan arrangements, both of which are specifically excluded from ASU 2014-09.

  

In February 2016, the FASB issued ASU 2016-02, Leases (“ASU 2016-02”), which amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. ASU 2016-02 will be effective for the Company beginning January 1, 2019. Early adoption of ASU 2016-02 as of its issuance is permitted. The new standard requires a modified retrospective transition approach for all leases existing at, or entered into after, the date of initial application, with an option to use certain transition relief. As a result of the pending adoption ASU 2016-02 and in connection with the pending adoption of ASU 2014-09, the Company may be required to record real estate tax revenues and an equal an offsetting real estate tax expense, as a result of our operators paying real estate taxes on our behalf. We are continuing to evaluate the other impacts of adopting ASU 2016-02 on our consolidated financial statements.

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) (“ASU 2016-13”), which changes the impairment model for most financial assets. The new model uses a forward-looking expected loss method, which will generally result in earlier recognition of allowances for losses. ASU 2016-13 is effective for annual and interim periods beginning after December 15, 2019 and early adoption is permitted for annual and interim periods beginning after December 15, 2018. We are currently evaluating the impact of adopting ASU 2016-13 on our consolidated financial statements.

XML 41 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
PROPERTIES AND INVESTMENTS
6 Months Ended
Jun. 30, 2017
Real Estate [Abstract]  
PROPERTIES AND INVESTMENTS

NOTE 2 – PROPERTIES AND INVESTMENTS

 

Leased Property

 

Our real estate properties, represented by 803 SNFs, 119 ALFs, 16 specialty facilities and one medical office building at June 30, 2017, are leased under provisions of single or master leases with initial terms typically ranging from five to 15 years, plus renewal options. Substantially all of our leases contain provisions for specified annual increases over the rents of the prior year and are generally computed in one of three methods depending on specific provisions of each lease as follows: (i) a specific annual percentage increase over the prior year’s rent, generally between 2.0% and 3.0%; (ii) an increase based on the change in pre-determined formulas from year to year (e.g., increases in the Consumer Price Index (“CPI”)); or (iii) specific dollar increases over prior years. Under the terms of the leases, the lessee is responsible for all maintenance, repairs, taxes and insurance on the leased properties.

 

A summary of our investment in leased real estate properties is as follows:

 

    June 30,     December 31,  
    2017     2016  
    (in thousands)  
Buildings   $ 6,055,423     $ 5,954,771  
Land     796,561       759,295  
Furniture, fixtures and equipment     458,427       454,760  
Site improvements     204,993       206,206  
Construction in progress     214,795       191,326  
Total real estate investments     7,730,199       7,566,358  
Less accumulated depreciation     (1,366,376 )     (1,240,336 )
Real estate investments - net   $ 6,363,823     $ 6,326,022  

 

 

The following table summarizes the significant acquisitions that occurred during the first six months of 2017:

 

  Number of
Facilities
    Country/   Total
Investment
    Land    

Building & Site 
Improvements

    Furniture 
& Fixtures
    Initial
Annual 
Cash Yield
 
Period   SNF     ALF     State   (in millions)     (2)(%)  
Q1     -       1     VA   $ 7.6     $ 0.5     $ 6.8     $ 0.3       7.50  
Q2     1       -     NC     8.6       0.7       7.3       0.6       9.50  
Q2     -       18     UK     124.2   (1)     34.1       85.1       5.0       8.50  
Total     1       19         $ 140.4     $ 35.3     $ 99.2     $ 5.9          

 

(1) Omega recorded a non-cash deferred tax liability and acquisitions costs of approximately $8.2 million and $1.2 million, respectively, in connection with this acquisition.
(2) The cash yield is based on the purchase price.

 

During the second quarter of 2017, we acquired two parcels of land which are not reflected in the table above for approximately $5.5 million with the intent of building new facilities for an existing operator.

 

Asset Sales, Impairments and Other

 

During the first quarter of 2017, we sold 15 facilities for approximately $45.8 million in net proceeds recognizing a gain on sale of approximately $7.4 million. Eleven of the sold facilities were previously classified as held for sale. In addition, we recorded a provision for impairment of approximately $7.6 million on three facilities, one of which was reclassified to held for sale as of March 31, 2017.

 

During the second quarter of 2017, we sold three facilities for approximately $18.3 million in net cash proceeds recognizing a loss on sale of approximately $0.6 million. Two of the sold facilities were previously classified as assets held for sale. In addition, we recorded a provision for impairment of approximately $10.1 million on six facilities.

 

We reduced the net book value of the impaired facilities to their estimated fair values or, with respect to the facility reclassified to held for sale, to its estimated fair value less costs to sell. To estimate the fair value of the facilities, we utilized a market approach and Level 3 inputs (which generally consist of non-binding offers from unrelated third parties). Also see Note 7 – Assets Held For Sale for details. Our recorded impairments were primarily the result of a decision to exit certain non-strategic facilities and/or operators.

XML 42 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
DIRECT FINANCING LEASES
6 Months Ended
Jun. 30, 2017
Leases, Capital [Abstract]  
DIRECT FINANCING LEASES

NOTE 3 – DIRECT FINANCING LEASES

 

The components of investments in direct financing leases consist of the following:

 

    June 30,     December 31,  
    2017     2016  
    (in thousands)  
Minimum lease payments receivable   $ 4,085,493     $ 4,287,069  
Less unearned income     (3,499,877 )     (3,685,131 )
Less allowance for loss on direct financing lease     (3,309 )      
Investment in direct financing leases - net   $ 582,307     $ 601,938  
                 
Properties subject to direct financing leases     53       58  

 

The following minimum rents are due under our direct financing leases for the remainder of 2017 and the subsequent five years (in thousands):

 

2017 2018 2019 2020 2021 2022
$24,407 $50,019 $51,246 $52,493 $53,681 $55,008

 

New Ark Investment Inc.

 

On November 27, 2013, we closed an aggregate $529 million purchase/leaseback transaction in connection with the acquisition of Ark Holding Company, Inc. (“Ark Holding”) by 4 West Holdings Inc. At closing, we acquired 55 SNFs and 1 ALF operated by Ark Holding and leased the facilities back to Ark Holding, now known as New Ark Investment Inc. (“New Ark”), pursuant to four 50-year master leases with rental payments yielding 10.6% per annum over the term of the leases. The purchase/leaseback transaction is being accounted for as a direct financing lease.

 

The lease agreements allow the tenant the right to purchase the facilities for a bargain purchase price plus closing costs at the end of the lease term. In addition, commencing in the 41st year of each lease, the tenant will have the right to prepay the remainder of its obligations thereunder for an amount equal to the sum of the unamortized portion of the original aggregate $529 million investment plus the net present value of the remaining payments under the lease and closing costs. In the event the tenant exercises either of these options, we have the right to purchase the properties for fair value at the time.

 

The remaining 50 facilities under these master leases as of June 30, 2017 are located in 10 states, predominantly in the southeastern U.S. The facilities are separated by region and divided amongst four cross-defaulted master leases. The four regions include the Southeast (38 facilities), the Northwest (2 facilities), Texas (9 facilities) and Indiana (1 facility).

 

Additionally, we own four facilities and lease them to New Ark under a master lease which expires in 2026. The four facility lease is being accounted for as an operating lease.

 

In March 2017, we executed sale agreements with two unrelated third parties to sell seven facilities leased to New Ark located in the Northwest with a carrying value of approximately $36.4 million for approximately $34.0 million. During the first quarter of 2017, we recorded an allowance for loss of approximately $2.4 million. In the second quarter of 2017, we sold five of the Northwest facilities and received net cash proceeds of approximately $27.3 million and recorded an additional allowance for loss of approximately $0.9 million. For the three and six months ended June 30, 2017, we recognized approximately $0.5 million and $1.3 million, respectively, of direct financing lease income on a cash basis related to the Northwest facilities lease. The sale of the remaining two Northwest facilities is expected to close in the third quarter of 2017.

XML 43 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
MORTGAGE NOTES RECEIVABLE
6 Months Ended
Jun. 30, 2017
Mortgage Notes Receivable Investments [Abstract]  
MORTGAGE NOTES RECEIVABLE

NOTE 4 – MORTGAGE NOTES RECEIVABLE

 

As of June 30, 2017, mortgage notes receivable relate to 29 fixed rate mortgages on 52 long-term care facilities. The mortgage notes are secured by first mortgage liens on the borrowers' underlying real estate and personal property. The mortgage notes receivable relate to facilities located in ten states that are operated by seven independent healthcare operating companies. We monitor compliance with mortgages and when necessary have initiated collection, foreclosure and other proceedings with respect to certain outstanding mortgage notes.

 

Mortgage interest income is recognized as earned over the terms of the related mortgage notes, using the effective yield method. Allowances are provided against earned revenues from mortgage interest when collection of amounts due becomes questionable or when negotiations for restructurings of troubled operators lead to lower expectations regarding ultimate collection. When collection is uncertain, mortgage interest income on impaired mortgage loans is recognized as received after taking into account the application of security deposits.

 

The outstanding principal amounts of mortgage notes receivable, net of allowances, were as follows:

 

    June 30,     December 31,  
    2017     2016  
    (in thousands)  
             
Mortgage note due 2024; interest at 9.98%   $ 112,500     $ 112,500  
Mortgage note due 2029; interest at 9.45%     411,467       412,140  
Other mortgage notes outstanding (1)     143,489       118,637  
Mortgage notes receivable, gross     667,456       643,277  
Allowance for loss on mortgage notes receivable     (4,747 )     (3,934 )
Total mortgages — net   $ 662,709     $ 639,343  

 

(1) Other mortgage notes outstanding have stated interest rates ranging from 8.35% to 14.0% and maturity dates through 2029.

 

XML 44 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
OTHER INVESTMENTS
6 Months Ended
Jun. 30, 2017
Receivables [Abstract]  
OTHER INVESTMENTS

NOTE 5 – OTHER INVESTMENTS

 

A summary of our other investments is as follows:

 

    June 30,     December 31,  
    2017     2016  
    (in thousands)  
             
Other investment note due 2019; interest at 10.96%   $ 49,583     $ 49,458  
Other investment note due 2020; interest at 14.00%     47,899       47,913  
Other investment note due 2022, interest at 9.00%     31,987       31,987  
Other investment note due 2030; interest at 6.66%     50,000       44,595  
Other investment notes outstanding (1)     104,314       87,691  
Other investments, gross     283,783       261,644  
Allowance for loss on other investments     (4,798 )     (4,798 )
Total other investments   $ 278,985     $ 256,846  

 

(1) Other investment notes have maturity dates through 2028 and interest rates ranging from 6.50% to 13.0%.
 
XML 45 R14.htm IDEA: XBRL DOCUMENT v3.7.0.1
INVESTMENT IN UNCONSOLIDATED JOINT VENTURE
6 Months Ended
Jun. 30, 2017
Equity Method Investments and Joint Ventures [Abstract]  
INVESTMENT IN UNCONSOLIDATED JOINT VENTURE

NOTE 6 – INVESTMENT IN UNCONSOLIDATED JOINT VENTURE

 

On November 1, 2016, we invested approximately $50.0 million for an approximate 15% ownership interest in a joint venture operating as Second Spring Healthcare Investments. The other approximate 85% interest is owned by affiliates of Lindsey Goldberg LLC. We account for the joint venture using the equity method. On November 1, 2016, the joint venture acquired 64 SNFs from Welltower Inc. for approximately $1.1 billion and leased them to a single operator.

 

We receive asset management fees from the joint venture for services provided. For the three and six months ended June 30, 2017, we recognized $0.5 million and $1.0 million, respectively, of asset management fees. These fees are included in miscellaneous income in the accompanying Consolidated Statements of Income. The accounting policies for the unconsolidated joint venture are the same as those of the Company.

XML 46 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
ASSETS HELD FOR SALE
6 Months Ended
Jun. 30, 2017
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]  
ASSETS HELD FOR SALE

NOTE 7 – ASSETS HELD FOR SALE

 

The following is a summary of our assets held for sale:

 

    Properties Held For Sale  
    Number of
Properties
    Net Book Value
(in thousands)
 
       
December 31, 2016     20     $ 52,868  
Properties sold/other (1)     (12 )     (30,023 )
Properties added (2)     1       400  
March 31, 2017     9     $ 23,245  
Properties sold/other (1)     (2 )     (4,356 )
June 30, 2017(3)     7     $ 18,889  

 

(1) In the first quarter of 2017, we sold nine SNFs and two ALFs for approximately $29.4 million in net proceeds recognizing a gain on sale of approximately $3.6 million. One SNF classified as an asset held for sale at December 31, 2016 was no longer considered held for sale during the first quarter of 2017 and was reclassified back to leased properties at approximately $5.1 million which represents the facility’s then carrying value adjusted for depreciation that was not recognized while classified as held for sale. In the second quarter of 2017, we sold one ALF and one SNF for approximately $5.0 million in net proceeds, generating a gain on sale of approximately $0.6 million.
(2) In the first quarter of 2017, we recorded a $3.5 million impairment to reduce one ALF’s net book value to its estimated fair value less costs to sell before it was reclassified to assets held for sale.
(3) We plan to sell the facilities classified as held for sale at June 30, 2017 within the next twelve months.
XML 47 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
INTANGIBLES
6 Months Ended
Jun. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLES

NOTE 8 – INTANGIBLES

 

The following is a summary of our intangibles as of June 30, 2017 and December 31, 2016:

 

    June 30,     December 31,  
    2017     2016  
    (in thousands)  
Assets:                
Goodwill   $ 644,184     $ 643,474  
                 
Above market leases   $ 22,426     $ 22,476  
In-place leases     167       167  
Accumulated amortization     (16,477 )     (15,864 )
Net intangible assets   $ 6,116     $ 6,779  
                 
Liabilities:                
Below market leases   $ 164,735     $ 165,028  
Accumulated amortization     (77,534 )     (70,738 )
Net intangible liabilities   $ 87,201     $ 94,290  

 

Above market leases and in-place leases, net of accumulated amortization, are included in other assets on our Consolidated Balance Sheets. Below market leases, net of accumulated amortization, are included in accrued expenses and other liabilities on our Consolidated Balance Sheets. The net amortization related to the above and below market leases is included in our Consolidated Statements of Income as an adjustment to rental income.

 

For the three months ended June 30, 2017 and 2016, our net amortization related to intangibles was $3.1 million and $3.6 million, respectively. For the six months ended June 30, 2017 and 2016, our net amortization related to intangibles was $6.2 million and $7.9 million, respectively. The estimated net amortization related to these intangibles for the remainder of 2017 and the subsequent four years is as follows: remainder of 2017 – $5.8 million; 2018 – $10.5 million; 2019 – $9.5 million; 2020 – $9.3 million and 2021 – $8.7 million. As of June 30, 2017 the weighted average remaining amortization period of above market leases (inclusive of in-place leases) and below market leases is approximately eight years and nine years, respectively.

 

The following is a reconciliation of our goodwill as of June 30, 2017:

 

    (in thousands)  
Balance as of December 31, 2016   $ 643,474  
Add: foreign currency translation     710  
Balance as of June 30, 2017   $ 644,184  

 

XML 48 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONCENTRATION OF RISK
6 Months Ended
Jun. 30, 2017
Risks and Uncertainties [Abstract]  
CONCENTRATION OF RISK

NOTE 9 – CONCENTRATION OF RISK

 

As of June 30, 2017, our portfolio of real estate investments consisted of 999 healthcare facilities, located in 42 states and the U.K. and operated by 77 third party operators. Our investment in these facilities, net of impairments and reserve for uncollectible loans, totaled approximately $9.0 billion at June 30, 2017, with approximately 99% of our real estate investments related to long-term care facilities. Our portfolio is made up of 803 SNFs, 119 ALFs, 16 specialty facilities, one medical office building, fixed rate mortgages on 47 SNFs and four ALFs, and nine facilities that are closed/held-for-sale. At June 30, 2017, we also held other investments of approximately $279.0 million, consisting primarily of secured loans to third-party operators of our facilities and a $39.0 million investment in an unconsolidated joint venture.

   

At June 30, 2017, we had investments with one operator/or manager that exceeded 10% of our total investments: Ciena Healthcare (10%). No operator generated more than 10% of our total revenues from operations for the three and six months ended June 30, 2017. At June 30, 2017, the three states in which we had our highest concentration of investments were Ohio (9%), Texas (9%) and Florida (9%).

XML 49 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCKHOLDERS'/OWNERS' EQUITY
6 Months Ended
Jun. 30, 2017
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS'/OWNERS' EQUITY

NOTE 10 – STOCKHOLDERS’/OWNERS' EQUITY

 

On July 13, 2017, the Board of Directors declared a common stock dividend of $0.64 per share, increasing the quarterly common dividend rate by $0.01 per share over the prior quarter, to be paid on August 15, 2017 to common stockholders of record as of the close of business on August 1, 2017.

 

On April 13, 2017, the Board of Directors declared a common stock dividend of $0.63 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter. The common dividends were paid May 15, 2017 to common stockholders of record as of the close of business on May 1, 2017.

 

On January 12, 2017, the Board of Directors declared a common stock dividend of $0.62 per share, increasing the quarterly common dividend by $0.01 per share over the previous quarter. The common dividends were paid February 15, 2017 to common stockholders of record as of the close of business on January 31, 2017.

 

On the same dates listed above, Omega OP Unit holders received the same distributions per unit as those paid to the common stockholders of Omega.

 

$500 Million Equity Shelf Program

 

For the three months ended June 30, 2017, no shares were issued under our $500 million Equity Shelf Program. For the six months ended June 30, 2017, we issued 0.2 million shares of common stock at an average price of $29.17 per share, net of issuance costs, generating net proceeds of $6.6 million under our $500 million Equity Shelf Program.

 

Dividend Reinvestment and Common Stock Purchase Plan

 

For the three months ended June 30, 2017, approximately 0.4 million shares of our common stock at an average price of $33.02 per share were issued through our Dividend Reinvestment and Common Stock Purchase Program for gross proceeds of approximately $12.4 million. For the six months ended June 30, 2017, approximately 0.6 million shares of our common stock at an average price of $32.11 per share were issued through our Dividend Reinvestment and Common Stock Purchase Program for gross proceeds of approximately $19.7 million.

   

Accumulated Other Comprehensive Loss

 

The following is a summary of our accumulated other comprehensive loss, net of tax where applicable:

 

  Omega 
  As of and For the Three
Months Ended June 30,
  As of and For the Six
Months Ended June 30,
 
  2017  2016  2017  2016 
  (in thousands) 
                 
Foreign Currency Translation:                
Beginning balance $(50,614) $(13,143) $(54,948) $(8,413)
Translation gain (loss)  10,195   (21,836)  14,468   (26,544)
Realized gain (loss)  79   -   140   (22)
Ending balance  (40,340)  (34,979)  (40,340)  (34,979)
                 
Derivative Instruments:                
Cash flow hedges:                
Beginning balance  (166)  (9,594)  (1,420)  (718)
Unrealized loss  (1,840)  (4,198)  (1,350)  (13,074)
Realized gain  626   -   1,390   - 
Ending balance  (1,380)  (13,792)  (1,380)  (13,792)
Net investment hedge:                
Beginning balance  -   -   -   - 
Unrealized loss  (2,193)  -   (2,193)  - 
Ending balance  (2,193)  -   (2,193)  - 
                 
Total accumulated other comprehensive loss  (43,913)  (48,771)  (43,913)  (48,771)
Add: portion included in noncontrolling interest  2,010   2,308   2,010   2,308 
                 
Total accumulated other comprehensive loss $(41,903) $(46,463) $(41,903) $(46,463)

   

  OHI Holdco 
  As of and For the Three
Months Ended June 30,
  As of and For the Six
Months Ended June 30,
 
  2017  2016  2017  2016 
  (in thousands) 
                 
Foreign Currency Translation:                
Beginning balance $(50,614) $(13,143) $(54,948) $(8,413)
Translation gain (loss)  10,195   (21,836)  14,468   (26,544)
Realized gain (loss)  79   -   140   (22)
Ending balance  (40,340)  (34,979)  (40,340)  (34,979)
                 
Derivative Instruments:                
Cash flow hedges:                
Beginning balance  (166)  (9,594)  (1,420)  (718)
Unrealized loss  (1,840)  (4,198)  (1,350)  (13,074)
Realized gain  626   -   1,390   - 
Ending balance  (1,380)  (13,792)  (1,380)  (13,792)
Net investment hedge:                
Beginning balance  -   -   -   - 
Unrealized loss  (2,193)  -   (2,193)  - 
Ending balance  (2,193)  -   (2,193)  - 
                 
Total accumulated other comprehensive loss  (43,913)  (48,771)  (43,913)  (48,771)
Add: portion included in noncontrolling interest  34,116   37,965   34,116   37,965 
                 
Total accumulated other comprehensive loss $(9,797) $(10,806) $(9,797) $(10,806)

 

  Omega OP 
  As of and For the Three
Months Ended June 30,
  As of and For the Six
Months Ended June 30,
 
  2017  2016  2017  2016 
  (in thousands) 
                 
Foreign Currency Translation:                
Beginning balance $(50,614) $(13,143) $(54,948) $(8,413)
Translation gain (loss)  10,195   (21,836)  14,468   (26,544)
Realized gain (loss)  79   -   140   (22)
Ending balance  (40,340)  (34,979)  (40,340)  (34,979)
                 
Derivative Instruments:                
Cash flow hedges:                
Beginning balance  (166)  (9,594)  (1,420)  (718)
Unrealized loss  (1,840)  (4,198)  (1,350)  (13,074)
Realized gain  626   -   1,390   - 
Ending balance  (1,380)  (13,792)  (1,380)  (13,792)
Net investment hedge:                
Beginning balance  -   -   -   - 
Unrealized loss  (2,193)  -   (2,193)  - 
Ending balance  (2,193)  -   (2,193)  - 
                 
Total accumulated other comprehensive loss $(43,913) $(48,771) $(43,913) $(48,771)
XML 50 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
TAXES
6 Months Ended
Jun. 30, 2017
Income Tax Disclosure [Abstract]  
TAXES

NOTE 11 – TAXES

 

OHI Holdco is a wholly owned subsidiary of Omega and is a qualified REIT subsidiary for United States federal income tax purposes, and Omega OP is a pass through entity for United States federal income tax purposes.

 

Since our inception, we have elected to be taxed as a REIT under the applicable provisions of the Internal Revenue Code (“Code”). A REIT is generally not subject to federal income tax on that portion of its REIT taxable income which is distributed to its stockholders, provided that at least 90% of such taxable income is distributed each tax year and certain other requirements are met, including asset and income tests. So long as we qualify as a REIT under the Code, we generally will not be subject to federal income taxes on the REIT taxable income that we distribute to stockholders, subject to certain exceptions.

 

If the Company fails to qualify as a REIT in any taxable year, the Company will be subject to federal income taxes on its taxable income at regular corporate rates and dividends paid to our stockholders will not be deductible by us in computing taxable income. Further, we will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year in which qualification is denied, unless the Internal Revenue Service grants us relief under certain statutory provisions. Failing to qualify as a REIT could materially and adversely affect the Company’s net income; however, we believe we are organized and operate in such a manner as to qualify for treatment as a REIT. We test our compliance within the REIT taxation rules to ensure that we are in compliance with the REIT rules on a quarterly and annual basis. We review our distributions and projected distributions each year to ensure we have met and will continue to meet the annual REIT distribution requirements. In 2017, we expect to distribute dividends in excess of our taxable income.

 

As a result of our UPREIT Conversion, our Company and its subsidiaries may be subject to income or franchise taxes in certain states and municipalities. Also, as a result of our UPREIT Conversion, we created five wholly owned subsidiary REITs and added a sixth wholly owned subsidiary REIT as of January 1, 2016, all of which are subject to all of the REIT qualification rules set forth in the Code. We merged five of the wholly owned subsidiary REITs into a single wholly owned subsidiary REIT in December 2015, and then merged the sixth wholly owned subsidiary REIT into our other wholly owned subsidiary REIT in December 2016, which wholly owned subsidiary REIT remains subject to all of the REIT qualification rules set forth in the Code.

 

Subject to the limitation under the REIT asset test rules, we are permitted to own up to 100% of the stock of one or more taxable REIT subsidiaries (“TRSs”). We have elected for two of our active subsidiaries to be treated as TRSs. One of our TRSs is subject to federal, state and local income taxes at the applicable corporate rates and the other is subject to foreign income taxes. As of June 30, 2017, our TRS that is subject to federal, state and local income taxes at the applicable corporate rates had a net operating loss carry-forward of approximately $0.8 million. The loss carry-forward is fully reserved as of June 30, 2017, with a valuation allowance due to uncertainties regarding realization.

 

During the second quarter of 2017, we recorded approximately $0.5 million of state and local income tax provision and approximately $0.1 million of tax provision for foreign income taxes. For the six months ended June 30, 2017, we recorded approximately $1.5 million of state and local income tax provision and approximately $0.2 million of tax provision for foreign income taxes. The expenses were included in provision for income taxes on our Consolidated Statements of Income.

XML 51 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK-BASED COMPENSATION
6 Months Ended
Jun. 30, 2017
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
STOCK-BASED COMPENSATION

NOTE 12 – STOCK-BASED COMPENSATION

 

The following is a summary of our stock-based compensation expense for the three and six months ended June 30, 2017 and 2016, respectively:

 

  Three Months Ended
June 30,
  Six Months Ended
June 30,
 
  2017  2016  2017  2016 
  (in thousands) 
                 
Stock-based compensation expense $3,734  $3,665  $7,478  $6,443 

 

Restricted Stock and Restricted Stock Units

 

Restricted stock and restricted stock units (“RSUs”) are subject to forfeiture if the holder’s service to us terminates prior to vesting, subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company. Prior to vesting, ownership of the shares/units cannot be transferred. Restricted stock has the same dividend and voting rights as our common stock. RSUs accrue dividend equivalents but have no voting rights. Restricted stock and RSUs are valued at the price of our common stock on the date of grant. We expense the cost of these awards ratably over their vesting period. We awarded 140,416 RSUs to employees on January 1, 2017.

 

Performance Restricted Stock Units and LTIP Units

 

Performance restricted stock units (“PRSUs”) and long term incentive plan units (“LTIP Units”) are subject to forfeiture if the performance requirements are not achieved or if the holder’s service to us terminates prior to vesting, subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company. The PRSUs and the LTIP Units have varying degrees of performance requirements to be earned and vested, and each PRSU and LTIP Units award represents the right to a variable number of shares of common stock or partnership units. Each LTIP Unit once earned and vested is convertible into one Omega OP Unit in Omega OP, subject to certain conditions. The earning requirements are based on either the (i) total shareholder return (“TSR”) of Omega or (ii) Omega’s TSR relative to other real estate investment trusts in the MSCI U.S. REIT Index or FTSE NAREIT Equity Health Care Index TSR (both “Relative TSR”). Vesting in general requires that the employee remain employed by us until the date specified in the applicable PRSU or LTIP agreement, which may be later than the date that the TSR or Relative TSR requirements are satisfied. We expense the cost of these awards ratably over their service period.

 

Prior to vesting and the distribution of shares, ownership of the PRSUs cannot be transferred. Dividend equivalents on the PRSUs accumulate and with respect to PRSUs granted before 2015 are paid when the PRSUs vest and with respect to PRSUs granted in 2015 or later are paid once the PRSUs are earned. While each LTIP Unit is unearned, the employee receives a partnership distribution equal to 10% of the quarterly approved regular periodic distributions per Omega OP Unit. The remaining partnership distributions (which in the case of normal periodic distributions is equal to the total approved quarterly dividend on Omega’s common stock) on the LTIP Units accumulate, and if the LTIP Units are earned, the accumulated distributions are paid.

 

The number of shares or units earned under the TSR PRSUs or LTIP Units depends generally on the level of achievement of Omega’s TSR over the indicated performance period. We awarded 399,726 LTIP Units to employees on January 1, 2017.

 

The number of shares earned under the Relative TSR PRSUs depends generally on the level of achievement of Omega’s TSR relative to other real estate investment trusts in the MSCI U.S. REIT Index or FTSE NAREIT Equity Health Care Index TSR over the performance period indicated. We awarded 285,338 Relative TSR PRSUs to employees on January 1, 2017.

 

The following table summarizes our total unrecognized compensation cost as of June 30, 2017 associated with restricted stock, restricted stock units, PRSU awards, and LTIP Unit awards to employees:

 

  Grant
Year
  Shares/ Units  Grant Date
Average
Fair Value
Per Unit/
Share
  Total
Compensation
Cost (in millions)
(1)
  Weighted
Average
Period of
Expense
Recognition
(in months)
  Unrecognized
Compensation
Cost (in
millions)
  Performance
Period
 Vesting
Dates
RSUs                            
                             
3/31/15 RSU  2015   109,985  $40.57  $4.5   33  $0.8  N/A 12/31/2017
4/1/15 RSU  2015   40,464   40.74   1.6   33   0.3  N/A 12/31/2017
Assumed Aviv RSU  2015   7,799   35.08   0.3   33   0.1  N/A 11/1/2017
3/17/16  RSU  2016   130,006   34.78   4.6   33   2.4  N/A 12/31/2018
1/1/2017  RSU  2017   140,416   31.26   4.3   36   3.6  N/A 12/31/2019
Restricted Stock Units Total      428,670  $35.68  $15.3      $7.2     
                             
TSR PRSUs and LTIP Units                            
                             
2016 TSR  2014   135,634  $8.67  $1.2   48  $0.2  1/1/2014-12/31/2016 Quarterly in 2017
3/31/15 2017 LTIP Units  2015   137,249   14.66   2.0   45   0.8  1/1/2015-12/31/2017 Quarterly in 2018
4/1/2015 2017 LTIP Units  2015   54,151   14.80   0.8   45   0.3  1/1/2015-12/31/2017 Quarterly in 2018
3/17/2016 2018 LTIP Units  2016   372,069   13.21   4.9   45   3.2  1/1/2016-12/31/2018 Quarterly in 2019
1/1/2017 2019 LTIP Units  2017   399,726   12.61   5.0   48   4.4  1/1/2017-12/31/2019 Quarterly in 2020
TSR PRSUs & LTIP Total      1,098,829  $12.69  $13.9      $8.9     
                             
Relative TSR PRSUs                            
                             
2016 Relative TSR  2014   135,634  $14.24  $1.9   48  $0.2  1/1/2014-12/31/2016 Quarterly in 2017
3/31/15 2017 Relative TSR  2015   137,249   22.50   3.1   45   1.2  1/1/2015-12/31/2017 Quarterly in 2018
4/1/2015 2017 Relative TSR  2015   54,151   22.91   1.2   45   0.5  1/1/2015-12/31/2017 Quarterly in 2018
3/17/2016 2018 Relative TSR  2016   307,480   16.45   5.1   45   3.4  1/1/2016-12/31/2018 Quarterly in 2019
1/1/2017 2019 Relative TSR  2017   285,338   18.04   5.1   48   4.5  1/1/2017-12/31/2019 Quarterly in 2020
Relative TSR PRSUs Total      919,852  $17.78  $16.4      $9.8     
Grand Total      2,447,351  $18.63  $45.6      $25.9     

 

(1)Total compensation costs are net of shares cancelled.

 

Director Restricted Stock Grants

 

As of June 30, 2017, we had 90,421 shares of restricted stock outstanding to directors. The outstanding restricted stock granted to directors prior to 2017 is scheduled to vest ratably over three years from the date of grant. Beginning with the 2017 grants, director restricted stock grants fully vest at the annual meeting following the grant date. As of June 30, 2017, the unrecognized compensation cost associated with outstanding director restricted stock grants is approximately $2.2 million.

XML 52 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
BORROWING ACTIVITIES AND ARRANGEMENTS
6 Months Ended
Jun. 30, 2017
Debt Disclosure [Abstract]  
BORROWING ACTIVITIES AND ARRANGEMENTS

NOTE 13 – BORROWING ACTIVITIES AND ARRANGEMENTS

 

Secured and Unsecured Borrowings

 

The following is a summary of our borrowings:

 

       

Annual Interest
Rate as of

June 30,

  June 30,     December 31,  
    Maturity   2017   2017     2016  
            (in thousands)  
Secured borrowings:                        
HUD mortgages assumed December 2011(1)   2044   3.06%   $ 54,316     $ 54,954  
Deferred financing costs – net             (579 )     (589 )
Total secured borrowings – net(2)             53,737       54,365  
                         
Unsecured borrowings:                        
Revolving line of credit   2021   2.47%     155,000       190,000  
                         
                         
Tranche A-1 term loan   -   -           200,000  
Tranche A-2 term loan   -   -           200,000  
Tranche A-3 term loan   -   -           350,000  
U.S. term loan   2022   2.67%     425,000        
Sterling term loan   2022   1.70%     130,250        
Omega OP term loan(2)   2022   2.67%     100,000       100,000  
2015 term loan   2022   3.80%     250,000       250,000  
Discounts and deferred financing costs – net(3)             (5,958 )     (5,657 )
Total term loans – net             899,292       1,094,343  
                         
2023 notes   2023   4.375%     700,000       700,000  
2024 notes   2024   5.875%           400,000  
2024 notes   2024   4.95%     400,000       400,000  
2025 notes   2025   4.50%     400,000       250,000  
2026 notes   2026   5.25%     600,000       600,000  
2027 notes   2027   4.50%     700,000       700,000  
2028 notes   2028   4.75%     550,000        
Other   2018   -     1,500       3,000  
Subordinated debt   2021   9.00%     20,000       20,000  
Discount - net             (22,345 )     (17,151 )
Deferred financing costs – net             (27,297 )     (27,703 )
Total unsecured borrowings – net             3,321,858       3,028,146  
                         
Total secured and unsecured borrowings – net           $ 4,429,887     $ 4,366,854  

 

(1) Reflects the weighted average annual contractual interest rate on the mortgages at June 30, 2017 excluding a third-party administration fee of approximately 0.5% annually. Secured by real estate assets with a net carrying value of $63.9 million as of June 30, 2017.
(2) These amounts represent borrowings that were incurred by Omega OP or wholly owned subsidiaries of Omega OP.
(3) This amount includes $0.6 million of net deferred financing costs related to the Omega OP term loan as of June 30, 2017.

 

Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants. As of June 30, 2017 and December 31, 2016, we were in compliance with all affirmative and negative covenants, including financial covenants, for our secured and unsecured borrowings. OHI Holdco and Omega OP, the guarantors of Parent’s outstanding senior notes, do not directly own any substantive assets other than OHI Holdco’s interest in Omega OP and Omega OP’s interest in non-guarantor subsidiaries.

 

New and Amended Unsecured Credit Facility – 2017

 

2017 Omega Credit Facilities

 

On May 25, 2017, Omega entered into a credit agreement (the “2017 Omega Credit Agreement”) providing us with a new $1.8 billion senior unsecured revolving and term loan credit facility, consisting of a $1.25 billion senior unsecured multicurrency revolving credit facility (the “Revolving Credit Facility”), a $425 million senior unsecured U.S. Dollar term loan facility (the “U.S. Term Loan Facility”), and a £100 million senior unsecured British Pound Sterling term loan facility (the “Sterling Term Loan Facility” and, together with the Revolving Credit Facility and the U.S. Term Loan Facility, collectively, the “2017 Omega Credit Facilities”). The 2017 Omega Credit Agreement contains an accordion feature permitting us, subject to compliance with customary conditions, to increase the maximum aggregate commitments under the 2017 Omega Credit Facilities to $2.5 billion.

 

The 2017 Omega Credit Facilities replace the previous $1.25 billion senior unsecured 2014 revolving credit facility, the previous $200 million Tranche A-1 senior unsecured term loan facility, and the previous $350 million Tranche A-3 senior unsecured incremental term loan facility established under our 2014 credit agreement, which has been terminated (the “2014 Omega Credit Agreement”). We had previously repaid and terminated the $200 million Tranche A-2 senior unsecured term loan facility established under the 2014 Omega Credit Agreement, with proceeds from our $550 million and $150 million unsecured senior notes issued in April 2017.

 

The Revolving Credit Facility bears interest at LIBOR plus an applicable percentage (with a range of 100 to 195 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The Revolving Credit Facility matures on May 25, 2021, subject to an option by us to extend such maturity date for two, six month periods. The 2017 Omega Credit Agreement provides for the Revolving Credit Facility to be drawn in Euros, British Pounds Sterling, Canadian Dollars (collectively, “Alternative Currencies”) or U.S. Dollars, with a $900 million tranche available in U.S. Dollars and a $350 million tranche available in U.S. Dollars or Alternative Currencies. For purposes of the 2017 Omega Credit Facilities, references to LIBOR include the Canadian dealer offered rates for amounts offered in Canadian Dollars and any other Alternative Currency rate approved in accordance with the terms of the 2017 Omega Credit Agreement for amounts offered in any other non-London interbank offered rate quoted currency, as applicable.

 

The U.S. Term Loan Facility and the Sterling Term Loan Facility bear interest at LIBOR plus an applicable percentage (with a range of 90 to 190 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The U.S. Term Loan Facility and the Sterling Term Loan Facility each mature on May 25, 2022.

 

For the three month period ending June 30, 2017, we recorded a one-time, non-cash charge of approximately $5.5 million relating to the write-off of deferred financing costs associated with the termination of the 2014 Omega Credit Facilities.

 

Amended 2015 Term Loan Facility

 

On May 25, 2017, Omega entered into an amended and restated credit agreement (the “Amended 2015 Credit Agreement”), which amended and restated our previous $250 million senior unsecured term loan facility (the “Amended 2015 Term Loan Facility”). The Amended 2015 Term Loan Facility bears interest at LIBOR plus an applicable percentage (with a range of 140 to 235 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The Amended 2015 Term Loan Facility continues to mature on December 16, 2022. The Amended 2015 Credit Agreement permits us, subject to compliance with customary conditions, to add one or more incremental tranches to the Amended 2015 Term Loan Facility in an aggregate principal amount not exceeding $150 million.

 

Omega’s obligations under the 2017 Omega Credit Facilities and the Amended 2015 Term Loan Facility are jointly and severally guaranteed by Omega OP, OHI Holdco, and any domestic subsidiary of Omega that provides a guaranty of any unsecured indebtedness of Omega for borrowed money evidenced by bonds, debentures, notes or other similar instruments in an amount of at least $50 million individually or in the aggregate.

 

2017 Omega OP Term Loan Facility

 

On May 25, 2017, Omega OP entered into a credit agreement (the “2017 Omega OP Credit Agreement”) providing it with a new $100 million senior unsecured term loan facility (the “2017 Omega OP Term Loan Facility”). The 2017 Omega OP Credit Agreement replaces the $100 million senior unsecured term loan facility obtained in 2015 (the “2015 Omega OP Term Loan Facility”) and the related credit agreement (the “2015 Omega OP Credit Agreement”). The 2017 Omega OP Term Loan Facility bears interest at LIBOR plus an applicable percentage (with a range of 90 to 190 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The 2017 Omega OP Term Loan Facility matures on May 25, 2022.

 

Omega OP’s obligations in connection with the 2017 Omega OP Term Loan Facility are not currently guaranteed, but will be jointly and severally guaranteed by any domestic subsidiary of Omega OP that provides a guaranty of any unsecured indebtedness of Omega or Omega OP for borrowed money evidenced by bonds, debentures, notes or other similar instruments in an amount of at least $50 million individually or in the aggregate.

 

$550 Million 4.75% Senior Notes and $150 Million 4.5% Senior Notes

 

On April 4, 2017, Omega issued (i) $550 million aggregate principal amount of our 4.75% Senior Notes due 2028 (the “2028 Notes”) and (ii) an additional $150 million aggregate principal amount of our existing 4.50% Senior Notes due 2025 (the “2025 Notes”, and together with the 2028 Notes collectively, the “Notes”). The 2028 Notes mature on January 15, 2028 and the 2025 Notes mature on January 15, 2025.

 

The 2028 Notes were sold at an issue price of 98.978% of their face value before the underwriters’ discount and the 2025 Notes were sold at an issue price of 99.540% of their face value before the underwriters’ discount. Our net proceeds from the Notes offering, after deducting underwriting discounts and expenses, were approximately $690.7 million. The net proceeds from the Notes offering were used to (i) redeem all of our outstanding $400 million aggregate principal amount of 5.875% Senior Notes due 2024 (the “5.875% Notes”) on April 28, 2017, (ii) prepay the $200 million Tranche A-2 Term Loan Facility on April 5, 2017 that otherwise would have become due on June 27, 2017, and (iii) repay outstanding borrowings under our revolving credit facility.

 

$400 Million 5.875% Senior Notes Redemption

 

On April 28, 2017, Omega redeemed all of our outstanding 5.875% Notes. As a result of the redemption, during the second quarter of 2017, we recorded approximately $16.5 million in redemption related costs and write-offs, including $11.8 million for the call premium and $4.7 million in net write-offs associated with unamortized deferred financing costs.

XML 53 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS
6 Months Ended
Jun. 30, 2017
Fair Value Disclosures [Abstract]  
FINANCIAL INSTRUMENTS

NOTE 14 – FINANCIAL INSTRUMENTS

 

The carrying amount of cash and cash equivalents, restricted cash and accounts receivable reported in the Consolidated Balance Sheets approximates fair value because of the short maturity of these instruments (i.e., less than 90 days) (Level 1).

 

At June 30, 2017 and December 31, 2016, the carrying amounts and fair values of our other financial instruments were as follows:

 

    June 30, 2017     December 31, 2016  
   

Carrying

Amount

   

Fair

Value

   

Carrying

Amount

   

Fair

Value

 
    (in thousands)  
Assets:                                
Investments in direct financing leases – net   $ 582,307     $ 578,998     $ 601,938     $ 598,665  
Mortgage notes receivable – net     662,709       676,396       639,343       644,961  
Other investments – net     278,985       271,306       256,846       253,385  
Total   $ 1,524,001     $ 1,526,700     $ 1,498,127     $ 1,497,011  
Liabilities:                                
Revolving line of credit   $ 155,000     $ 155,000     $ 190,000     $ 190,000  
Tranche A-1 term loan                 198,830       200,000  
Tranche A-2 term loan                 200,000       200,000  
Tranche A-3 term loan                 347,449       350,000  
U.S. term loan     422,280       425,000              
Sterling term loan     129,413       130,250              
Omega OP term loan(1)     99,373       100,000       100,000       100,000  
2015 term loan     248,226       250,000       248,064       250,000  
4.375% notes due 2023 – net     692,890       723,805       692,305       693,505  
5.875% notes due 2024 – net                 395,065       432,938  
4.95% notes due 2024 – net     393,175       421,504       392,669       406,361  
4.50% notes due 2025 – net     394,368       361,983       245,949       249,075  
5.25% notes due 2026 – net     593,969       641,199       593,616       611,461  
4.50% notes due 2027 – net     685,784       703,514       685,052       681,978  
4.75% notes due 2028 – net     539,741       557,520              
HUD debt – net(1)     53,737       52,535       54,365       52,510  
Subordinated debt – net     20,431       24,045       20,490       23,944  
Other     1,500       1,500       3,000       3,000  
Total   $ 4,429,887     $ 4,547,855     $ 4,366,854     $ 4,444,772  

 

(1) These amounts represent borrowings that were incurred by Omega OP or wholly owned subsidiaries of Omega OP.

 

Fair value estimates are subjective in nature and are dependent on a number of important assumptions, including estimates of future cash flows, risks, discount rates and relevant comparable market information associated with each financial instrument (see Note 2 – Summary of Significant Accounting Policies in our Annual Report on Form 10-K for the year ended December 31, 2016, as amended). The use of different market assumptions and estimation methodologies may have a material effect on the reported estimated fair value amounts.

 

The following methods and assumptions were used in estimating fair value disclosures for financial instruments.

 

· Direct financing leases: The fair value of the investments in direct financing leases are estimated using a discounted cash flow analysis, using interest rates being offered for similar leases to borrowers with similar credit ratings (Level 3).

 

· Mortgage notes receivable: The fair value of the mortgage notes receivables are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).

 

· Other investments: Other investments are primarily comprised of notes receivable. The fair values of notes receivable are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).

 

· Revolving line of credit and term loans: The fair value of our borrowings under variable rate agreements are estimated using a present value technique based on expected cash flows discounted using the current market rates (Level 3).

 

· Senior notes and subordinated debt: The fair value of our borrowings under fixed rate agreements are estimated using a present value technique based on inputs from trading activity provided by a third party (Level 2).

 

· HUD debt: The fair value of our borrowings under HUD debt agreements are estimated using an expected present value technique based on quotes obtained by HUD debt brokers (Level 2).
XML 54 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
LITIGATION
6 Months Ended
Jun. 30, 2017
Commitments and Contingencies Disclosure [Abstract]  
LITIGATION

NOTE 15 – LITIGATION

 

We are subject to various legal proceedings, claims and other actions arising out of the normal course of business. While any legal proceeding or claim has an element of uncertainty, management believes that the outcome of each lawsuit, claim or legal proceeding that is pending or threatened, or all of them combined, will not have a material adverse effect on our consolidated financial position or results of operations.

XML 55 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
EARNINGS PER SHARE/UNIT
6 Months Ended
Jun. 30, 2017
Net Income Available To Common Per Share  
EARNINGS PER SHARE/UNIT

NOTE 16 – EARNINGS PER SHARE/UNIT

 

The computation of basic earnings per share/unit (“EPS” or “EPU”) is computed by dividing net income available to common stockholders/Omega OP Unit holders by the weighted-average number of shares of common stock/Omega OP Units outstanding during the relevant period. Diluted EPS/EPU is computed using the treasury stock method, which is net income divided by the total weighted-average number of common outstanding shares/Omega OP Units plus the effect of dilutive common equivalent shares/units during the respective period. Dilutive common shares/Omega OP Units reflect the assumed issuance of additional common shares pursuant to certain of our share-based compensation plans, including stock options, restricted stock and performance restricted stock units and the assumed issuance of additional shares related to Omega OP Units held by outside investors. Dilutive Omega OP Units reflect the assumed issuance of additional Omega OP Units pursuant to certain of our share-based compensation plans, including stock options, restricted stock and performance restricted stock. No per share information was provided for OHI Holdco because the sole stockholder is Omega. OHI Holdco is a wholly owned subsidiary of Omega and has 1,000 shares of $0.01 par value per share common stock outstanding.

 

The following tables set forth the computation of basic and diluted earnings per share/unit:

 

    Omega  
   

Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
    2017     2016     2017     2016  
    (in thousands, except per share amounts)  
Numerator:                                
Net income   $ 68,157     $ 113,154     $ 177,269     $ 171,350  
Less: net income attributable to noncontrolling interests     (2,900 )     (5,102 )     (7,572 )     (7,743 )
Net income available to common stockholders   $ 65,257     $ 108,052     $ 169,697     $ 163,607  
                                 
Denominator:                                
Denominator for basic earnings per share     197,433       188,981       197,223       188,604  
Effect of dilutive securities:                                
Common stock equivalents     467       1,254       407       1,215  
Noncontrolling interest – Omega OP Units     8,772       8,922       8,793       8,935  
Denominator for diluted earnings per share     206,672       199,157       206,423       198,754  
                                 
Earnings per share – basic:                                
Net income available to common stockholders   $ 0.33     $ 0.57     $ 0.86     $ 0.87  
Earnings per share – diluted:                                
Net income   $ 0.33     $ 0.57     $ 0.86     $ 0.86  

 

    Omega OP  
   

Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
    2017     2016     2017     2016  
    (in thousands, except per share amounts)  
Numerator:                                
Net income   $ 68,157     $ 113,154     $ 177,269     $ 171,350  
                                 
Denominator:                                
Denominator for basic earnings per unit     206,205       197,903       206,016       197,539  
Effect of dilutive securities:                                
Omega OP Unit equivalents     467       1,254       407       1,215  
Denominator for diluted earnings per unit     206,672       199,157       206,423       198,754  
                                 
Earnings per unit – basic:                                
Net income available to Omega OP Unit holders   $ 0.33     $ 0.57     $ 0.86     $ 0.87  
Earnings per unit – diluted:                                
Net income   $ 0.33     $ 0.57     $ 0.86     $ 0.86  
XML 56 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Jun. 30, 2017
Organization, Consolidation and Presentation Of Financial Statements [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the interim periods reported herein are not necessarily indicative of results to be expected for the full year. These unaudited consolidated financial statements should be read in conjunction with the financial statements and the footnotes thereto included in our Form 10-K/A filed with the SEC on August 9, 2017.

 

Our consolidated financial statements include the accounts of (i) Omega, (ii) OHI Holdco, (iii) Omega OP, and (iv) all direct and indirect wholly owned subsidiaries of Omega. All intercompany transactions and balances have been eliminated in consolidationand our net earnings are reduced by the portion of net earnings attributable to noncontrolling interests.

Asset Impairment

Asset Impairment

 

Management evaluates our real estate investments for impairment indicators at each reporting period, including the evaluation of our assets’ useful lives. The judgment regarding the existence of impairment indicators is based on factors such as, but not limited to, market conditions, operator performance, legal structure, as well as our intent with respect to holding or disposing of the asset. If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows based on our intended use of the property are determined to be less than the carrying values of the assets. An adjustment is made to the net carrying value of the real estate investments for the excess of carrying value over fair value. The fair value of the real estate investment is determined based on current market conditions and consider matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. Additionally, our evaluation of fair value may consider valuing the property as a nursing home as well as alternative uses. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset. Management’s impairment evaluation process, and when applicable, impairment calculations involve estimation of the future cash flows from management’s intended use of the property. Changes in the facts and circumstances that drive management’s assumptions may result in an impairment of the Company’s assets in a future period that could be material to the Company’s results of operations.

 

For the three and six months ended June 30, 2017 and 2016, we recognized impairment losses of $10.1 million, $17.8 million, $6.9 million and $41.5 million, respectively. For additional information see Note 2 – Properties and Investments.

Goodwill Impairment

Goodwill Impairment

 

We assess goodwill for potential impairment during the fourth quarter of each fiscal year, or during the year if an event or other circumstance indicates that we may not be able to recover the carrying amount of the net assets of the reporting unit. In evaluating goodwill for impairment on an interim basis, we assess qualitative factors such as a significant decline in real estate valuations, current macroeconomic conditions, state of the equity and capital markets and our overall financial and operating performance or a significant decline in the value of our market capitalization, to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of the reporting unit is less than its carrying amount. On an annual basis during the fourth quarter of each fiscal year, or on an interim basis if we conclude it is more likely than not that the fair value of the reporting unit is less than its carrying value, we perform a two-step goodwill impairment test to identify potential impairment and measure the amount of impairment we will recognize, if any.

Noncontrolling Interests

Noncontrolling Interests

 

Noncontrolling interests is the portion of equity not attributable to the respective reporting entity. We present the portion of any equity that we do not own in consolidated entities as noncontrolling interests and classify those interests as a component of total equity, separate from total stockholders’ equity, or owners’ equity on our Consolidated Balance Sheets. We include net income attributable to the noncontrolling interests in net income in our Consolidated Statements of Income.

 

As our ownership of a controlled subsidiary increases or decreases, any difference between the aggregate consideration paid to acquire the noncontrolling interests and our noncontrolling interest balance is recorded as a component of equity in additional paid-in capital, so long as we maintain a controlling ownership interest.

 

The noncontrolling interest for Omega represents the outstanding Omega OP Units held by outside investors. The noncontrolling interest for OHI Holdco represents the Omega OP Units held by the Parent and the outstanding Omega OP Units held by outside investors.

Foreign Operations

Foreign Operations

 

The U.S. dollar is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound. For our consolidated subsidiaries whose functional currency is not the U.S. dollar, we translate their financial statements into the U.S. dollar. We translate assets and liabilities at the exchange rate in effect as of the financial statement date. Revenue and expense accounts are translated using an average exchange rate for the period. Gains and losses resulting from translation are included in accumulated other comprehensive loss (“AOCL”), as a separate component of equity and a proportionate amount of gain or loss is allocated to noncontrolling interests.

 

We and certain of our consolidated subsidiaries may have intercompany and third-party debt that is not denominated in the entity’s functional currency. When the debt is remeasured against the functional currency of the entity, a gain or loss can result. The resulting adjustment is reflected in results of operations, unless it is intercompany debt that is deemed to be long-term in nature and then the adjustments are included in AOCL.

Derivative Instruments

Derivative Instruments

 

Cash flow hedges

 

During our normal course of business, we may use certain types of derivative instruments for the purpose of managing interest rate and currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at the inception of a qualifying cash flow hedging relationship, the underlying transaction or transactions, must be, and are expected to remain, probable of occurring in accordance with the Company’s related assertions. The Company recognizes all derivative instruments, including embedded derivatives required to be bifurcated, as assets or liabilities in the Consolidated Balance Sheets at their fair value which are determined using a market approach and Level 2 inputs. Changes in the fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria of hedge accounting are recognized in earnings. For derivatives designated as qualifying cash flow hedging relationships, the change in fair value of the effective portion of the derivatives is recognized in AOCL as a separate component of equity and a proportionate amount of gain or loss is allocated to noncontrolling interest, whereas the change in fair value of the ineffective portion is recognized in earnings. We formally document all relationships between hedging instruments and hedged items, as well as our risk-management objectives and strategy for undertaking various hedge transactions. This process includes designating all derivatives that are part of a hedging relationship to specific forecasted transactions as well as recognized obligations or assets in the Consolidated Balance Sheets. We also assess and document, both at inception of the hedging relationship and on a quarterly basis thereafter, whether the derivatives are highly effective in offsetting the designated risks associated with the respective hedged items. If it is determined that a derivative ceases to be highly effective as a hedge, or that it is probable the underlying forecasted transaction will not occur, we discontinue hedge accounting prospectively and record the appropriate adjustment to earnings based on the current fair value of the derivative. As a matter of policy, we do not use derivatives for trading or speculative purposes. At June 30, 2017 and December 31, 2016, we had $1.4 million and $1.5 million, respectively, of qualifying cash flow hedges recorded at fair value in accrued expenses and other liabilities on our Consolidated Balance Sheets.

 

Net investment hedge

 

We use the spot method to measure the effectiveness of our net investment hedge. Under this method, for each reporting period, the change in the carrying value of the hedging instrument due to remeasurement of the effective portion is reported in AOCL in our Consolidated Balance Sheets and the remaining change in the carrying value of the ineffective portion, if any, is recognized in earnings. We evaluate the effectiveness of our net investment hedge on a quarterly basis. We did not record any ineffectiveness for fiscal 2017.

Accounts Receivable

Accounts Receivable

 

Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts. Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements. Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line rent receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement. Lease inducements result from value provided by us to the lessee, at the inception or renewal of the lease, and are amortized as a reduction of rental revenue over the non-cancellable lease term.

 

At June 30, 2017, two of our top 10 operators were approximately 90 days past due on rent payments to the Company. On a quarterly basis, we review our accounts receivable to determine their collectability. The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement.  If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance. In the case of a lease recognized on a straight-line basis, a mortgage recognized on an effective yield basis or the existence of lease inducements, we generally provide an allowance for straight-line, effective interest, and/or lease inducement accounts receivable when certain conditions or indicators of adverse collectability are present. If the accounts receivable balance is subsequently deemed uncollectible, the receivable and allowance for doubtful account balance are written off.

  

A summary of our net receivables by type is as follows:

 

    June 30,     December 31,  
    2017     2016  
    (in thousands)  
             
Contractual receivables   $ 40,484     $ 13,376  
Effective yield interest receivables     10,940       9,749  
Straight-line rent receivables     231,233       208,874  
Lease inducements     7,498       8,393  
Allowance     (1,469 )     (357 )
Accounts receivable – net   $ 288,686     $ 240,035  
 
Related Party Transactions

Related Party Transactions

 

The Company has a policy which generally requires related party transactions to be approved or ratified by the Audit Committee. On February 1, 2016, we acquired 10 SNFs from Laurel Healthcare Holdings, Inc. (“Laurel”) for approximately $169.0 million in cash and leased them to an unrelated existing operator. A former member of the Board of Directors of the Company, together with certain members of his immediate family, beneficially owned approximately 34% of the equity of Laurel prior to the transaction. Immediately following our acquisition, the unrelated existing operator acquired all of the outstanding equity interests of Laurel, including the interests previously held by the former director of the Company and his family.

Accounting Pronouncement Adopted in 2017

Accounting Pronouncement Adopted in 2017

 

In March 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-09, Compensation-Stock Compensation (Topic 718) (“ASU 2016-09”). ASU 2016-09 amends the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. This guidance is effective for annual and interim reporting periods of public entities beginning after December 15, 2016. We adopted this accounting standard on January 1, 2017, at which time the Company began prospectively accounting for excess tax benefits or tax deficiencies as an adjustment to income tax expense in our Consolidated Statements of Income as opposed to the prior requirement that these excess tax benefits be recognized in additional paid-in capital and tax deficiencies be recognized either as an offset to accumulated excess tax benefits, if any, or in the income statement. The Company will continue to account for forfeitures as they occur and present employee taxes paid as a financing activity on our Consolidated Statements of Cash Flows. The adoption of this accounting standard did not have a material impact on our consolidated financial statements.

Recent Accounting Pronouncements - Pending Adoption

Recent Accounting Pronouncements - Pending Adoption

 

In 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), which outlines a comprehensive model for entities to use in accounting for revenue arising from contracts with customers. ASU 2014-09 states that “an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.” While ASU 2014-09 specifically references contracts with customers, it may apply to certain other transactions such as the sale of real estate or equipment. ASU 2014-09 is effective for the Company beginning January 1, 2018. In addition, the FASB has begun to issue targeted updates to clarify specific implementation issues of ASU 2014-09. These updates include ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU 2016-10, Identifying Performance Obligations and Licensing, and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients. The Company is currently evaluating the provisions of ASU 2014-09 and its related updates and will be closely monitoring developments and additional guidance to determine the potential impact of the new standard. The Company intends to adopt ASU 2014-09 and its subsequent updates in accordance with the modified retrospective approach. We do not expect the adoption of ASU 2014-09 and its updates to have a significant impact on our consolidated financial statements, as a substantial portion of our revenue consists of rental income from leasing arrangements and interest income from loan arrangements, both of which are specifically excluded from ASU 2014-09.

 

In February 2016, the FASB issued ASU 2016-02, Leases (“ASU 2016-02”), which amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. ASU 2016-02 will be effective for the Company beginning January 1, 2019. Early adoption of ASU 2016-02 as of its issuance is permitted. The new standard requires a modified retrospective transition approach for all leases existing at, or entered into after, the date of initial application, with an option to use certain transition relief. As a result of the pending adoption ASU 2016-02 and in connection with the pending adoption of ASU 2014-09, the Company may be required to record real estate tax revenues and an equal an offsetting real estate tax expense, as a result of our operators paying real estate taxes on our behalf. We are continuing to evaluate the other impacts of adopting ASU 2016-02 on our consolidated financial statements.

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) (“ASU 2016-13”), which changes the impairment model for most financial assets. The new model uses a forward-looking expected loss method, which will generally result in earlier recognition of allowances for losses. ASU 2016-13 is effective for annual and interim periods beginning after December 15, 2019 and early adoption is permitted for annual and interim periods beginning after December 15, 2018. We are currently evaluating the impact of adopting ASU 2016-13 on our consolidated financial statements.

XML 57 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2017
Accounting Policies [Abstract]  
Schedule of summary of net receivables

 

    June 30,     December 31,  
    2017     2016  
    (in thousands)  
             
Contractual receivables   $ 40,484     $ 13,376  
Effective yield interest receivables     10,940       9,749  
Straight-line rent receivables     231,233       208,874  
Lease inducements     7,498       8,393  
Allowance     (1,469 )     (357 )
Accounts receivable – net   $ 288,686     $ 240,035  
 
XML 58 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
PROPERTIES AND INVESTMENTS (Tables)
6 Months Ended
Jun. 30, 2017
Real Estate [Abstract]  
Schedule of investment in leased real estate properties

 

    June 30,     December 31,  
    2017     2016  
    (in thousands)  
Buildings   $ 6,055,423     $ 5,954,771  
Land     796,561       759,295  
Furniture, fixtures and equipment     458,427       454,760  
Site improvements     204,993       206,206  
Construction in progress     214,795       191,326  
Total real estate investments     7,730,199       7,566,358  
Less accumulated depreciation     (1,366,376 )     (1,240,336 )
Real estate investments - net   $ 6,363,823     $ 6,326,022  
 
Schedule of significant acquisitions
  Number of
Facilities
    Country/   Total
Investment
    Land    

Building & Site 
Improvements

    Furniture 
& Fixtures
    Initial
Annual 
Cash Yield
 
Period   SNF     ALF     State   (in millions)     (2)(%)  
Q1     -       1     VA   $ 7.6     $ 0.5     $ 6.8     $ 0.3       7.50  
Q2     1       -     NC     8.6       0.7       7.3       0.6       9.50  
Q2     -       18     UK     124.2   (1)     34.1       85.1       5.0       8.50  
Total     1       19         $ 140.4     $ 35.3     $ 99.2     $ 5.9          

 

(1) Omega recorded a non-cash deferred tax liability and acquisitions costs of approximately $8.2 million and $1.2 million, respectively, in connection with this acquisition.
(2) The cash yield is based on the purchase price.
XML 59 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
DIRECT FINANCING LEASES (Tables)
6 Months Ended
Jun. 30, 2017
Leases, Capital [Abstract]  
Schedule of components of investment in direct financing leases

 

    June 30,     December 31,  
    2017     2016  
    (in thousands)  
Minimum lease payments receivable   $ 4,085,493     $ 4,287,069  
Less unearned income     (3,499,877 )     (3,685,131 )
Less allowance for loss on direct financing lease     (3,309 )      
Investment in direct financing leases - net   $ 582,307     $ 601,938  
                 
Properties subject to direct financing leases     53       58  
 
Schedule of rents due under direct financing leases for remainder of 2017 and subsequent five years
201720182019202020212022
$24,407$50,019$51,246$52,493$53,681$55,008
XML 60 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
MORTGAGE NOTES RECEIVABLE (Tables)
6 Months Ended
Jun. 30, 2017
Mortgage Notes Receivable Investments [Abstract]  
Schedule of outstanding principal amounts of mortgage notes receivable, net of allowances
    June 30,     December 31,  
    2017     2016  
    (in thousands)  
             
Mortgage note due 2024; interest at 9.98%   $ 112,500     $ 112,500  
Mortgage note due 2029; interest at 9.45%     411,467       412,140  
Other mortgage notes outstanding (1)     143,489       118,637  
Mortgage notes receivable, gross     667,456       643,277  
Allowance for loss on mortgage notes receivable     (4,747 )     (3,934 )
Total mortgages — net   $ 662,709     $ 639,343  

 

(1) Other mortgage notes outstanding have stated interest rates ranging from 8.35% to 14.0% and maturity dates through 2029.
XML 61 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
OTHER INVESTMENTS (Tables)
6 Months Ended
Jun. 30, 2017
Receivables [Abstract]  
Schedule of other investments
    June 30,     December 31,  
    2017     2016  
    (in thousands)  
             
Other investment note due 2019; interest at 10.96%   $ 49,583     $ 49,458  
Other investment note due 2020; interest at 14.00%     47,899       47,913  
Other investment note due 2022, interest at 9.00%     31,987       31,987  
Other investment note due 2030; interest at 6.66%     50,000       44,595  
Other investment notes outstanding (1)     104,314       87,691  
Other investments, gross     283,783       261,644  
Allowance for loss on other investments     (4,798 )     (4,798 )
Total other investments   $ 278,985     $ 256,846  

 

(1) Other investment notes have maturity dates through 2028 and interest rates ranging from 6.50% to 13.0%.
 
XML 62 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
ASSETS HELD FOR SALE (Tables)
6 Months Ended
Jun. 30, 2017
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]  
Schedule of properties held-for-sale
    Properties Held For Sale  
    Number of
Properties
    Net Book Value
(in thousands)
 
       
December 31, 2016     20     $ 52,868  
Properties sold/other (1)     (12 )     (30,023 )
Properties added (2)     1       400  
March 31, 2017     9     $ 23,245  
Properties sold/other (1)     (2 )     (4,356 )
June 30, 2017(3)     7     $ 18,889  

 

(1) In the first quarter of 2017, we sold nine SNFs and two ALFs for approximately $29.4 million in net proceeds recognizing a gain on sale of approximately $3.6 million. One SNF classified as an asset held for sale at December 31, 2016 was no longer considered held for sale during the first quarter of 2017 and was reclassified back to leased properties at approximately $5.1 million which represents the facility’s then carrying value adjusted for depreciation that was not recognized while classified as held for sale. In the second quarter of 2017, we sold one ALF and one SNF for approximately $5.0 million in net proceeds, generating a gain on sale of approximately $0.6 million.
(2) In the first quarter of 2017, we recorded a $3.5 million impairment to reduce one ALF’s net book value to its estimated fair value less costs to sell before it was reclassified to assets held for sale.
(3) We plan to sell the facilities classified as held for sale at June 30, 2017 within the next twelve months.
XML 63 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
INTANGIBLES (Tables)
6 Months Ended
Jun. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of intangibles
    June 30,     December 31,  
    2017     2016  
    (in thousands)  
Assets:                
Goodwill   $ 644,184     $ 643,474  
                 
Above market leases   $ 22,426     $ 22,476  
In-place leases     167       167  
Accumulated amortization     (16,477 )     (15,864 )
Net intangible assets   $ 6,116     $ 6,779  
                 
Liabilities:                
Below market leases   $ 164,735     $ 165,028  
Accumulated amortization     (77,534 )     (70,738 )
Net intangible liabilities   $ 87,201     $ 94,290  
 
Schedule of reconciliation of goodwill
  (in thousands) 
Balance as of December 31, 2016 $643,474 
Add: foreign currency translation  710 
Balance as of June 30, 2017 $644,184 
XML 64 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCKHOLDERS'/OWNERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2017
Stockholders' Equity Note [Abstract]  
Schedule of accumulated other comprehensive loss
    Omega  
    As of and For the Three
Months Ended June 30,
    As of and For the Six
Months Ended June 30,
 
    2017     2016     2017     2016  
    (in thousands)  
                                 
Foreign Currency Translation:                                
Beginning balance   $ (50,614 )   $ (13,143 )   $ (54,948 )   $ (8,413 )
Translation gain (loss)     10,195       (21,836 )     14,468       (26,544 )
Realized gain (loss)     79       -       140       (22 )
Ending balance     (40,340 )     (34,979 )     (40,340 )     (34,979 )
                                 
Derivative Instruments:                                
Cash flow hedges:                                
Beginning balance     (166 )     (9,594 )     (1,420 )     (718 )
Unrealized loss     (1,840 )     (4,198 )     (1,350 )     (13,074 )
Realized gain     626       -       1,390       -  
Ending balance     (1,380 )     (13,792 )     (1,380 )     (13,792 )
Net investment hedge:                                
Beginning balance     -       -       -       -  
Unrealized loss     (2,193 )     -       (2,193 )     -  
Ending balance     (2,193 )     -       (2,193 )     -  
                                 
Total accumulated other comprehensive loss     (43,913 )     (48,771 )     (43,913 )     (48,771 )
Add: portion included in noncontrolling interest     2,010       2,308       2,010       2,308  
                                 
Total accumulated other comprehensive loss   $ (41,903 )   $ (46,463 )   $ (41,903 )   $ (46,463 )

 

    OHI Holdco  
    As of and For the Three
Months Ended June 30,
    As of and For the Six
Months Ended June 30,
 
    2017     2016     2017     2016  
    (in thousands)  
                                 
Foreign Currency Translation:                                
Beginning balance   $ (50,614 )   $ (13,143 )   $ (54,948 )   $ (8,413 )
Translation gain (loss)     10,195       (21,836 )     14,468       (26,544 )
Realized gain (loss)     79       -       140       (22 )
Ending balance     (40,340 )     (34,979 )     (40,340 )     (34,979 )
                                 
Derivative Instruments:                                
Cash flow hedges:                                
Beginning balance     (166 )     (9,594 )     (1,420 )     (718 )
Unrealized loss     (1,840 )     (4,198 )     (1,350 )     (13,074 )
Realized gain     626       -       1,390       -  
Ending balance     (1,380 )     (13,792 )     (1,380 )     (13,792 )
Net investment hedge:                                
Beginning balance     -       -       -       -  
Unrealized loss     (2,193 )     -       (2,193 )     -  
Ending balance     (2,193 )     -       (2,193 )     -  
                                 
Total accumulated other comprehensive loss     (43,913 )     (48,771 )     (43,913 )     (48,771 )
Add: portion included in noncontrolling interest     34,116       37,965       34,116       37,965  
                                 
Total accumulated other comprehensive loss   $ (9,797 )   $ (10,806 )   $ (9,797 )   $ (10,806 )

 

    Omega OP  
    As of and For the Three
Months Ended June 30,
    As of and For the Six
Months Ended June 30,
 
    2017     2016     2017     2016  
    (in thousands)  
                                 
Foreign Currency Translation:                                
Beginning balance   $ (50,614 )   $ (13,143 )   $ (54,948 )   $ (8,413 )
Translation gain (loss)     10,195       (21,836 )     14,468       (26,544 )
Realized gain (loss)     79       -       140       (22 )
Ending balance     (40,340 )     (34,979 )     (40,340 )     (34,979 )
                                 
Derivative Instruments:                                
Cash flow hedges:                                
Beginning balance     (166 )     (9,594 )     (1,420 )     (718 )
Unrealized loss     (1,840 )     (4,198 )     (1,350 )     (13,074 )
Realized gain     626       -       1,390       -  
Ending balance     (1,380 )     (13,792 )     (1,380 )     (13,792 )
Net investment hedge:                                
Beginning balance     -       -       -       -  
Unrealized loss     (2,193 )     -       (2,193 )     -  
Ending balance     (2,193 )     -       (2,193 )     -  
                                 
Total accumulated other comprehensive loss   $ (43,913 )   $ (48,771 )   $ (43,913 )   $ (48,771 )
XML 65 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2017
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
Schedule of stock-based compensation expense
  Three Months Ended 
June 30,
  

Six Months Ended

June 30,

 
  2017  2016  2017  2016 
  (in thousands) 
                 
Stock-based compensation expense $3,734  $3,665  $7,478  $6,443 
Schedule of unrecognized compensation cost associated with outstanding restricted stock and PRSU awards and LTIP Unit awards
  Grant 
Year
 Shares/ Units  Grant Date 
Average 
Fair Value 
Per Unit/ 
Share
  Total 
Compensation
Cost (in millions)
(1)
  Weighted 
Average 
Period of 
Expense 
Recognition
(in months)
  Unrecognized 
Compensation 
Cost (in 
millions)
  Performance 
Period
 Vesting 
Dates
RSUs                          
                           
3/31/15 RSU 2015  109,985  $40.57  $4.5   33  $0.8  N/A 12/31/2017
4/1/15 RSU 2015  40,464   40.74   1.6   33   0.3  N/A 12/31/2017
Assumed Aviv RSU 2015  7,799   35.08   0.3   33   0.1  N/A 11/1/2017
3/17/16  RSU 2016  130,006   34.78   4.6   33   2.4  N/A 12/31/2018
1/1/2017  RSU 2017  140,416   31.26   4.3   36   3.6  N/A 12/31/2019
Restricted Stock Units Total    428,670  $35.68  $15.3      $7.2     
                           
TSR PRSUs and LTIP Units                          
                           
2016 TSR 2014  135,634  $8.67  $1.2   48  $0.2  1/1/2014-12/31/2016 Quarterly in 2017
3/31/15 2017 LTIP Units 2015  137,249   14.66   2.0   45   0.8  1/1/2015-12/31/2017 Quarterly in 2018
4/1/2015 2017 LTIP Units 2015  54,151   14.80   0.8   45   0.3  1/1/2015-12/31/2017 Quarterly in 2018
3/17/2016 2018 LTIP Units 2016  372,069   13.21   4.9   45   3.2  1/1/2016-12/31/2018 Quarterly in 2019
1/1/2017 2019 LTIP Units 2017  399,726   12.61   5.0   48   4.4  1/1/2017-12/31/2019 Quarterly in 2020
TSR PRSUs & LTIP Total    1,098,829  $12.69  $13.9      $8.9     
                           
Relative TSR PRSUs                          
                           
2016 Relative TSR 2014  135,634  $14.24  $1.9   48  $0.2  1/1/2014-12/31/2016 Quarterly in 2017
3/31/15 2017 Relative TSR 2015  137,249   22.50   3.1   45   1.2  1/1/2015-12/31/2017 Quarterly in 2018
4/1/2015 2017 Relative TSR 2015  54,151   22.91   1.2   45   0.5  1/1/2015-12/31/2017 Quarterly in 2018
3/17/2016 2018 Relative TSR 2016  307,480   16.45   5.1   45   3.4  1/1/2016-12/31/2018 Quarterly in 2019
1/1/2017 2019 Relative TSR 2017  285,338   18.04   5.1   48   4.5  1/1/2017-12/31/2019 Quarterly in 2020
Relative TSR PRSUs Total    919,852  $17.78  $16.4      $9.8     
Grand Total    2,447,351  $18.63  $45.6      $25.9     
(1)Total compensation costs are net of shares cancelled.
XML 66 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
BORROWING ACTIVITIES AND ARRANGEMENTS (Tables)
6 Months Ended
Jun. 30, 2017
Debt Disclosure [Abstract]  
Schedule of borrowings
       

Annual Interest
Rate as of

June 30,

  June 30,     December 31,  
    Maturity   2017   2017     2016  
            (in thousands)  
Secured borrowings:                        
HUD mortgages assumed December 2011(1)   2044   3.06%   $ 54,316     $ 54,954  
Deferred financing costs – net             (579 )     (589 )
Total secured borrowings – net(2)             53,737       54,365  
                         
Unsecured borrowings:                        
Revolving line of credit   2021   2.47%     155,000       190,000  
                         
                         
Tranche A-1 term loan   -   -           200,000  
Tranche A-2 term loan   -   -           200,000  
Tranche A-3 term loan   -   -           350,000  
U.S. term loan   2022   2.67%     425,000        
Sterling term loan   2022   1.70%     130,250        
Omega OP term loan(2)   2022   2.67%     100,000       100,000  
2015 term loan   2022   3.80%     250,000       250,000  
Discounts and deferred financing costs – net(3)             (5,958 )     (5,657 )
Total term loans – net             899,292       1,094,343  
                         
2023 notes   2023   4.375%     700,000       700,000  
2024 notes   2024   5.875%           400,000  
2024 notes   2024   4.95%     400,000       400,000  
2025 notes   2025   4.50%     400,000       250,000  
2026 notes   2026   5.25%     600,000       600,000  
2027 notes   2027   4.50%     700,000       700,000  
2028 notes   2028   4.75%     550,000        
Other   2018   -     1,500       3,000  
Subordinated debt   2021   9.00%     20,000       20,000  
Discount - net             (22,345 )     (17,151 )
Deferred financing costs – net             (27,297 )     (27,703 )
Total unsecured borrowings – net             3,321,858       3,028,146  
                         
Total secured and unsecured borrowings – net           $ 4,429,887     $ 4,366,854  

 

(1) Reflects the weighted average annual contractual interest rate on the mortgages at June 30, 2017 excluding a third-party administration fee of approximately 0.5% annually. Secured by real estate assets with a net carrying value of $63.9 million as of June 30, 2017.
(2) These amounts represent borrowings that were incurred by Omega OP or wholly owned subsidiaries of Omega OP.
(3) This amount includes $0.6 million of net deferred financing costs related to the Omega OP term loan as of June 30, 2017.
XML 67 R36.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS (Tables)
6 Months Ended
Jun. 30, 2017
Fair Value Disclosures [Abstract]  
Schedule of the carrying amounts and fair values of financial instruments
    June 30, 2017     December 31, 2016  
   

Carrying

Amount

   

Fair

Value

   

Carrying

Amount

   

Fair

Value

 
    (in thousands)  
Assets:                                
Investments in direct financing leases – net   $ 582,307     $ 578,998     $ 601,938     $ 598,665  
Mortgage notes receivable – net     662,709       676,396       639,343       644,961  
Other investments – net     278,985       271,306       256,846       253,385  
Total   $ 1,524,001     $ 1,526,700     $ 1,498,127     $ 1,497,011  
Liabilities:                                
Revolving line of credit   $ 155,000     $ 155,000     $ 190,000     $ 190,000  
Tranche A-1 term loan                 198,830       200,000  
Tranche A-2 term loan                 200,000       200,000  
Tranche A-3 term loan                 347,449       350,000  
U.S. term loan     422,280       425,000              
Sterling term loan     129,413       130,250              
Omega OP term loan(1)     99,373       100,000       100,000       100,000  
2015 term loan     248,226       250,000       248,064       250,000  
4.375% notes due 2023 – net     692,890       723,805       692,305       693,505  
5.875% notes due 2024 – net                 395,065       432,938  
4.95% notes due 2024 – net     393,175       421,504       392,669       406,361  
4.50% notes due 2025 – net     394,368       361,983       245,949       249,075  
5.25% notes due 2026 – net     593,969       641,199       593,616       611,461  
4.50% notes due 2027 – net     685,784       703,514       685,052       681,978  
4.75% notes due 2028 – net     539,741       557,520              
HUD debt – net(1)     53,737       52,535       54,365       52,510  
Subordinated debt – net     20,431       24,045       20,490       23,944  
Other     1,500       1,500       3,000       3,000  
Total   $ 4,429,887     $ 4,547,855     $ 4,366,854     $ 4,444,772  

 

(1) These amounts represent borrowings that were incurred by Omega OP or wholly owned subsidiaries of Omega OP.
XML 68 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
EARNINGS PER SHARE/UNIT (Tables)
6 Months Ended
Jun. 30, 2017
Net Income Available To Common Per Share  
Schedule of computation of basic and diluted earnings per share
    Omega  
   

Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
    2017     2016     2017     2016  
    (in thousands, except per share amounts)  
Numerator:                                
Net income   $ 68,157     $ 113,154     $ 177,269     $ 171,350  
Less: net income attributable to noncontrolling interests     (2,900 )     (5,102 )     (7,572 )     (7,743 )
Net income available to common stockholders   $ 65,257     $ 108,052     $ 169,697     $ 163,607  
                                 
Denominator:                                
Denominator for basic earnings per share     197,433       188,981       197,223       188,604  
Effect of dilutive securities:                                
Common stock equivalents     467       1,254       407       1,215  
Noncontrolling interest – Omega OP Units     8,772       8,922       8,793       8,935  
Denominator for diluted earnings per share     206,672       199,157       206,423       198,754  
                                 
Earnings per share – basic:                                
Net income available to common stockholders   $ 0.33     $ 0.57     $ 0.86     $ 0.87  
Earnings per share – diluted:                                
Net income   $ 0.33     $ 0.57     $ 0.86     $ 0.86  

 

    Omega OP  
   

Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
    2017     2016     2017     2016  
    (in thousands, except per share amounts)  
Numerator:                                
Net income   $ 68,157     $ 113,154     $ 177,269     $ 171,350  
                                 
Denominator:                                
Denominator for basic earnings per unit     206,205       197,903       206,016       197,539  
Effect of dilutive securities:                                
Omega OP Unit equivalents     467       1,254       407       1,215  
Denominator for diluted earnings per unit     206,672       199,157       206,423       198,754  
                                 
Earnings per unit – basic:                                
Net income available to Omega OP Unit holders   $ 0.33     $ 0.57     $ 0.86     $ 0.87  
Earnings per unit – diluted:                                
Net income   $ 0.33     $ 0.57     $ 0.86     $ 0.86  
XML 69 R38.htm IDEA: XBRL DOCUMENT v3.7.0.1
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Detail) - USD ($)
$ in Thousands
Jun. 30, 2017
Dec. 31, 2016
Organization, Consolidation and Presentation Of Financial Statements [Abstract]    
Contractual receivables $ 40,484 $ 13,376
Effective yield interest receivables 10,940 9,749
Straight-line rent receivables 231,233 208,874
Lease inducements 7,498 8,393
Allowance (1,469) (357)
Accounts receivable - net $ 288,686 $ 240,035
XML 70 R39.htm IDEA: XBRL DOCUMENT v3.7.0.1
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail)
6 Months Ended
Jun. 30, 2017
Segment
Accounting Policies [Abstract]  
Number of reportable segment 1
XML 71 R40.htm IDEA: XBRL DOCUMENT v3.7.0.1
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail 1)
3 Months Ended 6 Months Ended
Feb. 01, 2016
USD ($)
Facility
Jun. 30, 2017
USD ($)
Facility
Healthcare_facility
Mar. 31, 2017
USD ($)
Jun. 30, 2016
USD ($)
Jun. 30, 2017
USD ($)
Facility
Healthcare_facility
Jun. 30, 2016
USD ($)
Dec. 31, 2016
USD ($)
Basis Of Presentation And Significant Accounting Policies [Line Items]              
Impairment losses recognized   $ 10,135,000 $ 7,600,000 $ 6,893,000 $ 17,773,000 $ 41,451,000  
Number of leased real estate properties | Healthcare_facility   999     999    
SNF's              
Basis Of Presentation And Significant Accounting Policies [Line Items]              
Number of leased real estate properties | Facility   803     803    
Cash flow hedges              
Basis Of Presentation And Significant Accounting Policies [Line Items]              
Cash flow hedges recorded at fair value in accrued expenses and other liabilities   $ 1,400,000     $ 1,400,000   $ 1,500,000
Omega OP Units              
Basis Of Presentation And Significant Accounting Policies [Line Items]              
Percentage of limited partnership interests owned   96.00%     96.00%    
Other Investors | Omega OP Units              
Basis Of Presentation And Significant Accounting Policies [Line Items]              
Percentage of limited partnership interests owned   4.00%     4.00%    
Laurel | SNF's              
Basis Of Presentation And Significant Accounting Policies [Line Items]              
Number of leased real estate properties | Facility 10            
Purchase price of buildings acquired paid in cash $ 169,000,000            
Percentage of ownership interest 34.00%            
XML 72 R41.htm IDEA: XBRL DOCUMENT v3.7.0.1
PROPERTIES AND INVESTMENTS - Investment in leased real estate properties (Detail) - USD ($)
$ in Thousands
Jun. 30, 2017
Dec. 31, 2016
Property, Plant and Equipment [Line Items]    
Total real estate investments $ 7,730,199 $ 7,566,358
Less accumulated depreciation (1,366,376) (1,240,336)
Real estate investments - net 6,363,823 6,326,022
Buildings    
Property, Plant and Equipment [Line Items]    
Total real estate investments 6,055,423 5,954,771
Land    
Property, Plant and Equipment [Line Items]    
Total real estate investments 796,561 759,295
Furniture, fixtures and equipment    
Property, Plant and Equipment [Line Items]    
Total real estate investments 458,427 454,760
Site improvements    
Property, Plant and Equipment [Line Items]    
Total real estate investments 204,993 206,206
Construction in progress    
Property, Plant and Equipment [Line Items]    
Total real estate investments $ 214,795 $ 191,326
XML 73 R42.htm IDEA: XBRL DOCUMENT v3.7.0.1
PROPERTIES AND INVESTMENTS - Significant acquisitions that occurred during the first six months of 2017 (Detail 1)
$ in Millions
6 Months Ended
Jun. 30, 2017
USD ($)
Facility
Healthcare_facility
Real Estate Properties [Line Items]  
Number of Facilities | Healthcare_facility 999
SNF's  
Real Estate Properties [Line Items]  
Number of Facilities | Facility 803
ALFs  
Real Estate Properties [Line Items]  
Number of Facilities | Facility 119
2017 acquisitions and other  
Real Estate Properties [Line Items]  
Total Investment $ 140.4
2017 acquisitions and other | Land  
Real Estate Properties [Line Items]  
Total Investment 35.3
2017 acquisitions and other | Building & Site Improvements  
Real Estate Properties [Line Items]  
Total Investment 99.2
2017 acquisitions and other | Furniture & Fixtures  
Real Estate Properties [Line Items]  
Total Investment $ 5.9
2017 acquisitions and other | SNF's  
Real Estate Properties [Line Items]  
Number of Facilities | Facility 1
2017 acquisitions and other | ALFs  
Real Estate Properties [Line Items]  
Number of Facilities | Facility 19
2017 acquisitions and other | Q1 | VA  
Real Estate Properties [Line Items]  
Total Investment $ 7.6
Initial Annual Cash Yield (%) 7.50% [1]
2017 acquisitions and other | Q1 | VA | Land  
Real Estate Properties [Line Items]  
Total Investment $ 0.5
2017 acquisitions and other | Q1 | VA | Building & Site Improvements  
Real Estate Properties [Line Items]  
Total Investment 6.8
2017 acquisitions and other | Q1 | VA | Furniture & Fixtures  
Real Estate Properties [Line Items]  
Total Investment $ 0.3
2017 acquisitions and other | Q1 | ALFs  
Real Estate Properties [Line Items]  
Number of Facilities | Facility 1
2017 acquisitions and other | Q2 | NC  
Real Estate Properties [Line Items]  
Total Investment $ 8.6
Initial Annual Cash Yield (%) 9.50% [1]
2017 acquisitions and other | Q2 | NC | Land  
Real Estate Properties [Line Items]  
Total Investment $ 0.7
2017 acquisitions and other | Q2 | NC | Building & Site Improvements  
Real Estate Properties [Line Items]  
Total Investment 7.3
2017 acquisitions and other | Q2 | NC | Furniture & Fixtures  
Real Estate Properties [Line Items]  
Total Investment 0.6
2017 acquisitions and other | Q2 | UK  
Real Estate Properties [Line Items]  
Total Investment $ 124.2 [2]
Initial Annual Cash Yield (%) 8.50% [1]
2017 acquisitions and other | Q2 | UK | Land  
Real Estate Properties [Line Items]  
Total Investment $ 34.1
2017 acquisitions and other | Q2 | UK | Building & Site Improvements  
Real Estate Properties [Line Items]  
Total Investment 85.1
2017 acquisitions and other | Q2 | UK | Furniture & Fixtures  
Real Estate Properties [Line Items]  
Total Investment $ 5.0
2017 acquisitions and other | Q2 | SNF's  
Real Estate Properties [Line Items]  
Number of Facilities | Facility 1
2017 acquisitions and other | Q2 | ALFs  
Real Estate Properties [Line Items]  
Number of Facilities | Facility 18
[1] The cash yield is based on the purchase price.
[2] Omega recorded a non-cash deferred tax liability and acquisitions costs of approximately $8.2 million and $1.2 million, respectively, in connection with this acquisition.
XML 74 R43.htm IDEA: XBRL DOCUMENT v3.7.0.1
PROPERTIES AND INVESTMENTS (Parentheticals) (Detail 1) - 2017 acquisitions and other - Q2 - UK
$ in Millions
Jun. 30, 2017
USD ($)
Real Estate Properties [Line Items]  
Deferred tax liability $ 8.2
Acquisitions costs $ 1.2
XML 75 R44.htm IDEA: XBRL DOCUMENT v3.7.0.1
PROPERTIES AND INVESTMENTS - Leased Property (Narrative) (Detail)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2017
USD ($)
Facility
Healthcare_facility
Parcel
Jun. 30, 2017
Facility
Healthcare_facility
Real Estate Properties [Line Items]    
Number of real estate properties | Healthcare_facility 999 999
Property available for operating lease | Minimum    
Real Estate Properties [Line Items]    
Lease term   5 years
Increase in the specific annual percentage over the prior year's rent   2.00%
Property available for operating lease | Maximum    
Real Estate Properties [Line Items]    
Lease term   15 years
Increase in the specific annual percentage over the prior year's rent   3.00%
SNF's    
Real Estate Properties [Line Items]    
Number of real estate properties 803 803
ALFs    
Real Estate Properties [Line Items]    
Number of real estate properties 119 119
Specialty facilities    
Real Estate Properties [Line Items]    
Number of real estate properties 16 16
Medical office building    
Real Estate Properties [Line Items]    
Number of real estate properties 1 1
2017 acquisitions and other | SNF's    
Real Estate Properties [Line Items]    
Number of real estate properties 1 1
2017 acquisitions and other | ALFs    
Real Estate Properties [Line Items]    
Number of real estate properties 19 19
2017 acquisitions and other | Land    
Real Estate Properties [Line Items]    
Number of properties acquired | Parcel 2  
Cash payment to acquire facilities | $ $ 5.5  
XML 76 R45.htm IDEA: XBRL DOCUMENT v3.7.0.1
PROPERTIES AND INVESTMENTS - Assets Sold or Held for Sale (Narrative) (Detail 1)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
USD ($)
Facility
Mar. 31, 2017
USD ($)
Facility
Jun. 30, 2016
USD ($)
Jun. 30, 2017
USD ($)
Facility
Jun. 30, 2016
USD ($)
Real Estate [Abstract]          
Number of facilities sold 3 15   3  
Total cash proceeds | $ $ 18,300 $ 45,800      
Amount of gain (loss) from sale of facilities | $ $ (600) $ 7,400      
Number of previously classified as held for sale 2 11   2  
Provision for impairment on real estate properties | $ $ 10,135 $ 7,600 $ 6,893 $ 17,773 $ 41,451
Number of facilities with impairment charges 6 3   6  
Number of facilities with impairment charges classified as held for sale   1      
XML 77 R46.htm IDEA: XBRL DOCUMENT v3.7.0.1
DIRECT FINANCING LEASES (Detail)
$ in Thousands
Jun. 30, 2017
USD ($)
Lease
Dec. 31, 2016
USD ($)
Lease
Leases, Capital [Abstract]    
Minimum lease payments receivable $ 4,085,493 $ 4,287,069
Less unearned income (3,499,877) (3,685,131)
Less allowance for loss on direct financing lease (3,309)  
Investment in direct financing leases - net $ 582,307 $ 601,938
Properties subject to direct financing leases | Lease 53 58
XML 78 R47.htm IDEA: XBRL DOCUMENT v3.7.0.1
DIRECT FINANCING LEASES (Detail 1)
$ in Thousands
Jun. 30, 2017
USD ($)
Leases, Capital [Abstract]  
2017 $ 24,407
2018 50,019
2019 51,246
2020 52,493
2021 53,681
2022 $ 55,008
XML 79 R48.htm IDEA: XBRL DOCUMENT v3.7.0.1
DIRECT FINANCING LEASES (Narrative) (Detail)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Nov. 27, 2013
USD ($)
Facility
Lease
State
Jun. 30, 2017
USD ($)
Facility
Healthcare_facility
State
Mar. 31, 2017
USD ($)
Jun. 30, 2016
USD ($)
Jun. 30, 2017
USD ($)
Facility
Healthcare_facility
State
Jun. 30, 2016
USD ($)
Capital Leased Assets [Line Items]            
Number of facilities owned | Healthcare_facility   999     999  
Number of states | State   42     42  
Income from direct financing leases | $   $ 15,462   $ 15,521 $ 31,108 $ 30,963
Northwest | Direct financing leases | Sales Agreement            
Capital Leased Assets [Line Items]            
Carrying amount of facility | $     $ 36,400      
Estimated sell price | $     34,000      
Proceeds from sale of facility | $   27,300        
Allowance for loss under direct financing leases | $   900 $ 2,400      
Income from direct financing leases | $   $ 500     $ 1,300  
New Ark Investment Inc.            
Capital Leased Assets [Line Items]            
Purchase price of beds acquired paid in cash | $ $ 529,000          
Number of lease | Lease 4          
Master lease term 50 years          
Interest on lease per annum 10.60%          
Number of facilities owned 56 50     50  
Number of states | State 10          
New Ark Investment Inc. | Southeast            
Capital Leased Assets [Line Items]            
Number of additional facility owned 38          
New Ark Investment Inc. | Northwest            
Capital Leased Assets [Line Items]            
Number of additional facility owned 2          
Number of facilities sold   5     5  
New Ark Investment Inc. | Texas            
Capital Leased Assets [Line Items]            
Number of additional facility owned 9          
New Ark Investment Inc. | Indiana            
Capital Leased Assets [Line Items]            
Number of additional facility owned 1          
SNF's | New Ark Investment Inc. | Direct financing leases            
Capital Leased Assets [Line Items]            
Number of facilities owned 55          
ALFs | New Ark Investment Inc. | Direct financing leases            
Capital Leased Assets [Line Items]            
Number of facilities owned 1          
XML 80 R49.htm IDEA: XBRL DOCUMENT v3.7.0.1
MORTGAGE NOTES RECEIVABLE (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2017
Dec. 31, 2016
Mortgage Loans on Real Estate [Line Items]    
Mortgage notes receivable, gross $ 667,456 $ 643,277
Allowance for loss on mortgage notes receivable (4,747) (3,934)
Total mortgages - net 662,709 639,343
Mortgage note due 2024; interest at 9.98%    
Mortgage Loans on Real Estate [Line Items]    
Mortgage notes receivable, gross $ 112,500 $ 112,500
Mortgage loans on real estate, interest rate 9.98% 9.98%
Mortgage note due 2029; interest at 9.45%    
Mortgage Loans on Real Estate [Line Items]    
Mortgage notes receivable, gross $ 411,467 $ 412,140
Mortgage loans on real estate, interest rate 9.45% 9.45%
Other mortgage notes outstanding    
Mortgage Loans on Real Estate [Line Items]    
Mortgage notes receivable, gross [1] $ 143,489 $ 118,637
[1] Other mortgage notes outstanding have stated interest rates ranging from 8.35% to 14.0% and maturity dates through 2029.
XML 81 R50.htm IDEA: XBRL DOCUMENT v3.7.0.1
MORTGAGE NOTES RECEIVABLE (Parentheticals) (Details) - Other mortgage notes outstanding
6 Months Ended
Jun. 30, 2017
Minimum  
Mortgage Loans on Real Estate [Line Items]  
Mortgage loans on real estate, interest rate 8.35%
Maximum  
Mortgage Loans on Real Estate [Line Items]  
Mortgage loans on real estate, interest rate 14.00%
Maturity year 2029
XML 82 R51.htm IDEA: XBRL DOCUMENT v3.7.0.1
MORTGAGE NOTES RECEIVABLE (Narrative) (Detail)
6 Months Ended
Jun. 30, 2017
Facility
State
Mortgage
Entity
Mortgage Loans on Real Estate [Line Items]  
Number of states 42
Mortgage loans  
Mortgage Loans on Real Estate [Line Items]  
Number of fixed rate mortgages | Mortgage 29
Number of long term care facilities | Facility 52
Number of states 10
Number of independent healthcare operating companies | Entity 7
XML 83 R52.htm IDEA: XBRL DOCUMENT v3.7.0.1
OTHER INVESTMENTS (Details) - USD ($)
$ in Thousands
Jun. 30, 2017
Dec. 31, 2016
Schedule of Investments [Line Items]    
Other investments, gross $ 283,783 $ 261,644
Allowance for loss on other investments (4,798) (4,798)
Total other investments 278,985 256,846
Other investment note due 2019; interest at 10.96%    
Schedule of Investments [Line Items]    
Other investments, gross $ 49,583 $ 49,458
Interest rate 10.96% 10.96%
Other investment note due 2020; interest at 14.00%    
Schedule of Investments [Line Items]    
Other investments, gross $ 47,899 $ 47,913
Interest rate 14.00% 14.00%
Other investment note due 2022, interest at 9.00%    
Schedule of Investments [Line Items]    
Other investments, gross $ 31,987 $ 31,987
Interest rate 9.00% 9.00%
Other investment note due 2030; interest at 6.66%    
Schedule of Investments [Line Items]    
Other investments, gross $ 50,000 $ 44,595
Interest rate 6.66% 6.66%
Other investment notes outstanding    
Schedule of Investments [Line Items]    
Other investments, gross [1] $ 104,314 $ 87,691
[1] Other investment notes have maturity dates through 2028 and interest rates ranging from 6.50% to 13.0%.
XML 84 R53.htm IDEA: XBRL DOCUMENT v3.7.0.1
OTHER INVESTMENTS (Parentheticals) (Details) - Other investment notes outstanding
6 Months Ended
Jun. 30, 2017
Minimum  
Schedule of Investments [Line Items]  
Interest rate 6.50%
Maximum  
Schedule of Investments [Line Items]  
Interest rate 13.00%
Maturity year 2028
XML 85 R54.htm IDEA: XBRL DOCUMENT v3.7.0.1
INVESTMENT IN UNCONSOLIDATED JOINT VENTURE (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Nov. 01, 2016
USD ($)
Facility
Jun. 30, 2017
USD ($)
Jun. 30, 2017
USD ($)
Dec. 31, 2016
USD ($)
Schedule of Equity Method Investments [Line Items]        
Investment in unconsolidated joint venture   $ 38,968 $ 38,968 $ 48,776
Assets management fees recognized   $ 500 $ 1,000  
Second Spring Healthcare Investments        
Schedule of Equity Method Investments [Line Items]        
Investment in unconsolidated joint venture $ 50,000      
Percentage of ownership interest 15.00%      
Second Spring Healthcare Investments | Affiliates of Lindsey Goldberg LLC        
Schedule of Equity Method Investments [Line Items]        
Percentage of ownership interest 85.00%      
Second Spring Healthcare Investments | Welltower Inc | SNF's        
Schedule of Equity Method Investments [Line Items]        
Number of properties acquired | Facility 64      
Payments to acquire facilities $ 1,100,000      
XML 86 R55.htm IDEA: XBRL DOCUMENT v3.7.0.1
ASSETS HELD FOR SALE (Details)
$ in Thousands
3 Months Ended
Jun. 30, 2017
USD ($)
Property
Mar. 31, 2017
USD ($)
Property
Number Of Properties    
Beginning Balance | Property 9 20
Properties sold/other | Property [1] (2) (12)
Properties added | Property [2]   1
Ending balance | Property 7 [3] 9
Net Book Value    
Beginning Balance | $ $ 23,245 $ 52,868
Properties sold/other | $ [1] (4,356) (30,023)
Properties added | $ [2]   400
Ending balance | $ $ 18,889 [3] $ 23,245
[1] In the first quarter of 2017, we sold nine SNFs and two ALFs for approximately $29.4 million in net proceeds recognizing a gain on sale of approximately $3.6 million. One SNF classified as an asset held for sale at December 31, 2016 was no longer considered held for sale during the first quarter of 2017 and was reclassified back to leased properties at approximately $5.1 million which represents the facility's then carrying value adjusted for depreciation that was not recognized while classified as held for sale. In the second quarter of 2017, we sold one ALF and one SNF for approximately $5.0 million in net proceeds, generating a gain on sale of approximately $0.6 million.
[2] In the first quarter of 2017, we recorded a $3.5 million impairment to reduce one ALF's net book value to its estimated fair value less costs to sell before it was reclassified to assets held for sale.
[3] We plan to sell the facilities classified as held for sale at June 30, 2017 within the next twelve months.
XML 87 R56.htm IDEA: XBRL DOCUMENT v3.7.0.1
ASSETS HELD FOR SALE (Parentheticals) (Details)
$ in Millions
3 Months Ended
Jun. 30, 2017
USD ($)
Facility
Mar. 31, 2017
USD ($)
Facility
Property
Real Estate Properties [Line Items]    
Net proceeds from sale of facilities held for sale | $ $ 5.0 $ 29.4
Gain (loss) from sale of facilities | $ $ (0.6) $ 3.6
Number of facilities with impairment charges | Facility   1
SNF's    
Real Estate Properties [Line Items]    
Number of facilities held for sale sold | Facility 1 9
Number of property reclassified | Property   1
Carrying value for property reclassified | $   $ 5.1
ALFs    
Real Estate Properties [Line Items]    
Number of facilities held for sale sold | Facility 1 2
Impairment charges | $   $ 3.5
Number of facilities with impairment charges | Facility   1
XML 88 R57.htm IDEA: XBRL DOCUMENT v3.7.0.1
INTANGIBLES - Summary of our intangibles (Details) - USD ($)
$ in Thousands
Jun. 30, 2017
Dec. 31, 2016
Assets:    
Goodwill $ 644,184 $ 643,474
Accumulated amortization (16,477) (15,864)
Net intangible assets 6,116 6,779
Liabilities:    
Below market leases 164,735 165,028
Accumulated amortization (77,534) (70,738)
Net intangible liabilities 87,201 94,290
Above market leases    
Assets:    
Gross intangible assets 22,426 22,476
In-place leases    
Assets:    
Gross intangible assets $ 167 $ 167
XML 89 R58.htm IDEA: XBRL DOCUMENT v3.7.0.1
INTANGIBLES - Reconciliation of goodwill (Details 1)
$ in Thousands
6 Months Ended
Jun. 30, 2017
USD ($)
Goodwill [Roll Forward]  
Balance $ 643,474
Add: foreign currency translation 710
Balance $ 644,184
XML 90 R59.htm IDEA: XBRL DOCUMENT v3.7.0.1
INTANGIBLES (Narrative) (Detail) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]        
Amortization of intangible assets $ 3.1 $ 3.6 $ 6.2 $ 7.9
Remainder of 2017 5.8   5.8  
2018 10.5   10.5  
2019 9.5   9.5  
2020 9.3   9.3  
2021 $ 8.7   $ 8.7  
XML 91 R60.htm IDEA: XBRL DOCUMENT v3.7.0.1
INTANGIBLES (Narrative) (Detail 1)
6 Months Ended
Jun. 30, 2017
Finite-Lived Intangible Assets [Line Items]  
Below market leases, weighted average remaining amortization 9 years
Above market lease intangibles  
Finite-Lived Intangible Assets [Line Items]  
Weighted average remaining amortization 8 years
XML 92 R61.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONCENTRATION OF RISK (Narrative) (Detail)
$ in Thousands
6 Months Ended
Jun. 30, 2017
USD ($)
Facility
Healthcare_facility
State
Operator
Dec. 31, 2016
USD ($)
Concentration Risk [Line Items]    
Number of facilities owned | Healthcare_facility 999  
Number of states | State 42  
Number of operators | Operator 77  
Gross investment in facilities, net of impairments and before reserve for uncollectible loans | $ $ 9,000,000  
Investment in an unconsolidated joint venture | $ $ 39,000  
Percentage share of real estate investments related to long-term care facilities 99.00%  
Number of facilities held-for-sale/closed 9  
Other investments | $ $ 278,985 $ 256,846
Concentration risk, benchmark description No single operator or manager generated more than 10% of our total revenues for the six months ended June 30, 2017.  
Ohio    
Concentration Risk [Line Items]    
Concentration percent by state 9.00%  
Texas    
Concentration Risk [Line Items]    
Concentration percent by state 9.00%  
Florida    
Concentration Risk [Line Items]    
Concentration percent by state 9.00%  
SNF's    
Concentration Risk [Line Items]    
Number of facilities owned 803  
Number of facilities under fixed rate mortgage loan 47  
ALFs    
Concentration Risk [Line Items]    
Number of facilities owned 119  
Number of facilities under fixed rate mortgage loan 4  
Specialty facilities    
Concentration Risk [Line Items]    
Number of facilities owned 16  
Medical office building    
Concentration Risk [Line Items]    
Number of facilities owned 1  
Ciena Healthcare    
Concentration Risk [Line Items]    
Concentration risk, percentage 10.00%  
XML 93 R62.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCKHOLDERS'/OWNERS' EQUITY (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Cumulative Translation Adjustment Summary [Roll Forward]          
Total accumulated other comprehensive loss $ (43,913) $ (48,771) $ (43,913) $ (48,771)  
Add: portion included in noncontrolling interest 2,010 2,308 2,010 2,308  
Total accumulated other comprehensive loss (41,903) (46,463) (41,903) (46,463) $ (53,827)
OHI Holdco          
Cumulative Translation Adjustment Summary [Roll Forward]          
Total accumulated other comprehensive loss (43,913) (48,771) (43,913) (48,771)  
Add: portion included in noncontrolling interest 34,116 37,965 34,116 37,965  
Total accumulated other comprehensive loss (9,797) (10,806) (9,797) (10,806) $ (12,439)
Omega OP          
Cumulative Translation Adjustment Summary [Roll Forward]          
Total accumulated other comprehensive loss (43,913) (48,771) (43,913) (48,771)  
Foreign Currency Translation          
Cumulative Translation Adjustment Summary [Roll Forward]          
Beginning balance (50,614) (13,143) (54,948) (8,413)  
Translation gain (loss) 10,195 (21,836) 14,468 (26,544)  
Realized gain (loss) 79   140 (22)  
Ending balance (40,340) (34,979) (40,340) (34,979)  
Foreign Currency Translation | OHI Holdco          
Cumulative Translation Adjustment Summary [Roll Forward]          
Beginning balance (50,614) (13,143) (54,948) (8,413)  
Translation gain (loss) 10,195 (21,836) 14,468 (26,544)  
Realized gain (loss) 79 140 22  
Ending balance (40,340) (34,979) (40,340) (34,979)  
Foreign Currency Translation | Omega OP          
Cumulative Translation Adjustment Summary [Roll Forward]          
Beginning balance (50,614) (13,143) (54,948) (8,413)  
Translation gain (loss) 10,195 (21,836) 14,468 (26,544)  
Realized gain (loss) 79 140 (22)  
Ending balance (40,340) (34,979) (40,340) (34,979)  
Derivative Instruments          
Cumulative Translation Adjustment Summary [Roll Forward]          
Beginning balance (166) (9,594) (1,420) (718)  
Unrealized loss (1,840) (4,198) (1,350) (13,074)  
Realized gain (loss) 626   1,390    
Ending balance (1,380) (13,792) (1,380) (13,792)  
Derivative Instruments | OHI Holdco          
Cumulative Translation Adjustment Summary [Roll Forward]          
Beginning balance (166) (9,594) (1,420) (718)  
Unrealized loss (1,840) (4,198) (1,350) (13,074)  
Realized gain (loss) 626 1,390  
Ending balance (1,380) (13,792) (1,380) (13,792)  
Derivative Instruments | Omega OP          
Cumulative Translation Adjustment Summary [Roll Forward]          
Beginning balance (166) (9,594) (1,420) (718)  
Translation gain (loss) (1,840)   (1,350)    
Unrealized loss   (4,198)   (13,074)  
Realized gain (loss) 626 1,390  
Ending balance (1,380) (13,792) (1,380) (13,792)  
Net investment hedge          
Cumulative Translation Adjustment Summary [Roll Forward]          
Beginning balance  
Unrealized loss (2,193) (2,193)  
Ending balance (2,193) (2,193)  
Net investment hedge | OHI Holdco          
Cumulative Translation Adjustment Summary [Roll Forward]          
Beginning balance  
Unrealized loss (2,193) (2,193)  
Ending balance (2,193) (2,193)  
Net investment hedge | Omega OP          
Cumulative Translation Adjustment Summary [Roll Forward]          
Beginning balance  
Unrealized loss (2,193) (2,193)  
Ending balance $ (2,193) $ (2,193)  
XML 94 R63.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCKHOLDERS'/OWNERS' EQUITY (Narrative) (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jul. 13, 2017
Apr. 13, 2017
Jan. 12, 2017
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dividend [Line Items]              
Dividends declared per common share       $ 0.63 $ 0.58 $ 1.25 $ 1.15
Issuance of common stock (in shares)           228,000  
Dividend reinvestment plan (in shares)           614,000  
Gross proceeds from issuance of common stock           $ 6,634 $ 487
Board of Directors              
Dividend [Line Items]              
Dividends declared per common share   $ 0.63 $ 0.62        
Nature of common stock dividend payable   Quarterly Quarterly        
Increasing the quarterly common dividend   0.01 0.01        
Dividends declared, date of declaration   Apr. 13, 2017 Jan. 12, 2017        
Dividends declared, date of payment   May 15, 2017 Feb. 15, 2017        
Dividends declared, date of record   May 01, 2017 Jan. 31, 2017        
500 Million Equity Shelf Program              
Dividend [Line Items]              
Issuance of common stock (in shares)           200,000  
Issuance of common stock, average price per share           $ 29.17  
Gross proceeds from issuance of common stock           $ 6,600  
Sales price, equity distribution agreement       $ 500,000   $ 500,000  
Dividend Reinvestment and Common Stock Purchase Plan              
Dividend [Line Items]              
Issuance of common stock (in shares)       400,000   614,000  
Issuance of common stock, average price per share       $ 33.02   $ 32.11  
Gross proceeds from issuance of common stock       $ 12,400   $ 19,700  
Subsequent Event | Board of Directors              
Dividend [Line Items]              
Dividends declared per common share $ 0.64            
Nature of common stock dividend payable Quarterly            
Increasing the quarterly common dividend 0.01            
Dividends declared, date of declaration Jul. 13, 2017            
Dividends declared, date of payment Aug. 15, 2017            
Dividends declared, date of record Aug. 01, 2017            
XML 95 R64.htm IDEA: XBRL DOCUMENT v3.7.0.1
TAXES (Narrative) (Detail)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2017
USD ($)
Jun. 30, 2017
USD ($)
Income Tax Disclosure [Abstract]    
Percentage of minimum taxable income is distributed 90.00% 90.00%
Permitted ownership of a taxable REIT subsidiary ("TRS"), maximum percentage 100.00% 100.00%
Net operating loss carry-forward $ 0.8 $ 0.8
State and local income tax provision 0.5 1.5
Provision (benefit) for foreign income taxes $ 0.1 $ 0.2
XML 96 R65.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK-BASED COMPENSATION (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]        
Stock-based compensation expense $ 3,734 $ 3,665 $ 7,478 $ 6,443
XML 97 R66.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK-BASED COMPENSATION (Details 1)
$ / shares in Units, $ in Millions
6 Months Ended
Jun. 30, 2017
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares/Units | shares 2,447,351
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 18.63
Total Compensation Cost $ 45.6 [1]
Unrecognized Compensation Cost $ 25.9
RSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares/Units | shares 428,670
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 35.68
Total Compensation Cost $ 15.3 [1]
Unrecognized Compensation Cost $ 7.2
RSUs | 3/31/15 RSU  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grant Year 2015
Shares/Units | shares 109,985
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 40.57
Total Compensation Cost $ 4.5 [1]
Weighted Average Period of Expense Recognition 33 months
Unrecognized Compensation Cost $ 0.8
Vesting Dates 12/31/2017
RSUs | 4/1/15 RSU  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grant Year 2015
Shares/Units | shares 40,464
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 40.74
Total Compensation Cost $ 1.6 [1]
Weighted Average Period of Expense Recognition 33 months
Unrecognized Compensation Cost $ 0.3
Vesting Dates 12/31/2017
RSUs | Assumed Aviv RSU  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grant Year 2015
Shares/Units | shares 7,799
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 35.08
Total Compensation Cost $ 0.3 [1]
Weighted Average Period of Expense Recognition 33 months
Unrecognized Compensation Cost $ 0.1
Vesting Dates 11/1/2017
RSUs | 3/17/16 RSU  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grant Year 2016
Shares/Units | shares 130,006
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 34.78
Total Compensation Cost $ 4.6 [1]
Weighted Average Period of Expense Recognition 33 months
Unrecognized Compensation Cost $ 2.4
Vesting Dates 12/31/2018
RSUs | 1/1/2017 RSU  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grant Year 2017
Shares/Units | shares 140,416
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 31.26
Total Compensation Cost $ 4.3 [1]
Weighted Average Period of Expense Recognition 36 months
Unrecognized Compensation Cost $ 3.6
Vesting Dates 12/31/2019
TSR PRSUs and LTIP Units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares/Units | shares 1,098,829
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 12.69
Total Compensation Cost $ 13.9 [1]
Unrecognized Compensation Cost $ 8.9
TSR PRSUs and LTIP Units | 2016 TSR  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grant Year 2014
Shares/Units | shares 135,634
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 8.67
Total Compensation Cost $ 1.2 [1]
Weighted Average Period of Expense Recognition 48 months
Unrecognized Compensation Cost $ 0.2
Performance Period 1/1/2014-12/31/2016
Vesting Dates Quarterly in 2017
TSR PRSUs and LTIP Units | 3/31/15 2017 LTIP Units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grant Year 2015
Shares/Units | shares 137,249
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 14.66
Total Compensation Cost $ 2.0 [1]
Weighted Average Period of Expense Recognition 45 months
Unrecognized Compensation Cost $ 0.8
Performance Period 1/1/2015-12/31/2017
Vesting Dates Quarterly in 2018
TSR PRSUs and LTIP Units | 4/1/2015 2017 LTIP Units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grant Year 2015
Shares/Units | shares 54,151
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 14.80
Total Compensation Cost $ 0.8 [1]
Weighted Average Period of Expense Recognition 45 months
Unrecognized Compensation Cost $ 0.3
Performance Period 1/1/2015-12/31/2017
Vesting Dates Quarterly in 2018
TSR PRSUs and LTIP Units | 3/17/16 2018 LTIP Units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grant Year 2016
Shares/Units | shares 372,069
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 13.21
Total Compensation Cost $ 4.9 [1]
Weighted Average Period of Expense Recognition 45 months
Unrecognized Compensation Cost $ 3.2
Performance Period 1/1/2016-12/31/2018
Vesting Dates Quarterly in 2019
TSR PRSUs and LTIP Units | 1/1/2017 2019 LTIP Units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grant Year 2017
Shares/Units | shares 399,726
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 12.61
Total Compensation Cost $ 5.0 [1]
Weighted Average Period of Expense Recognition 48 months
Unrecognized Compensation Cost $ 4.4
Performance Period 1/1/2017-12/31/2019
Vesting Dates Quarterly in 2020
Relative TSR PRSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares/Units | shares 919,852
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 17.78
Total Compensation Cost $ 16.4 [1]
Unrecognized Compensation Cost $ 9.8
Relative TSR PRSUs | 2016 Relative TSR  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grant Year 2014
Shares/Units | shares 135,634
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 14.24
Total Compensation Cost $ 1.9 [1]
Weighted Average Period of Expense Recognition 48 months
Unrecognized Compensation Cost $ 0.2
Performance Period 1/1/2014-12/31/2016
Vesting Dates Quarterly in 2017
Relative TSR PRSUs | 3/31/15 2017 Relative TSR  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grant Year 2015
Shares/Units | shares 137,249
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 22.50
Total Compensation Cost $ 3.1 [1]
Weighted Average Period of Expense Recognition 45 months
Unrecognized Compensation Cost $ 1.2
Performance Period 1/1/2015-12/31/2017
Vesting Dates Quarterly in 2018
Relative TSR PRSUs | 4/1/2015 2017 Relative TSR  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grant Year 2015
Shares/Units | shares 54,151
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 22.91
Total Compensation Cost $ 1.2 [1]
Weighted Average Period of Expense Recognition 45 months
Unrecognized Compensation Cost $ 0.5
Performance Period 1/1/2015-12/31/2017
Vesting Dates Quarterly in 2018
Relative TSR PRSUs | 3/17/16 2018 Relative TSR  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grant Year 2016
Shares/Units | shares 307,480
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 16.45
Total Compensation Cost $ 5.1 [1]
Weighted Average Period of Expense Recognition 45 months
Unrecognized Compensation Cost $ 3.4
Performance Period 1/1/2016-12/31/2018
Vesting Dates Quarterly in 2019
Relative TSR PRSUs | 1/1/2017 2019 Relative TSR  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Grant Year 2017
Shares/Units | shares 285,338
Grant Date Average Fair Value Per Unit/ Share | $ / shares $ 18.04
Total Compensation Cost $ 5.1 [1]
Weighted Average Period of Expense Recognition 48 months
Unrecognized Compensation Cost $ 4.5
Performance Period 1/1/2017-12/31/2019
Vesting Dates Quarterly in 2020
[1] Total compensation costs are net of shares cancelled.
XML 98 R67.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK-BASED COMPENSATION (Narrative) (Detail)
$ in Millions
6 Months Ended
Jun. 30, 2017
USD ($)
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares of restricted stock outstanding 2,447,351
Unrecognized compensation cost | $ $ 25.9
Percentage of operating partnership units distributions 10.00%
Restricted stock | Directors  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares of restricted stock outstanding 90,421
Vesting period, years 3 years
Unrecognized compensation cost | $ $ 2.2
RSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares of restricted stock outstanding 428,670
Unrecognized compensation cost | $ $ 7.2
RSUs | January 1, 2017  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares of restricted stock outstanding 140,416
LTIP  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares of restricted stock outstanding 1,098,829
Unrecognized compensation cost | $ $ 8.9
LTIP | January 1, 2017  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares of restricted stock outstanding 399,726
Relative TSR PRSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares of restricted stock outstanding 919,852
Unrecognized compensation cost | $ $ 9.8
Relative TSR PRSUs | January 1, 2017  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares of restricted stock outstanding 285,338
XML 99 R68.htm IDEA: XBRL DOCUMENT v3.7.0.1
BORROWING ACTIVITIES AND ARRANGEMENTS (Details) - USD ($)
$ in Thousands
6 Months Ended
Apr. 04, 2017
Jun. 30, 2017
May 25, 2017
Dec. 31, 2016
Secured borrowings:        
Secured borrowings - net   $ 53,737   $ 54,365
Unsecured borrowings:        
Revolving line of credit   155,000   190,000
Term loans - net   899,292   1,094,343
Other   278,985   256,846
Total secured and unsecured borrowings - net   4,429,887   4,366,854
Secured Borrowings        
Secured borrowings:        
Secured borrowings - net [1]   $ 53,737   54,365
Secured Borrowings | HUD mortgages assumed December 2011        
Debt Instrument [Line Items]        
Maturity [2]   2044    
Rate [2]   3.06%    
Secured borrowings:        
Secured borrowings - net [2]   $ 54,316   54,954
Secured Borrowings | Deferred financing costs - net        
Secured borrowings:        
Deferred financing costs - net   (579)   (589)
Unsecured borrowings        
Unsecured borrowings:        
Discount - net   (22,345)   (17,151)
Total unsecured borrowings   3,321,858   3,028,146
Unsecured borrowings | Deferred financing costs - net        
Unsecured borrowings:        
Discounts and deferred financing costs - net [3]   (5,958)   (5,657)
Deferred financing costs - net   $ (27,297)   (27,703)
Unsecured borrowings | Revolving line of credit        
Debt Instrument [Line Items]        
Maturity   2021    
Rate   2.47%    
Unsecured borrowings:        
Revolving line of credit   $ 155,000   190,000
Unsecured borrowings | Tranche A-1 term loan        
Unsecured borrowings:        
Unsecured borrowing       200,000
Unsecured borrowings | Tranche A-2 term loan        
Unsecured borrowings:        
Unsecured borrowing       200,000
Unsecured borrowings | Tranche A-3 term loan        
Unsecured borrowings:        
Unsecured borrowing       350,000
Unsecured borrowings | U.S. Term Loan Facility        
Debt Instrument [Line Items]        
Maturity   2022    
Rate   2.67%    
Unsecured borrowings:        
Term loans - net   $ 425,000    
Unsecured borrowing      
Unsecured borrowings | Sterling Term Loan Facility        
Debt Instrument [Line Items]        
Maturity   2022    
Rate   1.70%    
Unsecured borrowings:        
Term loans - net   $ 130,250    
Unsecured borrowing      
Unsecured borrowings | Omega OP Term loan        
Debt Instrument [Line Items]        
Maturity [1]   2022    
Rate [1]   2.67%    
Unsecured borrowings:        
Term loans - net   $ 100,000 [1] $ 100,000 100,000 [1]
Discounts and deferred financing costs - net   $ (600)    
Unsecured borrowings | 2015 term loan        
Debt Instrument [Line Items]        
Maturity   2022    
Rate   3.80%    
Unsecured borrowings:        
Term loans - net   $ 250,000 $ 250,000 250,000
Unsecured borrowings | 2023 notes        
Debt Instrument [Line Items]        
Maturity   2023    
Rate   4.375%    
Unsecured borrowings:        
Aggregate principal amount   $ 700,000   700,000
Unsecured borrowings | 2024 notes        
Debt Instrument [Line Items]        
Maturity 2024 2024    
Rate   5.875%    
Unsecured borrowings:        
Aggregate principal amount $ 400,000   400,000
Unsecured borrowings | 2024 notes        
Debt Instrument [Line Items]        
Maturity   2024    
Rate   4.95%    
Unsecured borrowings:        
Aggregate principal amount   $ 400,000   400,000
Unsecured borrowings | 2025 notes        
Debt Instrument [Line Items]        
Maturity 2025 2025    
Rate 99.54% 4.50%    
Unsecured borrowings:        
Aggregate principal amount $ 150,000 $ 400,000   250,000
Unsecured borrowings | 2026 notes        
Debt Instrument [Line Items]        
Maturity   2026    
Rate   5.25%    
Unsecured borrowings:        
Aggregate principal amount   $ 600,000   600,000
Unsecured borrowings | 2027 notes        
Debt Instrument [Line Items]        
Maturity   2027    
Rate   4.50%    
Unsecured borrowings:        
Aggregate principal amount   $ 700,000   700,000
Unsecured borrowings | 2028 notes        
Debt Instrument [Line Items]        
Maturity 2028 2028    
Rate 98.978% 4.75%    
Unsecured borrowings:        
Aggregate principal amount $ 550,000 $ 550,000  
Unsecured borrowings | Other        
Debt Instrument [Line Items]        
Maturity   2018    
Unsecured borrowings:        
Other   $ 1,500   3,000
Unsecured borrowings | Subordinated debt        
Debt Instrument [Line Items]        
Maturity   2021    
Rate   9.00%    
Unsecured borrowings:        
Subordinated debt   $ 20,000   $ 20,000
[1] These amounts represent borrowings that were incurred by Omega OP or wholly owned subsidiaries of Omega OP.
[2] Reflects the weighted average annual contractual interest rate on the mortgages at June 30, 2017 excluding a third-party administration fee of approximately 0.5% annually. Secured by real estate assets with a net carrying value of $63.9 million as of June 30, 2017.
[3] This amount includes $0.6 million of net deferred financing costs related to the Omega OP term loan as of June 30, 2017.
XML 100 R69.htm IDEA: XBRL DOCUMENT v3.7.0.1
BORROWING ACTIVITIES AND ARRANGEMENTS (Parentheticals) (Details)
$ in Millions
6 Months Ended
Jun. 30, 2017
USD ($)
Secured Borrowings | HUD mortgages assumed December 2011  
Debt Instrument [Line Items]  
Percentage of third-party administration fee 0.50%
Real estate assets with a net carrying value $ 63.9
Unsecured borrowings | Omega OP Term loan  
Debt Instrument [Line Items]  
Discounts and deferred financing costs - net $ 0.6
XML 101 R70.htm IDEA: XBRL DOCUMENT v3.7.0.1
BORROWING ACTIVITIES AND ARRANGEMENTS (Narrative) (Detail)
$ in Thousands, £ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 04, 2017
May 25, 2017
USD ($)
Apr. 28, 2017
USD ($)
Jun. 30, 2017
USD ($)
Jun. 30, 2017
USD ($)
Jun. 30, 2016
USD ($)
May 25, 2017
GBP (£)
Dec. 31, 2016
USD ($)
Debt Instrument [Line Items]                
Long-term line of credit       $ 155,000 $ 155,000     $ 190,000
Term loan       899,292 899,292     1,094,343
Repayment of credit facility         852,000 $ 639,000    
Unsecured borrowings                
Debt Instrument [Line Items]                
Net write-offs associated with unamortized deferred financing costs     $ 4,700          
Unsecured borrowings | Revolving line of credit                
Debt Instrument [Line Items]                
Long-term line of credit       155,000 155,000     190,000
Unsecured borrowings | U.S. Term Loan Facility                
Debt Instrument [Line Items]                
Unsecured borrowing              
Term loan       425,000 425,000      
Unsecured borrowings | Sterling Term Loan Facility                
Debt Instrument [Line Items]                
Unsecured borrowing              
Term loan       130,250 130,250      
Unsecured borrowings | Tranche A-1 term loan                
Debt Instrument [Line Items]                
Unsecured borrowing               200,000
Unsecured borrowings | Tranche A-2 term loan                
Debt Instrument [Line Items]                
Unsecured borrowing               200,000
Unsecured borrowings | Tranche A-3 term loan                
Debt Instrument [Line Items]                
Unsecured borrowing               350,000
Unsecured borrowings | Amended 2015 Term Loan Facility                
Debt Instrument [Line Items]                
Debt maturity date   Dec. 16, 2022            
Term loan   $ 250,000   250,000 250,000     250,000
Credit facility, description of variable rate basis   LIBOR plus an applicable percentage (with a range of 140 to 235 basis points) based on our ratings from Standard & Poor's, Moody's and/or Fitch Ratings            
Maximum aggregate principal amount available under credit facility   $ 150,000            
Amount of guaranty of unsecured indebtedness   $ 50,000            
Unsecured borrowings | Omega OP Term loan                
Debt Instrument [Line Items]                
Debt maturity date   May 25, 2022            
Term loan   $ 100,000   100,000 [1] $ 100,000 [1]     $ 100,000 [1]
Credit facility, description of variable rate basis   LIBOR plus an applicable percentage (with a range of 90 to 190 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings            
Amount of guaranty of unsecured indebtedness   $ 50,000            
Unsecured borrowings | 2028 notes                
Debt Instrument [Line Items]                
Debt maturity date Jan. 15, 2028              
Unsecured borrowings | 2025 notes                
Debt Instrument [Line Items]                
Debt maturity date Jan. 15, 2025              
Unsecured borrowings | 2024 notes                
Debt Instrument [Line Items]                
Debt maturity date Apr. 28, 2017              
Unsecured borrowings | Minimum | Omega OP Term loan                
Debt Instrument [Line Items]                
Pricing of credit facility at LIBOR plus an applicable percentage   0.90%            
Unsecured borrowings | Maximum | Omega OP Term loan                
Debt Instrument [Line Items]                
Pricing of credit facility at LIBOR plus an applicable percentage   1.90%            
Unsecured borrowings | Omega Credit Facilities 2017                
Debt Instrument [Line Items]                
Long-term line of credit   $ 1,800,000            
Maximum borrowing capacity   2,500,000            
Net write-offs associated with unamortized deferred financing costs       $ 5,500        
Unsecured borrowings | Omega Credit Facilities 2017 | Revolving line of credit                
Debt Instrument [Line Items]                
Long-term line of credit   1,250,000            
Revolving credit facility to be drawn in Alternative Currencies or U.S. Dollars in tranche one   900,000            
Revolving credit facility to be drawn in Alternative Currencies or U.S. Dollars in tranche two   $ 350,000            
Credit facility, description of variable rate basis   LIBOR plus an applicable percentage (with a range of 100 to 195 basis points) based on our ratings from Standard & Poor's, Moody's and/or Fitch Ratings            
Unsecured borrowings | Omega Credit Facilities 2017 | U.S. Term Loan Facility                
Debt Instrument [Line Items]                
Long-term line of credit   $ 425,000            
Unsecured borrowings | Omega Credit Facilities 2017 | Sterling Term Loan Facility                
Debt Instrument [Line Items]                
Long-term line of credit | £             £ 100  
Unsecured borrowings | Omega Credit Facilities 2017 | US And Sterling Term Loan                
Debt Instrument [Line Items]                
Debt maturity date   May 25, 2022            
Credit facility, description of variable rate basis   LIBOR plus an applicable percentage (with a range of 90 to 190 basis points) based on our ratings from Standard & Poor's, Moody's and/or Fitch Ratings            
Unsecured borrowings | Omega Credit Facilities 2017 | Tranche A-1 term loan                
Debt Instrument [Line Items]                
Credit facility terminated   $ 200,000            
Unsecured borrowings | Omega Credit Facilities 2017 | Tranche A-2 term loan                
Debt Instrument [Line Items]                
Credit facility terminated   200,000            
Repayment of credit facility   200,000            
Unsecured borrowings | Omega Credit Facilities 2017 | Tranche A-3 term loan                
Debt Instrument [Line Items]                
Credit facility terminated   350,000            
Unsecured borrowings | Omega Credit Facilities 2017 | Senior unsecured 2014 revolving credit facility                
Debt Instrument [Line Items]                
Credit facility terminated   $ 1,250,000            
Unsecured borrowings | Omega Credit Facilities 2017 | Minimum | Revolving line of credit                
Debt Instrument [Line Items]                
Pricing of credit facility at LIBOR plus an applicable percentage   1.00%            
Unsecured borrowings | Omega Credit Facilities 2017 | Minimum | US And Sterling Term Loan                
Debt Instrument [Line Items]                
Pricing of credit facility at LIBOR plus an applicable percentage   0.90%            
Unsecured borrowings | Omega Credit Facilities 2017 | Minimum | Amended 2015 Term Loan Facility                
Debt Instrument [Line Items]                
Pricing of credit facility at LIBOR plus an applicable percentage   1.40%            
Unsecured borrowings | Omega Credit Facilities 2017 | Maximum | Revolving line of credit                
Debt Instrument [Line Items]                
Pricing of credit facility at LIBOR plus an applicable percentage   1.95%            
Unsecured borrowings | Omega Credit Facilities 2017 | Maximum | US And Sterling Term Loan                
Debt Instrument [Line Items]                
Pricing of credit facility at LIBOR plus an applicable percentage   1.90%            
Unsecured borrowings | Omega Credit Facilities 2017 | Maximum | Amended 2015 Term Loan Facility                
Debt Instrument [Line Items]                
Pricing of credit facility at LIBOR plus an applicable percentage   2.35%            
[1] These amounts represent borrowings that were incurred by Omega OP or wholly owned subsidiaries of Omega OP.
XML 102 R71.htm IDEA: XBRL DOCUMENT v3.7.0.1
BORROWING ACTIVITIES AND ARRANGEMENTS (Narrative) (Detail 1) - USD ($)
$ in Thousands
1 Months Ended 6 Months Ended
Apr. 04, 2017
Apr. 28, 2017
Jun. 30, 2017
Dec. 31, 2016
Unsecured borrowings        
Debt Instrument [Line Items]        
Net proceeds from the offering after deducting underwriting discounts and expenses $ 690,700      
Redemption related costs and write offs   $ 16,500    
Call premium   11,800    
Net write-offs associated with unamortized deferred financing costs   $ 4,700    
4.75% notes due 2028        
Debt Instrument [Line Items]        
Rate     4.75%  
4.75% notes due 2028 | Unsecured borrowings        
Debt Instrument [Line Items]        
Maturity 2028   2028  
Rate 4.75%      
Aggregate principal amount $ 550,000   $ 550,000
Maturity date Jan. 15, 2028      
Percentage of notes sold at an issue price 98.978%   4.75%  
4.50% notes due 2025        
Debt Instrument [Line Items]        
Rate     4.50%  
4.50% notes due 2025 | Unsecured borrowings        
Debt Instrument [Line Items]        
Maturity 2025   2025  
Rate 4.50%      
Aggregate principal amount $ 150,000   $ 400,000 250,000
Maturity date Jan. 15, 2025      
Percentage of notes sold at an issue price 99.54%   4.50%  
5.875% notes due 2024        
Debt Instrument [Line Items]        
Rate     5.875%  
5.875% notes due 2024 | Unsecured borrowings        
Debt Instrument [Line Items]        
Maturity 2024   2024  
Rate 5.875%      
Aggregate principal amount $ 400,000   $ 400,000
Maturity date Apr. 28, 2017      
Percentage of notes sold at an issue price     5.875%  
Tranche A-2 term loan | Unsecured borrowings        
Debt Instrument [Line Items]        
Prepay senior unsecured incremental term loan facility $ 200,000      
XML 103 R72.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS (Detail) - USD ($)
$ in Thousands
Jun. 30, 2017
Dec. 31, 2016
Assets:    
Investments in direct financing leases - net $ 582,307 $ 601,938
Mortgage notes receivable - net 662,709 639,343
Other investments - net 278,985 256,846
Liabilities:    
Revolving line of credit 155,000 190,000
2015 term loan 899,292 1,094,343
HUD debt - net 53,737 54,365
Carrying Amount    
Assets:    
Investments in direct financing leases - net 582,307 601,938
Mortgage notes receivable - net 662,709 639,343
Other investments - net 278,985 256,846
Total 1,524,001 1,498,127
Liabilities:    
Revolving line of credit 155,000 190,000
Tranche A-1 term loan 198,830
Tranche A-2 term loan 200,000
Tranche A-3 term loan 347,449
U.S. term loan 422,280  
Sterling term loan 129,413  
Omega OP term loan [1] 99,373 100,000
2015 term loan 248,226 248,064
HUD debt - net [1] 53,737 54,365
Subordinated debt - net 20,431 20,490
Other 1,500 3,000
Total 4,429,887 4,366,854
Carrying Amount | 4.375% notes due 2023    
Liabilities:    
Notes Payable 692,890 692,305
Carrying Amount | 5.875% notes due 2024    
Liabilities:    
Notes Payable 395,065
Carrying Amount | 4.95% notes due 2024    
Liabilities:    
Notes Payable 393,175 392,669
Carrying Amount | 4.50% notes due 2025    
Liabilities:    
Notes Payable 394,368 245,949
Carrying Amount | 5.25% notes due 2026    
Liabilities:    
Notes Payable 593,969 593,616
Carrying Amount | 4.50% notes due 2027    
Liabilities:    
Notes Payable 685,784 685,052
Carrying Amount | 4.75% notes due 2028    
Liabilities:    
Notes Payable 539,741
Fair Value    
Assets:    
Investments in direct financing leases - net 578,998 598,665
Mortgage notes receivable - net 676,396 644,961
Other investments - net 271,306 253,385
Total 1,526,700 1,497,011
Liabilities:    
Revolving line of credit 155,000 190,000
Tranche A-1 term loan 200,000
Tranche A-2 term loan 200,000
Tranche A-3 term loan 350,000
U.S. term loan 425,000  
Sterling term loan 130,250  
Omega OP term loan [1] 100,000 100,000
2015 Term loan 250,000 250,000
HUD debt - net [1] 52,535 52,510
Subordinated debt - net 24,045 23,944
Other 1,500 3,000
Total 4,547,855 4,444,772
Fair Value | 4.375% notes due 2023    
Liabilities:    
Notes Payable 723,805 693,505
Fair Value | 5.875% notes due 2024    
Liabilities:    
Notes Payable 432,938
Fair Value | 4.95% notes due 2024    
Liabilities:    
Notes Payable 421,504 406,361
Fair Value | 4.50% notes due 2025    
Liabilities:    
Notes Payable 361,983 249,075
Fair Value | 5.25% notes due 2026    
Liabilities:    
Notes Payable 641,199 611,461
Fair Value | 4.50% notes due 2027    
Liabilities:    
Notes Payable 703,514 681,978
Fair Value | 4.75% notes due 2028    
Liabilities:    
Notes Payable $ 557,520
[1] These amounts represent borrowings that were incurred by Omega OP or wholly owned subsidiaries of Omega OP.
XML 104 R73.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INSTRUMENTS (Parentheticals) (Detail)
Jun. 30, 2017
4.375% notes due 2023  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]  
Notes issued, interest rate 4.375%
5.875% notes due 2024  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]  
Notes issued, interest rate 5.875%
4.95% notes due 2024  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]  
Notes issued, interest rate 4.95%
4.50% notes due 2025  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]  
Notes issued, interest rate 4.50%
5.25% notes due 2026  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]  
Notes issued, interest rate 5.25%
4.50% notes due 2027  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]  
Notes issued, interest rate 4.50%
4.75% notes due 2028  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]  
Notes issued, interest rate 4.75%
XML 105 R74.htm IDEA: XBRL DOCUMENT v3.7.0.1
EARNINGS PER SHARE/UNIT - Computation of basic and diluted earnings per share (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Numerator:        
Net income $ 68,157 $ 113,154 $ 177,269 $ 171,350
Less: net income attributable to noncontrolling interests (2,900) (5,102) (7,572) (7,743)
Net income available to common stockholders $ 65,257 $ 108,052 $ 169,697 $ 163,607
Denominator:        
Denominator for basic earnings per share 197,433 188,981 197,223 188,604
Effect of dilutive securities:        
Common stock equivalents 467 1,254 407 1,215
Noncontrolling interest - Omega OP Units 8,772 8,922 8,793 8,935
Denominator for diluted earnings per share 206,672 199,157 206,423 198,754
Earnings per share - basic:        
Net income available to common stockholders (in dollars per share) $ 0.33 $ 0.57 $ 0.86 $ 0.87
Earnings per share - diluted:        
Net income (in dollars per share) $ 0.33 $ 0.57 $ 0.86 $ 0.86
Omega OP        
Numerator:        
Net income $ 68,157 $ 113,154 $ 177,269 $ 171,350
Denominator:        
Denominator for basic earnings per unit 206,205 197,903 206,016 197,539
Effect of dilutive securities:        
Noncontrolling interest - Omega OP Units 467 1,254 407 1,215
Denominator for diluted earnings per unit 206,672 199,157 206,423 198,754
Earnings per unit - basic:        
Net income available to Omega OP Unit holders (in shares) $ 0.33 $ 0.57 $ 0.86 $ 0.87
Earnings per unit - diluted:        
Net income (in dollars per shares) $ 0.33 $ 0.57 $ 0.86 $ 0.86
EXCEL 106 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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ƶ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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 108 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 110 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 437 400 1 true 114 0 false 15 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.omegahealthcare.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.omegahealthcare.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 003 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals) Sheet http://www.omegahealthcare.com/role/CONSOLIDATEDBALANCESHEETSParentheticals CONSOLIDATED BALANCE SHEETS (Parentheticals) Statements 3 false false R4.htm 004 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Unaudited) Sheet http://www.omegahealthcare.com/role/Consolidatedstatementsofincomeunaudited CONSOLIDATED STATEMENTS OF INCOME (Unaudited) Statements 4 false false R5.htm 005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) Sheet http://www.omegahealthcare.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) Statements 5 false false R6.htm 006 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (Unaudited) Sheet http://www.omegahealthcare.com/role/ConsolidatedStatementOfChangesInEquityUnaudited CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (Unaudited) Statements 6 false false R7.htm 007 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (Unaudited) (Parentheticals) Sheet http://www.omegahealthcare.com/role/ConsolidatedStatementOfChangesInEquityUnauditedParentheticals CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (Unaudited) (Parentheticals) Statements 7 false false R8.htm 008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://www.omegahealthcare.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 8 false false R9.htm 009 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.omegahealthcare.com/role/BasisOfPresentationAndSignificantAccountingPolicies BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 010 - Disclosure - PROPERTIES AND INVESTMENTS Sheet http://www.omegahealthcare.com/role/PropertiesAndInvestments PROPERTIES AND INVESTMENTS Notes 10 false false R11.htm 011 - Disclosure - DIRECT FINANCING LEASES Sheet http://www.omegahealthcare.com/role/DirectFinancingLeases DIRECT FINANCING LEASES Notes 11 false false R12.htm 012 - Disclosure - MORTGAGE NOTES RECEIVABLE Notes http://www.omegahealthcare.com/role/MortgageNotesReceivable MORTGAGE NOTES RECEIVABLE Notes 12 false false R13.htm 013 - Disclosure - OTHER INVESTMENTS Sheet http://www.omegahealthcare.com/role/OtherInvestments OTHER INVESTMENTS Notes 13 false false R14.htm 014 - Disclosure - INVESTMENT IN UNCONSOLIDATED JOINT VENTURE Sheet http://www.omegahealthcare.com/role/InvestmentInUnconsolidatedJointVenture INVESTMENT IN UNCONSOLIDATED JOINT VENTURE Notes 14 false false R15.htm 015 - Disclosure - ASSETS HELD FOR SALE Sheet http://www.omegahealthcare.com/role/AssetsHeldForSale ASSETS HELD FOR SALE Notes 15 false false R16.htm 016 - Disclosure - INTANGIBLES Sheet http://www.omegahealthcare.com/role/Intangibles INTANGIBLES Notes 16 false false R17.htm 017 - Disclosure - CONCENTRATION OF RISK Sheet http://www.omegahealthcare.com/role/ConcentrationOfRisk CONCENTRATION OF RISK Notes 17 false false R18.htm 018 - Disclosure - STOCKHOLDERS'/OWNERS' EQUITY Sheet http://www.omegahealthcare.com/role/STOCKHOLDERSOWNERSEQUITY STOCKHOLDERS'/OWNERS' EQUITY Notes 18 false false R19.htm 019 - Disclosure - TAXES Sheet http://www.omegahealthcare.com/role/Taxes TAXES Notes 19 false false R20.htm 020 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.omegahealthcare.com/role/StockBasedCompensation STOCK-BASED COMPENSATION Notes 20 false false R21.htm 021 - Disclosure - BORROWING ACTIVITIES AND ARRANGEMENTS Sheet http://www.omegahealthcare.com/role/BorrowingActivitiesAndArrangements BORROWING ACTIVITIES AND ARRANGEMENTS Notes 21 false false R22.htm 022 - Disclosure - FINANCIAL INSTRUMENTS Sheet http://www.omegahealthcare.com/role/FinancialInstruments FINANCIAL INSTRUMENTS Notes 22 false false R23.htm 023 - Disclosure - LITIGATION Sheet http://www.omegahealthcare.com/role/Litigation LITIGATION Notes 23 false false R24.htm 024 - Disclosure - EARNINGS PER SHARE/UNIT Sheet http://www.omegahealthcare.com/role/EarningsPerShare EARNINGS PER SHARE/UNIT Notes 24 false false R25.htm 025 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.omegahealthcare.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 25 false false R26.htm 026 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.omegahealthcare.com/role/Basisofpresentationandsignificantaccountingpoliciestables BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.omegahealthcare.com/role/BasisOfPresentationAndSignificantAccountingPolicies 26 false false R27.htm 027 - Disclosure - PROPERTIES AND INVESTMENTS (Tables) Sheet http://www.omegahealthcare.com/role/PropertiesAndInvestmentsTables PROPERTIES AND INVESTMENTS (Tables) Tables http://www.omegahealthcare.com/role/PropertiesAndInvestments 27 false false R28.htm 028 - Disclosure - DIRECT FINANCING LEASES (Tables) Sheet http://www.omegahealthcare.com/role/DIRECTFINANCINGLEASESTables DIRECT FINANCING LEASES (Tables) Tables http://www.omegahealthcare.com/role/DirectFinancingLeases 28 false false R29.htm 029 - Disclosure - MORTGAGE NOTES RECEIVABLE (Tables) Notes http://www.omegahealthcare.com/role/MORTGAGENOTESRECEIVABLETables MORTGAGE NOTES RECEIVABLE (Tables) Tables http://www.omegahealthcare.com/role/MortgageNotesReceivable 29 false false R30.htm 030 - Disclosure - OTHER INVESTMENTS (Tables) Sheet http://www.omegahealthcare.com/role/OTHERINVESTMENTSTables OTHER INVESTMENTS (Tables) Tables http://www.omegahealthcare.com/role/OtherInvestments 30 false false R31.htm 031 - Disclosure - ASSETS HELD FOR SALE (Tables) Sheet http://www.omegahealthcare.com/role/ASSETSHELDFORSALETables ASSETS HELD FOR SALE (Tables) Tables http://www.omegahealthcare.com/role/AssetsHeldForSale 31 false false R32.htm 032 - Disclosure - INTANGIBLES (Tables) Sheet http://www.omegahealthcare.com/role/INTANGIBLESTables INTANGIBLES (Tables) Tables http://www.omegahealthcare.com/role/Intangibles 32 false false R33.htm 033 - Disclosure - STOCKHOLDERS'/OWNERS' EQUITY (Tables) Sheet http://www.omegahealthcare.com/role/STOCKHOLDERSOWNERSEQUITYTables STOCKHOLDERS'/OWNERS' EQUITY (Tables) Tables http://www.omegahealthcare.com/role/STOCKHOLDERSOWNERSEQUITY 33 false false R34.htm 034 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.omegahealthcare.com/role/STOCKBASEDCOMPENSATIONTables STOCK-BASED COMPENSATION (Tables) Tables http://www.omegahealthcare.com/role/StockBasedCompensation 34 false false R35.htm 035 - Disclosure - BORROWING ACTIVITIES AND ARRANGEMENTS (Tables) Sheet http://www.omegahealthcare.com/role/BorrowingActivitiesAndArrangementsTables BORROWING ACTIVITIES AND ARRANGEMENTS (Tables) Tables http://www.omegahealthcare.com/role/BorrowingActivitiesAndArrangements 35 false false R36.htm 036 - Disclosure - FINANCIAL INSTRUMENTS (Tables) Sheet http://www.omegahealthcare.com/role/FINANCIALINSTRUMENTSTables FINANCIAL INSTRUMENTS (Tables) Tables http://www.omegahealthcare.com/role/FinancialInstruments 36 false false R37.htm 037 - Disclosure - EARNINGS PER SHARE/UNIT (Tables) Sheet http://www.omegahealthcare.com/role/EARNINGSPERSHARETables EARNINGS PER SHARE/UNIT (Tables) Tables http://www.omegahealthcare.com/role/EarningsPerShare 37 false false R38.htm 038 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Detail) Sheet http://www.omegahealthcare.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetail BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Detail) Details http://www.omegahealthcare.com/role/Basisofpresentationandsignificantaccountingpoliciestables 38 false false R39.htm 039 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail) Sheet http://www.omegahealthcare.com/role/BasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetail BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail) Details http://www.omegahealthcare.com/role/Basisofpresentationandsignificantaccountingpoliciestables 39 false false R40.htm 040 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail 1) Sheet http://www.omegahealthcare.com/role/BasisOfPresentationAndSignificantAccountingPoliciesNarrativeDetail1 BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail 1) Details http://www.omegahealthcare.com/role/Basisofpresentationandsignificantaccountingpoliciestables 40 false false R41.htm 041 - Disclosure - PROPERTIES AND INVESTMENTS - Investment in leased real estate properties (Detail) Sheet http://www.omegahealthcare.com/role/PROPERTIESANDINVESTMENTSInvestmentInLeasedRealEstatePropertiesDetail PROPERTIES AND INVESTMENTS - Investment in leased real estate properties (Detail) Details 41 false false R42.htm 042 - Disclosure - PROPERTIES AND INVESTMENTS - Significant acquisitions that occurred during the first six months of 2017 (Detail 1) Sheet http://www.omegahealthcare.com/role/PROPERTIESANDINVESTMENTSSignificantAcquisitionsOccurredInFirstQuarterOf2017Detail1 PROPERTIES AND INVESTMENTS - Significant acquisitions that occurred during the first six months of 2017 (Detail 1) Details 42 false false R43.htm 043 - Disclosure - PROPERTIES AND INVESTMENTS (Parentheticals) (Detail 1) Sheet http://www.omegahealthcare.com/role/PROPERTIESANDINVESTMENTSDetails PROPERTIES AND INVESTMENTS (Parentheticals) (Detail 1) Details http://www.omegahealthcare.com/role/PropertiesAndInvestmentsTables 43 false false R44.htm 044 - Disclosure - PROPERTIES AND INVESTMENTS - Leased Property (Narrative) (Detail) Sheet http://www.omegahealthcare.com/role/PROPERTIESANDINVESTMENTSLeasedPropertyNarrativeDetail PROPERTIES AND INVESTMENTS - Leased Property (Narrative) (Detail) Details 44 false false R45.htm 045 - Disclosure - PROPERTIES AND INVESTMENTS - Assets Sold or Held for Sale (Narrative) (Detail 1) Sheet http://www.omegahealthcare.com/role/PROPERTIESANDINVESTMENTSAssetsSoldOrHeldForSaleNarrativeDetail1 PROPERTIES AND INVESTMENTS - Assets Sold or Held for Sale (Narrative) (Detail 1) Details 45 false false R46.htm 046 - Disclosure - DIRECT FINANCING LEASES (Detail) Sheet http://www.omegahealthcare.com/role/DIRECTFINANCINGLEASESDetail DIRECT FINANCING LEASES (Detail) Details http://www.omegahealthcare.com/role/DIRECTFINANCINGLEASESTables 46 false false R47.htm 047 - Disclosure - DIRECT FINANCING LEASES (Detail 1) Sheet http://www.omegahealthcare.com/role/DIRECTFINANCINGLEASESDetail1 DIRECT FINANCING LEASES (Detail 1) Details http://www.omegahealthcare.com/role/DIRECTFINANCINGLEASESTables 47 false false R48.htm 048 - Disclosure - DIRECT FINANCING LEASES (Narrative) (Detail) Sheet http://www.omegahealthcare.com/role/DirectFinancingLeasesNarrativeDetail DIRECT FINANCING LEASES (Narrative) (Detail) Details http://www.omegahealthcare.com/role/DIRECTFINANCINGLEASESTables 48 false false R49.htm 049 - Disclosure - MORTGAGE NOTES RECEIVABLE (Details) Notes http://www.omegahealthcare.com/role/MortgageNotesReceivableDetails MORTGAGE NOTES RECEIVABLE (Details) Details http://www.omegahealthcare.com/role/MORTGAGENOTESRECEIVABLETables 49 false false R50.htm 050 - Disclosure - MORTGAGE NOTES RECEIVABLE (Parentheticals) (Details) Notes http://www.omegahealthcare.com/role/MORTGAGENOTESRECEIVABLEParentheticalsDetails MORTGAGE NOTES RECEIVABLE (Parentheticals) (Details) Details http://www.omegahealthcare.com/role/MORTGAGENOTESRECEIVABLETables 50 false false R51.htm 051 - Disclosure - MORTGAGE NOTES RECEIVABLE (Narrative) (Detail) Notes http://www.omegahealthcare.com/role/MortgageNotesReceivableNarrativeDetail MORTGAGE NOTES RECEIVABLE (Narrative) (Detail) Details http://www.omegahealthcare.com/role/MORTGAGENOTESRECEIVABLETables 51 false false R52.htm 052 - Disclosure - OTHER INVESTMENTS (Details) Sheet http://www.omegahealthcare.com/role/OtherInvestmentsDetails OTHER INVESTMENTS (Details) Details http://www.omegahealthcare.com/role/OTHERINVESTMENTSTables 52 false false R53.htm 053 - Disclosure - OTHER INVESTMENTS (Parentheticals) (Details) Sheet http://www.omegahealthcare.com/role/OtherInvestmentsParentheticalsDetails OTHER INVESTMENTS (Parentheticals) (Details) Details http://www.omegahealthcare.com/role/OTHERINVESTMENTSTables 53 false false R54.htm 054 - Disclosure - INVESTMENT IN UNCONSOLIDATED JOINT VENTURE (Details) Sheet http://www.omegahealthcare.com/role/INVESTMENTINUNCONSOLIDATEDJOINTVENTUREDetails INVESTMENT IN UNCONSOLIDATED JOINT VENTURE (Details) Details http://www.omegahealthcare.com/role/InvestmentInUnconsolidatedJointVenture 54 false false R55.htm 055 - Disclosure - ASSETS HELD FOR SALE (Details) Sheet http://www.omegahealthcare.com/role/ASSETSHELDFORSALEDetails ASSETS HELD FOR SALE (Details) Details http://www.omegahealthcare.com/role/ASSETSHELDFORSALETables 55 false false R56.htm 056 - Disclosure - ASSETS HELD FOR SALE (Parentheticals) (Details) Sheet http://www.omegahealthcare.com/role/AssetsHeldForSaleNarrativeDetail ASSETS HELD FOR SALE (Parentheticals) (Details) Details http://www.omegahealthcare.com/role/ASSETSHELDFORSALETables 56 false false R57.htm 057 - Disclosure - INTANGIBLES - Summary of our intangibles (Details) Sheet http://www.omegahealthcare.com/role/IntangiblesSummaryOfOurIntangiblesDetails INTANGIBLES - Summary of our intangibles (Details) Details 57 false false R58.htm 058 - Disclosure - INTANGIBLES - Reconciliation of goodwill (Details 1) Sheet http://www.omegahealthcare.com/role/IntangiblesReconciliationOfGoodwillDetails1 INTANGIBLES - Reconciliation of goodwill (Details 1) Details 58 false false R59.htm 059 - Disclosure - INTANGIBLES (Narrative) (Detail) Sheet http://www.omegahealthcare.com/role/IntangiblesNarrativeDetail INTANGIBLES (Narrative) (Detail) Details http://www.omegahealthcare.com/role/INTANGIBLESTables 59 false false R60.htm 060 - Disclosure - INTANGIBLES (Narrative) (Detail 1) Sheet http://www.omegahealthcare.com/role/IntangiblesNarrativeDetail1 INTANGIBLES (Narrative) (Detail 1) Details http://www.omegahealthcare.com/role/INTANGIBLESTables 60 false false R61.htm 061 - Disclosure - CONCENTRATION OF RISK (Narrative) (Detail) Sheet http://www.omegahealthcare.com/role/ConcentrationOfRiskNarrativeDetail CONCENTRATION OF RISK (Narrative) (Detail) Details http://www.omegahealthcare.com/role/ConcentrationOfRisk 61 false false R62.htm 062 - Disclosure - STOCKHOLDERS'/OWNERS' EQUITY (Details) Sheet http://www.omegahealthcare.com/role/STOCKHOLDERSOWNERSEQUITYDetails STOCKHOLDERS'/OWNERS' EQUITY (Details) Details http://www.omegahealthcare.com/role/STOCKHOLDERSOWNERSEQUITYTables 62 false false R63.htm 063 - Disclosure - STOCKHOLDERS'/OWNERS' EQUITY (Narrative) (Detail) Sheet http://www.omegahealthcare.com/role/STOCKHOLDERSOWNERSEQUITYNarrativeDetail STOCKHOLDERS'/OWNERS' EQUITY (Narrative) (Detail) Details http://www.omegahealthcare.com/role/STOCKHOLDERSOWNERSEQUITYTables 63 false false R64.htm 064 - Disclosure - TAXES (Narrative) (Detail) Sheet http://www.omegahealthcare.com/role/TaxesNarrativeDetail TAXES (Narrative) (Detail) Details http://www.omegahealthcare.com/role/Taxes 64 false false R65.htm 065 - Disclosure - STOCK-BASED COMPENSATION (Details) Sheet http://www.omegahealthcare.com/role/StockBasedCompensationDetails STOCK-BASED COMPENSATION (Details) Details http://www.omegahealthcare.com/role/STOCKBASEDCOMPENSATIONTables 65 false false R66.htm 066 - Disclosure - STOCK-BASED COMPENSATION (Details 1) Sheet http://www.omegahealthcare.com/role/StockBasedCompensationDetails1 STOCK-BASED COMPENSATION (Details 1) Details http://www.omegahealthcare.com/role/STOCKBASEDCOMPENSATIONTables 66 false false R67.htm 067 - Disclosure - STOCK-BASED COMPENSATION (Narrative) (Detail) Sheet http://www.omegahealthcare.com/role/Stockbasedcompensationnarrativedetail STOCK-BASED COMPENSATION (Narrative) (Detail) Details http://www.omegahealthcare.com/role/STOCKBASEDCOMPENSATIONTables 67 false false R68.htm 068 - Disclosure - BORROWING ACTIVITIES AND ARRANGEMENTS (Details) Sheet http://www.omegahealthcare.com/role/BORROWINGACTIVITIESANDARRANGEMENTSDetails BORROWING ACTIVITIES AND ARRANGEMENTS (Details) Details http://www.omegahealthcare.com/role/BorrowingActivitiesAndArrangementsTables 68 false false R69.htm 069 - Disclosure - BORROWING ACTIVITIES AND ARRANGEMENTS (Parentheticals) (Details) Sheet http://www.omegahealthcare.com/role/BorrowingActivitiesAndArrangementsParentheticalsDetails BORROWING ACTIVITIES AND ARRANGEMENTS (Parentheticals) (Details) Details http://www.omegahealthcare.com/role/BorrowingActivitiesAndArrangementsTables 69 false false R70.htm 070 - Disclosure - BORROWING ACTIVITIES AND ARRANGEMENTS (Narrative) (Detail) Sheet http://www.omegahealthcare.com/role/BorrowingActivitiesAndArrangementsNarrativeDetail BORROWING ACTIVITIES AND ARRANGEMENTS (Narrative) (Detail) Details http://www.omegahealthcare.com/role/BorrowingActivitiesAndArrangementsTables 70 false false R71.htm 071 - Disclosure - BORROWING ACTIVITIES AND ARRANGEMENTS (Narrative) (Detail 1) Sheet http://www.omegahealthcare.com/role/BorrowingActivitiesAndArrangementsNarrativeDetail1 BORROWING ACTIVITIES AND ARRANGEMENTS (Narrative) (Detail 1) Details http://www.omegahealthcare.com/role/BorrowingActivitiesAndArrangementsTables 71 false false R72.htm 072 - Disclosure - FINANCIAL INSTRUMENTS (Detail) Sheet http://www.omegahealthcare.com/role/FinancialInstrumentsDetail FINANCIAL INSTRUMENTS (Detail) Details http://www.omegahealthcare.com/role/FINANCIALINSTRUMENTSTables 72 false false R73.htm 073 - Disclosure - FINANCIAL INSTRUMENTS (Parentheticals) (Detail) Sheet http://www.omegahealthcare.com/role/Financialinstrumentsparentheticalsdetail FINANCIAL INSTRUMENTS (Parentheticals) (Detail) Details http://www.omegahealthcare.com/role/FINANCIALINSTRUMENTSTables 73 false false R74.htm 074 - Disclosure - EARNINGS PER SHARE/UNIT - Computation of basic and diluted earnings per share (Detail) Sheet http://www.omegahealthcare.com/role/EarningsPerShareComputationOfBasicAndDilutedEarningsPerShareDetail EARNINGS PER SHARE/UNIT - Computation of basic and diluted earnings per share (Detail) Details 74 false false All Reports Book All Reports ohi-20170630.xml ohi-20170630.xsd ohi-20170630_cal.xml ohi-20170630_def.xml ohi-20170630_lab.xml ohi-20170630_pre.xml true true ZIP 112 0001571049-17-007311-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001571049-17-007311-xbrl.zip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